<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003543.pub4" GROUP_ID="EPOC" ID="811301112309245637" MERGED_FROM="" MODIFIED="2017-02-21 19:38:49 +0000" MODIFIED_BY="Julia Worswick" REVIEW_NO="0001" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="12.0">
<COVER_SHEET MODIFIED="2017-02-21 14:24:39 -0500" MODIFIED_BY="Julia Worswick">
<TITLE MODIFIED="2016-06-06 02:16:57 -0400" MODIFIED_BY="[Empty name]">Interventions to improve antibiotic prescribing practices for hospital inpatients</TITLE>
<CONTACT>
<PERSON ID="13439" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Davey</LAST_NAME>
<SUFFIX/>
<POSITION>Lead Clinician for Clinical Quality Improvement</POSITION>
<EMAIL_1>p.g.davey@dundee.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Population Health Sciences</DEPARTMENT>
<ORGANISATION>University of Dundee</ORGANISATION>
<ADDRESS_1>Mackenzie Building</ADDRESS_1>
<ADDRESS_2>Kirsty Semple Way</ADDRESS_2>
<CITY>Dundee</CITY>
<ZIP>DD2 4BF</ZIP>
<REGION>Scotland</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>01382 420000</PHONE_1>
<PHONE_2/>
<FAX_1>01382 420010</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2017-02-21 14:24:39 -0500" MODIFIED_BY="Julia Worswick">
<PERSON ID="13439" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Davey</LAST_NAME>
<SUFFIX/>
<POSITION>Lead Clinician for Clinical Quality Improvement</POSITION>
<EMAIL_1>p.g.davey@dundee.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Population Health Sciences</DEPARTMENT>
<ORGANISATION>University of Dundee</ORGANISATION>
<ADDRESS_1>Mackenzie Building</ADDRESS_1>
<ADDRESS_2>Kirsty Semple Way</ADDRESS_2>
<CITY>Dundee</CITY>
<ZIP>DD2 4BF</ZIP>
<REGION>Scotland</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>01382 420000</PHONE_1>
<PHONE_2/>
<FAX_1>01382 420010</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="z1305270126406196301865691138867" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Charis</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Marwick</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Clinical Lecturer</POSITION>
<EMAIL_1>c.z.marwick@dundee.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Population Health Sciences Division, Medical Research Institute</DEPARTMENT>
<ORGANISATION>University of Dundee</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Dundee</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 1382 383786</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="z1309251007550791702239366202488" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Claire</FIRST_NAME>
<MIDDLE_INITIALS>L</MIDDLE_INITIALS>
<LAST_NAME>Scott</LAST_NAME>
<SUFFIX/>
<POSITION>Specialist Research Lead</POSITION>
<EMAIL_1>claire.scott@nes.scot.nhs.uk</EMAIL_1>
<EMAIL_2>c.y.peden@dundee.ac.uk</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Scottish Dental Clinical Effectiveness Programme</DEPARTMENT>
<ORGANISATION>NHS Education for Scotland</ORGANISATION>
<ADDRESS_1>Dundee Dental Education Centre</ADDRESS_1>
<ADDRESS_2>Small's Wynd</ADDRESS_2>
<CITY>Dundee</CITY>
<ZIP>DD1 4HN</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 (0)1382740958</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="65426295920731377561120209201028" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Esmita</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Charani</LAST_NAME>
<SUFFIX/>
<POSITION>Academic Research Pharmacist</POSITION>
<EMAIL_1>e.charani@imperial.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance</DEPARTMENT>
<ORGANISATION>Imperial College London</ORGANISATION>
<ADDRESS_1>Du Cane Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP>W12 OHS</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 79 58 31 7570</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="z1511041510359723012452394381543" ROLE="AUTHOR">
<PREFIX>Miss</PREFIX>
<FIRST_NAME>Kirsty</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>McNeil</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>k.mcneil@dundee.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Medicine</DEPARTMENT>
<ORGANISATION>University of Dundee</ORGANISATION>
<ADDRESS_1>147 Forth Crescent</ADDRESS_1>
<ADDRESS_2/>
<CITY>Dundee</CITY>
<ZIP>DD2 4JA</ZIP>
<REGION>Scotland</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>07817724104</PHONE_1>
<PHONE_2>01382 665700</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="13429" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Erwin</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Brown</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>erwinbrown31@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>No affiliation</ORGANISATION>
<ADDRESS_1>31 Park Crescent</ADDRESS_1>
<ADDRESS_2>Frenchay</ADDRESS_2>
<CITY>Bristol</CITY>
<ZIP>BS16 1NZ</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 117 956 6090</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="ABDD532682E26AA2014A5594F13927A2" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Ian</FIRST_NAME>
<MIDDLE_INITIALS>M</MIDDLE_INITIALS>
<LAST_NAME>Gould</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>i.m.gould@abdn.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Medical Microbiology</DEPARTMENT>
<ORGANISATION>Aberdeen Royal Infirmary</ORGANISATION>
<ADDRESS_1>Foresterhill</ADDRESS_1>
<ADDRESS_2/>
<CITY>Aberdeen</CITY>
<ZIP>AB25 2ZN</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>01224 840 688</PHONE_1>
<PHONE_2/>
<FAX_1>01224 840 632</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="13495" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Craig</FIRST_NAME>
<MIDDLE_INITIALS>R</MIDDLE_INITIALS>
<LAST_NAME>Ramsay</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Statistician</POSITION>
<EMAIL_1>c.r.ramsay@abdn.ac.uk</EMAIL_1>
<EMAIL_2>crramsay@ohri.ca</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Health Services Research Unit, Division of Applied Health Sciences</DEPARTMENT>
<ORGANISATION>University of Aberdeen</ORGANISATION>
<ADDRESS_1>Polwarth Building</ADDRESS_1>
<ADDRESS_2>Foresterhill</ADDRESS_2>
<CITY>Aberdeen</CITY>
<ZIP>AB25 2ZD</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 1224 558994</PHONE_1>
<PHONE_2/>
<FAX_1>+44 1224 554580</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="54302436044863118060090910123915" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Susan</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Michie</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of Health Psychology</POSITION>
<EMAIL_1>s.michie@ucl.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Research Department of Primary Care and Population Health</DEPARTMENT>
<ORGANISATION>University College London</ORGANISATION>
<ADDRESS_1>Upper Floor 3, Royal Free Hospital</ADDRESS_1>
<ADDRESS_2>Rowland Hill Street</ADDRESS_2>
<CITY>London</CITY>
<ZIP>NW3 2PF</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 20 7679 5930</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2017-02-15 04:10:48 -0500" MODIFIED_BY="Charis Marwick">
<UP_TO_DATE>
<DATE DAY="19" MONTH="1" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="19" MONTH="1" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="7" MONTH="2" YEAR="2019"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2002"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2005"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2017"/>
</DATES>
<WHATS_NEW MODIFIED="2017-02-20 11:59:59 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2017-02-20 11:59:59 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="20" MONTH="2" YEAR="2017"/>
<DESCRIPTION>
<P>The review has been amendment with a correction to the technical settings of the primary analysis.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2017-02-20 11:58:58 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2017-02-20 11:58:58 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="19" MONTH="1" YEAR="2015"/>
<DESCRIPTION>
<P>The addition of new data to the review has strengthened the conclusions regarding the effect on antibiotic prescribing and mortality. The review shows that there is a reduction in length of hospital stay. </P>
<P>The review now has identified that interventions are consistently more effective if they contain enabling components, which provide advice or feedback to help physicians make more informed decisions about their prescribing. However only 10% of interventions used the most effective enabling techniques: goal setting, feedback and action planning.</P>
<P>Given the high certainty of evidence for our primary outcome we believe that additional trials comparing antibiotic stewardship with no intervention are unlikely to change our conclusions or build on our understanding of the current evidence.</P>
<P>This review includes 221 studies.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-02-20 11:58:53 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="19" MONTH="1" YEAR="2015"/>
<DESCRIPTION>
<P>New searches performed to January 2015 and 132 new studies have been included in the review.</P>
<P>New authors: Charis Marwick, Kirsty McNeil, Claire Scott, replacing Lynda Fenelon, Alison Holmes, Phil Wiffen, and Mark Wilcox.</P>
<P>Important changes to the methods are inclusion of case control, cohort, or qualitative studies of unintended consequences, new data extraction forms to identify behaviour change techniques in the interventions, and a prespecified subgroup analysis and meta-regression by behaviour change technique.</P>
<P>Cluster non-randomised controlled trials and randomised controlled trials (RCTs) with fewer than 2 intervention or control sites have been excluded, including 1 non-randomised controlled trial from the previous version of the review.</P>
<P>Results updated, 'Characteristics of included studies' and 'Characteristics of excluded studies' tables re-written and updated to end of December 2014. Meta-analysis of RCTs completed prior to meta-regression of RCTs and interrupted time series studies.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2017-01-08 07:54:06 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="22" MONTH="11" YEAR="2014"/>
<DESCRIPTION>
<P>Major edits in preparation for next update, 'Characteristics of included studies' table re-written and updated to end of December 2012.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2017-01-08 07:54:08 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="5" YEAR="2014"/>
<DESCRIPTION>
<P>Protocol completely revised.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-05-01 11:34:08 -0400" MODIFIED_BY="Alain Mayhew">
<DATE DAY="26" MONTH="2" YEAR="2013"/>
<DESCRIPTION>
<P>New search, 89 studies found.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2013-05-01 11:34:04 -0400" MODIFIED_BY="Alain Mayhew">
<DATE DAY="26" MONTH="2" YEAR="2013"/>
<DESCRIPTION>
<P>New search, 89 new studies found.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2017-01-08 07:54:16 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="12" MONTH="2" YEAR="2009"/>
<DESCRIPTION>
<P>Minor edits, tables modified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-02-12 13:27:32 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="29" MONTH="7" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="28" MONTH="7" YEAR="2005"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2016-06-28 04:26:40 -0400" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2016-06-28 04:26:40 -0400" MODIFIED_BY="[Empty name]">
<SOURCE>
<NAME>Aberdeen Royal Infirmary, Aberdeen, Scotland</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Imperial College, London, England</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>University of Dundee, Dundee, Scotland</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2016-06-28 04:26:04 -0400" MODIFIED_BY="[Empty name]">
<NAME>University of Aberdeen</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2016-06-28 04:26:04 -0400" MODIFIED_BY="[Empty name]">
<NAME>UK Cochrane Centre</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2016-06-28 04:26:40 -0400" MODIFIED_BY="[Empty name]">
<NAME>University College London</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2016-06-28 04:22:01 -0400" MODIFIED_BY="[Empty name]">
<SOURCE>
<NAME>British Society for Antimicrobial Chemotherapy</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2016-06-28 04:22:01 -0400" MODIFIED_BY="[Empty name]">
<NAME>Chief Scientist Office for Scotland</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>Major grant CZH4861</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2017-02-21 14:29:39 -0500" MODIFIED_BY="Julia Worswick">
<SUMMARY MODIFIED="2017-02-21 14:26:25 -0500" MODIFIED_BY="Julia Worswick">
<TITLE MODIFIED="2017-01-08 08:02:03 -0500" MODIFIED_BY="[Empty name]">Improving how physicians working in hospital settings prescribe antibiotics</TITLE>
<SUMMARY_BODY MODIFIED="2017-02-21 14:26:25 -0500" MODIFIED_BY="Julia Worswick">
<P>
<B>Review aim</B>
</P>
<P>The aim of this Cochrane review was to learn of ways to improve how physicians working in hospital settings prescribe antibiotics. We collected and analysed all relevant studies to answer this question and found 221 studies.</P>
<P>
<B>Key messages</B>
</P>
<P>The use of an antibiotic policy leads to improved prescribing practices and decreases in the duration of antibiotic treatment.</P>
<P>Interventions that are directed to physicians to improve their antibiotic prescribing practices reduced participant length of stay in hospitals by 1.12 days (based on findings from 15 studies) and did not increase the risk of death (based on findings from 29 studies). Interventions providing advice or feedback to physicians were more effective in improving prescribing practices than those interventions that did not provide this information to physicians. Evidence from seven studies raised concerns that with interventions applying rules to make physicians prescribe properly there were delays in treatment and a breakdown in trust between infection specialists and clinical teams.</P>
<P>
<B>What was studied in the review?</B>
</P>
<P>Antibiotics are used to treat bacterial infections such as pneumonia. Many bacteria have become resistant to antibiotics over time. Antibiotic resistance is a serious problem for patients and healthcare systems because infections caused by antibiotic-resistant bacteria can lead to higher rates of death and longer hospital stays. Bacterial resistance often occurs because antibiotics are used when they are not needed. Studies have shown that in about half of cases physicians in hospital are not prescribing antibiotics properly.</P>
<P>We investigated the effectiveness and safety of interventions to help physicians prescribe antibiotics properly and what techniques of behaviour change could influence the success of the interventions.</P>
<P>
<B>Key results</B>
</P>
<P>We found 221 relevant studies. Ninety-six studies were from North America. The remaining 125 studies were from Europe (87), Asia (19), South America (8), Australia (8), and East Asia (3). The studies tested interventions that fell broadly into two categories: restrictive techniques, which apply rules to make physicians prescribe properly, and enablement techniques, which provide advice or feedback to help physicians prescribe properly.</P>
<P>We found high-certainty evidence that interventions lead to more hospital inpatients receiving the appropriate treatment for their condition according to antibiotic prescribing policies. We found moderate-certainty evidence that interventions reduce the length of hospital stay without increasing patient deaths. Both restriction and enabling techniques were successful in achieving effectiveness of the intervention. We do not need more studies to answer the question of whether these interventions reduce unnecessary antibiotic use, but we do need more research to understand the unintended consequences of the use of restrictive interventions.</P>
<P>Interventions were successful in safely reducing unnecessary antibiotic use in hospitals, despite the fact that the majority did not use a widely adopted behaviour change technique, which is to audit and provide feedback on performance. Effective communication of the review results could have considerable health service and policy impact.</P>
<P>
<B>How up-to-date is the review?</B>
</P>
<P>We searched for studies published up to January 2015.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2017-01-24 14:02:51 -0500" MODIFIED_BY="Julia Worswick">
<ABS_BACKGROUND MODIFIED="2017-01-09 10:10:20 -0500" MODIFIED_BY="Julia Worswick">
<P>Antibiotic resistance is a major public health problem. Infections caused by multidrug-resistant bacteria are associated with prolonged hospital stay and death compared with infections caused by susceptible bacteria. Appropriate antibiotic use in hospitals should ensure effective treatment of patients with infection and reduce unnecessary prescriptions. We updated this systematic review to evaluate the impact of interventions to improve antibiotic prescribing to hospital inpatients.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2016-12-29 21:41:56 -0500" MODIFIED_BY="[Empty name]">
<P>To estimate the effectiveness and safety of interventions to improve antibiotic prescribing to hospital inpatients and to investigate the effect of two intervention functions: restriction and enablement.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2017-01-24 13:46:42 -0500" MODIFIED_BY="Julia Worswick">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library), MEDLINE, and Embase. We searched for additional studies using the bibliographies of included articles and personal files. The last search from which records were evaluated and any studies identified incorporated into the review was January 2015. </P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2017-01-18 09:08:00 -0500" MODIFIED_BY="Julia Worswick">
<P>We included randomised controlled trials (RCTs) and non-randomised studies (NRS). We included three non-randomised study designs to measure behavioural and clinical outcomes and analyse variation in the effects: non- randomised trials (NRT), controlled before-after (CBA) studies and interrupted time series (ITS) studies. For this update we also included three additional NRS designs (case control, cohort, and qualitative studies) to identify unintended consequences. Interventions included any professional or structural interventions as defined by the Cochrane Effective Practice and Organisation of Care Group. We defined restriction as 'using rules to reduce the opportunity to engage in the target behaviour (or increase the target behaviour by reducing the opportunity to engage in competing behaviours)'. We defined enablement as 'increasing means/reducing barriers to increase capability or opportunity'. The main comparison was between intervention and no intervention.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2016-12-29 21:51:18 -0500" MODIFIED_BY="[Empty name]">
<P>Two review authors extracted data and assessed study risk of bias. We performed meta-analysis and meta-regression of RCTs and meta-regression of ITS studies. We classified behaviour change functions for all interventions in the review, including those studies in the previously published versions. We analysed dichotomous data with a risk difference (RD). We assessed certainty of evidence with GRADE criteria.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2017-01-24 14:02:51 -0500" MODIFIED_BY="Julia Worswick">
<P>This review includes 221 studies (58 RCTs, and 163 NRS). Most studies were from North America (96) or Europe (87). The remaining studies were from Asia (19), South America (8), Australia (8), and the East Asia (3). Although 62% of RCTs were at a high risk of bias, the results for the main review outcomes were similar when we restricted the analysis to studies at low risk of bias.</P>
<P>More hospital inpatients were treated according to antibiotic prescribing policy with the intervention compared with no intervention based on 29 RCTs of predominantly enablement interventions (RD 15%, 95% confidence interval (CI) 14% to 16%; 23,394 participants; high-certainty evidence). This represents an increase from 43% to 58% .There were high levels of heterogeneity of effect size but the direction consistently favoured intervention.</P>
<P>The duration of antibiotic treatment decreased by 1.95 days (95% CI 2.22 to 1.67; 14 RCTs; 3318 participants; high-certainty evidence) from 11.0 days. Information from non-randomised studies showed interventions to be associated with improvement in prescribing according to antibiotic policy in routine clinical practice, with 70% of interventions being hospital-wide compared with 31% for RCTs. The risk of death was similar between intervention and control groups (11% in both arms), indicating that antibiotic use can likely be reduced without adversely affecting mortality (RD 0%, 95% CI -1% to 0%; 28 RCTs; 15,827 participants; moderate-certainty evidence). Antibiotic stewardship interventions probably reduce length of stay by 1.12 days (95% CI 0.7 to 1.54 days; 15 RCTs; 3834 participants; moderate-certainty evidence). One RCT and six NRS raised concerns that restrictive interventions may lead to delay in treatment and negative professional culture because of breakdown in communication and trust between infection specialists and clinical teams (low-certainty evidence).</P>
<P>Both enablement and restriction were independently associated with increased compliance with antibiotic policies, and enablement enhanced the effect of restrictive interventions (high-certainty evidence). Enabling interventions that included feedback were probably more effective than those that did not (moderate-certainty evidence).</P>
<P>There was very low-certainty evidence about the effect of the interventions on reducing <I>Clostridium difficile</I> infections (median -48.6%, interquartile range -80.7% to -19.2%; 7 studies). This was also the case for resistant gram-negative bacteria (median -12.9%, interquartile range -35.3% to 25.2%; 11 studies) and resistant gram-positive bacteria (median -19.3%, interquartile range -50.1% to +23.1%; 9 studies). There was too much variance in microbial outcomes to reliably assess the effect of change in antibiotic use.</P>
<P>
<B>Heterogeneity of intervention effect on prescribing outcomes</B>
</P>
<P>We analysed effect modifiers in 29 RCTs and 91 ITS studies. Enablement and restriction were independently associated with a larger effect size (high-certainty evidence). Feedback was included in 4 (17%) of 23 RCTs and 20 (47%) of 43 ITS studies of enabling interventions and was associated with greater intervention effect. Enablement was included in 13 (45%) of 29 ITS studies with restrictive interventions and enhanced intervention effect.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2016-12-29 22:15:28 -0500" MODIFIED_BY="[Empty name]">
<P>We found high-certainty evidence that interventions are effective in increasing compliance with antibiotic policy and reducing duration of antibiotic treatment. Lower use of antibiotics probably does not increase mortality and likely reduces length of stay. Additional trials comparing antibiotic stewardship with no intervention are unlikely to change our conclusions. Enablement consistently increased the effect of interventions, including those with a restrictive component. Although feedback further increased intervention effect, it was used in only a minority of enabling interventions. Interventions were successful in safely reducing unnecessary antibiotic use in hospitals, despite the fact that the majority did not use the most effective behaviour change techniques. Consequently, effective dissemination of our findings could have considerable health service and policy impact. Future research should instead focus on targeting treatment and assessing other measures of patient safety, assess different stewardship interventions, and explore the barriers and facilitators to implementation. More research is required on unintended consequences of restrictive interventions.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2017-02-21 14:29:39 -0500" MODIFIED_BY="Julia Worswick">
<BACKGROUND MODIFIED="2017-01-27 08:39:00 -0500" MODIFIED_BY="Julia Worswick">
<CONDITION MODIFIED="2016-12-29 22:54:29 -0500" MODIFIED_BY="[Empty name]">
<P>Antibiotic resistance is a major public health problem. In comparison with infections caused by susceptible bacteria, those caused by multidrug-resistant bacteria are associated with higher incidences of mortality and prolonged hospital stay (<LINK REF="REF-de-Kraker-2011" TYPE="REFERENCE">de Kraker 2011</LINK>). <I>Clostridium difficile </I>infection (CDI) is another manifestation of the collateral damage caused by antimicrobial prescribing (<LINK REF="REF-Davey-2010" TYPE="REFERENCE">Davey 2010</LINK>). Such infections are also associated with increased costs resulting from the need to use more expensive antibiotics, prolonged hospital stay (the principal contributor), and expenses related to screening and surveillance, eradication regimens, and consumables (the gloves, gowns, and aprons used to prevent cross-infection) (<LINK REF="REF-de-Kraker-2011" TYPE="REFERENCE">de Kraker 2011</LINK>). The UK 5 Year Antimicrobial Resistance Strategy 2013 to 2018 recognises the importance of reducing inappropriate antibiotic prescribing (<LINK REF="REF-Department-of-Health-2013" TYPE="REFERENCE">Department of Health 2013</LINK>), the implication being that antibiotic resistance is largely a consequence of the selective pressures of antibiotic usage, and that reducing these pressures by the judicious administration of antibiotics will facilitate a return of susceptible bacteria or, at least, will prevent or slow the pace of the emergence of resistant strains.</P>
<P>At the same time, sepsis is a major cause of avoidable mortality in hospitals, with an estimated 100,000 cases per year in the UK alone (<LINK REF="REF-NCEPOD-2015" TYPE="REFERENCE">NCEPOD 2015</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2017-01-18 09:24:50 -0500" MODIFIED_BY="Julia Worswick">
<P>We included any intervention to improve antibiotic prescribing to hospital inpatients. Antibiotic stewardship has two aims: first, to ensure effective treatment of patients with infection, and second, to minimise collateral damage from antimicrobial use (<LINK REF="REF-Davey-2010" TYPE="REFERENCE">Davey 2010</LINK>). Hence the UK Department of Health's Guidance on Antimicrobial Stewardship emphasises the need for urgent treatment of serious infections in addition to minimising unnecessary use of antibiotics (<LINK REF="REF-Department-of-Health-2013" TYPE="REFERENCE">Department of Health 2013</LINK>). We compared interventions to change professional behaviour with standard practice (no intervention). We classified interventions by their intervention function (<LINK REF="REF-Michie-2011" TYPE="REFERENCE">Michie 2011</LINK>). The previous version of this review suggested that restrictive interventions had greater immediate effect on prescribing than interventions that used education or persuasion (<LINK REF="REF-Davey-2013" TYPE="REFERENCE">Davey 2013</LINK>). For this update, we identified interventions that were designed to increase enablement, defined as 'increasing means/reducing barriers to increase capability or opportunity' (<LINK REF="REF-Michie-2011" TYPE="REFERENCE">Michie 2011</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2017-01-27 08:39:00 -0500" MODIFIED_BY="Julia Worswick">
<P>In this update of the review we used new data extraction sheets to classify the intervention functions and to identify the behaviour change functions that are used in antimicrobial stewardship interventions (<LINK REF="REF-Michie-2013" TYPE="REFERENCE">Michie 2013</LINK>). In particular, we assessed the relative effectiveness of interventions according to how they used enablement and restriction to change behaviour (<LINK REF="REF-Michie-2011" TYPE="REFERENCE">Michie 2011</LINK>). We divided the interventions into four groups: enablement without restriction; restriction without enablement; both enablement and restriction; and neither enablement nor restriction.</P>
</THEORY>
<IMPORTANCE MODIFIED="2016-06-25 02:12:59 -0400" MODIFIED_BY="[Empty name]">
<P>This review is an update of <LINK REF="REF-Davey-2005" TYPE="REFERENCE">Davey 2005</LINK> and <LINK REF="REF-Davey-2013" TYPE="REFERENCE">Davey 2013</LINK>. It complements a review of interventions to improve prescribing of antibiotics to patients in ambulatory care (<LINK REF="REF-Arnold-2005" TYPE="REFERENCE">Arnold 2005</LINK>).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2016-12-29 23:04:09 -0500" MODIFIED_BY="[Empty name]">
<P>To estimate the effectiveness and safety of interventions to improve antibiotic prescribing to hospital inpatients and investigate the effect of two intervention functions: restriction and enablement.</P>
</OBJECTIVES>
<METHODS MODIFIED="2017-01-31 09:07:59 -0500" MODIFIED_BY="Petrer Davey">
<SELECTION_CRITERIA MODIFIED="2017-01-18 13:28:13 -0500" MODIFIED_BY="Julia Worswick">
<CRIT_STUDIES MODIFIED="2017-01-18 13:28:13 -0500" MODIFIED_BY="Julia Worswick">
<P>We included randomised controlled trials (RCTs) and non-randomised studies (NRS). We included three NRS study designs to measure behavioural and clinical outcomes and analyse variation in the effects: non-randomised trials (NRT), controlled before-after (CBA) studies and interrupted time series (ITS) studies. We used Cochrane Effective Practice and Organisation of Care (EPOC) Group eligibility guidance for CBAs and NRTs (<LINK REF="REF-EPOC-2016" TYPE="REFERENCE">EPOC 2016</LINK>). In addition, for the assessment of unintended consequences, we included three additional NRS designs (case control, cohort, and qualitative studies) to identify additional evidence about long-term effects and harms of interventions in order to enhance the directness of evidence from RCTs (<LINK REF="REF-Sch_x00fc_nemann-2013" TYPE="REFERENCE">Schünemann 2013</LINK>).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2016-12-29 23:10:21 -0500" MODIFIED_BY="[Empty name]">
<P>Healthcare professionals who prescribe antibiotics to hospital inpatients receiving acute care (including elective inpatient surgery). We excluded interventions targeted at residents in nursing homes or other long-term healthcare settings.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2016-12-29 23:17:09 -0500" MODIFIED_BY="[Empty name]">
<P>We included interventions relevant to improving antibiotic prescribing as outlined in the EPOC taxonomy (<LINK REF="REF-EPOC-2015" TYPE="REFERENCE">EPOC 2015</LINK>).</P>
<OL>
<LI>Audit and feedback defined as any summary of clinical performance of health care over a specified period of time.</LI>
<LI>Education through meetings or distribution of educational materials.</LI>
<LI>Educational outreach through academic detailing or review of individual patients with recommendation for change.</LI>
<LI>Reminders provided verbally, on paper, in the workplace environment (e.g. posters or messages printed on equipment) or on computer.</LI>
<LI>Structural: the influence on antibiotic prescribing of changing from paper to computerised records and of the introduction of new technology for rapid microbiology testing or measurement of inflammatory markers.</LI>
</OL>
<P>In addition, we included the following restrictive interventions: selective reporting of laboratory susceptibilities; formulary restriction; requiring prior authorisation (expert approval) therapeutic substitution; and automatic stop orders.</P>
<P>Enabling interventions were: audit and feedback; educational outreach through review of individual patients with recommendation for change; and circumstantial reminders that were targeted at doctors who were managing specific patients (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). We classified reminders in the form of posters or pocket cards summarising antibiotic policies as environmental restructuring but not as enabling (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). Terms used to describe interventions are described in more detail in the <LINK TAG="DATA_EXTRACTION" TYPE="SECTION">Data extraction and management</LINK> section.</P>
<P>We did not consider studies that compared the effectiveness of antibiotic treatments (e.g. intravenous versus oral administration of antibiotics) as eligible for this review.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2017-01-08 08:09:21 -0500" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2017-01-08 08:09:17 -0500" MODIFIED_BY="[Empty name]">
<P>The effect of interventions on antibiotic prescribing measured as either compliance with antibiotic guidelines or policies, the duration of antibiotic treatment, decision to treat, or total duration of treatment. We included studies without reliable or adequate information addressing the primary outcome measure, but we did not use these studies in data synthesis.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2017-01-08 08:09:21 -0500" MODIFIED_BY="[Empty name]">
<P>Mortality, length of stay, or other clinical outcomes (e.g. surgical-site infection or acute kidney injury), microbial outcomes (CDI, colonisation or infection with antimicrobial-resistant bacteria), unintended-consequences measures (e.g. a delay in start of antibiotic treatment, a change in threshold for diagnosis of hospital-acquired infection to justify existing prescribing practice). Note that clinical outcomes could be indicators of improved clinical outcomes associated with interventions to increase effective antibiotic treatment, or unintended consequences (e.g. to provide evidence about the safety of interventions to reduce unnecessary antibiotic treatment).</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2017-01-24 14:08:01 -0500" MODIFIED_BY="Julia Worswick">
<ELECTRONIC_SEARCHES MODIFIED="2017-01-24 14:08:01 -0500" MODIFIED_BY="Julia Worswick">
<P>We searched the Cochrane Database of Systematic Reviews (CDSR) and the Database of Abstracts of Reviews of Effects (DARE) for related systematic reviews and the following databases for primary studies without language, publication year, or publication status restrictions in January 2015.</P>
<SUBSECTION>
<HEADING LEVEL="5">Databases</HEADING>
<UL>
<LI>Cochrane Central Register of Controlled Trials (CENTRAL; 2015, Issue 1) in the Cochrane Library (searched 22 January 2015)</LI>
<LI>MEDLINE (1946 to 19 January 2015) (OvidSP)</LI>
<LI>Embase (1947 to 22 January 2015) (OvidSP)</LI>
</UL>
<P>The MEDLINE search strategy was developed by the Cochrane EPOC Group Information Specialist in consultation with the review authors and translated for use in other databases employing appropriate syntax and vocabulary. Results were limited by two methodological filters: the Cochrane Highly Sensitive Search Strategy (sensitivity- and precision-maximising version, 2008 revision) to identify randomised trials (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>), and a Cochrane EPOC Group study design filter to identify NRS. Full search strategies are provided in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
</SUBSECTION>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2016-12-29 23:34:25 -0500" MODIFIED_BY="[Empty name]">
<P>We searched for additional studies using the bibliographies of included articles, personal files, and by contacting experts in the field regarding any unpublished work.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2017-01-31 09:07:59 -0500" MODIFIED_BY="Petrer Davey">
<STUDY_SELECTION MODIFIED="2017-01-17 02:27:28 -0500" MODIFIED_BY="Petrer Davey">
<P>Two review authors (EB and PD) independently reviewed citations and abstracts retrieved in the search to identify all reports that included original data about interventions to change antibiotic prescribing. If either review author had doubts about eligibility, then both review authors reviewed the full papers. The review authors were not blinded to study author or location. We resolved disagreements by discussion and consensus.</P>
<P>We excluded studies that had no relevant and interpretable data presented or obtainable. We defined 'relevant data' as an intervention that included a change in antibiotic treatment for hospital inpatients and where at least one of the study's reported outcomes was directly attributable to change in antibiotic treatment. We defined 'interpretable data' as follows: CBA, NRT, or RCT designs had to include sufficient data to estimate effect size as change in at least one relevant outcome after the intervention. Interrupted time series studies had to include a clearly defined intervention point.</P>
<P>We did not exclude studies due to high risk of bias.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2017-01-27 08:39:50 -0500" MODIFIED_BY="Julia Worswick">
<P>Working in pairs, five review authors (PD, CM, CS, EC, KM) independently performed data abstraction using data extraction sheets including information on: study design, type of intervention (intervention components and functions), presence of controls, type of targeted behaviour, participants, setting, methods (unit of allocation, unit of analysis, study power, methodological risk of bias, consumer involvement), outcomes, and results.</P>
<SUBSECTION>
<HEADING LEVEL="4">Explanation of terms used to describe interventions</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Restriction</HEADING>
<P>We defined restriction as 'using rules to reduce the opportunity to engage in the target behaviour (or increase the target behaviour by reducing the opportunity to engage in competing behaviours)'.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Enablement</HEADING>
<P>We defined enablement as 'increasing means/reducing barriers to increase capability or opportunity'.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Goal setting</HEADING>
<P>We documented the specific prescribing behaviour that was targeted by the intervention (e.g. switch participants from parenteral to oral antibiotics) and how this was incorporated into an aim for the intervention. Was the aim simply a directional change of the target behaviour (e.g. increase or decrease behaviour?), or did the intervention include a specific threshold to be reached (e.g. target behaviour performed more than 95% of the time) or the duration within which the target had to be achieved (e.g. more than 95% reliability within six months)? If the study reported a power calculation, we did not accept this as evidence of a specific threshold unless it was clearly communicated to the professionals who were the targets of the intervention. For example, a power calculation showing that the study could detect a 10% improvement in the targeted behaviour would have to be accompanied by some explicit statement about the intervention aim being at least 10% improvement.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Feedback</HEADING>
<P>We classified interventions as including feedback only if they provided a "summary of clinical performance of healthcare over a specified period of time" (<LINK REF="REF-EPOC-2015" TYPE="REFERENCE">EPOC 2015</LINK>). We found that some studies did not meet this definition, even though they described their intervention as including feedback in the title (e.g. <LINK REF="STD-Elligsen-2012" TYPE="STUDY">Elligsen 2012</LINK> and <LINK REF="STD-Newland-2012" TYPE="STUDY">Newland 2012</LINK>) or in the methods (e.g. <LINK REF="STD-Palmay-2014" TYPE="STUDY">Palmay 2014</LINK>). The intervention in these studies was educational outreach by review and recommended change, so the feedback was limited to the individual participants who were reviewed with no feedback about the treatment of other participants over time. In contrast, <LINK REF="STD-Buising-2008a" TYPE="STUDY">Buising 2008a</LINK> is an example of an intervention in which "a formal feedback was provided to units regarding their compliance with the approval system over time" in addition to review and recommend change for individual participants. For studies that met our definition of feedback, we recorded frequency, format (verbal, written, or both) and whether it was delivered by a colleague, supervisor, or somebody external to the clinical team.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Action planning</HEADING>
<P>We documented whether there was a reward for meeting a target, which could be material or social reward (either from self or others) and the use of action plans if the target was not met. Our definition of an action plan was: prompt, detailed planning of performance of the behaviour, which had to include at least one of context, frequency, duration, or intensity. If there was evidence of action planning, we recorded to whom the action plan was tailored (e.g. individual participant or group) and whether participants were involved in developing the action plan.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intervention components and functions</HEADING>
<P>In the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> we have listed the intervention components (<LINK TAG="CRIT_INTERVENTIONS" TYPE="SECTION">Types of interventions</LINK>) and the intervention functions (<LINK REF="REF-Michie-2011" TYPE="REFERENCE">Michie 2011</LINK>; <LINK REF="REF-Michie-2013" TYPE="REFERENCE">Michie 2013</LINK>). Note that each intervention component may have more than one intervention function. We have presented definitions of intervention functions and their relationship to intervention components in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Assessment of the impact of interventions</HEADING>
<P>We have used meta-analysis to assess the impact of RCTs of interventions and meta-regression to understand variation in effect estimates for RCTs and ITS studies.</P>
</SUBSECTION>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2017-01-31 09:07:59 -0500" MODIFIED_BY="Petrer Davey">
<P>We applied the 2013 EPOC 'Risk of bias' criteria to all papers in the review, including articles in the 2003 review (<LINK REF="REF-EPOC-2013" TYPE="REFERENCE">EPOC 2013</LINK>). We scored each study for risk of bias as 'low' if all criteria were scored as 'low', 'medium' if one or two criteria were scored as 'unclear' or 'high', and 'high' if more than two criteria were scored as 'unclear' or 'high'.</P>
<P>We applied three additional criteria to studies with microbial outcomes, based on the ORION statement: Guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection (<A HREF="http://www.idrn.org/orion.php">Orion Statement</A>; <LINK REF="REF-Stone-2007" TYPE="REFERENCE">Stone 2007</LINK>).</P>
<OL>
<LI>Case definition: score as 'low' if there is a clear definition either of infection or of colonisation and there were no major changes in laboratory diagnostic methods during the study period.</LI>
<LI>Planned intervention: score as 'low' if the intervention was planned to reduce endemic rates of colonisation or infection and was not implemented in response to an outbreak. Regression to the mean following an outbreak is an important risk of bias for estimates of the effect of interventions in ITS studies of infection (<LINK REF="REF-Davey_x002d_Smith-2001" TYPE="REFERENCE">Davey-Smith 2001</LINK>; <LINK REF="REF-Stone-2007" TYPE="REFERENCE">Stone 2007</LINK>).</LI>
<LI>Other infection control measures: score as 'low' if infection control practices (hand hygiene, gowning, or other personal protection) and isolation or cohorting policies are described and there were no changes coincident with the intervention to change antibiotic prescribing.</LI>
</OL>
<P>We have presented microbial 'Risk of bias' results in the Notes section of the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. We have not included them in the 'Risk of bias' tables unless there might also be a risk to prescribing outcomes (e.g. appointment of additional infection control practitioners who might have influenced prescribing).</P>
<P>We assessed risk of bias in case control or cohort studies of unintended consequences with ROBINS-I: a tool for assessing Risk of Bias in Non-randomised Studies of Interventions (<LINK REF="REF-Sterne-2016" TYPE="REFERENCE">Sterne 2016</LINK>). We have reported these 'Risk of bias' assessments in the Notes section of the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2016-12-31 22:34:05 -0500" MODIFIED_BY="[Empty name]">
<P>We assessed the impact of interventions on clinical outcome for studies that provided reliable data about mortality, length of hospital stay, or other clinical outcomes such as acute kidney injury. We did not include clinical outcomes for studies that estimated the impact of their intervention based on modelling (<LINK REF="STD-Barlow-2007" TYPE="STUDY">Barlow 2007</LINK>). We analysed dichotomous data (such as increase in desired practice and mortality) as risk differences and analysed continuous data (such as length of hospital stay) as mean differences.</P>
<P>We critically examined the methods of analysis of ITS data. The preferred method is a statistical comparison of time trends before and after the intervention. If the original paper did not include an analysis of this type, we extracted the data presented in tables or graphs in the original paper and used them to perform new analyses where possible. We used segmented time series regression analysis to estimate the effect of the intervention whilst taking account of time trend and autocorrelation among the observations. We obtained estimates for regression coefficients corresponding to two standardised effect sizes for each study: a change in level and a change in trend before and after the intervention. A change in level was defined as the difference between the observed level at the first intervention time point and that predicted by the pre-intervention time trend. A change in trend was defined as the difference between post- and pre-intervention slopes (<LINK REF="REF-Ramsay-2003" TYPE="REFERENCE">Ramsay 2003</LINK>). We evaluated the direct effect of the intervention using results reported one month after the start of the intervention. We also reported the level effects at six months, and yearly thereafter when possible. We standardised the results of some ITS studies so that they were on the same scale (per cent change in outcome), thereby facilitating comparisons of different interventions. To do this, we used the change in level and change in slope to estimate the effect size with increasing time after the intervention (one month, six months, one year, etc.) as the per cent change in level at each time point. We did not extrapolate beyond the end of data collection after the intervention. We anticipated that the eligible studies would exhibit significant heterogeneity, due to variations in target clinical behaviours, patient and provider populations, methodological features, characteristics of the interventions, and the contexts in which the interventions were delivered. To address the source of variation in results due to the use of enabling or restrictive interventions, we undertook a random-effects meta-regression analysis on study-level summary effect size at each time point.</P>
<P>We assessed the impact of interventions on microbial outcomes if the study provided reliable data about colonisation or infection with <I>Clostridium difficile</I> or with antibiotic-resistant bacteria. We did not include microbial outcomes for studies that estimated the future impact of their intervention based on modelling (<LINK REF="STD-Paul-2006" TYPE="STUDY">Paul 2006</LINK>), or that used clinical definitions of infection that did not distinguish between resistant and sensitive bacteria (<LINK REF="STD-Micek-2004" TYPE="STUDY">Micek 2004</LINK>; <LINK REF="STD-Singh-2000" TYPE="STUDY">Singh 2000</LINK>).</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2016-12-31 22:41:34 -0500" MODIFIED_BY="[Empty name]">
<P>If an RCT did not take into account the effect of clustering in the analysis, we stated this in the 'Risk of bias' assessment. We incorporated consideration of unit of analysis issues as part of the sensitivity analyses.</P>
<P>We estimated intracluster correlation (ICC) for each outcome. The ICCs used reflect that process measures usually have higher ICC than outcome measures and were obtained from the database of ICCs held by the Health Services Research Unit, University of Aberdeen (<LINK REF="REF-Health-Services-Research-Unit-2016" TYPE="REFERENCE">Health Services Research Unit 2016</LINK>).</P>
<UL>
<LI>Prescribing 0.2</LI>
<LI>Mortality 0.01</LI>
<LI>Length of stay 0.2</LI>
</UL>
<P>Average cluster size (m) = (total number of participants (intervention + control)) &#8785; (total number of clusters). Inflation factor = 1 + (m-1) x ICC. For dichotomous outcomes, we divided events and participants by the inflation factor for intervention and control groups. For continuous outcomes, we multiplied intervention and control standard deviation by the inflation factor.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2017-01-17 02:27:28 -0500" MODIFIED_BY="Petrer Davey">
<P>We have not attempted to account for missing data in the meta-analysis of RCTs or meta-regression of ITS studies. For ITS studies, we only analysed effects at a specified time point when data were available, we have not carried forward regression lines beyond the last observation or used regression lines to estimate missing data..</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2017-01-17 02:27:28 -0500" MODIFIED_BY="Petrer Davey">
<P>We quantified heterogeneity among studies using the I<SUP>2</SUP> statistic and Cochran's Q test (<LINK REF="REF-Cochran-1954" TYPE="REFERENCE">Cochran 1954</LINK>). The I<SUP>2</SUP> statistic quantifies the percentage of the total variation across studies that is due to heterogeneity rather than chance (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>); smaller percentages suggest less observed heterogeneity.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2016-11-29 02:07:33 -0500" MODIFIED_BY="Petrer Davey">
<P>We assessed publication and selective reporting bias.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2017-01-17 02:27:28 -0500" MODIFIED_BY="Petrer Davey">
<P>We have analysed the results for RCTs, CBAs, NRT, and ITS studies separately. For the RCT data, we employed a standard meta-analysis approach using Review Manager 5 for binary (e.g. compliance with guidelines) and continuous (e.g. duration of treatment) outcomes. We analysed the data with a fixed-effect model (<LINK REF="REF-Review-Manager-5" TYPE="REFERENCE">Review Manager 5</LINK>).</P>
<P>We used Stata 14 for all statistical re-analyses and meta-regressions (<LINK REF="REF-Stata-2015" TYPE="REFERENCE">Stata 2015</LINK>), and Review Manager 5 for all data synthesis (<LINK REF="REF-Review-Manager-5" TYPE="REFERENCE">Review Manager 5</LINK>).</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2017-01-27 08:42:29 -0500" MODIFIED_BY="Julia Worswick">
<P>We used meta-regression to investigate potential effect modifiers. In meta-regression, the outcome variable is the effect estimate (e.g. a mean difference or a risk difference). The explanatory variables are characteristics of studies that might influence the size of intervention effect (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>We prespecified four subgroups as explanatory variables for the meta-regression (<LINK REF="REF-Davey-2014" TYPE="REFERENCE">Davey 2014</LINK>):</P>
<OL>
<LI>interventions that included enablement versus those that did not;</LI>
<LI>interventions that included restriction versus those that did not;</LI>
<LI>enabling interventions that included feedback versus those that did not;</LI>
<LI>feedback interventions that included goal setting or action planning versus those that did not.</LI>
</OL>
<P>Definitions of these terms can be found in <LINK TAG="DATA_EXTRACTION" TYPE="SECTION">Data extraction and management</LINK> and <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>. We expected restriction, enablement, feedback goal setting and action planning to be associated with increased effectiveness of interventions (<LINK REF="REF-Ivers-2012" TYPE="REFERENCE">Ivers 2012</LINK>).</P>
<P>We included the following three additional variables in the meta-regression because they might influence the size of intervention effect and explain heterogeneity.</P>
<OL>
<LI>Target: choice of antibiotic regimen versus time to first antibiotic dose or exposure to antibiotics, effects possibly greater for interventions targeting choice.</LI>
<LI>Setting: single unit versus multiple wards, effects possibly greater in single unit.</LI>
<LI>Intent: increase effective versus decrease excessive, effects possibly greater with increase effective.</LI>
</OL>
<P>The meta-regression was performed using standard weighted (by standard error of estimate) linear regression (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2017-01-17 02:27:28 -0500" MODIFIED_BY="Petrer Davey">
<P>We conducted sensitivity analyses by re-analysing data to investigate the effect of two risks of bias.</P>
<OL>
<LI>Lack of adjustment for the effect of clustering in cluster RCTs. We repeated all analyses that included cluster RCTs with adjusted numbers of events and total participants for dichotomous variables and adjusted standard deviation for continuous variables (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>; <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>).</LI>
<LI>Overall high risk of bias. We analysed all studies at medium and low risk of bias separately in sensitivity analyses (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>; <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). </LI>
</OL>
<SUBSECTION>
<HEADING LEVEL="3">Summary of findings</HEADING>
<P>We summarised the findings of the main intervention comparison for the most important outcomes in <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>. Two review authors independently assessed the certainty of the evidence for each key outcome (high, moderate, low, and very low) using the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) (<LINK REF="REF-Guyatt-2011" TYPE="REFERENCE">Guyatt 2011</LINK>). We assessed the following outcomes:</P>
<OL>
<LI>compliance with desired practice;</LI>
<LI>duration of antibiotic treatment;</LI>
<LI>mortality;</LI>
<LI>length of hospital stay;</LI>
<LI>delay in treatment;</LI>
<LI>negative professional culture.</LI>
</OL>
<P>We also assessed the evidence from the meta-regression in terms of the extent to which we believed it helped explain variation of effect. We included the following effect modifiers in our analysis.</P>
<OL>
<LI>Enablement (Yes/No)</LI>
<LI>Restriction (Yes/No)</LI>
<LI>Addition of feedback to enablement (Yes/No)</LI>
<LI>Addition of enablement to restriction (Yes/No)</LI>
</OL>
<P>We used the methods and recommendations described in Section 8.5 and Chapter 12 of the <I>Cochrane Handbook for Systematic Reviews of Interventions,</I> <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>, and the EPOC worksheets (<LINK REF="REF-EPOC-2013a" TYPE="REFERENCE">EPOC 2013a</LINK>). Disagreements on certainty ratings were resolved by discussion, and justification for decisions to down- or upgrade the ratings are provided in footnotes in the table and comments made to aid readers' understanding of the review where necessary. We used plain language statements to report these findings in the review. Further details about each of the five GRADE criteria are in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
<P>Evidence from randomised studies started at high certainty and was downgraded according to the five considerations described above. Evidence from non-randomised studies started at low certainty and was assessed against the same five criteria. We only considered upgrading for non-randomised evidence in the presence of a large treatment effect, dose response, or where plausible confounding would have reduced the observed effect.</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2017-02-21 14:29:39 -0500" MODIFIED_BY="Julia Worswick">
<STUDY_DESCRIPTION MODIFIED="2017-01-27 10:11:41 -0500" MODIFIED_BY="Julia Worswick">
<SEARCH_RESULTS MODIFIED="2017-01-27 10:11:41 -0500" MODIFIED_BY="Julia Worswick">
<P>The combined results of all literature searches are described in the study flow diagram (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2017-01-24 14:12:20 -0500" MODIFIED_BY="Julia Worswick">
<P>The <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table lists 221 studies, of which 211 used the following designs to evaluate the intended effect of interventions: 138 ITS studies, 58 RCTs (14 cluster RCTs), 6 CBAs, and 8 NRTs. The remaining 11 studies were designed to identify unintended consequences of interventions and used the following designs: 8 cohort (<LINK REF="STD-Connor-2007" TYPE="STUDY">Connor 2007</LINK>; <LINK REF="STD-Duvoisin-2014" TYPE="STUDY">Duvoisin 2014</LINK>; <LINK REF="STD-Friedberg-2009" TYPE="STUDY">Friedberg 2009</LINK>; <LINK REF="STD-Kanwar-2007" TYPE="STUDY">Kanwar 2007</LINK>; <LINK REF="STD-LaRosa-2007" TYPE="STUDY">LaRosa 2007</LINK>; <LINK REF="STD-Linkin-2007" TYPE="STUDY">Linkin 2007</LINK>; <LINK REF="STD-Welker-2008" TYPE="STUDY">Welker 2008</LINK>; <LINK REF="STD-Winters-2010" TYPE="STUDY">Winters 2010</LINK>), 1 case control (<LINK REF="STD-Calfee-2003" TYPE="STUDY">Calfee 2003</LINK>), and 1 qualitative (semi-structured interviews) (<LINK REF="STD-Baysari-2013" TYPE="STUDY">Baysari 2013</LINK>) and 1 ITS (<LINK REF="STD-Bell-2014" TYPE="STUDY">Bell 2014</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Geographical location of study</HEADING>
<P>Ninety-six studies were from North America. The remaining 125 were from Europe (87, includes Israel), Asia (19), South America (8), Australia (8), and East Asia (3). The number of studies by country (including the countries in four multinational studies) is: Argentina, 1; Australia, 9; Austria, 2; Belgium, 4; Brazil, 4; Canada, 8; China, 6; Colombia, 2; Croatia, 1; Denmark, 3; France, 11; Germany, 12; Greece, 1; Hong Kong, 1; Hungary, 1; India, 1; Indonesia, 1; Israel, 1; Italy, 3; Japan, 1; Korea, 3; Lebanon, 1; Mexico, 1; Netherlands, 11; Norway, 1; Serbia, 1; Singapore, 1; Spain, 5; Sweden, 2; Switzerland, 11; Taiwan, 3; Thailand, 4; Turkey, 1; UK, 22; USA, 89.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Number of hospitals</HEADING>
<P>A total of 178 (79%) studies were conducted in one hospital, 9 studies in 2 hospitals, 18 studies in 3 to 9 hospitals, and 16 studies in 10 or more hospitals.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Deliverer of intervention</HEADING>
<P>Of the 221 interventions, 112 (51%) were designed and delivered by a multidisciplinary team, 54 (24%) by specialist physicians (infectious diseases or microbiology), 35 (16%) by department physicians (e.g. emergency department or critical care), and 20 (9%) by pharmacists.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Funding</HEADING>
<P>Five studies received some funding from manufacturers of drugs or laboratory tests. The remaining 216 studies were funded by government agencies or the participating hospitals. Details are provided in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Power calculations</HEADING>
<P>Details of power calculations are provided in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2016-12-31 23:43:55 -0500" MODIFIED_BY="[Empty name]">
<P>We excluded 32 unique studies from the review because they did not contain relevant or interpretable data (<LINK TAG="STUDY_SELECTION" TYPE="SECTION">Selection of studies</LINK>). For details of each study, see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2017-01-17 02:27:28 -0500" MODIFIED_BY="Petrer Davey">
<P>All 14 CBAs and NRTs were at high risk of bias (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). High risk of bias was more common in RCTs (36/58, 62%) than in ITS studies (20/138, 14%) (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). All 51 studies at low risk of bias were ITS studies (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). Among RCTs, high risk of bias was much more likely in studies with two or fewer hospitals (31/36, 86%) versus three or more hospitals (11/22, 50%). Of the 11 RCTs with two or fewer hospitals with medium risk of bias, nine interventions were circumstantial reminders targeted at doctors who were managing specific patients (<LINK REF="STD-Christ_x002d_Crain-2004" TYPE="STUDY">Christ-Crain 2004</LINK>; <LINK REF="STD-Christ_x002d_Crain-2006" TYPE="STUDY">Christ-Crain 2006</LINK>; <LINK REF="STD-Esposito-2011" TYPE="STUDY">Esposito 2011</LINK>; <LINK REF="STD-Kerremans-2009" TYPE="STUDY">Kerremans 2009</LINK>; <LINK REF="STD-Lacroix-2014" TYPE="STUDY">Lacroix 2014</LINK>; <LINK REF="STD-Lesprit-2013" TYPE="STUDY">Lesprit 2013</LINK>; <LINK REF="STD-Long-2014" TYPE="STUDY">Long 2014</LINK>; <LINK REF="STD-Senn-2004" TYPE="STUDY">Senn 2004</LINK>; <LINK REF="STD-Stocker-2010" TYPE="STUDY">Stocker 2010</LINK>; <LINK REF="STD-Strom-2010" TYPE="STUDY">Strom 2010</LINK>), so the risks of allocation or contamination bias were relatively low compared with the other RCTs of interventions in one or two hospitals. However, the remaining two RCTs at low risk of bias show that these risks can be minimised for RCTs of review and recommend change interventions in single hospitals (<LINK REF="STD-Lesprit-2013" TYPE="STUDY">Lesprit 2013</LINK>; <LINK REF="STD-Palmay-2014" TYPE="STUDY">Palmay 2014</LINK>).</P>
<P>We have presented 'Risk of bias' criteria for the case control and cohort studies of unintended consequences in the Notes section in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.. For the nine studies, we assessed the risk of bias as high in two (<LINK REF="STD-Calfee-2003" TYPE="STUDY">Calfee 2003</LINK>; <LINK REF="STD-Friedberg-2009" TYPE="STUDY">Friedberg 2009</LINK>), medium in two (<LINK REF="STD-Linkin-2007" TYPE="STUDY">Linkin 2007</LINK>; <LINK REF="STD-Welker-2008" TYPE="STUDY">Welker 2008</LINK>), and low in five (<LINK REF="STD-Connor-2007" TYPE="STUDY">Connor 2007</LINK>; <LINK REF="STD-Duvoisin-2014" TYPE="STUDY">Duvoisin 2014</LINK>; <LINK REF="STD-Kanwar-2007" TYPE="STUDY">Kanwar 2007</LINK>; <LINK REF="STD-LaRosa-2007" TYPE="STUDY">LaRosa 2007</LINK>; <LINK REF="STD-Winters-2010" TYPE="STUDY">Winters 2010</LINK>).</P>
<ALLOCATION MODIFIED="2017-01-01 15:01:04 -0500" MODIFIED_BY="[Empty name]">
<P>Most of the RCTs had high risk of selection bias because of problems with concealment of allocation (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). The RCTs with low risk of selection bias were either cluster RCTs or interventions with circumstantial reminders, for which concealment of allocation is relatively straightforward.</P>
</ALLOCATION>
<BLINDING MODIFIED="2017-01-01 15:03:11 -0500" MODIFIED_BY="[Empty name]">
<P>Most of the RCTs also had high risk of performance and detection bias because RCTs in single hospitals were often single-blind and it was difficult to conceal the allocation of participants in these trials (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2017-01-01 15:05:41 -0500" MODIFIED_BY="[Empty name]">
<P>The RCTs used data collected specifically for the trial, and all provided convincing evidence about lack of attrition bias. Most of the ITS studies used data from routine systems for prescribing (pharmacy) and microbial (microbiology) outcomes; we assessed these sources as having low risk of attrition bias (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). Examples of high risk of attrition bias in routine data are changes in the number of participants who did not have serum creatinine measure preoperatively during the study period, which may have biased ascertainment of postoperative kidney injury (<LINK REF="STD-Bell-2014" TYPE="STUDY">Bell 2014</LINK>), and use of surveillance data about surgical-site infection that did not include information about infections arising after discharge from hospital (<LINK REF="STD-Dua-2014" TYPE="STUDY">Dua 2014</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2016-11-29 02:10:22 -0500" MODIFIED_BY="Petrer Davey">
<P>We also assessed routine data systems as being at low risk of reporting bias (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). Most of the ITS studies used computerised pharmacy systems to measure drug consumption. </P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2017-01-01 15:08:30 -0500" MODIFIED_BY="[Empty name]">
<P>Less than 25% of RCTs provided clear information about baseline outcome; most of these were cluster RCTs (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). The most common single risk of bias for ITS studies was that the intervention was not independent of other changes (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). For ITS studies, the main risks of bias were that there were insufficient data to account for seasonal variation or that one or more of the microbial 'Risk of bias' criteria were present (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2017-02-21 14:29:39 -0500" MODIFIED_BY="Julia Worswick">
<SUBSECTION>
<HEADING LEVEL="3">Studies included in evidence synthesis and 'Summary of findings' tables</HEADING>
<P>Outcomes from 49 (84%) of the 58 RCTs and110 (80%) of the 138 ITS studies were used in at least one meta-analysis or meta-regression or are summarised in text or <LINK TAG="ADDITIONAL_TABLES" TYPE="SECTION">Additional tables</LINK>. The contribution that each RCT made can be found in <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>. One ITS study contributed data about unintended consequences (<LINK REF="STD-Bell-2014" TYPE="STUDY">Bell 2014</LINK>). The contribution of 109 ITS studies to meta-regression of prescribing outcomes is summarised in <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>. Reasons for exclusion of 10 RCTs and 28 ITS studies from evidence synthesis can be found in <LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>.</P>
<P>The 10 case control, cohort, or qualitative studies of unintended consequences all contributed evidence about adverse effects.</P>
<P>None of the 6 CBAs or 8 NRTs included evidence about adverse effects of interventions, and there were not enough studies for evidence synthesis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intended prescribing outcomes for RCTs and ITS studies included in evidence synthesis</HEADING>
<P>Interventions were targeted at antibiotic treatment for 46 (94%) of 49 RCTs and 101 (92%) of 110 ITS studies. The remaining 11 studies targeted surgical antibiotic prophylaxis (<LINK REF="STD-Bell-2014" TYPE="STUDY">Bell 2014</LINK>; <LINK REF="STD-Dull-2008" TYPE="STUDY">Dull 2008</LINK>; <LINK REF="STD-Gulmezoglu-2007" TYPE="STUDY">Gulmezoglu 2007</LINK>; <LINK REF="STD-Kritchevsky-2008" TYPE="STUDY">Kritchevsky 2008</LINK>; <LINK REF="STD-Meyer-2010" TYPE="STUDY">Meyer 2010</LINK>; <LINK REF="STD-Perez-2003" TYPE="STUDY">Perez 2003</LINK>; <LINK REF="STD-Schwann-2011" TYPE="STUDY">Schwann 2011</LINK>; <LINK REF="STD-Sun-2011" TYPE="STUDY">Sun 2011</LINK>; <LINK REF="STD-Van-Kasteren-2005" TYPE="STUDY">Van Kasteren 2005</LINK>; <LINK REF="STD-Wax-2007" TYPE="STUDY">Wax 2007</LINK>; <LINK REF="STD-Weinberg-2001" TYPE="STUDY">Weinberg 2001</LINK>).</P>
<P>For the 148 interventions targeted at antibiotic treatment, the intended outcome of 137 (93%) interventions was to decrease excessive use of antibiotics: 45/46 (98%) RCTs and 93/102 (91%) ITS studies. The only RCT that was primarily intended to increase effective treatment targeted dosing of gentamicin (<LINK REF="STD-Burton-1991" TYPE="STUDY">Burton 1991</LINK>). Two RCTs with antibiotic choice as the primary outcome did include time to first antibiotic dose for participants with community-acquired pneumonia as a secondary outcome (<LINK REF="STD-Schouten-2007" TYPE="STUDY">Schouten 2007</LINK>; <LINK REF="STD-Yealy-2005" TYPE="STUDY">Yealy 2005</LINK>). The only other evidence about increasing effective treatment of sepsis came from six ITS studies that aimed to reduce time to first antibiotic dose (<LINK REF="STD-Barlow-2007" TYPE="STUDY">Barlow 2007</LINK>; <LINK REF="STD-Hitti-2012" TYPE="STUDY">Hitti 2012</LINK>; <LINK REF="STD-Jobson-2015" TYPE="STUDY">Jobson 2015</LINK>; <LINK REF="STD-Marwick-2013" TYPE="STUDY">Marwick 2013</LINK>; <LINK REF="STD-Volpe-2012" TYPE="STUDY">Volpe 2012</LINK>; <LINK REF="STD-Weiner-2009" TYPE="STUDY">Weiner 2009</LINK>).</P>
<P>In contrast, reduction in excessive use of antibiotics was the intended outcome of only 3 (25%) of the 12 interventions targeted at surgical antibiotic prophylaxis (<LINK REF="STD-Bell-2014" TYPE="STUDY">Bell 2014</LINK>; <LINK REF="STD-Sun-2011" TYPE="STUDY">Sun 2011</LINK>; <LINK REF="STD-Van-Kasteren-2005" TYPE="STUDY">Van Kasteren 2005</LINK>). The remaining nine interventions were all intended to increase effective use of antibiotics by increasing the number of participants who received prophylaxis or reducing the time to first antibiotic dose.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Effectiveness and adverse effects of interventions</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Effectiveness of interventions in RCTs</HEADING>
<P>Interventions were associated with an increase in compliance with desired practice by 15% (95% confidence interval (CI) 14% to 16%) in 29 RCTs (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). We obtained similar results in sensitivity analyses for unit of analysis errors (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>) or risk of bias (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). Interventions were associated with a reduction in duration of total antibiotic treatment by -1.95 days (95% CI -2.22 to -1.67) in 14 RCTs (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). We obtained similar results in sensitivity analyses for unit of analysis errors (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>) or risk of bias (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>).</P>
<P>In four RCTs the prescribing outcome was the consumption of targeted antibiotics measured in different units (cost, days, or defined daily dose), so results were expressed as standardised mean reduction (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>.).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Adverse effects of interventions</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Evidence from RCTs</HEADING>
<P>Interventions were not associated with any increase in mortality (95% CI 1 to 0 fewer deaths per 100 participants) in 28 RCTs (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). We obtained similar results in sensitivity analyses for unit of analysis errors (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>) or risk of bias (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>). Interventions were associated with reduction in length of stay by -1.12 days (95% CI -1.54 to -0.70) in 15 RCTs <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>; <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). We obtained similar results in sensitivity analyses for unit of analysis errors (<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>) or risk of bias (<LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). We found no evidence of a difference in results for interventions that targeted antibiotic exposure (decision to treat or duration of all antibiotic treatment) versus the choice of antibiotic prescribed (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>; <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>; <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>).<BR/>
</P>
<P>One RCT measured clinical outcome as potentially harmful delay in essential treatment (<LINK REF="STD-Strom-2010" TYPE="STUDY">Strom 2010</LINK>). The outcome was ascertained by the Trial Monitoring Committee, who stopped the trial prematurely when four participants were found to have potentially harmful delay in treatment with trimethoprim-sulphamethoxazole or warfarin. This was a restrictive intervention intended to prevent interactions between these drugs.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Evidence from NRS</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">ITS studies</HEADING>
<P>Clinical outcome data were measured as mortality in four ITS studies (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>) and length of stay in one ITS study (<LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>). However, we could only calculate 95% CI for three of these studies (<LINK REF="STD-Lee-2014" TYPE="STUDY">Lee 2014</LINK>; <LINK REF="STD-Popovski-2015" TYPE="STUDY">Popovski 2015</LINK>; <LINK REF="STD-Skaer-1993" TYPE="STUDY">Skaer 1993</LINK>), and the outcome data came from all participants in the hospital rather than just the participants who were the targets of the interventions.</P>
<P>Three ITS studies reported other clinical outcomes that provided more direct evidence about unintended consequences of the interventions (<LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>). An intervention to promote gentamicin for prophylaxis was intended to reduce risk of CDI but was associated with a large increase in acute kidney injury in the participants undergoing target operations, and as a consequence the antibiotic policy change was reversed (<LINK REF="STD-Bell-2014" TYPE="STUDY">Bell 2014</LINK>). An intervention designed to shorten time to first antibiotic dose for people with sepsis was not associated with any increase in the time left without being seen for all other participants in the emergency department (<LINK REF="STD-Volpe-2012" TYPE="STUDY">Volpe 2012</LINK>). An intervention to reduce the duration of surgical antibiotic prophylaxis was not associated with increased surgical-site infection (<LINK REF="STD-Van-Kasteren-2005" TYPE="STUDY">Van Kasteren 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Case control, cohort and qualitative studies</HEADING>
<P>Ten studies investigated unintended consequences of interventions to change antibiotic choice with cohort (n = 8), case control (n = 1), or qualitative case study (n = 1) designs (<LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>).</P>
<P>There was a restrictive component to the intervention in seven studies. One study showed that restriction of laboratory tests of inflammation (C-reactive protein and white blood cell count) was not associated with an increase in time to first antibiotic dose (<LINK REF="STD-Duvoisin-2014" TYPE="STUDY">Duvoisin 2014</LINK>). The remaining six studies all revealed unintended consequences of interventions that restricted antibiotic choice by requiring prior approval, as follows.</P>
<UL>
<LI>Negative professional culture through breakdown in trust and communication (<LINK REF="STD-Baysari-2013" TYPE="STUDY">Baysari 2013</LINK>; <LINK REF="STD-Calfee-2003" TYPE="STUDY">Calfee 2003</LINK>; <LINK REF="STD-Connor-2007" TYPE="STUDY">Connor 2007</LINK>; <LINK REF="STD-Linkin-2007" TYPE="STUDY">Linkin 2007</LINK>).</LI>
<LI>Delay in time to first antibiotic dose (<LINK REF="STD-LaRosa-2007" TYPE="STUDY">LaRosa 2007</LINK>; <LINK REF="STD-Winters-2010" TYPE="STUDY">Winters 2010</LINK>). Evidence of delay in essential treatment was also seen in one RCT (<LINK REF="STD-Strom-2010" TYPE="STUDY">Strom 2010</LINK>).</LI>
</UL>
<P>In three studies (<LINK REF="STD-Friedberg-2009" TYPE="STUDY">Friedberg 2009</LINK>; <LINK REF="STD-Kanwar-2007" TYPE="STUDY">Kanwar 2007</LINK>; <LINK REF="STD-Welker-2008" TYPE="STUDY">Welker 2008</LINK>), the intervention was a national financial incentive in the USA that was intended to reduce time to first antibiotic dose for people admitted to hospital with community-acquired pneumonia (CAP). In all three studies, the unintended consequence was misdiagnosis of pneumonia, which could lead to an increase in unnecessary antibiotic treatment. In two single-centre studies, there was a decrease in the percentage of participants with correct diagnosis of CAP based on prespecified criteria (<LINK REF="STD-Kanwar-2007" TYPE="STUDY">Kanwar 2007</LINK>; <LINK REF="STD-Welker-2008" TYPE="STUDY">Welker 2008</LINK>). In contrast, a large, multicentre study reported no evidence of an overall increase in the diagnosis of CAP (<LINK REF="STD-Friedberg-2009" TYPE="STUDY">Friedberg 2009</LINK>); however, this study was at high risk of bias.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Explaining heterogeneity in the intended effect of interventions</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Meta-regresson of RCTs</HEADING>
<P>We performed meta-regression on 29 RCTs with dichotomous prescribing outcomes (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). Outcomes for all of these trials could be expressed as number of participants where treatment was compliant with policy divided by total participants. We did not perform meta-regression on 15 RCTs with continuous prescribing outcomes because the outcomes were heterogeneous (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>) and because none of the interventions included restriction or feedback, and only two did not include enablement (<LINK REF="STD-Danaher-2009" TYPE="STUDY">Danaher 2009</LINK>; <LINK REF="STD-Kerremans-2008" TYPE="STUDY">Kerremans 2008</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">Meta-regression results for 29 RCTs with dichotomous outcomes</HEADING>
<P>In the meta-regression, enablement, restriction, targeting antibiotic choice versus exposure and high risk of bias were significantly associated with greater intervention effect in univariate analysis, and they all remained significant in multivariate analysis (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>).</P>
<P>Of the 23 RCTs of enabling interventions, four also included feedback (<LINK REF="STD-Camins-2009" TYPE="STUDY">Camins 2009</LINK>; <LINK REF="STD-Schnoor-2010" TYPE="STUDY">Schnoor 2010</LINK>; <LINK REF="STD-Schouten-2007" TYPE="STUDY">Schouten 2007</LINK>; <LINK REF="STD-Yealy-2005" TYPE="STUDY">Yealy 2005</LINK>). All four of these RCTs targeted antibiotic choice, so we have compared their effects with seven RCTs of enabling interventions without feedback that also targeted antibiotic choice. The mean risk difference for interventions with feedback was 19% (95% CI 16% to 22%) (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>) compared with 13% (95% CI 9% to 17%) (<LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>) for interventions with no feedback. Only two of the feedback RCTs also included action planning (<LINK REF="STD-Schouten-2007" TYPE="STUDY">Schouten 2007</LINK>; <LINK REF="STD-Yealy-2005" TYPE="STUDY">Yealy 2005</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Meta-regression of ITS studies</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Do interventions that involve enablement have greater initial effect?</HEADING>
<P>There were 107 ITS studies with data that could be used for meta-regression of prescribing outcomes at one, six, or 12 months' postintervention. We used multivariable meta-regression to identify effect modifiers in 91 ITS studies including data about prescribing at six months' postintervention. As with the RCTs (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>), both enablement and restriction were independently associated with increased effect in ITS studies (<LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>). Of 29 ITS studies with restrictive interventions, 13 (45%) also had enablement, and this independently enhanced intervention effect (<LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>). In comparison with interventions targeting antibiotic exposure, those targeting choice were associated with greater effect in RCTs (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>), but not in ITS studies (<LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>). The number of studies in each category only allowed analysis of the effects of setting in ITS studies (<LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>), and intention could only be included in meta-regression of ITS studies of enabling intervention (<LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>). The limited evidence suggests that intention and setting were not effect modifiers (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>; <LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Are interventions that include feedback more effective than those that do not?</HEADING>
<P>Feedback was included in 4 (17%) of 23 RCTs (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>) and 20 (47%) of 43 ITS studies (<LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>) of enabling interventions that did not include restriction. The intervention was audit and feedback alone in three RCTs and 10 ITS studies. In one RCT and 11 ITS studies, audit and feedback was combined with review and recommend change or circumstantial reminders. Interventions that included feedback were more effective than those that did not. However, there were too few studies with goal setting or action planning to assess their effect in addition to feedback.</P>
<P>There were only two ITS studies with enough data to analyse the effect of adding an additional component to an effective intervention. However, the second intervention component did not include goal setting, feedback, or action planning in either study (<LINK REF="STD-Mol-2005" TYPE="STUDY">Mol 2005</LINK>; <LINK REF="STD-Po-2012" TYPE="STUDY">Po 2012</LINK>)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Summary of interventions for the studies included in meta-regression</HEADING>
<P>In comparison with RCTs, the ITS studies were more likely to have multiple intervention components: 35 (38%) of 91 ITS studies versus 5 (17%) of 29 RCTs, odds ratio 3.00 (95% CI 1.05 to 8.59) (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>). There were also differences in the components for enabling interventions (review and recommend change was included in 53% of ITS studies versus 25% of RCTs) and restrictive interventions (removal of target drugs from clinical areas was included in 34% of ITS studies but in no RCTs) (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>). Educational meetings or distribution of educational materials was the most common intervention in studies that did include enablement or restriction (75% of RCTs and 89% of ITS studies) (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sustainability of intervention effect</HEADING>
<P>Sustainability was assessed in 64 of 91 ITS studies, with prescribing outcome data at both 6 and 12 months' postintervention. Intervention effect was sustained at 12 months' postintervention in 55 (86%) of these studies (95% CI 77% to 94%). There were 13 interventions with neither enablement nor restriction; intervention effect was sustained in 11 (85%) (95% CI 65% to 100%). Consequently, it was unlikely that either enablement or restriction would be associated with greater sustainability. However, the results suggest that restrictive interventions were less likely to have sustained effect if they did not include enablement: 5/8 (62%) versus 12/13 (92%) with enablement, risk difference 30% (95% CI -7% to 66%).</P>
<P>Five ITS studies with data about removal of interventions provided additional information about sustainability of interventions (<LINK REF="TBL-07" TYPE="TABLE">Table 7</LINK>). Three of these studies also provided data about the effect of the intervention. The intended effect of all interventions was decrease in the use of target antibiotics. Removal of the intervention was associated with increase in the use of target antibiotics in all five studies and, with one exception (<LINK REF="STD-Kim-2008" TYPE="STUDY">Kim 2008</LINK>), the 95% CI for effect size did not include decrease in use of target antibiotics. <LINK REF="STD-Kim-2008" TYPE="STUDY">Kim 2008</LINK> was the only one of these five interventions including enablement by audit and feedback.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Microbial outcomes (antibiotic resistance and CDI)</HEADING>
<P>There were 1 CBA and 5 RCTs with microbial outcome data, and these were too heterogeneous for data synthesis (<LINK REF="TBL-08" TYPE="TABLE">Table 8</LINK>).</P>
<P>We performed meta-regression on 26 ITS studies including reliable data about prescribing outcomes at 6 months and microbial outcomes at 12 months after the intervention (<LINK REF="TBL-09" TYPE="TABLE">Table 9</LINK>). Six unplanned interventions (in response to outbreaks) were associated with markedly greater effect on microbial outcomes (<LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>). When studies were ranked in descending order of effect size for microbial outcome at 12 months, the top five studies were all unplanned interventions (<LINK REF="STD-Kim-2008" TYPE="STUDY">Kim 2008</LINK>; <LINK REF="STD-May-2000" TYPE="STUDY">May 2000</LINK>; <LINK REF="STD-McNulty-1997" TYPE="STUDY">McNulty 1997</LINK>; <LINK REF="STD-Tangd_x00e9_n-2011" TYPE="STUDY">Tangdén 2011</LINK>; <LINK REF="STD-Valiquette-2007" TYPE="STUDY">Valiquette 2007</LINK>), with the remaining unplanned intervention ranking 9th (<LINK REF="STD-Lautenbach-2003" TYPE="STUDY">Lautenbach 2003</LINK>).</P>
<P>In the 20 studies of planned intervention, there were six studies with unclear information about other infection control interventions or changes during the study period (<LINK REF="STD-Chan-2011" TYPE="STUDY">Chan 2011</LINK>; <LINK REF="STD-Grohs-2014" TYPE="STUDY">Grohs 2014</LINK>; <LINK REF="STD-Jump-2012" TYPE="STUDY">Jump 2012</LINK>; <LINK REF="STD-Liebowitz-2008" TYPE="STUDY">Liebowitz 2008</LINK>; <LINK REF="STD-Meyer-2009" TYPE="STUDY">Meyer 2009</LINK>; <LINK REF="STD-Petrikkos-2007" TYPE="STUDY">Petrikkos 2007</LINK>). We performed meta-regression on the remaining 14 studies from <LINK REF="TBL-09" TYPE="TABLE">Table 9</LINK> (<LINK REF="FIG-14" TYPE="FIGURE">Figure 14</LINK>). In contrast with the meta-regression of all 27 studies (<LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>), the effects of setting, other infection control interventions, and microbial outcome type were all reversed so that each of these variables was associated with increase in effect size in the 14 studies with planned interventions and details of other infection control interventions (<LINK REF="FIG-14" TYPE="FIGURE">Figure 14</LINK>).</P>
<P>The antibiotic targets for the 20 studies of planned interventions were single antibiotic classes in nine studies (<LINK REF="STD-Cook-2011b" TYPE="STUDY">Cook 2011b</LINK>; <LINK REF="STD-Grohs-2014" TYPE="STUDY">Grohs 2014</LINK>; <LINK REF="STD-Knudsen-2014" TYPE="STUDY">Knudsen 2014</LINK>; <LINK REF="STD-Lafaurie-2012" TYPE="STUDY">Lafaurie 2012</LINK>; <LINK REF="STD-Lee-2007" TYPE="STUDY">Lee 2007</LINK>; <LINK REF="STD-Meyer-2009" TYPE="STUDY">Meyer 2009</LINK>; <LINK REF="STD-Petrikkos-2007" TYPE="STUDY">Petrikkos 2007</LINK>; <LINK REF="STD-Willemsen-2010" TYPE="STUDY">Willemsen 2010</LINK>; <LINK REF="STD-Yoon-2014" TYPE="STUDY">Yoon 2014</LINK>), high-risk antibiotics in nine studies (<LINK REF="STD-Aldeyab-2012" TYPE="STUDY">Aldeyab 2012</LINK>; <LINK REF="STD-Aldeyab-2014" TYPE="STUDY">Aldeyab 2014</LINK>; <LINK REF="STD-Ananda_x002d_Rajah-2010" TYPE="STUDY">Ananda-Rajah 2010</LINK>; <LINK REF="STD-Buising-2008a" TYPE="STUDY">Buising 2008a</LINK>; <LINK REF="STD-Chan-2011" TYPE="STUDY">Chan 2011</LINK>; <LINK REF="STD-Dancer-2013" TYPE="STUDY">Dancer 2013</LINK>; <LINK REF="STD-Fowler-2007" TYPE="STUDY">Fowler 2007</LINK>; <LINK REF="STD-Liebowitz-2008" TYPE="STUDY">Liebowitz 2008</LINK>; <LINK REF="STD-Talpaert-2011" TYPE="STUDY">Talpaert 2011</LINK>), and all antibiotics in the remaining two studies (<LINK REF="STD-Cook-2011a" TYPE="STUDY">Cook 2011a</LINK>; <LINK REF="STD-Jump-2012" TYPE="STUDY">Jump 2012</LINK>). High-risk antibiotics were a combination of drugs from more than one class of antibiotic, which were all considered to be high risk for the microbial outcome. The prescribing outcome data reported in these nine studies varied from just one of the high-risk antibiotics, in <LINK REF="STD-Dancer-2013" TYPE="STUDY">Dancer 2013</LINK>, through individual results for all of the high-risk antibiotics, in <LINK REF="STD-Buising-2008a" TYPE="STUDY">Buising 2008a</LINK>, <LINK REF="STD-Chan-2011" TYPE="STUDY">Chan 2011</LINK>, <LINK REF="STD-Fowler-2007" TYPE="STUDY">Fowler 2007</LINK>, and <LINK REF="STD-Talpaert-2011" TYPE="STUDY">Talpaert 2011</LINK>, to combined results for all of the high-risk antibiotics (<LINK REF="STD-Aldeyab-2012" TYPE="STUDY">Aldeyab 2012</LINK>; <LINK REF="STD-Aldeyab-2014" TYPE="STUDY">Aldeyab 2014</LINK>; <LINK REF="STD-Ananda_x002d_Rajah-2010" TYPE="STUDY">Ananda-Rajah 2010</LINK>; <LINK REF="STD-Liebowitz-2008" TYPE="STUDY">Liebowitz 2008</LINK>).</P>
<P>One study can be used to demonstrate the technical challenges of estimation of intervention effect on microbial outcomes (<LINK REF="STD-Dancer-2013" TYPE="STUDY">Dancer 2013</LINK>). The intervention was addition of complete restriction of ceftriaxone and ciprofloxacin to a pre-existing multifaceted intervention introduced seven months before restriction and remaining in place throughout the restrictive period (<LINK REF="STD-Dancer-2013" TYPE="STUDY">Dancer 2013</LINK>). We could not analyse the effect of the initial multifaceted intervention because there were no pre-intervention data about prescribing or microbial outcomes. However, the available data showed CDI was lower by -0.143 cases per 1000 occupied bed days per month in the nine months prior to the addition of the restrictive intervention. At the start of the restrictive intervention, CDI rates were already low (1.5 cases per 1000 occupied bed days). After the introduction of restriction, CDI rates continued to decline for five months, and then stabilised at around 0.5 cases per 1000 occupied bed days. These data suggest that the restrictive intervention had no additional effect on the rate of CDI. However, the segmented regression analysis estimated that there was a relative increase of 35.8% in CDI rate 12 months after the restrictive intervention with very wide confidence intervals (from 81.0% decrease to 152.7% increase).</P>
<P>Our review did include one multicentre controlled ITS study comparing CDI rates in six hospitals with antimicrobial stewardship programmes versus four control hospitals (<LINK REF="STD-Ostrowsky-2014" TYPE="STUDY">Ostrowsky 2014</LINK>). We did not include this study in evidence synthesis because neither the interventions nor the prescribing outcomes were standardised across the six hospitals with stewardship programmes. Baseline rates of CDI were only 0.8 cases per 1000 occupied bed days in the intervention and control hospitals before the intervention, and the authors did not report a decrease in aggregate CDI rates either between intervention and non-intervention groups or within the intervention groups over time (<LINK REF="STD-Ostrowsky-2014" TYPE="STUDY">Ostrowsky 2014</LINK>).</P>
<P>We have not attempted to synthesise microbial outcome data because of the small number of studies, the heterogeneity of intervention targets and prescribing outcomes, and the wide confidence intervals for estimated relative effect. We have focused on the 20 ITS studies of planned interventions and separated the results by microbial outcome type. Interventions were associated with consistent reduction in CDI (median -48.6%, interquartile range -80.7% to -19.2%) but inconsistent effect on resistant gram-negative bacteria (median -12.9%, interquartile range -35.3% to 25.2%) and resistant gram-positive bacteria (median -19.3%, interquartile range -50.1% to 23.1%). There were too few studies with too much variance in microbial outcomes to reliably assess the relationship between change in antibiotic use and each of the microbial outcomes.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2017-02-21 14:28:38 -0500" MODIFIED_BY="Julia Worswick">
<SUMMARY_OF_RESULTS MODIFIED="2017-01-01 22:52:34 -0500" MODIFIED_BY="[Empty name]">
<P>The RCTs provide high-certainty evidence that interventions are effective in increasing compliance with antibiotic policies and in reducing duration of antibiotic treatment safely, without an increase in mortality. Furthermore, interventions were associated with a reduction in length of stay. The mechanism is not clear, and further investigation is required. However, reducing length of stay is a key organisational objective for most hospitals, so this evidence should be used to prioritise antimicrobial stewardship in hospitals.</P>
<P>Analysis of effect modifiers in RCTs and ITS studies consistently supported the theory that involving enablement increases intervention effect, including those with restrictive components. However, feedback was only used in a minority of enablement interventions, and very few included goal setting or action planning.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey">
<P>The RCTs show that interventions increase compliance with policies or guidelines by 15%, which is a clinically important effect size. However, the result is less impressive when one considers that health professionals&#8217; adherence to prescribing recommendations increased from 43% to 58%, because 58% compliance is probably still far too low. Three studies did achieve 90% compliance with guidelines by making this an explicit goal for the intervention and using action planning to revise interventions until the goal was achieved (<LINK REF="STD-Jobson-2015" TYPE="STUDY">Jobson 2015</LINK>; <LINK REF="STD-Volpe-2012" TYPE="STUDY">Volpe 2012</LINK>; <LINK REF="STD-Weinberg-2001" TYPE="STUDY">Weinberg 2001</LINK>).</P>
<P>The ITS studies provided important additional evidence that the results of RCTs regarding effectiveness of interventions can be reproduced in routine practice: 70% of ITS studies reported on hospital-wide interventions compared with only 31% of RCTs.</P>
<P>Only two ITS studies included data that enabled assessment of the effect of adding an intervention component to an existing intervention (<LINK REF="STD-Mol-2005" TYPE="STUDY">Mol 2005</LINK>; <LINK REF="STD-Po-2012" TYPE="STUDY">Po 2012</LINK>). This is a strong study design that should be more widely used to evaluate these types of interventions.</P>
<SUBSECTION>
<HEADING LEVEL="3">Safety and unintended consequences of interventions</HEADING>
<P>The main limitation of the RCT evidence regarding safety of reducing unnecessary use was that only two interventions included restriction, and one was stopped early because of delay in the start of treatment (<LINK REF="STD-Strom-2010" TYPE="STUDY">Strom 2010</LINK>). Two NRS also raised concerns about delay in time to first antibiotic dose associated with restrictive interventions (<LINK REF="STD-LaRosa-2007" TYPE="STUDY">LaRosa 2007</LINK>; <LINK REF="STD-Winters-2010" TYPE="STUDY">Winters 2010</LINK>). Furthermore, four NRS described negative effects of restrictive interventions on professional culture through breakdown in trust and communication (<LINK REF="STD-Baysari-2013" TYPE="STUDY">Baysari 2013</LINK>; <LINK REF="STD-Calfee-2003" TYPE="STUDY">Calfee 2003</LINK>; <LINK REF="STD-Connor-2007" TYPE="STUDY">Connor 2007</LINK>; <LINK REF="STD-Linkin-2007" TYPE="STUDY">Linkin 2007</LINK>). These NRS used either case control, cohort, or qualitative designs because they required collection of data that were not available in routine clinical systems (<LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>).</P>
<P>The ITS studies provided very little evidence about the safety of interventions because they rely on routine clinical systems for outcome measures, which are currently largely incapable of providing information about specific patients, for example those with infection. Moreover, the range of clinical measures should be extended beyond infection outcomes to include safety indicators such as acute kidney injury (AKI). (<LINK REF="STD-Bell-2014" TYPE="STUDY">Bell 2014</LINK>). Scotland&#8217;s Infection Intelligence Platform was established to improve linkage and availability of routine data (<LINK REF="REF-ISD-2016" TYPE="REFERENCE">ISD 2016</LINK>), but research is required to improve timeliness, quality, and relevance of clinical outcome measures and to provide a richer understanding of the unintended consequences of improvement interventions (<LINK REF="REF-SISCC-2016" TYPE="REFERENCE">SISCC 2016</LINK>). We found only one example of a qualitative study of unintended consequences (<LINK REF="STD-Baysari-2013" TYPE="STUDY">Baysari 2013</LINK>). This is an important study design for investigation of unanticipated consequences of interventions and should be more widely used (<LINK REF="REF-Rogers-1995" TYPE="REFERENCE">Rogers 1995</LINK>).</P>
<P>Studying the effect of removal of an intervention can be used to provide additional evidence about the outcomes of the original intervention (<LINK REF="REF-Walker-2016" TYPE="REFERENCE">Walker 2016</LINK>). This study was from the same group that reported that an intervention that was intended to reduce risk of CDI in people undergoing orthopaedic surgery was associated with an increased risk of postoperative AKI (<LINK REF="STD-Bell-2014" TYPE="STUDY">Bell 2014</LINK>) (<LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>). The increase in AKI was attributed to change in antibiotic surgical prophylaxis policy from cefuroxime to flucloxacillin and gentamicin. This second study showed reduction in postoperative AKI associated with a change away from flucloxacillin and gentamicin, which provides persuasive additional evidence that gentamicin was responsible for the original increase in postoperative AKI (<LINK REF="REF-Walker-2016" TYPE="REFERENCE">Walker 2016</LINK>).</P>
<P>Interventions were consistently associated with reduced length of stay (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>), and the results were similar when analysis was restricted to RCTs at low or medium risk of bias (<LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). Measurement of length of stay was intended to provide reassurance about safety of the intervention so that reduction in length of stay is an example of an unanticipated beneficial outcome (<LINK REF="REF-Ash-2007" TYPE="REFERENCE">Ash 2007</LINK>; <LINK REF="REF-Rogers-1995" TYPE="REFERENCE">Rogers 1995</LINK>). We found similar results for interventions that targeted antibiotic choice (<LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>) or antibiotic exposure (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>). One possible mechanism for reduction in length of stay is that interventions reduced the duration of intravenous antibiotic therapy (<LINK REF="REF-Carratala-2012" TYPE="REFERENCE">Carratala 2012</LINK>). However, further research is required.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Microbial outcomes</HEADING>
<P>Interventions were consistently associated with reduction in CDI, but less consistently associated with reduction in infection by resistant bacteria. However, intervention effects on microbial outcomes could only be analysed reliably in planned interventions (<LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>), and our meta-analysis was limited by four technical challenges.</P>
<OL>
<LI>Each study had considerable variance because of the small number of microbial events in each time point.</LI>
<LI>Studies rarely had stable pre-intervention data, so that extrapolation of the pre-intervention trend throughout the postintervention phase was probably unreliable.</LI>
<LI>We analysed a single prescribing outcome for each study (even if more were reported). The criteria for selection of the prescribing outcome were determined by the analysis plan for the effect of interventions on prescribing behaviour. However, these criteria may not have been correct for analysis of the relationship between changes in prescribing and microbial outcomes.</LI>
<LI>We could only analyse the relationship between prescribing and microbial outcomes at fixed time points. We chose six and 12 months, respectively, imposing a six-month time lag for all interventions. However, the time lag will likely vary by prescribing and microbial outcomes, and by intervention context (<LINK REF="REF-Vernaz-2008" TYPE="REFERENCE">Vernaz 2008</LINK>).</LI>
</OL>
</SUBSECTION>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey">
<P>We found high-certainty evidence that interventions increase appropriate use of antibiotics, reduce duration of antibiotic treatment, and shorten hospital stay without increasing the risk of mortality. There was low-certainty evidence that these interventions can delay treatment and create a negative professional culture (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). High risk of bias was associated with greater intervention effect in RCTs (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>) for the outcome of compliance with desired practice. However, we have presented separate analysis of effects for RCTs at low or medium risk of bias (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>; <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). These analyses provide evidence supporting our decision not to downgrade for risk of bias, since excluding studies at high risk of bias did not substantively change the direction of effect. We did not downgrade for inconsistency since the direction of effect across the studies was consistent, and our meta-regression provides some explanation for the high levels of statistical heterogeneity between the results of the studies. The certainty of evidence about adverse effects was more variable, with particular concerns about the unintended consequences of restrictive interventions, namely delays in treatment and negative professional culture, for which we have low-certainty evidence.</P>
<P>The quality of reporting of interventions was poor, which makes it difficult for professionals and clinical teams to reliably implement interventions that have been shown to be useful and for other researchers to replicate or build on research findings (<LINK REF="REF-Hoffmann-2014" TYPE="REFERENCE">Hoffmann 2014</LINK>). We found high-certainty evidence that enablement and restriction both enhanced the effectiveness of interventions. However, we found only moderate-certainty evidence for the effectiveness of feedback, and there were too few studies with action planning and goal setting to provide any reliable information about the combined effects of these behaviour change techniques.</P>
<P>In the analysis of risk of bias equal weight is given to all criteria (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). Our results for microbial outcomes clearly showed that the risk of bias from unplanned interventions is much greater than the risk from other infection control interventions (<LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>; <LINK REF="FIG-14" TYPE="FIGURE">Figure 14</LINK>).</P>
<P>We found that some NRS study designs provided important additional evidence about intervention effects and sustainability in routine clinical practice (ITS studies) and about unintended consequences (case control, cohort, and qualitative studies). However, we found no useful evidence from CBAs or NRTs and suggest that these study designs should not be included in updates to this review.</P>
<SUBSECTION>
<HEADING LEVEL="3">Heterogeneity of intervention effect</HEADING>
<P>We found that two intervention functions, enablement and restriction, explained some of the variation in targeted prescribing behaviour. However, we found little evidence that behaviour change theory had been used to design interventions (<LINK REF="REF-Charani-2011" TYPE="REFERENCE">Charani 2011</LINK>). There were too few interventions with explicit goals or action planning to include these variables in meta-regression.</P>
<P>There was no consistent evidence that intervention setting or target explained variation in the effect of interventions (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>; <LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>)</P>
</SUBSECTION>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2017-01-24 14:08:51 -0500" MODIFIED_BY="Julia Worswick">
<P>Our decision not to use adjusted data for cluster RCTs for the primary analysis could be contested. The consequences of using unadjusted data would be to assign too much weight to cluster studies in the analysis, potentially biasing the effect from our analyses to their results (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We believe that taking clustering into account is unlikely to impact on the strength of the results in such a way as to change the conclusions of the review. Our sensitivity analyses provide some indirect support for the approach we have undertaken. In comparison to unadjusted results, analyses based on the effective sample sizes calculated from assumed ICCs consistently gave a larger average intervention effect (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK> versus <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK> versus <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>; <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK> versus <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>).The increased effect size could be explained by the lower weight assigned to the cluster studies, which tended to have smaller effects than the individually randomised studies.</P>
<P>The electronic literature search did not identify 42 (19%) of the 221 included studies, highlighting some of the challenges in constructing sensitive search terms for reviews of behavioural interventions and the identification of non-randomised studies. It is possible that additional eligible studies have not been retrieved by the search process we undertook for this review.</P>
<P>We did not find evidence of publication bias in the RCTs, however publication bias is more likely in the ITS studies because the decision to publish may have been made after the analysis of intervention effect.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2017-02-21 14:28:38 -0500" MODIFIED_BY="Julia Worswick">
<SUBSECTION>
<HEADING LEVEL="3">Agreements</HEADING>
<P>
<LINK REF="REF-Ivers-2012" TYPE="REFERENCE">Ivers 2012</LINK> included and analysed 140 RCTs that compared any intervention in which audit and feedback was a core, essential component to usual care and evaluated effects on professional practice. The review concluded that interventions were more effective if they also included goal setting and action planning. We were unable to reproduce their analysis because only four of our RCTs included feedback (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>). Although 20 ITS studies included feedback (<LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>), there were not enough studies with goal setting or action planning for reliable analysis.</P>
<P>Our findings are similar to a previous review that found that behavioural determinants and social norms were not given due consideration in the design and evaluation of interventions to change antibiotic prescribing (<LINK REF="REF-Charani-2011" TYPE="REFERENCE">Charani 2011</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Sustainability of intervention effect</HEADING>
<P>We found evidence that removal of restriction, in <LINK REF="STD-Himmelberg-1991" TYPE="STUDY">Himmelberg 1991</LINK>, <LINK REF="STD-Kallen-2009" TYPE="STUDY">Kallen 2009</LINK>, <LINK REF="STD-Kim-2008" TYPE="STUDY">Kim 2008</LINK>, and <LINK REF="STD-Skrlin-2011" TYPE="STUDY">Skrlin 2011</LINK>, or of review and recommend change (enablement, <LINK REF="STD-Standiford-2012" TYPE="STUDY">Standiford 2012</LINK>) was associated with reversal of intervention effect (<LINK REF="TBL-07" TYPE="TABLE">Table 7</LINK>). Three previous studies have shown that removal of financial incentives is associated with reversal of intervention effects in primary care (<LINK REF="REF-Avery-2012" TYPE="REFERENCE">Avery 2012</LINK>; <LINK REF="REF-Dreischulte-2016" TYPE="REFERENCE">Dreischulte 2016</LINK>; <LINK REF="REF-Lester-2010" TYPE="REFERENCE">Lester 2010</LINK>). This is an important issue because the attractiveness of interventions will be reduced if improvement resources cannot be moved on to new priorities. Restriction is a relatively low-cost intervention, but it is worrying that an enabling intervention (review and recommend change) apparently had no sustained effect on clinical teams after being in place for seven years (<LINK REF="STD-Standiford-2012" TYPE="STUDY">Standiford 2012</LINK>). Review and recommend change is a time-intensive process that was included in 36 (54%) of 67 of the enabling interventions in ITS studies.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Disagreements</HEADING>
<P>A systematic review on current evidence about antimicrobial stewardship objectives reported that "guideline-adherent empirical therapy was associated with a reduction for mortality (odds ratio 0.65, 95% CI 0.54-0.80)" (<LINK REF="REF-Schuts-2016" TYPE="REFERENCE">Schuts 2016</LINK>). Only two of the 39 studies in this review reported an intervention: one was invalid because it was an uncontrolled before-after study (<LINK REF="REF-Garcia-2007" TYPE="REFERENCE">Garcia 2007</LINK>), and the other was a CBA (<LINK REF="STD-Dean-2006" TYPE="STUDY">Dean 2006</LINK>). The remaining 37 studies used case control study or cohort designs to compare the outcomes of participants with and without guideline-adherent antibiotic treatment, and did not include an intervention to change professional practice. The results of this review are in marked contrast to our analysis of mortality in 11 RCTs targeting antibiotic choice (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>). The most likely explanation for the discrepancy between our results and <LINK REF="REF-Schuts-2016" TYPE="REFERENCE">Schuts 2016</LINK> is confounding by indication. It is likely that participants with less complex or severe illness were more likely to receive guideline-adherent antibiotic treatment and that there was residual confounding after adjustment for available clinical information.</P>
<P>A systematic review on the effect of antibiotic stewardship programmes on CDI reported that interventions were associated with a consistent, significant protective effect (pooled risk ratio for CDI 0.48, 95% CI 0.38 to 0.62) (<LINK REF="REF-Feazel-2014" TYPE="REFERENCE">Feazel 2014</LINK>). Of the 16 studies included in this systematic review, four were ITS studies that were also included in our review (<LINK REF="STD-Elligsen-2012" TYPE="STUDY">Elligsen 2012</LINK>; <LINK REF="STD-Fowler-2007" TYPE="STUDY">Fowler 2007</LINK>; <LINK REF="STD-Price-2010" TYPE="STUDY">Price 2010</LINK>; <LINK REF="STD-Talpaert-2011" TYPE="STUDY">Talpaert 2011</LINK>), and the remaining 12 studies were either uncontrolled before-after or inadequate ITS studies. The statistical analysis in this review was not appropriate (<LINK REF="REF-Feazel-2014" TYPE="REFERENCE">Feazel 2014</LINK>). Calculation of risk ratios for the post- versus pre-intervention periods is an uncontrolled before-after analysis, which does not provide a reliable estimate of intervention effect.</P>
<P>Additional details about the disagreements with <LINK REF="REF-Feazel-2014" TYPE="REFERENCE">Feazel 2014</LINK> and <LINK REF="REF-Schuts-2016" TYPE="REFERENCE">Schuts 2016</LINK> can be found in <LINK REF="APP-07" TYPE="APPENDIX">Appendix 7</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Limitations</HEADING>
<P>There are five weaknesses in the current evidence.</P>
<OL>
<LI>Evidence of intended effects is unbalanced towards reducing unnecessary treatment (compliance with guidelines that are intended to reduce use of broad-spectrum antibiotics or shorten duration of treatment). More evidence is required about finessing effective treatment of sepsis without also causing excessive use of antibiotics.</LI>
<LI>The limited evidence regarding adverse effects of restrictive interventions suggests that they can be associated with delay in essential treatment. There is a need for better patient safety outcome measures that can be used in studies of interventions in clinical practice.</LI>
<LI>The majority of the interventions do not use effective behaviour change techniques such as action planning or feedback.</LI>
<LI>Given the critical role of junior doctors in antimicrobial stewardship in hospitals, it is surprising that there is only a single example of an intervention that involved junior doctors in self monitoring and reflection on feedback about their prescribing (<LINK REF="STD-Price-2010" TYPE="STUDY">Price 2010</LINK>).</LI>
<LI>Analysis of the impact of interventions on microbial outcomes requires large, multihospital RCTs.</LI>
</OL>
</SUBSECTION>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2017-01-31 09:09:59 -0500" MODIFIED_BY="Petrer Davey">
<IMPLICATIONS_PRACTICE MODIFIED="2017-01-24 14:09:20 -0500" MODIFIED_BY="Julia Worswick">
<P>Reducing antimicrobial resistance and hospital-associated infection is a public health priority. Our review shows that antimicrobial stewardship interventions can safely reduce unnecessary antibiotic use in hospitals, despite the fact that the majority of interventions did not use the most effective behaviour change techniques. Consequently, effective dissemination of the review results could have considerable health service and policy impact through greater use of interventions that enhance enablement.</P>
<P>The randomised controlled trials provided high-certainty evidence that the interventions we have assessed are effective in increasing compliance with guidelines to reduce unnecessary treatment without increasing the risk of mortality. Furthermore, the interventions were associated with reduction in length of stay. The evidence from this review should inform implementation decisions regarding antimicrobial stewardship interventions in hospitals.</P>
<P>In randomised controlled trials and interrupted time series studies, enablement consistently increased the effectiveness of interventions, including restrictive interventions; however, feedback was used in only a minority of enablement interventions, and very few included goal setting or action planning. Antimicrobial management teams might consider using evidence about effective feedback from other clinical settings (<LINK REF="REF-Ivers-2012" TYPE="REFERENCE">Ivers 2012</LINK>). Training in the design and reporting of behaviour change interventions should be a priority for antimicrobial management teams.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2017-01-31 09:09:59 -0500" MODIFIED_BY="Petrer Davey">
<P>Given the high certainty of evidence for our primary outcome, we believe that additional trials comparing antibiotic stewardship with no intervention are unlikely to change our conclusions or build on our understanding of the current evidence. Future research should instead focus on measuring clinical outcomes and assessing other measures of patient safety and different stewardship interventions and explore the barriers and facilitators to implementation.</P>
<P>We included 163 NRS but only 11 of these were about unintended consequences. Moreover only one NRS used qualitative methods, which are likely to be required in addition to survey methods for the investigation of unanticipated consequences (<LINK REF="REF-Rogers-1995" TYPE="REFERENCE">Rogers 1995</LINK>). Future research should make greater use of qualitative methods for investigation of consequences of interventions, for example in process evaluation alongside clinical trials (<LINK REF="REF-Grant-2013" TYPE="REFERENCE">Grant 2013</LINK>). Anticipated, undesirable consequences should be regarded as trade-offs which may need to be accepted in exchange for a greater good (<LINK REF="REF-Ash-2007" TYPE="REFERENCE">Ash 2007</LINK>). Future research should examine how decisions are made about the acceptability of trade-offs (<LINK REF="REF-SISCC-2016" TYPE="REFERENCE">SISCC 2016</LINK>). The purpose, design, and use of balancing measures in quality and safety improvement has been identified as a priority for research on methods in improvement science (<LINK REF="REF-SISCC-2016" TYPE="REFERENCE">SISCC 2016</LINK>). Antimicrobial stewardship is an important topic for further research because of the clear competing risks of excessive use of antibiotics and delayed or ineffective treatment of life threatening infection.</P>
<P>Antibiotic stewardship requires clinicians to change their infection control behaviours. Given that the extent to which current antibiotic stewardship programs have incorporated insights and approaches from behavioural science is limited, there is an urgent need to bring together key stakeholders in the design and delivery of stewardship programmes and research experts in improvement and social sciences to develop more impactful stewardship programmes. We propose three key questions, which a Transnational Working Group within the Joint Programming Initiative in Antimicrobial Resistance will address in 2017 (<LINK REF="REF-JPIAMR-2016" TYPE="REFERENCE">JPIAMR 2016</LINK>):</P>
<OL>
<LI>What behaviour change approaches can be recommended now to optimise hospital stewardship programmes?</LI>
<LI>How can hospital stewardship programmes be designed to maximise implementation across countries?</LI>
<LI>What is the research agenda to optimise efficient implementation of antibiotic stewardship programmes worldwide?</LI>
</OL>
<P>We were unable to perform reliable evidence synthesis on the relationship between prescribing and microbial outcomes with segmented regression analysis of interrupted time series studies from single hospitals. There is an urgent need for co-ordinated, multicentre research studies.</P>
<P>We found consistent evidence of reduced length of stay as an unanticipated beneficial consequence of interventions that targeted either choice of antibiotic or duration of antibiotic treatment. Further research is required to understand the mechanism for this effect.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2017-02-03 09:53:36 -0500" MODIFIED_BY="Julia Worswick">
<P>Lynda Fenelon, Roger Finch, Giles Hartman, Alison Holmes, Eric Taylor, Phil Wiffen, and Mark Wilcox were authors on the previous versions of this review.</P>
<P>We are grateful to Vittoria Lutje and Virginia Hernandez-Santiago for help with screening of titles and abstracts.</P>
<P>We are grateful to Weihua Meng, Celine Pulcini, and Virginia Hernandez-Santiago for help with translation of papers from Chinese, French, and Spanish.</P>
<P>We are grateful to Jemma Hudson (Statistician), Paul Miller (Information Specialist), Kay Wang (External Referee), Atle Fretheim (Internal Editor), Sasha Shepperd (Contact Editor), and Julia Worswick (Managing Editor) for their comments and contributions to the review.</P>
<P>We are grateful to the Chief Scientist Office for a major grant that funded Claire Scott full time for 18 months (CSO CZH_4_861) and to the British Society for Antimicrobial Chemotherapy for their significant financial support for the costs of meetings, literature searches, obtaining full texts of papers, and construction of a web-based system for double data entry. We are grateful to Keith Milburn for creating and managing the online database.</P>
<P>The authors (EC) would also like to acknowledge the National Institute of Health Research Imperial Biomedical Research Centre and the National Institute for Health Research, Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London in partnership with Public Health England (PHE) and the NIHR Imperial Patient Safety Translational Research Centre.</P>
<P>This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding and a Cochrane programme grant to the EPOC Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2017-01-18 10:06:39 -0500" MODIFIED_BY="Julia Worswick">
<P>Peter Davey is an author of four of the included studies. Charis Marwick is an author of two of the included studies. Ian Gould is an author of one of the included studies. Craig Ramsay is an author of one of the included studies. Other review authors completed data extractions for these studies. The institutions of the following authors received funding from the Chief Scientist Office that helped to support the conduct of this review: Peter Davey, Charis Marwick, Esmita Charani.</P>
<P>Peter Davey, none other than as indicated above.<BR/>Charis Marwick, none other than as indicated above.<BR/>Claire Scott, none other than as indicated above.<BR/>Esmita Charani, none other than as indicated above.<BR/>Kirsty McNeil, none other than as indicated above.<BR/>Susan Michie, none other than as indicated above.<BR/>Erwin Brown, none other than as indicated above.<BR/>Ian Gould, none other than as indicated above.<BR/>Craig Ramsay, none other than as indicated above.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey">
<P>Peter Davey (Clinical Pharmacologist) wrote the protocol; assisted with the literature search; reviewed all intervention studies for risk of bias using Cochrane Effective Practice and Organisation of Care (EPOC) Group methodology; contributed to re-analysis of data from interrupted time series (ITS) studies and meta-regression of ITS studies and randomised controlled trials (RCTs); wrote the first draft of the review and was responsible for final decisions about included studies; contributed to EPOC check sheets, data extraction, and GRADE assessment of certainty of evidence.<BR/>
<BR/>Charis Marwick (Infectious Diseases Physician) re-analysed all of the ITS studies and performed meta-regression of ITS studies and RCTs with an analysis plan written by Craig Ramsay (Statistician); was a member of the review writing group; and contributed to EPOC check sheets, data extraction, and GRADE assessment of certainty of evidence.</P>
<P>Claire Scott (Psychologist) managed the review; set up the database; was a member of the review writing group; and contributed to EPOC check sheets, data extraction, and GRADE assessment of certainty of evidence.</P>
<P>Esmita Charani (Pharmacist) and Kirsty McNeil (Medical Student) were members of the review writing group and contributed to EPOC check sheets, data extraction, and GRADE assessment of certainty of evidence.</P>
<P>Erwin Brown (Medical Microbiologist) initiated the review in 2000 and for this update handsearched bibliographies of individual papers for additional references; screened titles and abstracts; and reviewed all papers to identify those that reported the results of an intervention to change antibiotic prescribing.</P>
<P>Ian Gould (Medical Microbiologist) reviewed papers for microbial risk of bias and was a member of the review writing group.<BR/>
<BR/>Craig Ramsay (Statistician) wrote the analysis plan for re-analysis of ITS studies and meta-regression of ITS studies and RCTs.</P>
<P>Susan Michie (Psychologist) advised on the design of data extraction for behaviour change techniques and the analysis of intervention functions; was a member of the review writing group; and contributed to GRADE assessment of certainty of evidence.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey">
<P>The protocol was completely revised for this update of the review. The most notable changes to the original protocol used for the first version of the review are as follows.</P>
<OL>
<LI>We amended the main outcome of interest to reflect desired change in practice. This fits better with the overall objective of the review relating to appropriate prescription in order to provide evidence of better targeting of antibiotic prescribing.</LI>
<LI>We changed the measure of effect from risk ratios to risk differences to better convey the intervention effect in absolute terms.</LI>
<LI>We adjusted for the effect of clustering in sensitivity analyses, as we had not considered this aspect of trial design in the previous version of the review.</LI>
</OL>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2017-02-21 19:38:49 +0000" MODIFIED_BY="Julia Worswick">
<STUDIES MODIFIED="2017-01-19 09:04:16 -0500" MODIFIED_BY="Julia Worswick">
<INCLUDED_STUDIES MODIFIED="2017-01-18 12:06:42 -0500" MODIFIED_BY="Julia Worswick">
<STUDY DATA_SOURCE="PUB" ID="STD-Abramowitz-1982" MODIFIED="2013-02-14 14:43:31 -0500" MODIFIED_BY="[Empty name]" NAME="Abramowitz 1982" YEAR="1982">
<REFERENCE MODIFIED="2013-02-14 14:43:31 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;The financial impact of using cefamandole and cefoxitin rather than cefazolin and of using ticarcillin rather than carbenicillin was assessed; the effectiveness of using clinical pharmacists in reducing costs associated with these drugs was also determined&lt;/p&gt;" NOTES_MODIFIED="2013-02-14 14:43:31 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abramowitz PW, Nold EG, Hatfield SM</AU>
<TI>Use of clinical pharmacists to reduce cefamandole, cefoxitin and ticarcillin costs</TI>
<SO>American Journal of Hospital Pharmacy</SO>
<YR>1982</YR>
<VL>39</VL>
<PG>1176-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839546"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839545"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Adachi-1997" NAME="Adachi 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Adachi W, Bolding F, Armstrong R</AU>
<TI>Experience with vancomycin education and order sheet to limit vancomycin use</TI>
<SO>Hospital Pharmacy</SO>
<YR>1997</YR>
<VL>32</VL>
<PG>1370-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839548"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839547"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Akenroye-2014" MODIFIED="2016-12-07 13:33:58 -0500" MODIFIED_BY="Julia Worswick" NAME="Akenroye 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-12-07 13:33:58 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Akenroye AT, Baskin MN, Samnaliev M, Stack AM</AU>
<TI>Impact of a bronchiolitis guideline on ED resource use and cost: a segmented time-series analysis</TI>
<SO>Pediatrics</SO>
<YR>2014</YR>
<VL>133</VL>
<PG>e227-34</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839550"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839549"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aldeyab-2012" MODIFIED="2015-11-29 01:17:45 -0500" MODIFIED_BY="[Empty name]" NAME="Aldeyab 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-11-29 01:17:45 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( Article Number: dks330 Date of Publication: December 2012&lt;/p&gt;" NOTES_MODIFIED="2015-11-29 01:17:45 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aldeyab M, Kearney M, Scott M, Aldiab M, Alahmadi Y, Darwish Elhajji F, et al</AU>
<TI>An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2012</YR>
<VL>67</VL>
<PG>2988-96</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839552"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839551"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aldeyab-2014" MODIFIED="2016-12-07 13:09:58 -0500" MODIFIED_BY="Julia Worswick" NAME="Aldeyab 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-12-07 13:09:58 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aldeyab MA, Scott MG, Kearney MP, Alahmadi YM, Magee FA, Conlon G, et al</AU>
<TI>Impact of an enhanced antibiotic stewardship on reducing methicillin-resistant Staphylococcus aureus in primary and secondary healthcare settings</TI>
<SO>Epidemiology and Infection</SO>
<YR>2014</YR>
<VL>142</VL>
<PG>494-500</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839554"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839553"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ananda_x002d_Rajah-2010" MODIFIED="2016-12-07 13:34:29 -0500" MODIFIED_BY="Julia Worswick" NAME="Ananda-Rajah 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-12-07 13:34:29 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;JC - h2j, 7704851SB - IMCP - United StatesLG - EnglishDC - 20101011ED 20110222OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-EPOC&lt;br&gt;PM: 20689907&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:34:29 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ananda-Rajah MR, McBryde ES, Buising KL, Redl L, Macisaac C, Cade JF, et al</AU>
<TI>The role of general quality improvement measures in decreasing the burden of endemic MRSA in a medical-surgical intensive care unit</TI>
<SO>Intensive Care Medicine</SO>
<YR>2010</YR>
<VL>36</VL>
<PG>1890-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839556"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839555"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Annane-2013" MODIFIED="2016-12-07 13:35:23 -0500" MODIFIED_BY="Julia Worswick" NAME="Annane 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-12-07 13:35:23 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Annane D, Maxime V, Faller JP, Mezher C, Clec'h C, Martel P, et al</AU>
<TI>Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial</TI>
<SO>BMJ Open</SO>
<YR>2013</YR>
<VL>3</VL>
<PG>e002186</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839558"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839557"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ansari-2003" MODIFIED="2009-04-08 03:53:06 -0400" MODIFIED_BY="Philip J Wiffen" NAME="Ansari 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-04-08 03:53:06 -0400" MODIFIED_BY="Philip J Wiffen" NOTES="NOT IN FILE" NOTES_MODIFIED="2009-04-08 03:53:06 -0400" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ansari F, Gray K, Nathwani D, Phillips G, Ogston S, Ramsay C, et al</AU>
<TI>Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2003</YR>
<VL>52</VL>
<NO>5</NO>
<PG>842-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839560"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839559"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Avorn-1988" NAME="Avorn 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Avorn J, Soumerai SB, Taylor W, Wessels MR, Janousek J, Weiner M</AU>
<TI>Reduction of incorrect antibiotic dosing through a structured educational order form</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1988</YR>
<VL>148</VL>
<PG>1720-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839562"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839561"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bailey-1997" NAME="Bailey 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bailey TC, Ritchie DJ, McMullin ST, Kahn M, Reichley RM, Casabar E, et al</AU>
<TI>A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions</TI>
<SO>Pharmacotherapy</SO>
<YR>1997</YR>
<VL>17</VL>
<NO>2</NO>
<PG>277-81</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839564"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839563"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bantar-2006" MODIFIED="2014-10-29 11:43:54 -0400" MODIFIED_BY="Claire Peden" NAME="Bantar 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-10-29 11:43:54 -0400" MODIFIED_BY="Claire Peden" NOTES="&lt;p&gt;JC - c3r, 9610933SB - IMCP - CanadaLG - EnglishDC - 20060426ED 20060627OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2014-10-29 11:43:54 -0400" NOTES_MODIFIED_BY="Claire Peden" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bantar C, Franco D, Heft C, Vesco E, Arango C, Izaguirre M, et al</AU>
<TI>Does a reduction in antibiotic consumption always represent a favorable outcome from an intervention program on prescribing practice?</TI>
<SO>International Journal of Infectious Diseases</SO>
<YR>2006</YR>
<VL>10</VL>
<PG>231-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839566"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839565"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barlow-2007" MODIFIED="2017-01-07 22:52:12 -0500" MODIFIED_BY="[Empty name]" NAME="Barlow 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-01-07 22:52:12 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;CP - United KingdomRF - 3LG - EnglishEM - 200600DD - 20090524&lt;br&gt;EM2-EPOC-2006-2012&lt;br&gt;EM 2006167410&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 22:52:12 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barlow G, Nathwani D, Davey P</AU>
<TI>The effect of implementing the British Thoracic Society community-acquired pneumonia guidelines on antibiotic prescribing and costs in a UK teaching hospital</TI>
<SO>Clinical Microbiology and Infection</SO>
<YR>2006</YR>
<VL>12</VL>
<PG>498-500</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889685"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-12-01 10:44:59 -0500" MODIFIED_BY="Julia Worswick" NOTES="eng" NOTES_MODIFIED="2016-12-01 10:44:59 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Barlow G, Nathwani D, Williams F, Ogston S, Winter J, Jones M, et al</AU>
<TI>Reducing door-to-antibiotic time in community-acquired pneumonia: Controlled before-and-after evaluation and cost-effectiveness analysis</TI>
<SO>Thorax</SO>
<YR>2007</YR>
<VL>62</VL>
<NO>1</NO>
<PG>67-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839568"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839567"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bassetti-2009" MODIFIED="2016-12-07 13:35:51 -0500" MODIFIED_BY="Julia Worswick" NAME="Bassetti 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-12-07 13:35:51 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;CM - Comment in: J Chemother. 2010 Dec;22(6):431; author reply 432; PMID: 21303754JC - jcy, 8907348SB - IMCP - ItalyLG - EnglishDC - 20100114ED 20100309OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-RCT&lt;br&gt;PM: 20071286&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:35:51 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bassetti M, Righi E, Ansaldi F, Molinari MP, Rebesco B, McDermott JL, et al</AU>
<TI>Impact of limited cephalosporin use on prevalence of methicillin-resistant Staphylococcus aureus in the intensive care unit</TI>
<SO>Journal of Chemotherapy</SO>
<YR>2009</YR>
<VL>21</VL>
<PG>633-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839570"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839569"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baysari-2013" MODIFIED="2017-01-07 22:53:04 -0500" MODIFIED_BY="[Empty name]" NAME="Baysari 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-01-07 22:53:04 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baysari MT, Oliver K, Egan B, Li L, Richardson K, Sandaradura I, et al</AU>
<TI>Audit and feedback of antibiotic use: utilising electronic prescription data</TI>
<SO>Applied Clinical Informatics</SO>
<YR>2013</YR>
<VL>4</VL>
<PG>583-95</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839572"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839571"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bell-2014" MODIFIED="2015-04-03 23:41:52 -0400" MODIFIED_BY="[Empty name]" NAME="Bell 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-04-03 23:41:52 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bell S, Davey P, Nathwani D, Marwick C, Vadiveloo T, Sneddon J, et al</AU>
<TI>Risk of Acute Kidney Injury with gentamicin as surgical prophylaxis</TI>
<SO>JASN Journal of the American Society of Nephrologists</SO>
<YR>2014</YR>
<VL>25</VL>
<PG>2625-32</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839574"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839573"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Belliveau-1996" NAME="Belliveau 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Belliveau PP, Rothman AL, Maday CE</AU>
<TI>Limiting vancomycin use to combat vancomycin-resistant Enterococcus faecium</TI>
<SO>American Journal of Health-System Pharmacy</SO>
<YR>1996</YR>
<VL>53</VL>
<NO>13</NO>
<PG>1570-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839576"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839575"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Benson-2014" MODIFIED="2017-01-07 22:54:40 -0500" MODIFIED_BY="[Empty name]" NAME="Benson 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-01-07 22:54:40 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Benson JM</AU>
<TI>Incorporating pharmacy student activities into an antimicrobial stewardship program in a long-term acute care hospital</TI>
<SO>American Journal of Health-System Pharmacy</SO>
<YR>2014</YR>
<VL>71</VL>
<PG>227-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839578"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839577"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Berild-2002" MODIFIED="2013-02-14 16:20:31 -0500" MODIFIED_BY="[Empty name]" NAME="Berild 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-02-14 16:20:31 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Berild D, Ringertz SH, Aabyholm G, Lelek M, Fosse B</AU>
<TI>Impact of an antibiotic policy on antibiotic use in a paediatric department. Individual based follow-up shows that antibiotics were chosen according to diagnoses and bacterial findings</TI>
<SO>International Journal of Antimicrobial Agents</SO>
<YR>2002</YR>
<VL>20</VL>
<PG>333-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839580"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839579"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Borde-2014a" MODIFIED="2016-12-07 13:36:38 -0500" MODIFIED_BY="Julia Worswick" NAME="Borde 2014a" YEAR="2014">
<REFERENCE MODIFIED="2016-12-07 13:36:38 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Borde JP, Kaier K, Steib-Bauert M, Vach W, Geibel-Zehender A, Busch H, et al</AU>
<TI>Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center</TI>
<SO>BMC Infectious Diseases</SO>
<YR>2014</YR>
<VL>14</VL>
<PG>201</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839582"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839581"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Borde-2014b" MODIFIED="2017-01-07 22:57:11 -0500" MODIFIED_BY="[Empty name]" NAME="Borde 2014b" YEAR="2014">
<REFERENCE MODIFIED="2017-01-07 22:57:11 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Borde JP, Batin N, Rieg S, Feik R, Reimling C, Kern WV, et al</AU>
<TI>Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital</TI>
<SO>Infection</SO>
<YR>2014</YR>
<VL>42</VL>
<NO>4</NO>
<PG>713-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839584"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839583"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Borde-2015a" MODIFIED="2016-12-07 13:10:30 -0500" MODIFIED_BY="Julia Worswick" NAME="Borde 2015a" YEAR="2015">
<REFERENCE MODIFIED="2016-12-07 13:10:30 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Borde, Johannes P&lt;br&gt;Kern, Winfried V&lt;br&gt;Hug, Martin&lt;br&gt;Steib-Bauert, Michaela&lt;br&gt;With, Katja de&lt;br&gt;Busch, Hans-Jorg&lt;br&gt;Kaier, Klaus&lt;br&gt;Emergency medicine journal : EMJ&lt;br&gt;Emerg Med J. 2014 Sep 26. pii: emermed-2014-204067. doi: 10.1136/emermed-2014-204067.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:10:30 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Borde JP, Kern WV, Hug M, Steib-Bauert M, With KD, Busch HJ, et al</AU>
<TI>Implementation of an intensified antibiotic stewardship programme targeting third-generation cephalosporin and fluoroquinolone use in an emergency medicine department</TI>
<SO>Emergency Medicine Journal (EMJ)</SO>
<YR>2015</YR>
<VL>32</VL>
<NO>7</NO>
<PG>509-15</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839586"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839585"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Borde-2015b" MODIFIED="2017-01-07 22:57:44 -0500" MODIFIED_BY="[Empty name]" NAME="Borde 2015b" YEAR="2015">
<REFERENCE MODIFIED="2017-01-07 22:57:44 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Borde, J P&lt;br&gt;Litterst, S&lt;br&gt;Ruhnke, M&lt;br&gt;Feik, R&lt;br&gt;Hubner, J&lt;br&gt;deWith, K&lt;br&gt;Kaier, K&lt;br&gt;Kern, W V&lt;br&gt;Infection&lt;br&gt;Infection. 2014 Oct 25.&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 22:57:44 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Borde JP, Litterst S, Ruhnke M, Feik R, Hubner J, deWith K, et al</AU>
<TI>Implementing an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a 200-bed community hospital in Germany</TI>
<SO>Infection</SO>
<YR>2015</YR>
<VL>43</VL>
<NO>1</NO>
<PG>45-50</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839588"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839587"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bouadma-2010" MODIFIED="2016-12-07 13:36:59 -0500" MODIFIED_BY="Julia Worswick" NAME="Bouadma 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-12-01 10:48:57 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;OT - Antibiotikamanagement mittels Prokalzitoninspiegel: PRORATA-Studie (PROcalcitonin to Reduce Antibiotika Treatments in Acutely ill patients)CM - Comment on: Lancet. 2010 Feb 6;375(9713):463-74; PMID: 20097417JC - 0264620, gvxCP - GermanyLG - GermanDC - 20101206ED 20110504OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-RCT&lt;br&gt;PM: 21104218&lt;/p&gt;" NOTES_MODIFIED="2016-12-01 10:48:57 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bogner J, Nitschmann S</AU>
<TI>Management of antibiotics in regard of procalcitonin levels: PRORATA trial (PROcalcitonin to Reduce Antibiotic Treatments in Acutely ill patients)</TI>
<SO>Internist</SO>
<YR>2010</YR>
<VL>51</VL>
<PG>1582-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889686"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-12-07 13:36:59 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;CM - Comment in: Lancet. 2010 Feb 6;375(9713):435-6; PMID: 20097416, Comment in: Lancet. 2010 May 8;375(9726):1605; author reply 1606-7; PMID: 20452515, Comment in: Internist (Berl). 2010 Dec;51(12):1582-4; PMID: 21104218, Comment in: Lancet. 2010 May 8;375(9726):1605-6; author reply 1606-7; PMID: 20452514, Comment in: Lancet. 2010 May 8;375(9726):1606; author reply 1606-7; PMID: 20452516, Comment in: Lancet. 2010 May 8;375(9726):1605; author reply 1606-7; PMID: 20452513JC - 2985213r, l0s, 0053266SB - AIM, IMCP - EnglandSI - ClinicalTrials.govSA - ClinicalTrials.gov/NCT00472667LG - EnglishDC - 20100215ED 20100308OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-RCT&lt;br&gt;PM: 20097417&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:36:59 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, et al</AU>
<TI>Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2010</YR>
<VL>375</VL>
<PG>463-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839590"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839589"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bouza-2004" MODIFIED="2017-01-07 22:59:12 -0500" MODIFIED_BY="[Empty name]" NAME="Bouza 2004" YEAR="2004">
<REFERENCE MODIFIED="2017-01-07 22:59:12 -0500" MODIFIED_BY="[Empty name]" NOTES="eng" NOTES_MODIFIED="2017-01-07 22:59:12 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bouza E, Sousa D, Munoz P, Rodriguez-Creixems M, Fron C, Lechuz JG</AU>
<TI>Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2004</YR>
<VL>39</VL>
<NO>8</NO>
<PG>1161-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839592"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839591"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bouza-2007" MODIFIED="2017-01-07 22:59:50 -0500" MODIFIED_BY="[Empty name]" NAME="Bouza 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-01-07 22:59:50 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;IN - Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Maranon, Universidad Complutense, Madrid, Spain. ebouza@microb.netCochrane Acute Respiratory Infections Group PubMed Identifier 17205445 10.1086/510587 Coch-2012&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 22:59:50 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bouza E, Torres MV, Radice C, Cercenado E, de Diego R, Sanchez-Carrillo C, et al</AU>
<TI>Direct E-test (AB Biodisk) of respiratory samples improves antimicrobial use in ventilator-associated pneumonia</TI>
<SO>Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America</SO>
<YR>2007</YR>
<VL>44</VL>
<PG>382-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839594"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839593"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bradley-1999" NAME="Bradley 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bradley SJ, Wilson ALT, Allen MC, Sher HA, Goldstone AH, Scott GM</AU>
<TI>The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>1999</YR>
<VL>43</VL>
<NO>2</NO>
<PG>261-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839596"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839595"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bruins-2005" MODIFIED="2013-02-14 14:46:04 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Bruins 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-02-14 14:46:04 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="eng" NOTES_MODIFIED="2013-02-14 14:46:04 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bruins M, Oord H, Bloembergen P, Wolfhagen M, Casparie A, Degener J, et al</AU>
<TI>Lack of effect of shorter turnaround time of microbiological procedures on clinical outcomes: a randomised controlled trial among hospitalised patients in the Netherlands</TI>
<SO>European Journal of Clinical Microbiology and Infectious Diseases</SO>
<YR>2005</YR>
<VL>24</VL>
<NO>5</NO>
<PG>305-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839598"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839597"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Buising-2008a" MODIFIED="2017-01-07 23:01:36 -0500" MODIFIED_BY="[Empty name]" NAME="Buising 2008a" YEAR="2008">
<REFERENCE MODIFIED="2017-01-07 23:01:36 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Buising, K L&lt;br&gt;Thursky, K A&lt;br&gt;Robertson, M B&lt;br&gt;Black, J F&lt;br&gt;Street, A C&lt;br&gt;Richards, M J&lt;br&gt;Brown, G V&lt;br&gt;eng&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;England&lt;br&gt;2008/06/14 09:00&lt;br&gt;J Antimicrob Chemother. 2008 Sep;62(3):608-16. doi: 10.1093/jac/dkn218. Epub 2008 Jun 11.&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 23:01:36 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Buising KL, Thursky KA, Robertson MB, Black JF, Street AC, Richards MJ, et al</AU>
<TI>Electronic antibiotic stewardship - reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2008</YR>
<VL>62</VL>
<PG>608-16</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839600"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839599"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Buising-2008b" MODIFIED="2017-01-09 13:41:18 -0500" MODIFIED_BY="Julia Worswick" NAME="Buising 2008b" YEAR="2008">
<REFERENCE MODIFIED="2017-01-09 13:41:18 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;JC - 101088682SB - IMCP - EnglandLG - EnglishDC - 20080902ED 20080911OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2017-01-09 13:41:18 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Buising KL, Thursky KA, Black JF, MacGregor L, Street AC, Kennedy MP, et al</AU>
<TI>Improving antibiotic prescribing for adults with community acquired pneumonia: Does a computerised decision support system achieve more than academic detailing alone? A time series analysis</TI>
<SO>BMC Medical Informatics &amp; Decision Making</SO>
<YR>2008</YR>
<VL>8</VL>
<PG>35</PG>
<IDENTIFIERS MODIFIED="2017-01-07 23:03:07 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839602"/><IDENTIFIER MODIFIED="2017-01-07 23:03:07 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1186/1472-6947-8-35"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839601"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bunz-1990" NAME="Bunz 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bunz D, Gupta S, Jewesson P</AU>
<TI>Metronidazole cost containment: a two-stage intervention</TI>
<SO>Hospital Formulary</SO>
<YR>1990</YR>
<VL>25</VL>
<NO>11</NO>
<PG>1167-77</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839604"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839603"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burton-1991" NAME="Burton 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burton ME, Ash CL, Hill DP, Handy T, Shepherd MD, Vasko MR</AU>
<TI>A controlled trial of the cost benefit of computerized bayesian aminoglycoside administration</TI>
<SO>Clinical Pharmacology Therapeutics</SO>
<YR>1991</YR>
<VL>49</VL>
<NO>6</NO>
<PG>685-94</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839606"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839605"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buyle-2010" MODIFIED="2014-10-29 11:43:54 -0400" MODIFIED_BY="Claire Peden" NAME="Buyle 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-10-29 11:43:54 -0400" MODIFIED_BY="Claire Peden" NOTES="&lt;p&gt;JC - bo7, 9307352SB - IMCP - NetherlandsLG - EnglishDC - 20100521ED 20110126OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2014-10-29 11:43:54 -0400" NOTES_MODIFIED_BY="Claire Peden" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Buyle F, Vogelaers D, Peleman R, Van Maele G, Robays H</AU>
<TI>Implementation of guidelines for sequential therapy with fluoroquinolones in a Belgian hospital</TI>
<SO>Pharmacy World &amp; Science</SO>
<YR>2010</YR>
<VL>32</VL>
<PG>404-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839608"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839607"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Calfee-2003" MODIFIED="2016-12-07 12:53:50 -0500" MODIFIED_BY="Julia Worswick" NAME="Calfee 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-12-07 12:53:50 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Calfee DP, Brooks J, Zirk NM, Giannetta ET, Scheld WM, Farr BM</AU>
<TI>A pseudo-outbreak of nosocomial infections associated with the introduction of an antibiotic management programme</TI>
<SO>Journal of Hospital Infection</SO>
<YR>2003</YR>
<VL>55</VL>
<NO>1</NO>
<PG>26-32</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839610"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839609"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Calil-2001" MODIFIED="2013-03-18 13:45:04 -0400" MODIFIED_BY="Kate Cahill" NAME="Calil 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-03-18 13:45:04 -0400" MODIFIED_BY="Kate Cahill" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Calil R, Marba ST, Von Nowakonski A, Tresoldi AT</AU>
<TI>Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins</TI>
<SO>American Journal of Infection Control</SO>
<YR>2001</YR>
<VL>29</VL>
<NO>3</NO>
<PG>133-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839612"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839611"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Camins-2009" MODIFIED="2016-12-07 12:54:56 -0500" MODIFIED_BY="Julia Worswick" NAME="Camins 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-12-07 12:54:56 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Camins, Bernard C&lt;br&gt;King, Mark D&lt;br&gt;Wells, Jane B&lt;br&gt;Googe, Heidi L&lt;br&gt;Patel, Manish&lt;br&gt;Kourbatova, Ekaterina V&lt;br&gt;Blumberg, Henry M&lt;br&gt;K12 RR017643/RR/NCRR NIH HHS/United States&lt;br&gt;K12 RR017643-05/RR/NCRR NIH HHS/United States&lt;br&gt;K23 AI054371/AI/NIAID NIH HHS/United States&lt;br&gt;K23 AI054371-01A1/AI/NIAID NIH HHS/United States&lt;br&gt;UL1 RR024992-01/RR/NCRR NIH HHS/United States&lt;br&gt;UL1 RR025008/RR/NCRR NIH HHS/United States&lt;br&gt;UL1 RR025008-02/RR/NCRR NIH HHS/United States&lt;br&gt;UL1RR024992/RR/NCRR NIH HHS/United States&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, N.I.H., Extramural&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;United States&lt;br&gt;Infect Control Hosp Epidemiol. 2009 Oct;30(10):931-8. doi: 10.1086/605924.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 12:54:56 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Camins BC, King MD, Wells JB, Googe HL, Patel M, Kourbatova EV, et al</AU>
<TI>Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2009</YR>
<VL>30</VL>
<PG>931-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839614"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839613"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carling-2003" NAME="Carling 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carling P, Fung T, Killion A, Terrin N, Barza M</AU>
<TI>Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2003</YR>
<VL>24</VL>
<NO>9</NO>
<PG>699-706</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839616"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839615"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chan-2011" MODIFIED="2017-01-07 23:06:01 -0500" MODIFIED_BY="[Empty name]" NAME="Chan 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-01-07 23:06:01 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;CP - NetherlandsRF - 22LG - EnglishEM - 201100DD - 20111126&lt;br&gt;EM2-EPOC-2006-2012&lt;br&gt;EM 2011604023&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 23:06:01 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chan YY, Lin TY, Huang CT, Deng ST, Wu TL, Leu HS, et al</AU>
<TI>Implementation and outcomes of a hospital-wide computerised antimicrobial stewardship programme in a large medical centre in Taiwan</TI>
<SO>International Journal of Antimicrobial Agents</SO>
<YR>2011</YR>
<VL>38</VL>
<NO>6</NO>
<PG>486-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839618"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839617"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chan-2015" MODIFIED="2017-01-07 23:06:37 -0500" MODIFIED_BY="[Empty name]" NAME="Chan 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-01-07 23:06:37 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Chan, Shannon&lt;br&gt;Hossain, Jobayer&lt;br&gt;Di Pentima, M Cecilia&lt;br&gt;The Pediatric infectious disease journal&lt;br&gt;Pediatr Infect Dis J. 2014 Nov 6.&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 23:06:37 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chan S, Hossain J, Di Pentima MC</AU>
<TI>Implications and impact of prior authorization policy on vancomycin use at a tertiary pediatric teaching hospital</TI>
<SO>Pediatric Infectious Disease Journal</SO>
<YR>2015</YR>
<VL>34</VL>
<NO>5</NO>
<PG>506-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839620"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839619"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Chandy-2014" MODIFIED="2017-01-07 23:07:23 -0500" MODIFIED_BY="[Empty name]" NAME="Chandy 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-01-07 23:07:23 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chandy SJ, Naik GS, Charles R, Jeyaseelan V, Naumova EN, Thomas K, et al</AU>
<TI>The impact of policy guidelines on hospital antibiotic use over a decade: A segmented time series analysis</TI>
<SO>PLoS ONE</SO>
<YR>2014</YR>
<VL>9</VL>
<NO>3</NO>
<PG>e92206</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839622"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839621"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Charbonneau-2006" MODIFIED="2016-12-07 13:38:50 -0500" MODIFIED_BY="Julia Worswick" NAME="Charbonneau 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-12-07 13:38:50 -0500" MODIFIED_BY="Julia Worswick" NOTES="eng" NOTES_MODIFIED="2016-12-07 13:38:50 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Charbonneau P, Parienti JJ, Thibon P, Ramakers M, Daubin C, du Cheyron D, et al</AU>
<TI>Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2006</YR>
<VL>42</VL>
<NO>6</NO>
<PG>778-84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839624"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839623"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cheng-2009" MODIFIED="2016-09-28 08:52:59 -0400" MODIFIED_BY="Paul Miller" NAME="Cheng 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-09-28 08:52:59 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cheng VCC, To KKW, Li IWS, Tang BSF, Chan JFW, Kwan S, et al</AU>
<TI>Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital</TI>
<SO>European Journal of Clinical Microbiology &amp; Infectious Diseases</SO>
<YR>2009</YR>
<VL>28</VL>
<PG>1447-56</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839626"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839625"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Christ_x002d_Crain-2004" MODIFIED="2013-02-14 16:28:56 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Christ-Crain 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-02-14 16:28:56 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="eng" NOTES_MODIFIED="2013-02-14 16:28:56 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al</AU>
<TI>Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial</TI>
<SO>Lancet</SO>
<YR>2004</YR>
<VL>363</VL>
<NO>9409</NO>
<PG>600-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839628"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839627"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Christ_x002d_Crain-2006" MODIFIED="2017-01-07 23:08:44 -0500" MODIFIED_BY="[Empty name]" NAME="Christ-Crain 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-01-07 23:08:44 -0500" MODIFIED_BY="[Empty name]" NOTES="eng" NOTES_MODIFIED="2017-01-07 23:08:44 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, et al</AU>
<TI>Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2006</YR>
<VL>174</VL>
<NO>1</NO>
<PG>84-93</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839630"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839629"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chu-2003" NAME="Chu 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chu LA, Bratzler DW, Lewis RJ, Murray C, Moore L, Shook C, et al</AU>
<TI>Improving the quality of care for patients with pneumonia in very small hospitals</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2003</YR>
<VL>163</VL>
<NO>3</NO>
<PG>326-32</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839632"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839631"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clerc-2014" MODIFIED="2017-01-07 23:10:27 -0500" MODIFIED_BY="[Empty name]" NAME="Clerc 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-01-07 23:10:27 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Journal: Article&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 23:10:27 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Clerc O, Prod'hom G, Senn L, Jaton K, Zanetti G, Calandra T, et al</AU>
<TI>Matrix-assisted laser desorption ionization time-of-flight mass spectrometry and PCR-based rapid diagnosis of Staphylococcus aureus bacteraemia</TI>
<SO>Clinical Microbiology and Infection</SO>
<YR>2014</YR>
<VL>20</VL>
<NO>4</NO>
<PG>355-60</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839634"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839633"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Climo-1998" MODIFIED="2010-08-11 04:58:16 -0400" MODIFIED_BY="[Empty name]" NAME="Climo 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Climo MW, Israel DS, Wong ES, Williams D, Coudron P, Markowitz SM</AU>
<TI>Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1998</YR>
<VL>128</VL>
<NO>12 Pt 1</NO>
<PG>989-95</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839636"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839635"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Connor-2007" MODIFIED="2016-12-07 13:39:23 -0500" MODIFIED_BY="Julia Worswick" NAME="Connor 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-12-07 13:39:23 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Connor, Denise M&lt;br&gt;Binkley, Shawn&lt;br&gt;Fishman, Neil O&lt;br&gt;Gasink, Leanne B&lt;br&gt;Linkin, Darren&lt;br&gt;Lautenbach, Ebbing&lt;br&gt;Infect Control Hosp Epidemiol. 2007 Dec;28(12):1408-10. Epub 2007 Nov 1.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:39:23 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Connor DM, Binkley S, Fishman NO, Gasink LB, Linkin D, Lautenbach E</AU>
<TI>Impact of automatic orders to discontinue vancomycin therapy on vancomycin use in an antimicrobial stewardship program</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2007</YR>
<VL>28</VL>
<PG>1408-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839638"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839637"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cook-2011a" MODIFIED="2016-12-07 13:10:08 -0500" MODIFIED_BY="Julia Worswick" NAME="Cook 2011a" YEAR="2011">
<REFERENCE MODIFIED="2016-12-01 11:59:46 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;DA - 20040430&lt;br&gt;NOT IN FILE&lt;br&gt;JAC&lt;/p&gt;" NOTES_MODIFIED="2016-12-01 11:59:46 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cook PP, Catrou PG, Christie JD, Young PD, Polk RE</AU>
<TI>Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2004</YR>
<VL>53</VL>
<PG>853-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889687"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-12-07 13:10:08 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Cook, Paul P&lt;br&gt;Rizzo, Shemra&lt;br&gt;Gooch, Michael&lt;br&gt;Jordan, Michelle&lt;br&gt;Fang, Xiangming&lt;br&gt;Hudson, Suzanne&lt;br&gt;eng&lt;br&gt;England&lt;br&gt;2010/11/10 06:00&lt;br&gt;J Antimicrob Chemother. 2011 Jan;66(1):205-9. doi: 10.1093/jac/dkq404. Epub 2010 Nov 8.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:10:08 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cook PP, Rizzo S, Gooch M, Jordan M, Fang X, Hudson S</AU>
<TI>Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2011</YR>
<VL>66</VL>
<PG>205-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839640"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839639"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cook-2011b" MODIFIED="2017-01-07 23:12:16 -0500" MODIFIED_BY="[Empty name]" NAME="Cook 2011b" YEAR="2011">
<REFERENCE MODIFIED="2017-01-07 23:12:16 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JC - 6hk, c98, 0315061, 0116415SB - IMCP - United StatesLG - EnglishDC - 20111114ED 20120329OVID MEDLINE UP 20120330&lt;br&gt;ML-2006-2012-KW-EPOC&lt;br&gt;PM: 21968357&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 23:12:16 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cook PP, Gooch M, Rizzo S</AU>
<TI>Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study</TI>
<SO>Antimicrobial Agents &amp; Chemotherapy</SO>
<YR>2011</YR>
<VL>55</VL>
<PG>5597-601</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839642"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839641"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cortoos-2011" MODIFIED="2016-09-28 08:53:25 -0400" MODIFIED_BY="Paul Miller" NAME="Cortoos 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-09-28 08:53:25 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;JC - hd7, 7513617SB - IMCP - EnglandLG - EnglishDC - 20111115ED 20120301OVID MEDLINE UP 20120302&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 08:53:25 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cortoos PJ, Gilissen C, Mol PG, Van den Bossche F, Simoens S, Willems L, et al</AU>
<TI>Empirical management of community-acquired pneumonia: impact of concurrent A/H1N1 influenza pandemic on guideline implementation</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2011</YR>
<VL>66</VL>
<PG>2864-71</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839644"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839643"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Danaher-2009" MODIFIED="2017-01-07 23:14:06 -0500" MODIFIED_BY="[Empty name]" NAME="Danaher 2009" YEAR="2009">
<REFERENCE MODIFIED="2017-01-07 23:14:06 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Danaher PJ, Milazzo NA, Kerr KJ, Lagasse CA, Lane JW</AU>
<TI>The Antibiotic Support Team - a successful educational approach to antibiotic stewardship</TI>
<SO>Military Medicine</SO>
<YR>2009</YR>
<VL>174</VL>
<PG>201-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839646"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839645"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dancer-2013" MODIFIED="2017-01-07 23:14:36 -0500" MODIFIED_BY="[Empty name]" NAME="Dancer 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-01-07 23:14:36 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: February 2013&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 23:14:36 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dancer S, Kirkpatrick P, Corcoran D, Christison F, Farmer D, Robertson C</AU>
<TI>Approaching zero: Temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum beta-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus</TI>
<SO>International Journal of Antimicrobial Agents</SO>
<YR>2013</YR>
<VL>41</VL>
<PG>137-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839648"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839647"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dean-2001" NAME="Dean 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dean NC, Silver MP, Bateman KA, James B, Hadlock CJ, Hale D</AU>
<TI>Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia</TI>
<SO>American Journal of Medicine</SO>
<YR>2001</YR>
<VL>110</VL>
<NO>6</NO>
<PG>451-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839650"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839649"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dean-2006" MODIFIED="2013-02-14 16:30:37 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Dean 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-02-14 16:30:37 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="NOT IN FILE" NOTES_MODIFIED="2013-02-14 16:30:37 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dean NC, Bateman KA, Donnelly SM, Silver MP, Snow GL, Hale D</AU>
<TI>Improved clinical outcomes with utilization of a community-acquired pneumonia guideline</TI>
<SO>Chest</SO>
<YR>2006</YR>
<VL>130</VL>
<NO>3</NO>
<PG>794-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839652"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839651"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Champs-1994" MODIFIED="2013-02-14 16:31:07 -0500" MODIFIED_BY="[Empty name]" NAME="de Champs 1994" YEAR="11/19">
<REFERENCE MODIFIED="2013-02-14 16:31:07 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Champs C, Franchineau P, Gourgand JM, Loriette Y, Gaulme J, Sirot J</AU>
<TI>Clinical and bacteriological survey after change in aminoglycoside treatment to control an epidemic of Enterobacter cloacae</TI>
<SO>Journal of Hospital Infection</SO>
<YR>1994</YR>
<VL>28</VL>
<NO>3</NO>
<PG>219-29</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839654"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839653"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dempsey--1995" NAME="Dempsey  1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dempsey CL</AU>
<TI>Nursing home-acquired pneumonia: outcomes from a clinical process improvement program</TI>
<SO>Pharmacotherapy</SO>
<YR>1995</YR>
<VL>15</VL>
<NO>1 Pt 2</NO>
<PG>33S-8S</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839656"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839655"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ding-2013" MODIFIED="2015-04-04 00:45:33 -0400" MODIFIED_BY="[Empty name]" NAME="Ding 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-04-04 00:45:33 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp Date of Publication: 20 May 2013&lt;/p&gt;" NOTES_MODIFIED="2015-04-04 00:45:33 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ding J, Chen Z, Feng K</AU>
<TI>Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis</TI>
<SO>International Journal of Medical Sciences</SO>
<YR>2013</YR>
<VL>10</VL>
<PG>903-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839658"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839657"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dranitsaris-2001" NAME="Dranitsaris 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dranitsaris G, Spizzirri D, Pitre M, McGeer A</AU>
<TI>A randomized trial to measure the optimal role of the pharmacist in promoting evidence-based antibiotic use in acute care hospitals</TI>
<SO>International Journal of Technology Assessment in Health Care</SO>
<YR>2001</YR>
<VL>17</VL>
<NO>2</NO>
<PG>171-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839660"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839659"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dua-2014" MODIFIED="2016-12-07 12:58:04 -0500" MODIFIED_BY="Julia Worswick" NAME="Dua 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-12-07 12:58:04 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Dua, Anahita&lt;br&gt;Desai, Sapan S&lt;br&gt;Seabrook, Gary R&lt;br&gt;Brown, Kellie R&lt;br&gt;Lewis, Brian D&lt;br&gt;Rossi, Peter J&lt;br&gt;Edmiston, Charles E&lt;br&gt;Lee, Cheong J&lt;br&gt;eng&lt;br&gt;2014/12/03 06:00&lt;br&gt;J Vasc Surg. 2014 Dec;60(6):1635-9. doi: 10.1016/j.jvs.2014.08.072. Epub 2014 Nov 21.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 12:58:04 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dua A, Desai SS, Seabrook GR, Brown KR, Lewis BD, Rossi PJ, et al</AU>
<TI>The effect of Surgical Care Improvement Project measures on national trends on surgical site infections in open vascular procedures</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2014</YR>
<VL>60</VL>
<PG>1635-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839662"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839661"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dull-2008" MODIFIED="2016-12-07 13:39:54 -0500" MODIFIED_BY="Julia Worswick" NAME="Dull 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-12-07 13:39:54 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;JC - bbo, 9202994SB - HCP - United StatesLG - EnglishDC - 20090123ED 20090219OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-EPOC&lt;br&gt;PM: 19160875&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:39:54 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dull D, Baird SK, Dulac J, Fox L</AU>
<TI>Improving prophylactic perioperative antibiotic utilization in a hospital system</TI>
<SO>Journal for Healthcare Quality</SO>
<YR>2008</YR>
<VL>30</VL>
<PG>48-56</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839664"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839663"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Duvoisin-2014" MODIFIED="2016-12-07 12:58:47 -0500" MODIFIED_BY="Julia Worswick" NAME="Duvoisin 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-12-07 12:58:47 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Duvoisin, Gilles&lt;br&gt;Fischer, Celine&lt;br&gt;Maucort-Boulch, Delphine&lt;br&gt;Giannoni, Eric&lt;br&gt;eng&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;Switzerland&lt;br&gt;2014/06/26 06:00&lt;br&gt;Swiss Med Wkly. 2014 Jun 25;144:w13981. doi: 10.4414/smw.2014.13981. eCollection 2014.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 12:58:47 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Duvoisin G, Fischer C, Maucort-Boulch D, Giannoni E</AU>
<TI>Reduction in the use of diagnostic tests in infants with risk factors for early-onset neonatal sepsis does not delay antibiotic treatment</TI>
<SO>Swiss Medical Weekly</SO>
<YR>2014</YR>
<VL>144</VL>
<PG>w13981</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839666"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839665"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elligsen-2012" MODIFIED="2016-12-07 13:00:12 -0500" MODIFIED_BY="Julia Worswick" NAME="Elligsen 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-12-07 13:00:12 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Elligsen M, Walker SAN, Pinto R, Simor A, Mubareka S, Rachlis A, et al</AU>
<TI>Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: a controlled interrupted time series analysis</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2012</YR>
<VL>33</VL>
<PG>354-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839668"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839667"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Esposito-2011" MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NAME="Esposito 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JC - 8908438, rmeSB - IMCP - EnglandLG - EnglishDC - 20111114ED 20120125OVID MEDLINE UP 20120126&lt;br&gt;ML-2006-2012-KW-RCT&lt;br&gt;PM: 21959024&lt;/p&gt;" NOTES_MODIFIED="2015-04-03 23:43:37 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Esposito S, Tagliabue C, Picciolli I, Semino M, Sabatini C, Consolo S, et al</AU>
<TI>Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia</TI>
<SO>Respiratory Medicine</SO>
<YR>2011</YR>
<VL>105</VL>
<PG>1939-45</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839670"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839669"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Everitt-1990" NAME="Everitt 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Everitt DE, Soumerai SB, Avorn J, Klapholz H, Wessels M</AU>
<TI>Changing surgical antimicrobial prophylaxis practices through education targeted at senior department leaders</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>1990</YR>
<VL>11</VL>
<NO>11</NO>
<PG>578-83</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839672"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839671"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Farinas-2012" MODIFIED="2015-11-29 01:19:38 -0500" MODIFIED_BY="[Empty name]" NAME="Farinas 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-11-29 01:19:38 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;Article Number: Date of Publication: 09 Nov 2012&lt;/p&gt;" NOTES_MODIFIED="2015-11-29 01:19:38 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Farinas M, Saravia G, Calvo-Montes J, Benito N, Martinez-Garde J, Farinas-Alvarez C, et al</AU>
<TI>Adherence to recommendations by infectious disease consultants and its influence on outcomes of intravenous antibiotic-treated hospitalized patients</TI>
<SO>BMC Infectious Diseases</SO>
<YR>2012</YR>
<VL>12</VL>
<PG>292</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839674"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839673"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fine-2003" MODIFIED="2013-02-14 16:32:31 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Fine 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-02-14 16:32:31 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="NOT IN FILE" NOTES_MODIFIED="2013-02-14 16:32:31 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fine MJ, Stone RA, Lave JR, Hough LJ, Obrosky DS, Mor MK, et al</AU>
<TI>Implementation of an evidence-based guideline to reduce duration of intravenous antibiotic therapy and length of stay for patients hospitalized with community-acquired pneumonia: a randomized controlled trial</TI>
<SO>American Journal of Medicine</SO>
<YR>2003</YR>
<VL>115</VL>
<NO>5</NO>
<PG>343-51</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839676"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839675"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fitzpatrick-2008" MODIFIED="2016-09-28 08:54:41 -0400" MODIFIED_BY="Paul Miller" NAME="Fitzpatrick 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-09-28 08:54:41 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fitzpatrick RW, Edwards CMC</AU>
<TI>Evaluation of a tool to benchmark hospital antibiotic prescribing in the United Kingdom</TI>
<SO>Pharmacy World &amp; Science</SO>
<YR>2008</YR>
<VL>30</VL>
<PG>73-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839678"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839677"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fowler-2007" MODIFIED="2016-12-07 13:40:37 -0500" MODIFIED_BY="Julia Worswick" NAME="Fowler 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-12-07 13:40:37 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fowler S, Webber A, Cooper BS, Phimister A, Price K, Carter Y, et al</AU>
<TI>Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2007</YR>
<VL>59</VL>
<PG>990-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839680"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839679"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Franz-2004" MODIFIED="2013-02-14 16:38:52 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Franz 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-02-14 16:38:52 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="Measurement of Interleukin 8 in Combination With C-Reactive Protein Reduced Unnecessary Antibiotic Therapy in Newborn Infants: A Multicenter, Randomized, Controlled Trial" NOTES_MODIFIED="2013-02-14 16:38:52 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Franz AR, Bauer K, Schalk A, Garland SM, Bowman ED, Rex K, et al</AU>
<TI>Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: a multicenter, randomized, controlled trial</TI>
<SO>Pediatrics</SO>
<YR>2004</YR>
<VL>114</VL>
<NO>1</NO>
<PG>1-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839682"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839681"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fraser-1997" MODIFIED="2017-01-07 23:22:42 -0500" MODIFIED_BY="[Empty name]" NAME="Fraser 1997" YEAR="1997">
<REFERENCE MODIFIED="2017-01-07 23:22:42 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fraser GL, Stogsdill P, Dickens JD, Wennberg DE, Smith RP, Prato S</AU>
<TI>Antibiotic optimization: an evaluation of patient safety and economic outcomes</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1997</YR>
<VL>157</VL>
<PG>1689-94</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839684"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839683"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fridkin-2002" MODIFIED="2013-03-18 13:46:06 -0400" MODIFIED_BY="Kate Cahill" NAME="Fridkin 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-03-18 13:46:06 -0400" MODIFIED_BY="Kate Cahill" NOTES="eng" NOTES_MODIFIED="2013-03-18 13:46:06 -0400" NOTES_MODIFIED_BY="Kate Cahill" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fridkin SK, Lawton R, Edwards JR, Tenover FC, McGowan JE Jr, Gaynes RP</AU>
<TI>Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci</TI>
<SO>Emerging Infectious Diseases</SO>
<YR>2002</YR>
<VL>8</VL>
<NO>7</NO>
<PG>702-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839686"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839685"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Friedberg-2009" MODIFIED="2016-09-28 08:55:02 -0400" MODIFIED_BY="Paul Miller" NAME="Friedberg 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-09-28 08:55:02 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;JC - cw0, 9613960SB - HCP - United StatesLG - EnglishDC - 20090316ED 20090605OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-EPOC&lt;br&gt;PM: 19284811&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 08:55:02 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Friedberg MW, Mehrotra A, Linder JA</AU>
<TI>Reporting hospitals' antibiotic timing in pneumonia: adverse consequences for patients?</TI>
<SO>American Journal of Managed Care</SO>
<YR>2009</YR>
<VL>15</VL>
<PG>137-44</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839688"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839687"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fukuda-2014" MODIFIED="2017-01-07 23:23:52 -0500" MODIFIED_BY="[Empty name]" NAME="Fukuda 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-01-07 23:23:52 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Fukuda, Tetsuya&lt;br&gt;Watanabe, Hidemi&lt;br&gt;Ido, Saeko&lt;br&gt;Shiragami, Makoto&lt;br&gt;eng&lt;br&gt;England&lt;br&gt;2014/08/20 06:00&lt;br&gt;J Pharm Policy Pract. 2014 Aug 5;7(1):10. doi: 10.1186/2052-3211-7-10. eCollection 2014.&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 23:23:52 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fukuda T, Watanabe H, Ido S, Shiragami M</AU>
<TI>Contribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 beds - before-after comparative two-year trial in Japan</TI>
<SO>Journal of Pharmaceutical Policy and Practice</SO>
<YR>2014</YR>
<VL>7</VL>
<PG>10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839690"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839689"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gerding-1985" MODIFIED="2013-03-21 16:12:00 -0400" MODIFIED_BY="[Empty name]" NAME="Gerding 1985" YEAR="1985">
<REFERENCE MODIFIED="2013-03-21 16:12:00 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gerding DN, Larson TA</AU>
<TI>Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Comparison of experience in 14 United States hospitals with experience in the Minneapolis Veterans Administration Medical Center</TI>
<SO>American Journal of Medicine</SO>
<YR>1985</YR>
<VL>79</VL>
<NO>1A</NO>
<PG>1-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839692"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839691"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldstein-2009" MODIFIED="2016-09-28 08:55:15 -0400" MODIFIED_BY="Paul Miller" NAME="Goldstein 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-09-28 08:55:15 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;CM - Comment in: Antimicrob Agents Chemother. 2010 Jul;54(7):3076; author reply 3076-7; PMID: 20554969JC - 6hk, c98, 0315061, 0116415SB - IMCP - United StatesLG - EnglishDC - 20091117ED 20100201OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-EPOC&lt;br&gt;PM: 19786596&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 08:55:15 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goldstein EJ, Citron DM, Peraino V, Elgourt T, Meibohm AR, Lu S</AU>
<TI>Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa</TI>
<SO>Antimicrobial Agents &amp; Chemotherapy</SO>
<YR>2009</YR>
<VL>53</VL>
<PG>5122-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839694"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839693"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grohs-2014" MODIFIED="2016-12-07 13:02:05 -0500" MODIFIED_BY="Julia Worswick" NAME="Grohs 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-12-07 13:02:05 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Grohs, P&lt;br&gt;Kerneis, S&lt;br&gt;Sabatier, B&lt;br&gt;Lavollay, M&lt;br&gt;Carbonnelle, E&lt;br&gt;Rostane, H&lt;br&gt;Souty, C&lt;br&gt;Meyer, G&lt;br&gt;Gutmann, L&lt;br&gt;Mainardi, J L&lt;br&gt;eng&lt;br&gt;England&lt;br&gt;2013/10/26 06:00&lt;br&gt;J Antimicrob Chemother. 2014 Mar;69(3):786-9. doi: 10.1093/jac/dkt403. Epub 2013 Oct 24.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:02:05 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grohs P, Kerneis S, Sabatier B, Lavollay M, Carbonnelle E, Rostane H, et al</AU>
<TI>Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2014</YR>
<VL>69</VL>
<PG>786-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839696"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839695"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gulmezoglu-2007" MODIFIED="2016-09-28 08:56:11 -0400" MODIFIED_BY="Paul Miller" NAME="Gulmezoglu 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-09-28 08:56:11 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;JC - 100935741SB - AIM, IMCP - EnglandSI - ISRCTNSA - ISRCTN/ISRCTN14055385LG - EnglishDC - 20070119ED 20070313OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 08:56:11 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gulmezoglu AM, Langer A, Piaggio G, Lumbiganon P, Villar J, Grimshaw J</AU>
<TI>Cluster randomised trial of an active, multifaceted educational intervention based on the WHO Reproductive Health Library to improve obstetric practices</TI>
<SO>BJOG: An International Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2007</YR>
<VL>114</VL>
<PG>16-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839698"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839697"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gums-1999" MODIFIED="2013-03-18 13:46:17 -0400" MODIFIED_BY="Kate Cahill" NAME="Gums 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-03-18 13:46:17 -0400" MODIFIED_BY="Kate Cahill" NOTES="&lt;p&gt;CLINICAL TRIAL JOURNAL ARTICLE RANDOMIZED CONTROLLED TRIAL Eng&lt;/p&gt;" NOTES_MODIFIED="2013-03-18 13:46:17 -0400" NOTES_MODIFIED_BY="Kate Cahill" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gums JG, Yancey RW Jr, Hamilton CA, Kubilis PS</AU>
<TI>A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team</TI>
<SO>Pharmacotherapy</SO>
<YR>1999</YR>
<VL>19</VL>
<NO>12</NO>
<PG>1369-77</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839700"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839699"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gupta-1989" NAME="Gupta 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gupta S, Bachand RL, Jewesson PJ</AU>
<TI>Impact of a two-stage intervention program on cefazolin usage at a major teaching hospital</TI>
<SO>Hospital Formulary</SO>
<YR>1989</YR>
<VL>24</VL>
<NO>1</NO>
<PG>41-4, 46</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839702"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839701"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hadi-2008" MODIFIED="2017-01-07 23:31:03 -0500" MODIFIED_BY="[Empty name]" NAME="Hadi 2008" YEAR="2008">
<REFERENCE MODIFIED="2017-01-07 23:31:03 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;(AMRIN)&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 23:31:03 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hadi U, Keuter M, Van Asten H, Van Den Broek P, on behalf of the study group Antimicrobial Resistance in Indonesia Prevalence, Prevention</AU>
<TI>Optimizing antibiotic usage in adults admitted with fever by a multifaceted intervention in an Indonesian governmental hospital</TI>
<SO>Tropical Medicine &amp; International Health</SO>
<YR>2008</YR>
<VL>13</VL>
<PG>888-99</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839704"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839703"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Halm-2004" MODIFIED="2013-02-15 09:20:31 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Halm 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-02-15 09:20:31 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="10.1378/chest.126.1.100" NOTES_MODIFIED="2013-02-15 09:20:31 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Halm EA, Horowitz C, Silver A, Fein A, Dlugacz YD, Hirsch B, et al</AU>
<TI>Limited impact of a multicenter intervention to improve the quality and efficiency of pneumonia care</TI>
<SO>Chest</SO>
<YR>2004</YR>
<VL>126</VL>
<NO>1</NO>
<PG>100-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839706"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839705"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hess-1990" NAME="Hess 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Clinical intervention strategies include the use of antimicrobial order sheets, standardized dosage regimens, restriction policies for certain antimicrobial agents and position statements on the use of restricted agents. This combination of clinical and administrative strategies reduced expenditures for antimicrobial agents by more than $700,000 over two years without the use of clinical specialists or any apparent sacrifice in patient care&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hess DA, Mahoney CD, Johnson PN, Corrao WM, Fisher A</AU>
<TI>Integration of clinical and administrative strategies to reduce expenditures for antimicrobial agents</TI>
<SO>American Journal of Hospital Pharmacy</SO>
<YR>1990</YR>
<VL>47</VL>
<PG>585-91</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839708"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839707"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Himmelberg-1991" NAME="Himmelberg 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Removal of a restriction policy for antimicrobials was shown to result in an increase in the costs and inappropriate use of these agents&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Himmelberg CJ, Pleasants RA, Weber DJ, Kessler JM, Samsa GP, Spivey JM, et al</AU>
<TI>Use of antimicrobial drugs in adults before and after removal of a restriction policy</TI>
<SO>American Journal of Public Health</SO>
<YR>1991</YR>
<VL>48</VL>
<PG>1220-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839710"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839709"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Hitti-2012" MODIFIED="2017-01-07 23:32:50 -0500" MODIFIED_BY="[Empty name]" NAME="Hitti 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-01-07 23:32:50 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JC - ibo, 8412174SB - IMCP - United StatesLG - EnglishDC - 20120416OVID MEDLINE UP 20120417&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 23:32:50 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hitti EA, Lewin JJ III, Lopez J, Hansen J, Pipkin M, Itani T, et al</AU>
<TI>Improving door-to-antibiotic time in severely septic emergency department patients</TI>
<SO>Journal of Emergency Medicine</SO>
<YR>2012</YR>
<VL>42</VL>
<PG>462-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839712"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839711"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hochreiter-2009" MODIFIED="2016-12-07 13:41:20 -0500" MODIFIED_BY="Julia Worswick" NAME="Hochreiter 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-12-07 13:41:20 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;DA - 20090729IS - 1466-609X (Electronic)IS - 1364-8535 (Linking)LA - engPT - Journal ArticlePT - Randomized Controlled TrialRN - 0 (Anti-Bacterial Agents)RN - 0 (Biological Markers)RN - 0 (Protein Precursors)RN - 56645-65-9 (procalcitonin)RN - 9007-12-9 (Calcitonin)SB - IM PM2&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:41:20 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hochreiter M, Kohler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, et al</AU>
<TI>Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial</TI>
<SO>Critical Care (London, England)</SO>
<YR>2009</YR>
<VL>13</VL>
<PG>R83</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839714"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839713"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huber-1982" NAME="Huber 1982" YEAR="1982">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huber SL, Patry RA, Hudson HD</AU>
<TI>Influencing drug use through prescribing restrictions</TI>
<SO>American Journal of Hospital Pharmacy</SO>
<YR>1982</YR>
<VL>39</VL>
<PG>1898-901</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839716"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839715"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hulgan-2004" MODIFIED="2013-02-15 09:27:00 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Hulgan 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-02-15 09:27:00 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="eng" NOTES_MODIFIED="2013-02-15 09:27:00 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hulgan T, Rosenbloom ST, Hargrove F, Talbert DA, Arbogast PG, Bansal P, et al</AU>
<TI>Oral quinolones in hospitalized patients: an evaluation of a computerized decision support intervention</TI>
<SO>Journal of Internal Medicine</SO>
<YR>2004</YR>
<VL>256</VL>
<NO>4</NO>
<PG>349-57</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839718"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839717"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Inaraja-1986" NAME="Inaraja 1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Inaraja MT, Paloma JM, Giraldez J, Idoate AJ, Hualde S</AU>
<TI>Computer-assisted antimicrobial-use monitoring</TI>
<SO>American Journal of Hospital Pharmacy</SO>
<YR>1986</YR>
<VL>43</VL>
<PG>664-70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839720"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839719"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jensen-2011" MODIFIED="2016-09-28 08:57:25 -0400" MODIFIED_BY="Paul Miller" NAME="Jensen 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-09-28 08:57:25 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;(PASS)&lt;br&gt;CM - Comment in: Crit Care Med. 2011 Sep;39(9):2182-3; PMID: 21849827JC - dtf, 0355501SB - AIM, IMCP - United StatesSI - ClinicalTrials.govSA - ClinicalTrials.gov/NCT00271752LG - EnglishDC - 20110818ED 20111024OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-RCT&lt;br&gt;PM: 21572328&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 08:57:25 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr TT, Andersen MH, et al</AU>
<TI>Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial</TI>
<SO>Critical Care Medicine</SO>
<YR>2011</YR>
<VL>39</VL>
<PG>2048-58</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839722"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839721"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jobson-2015" MODIFIED="2016-12-07 13:41:38 -0500" MODIFIED_BY="Julia Worswick" NAME="Jobson 2015" YEAR="2015">
<REFERENCE MODIFIED="2016-12-07 13:41:38 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Jobson, Meghan&lt;br&gt;Sandrof, Moses&lt;br&gt;Valeriote, Timothy&lt;br&gt;Liberty, Abigail Lees&lt;br&gt;Walsh-Kelly, Christine&lt;br&gt;Jackson, Cheryl&lt;br&gt;eng&lt;br&gt;2014/12/10 06:00&lt;br&gt;Pediatrics. 2015 Jan;135(1):e187-95. doi: 10.1542/peds.2014-1192. Epub 2014 Dec 8.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:41:38 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jobson M, Sandrof M, Valeriote T, Liberty AL, Walsh-Kelly C, Jackson C</AU>
<TI>Decreasing time to antibiotics in febrile patients with central lines in the emergency department</TI>
<SO>Pediatrics</SO>
<YR>2015</YR>
<VL>135</VL>
<PG>e187-95</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839724"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839723"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jump-2012" MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NAME="Jump 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( (pp 2012 Date of Publication: December 2012&lt;/p&gt;" NOTES_MODIFIED="2015-04-03 23:43:37 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jump R, Olds D, Seifi N, Kypriotakis G, Jury L, Peron E, et al</AU>
<TI>Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: Keeping a LID on antibiotic use</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2012</YR>
<VL>33</VL>
<PG>1185-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839726"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839725"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Kallen-2009" MODIFIED="2016-09-28 08:57:44 -0400" MODIFIED_BY="Paul Miller" NAME="Kallen 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-09-28 08:57:44 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;JC - ich, 8804099SB - IM, NCP - United StatesLG - EnglishDC - 20090213ED 20090702OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 08:57:44 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kallen AJ, Thompson A, Ristaino P, Chapman L, Nicholson A, Sim BT, et al</AU>
<TI>Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital</TI>
<SO>Infection Control &amp; Hospital Epidemiology</SO>
<YR>2009</YR>
<VL>30</VL>
<PG>264-72</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839728"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839727"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kanwar-2007" MODIFIED="2016-12-07 13:41:54 -0500" MODIFIED_BY="Julia Worswick" NAME="Kanwar 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-12-07 13:41:54 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;CM - Comment in: Chest. 2007 Dec;132(6):2060; author reply 2060-1; PMID: 18079251JC - 0231335, d1cSB - AIM, IMCP - United StatesLG - EnglishDC - 20070613ED 20070816OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-EPOC&lt;br&gt;PM: 17400668&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:41:54 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kanwar M, Brar N, Khatib R, Fakih MG</AU>
<TI>Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule</TI>
<SO>Chest</SO>
<YR>2007</YR>
<VL>131</VL>
<PG>1865-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839730"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839729"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kerremans-2008" MODIFIED="2016-09-28 08:58:11 -0400" MODIFIED_BY="Paul Miller" NAME="Kerremans 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-09-28 08:58:11 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kerremans JJ, Verboom P, Stijnen T, Hakkaart-van Roijen L, Goessens W, Verbrugh HA, et al</AU>
<TI>Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2008</YR>
<VL>61</VL>
<PG>428-35</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839732"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839731"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kerremans-2009" MODIFIED="2017-01-07 23:37:47 -0500" MODIFIED_BY="[Empty name]" NAME="Kerremans 2009" YEAR="2009">
<REFERENCE MODIFIED="2017-01-07 23:37:47 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kerremans JJ, van der Bij AK, Goessens W, Verbrugh HA, Vos MC</AU>
<TI>Immediate incubation of blood cultures outside routine laboratory hours of operation accelerates antibiotic switching</TI>
<SO>Journal of Clinical Microbiology</SO>
<YR>2009</YR>
<VL>47</VL>
<PG>3520-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839734"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839733"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khan-2003" NAME="Khan 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khan R, Cheesbrough J</AU>
<TI>Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital</TI>
<SO>Journal of Hospital Infection</SO>
<YR>2003</YR>
<VL>54</VL>
<NO>2</NO>
<PG>104-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839736"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839735"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2008" MODIFIED="2016-09-28 08:58:33 -0400" MODIFIED_BY="Paul Miller" NAME="Kim 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-09-28 08:58:33 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;CM - Comment in: J Antimicrob Chemother. 2008 Nov;62(5):1165; author reply 1165-6; PMID: 18658195JC - hd7, 7513617SB - IMCP - EnglandLG - EnglishDC - 20080711ED 20080812OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 08:58:33 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kim JY, Sohn JW, Park DW, Yoon YK, Kim YM, Kim MJ</AU>
<TI>Control of extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2008</YR>
<VL>62</VL>
<PG>416-21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839738"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839737"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Knudsen-2014" MODIFIED="2017-01-07 23:39:32 -0500" MODIFIED_BY="[Empty name]" NAME="Knudsen 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-01-07 23:39:32 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Knudsen JD, Andersen SE; Bispebjerg Intervention Group</AU>
<TI>A multidisciplinary intervention to reduce infections of ESBL- and AmpC-producing, gram-negative bacteria at a University Hospital</TI>
<SO>PLoS ONE</SO>
<YR>2014</YR>
<VL>9</VL>
<PG>e86457</PG>
<IDENTIFIERS MODIFIED="2016-09-28 09:00:36 -0400" MODIFIED_BY="Paul Miller"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839740"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839739"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kristoffersen-2009" MODIFIED="2017-01-07 23:41:09 -0500" MODIFIED_BY="[Empty name]" NAME="Kristoffersen 2009" YEAR="2009">
<REFERENCE MODIFIED="2017-01-07 23:41:09 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JC - dy9, 9516420SB - IMCP - FranceSI - ClinicalTrials.govSA - ClinicalTrials.gov/NCT00415753LG - EnglishDC - 20090603ED 20090817OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 23:41:09 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kristoffersen KB, Sogaard OS, Wejse C, Black FT, Greve T, Tarp B, et al</AU>
<TI>Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission - a randomized trial</TI>
<SO>Clinical Microbiology &amp; Infection</SO>
<YR>2009</YR>
<VL>15</VL>
<PG>481-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839742"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839741"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kritchevsky-2008" MODIFIED="2017-01-07 23:42:21 -0500" MODIFIED_BY="[Empty name]" NAME="Kritchevsky 2008" YEAR="2008">
<REFERENCE MODIFIED="2017-01-07 23:42:21 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;10.7326/0003-4819-149-7-200810070-00007&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 23:42:21 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kritchevsky SB, Braun BI, Bush AJ, Bozikis MR, Kusek L, Burke JP, et al</AU>
<TI>The effect of a quality improvement collaborative to improve antimicrobial prophylaxis in surgical patients: a randomized trial</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2008</YR>
<VL>149</VL>
<PG>472-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839744"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839743"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kumana-2001" MODIFIED="2013-02-15 09:28:15 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Kumana 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-02-15 09:28:15 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="eng" NOTES_MODIFIED="2013-02-15 09:28:15 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kumana CR, Ching TY, Kong Y, Ma EC, Kou M, Lee RA, et al</AU>
<TI>Curtailing unnecessary vancomycin usage in a hospital with high rates of methicillin resistant Staphylococcus aureus infections</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>2001</YR>
<VL>52</VL>
<NO>4</NO>
<PG>427-32</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839746"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839745"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lacroix-2014" MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NAME="Lacroix 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Lacroix, Laurence&lt;br&gt;Manzano, Sergio&lt;br&gt;Vandertuin, Lynda&lt;br&gt;Hugon, Florence&lt;br&gt;Galetto-Lacour, Annick&lt;br&gt;Gervaix, Alain&lt;br&gt;eng&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;2014/12/17 06:00&lt;br&gt;PLoS One. 2014 Dec 11;9(12):e115061. doi: 10.1371/journal.pone.0115061. eCollection 2014.&lt;/p&gt;" NOTES_MODIFIED="2015-04-03 23:43:37 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lacroix L, Manzano S, Vandertuin L, Hugon F, Galetto-Lacour A, Gervaix A</AU>
<TI>Impact of the lab-score on antibiotic prescription rate in children with fever without source: a randomized controlled trial</TI>
<SO>PLoS One</SO>
<YR>2014</YR>
<VL>9</VL>
<PG>e115061</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839748"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839747"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lafaurie-2012" MODIFIED="2016-09-28 09:01:55 -0400" MODIFIED_BY="Paul Miller" NAME="Lafaurie 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-09-28 09:01:55 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;JC - hd7, 7513617SB - IMCP - EnglandLG - EnglishDC - 20120313OVID MEDLINE UP 20120418&lt;br&gt;ML-2006-2012-KW-EPOC&lt;br&gt;PM: 22240401&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:01:55 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lafaurie M, Porcher R, Donay JL, Touratier S, Molina JM</AU>
<TI>Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2012</YR>
<VL>67</VL>
<PG>1010-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839750"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839749"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Landgren-1988" MODIFIED="2017-01-07 23:44:18 -0500" MODIFIED_BY="[Empty name]" NAME="Landgren 1988" YEAR="1988">
<REFERENCE MODIFIED="2017-01-07 23:44:18 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Controlled crossover study in 12 Australian hospitals aimed at surgical prophylaxis. Costs fell in test hospitals but rose in control hospitals. Overall difference in costs after two campaigns was $125,070 whereas the cost of mounting the two campaigns was $71,950&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 23:44:18 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Landgren FT, Harvey KJ, Mashford ML, Moulds RFW, Guthrie B, Hemming M</AU>
<TI>Changing antibiotic prescribing by educational marketing</TI>
<SO>Medical Journal of Australia</SO>
<YR>1988</YR>
<VL>149</VL>
<PG>595-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839752"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839751"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Landman-1999" NAME="Landman 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Landman D, Chockalingam M, Quale JM</AU>
<TI>Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>1999</YR>
<VL>28</VL>
<NO>5</NO>
<PG>1062-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839754"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839753"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-LaRosa-2007" MODIFIED="2016-09-28 09:02:28 -0400" MODIFIED_BY="Paul Miller" NAME="LaRosa 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-09-28 09:02:28 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;LaRosa, Lori Ann&lt;br&gt;Fishman, Neil O&lt;br&gt;Lautenbach, Ebbing&lt;br&gt;Koppel, Ross J&lt;br&gt;Morales, Knashawn H&lt;br&gt;Linkin, Darren R&lt;br&gt;DK-02987-01/DK/NIDDK NIH HHS/&lt;br&gt;K23 AI060887-01/AI/NIAID NIH HHS/&lt;br&gt;K23 DK002897-01/DK/NIDDK NIH HHS/&lt;br&gt;K23-AI-060887-01/AI/NIAID NIH HHS/&lt;br&gt;P01-HS1153-01/HS/AHRQ HHS/&lt;br&gt;U18-HS10399/HS/AHRQ HHS/&lt;br&gt;Infect Control Hosp Epidemiol. 2007 May;28(5):551-6. Epub 2007 Mar 22.&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:02:28 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>LaRosa LA, Fishman NO, Lautenbach E, Koppel RJ, Morales KH, Linkin DR</AU>
<TI>Evaluation of antimicrobial therapy orders circumventing an antimicrobial stewardship program: investigating the strategy of "stealth dosing"</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2007</YR>
<VL>28</VL>
<PG>551-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839756"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839755"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lautenbach-2003" NAME="Lautenbach 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lautenbach E, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO</AU>
<TI>Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2003</YR>
<VL>36</VL>
<NO>4</NO>
<PG>440-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839758"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839757"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lawes-2012" MODIFIED="2015-11-29 01:26:22 -0500" MODIFIED_BY="[Empty name]" NAME="Lawes 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-11-29 01:26:22 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;( Article Number: e000797 Date of Publication: 2012&lt;/p&gt;" NOTES_MODIFIED="2015-11-29 01:26:22 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lawes T, Edwards B, Lopez-Lozano J, Gould I</AU>
<TI>Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006-2010: Retrospective cohort study and time-series intervention analysis</TI>
<SO>BMJ Open</SO>
<YR>2012</YR>
<VL>2</VL>
<PG>e000797</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839760"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839759"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Layios-2012" MODIFIED="2017-01-07 23:46:48 -0500" MODIFIED_BY="[Empty name]" NAME="Layios 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-01-07 23:46:48 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;2012 Aug&lt;/p&gt;" NOTES_MODIFIED="2017-01-07 23:46:48 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Layios N, Lambermont B, Canivet JL, Morimont P, Preiser JC, Garweg C, et al</AU>
<TI>Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients</TI>
<SO>Critical Care Medicine</SO>
<YR>2012</YR>
<VL>40</VL>
<PG>2304-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839762"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839761"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-1995" MODIFIED="2013-02-15 09:29:00 -0500" MODIFIED_BY="[Empty name]" NAME="Lee 1995" YEAR="1995">
<REFERENCE MODIFIED="2013-02-15 09:29:00 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee J, Carlson JA, Chamberlain MA</AU>
<TI>A team approach to hospital formulary replacement</TI>
<SO>Diagnostic Microbiology and Infectious Diseases</SO>
<YR>1995</YR>
<VL>22</VL>
<PG>239-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839764"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839763"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2007" MODIFIED="2016-09-28 09:04:01 -0400" MODIFIED_BY="Paul Miller" NAME="Lee 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-09-28 09:04:01 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;JC - hd7, 7513617SB - IMCP - EnglandLG - EnglishDC - 20070816ED 20071210OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:04:01 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, et al</AU>
<TI>Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2007</YR>
<VL>60</VL>
<PG>629-37</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839766"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839765"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2014" MODIFIED="2016-12-07 13:04:22 -0500" MODIFIED_BY="Julia Worswick" NAME="Lee 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-12-07 13:04:22 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee TC, Frenette C, Jayaraman D, Green L, Pilote L</AU>
<TI>Antibiotic self-stewardship: trainee-led structured antibiotic time-outs to improve antimicrobial use</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2014</YR>
<VL>161</VL>
<PG>S53-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839768"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839767"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lesprit-2013" MODIFIED="2017-01-07 23:48:11 -0500" MODIFIED_BY="[Empty name]" NAME="Lesprit 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-01-07 23:48:11 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lesprit P, Landelle C, Brun-Buisson C</AU>
<TI>Clinical impact of unsolicited post-prescription antibiotic review in surgical and medical wards: a randomized controlled trial</TI>
<SO>Clinical Microbiology and Infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases</SO>
<YR>2013</YR>
<VL>19</VL>
<PG>E91-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839770"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839769"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leverstein_x002d_van-Hall-2001" MODIFIED="2015-04-04 00:03:16 -0400" MODIFIED_BY="[Empty name]" NAME="Leverstein-van Hall 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-02-15 09:30:22 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leverstein-van Hall MA, Fluit AC, Blok HE, Box AT, Peters ED, Weersink AJ, et al</AU>
<TI>Control of nosocomial multiresistant Enterobacteriaceae using a temporary restrictive antibiotic agent policy</TI>
<SO>European Journal of Clinical Microbiology and Infectious Diseases</SO>
<YR>2001</YR>
<VL>20</VL>
<PG>785-91</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839772"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839771"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liebowitz-2008" MODIFIED="2016-09-28 09:04:45 -0400" MODIFIED_BY="Paul Miller" NAME="Liebowitz 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-09-28 09:04:45 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liebowitz LD, Blunt MC</AU>
<TI>Modification in prescribing practices for third-generation cephalosporins and ciprofloxacin is associated with a reduction in meticillin-resistant Staphylococcus aureus bacteraemia rate</TI>
<SO>Journal of Hospital Infection</SO>
<YR>2008</YR>
<VL>69</VL>
<PG>328-36</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839774"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839773"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Linkin-2007" MODIFIED="2016-09-28 09:05:14 -0400" MODIFIED_BY="Paul Miller" NAME="Linkin 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-09-28 09:05:14 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;Linkin, Darren R&lt;br&gt;Fishman, Neil O&lt;br&gt;Landis, J Richard&lt;br&gt;Barton, Todd D&lt;br&gt;Gluckman, Steven&lt;br&gt;Kostman, Jay&lt;br&gt;Metlay, Joshua P&lt;br&gt;F32-HS-023982/HS/AHRQ HHS/&lt;br&gt;K23-AI-060887/AI/NIAID NIH HHS/&lt;br&gt;U18-HS10399/HS/AHRQ HHS/&lt;br&gt;Infect Control Hosp Epidemiol. 2007 Dec;28(12):1374-81. Epub 2007 Nov 1.&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:05:14 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Linkin DR, Fishman NO, Landis JR, Barton TD, Gluckman S, Kostman J, et al</AU>
<TI>Effect of communication errors during calls to an antimicrobial stewardship program</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2007</YR>
<VL>28</VL>
<PG>1374-81</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839776"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839775"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2013" MODIFIED="2017-01-07 23:54:33 -0500" MODIFIED_BY="[Empty name]" NAME="Liu 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-01-07 23:54:33 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu BH, Li HF, Lei Y, Zhao SX, Sun ML</AU>
<TI>Clinical significance of dynamic monitoring of procalcitonin in guiding the use of antibiotics in patients with sepsis in ICU</TI>
<SO>Chinese Critical Care Medicine</SO>
<YR>2013</YR>
<VL>25</VL>
<NO>11</NO>
<PG>690-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839778"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839777"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Long-2014" MODIFIED="2017-01-07 23:55:01 -0500" MODIFIED_BY="[Empty name]" NAME="Long 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-01-07 23:55:01 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Long W, Li LJ, Huang GZ, Zhang XM, Zhang YC, Tang JG, et al</AU>
<TI>Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: A randomized controlled study with 12-month follow-up</TI>
<SO>Critical Care</SO>
<YR>2014</YR>
<VL>18</VL>
<NO>5</NO>
<PG>471</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839780"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839779"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Madaras_x002d_Kelly-2006" MODIFIED="2013-02-15 09:30:56 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Madaras-Kelly 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-02-15 09:30:56 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="eng" NOTES_MODIFIED="2013-02-15 09:30:56 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Madaras-Kelly KJ, Remington RE, Lewis PG, Stevens DL</AU>
<TI>Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2006</YR>
<VL>27</VL>
<NO>2</NO>
<PG>155-69</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839782"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839781"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Magedanz-2012" MODIFIED="2016-09-28 09:06:35 -0400" MODIFIED_BY="Paul Miller" NAME="Magedanz 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-09-28 09:06:35 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Magedanz L, Silliprandi EM, Santos RP</AU>
<TI>Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study</TI>
<SO>International Journal of Clinical Pharmacy</SO>
<YR>2012</YR>
<VL>34</VL>
<PG>290-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839784"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839783"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maravic_x002d_Stojkovic-2011" MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NAME="Maravic-Stojkovic 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JC - 0027440, uzgSB - IMCP - SerbiaLG - EnglishDC - 20120217ED 20120320OVID MEDLINE UP 20120321&lt;br&gt;ML-2006-2012-KW-RCT&lt;br&gt;PM: 22338468&lt;/p&gt;" NOTES_MODIFIED="2015-04-03 23:43:37 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maravic-Stojkovic V, Lausevic-Vuk L, Jovic M, Rankovic A, Borzanovic M, Marinkovic J</AU>
<TI>Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial</TI>
<SO>Srpski Arhiv Za Celokupno Lekarstvo</SO>
<YR>2011</YR>
<VL>139</VL>
<PG>736-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839786"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839785"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marwick-2013" MODIFIED="2017-01-07 23:58:40 -0500" MODIFIED_BY="[Empty name]" NAME="Marwick 2013" YEAR="">
<REFERENCE MODIFIED="2017-01-07 23:58:40 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marwick C, Guthrie B, Pringle J, Evans J, Nathwani D, Donnan P, et al</AU>
<TI>A multifaceted intervention to improve sepsis management in general hospital wards with evaluation using segmented regression of interrupted time series</TI>
<SO>BMJ Quality &amp; Safety</SO>
<YR>2014</YR>
<VL>23</VL>
<PG>e2</PG>
<IDENTIFIERS MODIFIED="2017-01-07 23:57:55 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839788"/><IDENTIFIER MODIFIED="2017-01-07 23:57:55 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/bmjqs-2013-002176"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839787"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Masia-2008" MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NAME="Masia 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JC - em5, 8804297SB - IMCP - GermanyLG - EnglishDC - 20080613ED 20081002OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-RCT&lt;br&gt;PM: 18392866&lt;/p&gt;" NOTES_MODIFIED="2015-04-03 23:43:37 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Masia M, Matoses C, Padilla S, Murcia A, Sanchez V, Romero I, et al</AU>
<TI>Limited efficacy of a nonrestricted intervention on antimicrobial prescription of commonly used antibiotics in the hospital setting: results of a randomized controlled trial</TI>
<SO>European Journal of Clinical Microbiology &amp; Infectious Diseases</SO>
<YR>2008</YR>
<VL>27</VL>
<PG>597-605</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839790"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839789"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-May-2000" MODIFIED="2013-02-15 09:31:49 -0500" MODIFIED_BY="Philip J Wiffen" NAME="May 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-02-15 09:31:49 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="eng" NOTES_MODIFIED="2013-02-15 09:31:49 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>May AK, Melton SM, McGwin G, Cross JM, Moser SA, Rue LW</AU>
<TI>Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit</TI>
<SO>Shock</SO>
<YR>2000</YR>
<VL>14</VL>
<NO>3</NO>
<PG>259-64</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839792"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839791"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McElnay-1995" MODIFIED="2013-02-15 09:32:16 -0500" MODIFIED_BY="[Empty name]" NAME="McElnay 1995" YEAR="1995">
<REFERENCE MODIFIED="2013-02-15 09:32:16 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McElnay JC, Scott MG, Sidara JY, Kearney P</AU>
<TI>Audit of antibiotic usage in medium-sized general hospital over an 11-year period. The impact of antibiotic policies</TI>
<SO>Pharmacy World and Science</SO>
<YR>1995</YR>
<VL>17</VL>
<NO>6</NO>
<PG>207-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839794"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839793"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McGowan-1976" MODIFIED="2016-12-01 12:09:47 -0500" MODIFIED_BY="Julia Worswick" NAME="McGowan 1976" YEAR="1976">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McGowan JE, Findland M</AU>
<TI>Usage of antibiotics in a general hospital: Effect of requiring justification</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1974</YR>
<VL>130</VL>
<NO>2</NO>
<PG>165-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839796"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-02-15 09:32:33 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>McGowan JE, Finland M</AU>
<TI>Effects of monitoring the usage of antibiotics: An interhospital comparison</TI>
<SO>Southern Medical Journal</SO>
<YR>1976</YR>
<VL>69</VL>
<NO>2</NO>
<PG>193-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839797"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839795"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McLaughlin-2005" MODIFIED="2013-03-18 13:46:28 -0400" MODIFIED_BY="Kate Cahill" NAME="McLaughlin 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-03-18 13:46:28 -0400" MODIFIED_BY="Kate Cahill" NOTES="eng" NOTES_MODIFIED="2013-03-18 13:46:28 -0400" NOTES_MODIFIED_BY="Kate Cahill" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McLaughlin CM, Bodasing N, Boyter AC, Fenelon C, Fox JG, Seaton RA</AU>
<TI>Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: an intervention study</TI>
<SO>Quarterly Journal of Medicine</SO>
<YR>2005</YR>
<VL>98</VL>
<NO>10</NO>
<PG>745-52</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839799"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839798"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McNulty-1997" MODIFIED="2013-02-15 09:35:02 -0500" MODIFIED_BY="[Empty name]" NAME="McNulty 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-02-15 09:35:02 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McNulty C, Logan M, Donald IP, Ennis D, Taylor D, Baldwin RN, et al</AU>
<TI>Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>1997</YR>
<VL>40</VL>
<PG>707-11</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839801"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839800"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mercer-1999" NAME="Mercer 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mercer KA, Chintalapudi SR, Visconti EB</AU>
<TI>Impact of targeted antibiotic restriction on usage and cost in a community hospital</TI>
<SO>Journal of Pharmacy Technology</SO>
<YR>1999</YR>
<VL>15</VL>
<PG>79-84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839803"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839802"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meyer-1993" NAME="Meyer 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ</AU>
<TI>Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1993</YR>
<VL>119</VL>
<NO>5</NO>
<PG>353-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839805"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839804"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meyer-2007" MODIFIED="2016-09-28 09:07:39 -0400" MODIFIED_BY="Paul Miller" NAME="Meyer 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-09-28 09:07:39 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meyer E, Buttler J, Schneider C, Strehl E, Schroeren-Boersch B, Gastmeier P, et al</AU>
<TI>Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2007</YR>
<VL>59</VL>
<PG>1148-54</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839807"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839806"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meyer-2009" MODIFIED="2014-10-29 11:43:54 -0400" MODIFIED_BY="Claire Peden" NAME="Meyer 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-10-29 11:43:54 -0400" MODIFIED_BY="Claire Peden" NOTES="&lt;p&gt;JC - h2j, 7704851SB - IMCP - United StatesLG - EnglishDC - 20090501ED 20090921OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2014-10-29 11:43:54 -0400" NOTES_MODIFIED_BY="Claire Peden" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meyer E, Lapatschek M, Bechtold A, Schwarzkopf G, Gastmeier P, Schwab F</AU>
<TI>Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU</TI>
<SO>Intensive Care Medicine</SO>
<YR>2009</YR>
<VL>35</VL>
<PG>862-70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839809"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839808"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meyer-2010" MODIFIED="2017-01-08 00:04:15 -0500" MODIFIED_BY="[Empty name]" NAME="Meyer 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-01-08 00:04:15 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meyer E, Schwab F, Pollitt A, Bettolo W, Schroeren-Boersch B, Trautmann M</AU>
<TI>Impact of a change in antibiotic prophylaxis on total antibiotic use in a surgical intensive care unit</TI>
<SO>Infection</SO>
<YR>2010</YR>
<VL>38</VL>
<PG>19-24</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839811"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839810"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Micek-2004" MODIFIED="2013-02-15 09:35:36 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Micek 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-02-15 09:35:36 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="NOT IN FILE" NOTES_MODIFIED="2013-02-15 09:35:36 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Micek ST, Ward S, Fraser VJ, Kollef MH</AU>
<TI>A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia</TI>
<SO>Chest</SO>
<YR>2004</YR>
<VL>125</VL>
<NO>5</NO>
<PG>1791-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839813"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839812"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mittal-2014" MODIFIED="2016-09-28 09:08:10 -0400" MODIFIED_BY="Paul Miller" NAME="Mittal 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-09-28 09:08:10 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mittal V, Darnell C, Walsh B, Mehta A, Badawy M, Morse R, et al</AU>
<TI>Inpatient bronchiolitis guideline implementation and resource utilization</TI>
<SO>Pediatrics</SO>
<YR>2014</YR>
<VL>133</VL>
<PG>e730-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839815"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839814"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mol-2005" MODIFIED="2013-03-18 13:46:37 -0400" MODIFIED_BY="Kate Cahill" NAME="Mol 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-03-18 13:46:37 -0400" MODIFIED_BY="Kate Cahill" NOTES="10.1093/jac/dki037" NOTES_MODIFIED="2013-03-18 13:46:37 -0400" NOTES_MODIFIED_BY="Kate Cahill" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mol PGM, Wieringa JE, Nannan Panday PV, Gans ROB, Degener JE, Laseur M, et al</AU>
<TI>Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2005</YR>
<VL>55</VL>
<NO>4</NO>
<PG>550-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839817"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839816"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Newland-2012" MODIFIED="2017-01-08 00:07:11 -0500" MODIFIED_BY="[Empty name]" NAME="Newland 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-01-08 00:06:33 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Newland JG, Stach LM, De Lurgio SA, Hedican E, Yu D, Herigon JC, et al</AU>
<TI>Impact of a prospective-audit-with-feedback antimicrobial stewardship program at a children's hospital</TI>
<SO>Journal of the Pediatric Infectious Diseases Society</SO>
<YR>2012</YR>
<VL>1</VL>
<PG>179-86</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839819"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-01-08 00:07:11 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Newman RE, Hedican EB, Herigon JC, Williams DD, Williams AR, Newland JG</AU>
<TI>Impact of a guideline on management of children hospitalized with community-acquired pneumonia</TI>
<SO>Pediatrics</SO>
<YR>2012</YR>
<VL>129</VL>
<PG>e597-604</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889688"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839818"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nobre-2008" MODIFIED="2016-09-28 09:08:46 -0400" MODIFIED_BY="Paul Miller" NAME="Nobre 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-09-28 09:08:46 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;CM - Comment in: Crit Care. 2008;12(6):309; PMID: 19090974JC - 9421642, bzsSB - AIM, IMCP - United StatesSI - ClinicalTrials.govSA - ClinicalTrials.gov/NCT00250666LG - EnglishDC - 20080225ED 20080313OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-RCT&lt;br&gt;PM: 18096708&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:08:46 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J</AU>
<TI>Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial</TI>
<SO>American Journal of Respiratory &amp; Critical Care Medicine</SO>
<YR>2008</YR>
<VL>177</VL>
<PG>498-505</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839821"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839820"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nuila-2008" MODIFIED="2016-12-07 13:06:48 -0500" MODIFIED_BY="Julia Worswick" NAME="Nuila 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-12-07 13:06:48 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Nuila, Franziska&lt;br&gt;Cadle, Richard M&lt;br&gt;Logan, Nancy&lt;br&gt;Musher, Daniel M&lt;br&gt;Members of the Infectious Disease Section of the Michael E DeBakey VA Medical Center&lt;br&gt;Letter&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;Research Support, U.S. Gov't, Non-P.H.S.&lt;br&gt;United States&lt;br&gt;Infect Control Hosp Epidemiol. 2008 Nov;29(11):1096-7. doi: 10.1086/591450.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:06:48 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nuila F, Cadle RM, Logan N, Musher DM</AU>
<TI>Antibiotic stewardship and Clostridium difficile-associated disease</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2008</YR>
<VL>29</VL>
<PG>1096-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839823"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839822"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oliveira-2013" MODIFIED="2016-12-07 13:07:03 -0500" MODIFIED_BY="Julia Worswick" NAME="Oliveira 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-12-07 13:07:03 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Comment in: Crit Care Med. 2013 Oct;41(10):2447-8; PMID: 24060778&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:07:03 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oliveira CF, Botoni FA, Oliveira CRA, Silva CB, Pereira HA, Serufo JC, et al</AU>
<TI>Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial</TI>
<SO>Critical Care Medicine</SO>
<YR>2013</YR>
<VL>41</VL>
<PG>2336-43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839825"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839824"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oosterheert-2005" MODIFIED="2013-03-18 13:46:56 -0400" MODIFIED_BY="Kate Cahill" NAME="Oosterheert 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-03-18 13:46:56 -0400" MODIFIED_BY="Kate Cahill" NOTES="eng" NOTES_MODIFIED="2013-03-18 13:46:56 -0400" NOTES_MODIFIED_BY="Kate Cahill" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oosterheert JJ, Van Loon AM, Schuurman R, Hoepelman AI, Hak E, Thijsen S, et al</AU>
<TI>Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2005</YR>
<VL>41</VL>
<NO>10</NO>
<PG>1438-44</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839827"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839826"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ostrowsky-2014" MODIFIED="2016-09-28 09:09:48 -0400" MODIFIED_BY="Paul Miller" NAME="Ostrowsky 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-09-28 09:09:48 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ostrowsky B, Ruiz R, Brown S, Chung P, Koppelman E, van Deusen LC, et al</AU>
<TI>Lessons learned from implementing Clostridium difficile-focused antibiotic stewardship interventions</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2014</YR>
<VL>35</VL>
<PG>S86-95</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839829"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839828"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ozkaya-2009" MODIFIED="2016-12-07 13:07:43 -0500" MODIFIED_BY="Julia Worswick" NAME="Ozkaya 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-12-07 13:07:43 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Ozkaya, E&lt;br&gt;Cambaz, N&lt;br&gt;Coskun, Y&lt;br&gt;Mete, F&lt;br&gt;Geyik, M&lt;br&gt;Samanci, N&lt;br&gt;eng&lt;br&gt;Norway&lt;br&gt;Oslo, Norway : 1992&lt;br&gt;2009/06/27 09:00&lt;br&gt;Acta Paediatr. 2009 Oct;98(10):1589-92. doi: 10.1111/j.1651-2227.2009.01384.x. Epub 2009 Jun 23.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:07:43 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ozkaya E, Cambaz N, Coskun Y, Mete F, Geyik M, Samanci N</AU>
<TI>The effect of rapid diagnostic testing for influenza on the reduction of antibiotic use in paediatric emergency department</TI>
<SO>Acta Paediatrica</SO>
<YR>2009</YR>
<VL>98</VL>
<PG>1589-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839831"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839830"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Palmay-2014" MODIFIED="2017-01-08 00:12:18 -0500" MODIFIED_BY="[Empty name]" NAME="Palmay 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-01-08 00:12:18 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Palmay L, Elligsen M, Walker SAN, Pinto R, Walker S, Einarson T, et al</AU>
<TI>Hospital-wide rollout of antimicrobial stewardship: A stepped-wedge randomized trial</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2014</YR>
<VL>59</VL>
<NO>6</NO>
<PG>867-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839833"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839832"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Parienti-2011" MODIFIED="2016-09-28 09:10:14 -0400" MODIFIED_BY="Paul Miller" NAME="Parienti 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-09-28 09:10:14 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;JC - id6, 8007166SB - IMCP - EnglandLG - EnglishDC - 20110518ED 20110926OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-MeSH-EPOC&lt;br&gt;PM: 21497946&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:10:14 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Parienti JJ, Cattoir V, Thibon P, Lebouvier G, Verdon R, Daubin C, et al</AU>
<TI>Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis</TI>
<SO>Journal of Hospital Infection</SO>
<YR>2011</YR>
<VL>78</VL>
<PG>118-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839835"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839834"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Parikh-2014" MODIFIED="2016-09-28 09:10:36 -0400" MODIFIED_BY="Paul Miller" NAME="Parikh 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-09-28 09:10:36 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Parikh K, Hall M, Teach SJ</AU>
<TI>Bronchiolitis management before and after the AAP guidelines</TI>
<SO>Pediatrics</SO>
<YR>2014</YR>
<VL>133</VL>
<PG>e1-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839837"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839836"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Patel-1989" MODIFIED="2013-02-15 09:38:55 -0500" MODIFIED_BY="[Empty name]" NAME="Patel 1989" YEAR="1989">
<REFERENCE MODIFIED="2013-02-15 09:38:55 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Patel M, Jackson C</AU>
<TI>Targeted interventions on oral antibiotic expenditure</TI>
<SO>British Journal of Pharmaceutical Practice</SO>
<YR>1989</YR>
<VL>11</VL>
<PG>306-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839839"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839838"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Paul-2006" MODIFIED="2017-01-08 00:13:54 -0500" MODIFIED_BY="[Empty name]" NAME="Paul 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-12-01 12:06:10 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;JC - hd7, 7513617SB - IMCP - EnglandLG - EnglishDC - 20090114ED 20090216OVID MEDLINE UP 20111214&lt;br&gt;2006-screened&lt;br&gt;PM: 19091808&lt;/p&gt;" NOTES_MODIFIED="2016-12-01 12:06:10 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kofoed K, Zalounina A, Andersen O, Lisby G, Paul M, Leibovici L, et al</AU>
<TI>Performance of the TREAT decision support system in an environment with a low prevalence of resistant pathogens</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2009</YR>
<VL>63</VL>
<PG>400-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889689"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-01-08 00:13:54 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leibovici l, Kariv G, Paul M</AU>
<TI>Long-term survival in patients included in a randomized controlled trial of TREAT, a decision support system for antibiotic treatment</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2013</YR>
<VL>68</VL>
<PG>2664-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889690"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-12-01 12:06:17 -0500" MODIFIED_BY="Julia Worswick" NOTES="10.1093/jac/dkl372" NOTES_MODIFIED="2016-12-01 12:06:17 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Paul M, Andreassen S, Tacconelli E, Nielsen AD, Almanasreh N, Frank U, et al</AU>
<TI>Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2006</YR>
<VL>58</VL>
<NO>6</NO>
<PG>1238-45</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839841"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839840"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pear-1994" NAME="Pear 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pear SM, Williamson TH, Bettin KM, Gerding DN, Galgiani JN</AU>
<TI>Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1994</YR>
<VL>120</VL>
<NO>4</NO>
<PG>272-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839843"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839842"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perez-2003" NAME="Perez 2003" YEAR="2003">
<REFERENCE NOTES="&lt;p&gt;DA - 20031021&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perez A, Dennis RJ, Rodriguez B, Castro AY, Delgado V, Lozano JM, et al</AU>
<TI>An interrupted time series analysis of parenteral antibiotic use in Colombia</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2003</YR>
<VL>56</VL>
<NO>10</NO>
<PG>1013-20</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839845"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839844"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peto-2008" MODIFIED="2017-01-08 00:16:48 -0500" MODIFIED_BY="[Empty name]" NAME="Peto 2008" YEAR="2008">
<REFERENCE MODIFIED="2017-01-08 00:16:48 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peto Z, Benko R, Matuz M, Csullog E, Molnar A, Hajdu E</AU>
<TI>Results of a local antibiotic management program on antibiotic use in a tertiary intensive care unit in Hungary</TI>
<SO>Infection</SO>
<YR>2008</YR>
<VL>36</VL>
<PG>560-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839847"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839846"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Petrikkos-2007" MODIFIED="2016-12-07 13:09:00 -0500" MODIFIED_BY="Julia Worswick" NAME="Petrikkos 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-12-07 13:09:00 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Petrikkos, George&lt;br&gt;Markogiannakis, Antonios&lt;br&gt;Papaparaskevas, Joseph&lt;br&gt;Daikos, George L&lt;br&gt;Stefanakos, George&lt;br&gt;Zissis, Nicholas P&lt;br&gt;Avlamis, Athina&lt;br&gt;eng&lt;br&gt;Netherlands&lt;br&gt;2006/12/26 09:00&lt;br&gt;Int J Antimicrob Agents. 2007 Jan;29(1):34-8.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:09:00 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Petrikkos G, Markogiannakis A, Papaparaskevas J, Daikos GL, Stefanakos G, Zissis NP, et al</AU>
<TI>Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital</TI>
<SO>International Journal of Antimicrobial Agents</SO>
<YR>2007</YR>
<VL>29</VL>
<PG>34-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839849"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839848"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pires-2011" MODIFIED="2016-09-28 09:11:14 -0400" MODIFIED_BY="Paul Miller" NAME="Pires 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-09-28 09:11:14 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;JC - ich, 8804099SB - IM, NCP - United StatesLG - EnglishDC - 20110511ED 20111026OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:11:14 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pires dos Santos R, Jacoby T, Pires Machado D, Lisboa T, Gastal SL, Nagel FM, et al</AU>
<TI>Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates</TI>
<SO>Infection Control &amp; Hospital Epidemiology</SO>
<YR>2011</YR>
<VL>32</VL>
<PG>584-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839851"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839850"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Po-2012" MODIFIED="2016-12-07 13:09:41 -0500" MODIFIED_BY="Julia Worswick" NAME="Po 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-12-07 13:09:41 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Po, John Leander&lt;br&gt;Nguyen, Bao Q&lt;br&gt;Carling, Philip C&lt;br&gt;Letter&lt;br&gt;United States&lt;br&gt;Infect Control Hosp Epidemiol. 2012 Apr;33(4):434-5. doi: 10.1086/664766.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:09:41 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Po JL, Nguyen BQ, Carling PC</AU>
<TI>The impact of an infectious diseases specialist-directed computerized physician order entry antimicrobial stewardship program targeting linezolid use</TI>
<SO>Infection Control &amp; Hospital Epidemiology</SO>
<YR>2012</YR>
<VL>33</VL>
<PG>434-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839853"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839852"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poehling-2006" MODIFIED="2017-01-08 00:18:31 -0500" MODIFIED_BY="[Empty name]" NAME="Poehling 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-01-08 00:18:31 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JC - 9422751, bwfSB - AIM, IMCP - United StatesLG - EnglishDC - 20060704ED 20060808OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2017-01-08 00:18:31 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poehling KA, Zhu Y, Tang YW, Edwards K</AU>
<TI>Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses</TI>
<SO>Archives of Pediatrics &amp; Adolescent Medicine</SO>
<YR>2006</YR>
<VL>160</VL>
<PG>713-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839855"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839854"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Popovski-2015" MODIFIED="2016-12-07 13:11:08 -0500" MODIFIED_BY="Julia Worswick" NAME="Popovski 2015" YEAR="2014">
<REFERENCE MODIFIED="2016-12-07 13:11:08 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Popovski, Zagorka&lt;br&gt;Mercuri, Mathew&lt;br&gt;Main, Cheryl&lt;br&gt;Sne, Niv&lt;br&gt;Walsh, Kate&lt;br&gt;Sung, Melani&lt;br&gt;Rice, Timothy&lt;br&gt;Mertz, Dominik&lt;br&gt;The Journal of antimicrobial chemotherapy&lt;br&gt;J Antimicrob Chemother. 2014 Dec 11. pii: dku498.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:11:08 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Popovski Z, Mercuri M, Main C, Sne N, Walsh K, Sung M, et al</AU>
<TI>Multifaceted intervention to optimize antibiotic use for intra-abdominal infections</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2015</YR>
<VL>70</VL>
<PG>1226-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839857"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-11-29 00:36:19 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839856"/><IDENTIFIER MODIFIED="2015-11-29 00:36:19 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1093/jac/dku498"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Price-2010" MODIFIED="2017-01-08 00:19:22 -0500" MODIFIED_BY="[Empty name]" NAME="Price 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-01-08 00:19:22 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JC - dy9, 9516420SB - IMCP - FranceLG - EnglishDC - 20100730ED 20101104OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2017-01-08 00:19:22 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Price J, Cheek E, Lippett S, Cubbon M, Gerding DN, Sambol SP, et al</AU>
<TI>Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis</TI>
<SO>Clinical Microbiology &amp; Infection</SO>
<YR>2010</YR>
<VL>16</VL>
<PG>1297-302</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839859"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839858"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Pulcini-2011" MODIFIED="2017-01-18 12:06:42 -0500" MODIFIED_BY="Julia Worswick" NAME="Pulcini 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-01-18 12:06:42 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pulcini C, Defres S, Aggarwal I, Nathwani D, Davey P.</AU>
<TI>Design of a 'day 3 bundle' to improve the reassessment of inpatient empirical antibiotic prescriptions</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2008</YR>
<VL>61</VL>
<NO>6</NO>
<PG>1384-8. doi: 10.1093/jac/dkn113.</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889691"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-01-09 11:32:40 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;JC - 0311416SB - IMCP - FranceLG - EnglishDC - 20111017ED 20120224OVID MEDLINE UP 20120227&lt;/p&gt;" NOTES_MODIFIED="2017-01-09 11:32:40 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Pulcini C, Dellamonica J, Bernardin G, Molinari N, Sotto A</AU>
<TI>Impact of an intervention designed to improve the documentation of the reassessment of antibiotic therapies in an intensive care unit</TI>
<SO>Medecine et Maladies Infectieuses</SO>
<YR>2011</YR>
<VL>41</VL>
<PG>546-52</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839861"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839860"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Qu-2012" MODIFIED="2017-01-08 00:23:11 -0500" MODIFIED_BY="[Empty name]" NAME="Qu 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-01-08 00:23:11 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Qu, Rong&lt;br&gt;Ji, Yan&lt;br&gt;Ling, Yun&lt;br&gt;Ye, Chu-Yang&lt;br&gt;Yang, Si-Ming&lt;br&gt;Liu, Yan-Yuan&lt;br&gt;Yang, Ri-Yan&lt;br&gt;Luo, Yu-Feng&lt;br&gt;Guo, Zhi&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Saudi Arabia&lt;br&gt;Saudi Med J. 2012 Apr;33(4):382-7.&lt;/p&gt;" NOTES_MODIFIED="2017-01-08 00:23:11 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Qu R, Ji Y, Ling Y, Ye CY, Yang SM, Liu YY, et al</AU>
<TI>Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial</TI>
<SO>Saudi Medical Journal</SO>
<YR>2012</YR>
<VL>33</VL>
<PG>382-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839863"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839862"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rattanaumpawan-2010" MODIFIED="2016-09-28 09:12:06 -0400" MODIFIED_BY="Paul Miller" NAME="Rattanaumpawan 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-09-28 09:12:06 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rattanaumpawan P, Sutha P, Thamlikitkul V</AU>
<TI>Effectiveness of drug use evaluation and antibiotic authorization on patients' clinical outcomes, antibiotic consumption, and antibiotic expenditures</TI>
<SO>American Journal of Infection Control</SO>
<YR>2010</YR>
<VL>38</VL>
<PG>38-43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839865"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839864"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rattanaumpawan-2011" MODIFIED="2016-09-28 09:12:28 -0400" MODIFIED_BY="Paul Miller" NAME="Rattanaumpawan 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-09-28 09:12:28 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rattanaumpawan P, Morales KH, Binkley S, Synnestvedt M, Weiner MG, Gasink LB, et al</AU>
<TI>Impact of antimicrobial stewardship programme changes on unnecessary double anaerobic coverage therapy</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2011</YR>
<VL>66</VL>
<PG>2655-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839867"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839866"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Richards-2003" MODIFIED="2013-02-15 09:40:04 -0500" MODIFIED_BY="[Empty name]" NAME="Richards 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-02-15 09:40:04 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Richards MJ, Robertson MB, Dartnell JG, Duarte MM, Jones NR, Kerr DA, et al</AU>
<TI>Impact of a web-based antimicrobial approval system on broad-spectrum cephalosporin use at a teaching hospital</TI>
<SO>Medical Journal of Australia</SO>
<YR>2003</YR>
<VL>178</VL>
<PG>386-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839869"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839868"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Richardson-2000" NAME="Richardson 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Richardson LP, Wiseman SW, Melani PN, Lyons MJ, Kauffman CA</AU>
<TI>Effectiveness of a vancomycin restriction policy in changing the prescribing patterns of house staff</TI>
<SO>Microbial Drug Resistance</SO>
<YR>2000</YR>
<VL>6</VL>
<NO>4</NO>
<PG>327-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839871"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839870"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ross-2014" MODIFIED="2017-01-08 00:26:15 -0500" MODIFIED_BY="[Empty name]" NAME="Ross 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-01-08 00:26:15 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ross RK, Hersh AL, Kronman MP, Newland JG, Metjian TA, Localio AR, et al</AU>
<TI>Impact of Infectious Diseases Society of America/Pediatric Infectious Diseases Society guidelines on treatment of community-acquired pneumonia in hospitalized children</TI>
<SO>Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America</SO>
<YR>2014</YR>
<VL>58</VL>
<PG>834-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839873"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839872"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saizy_x002d_Callaert-2003" MODIFIED="2013-02-15 09:41:38 -0500" MODIFIED_BY="[Empty name]" NAME="Saizy-Callaert 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-02-15 09:41:38 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saizy-Callaert S, Causse R, Furhman C, Le Paih MF, Thebault A, Chouaid C</AU>
<TI>Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital</TI>
<SO>Journal of Hospital Infection</SO>
<YR>2003</YR>
<VL>53</VL>
<NO>3</NO>
<PG>177-82</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839875"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839874"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salama-1996" MODIFIED="2013-02-15 09:41:56 -0500" MODIFIED_BY="[Empty name]" NAME="Salama 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-02-15 09:41:56 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salama S, Rotstein C, Mandell L</AU>
<TI>A multidisciplinary hospital-based antimicrobial use program: impact on hospital pharmacy expenditures and drug use</TI>
<SO>Canadian Journal of Infectious Diseases</SO>
<YR>1996</YR>
<VL>7</VL>
<PG>104-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839877"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839876"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Schnoor-2010" MODIFIED="2015-05-06 07:29:57 -0400" MODIFIED_BY="[Empty name]" NAME="Schnoor 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-10-29 11:43:54 -0400" MODIFIED_BY="Claire Peden" NOTES="&lt;p&gt;CM - Comment in: Qual Saf Health Care. 2010 Dec;19(6):471-2; PMID: 21127105JC - 101136980SB - HCP - EnglandLG - EnglishDC - 20101203ED 20110406OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2014-10-29 11:43:54 -0400" NOTES_MODIFIED_BY="Claire Peden" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schnoor M, Meyer T, Suttorp N, Raspe H, Welte T, Schafer T, et al</AU>
<TI>Development and evaluation of an implementation strategy for the German guideline on community-acquired pneumonia</TI>
<SO>Quality &amp; Safety in Health Care</SO>
<YR>2010</YR>
<VL>19</VL>
<PG>498-502</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839879"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839878"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schouten-2007" MODIFIED="2017-01-08 00:28:02 -0500" MODIFIED_BY="[Empty name]" NAME="Schouten 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-01-08 00:28:02 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schouten JA, Hulscher MEJL, Trap-Liefers J, Akkermans RP, Kullberg BJ, Grol RPTM, et al</AU>
<TI>Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2007</YR>
<VL>44</VL>
<PG>931-41</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839881"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839880"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schroeder-2009" MODIFIED="2017-01-08 00:28:47 -0500" MODIFIED_BY="[Empty name]" NAME="Schroeder 2009" YEAR="2009">
<REFERENCE MODIFIED="2017-01-08 00:28:47 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20090203IS - 1435-2451 (Electronic)IS - 1435-2443 (Linking)LA - engPT - Comparative StudyPT - Journal ArticlePT - Randomized Controlled TrialRN - 0 (Anti-Bacterial Agents)RN - 0 (Protein Precursors)RN - 56645-65-9 (procalcitonin)RN - 9007-12-9 (Calcitonin)RN - 9007-41-4 (C-Reactive Protein)SB - IM&lt;br&gt;PM2&lt;br&gt;PM:19034493&lt;/p&gt;" NOTES_MODIFIED="2017-01-08 00:28:47 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, Keck FS, et al</AU>
<TI>Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study</TI>
<SO>Langenbeck's Archives of Surgery/Deutsche Gesellschaft fur Chirurgie</SO>
<YR>2009</YR>
<VL>394</VL>
<PG>221-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839883"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839882"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schuetz-2009" MODIFIED="2017-01-08 00:32:05 -0500" MODIFIED_BY="[Empty name]" NAME="Schuetz 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-12-07 13:13:23 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Schuetz, P&lt;br&gt;Batschwaroff, M&lt;br&gt;Dusemund, F&lt;br&gt;Albrich, W&lt;br&gt;Burgi, U&lt;br&gt;Maurer, M&lt;br&gt;Brutsche, M&lt;br&gt;Huber, A R&lt;br&gt;Muller, B&lt;br&gt;eng&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Germany&lt;br&gt;2009/12/30 06:00&lt;br&gt;Eur J Clin Microbiol Infect Dis. 2010 Mar;29(3):269-77. doi: 10.1007/s10096-009-0851-0. Epub 2009 Dec 29.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:13:23 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schuetz P, Batschwaroff M, Dusemund F, Albrich W, Burgi U, Maurer M, et al</AU>
<TI>Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey</TI>
<SO>European Journal of Clinical Microbiology &amp; Infectious Diseases</SO>
<YR>2010</YR>
<VL>29</VL>
<PG>269-77</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889692"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-01-08 00:29:45 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Schuetz, Philipp&lt;br&gt;Christ-Crain, Mirjam&lt;br&gt;Albrich, Werner&lt;br&gt;Zimmerli, Werner&lt;br&gt;Mueller, Beat&lt;br&gt;eng&lt;br&gt;Multicenter Study&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;2010/12/24 06:00&lt;br&gt;Virulence. 2010 Mar-Apr;1(2):88-92. doi: 10.4161/viru.1.2.10488.&lt;/p&gt;" NOTES_MODIFIED="2017-01-08 00:29:45 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schuetz P, Christ-Crain M, Albrich W, Zimmerli W, Mueller B; Pro Hosp Study Group</AU>
<TI>Guidance of antibiotic therapy with procalcitonin in lower respiratory tract infections: insights into the ProHOSP study</TI>
<SO>Virulence</SO>
<YR>2010</YR>
<VL>1</VL>
<PG>88-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889693"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-01-08 00:32:05 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;10.1001/jama.2009.1297&lt;/p&gt;" NOTES_MODIFIED="2017-01-08 00:32:05 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al</AU>
<TI>Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2009</YR>
<VL>302</VL>
<PG>1059-66</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839885"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839884"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwann-2011" MODIFIED="2016-12-07 13:14:12 -0500" MODIFIED_BY="Julia Worswick" NAME="Schwann 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-12-07 13:14:12 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Schwann, Nanette M&lt;br&gt;Bretz, Karen A&lt;br&gt;Eid, Sherrine&lt;br&gt;Burger, Terry&lt;br&gt;Fry, Deborah&lt;br&gt;Ackler, Frederick&lt;br&gt;Evans, Paul&lt;br&gt;Romancheck, David&lt;br&gt;Beck, Michelle&lt;br&gt;Ardire, Anthony J&lt;br&gt;Lukens, Harry&lt;br&gt;McLoughlin, Thomas M&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;United States&lt;br&gt;Anesth Analg. 2011 Oct;113(4):869-76. doi: 10.1213/ANE.0b013e318227b511. Epub 2011 Jul 25.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:14:12 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwann NM, Bretz KA, Eid S, Burger T, Fry D, Ackler F, et al</AU>
<TI>Point-of-care electronic prompts: an effective means of increasing compliance, demonstrating quality, and improving outcome</TI>
<SO>Anesthesia &amp; Analgesia</SO>
<YR>2011</YR>
<VL>113</VL>
<PG>869-76</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839887"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839886"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwartz-2007" MODIFIED="2017-01-08 00:33:19 -0500" MODIFIED_BY="[Empty name]" NAME="Schwartz 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-01-08 00:33:19 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwartz DN, Abiad H, DeMarais PL, Armeanu E, Trick WE, Wang Y, et al</AU>
<TI>An educational intervention to improve antimicrobial use in a hospital-based long-term care facility</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>2007</YR>
<VL>55</VL>
<PG>1236-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839889"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839888"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Senn-2004" MODIFIED="2013-02-15 09:47:23 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Senn 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-02-15 09:47:23 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="10.1093/jac/dkh236" NOTES_MODIFIED="2013-02-15 09:47:23 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Senn L, Burnand B, Francioli P, Zanetti G</AU>
<TI>Improving appropriateness of antibiotic therapy: randomized trial of an intervention to foster reassessment of prescription after 3 days</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2004</YR>
<VL>53</VL>
<NO>6</NO>
<PG>1062-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839891"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839890"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shehabi-2014" MODIFIED="2016-12-07 13:15:50 -0500" MODIFIED_BY="Julia Worswick" NAME="Shehabi 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-12-07 13:15:50 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Comment in: Am J Respir Crit Care Med. 2014 Nov 15;190(10):1081-2; PMID: 25398103&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:15:50 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shehabi Y, Sterba M, Garrett PM, Rachakonda KS, Stephens D, Harrigan P, et al</AU>
<TI>Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2014</YR>
<VL>190</VL>
<PG>1102-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839893"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839892"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shen-2011" MODIFIED="2016-09-28 09:15:17 -0400" MODIFIED_BY="Paul Miller" NAME="Shen 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-09-28 09:15:17 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shen J, Sun Q, Zhou X, Wei Y, Qi Y, Zhu J, et al</AU>
<TI>Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital</TI>
<SO>International Journal of Clinical Pharmacy</SO>
<YR>2011</YR>
<VL>33</VL>
<PG>929-33</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839895"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839894"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shojania-1998" NAME="Shojania 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shojania KG, Yokoe D, Platt R, Fiskio J, Ma'luf N, Bates DW</AU>
<TI>Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial</TI>
<SO>Journal of the American Medical Informatics Association</SO>
<YR>1998</YR>
<VL>5</VL>
<NO>6</NO>
<PG>554-62</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839897"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839896"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Singh-2000" NAME="Singh 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL</AU>
<TI>Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2000</YR>
<VL>162</VL>
<NO>2 Pt 1</NO>
<PG>505-11</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839899"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839898"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sirinavin-1998" NAME="Sirinavin 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sirinavin S, Suvanakoot P, Sathapatayavongs B, Malatham K</AU>
<TI>Effect of antibiotic order form guiding rational use of expensive drugs on cost containment</TI>
<SO>Southeast Asian Journal of Tropical Medicine and Public Health</SO>
<YR>1998</YR>
<VL>29</VL>
<NO>3</NO>
<PG>636-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839901"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839900"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Skaer-1993" MODIFIED="2013-02-15 09:48:27 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Skaer 1993" YEAR="1993">
<REFERENCE MODIFIED="2013-02-15 09:48:27 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="0011-393X" NOTES_MODIFIED="2013-02-15 09:48:27 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Skaer TL, Sclar DA, Won JKH, Markowski DJ</AU>
<TI>Effect of academic detailing on the utilization of intravenous antimicrobial therapy</TI>
<SO>Current Therapeutic Research</SO>
<YR>1993</YR>
<VL>53</VL>
<NO>4</NO>
<PG>349-55</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839903"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839902"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Skrlin-2011" MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NAME="Skrlin 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;Dec&lt;/p&gt;" NOTES_MODIFIED="2015-04-03 23:43:37 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Skrlin J, Bacic Vrca V, Marusic S, Ciric-Crncec M, Mayer L</AU>
<TI>Impact of ceftriaxone de-restriction on the occurrence of ESBL-positive bacterial strains and antibiotic consumption</TI>
<SO>Journal of Chemotherapy</SO>
<YR>2011</YR>
<VL>23</VL>
<PG>341-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839905"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839904"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Solomon-2001" MODIFIED="2017-01-08 00:36:47 -0500" MODIFIED_BY="[Empty name]" NAME="Solomon 2001" YEAR="2001">
<REFERENCE MODIFIED="2017-01-08 00:36:47 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Solomon DH, Van Houten L, Glynn RJ, Baden L, Curtis K, Schrager H, et al</AU>
<TI>Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2001</YR>
<VL>161</VL>
<NO>15</NO>
<PG>1897-902</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839907"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839906"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Standiford-2012" MODIFIED="2016-09-28 09:15:54 -0400" MODIFIED_BY="Paul Miller" NAME="Standiford 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-09-28 09:15:54 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Standiford HC, Chan S, Tripoli M, Weekes E, Forrest GN</AU>
<TI>Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2012</YR>
<VL>33</VL>
<PG>338-45</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839909"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839908"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stevenson-1988" MODIFIED="2016-12-01 12:03:39 -0500" MODIFIED_BY="Julia Worswick" NAME="Stevenson 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-03-23 12:39:06 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hampson JP, Corkhill JE, Murray A, Griffiths LR, Smith JC, Bartzokas CA</AU>
<TI>Potential financial benefits of a local antibiotic policy</TI>
<SO>Pharmaceutical Journal</SO>
<YR>1988</YR>
<VL>241</VL>
<PG>660-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839911"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Stevenson RC, Blackman SC, Williams CL, Bartzokas CA</AU>
<TI>Measuring the saving attributable to an antibiotic prescribing policy</TI>
<SO>Journal of Hospital Infection</SO>
<YR>1988</YR>
<VL>11</VL>
<PG>16-25</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839912"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839910"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stocker-2010" MODIFIED="2016-09-28 09:18:41 -0400" MODIFIED_BY="Paul Miller" NAME="Stocker 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-09-28 09:18:41 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stocker M, Fontana M, el Helou S, Wegscheider K, Berger TM</AU>
<TI>Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial</TI>
<SO>Neonatology</SO>
<YR>2010</YR>
<VL>97</VL>
<PG>165-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839914"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839913"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stolz-2007" MODIFIED="2015-08-07 03:18:32 -0400" MODIFIED_BY="[Empty name]" NAME="Stolz 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-08-07 03:18:32 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;CM - Comment in: Chest. 2007 Jan;131(1):1-2; PMID: 17218546, Comment in: J Fam Pract. 2007 Apr;56(4):273; PMID: 17607835, Comment in: ACP J Club. 2007 May-Jun;146(3):57; PMID: 17474666JC - 0231335, d1cSB - AIM, IMCP - United StatesLG - EnglishDC - 20070112ED 20071105OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-RCT&lt;br&gt;PM: 17218551&lt;/p&gt;" NOTES_MODIFIED="2015-08-07 03:18:32 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Muller C, et al</AU>
<TI>Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy</TI>
<SO>Chest</SO>
<YR>2007</YR>
<VL>131</VL>
<PG>9-19</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839916"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839915"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stolz-2009" MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NAME="Stolz 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-04-03 23:43:37 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;CM - Comment in: Eur Respir J. 2011 Mar;37(3):486-8; PMID: 21357922JC - 8803460, erySB - IMCP - SwitzerlandSI - ISRCTNSA - ISRCTN/ISRCTN61015974LG - EnglishDC - 20091201ED 20100304OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-RCT&lt;br&gt;PM: 19797133&lt;/p&gt;" NOTES_MODIFIED="2015-04-03 23:43:37 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M, et al</AU>
<TI>Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study</TI>
<SO>European Respiratory Journal</SO>
<YR>2009</YR>
<VL>34</VL>
<PG>1364-75</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839918"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839917"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Strom-2010" MODIFIED="2017-01-08 00:40:21 -0500" MODIFIED_BY="[Empty name]" NAME="Strom 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-01-08 00:40:21 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Strom BL, Schinnar R, Aberra F, Bilker W, Hennessy S, Leonard CE, et al</AU>
<TI>Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2010</YR>
<VL>170</VL>
<PG>1578</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839920"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839919"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sun-2011" MODIFIED="2017-01-08 00:40:46 -0500" MODIFIED_BY="[Empty name]" NAME="Sun 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-01-08 00:40:46 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sun TB, Chao SF, Chang BS, Chen TY, Gao PY, Shyr MH</AU>
<TI>Quality Improvements of antimicrobial prophylaxis in coronary artery bypass grafting</TI>
<SO>Journal of Surgical Research</SO>
<YR>2011</YR>
<VL>167</VL>
<PG>329-35</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839922"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839921"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Suwangool-1991" MODIFIED="2013-02-15 09:49:04 -0500" MODIFIED_BY="[Empty name]" NAME="Suwangool 1991" YEAR="1991">
<REFERENCE MODIFIED="2013-02-15 09:49:04 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Suwangool P, Moola-Or P, Waiwatana A, Sitthi-amorn C, Israsena S, Hanvanich M</AU>
<TI>Effect of a selective restriction policy on antibiotic expenditure and use: an institutional model</TI>
<SO>Journal of the Medical Association of Thailand</SO>
<YR>1991</YR>
<VL>74</VL>
<PG>272-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839924"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839923"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Talpaert-2011" MODIFIED="2016-12-07 13:16:44 -0500" MODIFIED_BY="Julia Worswick" NAME="Talpaert 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-12-07 13:16:44 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Talpaert MJ, Rao GG, Cooper BS, Wade P</AU>
<TI>Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2011</YR>
<VL>66</VL>
<PG>2168-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839926"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839925"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tangd_x00e9_n-2011" MODIFIED="2017-01-08 00:42:08 -0500" MODIFIED_BY="[Empty name]" NAME="Tangdén 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-01-08 00:42:08 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Research Support, Non-U.S. Gov't&lt;/p&gt;" NOTES_MODIFIED="2017-01-08 00:42:08 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tängdén T, Eriksson BM, Melhus A, Svennblad B, Cars O</AU>
<TI>Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2011</YR>
<VL>66</VL>
<PG>1161-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839928"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839927"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Toltzis-1998" MODIFIED="2013-02-15 09:49:16 -0500" MODIFIED_BY="[Empty name]" NAME="Toltzis 1998" YEAR="1998">
<REFERENCE MODIFIED="2013-02-15 09:49:16 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Toltzis P, Yamashita T, Vilt L, Green M, Morrissey A, Spinner-Block S, et al</AU>
<TI>Antibiotic restriction does not alter endemic colonization with resistant gram-negative rods in a pediatric intensive care unit</TI>
<SO>Critical Care Medicine</SO>
<YR>1998</YR>
<VL>26</VL>
<NO>11</NO>
<PG>1893-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839930"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839929"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Toltzis-2002" MODIFIED="2013-02-15 09:49:42 -0500" MODIFIED_BY="[Empty name]" NAME="Toltzis 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-02-15 09:49:42 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Toltzis P, Dul MJ, Hoyen C, Salvator A, Walsh M, Zetts L, et al</AU>
<TI>The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit</TI>
<SO>Pediatrics</SO>
<YR>2002</YR>
<VL>110</VL>
<PG>707-11</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839932"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839931"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Toltzis-2014" MODIFIED="2016-12-07 13:45:34 -0500" MODIFIED_BY="Julia Worswick" NAME="Toltzis 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-12-07 13:45:34 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Toltzis, Philip&lt;br&gt;O'Riordan, Maryanne&lt;br&gt;Cunningham, Dennis J&lt;br&gt;Ryckman, Frederick C&lt;br&gt;Bracke, Tracey M&lt;br&gt;Olivea, Jason&lt;br&gt;Lyren, Anne&lt;br&gt;eng&lt;br&gt;Multicenter Study&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;2014/09/10 06:00&lt;br&gt;Pediatrics. 2014 Oct;134(4):e1174-80. doi: 10.1542/peds.2014-0097. Epub 2014 Sep 8.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:45:34 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Toltzis P, O'Riordan M, Cunningham DJ, Ryckman FC, Bracke TM, Olivea J, et al</AU>
<TI>A statewide collaborative to reduce pediatric surgical site infections</TI>
<SO>Pediatrics</SO>
<YR>2014</YR>
<VL>134</VL>
<PG>e1174-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839934"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839933"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trenholme-1989" MODIFIED="2017-01-08 00:45:07 -0500" MODIFIED_BY="[Empty name]" NAME="Trenholme 1989" YEAR="1989">
<REFERENCE MODIFIED="2017-01-08 00:45:07 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;226 patients with bacteremia were prospectively enrolled in a randomized trial that was performed to determine the clinical impact of the receipt of in vitro microbiolgical data by the physician soon after organism detection as opposed to having the physicians wait until similar data were available by routine methods. Saving of $158 per patient estimated from earlier reporting because of modification or stopping antibiotic treatment&lt;/p&gt;" NOTES_MODIFIED="2017-01-08 00:45:07 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trenholme GM, Kaplan RL, Karakusis PH, Stine T, Fuhrer J, Landau W, et al</AU>
<TI>Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates</TI>
<SO>Journal of Clinical Microbiology</SO>
<YR>1989</YR>
<VL>27</VL>
<NO>6</NO>
<PG>1342-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839936"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839935"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-U_x00e7_kay-2009" MODIFIED="2016-09-28 09:21:22 -0400" MODIFIED_BY="Paul Miller" NAME="Uçkay 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-09-28 09:21:22 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Uçkay I, Vernaz-Hegi N, Harbarth S, Stern R, Legout L, Vauthey L, et al</AU>
<TI>Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unit</TI>
<SO>Journal of Infection</SO>
<YR>2009</YR>
<VL>58</VL>
<PG>205-12</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839938"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839937"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Valiquette-2007" MODIFIED="2017-01-08 00:46:51 -0500" MODIFIED_BY="[Empty name]" NAME="Valiquette 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-01-08 00:46:51 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Valiquette L, Cossette B, Garant M-P, Diab H, Pépin J</AU>
<TI>Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2007</YR>
<VL>45</VL>
<PG>S112-21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839940"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839939"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-Hees-2008" MODIFIED="2016-09-28 09:21:49 -0400" MODIFIED_BY="Paul Miller" NAME="van Hees 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-09-28 09:21:49 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;JC - hd7, 7513617SB - IMCP - EnglandLG - EnglishDC - 20071218ED 20080228OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-MeSH-EPOC&lt;br&gt;PM: 17977911&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:21:49 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Hees BC, de Ruiter E, Wiltink EH, de Jongh BM, Tersmette M</AU>
<TI>Optimizing use of ciprofloxacin: a prospective intervention study</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2008</YR>
<VL>61</VL>
<PG>210-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839942"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839941"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Kasteren-2005" MODIFIED="2016-12-01 12:08:22 -0500" MODIFIED_BY="Julia Worswick" NAME="Van Kasteren 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-12-01 12:08:06 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;JC - ich, 8804099SB - IM, NCP - United StatesLG - EnglishDC - 20061207ED 20070215OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-EPOC&lt;br&gt;PM: 17152032&lt;/p&gt;" NOTES_MODIFIED="2016-12-01 12:08:06 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mannien J, van Kasteren ME, Nagelkerke NJ, Gyssens IC, Kullberg BJ, Wille JC, et al</AU>
<TI>Effect of optimized antibiotic prophylaxis on the incidence of surgical site infection</TI>
<SO>Infection Control &amp; Hospital Epidemiology</SO>
<YR>2006</YR>
<VL>27</VL>
<PG>1340-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889694"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-12-01 12:08:22 -0500" MODIFIED_BY="Julia Worswick" NOTES="eng" NOTES_MODIFIED="2016-12-01 12:08:22 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Van Kasteren ME, Mannien J, Kullberg BJ, de Boer AS, Nagelkerke NJ, Ridderhof M, et al</AU>
<TI>Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2005</YR>
<VL>56</VL>
<NO>6</NO>
<PG>1094-102</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839944"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839943"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Volpe-2012" MODIFIED="2016-09-28 09:22:00 -0400" MODIFIED_BY="Paul Miller" NAME="Volpe 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-09-28 09:22:00 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;br&gt;e201-10, Jul&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:22:00 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Volpe D, Harrison S, Damian F, Rachh P, Kahlon PS, Morrissey L, et al</AU>
<TI>Improving timeliness of antibiotic delivery for patients with fever and suspected neutropenia in a pediatric emergency department</TI>
<SO>Pediatrics</SO>
<YR>2012</YR>
<VL>130</VL>
<PG>e201-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839946"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839945"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Walker-1998" NAME="Walker 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walker SE</AU>
<TI>Physicians' acceptance of a preformatted pharmacy intervention chart note in a community hospital antibiotic step down program</TI>
<SO>Journal of Pharmacy Technology</SO>
<YR>1998</YR>
<VL>14</VL>
<PG>141-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839948"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839947"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2014" MODIFIED="2017-01-08 00:49:53 -0500" MODIFIED_BY="[Empty name]" NAME="Wang 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-01-08 00:49:53 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang HY, Chiu CH, Huang CT, Cheng CW, Lin YJ, Hsu YJ, et al</AU>
<TI>Blood culture-guided de-escalation of empirical antimicrobial regimen for critical patients in an online antimicrobial stewardship programme</TI>
<SO>International Journal of Antimicrobial Agents</SO>
<YR>2014</YR>
<VL>44</VL>
<NO>6</NO>
<PG>520-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839950"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839949"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wax-2007" MODIFIED="2016-09-28 09:22:41 -0400" MODIFIED_BY="Paul Miller" NAME="Wax 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-09-28 09:22:41 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wax DB, Beilin Y, Levin M, Chadha N, Krol M, Reich DL</AU>
<TI>The effect of an interactive visual reminder in an anesthesia information management system on timeliness of prophylactic antibiotic administration</TI>
<SO>Anesthesia &amp; Analgesia</SO>
<YR>2007</YR>
<VL>104</VL>
<PG>1462-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839952"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839951"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weinberg-2001" MODIFIED="2013-02-15 09:51:18 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Weinberg 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-02-15 09:51:18 -0500" MODIFIED_BY="Philip J Wiffen" NOTES="eng" NOTES_MODIFIED="2013-02-15 09:51:18 -0500" NOTES_MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weinberg M, Fuentes JM, Ruiz A I, Lozano FW, Angel E, Gaitan H, et al</AU>
<TI>Reducing infections among women undergoing cesarean section in Colombia by means of continuous quality improvement methods</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2001</YR>
<VL>161</VL>
<NO>19</NO>
<PG>2357-65</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839954"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839953"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weiner-2009" MODIFIED="2016-09-28 09:23:09 -0400" MODIFIED_BY="Paul Miller" NAME="Weiner 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-09-28 09:23:09 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;JC - ce1, 9418450SB - IMCP - United StatesLG - EnglishDC - 20090820ED 20091207OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-EPOC&lt;br&gt;PM: 19538501&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:23:09 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weiner SG, Brown SF, Goetz JD, Webber CA</AU>
<TI>Weekly E-mail reminders influence emergency physician behavior: a case study using the Joint Commission and Centers for Medicare and Medicaid Services Pneumonia Guidelines</TI>
<SO>Academic Emergency Medicine</SO>
<YR>2009</YR>
<VL>16</VL>
<PG>626-31</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839956"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839955"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weiss-2013" MODIFIED="2017-01-09 13:40:35 -0500" MODIFIED_BY="Julia Worswick" NAME="Weiss 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-12-07 13:18:11 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Weiss CH, Dibardino D, Rho J, Sung N, Collander B, Wunderink RG</AU>
<TI>A clinical trial comparing physician prompting with an unprompted automated electronic checklist to reduce empirical antibiotic utilization</TI>
<SO>Critical Care Medicine</SO>
<YR>2013</YR>
<VL>41</VL>
<PG>2563-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839958"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-01-09 13:40:35 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Using Smart Source Parsing&lt;/p&gt;" NOTES_MODIFIED="2017-01-09 13:40:35 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weiss CH, Persell SD, Wunderink RG, Baker DW</AU>
<TI>Empiric antibiotic, mechanical ventilation, and central venous catheter duration as potential factors mediating the effect of a checklist prompting intervention on mortality: an exploratory analysis</TI>
<SO>BMC Health Services Research</SO>
<YR>2012</YR>
<VL>12</VL>
<PG>198</PG>
<IDENTIFIERS MODIFIED="2017-01-08 00:52:35 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889695"/><IDENTIFIER MODIFIED="2017-01-08 00:52:35 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1186/1472-6963-12-198"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839957"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Welker-2008" MODIFIED="2016-09-28 09:23:50 -0400" MODIFIED_BY="Paul Miller" NAME="Welker 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-09-28 09:23:50 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;Welker, James A&lt;br&gt;Huston, Michelle&lt;br&gt;McCue, Jack D&lt;br&gt;Arch Intern Med. 2008 Feb 25;168(4):351-6. doi: 10.1001/archinternmed.2007.84.&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:23:50 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Welker JA, Huston M, McCue JD</AU>
<TI>Antibiotic timing and errors in diagnosing pneumonia</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2008</YR>
<VL>168</VL>
<PG>351-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839960"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839959"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wenisch-2014" MODIFIED="2016-12-07 13:19:11 -0500" MODIFIED_BY="Julia Worswick" NAME="Wenisch 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-12-07 13:19:11 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wenisch JM, Equiluz-Bruck S, Fudel M, Reiter I, Schmid A, Singer E, et al</AU>
<TI>Decreasing Clostridium difficile infections by an antimicrobial stewardship program that reduces moxifloxacin use</TI>
<SO>Antimicrobial Agents and Chemotherapy</SO>
<YR>2014</YR>
<VL>58 (9)</VL>
<PG>5079-83</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839962"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839961"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Willemsen-2010" MODIFIED="2017-01-08 00:55:00 -0500" MODIFIED_BY="[Empty name]" NAME="Willemsen 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-01-08 00:55:00 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Willemsen I, Cooper B, van Buitenen C, Winters M, Andriesse G, Kluytmans J</AU>
<TI>Improving quinolone use in hospitals by using a bundle of interventions in an interrupted time series analysis</TI>
<SO>Antimicrobial Agents and Chemotherapy</SO>
<YR>2010</YR>
<VL>54</VL>
<PG>3763-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839964"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839963"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-1991" MODIFIED="2013-02-15 09:52:28 -0500" MODIFIED_BY="[Empty name]" NAME="Wilson 1991" YEAR="1991">
<REFERENCE MODIFIED="2013-02-15 09:52:28 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;The usage of three pairs of drugs, featured as alternatives in a prescribers newsletter published by a hospital therapeutics committee, was examined. A marked change in prescribing pattern was observed for each of the three pairs, with the recommended drug being prescribed in preference to the alternative. The combined usage of each of the pairs of drugs remained similar. Overall cash savings as a result of the recommendations in the newsletters were estimated at &amp;#163;26,000/annum for the three pairs of drugs&lt;/p&gt;" NOTES_MODIFIED="2013-02-15 09:52:28 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson J, Gordon A, French S, Aslam M</AU>
<TI>The effectiveness of prescribers newsletters in influencing hospital drug expenditure</TI>
<SO>Hospital Pharmacy Practice</SO>
<YR>1991</YR>
<VL>1</VL>
<PG>33-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839966"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839965"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Winters-2010" MODIFIED="2016-09-28 09:24:29 -0400" MODIFIED_BY="Paul Miller" NAME="Winters 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-09-28 09:24:29 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;Winters, Bradford D&lt;br&gt;Thiemann, David R&lt;br&gt;Brotman, Daniel J&lt;br&gt;J Hosp Med. 2010 Jan;5(1):E41-5. doi: 10.1002/jhm.561.&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:24:29 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Winters BD, Thiemann DR, Brotman DJ</AU>
<TI>Impact of a restrictive antimicrobial policy on the process and timing of antimicrobial administration</TI>
<SO>Journal of Hospital Medicine</SO>
<YR>2010</YR>
<VL>5</VL>
<PG>E41-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839968"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839967"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wishaupt-2011" MODIFIED="2016-09-28 09:24:45 -0400" MODIFIED_BY="Paul Miller" NAME="Wishaupt 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-09-28 09:24:45 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;JC - oxv, 0376422SB - AIM, IMCP - United StatesSI - ISRCTNSA - ISRCTN/ISRCTN13015410LG - EnglishDC - 20111102ED 20120124OVID MEDLINE UP 20120125&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:24:45 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wishaupt JO, Russcher A, Smeets LC, Versteegh FG, Hartwig NG</AU>
<TI>Clinical impact of RT-PCR for pediatric acute respiratory infections: a controlled clinical trial</TI>
<SO>Pediatrics</SO>
<YR>2011</YR>
<VL>128</VL>
<PG>e1113-20</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839970"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839969"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Woodward-1987" NAME="Woodward 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Woodward RS, Medoff G, Smith MD, Gray JLI</AU>
<TI>Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital</TI>
<SO>American Journal of Medicine</SO>
<YR>1987</YR>
<VL>83</VL>
<NO>5</NO>
<PG>817-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839972"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839971"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wyatt-1998" MODIFIED="2013-02-15 09:53:16 -0500" MODIFIED_BY="[Empty name]" NAME="Wyatt 1998" YEAR="1998">
<REFERENCE MODIFIED="2013-02-15 09:53:16 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wyatt JC, Paterson-Brown S, Johanson R, Altman DG, Bradburn MJ, Fisk NM</AU>
<TI>Randomised trial of educational visits to enhance use of systematic reviews in 25 obstetric units</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>317</VL>
<NO>7165</NO>
<PG>1041-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839974"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839973"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yealy-2005" MODIFIED="2016-12-01 12:05:07 -0500" MODIFIED_BY="Julia Worswick" NAME="Yealy 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-12-01 12:04:56 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;JC - 3l2, 0370506SB - AIM, IMCP - United StatesLG - EnglishDC - 20100408ED 20100419OVID MEDLINE UP 20111214&lt;br&gt;ML-2006-2012-KW-RCT&lt;br&gt;PM: 20224313&lt;/p&gt;" NOTES_MODIFIED="2016-12-01 12:04:56 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hsu DJ, Stone RA, Obrosky DS, Yealy DM, Meehan TP, Fine JM, et al</AU>
<TI>Predictors of timely antibiotic administration for patients hospitalized with community-acquired pneumonia from the cluster-randomized EDCAP trial</TI>
<SO>American Journal of the Medical Sciences</SO>
<YR>2010</YR>
<VL>339</VL>
<PG>307-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889696"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-12-01 12:05:07 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;CP - United StatesRF - 35LG - EnglishEM - 201100 EM2-RCT-2006-2012&lt;/p&gt;" NOTES_MODIFIED="2016-12-01 12:05:07 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Yealy DM, Auble TE, Stone RA, Lave JR, Meehan TP, Graff LG, et al</AU>
<TI>Effect of increasing the intensity of implementing pneumonia guidelines: A randomized, controlled trial</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2005</YR>
<VL>143</VL>
<PG>881-94</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839976"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839975"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yeo-2012" MODIFIED="2016-09-28 09:25:21 -0400" MODIFIED_BY="Paul Miller" NAME="Yeo 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-09-28 09:25:21 -0400" MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yeo CL, Chan DSG, Earnest A, Wu TS, Yeoh SF, Lim R, et al</AU>
<TI>Prospective audit and feedback on antibiotic prescription in an adult hematology-oncology unit in Singapore</TI>
<SO>European Journal of Clinical Microbiology &amp; Infectious Diseases</SO>
<YR>2012</YR>
<VL>31</VL>
<PG>583-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839978"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839977"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yong-2010" MODIFIED="2016-09-28 09:25:38 -0400" MODIFIED_BY="Paul Miller" NAME="Yong 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-09-28 09:25:38 -0400" MODIFIED_BY="Paul Miller" NOTES="&lt;p&gt;JC - hd7, 7513617SB - IMCP - EnglandLG - EnglishDC - 20100409ED 20100622OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2016-09-28 09:25:38 -0400" NOTES_MODIFIED_BY="Paul Miller" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yong MK, Buising KL, Cheng AC, Thursky KA</AU>
<TI>Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2010</YR>
<VL>65</VL>
<PG>1062-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839980"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839979"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yoon-2014" MODIFIED="2017-01-08 00:59:00 -0500" MODIFIED_BY="[Empty name]" NAME="Yoon 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-01-08 00:59:00 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yoon YK, Yang KS, Lee SE, Kim HJ, Sohn JW, Kim MJ</AU>
<TI>Effects of Group 1 versus Group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems: A before and after intervention study of carbapenem-use stewardship</TI>
<SO>PLoS ONE</SO>
<YR>2014</YR>
<VL>9</VL>
<NO>6</NO>
<PG>e99101</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839982"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839981"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Young-1985" NAME="Young 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Young EJ, Sewell CM, Koza MA, Clarridge JE</AU>
<TI>Antibiotic resistance patterns during aminoglycoside restriction</TI>
<SO>American Journal of Medical Science</SO>
<YR>1985</YR>
<VL>290</VL>
<NO>6</NO>
<PG>223-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839984"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839983"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2014" MODIFIED="2017-01-08 00:59:59 -0500" MODIFIED_BY="[Empty name]" NAME="Yu 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-01-08 00:59:59 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yu K, Rho J, Morcos M, Nomura J, Kaplan D, Sakamoto K, et al</AU>
<TI>Evaluation of dedicated infectious diseases pharmacists on antimicrobial stewardship teams</TI>
<SO>American Journal of Health-System Pharmacy</SO>
<YR>2014</YR>
<VL>71</VL>
<PG>1019-28</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839986"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839985"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zanetti-2003" NAME="Zanetti 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zanetti G, Flanagan HL Jr, Cohn LH, Giardina R, Platt R</AU>
<TI>Improvement of intraoperative antibiotic prophylaxis in prolonged cardiac surgery by automated alerts in the operating room</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2003</YR>
<VL>24</VL>
<PG>13-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839988"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839987"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2017-01-18 12:07:26 -0500" MODIFIED_BY="Julia Worswick">
<STUDY DATA_SOURCE="PUB" ID="STD-Ahronheim-2000" MODIFIED="2013-02-15 09:56:59 -0500" MODIFIED_BY="[Empty name]" NAME="Ahronheim 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-02-15 09:56:59 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2013-02-15 09:56:59 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Ahronheim JC, Morrison RS, Morris J, Baskin S, Meier DE</AU>
<TI>Palliative care in advanced dementia: a randomized controlled trial and descriptive analysis</TI>
<SO>Journal of Palliative Medicine</SO>
<YR>2000</YR>
<VL>3</VL>
<NO>3</NO>
<PG>265-73</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839990"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839989"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bruno_x002d_Murtha-2005" MODIFIED="2013-02-15 09:57:47 -0500" MODIFIED_BY="[Empty name]" NAME="Bruno-Murtha 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-02-15 09:57:47 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Bruno-Murtha, Lou Ann&lt;br&gt;Brusch, John&lt;br&gt;Bor, David&lt;br&gt;Li, Wenjun&lt;br&gt;Zucker, Deborah&lt;br&gt;Clinical Trial&lt;br&gt;Multicenter Study&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;United States&lt;br&gt;Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America&lt;br&gt;Infect Control Hosp Epidemiol. 2005 Jan;26(1):81-7.&lt;/p&gt;" NOTES_MODIFIED="2013-02-15 09:57:47 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bruno-Murtha LA, Brusch J, Bor D, Li W, Zucker D</AU>
<TI>A pilot study of antibiotic cycling in the community hospital setting</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2005</YR>
<VL>26</VL>
<PG>81-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839996"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839995"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burke-1997" MODIFIED="2013-02-15 09:58:11 -0500" MODIFIED_BY="[Empty name]" NAME="Burke 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-02-15 09:58:11 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burke CE, Piper J, Holloway W</AU>
<TI>Order form for restricting vancomycin prescribing</TI>
<SO>American Journal of Health-System Pharmacy</SO>
<YR>1997</YR>
<VL>54</VL>
<NO>16</NO>
<PG>1893, 1897</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2839998"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2839997"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cook-2006" MODIFIED="2013-02-15 10:00:36 -0500" MODIFIED_BY="[Empty name]" NAME="Cook 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-02-15 10:00:36 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;EPOC inc&lt;/p&gt;" NOTES_MODIFIED="2013-02-15 10:00:36 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cook PP, Catrou P, Gooch M, Holbert D</AU>
<TI>Effect of reduction in ciprofloxacin use on prevalence of meticillin-resistant Staphylococcus aureus rates within individual units of a tertiary care hospital</TI>
<SO>Journal of Hospital Infection</SO>
<YR>2006</YR>
<VL>64</VL>
<PG>348-51</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840002"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840001"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Crist-1987" NAME="Crist 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Crist KD, Nahata MC, Ety J</AU>
<TI>Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization</TI>
<SO>Therapeutic Drug Monitoring</SO>
<YR>1987</YR>
<VL>9</VL>
<NO>3</NO>
<PG>306-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840004"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840003"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cunningham-2008" MODIFIED="2016-12-07 13:20:44 -0500" MODIFIED_BY="Julia Worswick" NAME="Cunningham 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-12-07 13:20:44 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Cunningham, Thomas R&lt;br&gt;Geller, E Scott&lt;br&gt;Clarke, Steven W&lt;br&gt;eng&lt;br&gt;Comparative Study&lt;br&gt;Ireland&lt;br&gt;2007/12/07 09:00&lt;br&gt;Int J Med Inform. 2008 Aug;77(8):546-54. Epub 2007 Nov 28.&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:20:44 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cunningham TR, Geller ES, Clarke SW</AU>
<TI>Impact of electronic prescribing in a hospital setting: a process-focused evaluation</TI>
<SO>International Journal of Medical Informatics</SO>
<YR>2008</YR>
<VL>77</VL>
<PG>546-54</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840006"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840005"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dellinger-2005" MODIFIED="2013-02-15 10:01:39 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Dellinger 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-02-15 10:01:39 -0500" MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dellinger EP, Hausmann SM, Bratzler DW, Johnson RM, Daniel DM, Bunt KM, et al</AU>
<TI>Hospitals collaborate to decrease surgical site infections</TI>
<SO>American Journal of Surgery</SO>
<YR>2005</YR>
<VL>190</VL>
<NO>1</NO>
<PG>9-15</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840008"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840007"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Destache-1990" MODIFIED="2010-10-14 11:35:46 -0400" MODIFIED_BY="[Empty name]" NAME="Destache 1990" YEAR="1990">
<REFERENCE MODIFIED="2010-10-14 11:35:46 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Destache CJ, Meyer SK, Bittner MJ, Hermann KG</AU>
<TI>Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides: a cost-benefit analysis</TI>
<SO>Therapeutic Drug Monitoring</SO>
<YR>1990</YR>
<VL>12</VL>
<NO>5</NO>
<PG>419-26</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840010"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840009"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ehrenkranz-1992" NAME="Ehrenkranz 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ehrenkranz NJ, Nerenberg DE, Shultz JM, Slater KC</AU>
<TI>Intervention to discontinue parenteral antimicrobial therapy in patients hospitalized with pulmonary infections: effect on shortening patient stay</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>1992</YR>
<VL>13</VL>
<NO>1</NO>
<PG>21-32</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840012"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840011"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ehrenkranz-1993" NAME="Ehrenkranz 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ehrenkranz NJ, Nerenberg DE, Slater KC, Shultz JM</AU>
<TI>Intervention to discontinue parenteral antimicrobial therapy in hospitalized patients with urinary tract infection, skin and soft tissue infection, or no evident infection</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>1993</YR>
<VL>14</VL>
<NO>9</NO>
<PG>517-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840014"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840013"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Evans-1994" NAME="Evans 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Evans RS, Classen DC, Pestotnik SL, Lundsgaarde HP, Burke JP</AU>
<TI>Improving empiric antibiotic selection using computer decision support</TI>
<SO>Archives of Internal Medicine.</SO>
<YR>1994</YR>
<VL>154</VL>
<NO>8</NO>
<PG>878-84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840016"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840015"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Foy-2004" MODIFIED="2016-12-07 13:21:50 -0500" MODIFIED_BY="Julia Worswick" NAME="Foy 2004" YEAR="2004">
<REFERENCE MODIFIED="2016-12-07 13:21:50 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;IN - Simpson Centre for Reproductive Health, University of Edinburgh, UKCochrane Effective Practice and Organisation of Care Group (EPOC)&lt;br&gt;PubMed Identifier 15198764 10.1111/j.1471-0528.2004.00168.x&lt;br&gt;2006-screened&lt;br&gt;CN-00468106 UPDATE&lt;/p&gt;" NOTES_MODIFIED="2016-12-07 13:21:50 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Foy R, Penney GC, Grimshaw JM, Ramsay CR, Walker AE, Maclennan G, et al</AU>
<TI>A randomised controlled trial of a tailored multifaceted strategy to promote implementation of a clinical guideline on induced abortion care</TI>
<SO>BJOG: An International Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2004</YR>
<VL>111</VL>
<PG>726-33</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840018"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840017"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garcia_x002d_San-Miguel-2014" MODIFIED="2017-01-08 02:28:10 -0500" MODIFIED_BY="[Empty name]" NAME="Garcia-San Miguel 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-01-08 02:28:10 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Garcia-San Miguel, Lucia&lt;br&gt;Cobo, Javier&lt;br&gt;Martinez, Jose Antonio&lt;br&gt;Arnau, Josep Maria&lt;br&gt;Murillas, Javier&lt;br&gt;Pena, Carmen&lt;br&gt;Segura, Ferran&lt;br&gt;Gurgui, Montserrat&lt;br&gt;Galvez, Juan&lt;br&gt;Gimenez, Montserrat&lt;br&gt;Gudiol, Francesc&lt;br&gt;spa&lt;br&gt;English Abstract&lt;br&gt;Spain&lt;br&gt;2014/05/13 06:00&lt;br&gt;Enferm Infecc Microbiol Clin. 2014 Dec;32(10):654-61. doi: 10.1016/j.eimc.2013.09.021. Epub 2014 May 9.&lt;/p&gt;" NOTES_MODIFIED="2017-01-08 02:28:10 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garcia-San Miguel L, Cobo J, Martinez JA, Arnau JM, Murillas J, Pena C, et al</AU>
<TI>'Third day intervention': an analysis of the factors associated with following the recommendations on the prescribing of antibiotics</TI>
<SO>Enfermedades Infecciosas y Microbiología Clínica</SO>
<YR>2014</YR>
<VL>32</VL>
<PG>654-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840020"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840019"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gerding-1991" NAME="Gerding 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gerding DN, Larson TA, Hughes RA, Weiler M, Shanholtzer C, Peterson LR</AU>
<TI>Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital</TI>
<SO>Antimicrobial Agents and Chemotherapy</SO>
<YR>1991</YR>
<VL>35</VL>
<NO>7</NO>
<PG>1284-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840022"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840021"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kolar-1999" MODIFIED="2017-01-18 12:07:26 -0500" MODIFIED_BY="Julia Worswick" NAME="Kolar 1999" YEAR="1999">
<REFERENCE MODIFIED="2017-01-09 12:03:15 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kolar M, Latal T</AU>
<TI>Implementation of a practical antibiotic policy in the Czech Republic</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>1999</YR>
<VL>20</VL>
<NO>6</NO>
<PG>440-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840030"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-01-18 12:07:26 -0500" MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Monnet DL, Sørensen TL, Jepsen OB</AU>
<TI>Implementation of a practical antibiotic policy in the Czech Republic</TI>
<SO>Infect Control Hosp Epidemiol.</SO>
<YR>2000</YR>
<VL>21</VL>
<NO>1</NO>
<PG>7-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889697"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840029"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lan-2003" MODIFIED="2013-02-15 10:04:46 -0500" MODIFIED_BY="[Empty name]" NAME="Lan 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-02-15 10:04:46 -0500" MODIFIED_BY="[Empty name]" NOTES="eng" NOTES_MODIFIED="2013-02-15 10:04:46 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lan CK, Hsueh PR, Wong WW, Fung CP, Lau YT, Yeung JY, et al</AU>
<TI>Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms</TI>
<SO>Journal of Microbiology, Immunology, and Infection</SO>
<YR>2003</YR>
<VL>36</VL>
<NO>3</NO>
<PG>182-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840032"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840031"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2004" MODIFIED="2013-02-15 10:05:19 -0500" MODIFIED_BY="[Empty name]" NAME="Lee 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-02-15 10:05:19 -0500" MODIFIED_BY="[Empty name]" NOTES="eng" NOTES_MODIFIED="2013-02-15 10:05:19 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee SO, Lee ES, Park SY, Kim SY, Seo YH, Cho YK</AU>
<TI>Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2004</YR>
<VL>25</VL>
<NO>10</NO>
<PG>832-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840034"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840033"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MacCosbe-1985" MODIFIED="2017-01-08 02:32:03 -0500" MODIFIED_BY="[Empty name]" NAME="MacCosbe 1985" YEAR="1985">
<REFERENCE MODIFIED="2017-01-08 02:32:03 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MacCosbe PE, Gartenberg G</AU>
<TI>Modifying empiric antibiotic prescribing: experience with one strategy in a medical residency program</TI>
<SO>Hospital Formulary</SO>
<YR>1985</YR>
<VL>20</VL>
<NO>9</NO>
<PG>986-8, 993-5, 999</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840038"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840037"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marrie-2000" MODIFIED="2017-01-08 02:32:49 -0500" MODIFIED_BY="[Empty name]" NAME="Marrie 2000" YEAR="2000">
<REFERENCE MODIFIED="2017-01-08 02:32:49 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG</AU>
<TI>A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin</TI>
<SO>JAMA</SO>
<YR>2000</YR>
<VL>283</VL>
<NO>6</NO>
<PG>749-55</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840042"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-12-01 12:16:40 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2016-12-01 12:16:40 -0500" NOTES_MODIFIED_BY="Julia Worswick" PRIMARY="NO" TYPE="OTHER">
<AU>Palmer CS, Zhan C, Elixhauser A, Halpern MT, Rance L, Feagan BG, et al</AU>
<TI>Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin</TI>
<SO>Clinical Therapeutics</SO>
<YR>2000</YR>
<VL>22</VL>
<NO>2</NO>
<PG>250-64</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4889698"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840041"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martin-2005" MODIFIED="2013-02-15 10:05:55 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Martin 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-02-15 10:05:55 -0500" MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martin C, Ofotokun I, Rapp R, Empey K, Armitstead J, Pomeroy C, et al</AU>
<TI>Results of an antimicrobial control program at a university hospital</TI>
<SO>American Journal of Health-System Pharmacy</SO>
<YR>2005</YR>
<VL>62</VL>
<NO>7</NO>
<PG>732-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840044"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840043"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McGregor-2006" MODIFIED="2013-03-18 13:47:20 -0400" MODIFIED_BY="Kate Cahill" NAME="McGregor 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-03-18 13:47:20 -0400" MODIFIED_BY="Kate Cahill" NOTES="eng" NOTES_MODIFIED="2013-03-18 13:47:20 -0400" NOTES_MODIFIED_BY="Kate Cahill" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McGregor JC, Weekes E, Forrest GN, Standiford HC, Perencevich EN, Furuno JP, et al</AU>
<TI>Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial</TI>
<SO>Journal of the American Medical Informatics Association</SO>
<YR>2006</YR>
<VL>13</VL>
<NO>4</NO>
<PG>378-84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840048"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840047"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nagao-2010" MODIFIED="2015-05-31 01:03:27 -0400" MODIFIED_BY="[Empty name]" NAME="Nagao 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-05-31 01:03:27 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JC - dy9, 9516420SB - IMCP - FranceLG - EnglishDC - 20101116ED 20110517OVID MEDLINE UP 20111214&lt;/p&gt;" NOTES_MODIFIED="2015-05-31 01:03:27 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nagao M, Iinuma Y, Saito T, Matsumura Y, Shirano M, Matsushima A, et al</AU>
<TI>Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia</TI>
<SO>Clinical Microbiology &amp; Infection</SO>
<YR>2010</YR>
<VL>16</VL>
<PG>1783-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840050"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840049"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Naughton-2001" MODIFIED="2017-01-08 02:35:25 -0500" MODIFIED_BY="[Empty name]" NAME="Naughton 2001" YEAR="2001">
<REFERENCE MODIFIED="2017-01-08 02:35:25 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Naughton BJ, Mylotte JM, Ramadan F, Karuza J, Priore RL</AU>
<TI>Antibiotic use, hospital admissions, and mortality before and after implementing guidelines for nursing home-acquired pneumonia</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>2001</YR>
<VL>49</VL>
<PG>1020-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840052"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840051"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pastel-1992" MODIFIED="2010-10-14 11:37:38 -0400" MODIFIED_BY="[Empty name]" NAME="Pastel 1992" YEAR="1992">
<REFERENCE MODIFIED="2010-10-14 11:37:38 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pastel DA, Chang S, Nessim S, Shane R, Morgan MA</AU>
<TI>Department of pharmacy-initiated program for streamlining empirical antibiotic therapy</TI>
<SO>Hospital Pharmacy</SO>
<YR>1992</YR>
<VL>27</VL>
<NO>7</NO>
<PG>596-603, 614</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840058"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840057"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ronning-1998" NAME="Ronning 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ronning OM, Guldvog B</AU>
<TI>Stroke unit versus general medical wards, II: neurological deficits and activities of daily living: a quasi-randomized controlled trial</TI>
<SO>Stroke</SO>
<YR>1998</YR>
<VL>29</VL>
<NO>3</NO>
<PG>586-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840060"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840059"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sanazaro-1978" MODIFIED="2013-03-18 13:47:34 -0400" MODIFIED_BY="Kate Cahill" NAME="Sanazaro 1978" YEAR="1978">
<REFERENCE MODIFIED="2013-03-18 13:47:34 -0400" MODIFIED_BY="Kate Cahill" NOTES="&lt;p&gt;NOT IN FILE&lt;br&gt;nejm&lt;/p&gt;" NOTES_MODIFIED="2013-03-18 13:47:34 -0400" NOTES_MODIFIED_BY="Kate Cahill" PRIMARY="NO" TYPE="OTHER">
<AU>Sanazaro PJ, Worth RM</AU>
<TI>Concurrent quality assurance in hospital care. Report of a study by private initiative in PSRO</TI>
<SO>New England Journal of Medicine</SO>
<YR>1978</YR>
<VL>298</VL>
<NO>21</NO>
<PG>1171-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840062"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840061"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Takahashi-2010" MODIFIED="2017-01-08 02:37:26 -0500" MODIFIED_BY="[Empty name]" NAME="Takahashi 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-01-08 02:37:26 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Takahashi Y, Takesue Y, Nakajima K, Ichiki K, Wada Y, Tsuchida T, et al</AU>
<TI>Implementation of a hospital-wide project for appropriate antimicrobial prophylaxis</TI>
<SO>Journal of Infection and Chemotherapy</SO>
<YR>2010</YR>
<VL>16</VL>
<PG>418-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840068"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840067"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thomas-2002" MODIFIED="2013-02-15 10:10:20 -0500" MODIFIED_BY="Philip J Wiffen" NAME="Thomas 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-02-15 10:10:20 -0500" MODIFIED_BY="Philip J Wiffen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thomas AR, Cieslak PR, Strausbaugh LJ, Fleming DW</AU>
<TI>Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2002</YR>
<VL>23</VL>
<NO>11</NO>
<PG>683-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840070"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840069"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tiley-2003" MODIFIED="2013-03-18 13:47:48 -0400" MODIFIED_BY="Kate Cahill" NAME="Tiley 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-03-18 13:47:48 -0400" MODIFIED_BY="Kate Cahill" NOTES="&lt;p&gt;DA - 20030616&lt;br&gt;NOT IN FILE&lt;/p&gt;" NOTES_MODIFIED="2013-03-18 13:47:48 -0400" NOTES_MODIFIED_BY="Kate Cahill" PRIMARY="NO" TYPE="OTHER">
<AU>Tiley SM, MacDonald JJ, Doherty PL, Ferguson JK, Fergusson JE</AU>
<TI>Active promotion of antibiotic guidelines: an intensive program</TI>
<SO>Communicable Disease Intelligence</SO>
<YR>2003</YR>
<VL>27 Suppl</VL>
<PG>13-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840072"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840071"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tsiata-2001" MODIFIED="2013-03-18 13:48:00 -0400" MODIFIED_BY="Kate Cahill" NAME="Tsiata 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-03-18 13:48:00 -0400" MODIFIED_BY="Kate Cahill" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tsiata C, Tsekouras V, Karokis A, Starakis J, Bassaris HP, Maragoudakis M, et al</AU>
<TI>Cost effectiveness of antibacterial restriction strategies in a tertiary care university teaching hospital</TI>
<SO>Disease Management and Health Outcomes</SO>
<YR>2001</YR>
<VL>9</VL>
<PG>23-32</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840074"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840073"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Loon-2005" MODIFIED="2013-03-18 13:48:10 -0400" MODIFIED_BY="Kate Cahill" NAME="Van Loon 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-03-18 13:48:10 -0400" MODIFIED_BY="Kate Cahill" NOTES="eng" NOTES_MODIFIED="2013-03-18 13:48:10 -0400" NOTES_MODIFIED_BY="Kate Cahill" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Loon HJ, Vriens MR, Fluit AC, Troelstra A, Van der Werken C, Verhoef J, et al</AU>
<TI>Antibiotic rotation and development of gram-negative antibiotic resistance</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2005</YR>
<VL>171</VL>
<NO>5</NO>
<PG>480-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840076"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840075"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wahlstrom-2003" MODIFIED="2017-01-08 02:40:43 -0500" MODIFIED_BY="[Empty name]" NAME="Wahlstrom 2003" YEAR="2003">
<REFERENCE MODIFIED="2017-01-08 02:40:43 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wahlstrom R, Kounnavong S, Sisounthone B, Phanyanouvong A, Southammavong T, Eriksson B, et al</AU>
<TI>Effectiveness of feedback for improving case management of malaria, diarrhoea and pneumonia - a randomized controlled trial at provincial hospitals in Lao PDR</TI>
<SO>Tropical Medicine and International Health</SO>
<YR>2003</YR>
<VL>8</VL>
<NO>10</NO>
<PG>901-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2840078"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2840077"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2017-01-19 09:04:16 -0500" MODIFIED_BY="Julia Worswick"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2017-01-18 13:35:52 -0500" MODIFIED_BY="Julia Worswick">
<ADDITIONAL_REFERENCES MODIFIED="2017-01-18 13:35:52 -0500" MODIFIED_BY="Julia Worswick">
<REFERENCE ID="REF-Arnold-2005" MODIFIED="2013-03-22 14:24:29 -0400" MODIFIED_BY="Kate Cahill" NAME="Arnold 2005" TYPE="COCHRANE_REVIEW">
<AU>Arnold SR, Straus SE</AU>
<TI>Interventions to improve antibiotic prescribing practices in ambulatory care</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2013-03-22 14:24:29 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2013-03-22 14:24:29 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003539.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ash-2007" MODIFIED="2016-12-07 13:24:54 -0500" MODIFIED_BY="Julia Worswick" NAME="Ash 2007" TYPE="JOURNAL_ARTICLE">
<AU>Ash JS, Sittig DF, Dykstra RH, Guappone K, Carpenter JD, Seshadri V</AU>
<TI>Categorizing the unintended sociotechnical consequences of computerized provider order entry</TI>
<SO>International Journal of Medical Informatics</SO>
<YR>2007</YR>
<VL>76 Suppl 1</VL>
<PG>S21-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Avery-2012" MODIFIED="2016-09-28 09:35:14 -0400" MODIFIED_BY="Paul Miller" NAME="Avery 2012" TYPE="JOURNAL_ARTICLE">
<AU>Avery AJ, Rodgers S, Cantrill JA, Armstrong S, Cresswell K, Eden M, et al</AU>
<TI>A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis</TI>
<SO>Lancet</SO>
<YR>2012</YR>
<VL>379</VL>
<PG>1310-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carratala-2012" MODIFIED="2016-12-07 13:25:25 -0500" MODIFIED_BY="Julia Worswick" NAME="Carratala 2012" TYPE="JOURNAL_ARTICLE">
<AU>Carratala J, Garcia-Vidal C, Ortega L, Fernandez-Sabe N, Clemente M, Albero G, et al</AU>
<TI>Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2012</YR>
<VL>172</VL>
<PG>922-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Charani-2011" MODIFIED="2016-07-28 00:52:36 -0400" MODIFIED_BY="Petrer Davey" NAME="Charani 2011" TYPE="JOURNAL_ARTICLE">
<AU>Charani E, Edwards R, Sevdalis N, Alexandrou B, Sibley E, Mullett D, et al</AU>
<TI>Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2011</YR>
<VL>53</VL>
<NO>7</NO>
<PG>651-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cochran-1954" MODIFIED="2017-01-18 12:08:29 -0500" MODIFIED_BY="Julia Worswick" NAME="Cochran 1954" TYPE="JOURNAL_ARTICLE">
<AU>Cochran WG</AU>
<TI>The combination of estimates from different experiments</TI>
<SO>Biometrics</SO>
<YR>1954</YR>
<VL>10</VL>
<PG>101-29</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Conlon-2011" MODIFIED="2017-01-18 12:20:18 -0500" MODIFIED_BY="Julia Worswick" NAME="Conlon 2011" TYPE="JOURNAL_ARTICLE">
<AU>Conlon G, Aldeyab MA, McElnay JC, Scott MG, Magee FA, Davies E, et al</AU>
<TI>Improving and maintaining adherence with hospital antibiotic policies: a strategy for success</TI>
<SO>Journal of Hospital Infection</SO>
<YR>2011</YR>
<VL>77</VL>
<PG>88-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davey-2010" MODIFIED="2012-11-30 00:38:25 -0500" MODIFIED_BY="[Empty name]" NAME="Davey 2010" TYPE="JOURNAL_ARTICLE">
<AU>Davey P, Sneddon J, Nathwani D</AU>
<TI>Overview of strategies for overcoming the challenge of antimicrobial resistance</TI>
<SO>Expert Reviews in Clinical Pharmacology</SO>
<YR>2010</YR>
<VL>3</VL>
<NO>5</NO>
<PG>667-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davey_x002d_Smith-2001" MODIFIED="2017-01-08 02:59:09 -0500" MODIFIED_BY="[Empty name]" NAME="Davey-Smith 2001" TYPE="JOURNAL_ARTICLE">
<AU>Davey Smith G, Ebrahim S</AU>
<TI>Epidemiology - is it time to call it a day?</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2001</YR>
<VL>30</VL>
<PG>1-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-de-Kraker-2011" MODIFIED="2017-01-08 02:59:32 -0500" MODIFIED_BY="[Empty name]" NAME="de Kraker 2011" TYPE="JOURNAL_ARTICLE">
<AU>de Kraker ME, Davey PG, Grundmann H</AU>
<TI>Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe</TI>
<SO>PLoS Medicine</SO>
<YR>2011</YR>
<VL>8</VL>
<NO>10</NO>
<PG>e1001104</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Department-of-Health-2013" MODIFIED="2017-01-08 03:05:06 -0500" MODIFIED_BY="[Empty name]" NAME="Department of Health 2013" TYPE="OTHER">
<AU>Department of Health</AU>
<TI>UK 5 Year Antimicrobial Resistance Strategy 2013 to 2018</TI>
<SO>www.gov.uk/government/publications/uk-5-year-antimicrobial-resistance-strategy-2013-to-2018</SO>
<YR>2013 (accessed prior to 6 January 2017)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Doern-1994" MODIFIED="2017-01-17 02:15:25 -0500" MODIFIED_BY="Petrer Davey" NAME="Doern 1994" TYPE="JOURNAL_ARTICLE">
<AU>Doern G V, Vautour R, Gaudet M, Levy B</AU>
<TI>Clinical impact of rapid in vitro susceptibility testing and bacterial identification</TI>
<SO>Journal of Clinical Microbiology</SO>
<YR>1994</YR>
<VL>32</VL>
<PG>1757-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dreischulte-2016" MODIFIED="2017-01-08 03:01:03 -0500" MODIFIED_BY="[Empty name]" NAME="Dreischulte 2016" TYPE="JOURNAL_ARTICLE">
<AU>Dreischulte T, Donnan P, Grant A, Hapca A, McCowan C, Guthrie B</AU>
<TI>Safer prescribing - a trial of education, informatics, and financial incentives</TI>
<SO>New England Journal of Medicine</SO>
<YR>2016</YR>
<VL>374</VL>
<PG>1053-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Elligson-2012a" MODIFIED="2017-01-18 13:35:52 -0500" MODIFIED_BY="Julia Worswick" NAME="Elligson 2012a" TYPE="JOURNAL_ARTICLE">
<AU>Elligsen M, Walker SA, Simor A, Daneman N</AU>
<TI>Prospective audit and feedback of antimicrobial stewardship in critical care: program implementation, experience, and challenges</TI>
<SO>Canadian Journal of Hospital Pharmacy</SO>
<YR>2012</YR>
<VL>65</VL>
<PG>31-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EPOC-2013" MODIFIED="2017-01-08 03:04:13 -0500" MODIFIED_BY="[Empty name]" NAME="EPOC 2013" TYPE="OTHER">
<AU>Effective Practice and Organisation of Care (EPOC)</AU>
<TI>Suggested risk of bias criteria for EPOC reviews. EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2013</TI>
<SO>epoc.cochrane.org/epoc-specific-resources-review-authors</SO>
<YR>(accessed prior to 6 January 2017)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EPOC-2013a" MODIFIED="2017-01-08 03:06:32 -0500" MODIFIED_BY="[Empty name]" NAME="EPOC 2013a" TYPE="OTHER">
<AU>Effective Practice and Organisation of Care (EPOC)</AU>
<TI>EPOC worksheets for preparing a 'Summary of findings' (SoF) table using GRADE. EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2013</TI>
<SO>epoc.cochrane.org/epoc-specific-resources-review-authors</SO>
<YR>(accessed prior to 6 January 2017)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EPOC-2015" MODIFIED="2017-01-08 03:07:12 -0500" MODIFIED_BY="[Empty name]" NAME="EPOC 2015" TYPE="OTHER">
<AU>Effective Practice and Organisation of Care (EPOC)</AU>
<TI>EPOC Taxonomy; 2015</TI>
<SO>epoc.cochrane.org/epoc-taxonomy</SO>
<YR>(accessed prior to 6 January 2017)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EPOC-2016" MODIFIED="2017-01-08 03:07:50 -0500" MODIFIED_BY="[Empty name]" NAME="EPOC 2016" TYPE="OTHER">
<AU>Effective Practice and Organisation of Care (EPOC)</AU>
<TI>What study designs should be included in an EPOC review? EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2016</TI>
<SO>epoc.cochrane.org/epoc-specific-resources-review-authors</SO>
<YR>(accessed prior to 6 January 2017)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Feazel-2014" MODIFIED="2017-01-08 03:09:02 -0500" MODIFIED_BY="[Empty name]" NAME="Feazel 2014" TYPE="JOURNAL_ARTICLE">
<AU>Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, Schweizer ML</AU>
<TI>Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2014</YR>
<VL>69</VL>
<NO>7</NO>
<PG>1748-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Garcia-2007" MODIFIED="2016-12-07 13:27:45 -0500" MODIFIED_BY="Julia Worswick" NAME="Garcia 2007" TYPE="JOURNAL_ARTICLE">
<AU>Garcia JC, Ferreira FOF, Grion CM, Carrilho CM</AU>
<TI>Impact of the implementation of a therapeutic guideline on the treatment of nosocomial pneumonia acquired in the intensive care unit of a university hospital</TI>
<SO>Jornal Brasileiro de Pneumologia i</SO>
<YR>2007</YR>
<VL>33</VL>
<PG>175-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grant-2013" MODIFIED="2017-01-17 02:15:13 -0500" MODIFIED_BY="Petrer Davey" NAME="Grant 2013" TYPE="JOURNAL_ARTICLE">
<AU>Grant A, Treweek S, Dreischulte T, Foy R, Guthrie B</AU>
<TI>Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting</TI>
<SO>Trials</SO>
<YR>2013</YR>
<VL>14</VL>
<PG>15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011" MODIFIED="2017-01-08 03:09:44 -0500" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al</AU>
<TI>GRADE guidelines: 5. Rating the quality of evidence - publication bias</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<PG>1277-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Health-Services-Research-Unit-2016" MODIFIED="2017-01-08 03:10:28 -0500" MODIFIED_BY="[Empty name]" NAME="Health Services Research Unit 2016" TYPE="OTHER">
<AU>Health Services Research Unit</AU>
<TI>Empirical estimates of ICCs from changing professional practice studies</TI>
<SO>www.abdn.ac.uk/hsru/documents/iccs-web.xls</SO>
<VL>2016 (accessed prior to 6 January 2017)</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2017-01-17 02:15:17 -0500" MODIFIED_BY="Petrer Davey" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins J P, Thompson S G, Deeks J J, Altman D G</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2017-01-08 03:12:01 -0500" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JP, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from handbook.cochrane.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hoffmann-2014" MODIFIED="2017-01-09 13:35:04 -0500" MODIFIED_BY="Julia Worswick" NAME="Hoffmann 2014" TYPE="JOURNAL_ARTICLE">
<AU>Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al</AU>
<TI>Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide</TI>
<SO>BMJ</SO>
<YR>2014</YR>
<VL>348</VL>
<PG>g1687</PG>
<IDENTIFIERS MODIFIED="2017-01-08 03:12:45 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-01-08 03:12:45 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/bmj.g1687"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-ISD-2016" MODIFIED="2017-01-08 03:14:07 -0500" MODIFIED_BY="[Empty name]" NAME="ISD 2016" TYPE="OTHER">
<AU>ISD Scotland</AU>
<TI>NHS Scotland's Infection Intelligence Platform (IIP) - a shared resource for Healthcare Associated Infection surveillance and research</TI>
<SO>www.isdscotland.org/Health-Topics/Health-and-Social-Community-Care/Infection-Intelligence-Platform/</SO>
<YR>2016 (accessed prior to 6 January 2017)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ivers-2012" MODIFIED="2015-11-29 01:39:05 -0500" MODIFIED_BY="[Empty name]" NAME="Ivers 2012" TYPE="COCHRANE_REVIEW">
<AU>Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, et al</AU>
<TI>Audit and feedback: effects on professional practice and healthcare outcomes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>6</NO>
<IDENTIFIERS MODIFIED="2013-03-17 07:14:55 -0400" MODIFIED_BY="Kate Cahill"><IDENTIFIER MODIFIED="2013-03-17 07:14:55 -0400" MODIFIED_BY="Kate Cahill" TYPE="DOI" VALUE="10.1002/14651858.CD000259.pub3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-JPIAMR-2016" MODIFIED="2017-01-08 03:15:08 -0500" MODIFIED_BY="[Empty name]" NAME="JPIAMR 2016" TYPE="OTHER">
<AU>JPIAMR Joint Programming Initiative on Antimicrobial Resistance</AU>
<TI>4th Joint Call: Networks Working Groups</TI>
<SO>www.jpiamr.eu/activities/4th-joint-call-research-networking-groups/</SO>
<YR>2016 (accessed prior to 6 January 2017)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jump-2013" MODIFIED="2016-12-07 13:28:57 -0500" MODIFIED_BY="Julia Worswick" NAME="Jump 2013" TYPE="JOURNAL_ARTICLE">
<AU>Jump RL, Olds DM, Jury LA, Sitzlar B, Saade E, Watts B, et al</AU>
<TI>Specialty care delivery: bringing infectious disease expertise to the residents of a Veterans Affairs long-term care facility</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>2013</YR>
<VL>61</VL>
<PG>782-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lester-2010" MODIFIED="2016-07-28 00:55:09 -0400" MODIFIED_BY="Petrer Davey" NAME="Lester 2010" TYPE="JOURNAL_ARTICLE">
<AU>Lester H, Schmittdiel J, Selby J, Fireman B, Campbell S, Lee J, et al</AU>
<TI>The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators</TI>
<SO>BMJ</SO>
<YR>2010</YR>
<VL>340</VL>
<PG>c1898</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Michie-2011" MODIFIED="2016-09-28 09:38:32 -0400" MODIFIED_BY="Paul Miller" NAME="Michie 2011" TYPE="JOURNAL_ARTICLE">
<AU>Michie S, van Stralen MM, West R</AU>
<TI>The behaviour change wheel: a new method for characterising and designing behaviour change interventions</TI>
<SO>Implementation Science</SO>
<YR>2011</YR>
<VL>6</VL>
<PG>42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Michie-2013" MODIFIED="2016-07-28 00:55:14 -0400" MODIFIED_BY="Petrer Davey" NAME="Michie 2013" TYPE="JOURNAL_ARTICLE">
<AU>Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al</AU>
<TI>The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered Techniques: Building an International Consensus for the Reporting of Behavior Change Interventions</TI>
<SO>Annals of Behavioral Medicine</SO>
<YR>2013</YR>
<VL>46</VL>
<PG>81-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Monnet-2000" MODIFIED="2017-01-18 12:09:25 -0500" MODIFIED_BY="Julia Worswick" NAME="Monnet 2000" TYPE="JOURNAL_ARTICLE">
<AU>Monnet DL, Sørensen TL, Jepsen OB</AU>
<TI>Implementation of a practical antibiotic policy in the Czech Republic</TI>
<SO>Infection Control and Hospital Epidemiology</SO>
<YR>2000</YR>
<VL>21</VL>
<NO>1</NO>
<PG>7-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NCEPOD-2015" MODIFIED="2017-01-08 03:17:22 -0500" MODIFIED_BY="[Empty name]" NAME="NCEPOD 2015" TYPE="OTHER">
<AU>NCEPOD National Confidential Enquiry Into Patient Outcome and Death</AU>
<TI>Just Say Sepsis! A review of the process of care received by patients with sepsis</TI>
<SO>www.ncepod.org.uk/2015report2/downloads/JustSaySepsis_SummarySheet.pdf</SO>
<YR>2015 (accessed prior to 6 January 2017)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pulcini-2008" MODIFIED="2017-01-18 12:10:08 -0500" MODIFIED_BY="Julia Worswick" NAME="Pulcini 2008" TYPE="JOURNAL_ARTICLE">
<AU>Pulcini C, Defres S, Aggarwal I, Nathwani D, Davey P.</AU>
<TI>Design of a 'day 3 bundle' to improve the reassessment of inpatient empirical antibiotic prescriptions</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2008</YR>
<VL>61</VL>
<NO>6</NO>
<PG>1384-8. doi: 10.1093/jac/dkn113.</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ramsay-2003" NAME="Ramsay 2003" TYPE="JOURNAL_ARTICLE">
<AU>Ramsay C, Brown E, Hartman G, Davey P</AU>
<TI>Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2003</YR>
<VL>52</VL>
<PG>764-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Review-Manager-5" MODIFIED="2017-01-09 12:35:15 -0500" MODIFIED_BY="Julia Worswick" NAME="Review Manager 5" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager 5 (RevMan 5)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rogers-1995" MODIFIED="2017-01-08 03:18:03 -0500" MODIFIED_BY="[Empty name]" NAME="Rogers 1995" TYPE="BOOK_SECTION">
<AU>Rogers ER</AU>
<TI>Consequences of innovations</TI>
<SO>Diffusion of Innovations</SO>
<YR>1995</YR>
<PG>405-39</PG>
<PB>Free Press</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schuts-2016" MODIFIED="2017-01-08 03:18:57 -0500" MODIFIED_BY="[Empty name]" NAME="Schuts 2016" TYPE="JOURNAL_ARTICLE">
<AU>Schuts EC, Hulscher ME, Mouton JW, Verduin CM, Stuart JW, Overdiek HW, et al</AU>
<TI>Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis</TI>
<SO>Lancet Infectious Diseases</SO>
<YR>2016</YR>
<VL>16</VL>
<PG>847-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sch_x00fc_nemann-2013" MODIFIED="2016-09-28 09:39:08 -0400" MODIFIED_BY="Paul Miller" NAME="Schünemann 2013" TYPE="JOURNAL_ARTICLE">
<AU>Schünemann HJ, Tugwell P, Reeves BC, Akl EA, Santesso N, Spencer FA, et al</AU>
<TI>Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions</TI>
<SO>Research Synthesis Methods</SO>
<YR>2013</YR>
<VL>4</VL>
<PG>49-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-SISCC-2016" MODIFIED="2017-01-08 03:20:07 -0500" MODIFIED_BY="[Empty name]" NAME="SISCC 2016" TYPE="OTHER">
<AU>SISCC Improvement Science Methods Research Theme</AU>
<TI>SISCC Snapshot - April 2016</TI>
<SO>www.siscc.dundee.ac.uk/Media/Default/Documents/2016-05-11%20SISCC%20ISM%20Snapshot%20v0.4.pdf</SO>
<YR>2016 (accessed prior to 6 January 2017)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stata-2015" MODIFIED="2017-01-08 03:25:00 -0500" MODIFIED_BY="[Empty name]" NAME="Stata 2015" TYPE="OTHER">
<AU>StataCorp</AU>
<TI>Stata Data Analysis and Statistical Software: Stata 14</TI>
<SO>www.stata.com/new-in-stata/</SO>
<YR>2015</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sterne-2016" MODIFIED="2017-01-18 11:35:02 -0500" MODIFIED_BY="Julia Worswick" NAME="Sterne 2016" TYPE="OTHER">
<AU>Sterne JA, Hernán MA, Reeves BC, Savovi&#263; J, Berkman ND, Viswanathan N, et al</AU>
<TI>ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions</TI>
<SO>BMJ</SO>
<YR>2016</YR>
<VL>355</VL>
<PG>:i4919</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stone-2007" MODIFIED="2017-01-08 03:30:29 -0500" MODIFIED_BY="[Empty name]" NAME="Stone 2007" TYPE="JOURNAL_ARTICLE">
<AU>Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al</AU>
<TI>The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection</TI>
<SO>Lancet Infectious Diseases</SO>
<YR>2007</YR>
<VL>7</VL>
<NO>4</NO>
<PG>282-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Thursky-2006" MODIFIED="2016-12-07 13:30:02 -0500" MODIFIED_BY="Julia Worswick" NAME="Thursky 2006" TYPE="JOURNAL_ARTICLE">
<AU>Thursky KA, Buising KL, Bak N, Macgregor L, Street AC, Macintyre CR, et al</AU>
<TI>Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit</TI>
<SO>International Journal for Quality in Health Care</SO>
<YR>2006</YR>
<VL>18</VL>
<PG>224-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vernaz-2008" MODIFIED="2016-07-28 00:55:31 -0400" MODIFIED_BY="Petrer Davey" NAME="Vernaz 2008" TYPE="JOURNAL_ARTICLE">
<AU>Vernaz N, Sax H, Pittet D, Bonnabry P, Schrenzel J, Harbarth S</AU>
<TI>Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2008</YR>
<VL>62</VL>
<PG>601-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Walker-2016" MODIFIED="2017-01-09 13:33:09 -0500" MODIFIED_BY="Julia Worswick" NAME="Walker 2016" TYPE="OTHER">
<AU>Walker H, Patton A, Bayne G, Marwick C, Sneddon J, Davey P, et al</AU>
<TI>Reduction in post-operative acute kidney injury following a change in antibiotic prophylaxis policy for orthopaedic surgery: an observational study</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2016 May 26.[Epub ahead of print]</YR>
<IDENTIFIERS MODIFIED="2017-01-08 03:32:09 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-01-08 03:32:09 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1093/jac/dkw166"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Weiss-2011" MODIFIED="2016-12-07 13:30:52 -0500" MODIFIED_BY="Julia Worswick" NAME="Weiss 2011" TYPE="JOURNAL_ARTICLE">
<AU>Weiss CH, Moazed F, McEvoy CA, Singer BD, Szleifer I, Amaral LA, et al</AU>
<TI>Prompting physicians to address a daily checklist and process of care and clinical outcomes: a single-site study</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2011</YR>
<VL>184</VL>
<PG>680-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yealy-2004" MODIFIED="2016-12-07 13:31:15 -0500" MODIFIED_BY="Julia Worswick" NAME="Yealy 2004" TYPE="JOURNAL_ARTICLE">
<AU>Yealy DM, Auble TE, Stone RA, Lave JR, Meehan TP, Graff LG, et al</AU>
<TI>The emergency department community-acquired pneumonia trial: Methodology of a quality improvement intervention</TI>
<SO>Annals of Emergency Medicine</SO>
<YR>2004</YR>
<VL>43</VL>
<PG>770-82</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2017-01-09 13:27:28 -0500" MODIFIED_BY="Julia Worswick">
<REFERENCE ID="REF-Davey-2005" MODIFIED="2016-09-28 09:40:42 -0400" MODIFIED_BY="Paul Miller" NAME="Davey 2005" TYPE="COCHRANE_REVIEW">
<AU>Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, et al</AU>
<TI>Interventions to improve antibiotic prescribing practices for hospital inpatients</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2013-02-25 16:34:35 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2013-02-25 16:34:35 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003543.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Davey-2013" MODIFIED="2017-01-09 13:27:28 -0500" MODIFIED_BY="Julia Worswick" NAME="Davey 2013" TYPE="COCHRANE_REVIEW">
<AU>Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al</AU>
<TI>Interventions to improve antibiotic prescribing practices for hospital inpatients</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2017-01-09 12:56:23 -0500" MODIFIED_BY="Julia Worswick"><IDENTIFIER MODIFIED="2017-01-09 12:56:23 -0500" MODIFIED_BY="Julia Worswick" TYPE="DOI" VALUE="10.1002/14651858.CD003543.pub3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Davey-2014" MODIFIED="2017-01-09 12:21:36 -0500" MODIFIED_BY="Julia Worswick" NAME="Davey 2014" TYPE="COCHRANE_PROTOCOL">
<AU>Davey P, Peden C, Brown E, Charani E, Michie S, Ramsay CR, et al</AU>
<TI>Interventions to improve antibiotic prescribing practices for hospital inpatients (updated protocol)</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<NO>8</NO>
<IDENTIFIERS MODIFIED="2017-01-09 12:21:36 -0500" MODIFIED_BY="Julia Worswick"><IDENTIFIER MODIFIED="2017-01-09 12:21:36 -0500" MODIFIED_BY="Julia Worswick" TYPE="DOI" VALUE="10.1002/14651858.CD011236"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2010-07-13 10:28:22 -0400" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2017-01-31 09:08:20 -0500" MODIFIED_BY="Petrer Davey">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2017-01-18 13:49:01 -0500" MODIFIED_BY="Julia Worswick" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2017-01-02 21:51:01 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Abramowitz-1982">
<CHAR_METHODS MODIFIED="2017-01-02 17:55:42 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 17:56:02 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital<BR/>PARTICIPANTS: all adult patients in the hospital</P>
<P>CLINICAL PROBLEM: receiving treatment with target antibiotics</P>
<P>SETTING: single university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 21:50:16 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational meetings with dissemination of materials; audit and feedback; educational outreach by review and recommend change</P>
<P>
<B>Intervention Functions: </B>education; enablement; persuasion</P>
<P>DELIVERER: pharmacist</P>
<P>COMPARISON: 9 months' pre-intervention. Usual care</P>
<P>DESIRED CHANGE: reduce inappropriate</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 21:51:01 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>decrease in use of cefoxitin and cefamandole</P>
<P>COST: total cost of 6 target antibiotics (calculated from data in Tables 1 and 2)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-02 00:40:27 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information provided</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 21:56:02 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Adachi-1997">
<CHAR_METHODS MODIFIED="2014-10-01 10:22:45 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 21:54:26 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients requiring antibiotic treatment<BR/>SETTING: single hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 21:55:45 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>dissemination of educational materials; educational outreach by review and recommend change; reminders (physical - newsletter)<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion</P>
<P>DELIVERER: pharmacist<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 21:56:02 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>reduce vancomycin prescribing and increase appropriate use of vancomycin</P>
<P>COST: valid financial savings<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-02 00:44:54 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information provided</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 22:02:44 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Akenroye-2014">
<CHAR_METHODS MODIFIED="2015-06-23 23:59:57 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 22:00:37 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all paediatricians and nurses in the ED<BR/>PARTICIPANTS: all children with bronchiolitis<BR/>CLINICAL PROBLEM: acute bronchiolitis presenting to a paediatric ED<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 22:01:49 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>audit and feedback; dissemination of educational materials; educational outreach by review and recommend change; reminders (physical - posters and email)<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion</P>
<P>DELIVERER: departmental physicians, nurses, and managers<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-24 00:05:09 -0400" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>exposure</B>, % children treated with antibiotics</P>
<P>CLINICAL: <B>balancing</B>, % admission rate, % return ED visit rate, ED length of stay (minutes)</P>
<P>FINANCIAL: total cost per patient. No data about the intervention cost.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 22:02:44 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding</B>: Boston Children&#8217;s Hospital Department of Medicine Quality Improvement Publication (QIPub) grant. <B>Competing Interest:</B> none declared</P>
<P>ADDITIONAL INFORMATION: care pathway is in a supplementary online file</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 12:21:17 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Aldeyab-2012">
<CHAR_METHODS MODIFIED="2015-06-19 02:07:03 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 22:04:14 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all adult patients in the hospital<BR/>CLINICAL PROBLEM: patients requiring therapeutic or prophylactic antibiotics<BR/>SETTING: 1 university hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 22:05:04 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>audit and feedback; restrictive - expert approval<BR/>
</P>
<P>
<B>Intervention Functions: </B>enablement, restriction</P>
<P>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 22:07:25 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of target antibiotics in DDD/100 OBD</P>
<P>MICROBIAL: <I>Clostridium difficile</I> infections/100 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-18 12:21:17 -0500" MODIFIED_BY="Julia Worswick">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah grant no. 7-968-D1432. <B>Competing interest:</B> none declared</P>
<P>ADDITIONAL DATA: restriction policy is described in detail in an additional online file for this paper and in <LINK REF="REF-Conlon-2011" TYPE="REFERENCE">Conlon 2011</LINK>.</P>
<P>
<B>Microbial Risk of Bias: LOW, </B>case definition Low, planned intervention Low, other infection control Low</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 03:50:15 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Aldeyab-2014">
<CHAR_METHODS MODIFIED="2015-08-11 02:01:55 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 22:11:19 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all adult patients in the hospital<BR/>CLINICAL PROBLEM: patients requiring therapeutic or prophylactic antibiotics<BR/>SETTING: 1 university hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 22:11:38 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: same as in <LINK REF="STD-Aldeyab-2012" TYPE="STUDY">Aldeyab 2012</LINK>; this article provides additional microbial outcome data for impact on MRSA infections<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 22:11:44 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: same as in <LINK REF="STD-Aldeyab-2012" TYPE="STUDY">Aldeyab 2012</LINK>
</P>
<P>MICROBIAL: MRSA infections/100 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-15 03:50:15 -0500" MODIFIED_BY="Petrer Davey">
<P>FINANCIAL SUPPORT: same as in <LINK REF="STD-Aldeyab-2012" TYPE="STUDY">Aldeyab 2012</LINK>
</P>
<P>ADDITIONAL DATA: restriction policy is described in detail in an additional online file for <LINK REF="STD-Aldeyab-2012" TYPE="STUDY">Aldeyab 2012</LINK> and in Conlon 2011 (additional studies)</P>
<P>
<B>Microbial Risk of Bias: LOW, </B>case definition Low, planned intervention Low, other infection control Low</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 22:23:26 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<CHAR_METHODS MODIFIED="2015-09-02 00:51:53 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 22:15:02 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the medical-surgical ICU<BR/>PARTICIPANTS: all patients in the ICU<BR/>CLINICAL PROBLEM: reduction in use of broad-spectrum antibiotics considered high risk for selection of MRSA<BR/>SETTING: 1 university hospital in Australia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 22:15:44 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational outreach by review and recommend change<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion</P>
<P>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 22:16:09 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of broad-spectrum antibiotics in DDD/1000 OBD</P>
<P>MICROBIAL: MRSA bacteraemia rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 22:23:26 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: none declared. <B>Competing Interest: </B>none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias:</B> <B>HIGH, </B>case definition Low, planned intervention Low, other infection control High. Infection control interventions close to antibiotic stewardship interventions clearly documented in Figure 1.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 10:07:31 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Annane-2013">
<CHAR_METHODS MODIFIED="2015-09-02 01:07:58 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-18 10:07:31 -0500" MODIFIED_BY="Julia Worswick">
<P>PROVIDERS: all physicians in participating ICUs<BR/>PARTICIPANTS: all patients in the ICUs with sepsis. Over a 3-year period, 62/1250 screened patients were eligible for the study, of whom 31 were randomised to each arm<BR/>CLINICAL PROBLEM: sepsis<BR/>SETTING: 8 hospitals in France</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT, <B>Interventions: </B>structural - rapid testing of PCT with decision support algorithm<BR/>
</P>
<P>
<B>Intervention Functions: </B>enablement, environmental restructuring</P>
<P>DELIVERER: departmental physician<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 140 participants in total (70 in each arm) would be needed (details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-11-02 06:49:52 -0400" MODIFIED_BY="Petrer Davey">
<P>PRESCRIBING: <B>exposure</B>, % receiving antibiotics at day 5</P>
<P>CLINICAL: mortality, length of ICU stay, length of hospital stay</P>
<P>MICROBIAL: colonisation with MRSA (nasal swab) and GNRB (rectal swabs)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 22:38:10 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> commercial, Thermo Fisher B.R.A.H.M.S. France, a subsidiary of the maker of the PCT assay used in this study. <B>Competing interests:</B> none declared</P>
<P>ADDITIONAL INFORMATION: supplementary online file has PCT algorithm, authors provided full study protocol (in French)</P>
<P>
<B>Microbial Risk of Bias: MEDIUM </B>(no data about infection control)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 22:46:00 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ansari-2003">
<CHAR_METHODS MODIFIED="2014-10-01 10:41:31 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 22:41:19 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital</P>
<P>CLINICAL PROBLEM: antibiotics dispensed to hospital wards for administration for therapy or prophylaxis</P>
<P>SETTING: 1 university hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 22:42:06 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational meetings; dissemination of educational materials; educational outreach by review and recommend change<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 22:45:15 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>total use of Alert Antibiotics in DDD/1000 OBD</P>
<P>FINANCIAL: cost of antibiotics adjusted for changes in price over the 4-year study period. Cost of the Alert Antibiotic Monitoring intervention and of the setup and analysis of the ward antimicrobial supply database (Table 3)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 22:46:00 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no financial support. <B>Competing Interests</B>: none declared</P>
<P>ADDITIONAL DATA: email response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 22:52:02 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Avorn-1988">
<CHAR_METHODS MODIFIED="2014-10-01 10:53:31 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS<BR/>
</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 22:49:32 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians at 1 teaching hospital<BR/>PARTICIPANTS: all patients with clinical problem<BR/>CLINICAL PROBLEM: patients receiving therapy with cefazolin, clindamycin, or metronidazole<BR/>SETTING: a 460-bed teaching hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 22:50:42 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational meetings; dissemination of educational materials; reminders - circumstantial (order form triggered by receiving target antibiotic) and physical (posters)<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion</P>
<P>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 22:51:50 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>inappropriate dosing intervals of cefazolin, clindamycin, and metronidazole<BR/>FINANCIAL: estimated annual expenditure on the 3 drugs<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 22:52:02 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: Fund for Cooperative Innovation of Blue Cross of Massachusetts and the Massachusetts Hospital Association. <B>Competing interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 23:02:29 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bailey-1997">
<CHAR_METHODS MODIFIED="2017-01-02 22:55:30 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT stratified by type of infection</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 22:57:34 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians at 2 teaching hospitals, excluding ICUs</P>
<P>PARTICIPANTS: a total of 102 inpatients, 51 intervention and 51 control</P>
<P>CLINICAL PROBLEM: patients receiving IV ABs for at least 3 days, but excluded if in ICU or with uncontrolled infection or close to discharge</P>
<P>SETTING: 2 tertiary-care teaching hospitals in USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 22:58:30 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational outreach by review and recommend change<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion</P>
<P>DELIVERER: pharmacist</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: none reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 23:01:48 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: patients switched from parenteral to oral antibiotics or discontinuation of 1 or more antibiotics and mean IV antibiotic days</P>
<P>COST: mean antibiotic costs</P>
<P>CLINICAL: 30-day re-admission (total and infection-related) and in-hospital mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 23:02:29 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Department of Pharmacy. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 23:09:01 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bantar-2006">
<CHAR_METHODS MODIFIED="2015-03-31 00:33:46 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 23:05:09 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital</P>
<P>CLINICAL PROBLEM: IV antibiotics, restriction applied to carbapenems</P>
<P>SETTING: a single university hospital in Argentina. Total use was compared for &gt; 2 years before and after the intervention</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 23:07:50 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Intervention 1: </B>educational outreach by review and recommend change; restrictive - compulsory order form<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion, restriction</P>
<P>
<B>Intervention 2: </B>unavailability of antibiotics during a national financial crisis</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive (choice)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 23:08:28 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: use of all IV antibiotics and carbapenems in DDD/1000 OBD</P>
<P>CLINICAL: all-cause inpatient mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 23:09:01 -0500" MODIFIED_BY="[Empty name]">
<P>FUNDING: none. <B>Competing Interests: </B>2 authors declared conflicts of interest for speaker and advisory board fees</P>
<P>ADDITIONAL INFORMATION: no response from authors</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 23:16:31 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barlow-2007">
<CHAR_METHODS MODIFIED="2017-01-02 23:14:13 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: Controlled ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 23:13:40 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital<BR/>PARTICIPANTS: all patients presenting with pneumonia were recruited prospectively</P>
<P>CLINICAL PROBLEM: adults with community-acquired pneumonia</P>
<P>SETTING: 2 acute university hospitals in Scotland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 23:15:00 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>audit and feedback; educational meetings; dissemination of educational materials; reminders - physical by posters and email<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: control hospital with no intervention</P>
<P>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 23:15:25 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>% appropriate antibiotics within 4 h of admission</P>
<P>COST: cost-effectiveness, intervention cost, and estimated impact on mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 23:16:31 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> NHS Education Scotland and Chief Scientist Office, Scotland. <B>Competing Interests: </B>none declared</P>
<P>ADDITIONAL DATA: email response from authors with additional information about intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 23:24:27 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bassetti-2009">
<CHAR_METHODS MODIFIED="2015-05-06 04:50:01 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 23:20:49 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the ICU (mixed medical/surgical)<BR/>PARTICIPANTS: all patients in the ICU<BR/>CLINICAL PROBLEM: requiring empirical antibiotic therapy<BR/>SETTING: 1 university hospital in Italy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 23:21:50 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational outreach by review and recommend change; restrictive - compulsory order form<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion, restriction</P>
<P>DELIVERER: specialist physicians (ID)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 23:22:00 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of cephalosporins in DDD/1000 OBD</P>
<P>MICROBIAL: MRSA</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 23:24:27 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: none. <B>Competing Interests: </B>none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias: LOW</B>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 10:08:03 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Baysari-2013">
<CHAR_METHODS MODIFIED="2017-01-18 10:08:03 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: unintended consequences, qualitative</P>
<P>
<B>Risk of Bias: </B>not assessed (qualitative study)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 23:27:57 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: 36 physicians<BR/>PARTICIPANTS: patients receiving antibiotic treatment<BR/>CLINICAL PROBLEM: patients receiving antibiotics that the hospital policy designated as requiring approval<BR/>SETTING: 1 hospital in Australia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 23:28:36 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Intervention</B>: audit and feedback; restriction by prior approval</P>
<P>
<B>Intervention Functions: </B>enablement, persuasion, restriction</P>
<P>DELIVERER: AMT<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-09 00:09:59 -0400" MODIFIED_BY="[Empty name]">
<P>UNINTENDED CONSEQUENCES: problems with antibiotic policy and approval process identified through semi-structured interviews with prescribers who had received feedback letters</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 23:30:09 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>St Vincent&#8217;s Clinic Foundation Research Grant, annual Grant #3 and National Health and Medical Research Council program grant #568612. <B>Competing Interests: </B>none declared</P>
<P>ADDITIONAL DATA: email from authors with additional data about the antibiotic policy and feedback</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 23:34:04 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bell-2014">
<CHAR_METHODS MODIFIED="2017-01-02 23:30:36 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: unintended consequences, ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 23:31:49 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in general, gynaecological, orthopaedic, urological, and vascular surgery wards<BR/>PARTICIPANTS: 12,883 patients undergoing elective surgery<BR/>CLINICAL PROBLEM: risk of postoperative AKI following policy change to gentamicin for prophylaxis<BR/>SETTING: 1 hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 23:33:43 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational meetings; dissemination of antibiotic policy; reminders (physical - posters in operating theatres)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive, the policy was intended to reduce <I>Clostridium difficile </I>infection</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-09 00:10:21 -0400" MODIFIED_BY="[Empty name]">
<P>UNINTENDED CONSEQUENCES: % postoperative AKI before and after antibiotic policy change</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 23:34:04 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Scottish Government Healthcare Associated Infection Task Force. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: email response from authors but no additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 23:39:11 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Belliveau-1996">
<CHAR_METHODS MODIFIED="2014-10-03 11:37:48 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 23:36:13 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital</P>
<P>PARTICIPANTS: all patients in hospital</P>
<P>CLINICAL PROBLEM: patients receiving vancomycin therapy</P>
<P>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 23:39:11 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational meetings; dissemination of educational materials; educational outreach by academic detailing; reminders (physical - posters and newsletter); restrictive - expert approval<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, environmental restructuring, persuasion, restriction</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-09-02 02:22:08 -0400" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>vancomycin doses/1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-02 02:21:31 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information provided</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 23:42:04 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Benson-2014">
<CHAR_METHODS MODIFIED="2015-06-20 02:55:31 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 23:40:59 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients receiving therapeutic antibiotics<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 23:41:45 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>audit and feedback; educational outreach by academic detailing<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion</P>
<P>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 23:41:52 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> antibiotic cost per patient day</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 23:42:04 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: none. <B>Competing Interests; </B>none declared</P>
<P>ADDITIONAL INFORMATION: no response from author</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 23:44:08 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Berild-2002">
<CHAR_METHODS MODIFIED="2014-10-07 11:05:15 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 23:43:06 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians (paediatricians) in the hospital</P>
<P>PARTICIPANTS: all paediatric patients in the hospital</P>
<P>CLINICAL PROBLEM: children with infections requiring antibiotic therapy</P>
<P>SETTING: 1 paediatric university hospital in Norway</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 23:43:53 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>audit and feedback; educational meetings; dissemination of educational materials<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 23:44:08 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>total antibiotic usage and usage of 5 specific groups of antibiotics in DDD/100 OBD<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-02 02:26:50 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information provided</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 23:53:52 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Borde-2014a">
<CHAR_METHODS MODIFIED="2017-01-02 23:46:36 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 23:46:59 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians and pharmacists in the Medical Service<BR/>PARTICIPANTS: all adult patients in the Medical Service</P>
<P>CLINICAL PROBLEM: patients receiving antibiotics<BR/>SETTING: 1 university hospital in Germany</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 23:49:19 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>audit and feedback; educational meetings; dissemination of educational materials; educational outreach by review and recommend change; reminders - circumstantial, on rounds<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion</P>
<P>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive, aim was to reduce use of 3rd-generation cephalosporins and fluoroquinolones by 30% in 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 23:51:52 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> drug use measured in RDD/100 OBD</P>
<P>FINANCIAL: cost of intervention and impact on prescribing cost</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 23:53:52 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>internal funds from the Department of Medicine and Federal Ministry of Health (BMG grant IIA5-2011-2511FSB340). <B>Competing Interests:</B> none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 23:59:58 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Borde-2014b">
<CHAR_METHODS MODIFIED="2015-06-20 08:40:28 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 23:56:48 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients with <I>Staphylococcus aureus </I>bacteraemia<BR/>CLINICAL PROBLEM: compliance with a bundle of indicators of effective treatment and investigation<BR/>SETTING: 1 community hospital in Southern Germany</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 23:57:43 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>dissemination of educational materials; reminders - circumstantial, on microbiology reports for positive blood cultures<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, environmental restructuring</P>
<P>DELIVERER: ID physician<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 23:58:32 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> average score per participant, with 0.5 points for each of 4 prescribing indicators, maximum score 2.0 per participant</P>
<P>CLINICAL: not valid (mean mortality in pre- and postintervention phases)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 23:59:58 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>internal funds from the Department of Medicine and Federal Ministry of Health (BMG grant IIA5-2011-2511FSB340). <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: the original paper reports average scores per participant for compliance, with 5 bundle elements of which only 2 were about antibiotic prescribing (Figure 2). The authors provided us with additional data about scores for the 2 prescribing elements in the bundle.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 00:06:11 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Borde-2015a">
<CHAR_METHODS MODIFIED="2017-01-03 00:01:49 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 00:02:49 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians caring for medical emergency patients<BR/>PARTICIPANTS: all medical patients in the ED<BR/>CLINICAL PROBLEM: patients requiring antibiotic treatment<BR/>SETTING: 1 university hospital in Germany</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 00:05:13 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>audit and feedback; educational meetings; dissemination of educational materials; educational outreach by review and recommend change; reminders - circumstantial, on rounds<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion</P>
<P>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive, aim was to reduce use of 3rd-generation cephalosporins by 20% in 12 to 24 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 00:05:31 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> drug use measured in RDD/100 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 00:06:11 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>internal funds from the Department of Medicine and Federal Ministry of Health (BMG grant IIA5-2011-2511FSB340). <B>Competing Interests:</B> none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 00:10:39 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Borde-2015b">
<CHAR_METHODS MODIFIED="2017-01-03 00:07:58 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 00:08:23 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians and pharmacists in the Medical Service<BR/>PARTICIPANTS: all adult patients in the Medical Service</P>
<P>CLINICAL PROBLEM: patients receiving antibiotics<BR/>SETTING: 1 200-bed community hospital</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 00:09:41 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational meetings; dissemination of educational materials; educational outreach by review and recommend change in ICU and for bacteraemic patients in other wards; reminders - circumstantial, on rounds<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion</P>
<P>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive, aim was to reduce use of 3rd-generation cephalosporins and fluoroquinolones by 30% in 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 00:10:15 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> target drug use measured in RDD/100 OBD. <B>Exposure: </B>impact on total anti-infective use was measured</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 00:10:39 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Bouadma-2010">
<CHAR_METHODS MODIFIED="2015-12-05 00:56:51 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 02:15:50 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the ICU<BR/>PARTICIPANTS: all patients in the ICU, 311 randomised to intervention and 319 to control<BR/>CLINICAL PROBLEM: patients requiring antibiotic treatment<BR/>SETTING: 5 hospitals in France, 4 university and 1 general</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT, <B>Interventions: </B>reminders - circumstantial; structural - procalcitonin testing with decision support by treatment algorithm<BR/>
</P>
<P>
<B>Intervention Functions: </B>enablement, environmental restructuring</P>
<P>DELIVERER: departmental physicians (Anaesthesiology and Intensive Care)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 133 participants per study group (details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 02:18:59 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>days of antibiotic exposure per 1000 patient days</P>
<P>CLINICAL: <B>primary outcome measure 28-day mortality</B>, also 60-day mortality, length of ICU stay, and length of hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 02:20:56 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Assistance Publique-Hopitaux de Paris, France and B.R.A.H.M.S, Germany. <B>Competing Interests:</B> 4 authors declared conflicts of interest from several pharmaceutical companies</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 02:29:04 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bouza-2004">
<CHAR_METHODS MODIFIED="2014-10-07 11:56:16 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 02:25:11 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: ICU staff</P>
<P>PARTICIPANTS: 297 patients with bloodstream infection in hospital, 109 control and 188 intervention</P>
<P>CLINICAL PROBLEM: bacteraemia/fungaemia (bloodstream infection)</P>
<P>SETTING: 1 university hospital in Spain</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 02:26:05 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational outreach by review and recommend change<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion</P>
<P>DELIVERER: microbiologists (specialist physicians)</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: reduce inappropriate</P>
<P>POWER CALCULATION: no information about sample size</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 02:26:33 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>proportion of days on which adequate treatment received</P>
<P>CLINICAL: <B>Intended:</B> length of stay, mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 02:29:04 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Red Española de Investigación de Patología Infecciosa (REIPI C03-14) and Fondo de Investigaciones Sanitarias of Spain (FIS 02-1049). <B>Competing Interest:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 02:39:08 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bouza-2007">
<CHAR_METHODS MODIFIED="2015-03-28 02:46:41 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 02:33:24 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: ICU staff</P>
<P>PARTICIPANTS: 250 patients in the adult ICU, 167 intervention and 83 control</P>
<P>CLINICAL PROBLEM: ventilator-associated pneumonia with bacteria identified on gram stain of first tracheal aspirate</P>
<P>SETTING: single general, teaching, and referral hospital in Spain</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 02:34:57 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational outreach by review and recommend change<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion</P>
<P>DELIVERER: microbiologists (specialist physicians)</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: reduce inappropriate</P>
<P>POWER CALCULATION: no information about sample size</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 02:35:23 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>mean days of therapy</P>
<P>MICROBIAL: <I>Clostridium difficile </I>infection</P>
<P>CLINICAL:<B> Balancing: </B>median days of fever and mechanical ventilation</P>
<P>FINANCIAL: cost of antibiotics</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 02:39:08 -0500" MODIFIED_BY="[Empty name]">
<P>
<B>Microbial Risk of Bias HIGH: </B>no case definition, no details of other infection control measures</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>FINANCIAL SUPPORT: Red Española de Investigación de Patología Infecciosas (REIPI) and Fondo de Investigación Sanitaria (FIS). The Spanish Ministry of Health (BEFI BF03/00237, to M.V.T.). <B>Competing Interest:</B> none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 02:47:44 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bradley-1999">
<CHAR_METHODS MODIFIED="2014-10-08 09:30:39 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 02:45:18 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians in an adult haematology unit</P>
<P>PARTICIPANTS: all patients with clinical problem</P>
<P>CLINICAL PROBLEM: adult patients receiving treatment for haematological malignancy</P>
<P>SETTING: adult haematology unit in a university hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 02:46:30 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>restrictive<BR/>
</P>
<P>
<B>Intervention Functions: </B>restriction by removal</P>
<P>DELIVERER: specialist physician (microbiologist)</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 02:47:06 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of 4 principal IV antibiotics in patient days per month</P>
<P>MICROBIAL: probability of remaining free of colonisation by GRE by weeks of exposure on the ward from date of first admission</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 02:47:44 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>commercial, Wyeth Pharmaceuticals. <B>Competing Interest:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 13:32:10 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Bruins-2005">
<CHAR_METHODS MODIFIED="2017-01-18 13:32:10 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: NRT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 03:00:42 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital<BR/>PARTICIPANTS: 1833 patients with bacterial infection in hospital in 3 study periods. Period 1: 294 intervention, 320 control; Period 2: 303 intervention, 317 control; Period 3: 308 intervention, 328 control</P>
<P>CLINICAL PROBLEM: inappropriate antibiotic therapy</P>
<P>SETTING: 1 university hospital in the Netherlands</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT, <B>Interventions: </B>structural - rapid microbiology laboratory testing<BR/>
</P>
<P>
<B>Intervention Functions: </B>environmental restructuring</P>
<P>DELIVERER: specialist physician (microbiologist)</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: reduce inappropriate</P>
<P>POWER CALCULATION: yes, 296 participants in each study arm (details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 03:03:43 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: % of participants who receive appropriate treatment in first 48 h. Turnaround times for microbiology tests and results</P>
<P>CLINICAL: intended clinical outcomes, total hospital mortality rate and length of hospital stay</P>
<P>COST: valid financial savings</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 03:04:10 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>commercial, bioMerieux and Stichting Zorg op Regionale ´ Grondslag (ZORG). <B>Competing Interest:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 03:19:27 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Buising-2008a">
<CHAR_METHODS MODIFIED="2015-09-02 04:53:16 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 03:10:50 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: use of restricted antibiotics: cephalosporins, carbapenems, quinolones, glycopeptides, and aminoglycosides<BR/>SETTING: 1 university hospital in Australia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 03:11:49 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>audit and feedback; educational outreach by review and recommend change; restrictive - expert approval and removal<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, environmental, persuasion, restriction</P>
<P>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 03:17:50 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of restricted antibiotics in DDD/1000 OBD</P>
<P>MICROBIAL<B>: </B>ARGNB (<I>Escherichia coli</I>,<I> Pseudomonas aeruginosa</I>); ARGPB (MRSA)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 03:19:27 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>National Health and Medical Research Council of Australia; Biotechnology Innovation Fund from the Commonwealth Government of Australia; Melbourne Health. <B>Competing Interest:</B> none declared</P>
<P>
<B>Microbial Risk of Bias: LOW </B>(case definition, planned intervention, and other infection control measures all low risk)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 17:35:50 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Buising-2008b">
<CHAR_METHODS MODIFIED="2015-09-02 04:26:57 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 17:27:59 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the ED<BR/>PARTICIPANTS: all patients with community-acquired pneumonia in the ED<BR/>CLINICAL PROBLEM: rate of empiric antibiotic prescribing that was concordant with recommendations<BR/>SETTING: 1 university hospital in Australia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 17:35:50 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions 1: </B>educational outreach by academic detailing; reminders - physical, posters<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, environmental restructuring, persuasion</P>
<P>
<B>Intervention 2: </B>structural - computerised decision support</P>
<P>
<B>Intervention Functions: </B>enablement, environmental restructuring<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-12-07 01:05:26 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>% prescribing concordant with recommendation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 17:30:47 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> National Health and Medical Research Council of Australia. <B>Competing Interest:</B> none declared</P>
<P>ADDITIONAL DATA: email response from authors with further details about intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 17:36:17 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bunz-1990">
<CHAR_METHODS MODIFIED="2017-01-03 17:33:51 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 17:34:10 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital</P>
<P>PARTICIPANTS: all patients in hospital</P>
<P>CLINICAL PROBLEM: receiving metronidazole</P>
<P>SETTING: single university hospital in Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 17:36:17 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational meetings; dissemination of educational materials; reminders - circumstantial, on rounds; restrictive - review and make change<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, restriction</P>
<P>DELIVERER: pharmacist</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-12-07 01:05:39 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>% doses of metronidazole prescribed 12-hourly</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-02 05:01:46 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 17:43:48 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burton-1991">
<CHAR_METHODS MODIFIED="2017-01-03 17:43:48 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 17:42:40 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital</P>
<P>PARTICIPANTS: 147 receiving aminoglycosides</P>
<P>CLINICAL PROBLEM: patients receiving IV aminoglycosides</P>
<P>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 17:43:22 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational outreach by review and recommend change<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion</P>
<P>DELIVERER: pharmacist</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: reduce inappropriate</P>
<P>POWER CALCULATION: no information about sample size</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 17:43:38 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>aminoglycoside dosing and serum concentration</P>
<P>CLINICAL: <B>Intended:</B> length of stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-02 05:04:40 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 17:52:24 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Buyle-2010">
<CHAR_METHODS MODIFIED="2017-01-03 17:46:30 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 17:46:52 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital</P>
<P>PARTICIPANTS: all patients receiving IV fluoroquinolones</P>
<P>CLINICAL PROBLEM: switch from IV fluoroquinolones to oral</P>
<P>SETTING: 1 hospital in Belgium</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 17:51:04 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational meetings; dissemination of guideline; reminders - circumstantial and physical (pre-printed note placed in patient notes when the patient fulfilled criteria for IV to oral switch). NB: the circumstantial reminder was only implemented on some wards (abdominal surgery, gastro-enterology, and plastic surgery) over 2 months, and there are no reliable data to estimate the effect of this component.<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement (only for the circumstantial reminder), environmental restructuring (only for the circumstantial reminder)</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: reduce inappropriate</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 17:51:50 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>% IV/(IV + oral) fluoroquinolone usage</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 17:52:24 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interest:</B> none declared</P>
<P>ADDITIONAL DATA: email from authors with further information about the intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Calfee-2003">
<CHAR_METHODS MODIFIED="2017-01-03 17:54:23 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: unintended consequences, case control</P>
<P>
<B>Risk of Bias:</B> <B>HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 17:56:05 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in adult medical and surgical units<BR/>PARTICIPANTS: all patients in the units<BR/>CLINICAL PROBLEM: use of targeted antibiotics (3rd-generation cephalosporins, piperacillin/tazobactam, aztreonam, carbapenems, parenteral clindamycin, oral and parenteral vancomycin, parenteral fluoroquinolones and macrolides, and fluconazole)<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 17:56:49 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>restrictive by review and make change, automatic stop order for prescriptions not meeting policy indications<BR/>
<B>Intervention Functions: </B>restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: case control study<BR/>DESIRED CHANGE: decrease excessive use of targeted drugs</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 17:56:56 -0500" MODIFIED_BY="[Empty name]">
<P>UNINTENDED CONSEQUENCES: proportion of nosocomial infections reported solely on the basis of a treating physician&#8217;s diagnosis during the endemic and epidemic periods (Table 1)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey">
<P>ROBINS-I RISK OF BIAS CRITERIA:</P>
<P>1. Confounding: Low, confounding unlikely</P>
<P>2. Selection of participants into the study: Unclear, insufficient detail about selection of cases for the endemic and epidemic period</P>
<P>3. Measurement classification of interventions: Low, intervention status well defined, recorded at the time of intervention, and unaffected by knowledge of the outcome or risk of the outcome</P>
<P>4. Deviation from intended interventions: Low, no switches to other interventions or evidence of intervention failure</P>
<P>5. Missing data: Unclear, outcomes are reported as % with no numerator or denominator data</P>
<P>6. Measurement of outcome: High, outcome measure objective, but outcome assessors were aware of the intervention status, and the study does not report the actual number of cases</P>
<P>7. Selection of the reported result: High, reported effect selected from multiple measurements within the outcome domain</P>
<P>FINANCIAL SUPPORT:<B> Funding:</B> no information. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 18:04:06 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Calil-2001">
<CHAR_METHODS MODIFIED="2014-10-14 10:15:43 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 18:02:40 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: staff in a neonatal unit<BR/>PARTICIPANTS: all patients in the neonatal care unit</P>
<P>CLINICAL PROBLEM: requiring neonatal care</P>
<P>SETTING: 1 neonatal care unit in a university hospital in Brazil</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 18:03:42 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing data. Restrictive</P>
<P>DELIVERER: specialist physician</P>
<P>COMPARISON: usual carer</P>
<P>DESIRED CHANGE: decrease exessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 18:04:06 -0500" MODIFIED_BY="[Empty name]">
<P>MICROBIAL: monthly incidence of <I>Enterobacter cloacae </I>infections</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-04 01:48:09 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information provided</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 10:09:59 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Camins-2009">
<CHAR_METHODS MODIFIED="2017-01-03 18:09:30 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: cluster RCT, service level</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 18:10:26 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all internal medicine teams in the hospital<BR/>PARTICIPANTS: 784 patients prescribed antibiotics in the hospital (390 intervention, 394 control), 12 clusters (internal medicine teams)</P>
<P>CLINICAL PROBLEM: patients receiving therapeutic piperacillin-tazobactam, levofloxacin, or vancomycin</P>
<P>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-18 10:09:59 -0500" MODIFIED_BY="Julia Worswick">
<P>
<B>Interventions: </B>audit and feedback; dissemination of guidelines; educational outreach by review and recommend change<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease in excessive treatment</P>
<P>POWER CALCULATION: assuming a baseline proportion of inappropriate use for target antimicrobials of 35% (with inappropriate-use data based on preliminary-usage data from Grady Memorial Hospital), review of at least 330 antimicrobial prescriptions in each arm would allow for detection of a 10% reduction in inappropriate antimicrobial use.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 18:13:29 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> % appropriate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 18:16:37 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: Emory Medical Care Foundation; National Institutes of Health (UL1RR024992 to BCC, K12 RR017643 to MDK and HMB, K23 AI054371 to MDK, and UL1 RR025008 to HMB). <B>Competing Interests:</B> BCC reports was on the speakers&#8217; bureau for Wyeth Pharmaceuticals. All other authors report no conflicts of interest.</P>
<P>ADDITIONAL DATA: no additional data requested</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 18:32:55 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Carling-2003">
<CHAR_METHODS MODIFIED="2014-10-15 10:05:22 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 18:32:24 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: NOT CLEAR<BR/>SETTING: 1 community teaching hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 18:32:55 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing data. Educational outreach - review and recommend change; educational meetings with dissemination of educational materials<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 18:32:36 -0500" MODIFIED_BY="[Empty name]">
<P>MICROBIAL: prevalence of <I>Clostridium difficile</I>, ceftazidime-resistant Enterobacteriaceae, and MRSA</P>
<P>FINANCIAL: cost of intervention</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 18:32:41 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>institutional support. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no additional data requested</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 18:44:25 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chan-2011">
<CHAR_METHODS MODIFIED="2016-12-06 12:42:20 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 18:42:06 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients<BR/>CLINICAL PROBLEM: use of restricted antibiotics (amikacin, 3rd- and 4th-generation cephalosporins, carbapenems, fluoroquinolones, glycopeptides, and piperacillin/tazobactam)<BR/>SETTING: 1 university hospital in Taiwan</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 18:43:28 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational outreach by review and recommend change; restrictive - expert approval required plus review and make change<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion, restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 18:44:01 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> DDD/1000 OBD of restricted antibiotics</P>
<P>MICROBIAL: isolation rates <I>Clostridium difficile, </I>MRSA, and multidrug-resistant gram-negative bacteria</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 18:44:25 -0500" MODIFIED_BY="[Empty name]">
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>FINANCIAL SUPPORT: <B>Funding: </B>Chang Gung Memorial Hospital (Taoyuan, Taiwan) (grant CMRPG340236). <B>Competing Interests:</B> none declared</P>
<P>
<B>Microbial Risk of Bias: HIGH</B> (case definition clear, planned intervention but no data about infection control)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 18:49:00 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chan-2015">
<CHAR_METHODS MODIFIED="2015-05-04 01:47:50 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 18:47:59 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients requring vancomycin<BR/>CLINICAL PROBLEM: patients requiring more than 2 doses of vancomycin treatment<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 18:48:41 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT <B>Interventions: </B>restrictive - expert approval<BR/>
</P>
<P>
<B>Intervention Functions: </B>restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: pre-existing antimicrobial stewardship programme with audit and feedback. No valid data about impact of this programme (UBA).<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 18:48:45 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of vancomycin in DDD/1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 18:49:00 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 18:51:08 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chandy-2014">
<CHAR_METHODS MODIFIED="2015-05-06 01:16:58 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 18:49:48 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients receiving antibiotics<BR/>CLINICAL PROBLEM: total antibiotic use in the hospital<BR/>SETTING: 1 university hospital in India</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 18:50:27 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT <B>Interventions: </B>dissemination of educational materials (guidelines)<BR/>
</P>
<P>
<B>Intervention Functions: </B>education<BR/>DELIVERER: AMT<BR/>COMPARISON: pre-dissemination<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 18:50:31 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> total antibiotic use in DDD/100 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 18:51:08 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL INFORMATION: authors provided additional detail about the antibiotic policy and confirmed that feedback was not used in this intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 18:53:18 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Charbonneau-2006">
<CHAR_METHODS MODIFIED="2014-10-15 11:50:24 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: Controlled ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 18:52:18 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital</P>
<P>PARTICIPANTS: all patients who qualified for fluoroquinolone therapy</P>
<P>CLINICAL PROBLEM: infection with MRSA</P>
<P>SETTING: 1 university hospital in France</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 18:52:55 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing data. Restriction, educational meetings, and dissemination of educational materials</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 18:53:02 -0500" MODIFIED_BY="[Empty name]">
<P>MICROBIAL: reduction of MRSA infections</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 18:53:18 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Programme Hospitalier de Recherche Clinique. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 19:00:05 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cheng-2009">
<CHAR_METHODS MODIFIED="2015-09-04 02:32:25 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 18:59:04 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients receiving IV antibiotics<BR/>CLINICAL PROBLEM: reduce inappropriate prescribing of broad-spectrum IV antibiotics in hospital inpatients<BR/>SETTING: 1 university hospital in China</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 18:59:58 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational meetings with dissemination of guidelines; educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>education, enablement, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 19:00:05 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of targeted antibiotics in DDD/1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-04 02:36:57 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 19:07:31 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Christ_x002d_Crain-2004">
<CHAR_METHODS MODIFIED="2017-01-03 19:01:59 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: cluster RCT</P>
<P>
<B>Risk of bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 19:02:56 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians in hospital<BR/>PARTICIPANTS: 234 patients (124 intervention, 119 control), 16 clusters (weeks randomly assigned to either standard or procalcitonin)</P>
<P>CLINICAL PROBLEM: suspected  lower respiratory tract infection</P>
<P>SETTING: 1 university hospital in Switzerland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 19:05:00 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>dissemination of educational materials; reminders - circumstantial and physical (procalcitonin algorithm) triggered by prescribing antibiotics; structural<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>
</P>
<P>DELIVERER: department physician</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 105 participants in each group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 19:05:38 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>relative risk of antibiotic exposure measured in percentage and patient-days</P>
<P>CLINICAL: <B>Balancing: </B>length of stay; mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 19:07:31 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>B.R.A.H.M.S (Hennigsdorf, Germany) and Orgenium Laboratories (Turku, Finland) provided assay material and partial support of this investigator-initiated project. Freiwillige Akademische Gesellschaft Basel, Switzerland; internal from the Department of Internal Medicine and the Divisions of Endocrinology and Pneumology. <B>Competing Interests:</B> BM served as consultant and received payments from B.R.A.H.M.S (the manufacturer of procalcitonin assays) to attend meetings related to the trial and for travel expenses, speaking engagements, or research</P>
<P>ADDITIONAL DATA: email response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 22:25:42 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Christ_x002d_Crain-2006">
<CHAR_METHODS MODIFIED="2014-10-16 12:21:18 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 22:19:08 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians in hospital<BR/>PARTICIPANTS: 302 patients (151 intervention, 151 control)</P>
<P>CLINICAL PROBLEM: suspected community-acquired pneumonia</P>
<P>SETTING: 1 university hospital in Switzerland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 22:20:49 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>dissemination of educational materials; reminders - circumstantial and physical (procalcitonin algorithm) triggered by prescribing antibiotics; structural<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion</P>
<P>DELIVERER: department physician</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 150 participants in each group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 22:21:39 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> relative risk of antibiotic exposure, total antibiotic use. Duration of antibiotic course</P>
<P>CLINICAL: <B>Balancing:</B> mortality and length of hospital stay</P>
<P>FINANCIAL: total antibiotic cost and cost per patient</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 22:25:42 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>B.R.A.H.M.S (Hennigsdorf, Germany), Pfizer (Schweiz AG), and Mepha (Schweiz AG) was used for assay material and salaries of technical personnel; internal from Departments of Internal Medicine and Emergency Medicine, the Stiftung Forschung Infektionskrankheiten (SFI), and Departments of Endocrinology and Pulmonary Medicine, University Hospital Basel, Switzerland. <B>Competing Interests:</B> 2 authors received payments from B.R.A.H.M.S AG, the manufacturer of the procalcitonin assay.</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 22:31:57 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chu-2003">
<CHAR_METHODS MODIFIED="2014-10-23 05:23:20 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: CBA</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 22:29:09 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital<BR/>PARTICIPANTS: patients with clinical problem<BR/>CLINICAL PROBLEM: community-acquired pneumonia<BR/>SETTING: a total of 36 (20 intervention, 16 control), non-university community hospitals in USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 22:29:56 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>audit and feedback; educational meetings; dissemination of educational materials - pack including guideline and literature review<BR/>
</P>
<P>
<B>Intervention Functions: </B>education, enablement<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 22:30:26 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> process measures sputum and blood cultures within 4 hours, antibiotics within 4 hours, first antibiotic in emergency room<BR/>CLINICAL: <B>Intended:</B> mortality and LOS<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 22:31:57 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>contract 500-99-P619 "Utilization and Quality Control Peer Review Organization for the State of Oklahoma" from the Centers for Medicare and Medicaid Services. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 13:34:00 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Clerc-2014">
<CHAR_METHODS MODIFIED="2017-01-18 13:34:00 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: NRT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 22:34:47 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: "We planned to include around 100 patients in the intervention group". No power calculation provided. Recruited 106 intervention and 91 control participants.<BR/>CLINICAL PROBLEM: first episode of <I>Staphylococcus aureus </I>bacteraemia<BR/>SETTING: 1 university hospital in Switzerland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 22:36:11 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions:</B> structural - rapid laboratory testing for meticillin resistance<BR/>
<B>Intervention Functions: </B>environmental restructuring<BR/>DELIVERER: specialist physician (ID and Microbiology)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 22:36:33 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> % compliance with guideline recommended use of vancomycin</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 22:36:58 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL INFORMATION: the authors confirmed that this intervention did not include feedback to participants</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 22:42:41 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Climo-1998">
<CHAR_METHODS MODIFIED="2014-10-23 07:36:57 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 22:40:58 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: all patients in the hospital<BR/>SETTING: a 703-bed tertiary-care university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 22:41:29 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no reliable prescribing data. Restriction by expert approval</P>
<P>DELIVERER: specialist physician<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 22:42:41 -0500" MODIFIED_BY="[Empty name]">
<P>MICROBIAL: cases of <I>Clostridium difficile</I>-associated diarrhoea per quarter (ITS data). Prevalence of clindamycin-resistant <I>C difficile</I>
<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-05 01:33:31 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information provided</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Connor-2007">
<CHAR_METHODS MODIFIED="2017-01-03 22:49:20 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: unintended consequences, cohort study</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-15 02:44:40 -0500" MODIFIED_BY="Petrer Davey">
<P>PROVIDERS: all physicians prescribing vancomycin<BR/>PARTICIPANTS: 120 patients with vancomycin prescription approved for only 72 hours<BR/>CLINICAL PROBLEM: interruption of vancomycin treatment<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 22:56:29 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>reminders (circumstantial and physical) stickers in medical records on day 3 warning of impending stop order; restrictive: stop order if approval not obtained<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring, restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: participants with and without sticker<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-09 01:02:17 -0400" MODIFIED_BY="[Empty name]">
<P>UNINTENDED CONSEQUENCES: interruption of vancomycin treatment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey">
<P>ROBINS-I RISK OF BIAS CRITERIA:</P>
<P>1. Confounding: Low, confounding unlikely</P>
<P>2. Selection of participants into the study: Low, selection into the study unrelated to intervention (sticker in notes) or outcome</P>
<P>3. Measurement classification of interventions: Low, intervention status well defined, recorded at the time of intervention and unaffected by knowledge of the outcome</P>
<P>4. Deviations from intended interventions: Low, the study was designed to detect intervention failure (no warning sticker)</P>
<P>5. Missing data: Low, outcome data and intervention status complete on all 120 participants</P>
<P>6. Measurement of outcome: Low, outcome measure objective and unaffected by intervention status</P>
<P>7. Selection of the reported result: Low, reported effect predefined</P>
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interests:</B> EL received research support from Merck Pharmaceuticals and Ortho-McNeil Pharmaceuticals. All other authors reported no conflicts of interest.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 23:00:56 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cook-2011a">
<CHAR_METHODS MODIFIED="2015-09-05 01:53:40 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 22:57:04 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients receiving antibiotics<BR/>CLINICAL PROBLEM: use of all prophylactic and therapeutic antibiotics<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 22:57:39 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>education, enablement, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 22:58:48 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> total use of all antibiotics in DDD/1000 OBD</P>
<P>MICROBIAL: <I>Clostridium difficile </I>and MRSA infections/1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 23:00:56 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interests:</B> PPC is a member of the speakers&#8217; bureau of Pfizer, Astellas, and Merck. PPC has received research funding from GlaxoSmithKline, Merck, Gilead, Pfizer, and Bristol-Myers Squibb. All other authors have none to declare.</P>
<P>ADDITIONAL DATA: email response from authors with additional data about intervention</P>
<P>
<B>Microbial Risk of Bias HIGH: </B>case definition low; planned intervention, other infection control high - new policy for screening and isolation of MRSA introduced just before prescribing intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 23:06:52 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cook-2011b">
<CHAR_METHODS MODIFIED="2015-09-29 01:29:46 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 23:02:33 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients receiving antibiotics<BR/>CLINICAL PROBLEM: patients receiving ciprofloxacin for treatment of any infection<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 23:03:19 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Intervention 1 component: </B>educational outreach by review and recommend change<BR/>
<B>Intervention 1 functions: </B>education, enablement, persuasion</P>
<P>
<B>Intervention 2 component: </B>restrictive by expert approval</P>
<P>
<B>Intervention 2 function: </B>restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 23:03:35 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of ciprofloxacin in DDD/1000 OBD</P>
<P>MICROBIAL: infections with ARGNB - <I>% </I>carbapenem resistant <I>Pseudomonas aeruginosa</I>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 23:06:52 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>commercial, grant from Merck &amp; Co., Inc. <B>Competing Interests:</B> PC is a member of the speakers&#8217; bureau of Merck and Astellas. He has received research support from Merck, Gilead, and Pfizer.</P>
<P>ADDITIONAL DATA: email response from authors with additional data about intervention</P>
<P>
<B>Microbial Risk of Bias HIGH</B> case definition low; planned intervention, other infection control <B>high</B> - change in screening and isolation for MRSA just before prescribing intervention may have impacted on transmission of <I>P aeruginosa</I>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 23:12:22 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cortoos-2011">
<CHAR_METHODS MODIFIED="2017-01-03 23:08:52 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 23:09:55 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all adult patients with community-acquired pneumonia<BR/>CLINICAL PROBLEM: compliance with guideline for community-acquired pneumonia<BR/>SETTING: 1 university hospital in the Netherlands</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 23:12:05 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention 1: </B>dissemination of educational materials</P>
<P>
<B>Intervention 1 function: </B>education</P>
<P>
<B>Intervention 2: </B>reminders - physical, questionnaire about guideline compliance, distributed once<BR/>
<B>Intervention 2 functions: </B>environmental restructuring, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 23:12:09 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>% guideline compliance</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 23:12:22 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL INFORMATION: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 23:23:42 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Danaher-2009">
<CHAR_METHODS MODIFIED="2017-01-03 23:18:51 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 23:19:29 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: 52 patients (14 intervention, 38 control)</P>
<P>CLINICAL PROBLEM: excessive prescribing of antibiotics</P>
<P>SETTING: 1 military teaching hospital in USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 23:21:52 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>education, enablement, persuasion<BR/>
</P>
<P>FORMAT: <B>Persuasive: </B>educational outreach - review and recommend change</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: "Since this was an explanatory study, no a priori estimates of effect size were available to perform power and sample size calculations." The goal was to have 180 participants in the trial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 23:23:20 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>antibiotic use (DDDs and days of treatment)</P>
<P>CLINICAL: <B>Balancing:</B> clinical outcomes, mortality, and re-admission</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 23:23:42 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT<B>: Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 23:33:45 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dancer-2013">
<CHAR_METHODS MODIFIED="2015-05-06 04:32:52 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 23:28:02 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: requiring antibiotic prophylaxis or treatment<BR/>SETTING: 1 district general hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 23:32:22 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>restrictive<BR/>
<B>Intervention Functions:</B> restriction by removal from all wards except for ED and ICU and by therapeutic substitution ("empirical prescription of ceftriaxone and ciprofloxacin for systemic sepsis and surgical prophylaxis was changed to amoxicillin, gentamicin and metronidazole")<BR/>DELIVERER: AMT<BR/>COMPARISON: multifaceted intervention introduced 7 months before restriction and remaining in place throughout restrictive period. Components: audit and feedback; educational outreach by review and recommend change; educational meetings and reminders on microbiology reports. There is only 2 months' data before the multifaceted intervention, so it is not possible to estimate its effect.<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 23:32:38 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of cephalosporins and ciprofloxacin in DDD/1000 OBD</P>
<P>MICROBIAL: CDI, MRSA, and resistant gram-negative bacteria</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 23:33:45 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interests:</B> SD received financial support for attending conferences by Janssen-Cilag, Pfizer, and Novartis</P>
<P>ADDITIONAL DATA: authors provided additional details about the intervention, including information about regular feedback to participants that was not in the original paper</P>
<P>
<B>Microbial Risk of Bias LOW </B>case definition <B>Low</B>, planned intervention <B>Low</B>, other infection control practices <B>Low</B>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 23:40:33 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-de-Champs-1994">
<CHAR_METHODS MODIFIED="2014-10-23 11:37:22 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 23:39:11 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians on a paediatric ICU<BR/>PARTICIPANTS: all patients on paediatric ICU<BR/>CLINICAL PROBLEM: neonates requiring intensive care including empirical antibiotic treatment<BR/>SETTING: paediatric ICU in a university hospital in France</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 23:39:58 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: No valid prescribing data. Restrictive: change in antibiotic policy from gentamicin to amikacin</P>
<P>DELIVERER: specialist physician<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 23:40:01 -0500" MODIFIED_BY="[Empty name]">
<P>MICROBIAL: monthly incidence of infection with multiresistant <I>Enterobacter cloacae</I>
<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 23:40:33 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>grant from D.R.E.D. (Direction de la Recherche et des Etudes Doctorales). <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 23:53:01 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dean-2001">
<CHAR_METHODS MODIFIED="2014-10-25 12:32:06 -0400" MODIFIED_BY="Kate Cahill">
<P>STUDY DESIGN: CBA </P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 23:49:19 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all inpatient and outpatient services in the state of Utah<BR/>PARTICIPANTS: 22,985 Medicare beneficiaries aged 65 or older with 28,661 episodes of community-acquired pneumonia, of which 7719 were hospitalised<BR/>CLINICAL PROBLEM: community-acquired pneumonia<BR/>SETTING: 23 hospitals (and 60 outpatient clinics), all in Utah, USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 23:50:29 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing data. Reminder; educational outreach - academic detailing; and educational meetings or dissemination of educational material</P>
<P>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 23:50:39 -0500" MODIFIED_BY="[Empty name]">
<P>CLINICAL: <B>Intended:</B> 30-day mortality and length of stay<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 23:53:01 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: supported by HealthInsight and Intermountain Healthcare. The analyses upon which this publication is based were performed under contract number 500 &#8211;96-P604, entitled &#8220;Utilization and Quality Control Peer Review Organization for the State of Utah&#8221;, sponsored by the Health Care Financing Administration (HCFA), Department of Health and Human Services. This article is a direct result of the Health Care Quality Improvement Program initiated by HCFA, which has encouraged identification of quality improvement projects derived from analysis of patterns of care, and therefore required no special funding on the part of the contractor. Conflict of interest: no information</P>
<P>ADDITIONAL DATA: authors provided additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 23:58:29 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dean-2006">
<CHAR_METHODS MODIFIED="2014-10-25 14:17:16 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: CBA</P>
<P>
<B>Risk of bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-03 23:56:51 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital<BR/>PARTICIPANTS: a total of 17,728 patients aged 66 years or older</P>
<P>CLINICAL PROBLEM: admitted with community-acquired pneumonia</P>
<P>SETTING: 35 hospitals in Utah, USA (16 from Intermountain Healthcare and 19 from other systems)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-03 23:57:55 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing data. Reminder; educational outreach by academic detailing; and educational meetings with dissemination of educational materials</P>
<P>DELIVERER: specialist physician</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-03 23:58:19 -0500" MODIFIED_BY="[Empty name]">
<P>CLINICAL: <B>Intended:</B> 30-day mortality, LOS, and 30-day re-admission</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 23:58:29 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: this study was funded by the Deseret Foundation and HealthInsight, Salt Lake City. The authors have no relevant conflicts of interest to report.</P>
<P>ADDITIONAL DATA: authors provided additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-04 00:02:07 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dempsey--1995">
<CHAR_METHODS MODIFIED="2017-01-04 00:01:03 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 00:01:20 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients with clinical problem<BR/>CLINICAL PROBLEM: patients with nursing home-acquired pneumonia<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-04 00:01:59 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing data. Audit and feedback; reminders; and educational meetings with dissemination of educational materials</P>
<P>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 00:02:07 -0500" MODIFIED_BY="[Empty name]">
<P>CLINICAL: <B>Intended:</B> length of stay</P>
<P>FINANCIAL: charge per case of nursing home-acquired pneumonia</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-12 04:41:06 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information provided</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-04 00:06:53 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ding-2013">
<CHAR_METHODS MODIFIED="2015-09-12 04:53:53 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 00:05:11 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians<BR/>PARTICIPANTS: 78 patients with acute exacerbations of idiopathic pulmonary fibrosis (39 intervention, 39 control)<BR/>CLINICAL PROBLEM: management of acute exacerbations<BR/>SETTING: 1 hospital in China</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-04 00:05:56 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>structural - introduction of procalcitonin testing with decision support algorithm<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring<BR/>
</P>
<P>DELIVERER: respiratory physicians<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: no information</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 00:06:29 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> % participants treated and duration of antibiotic treatment</P>
<P>CLINICAL: <B>Balancing: </B>mortality, length of stay, duration of mechanical ventilation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-04 00:06:53 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response to request from authors</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Dranitsaris-2001">
<CHAR_METHODS MODIFIED="2014-10-26 17:41:09 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 00:09:25 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians assigned to the 7 services<BR/>PARTICIPANTS: 309 patients with clinical problem (162 intervention, 147 control)<BR/>CLINICAL PROBLEM: adult patients with infections requiring IV cefotaxime<BR/>SETTING: 2 hospitals in Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>educational outreach - review and recommend change</P>
<P>
<B>Intervention Functions: </B>enablement, persuasion</P>
<P>DELIVERER: pharmacist<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 330 participants, 165 in each group. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 00:10:47 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>percentage of cefotaxime prescriptions that were consistent with guideline for both indication and dosage<BR/>SECONDARY: mean duration of therapy and cost per treatment course<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-12 05:03:24 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information provided</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-04 02:07:42 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dua-2014">
<CHAR_METHODS MODIFIED="2015-06-21 01:03:24 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 02:06:54 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians involved in vascular surgery<BR/>PARTICIPANTS: all patients undergoing vascular surgery<BR/>CLINICAL PROBLEM: surgical-site infection following vascular surgery<BR/>SETTING: USA, multiple hospitals (stratified, random sample of 20% of all non-federal inpatient hospital admissions throughout the USA)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-04 02:07:23 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing data. Surgical Care Improvement Project core measures with financial incentives implemented in 2006<BR/>DELIVERER: specialist phsicians<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 02:07:30 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>no data</B>
</P>
<P>CLINICAL: inpatient surgical-site infection</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-04 02:07:42 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no funding. <B>Competing Interests:</B> none declared</P>
<P>ADDIDIONAL DATA: authors responded to request but had no additional relevant data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-04 02:17:48 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dull-2008">
<CHAR_METHODS MODIFIED="2015-06-21 01:44:08 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 02:15:58 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians, pharmacists, and nurses in surgical department<BR/>PARTICIPANTS: all patients undergoing elective surgery<BR/>CLINICAL PROBLEM: choice, timing, and duration of antibiotic prophylaxis<BR/>SETTING: 7 hospitals in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-04 02:17:33 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational meetings with dissemination of educational materials; educational outreach by academic detailing; reminders (physical, posters, intranet, and faxes to physicians)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 02:17:48 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>% participants with prophylaxis discontinued within 24 h of surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-05 01:28:34 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information provided</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Duvoisin-2014">
<CHAR_METHODS MODIFIED="2015-10-09 01:49:20 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: unintended consequences, cohort study</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey">
<P>PROVIDERS: all physicians<BR/>PARTICIPANTS: 222 infants with early-onset neonatal sepsis<BR/>CLINICAL PROBLEM: early onset sepsis<BR/>SETTING: 1 hospital in Switzerland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-04 02:22:16 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>restrictive by review and make change targeted at ordering of CBC and CRP tests<BR/>
<B>Intervention Functions: </B>restriction<BR/>DELIVERER: specialist physician (ID)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive use of diagnostic tests</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 02:23:00 -0500" MODIFIED_BY="[Empty name]">
<P>UNINTENDED CONSEQUENCES: time to first antibiotic dose and complications (requirement for catecholamine treatment and/or mechanical ventilation, meningitis, or death)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey">
<P>ROBINS-I RISK OF BIAS CRITERIA:</P>
<P>1. Confounding: Low, confounding unlikely</P>
<P>2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome</P>
<P>3. Measurement classification of interventions: Low, intervention status well defined, recorded at the time of intervention and unaffected by knowledge of the outcome</P>
<P>4. Deviations from intended interventions: Low, the study demonstrated large reduction in CBC (30%) and CRP (91%)</P>
<P>5. Missing data: Low, outcome data and intervention status complete on all 222 participants</P>
<P>6. Measurement of outcome: Low, outcome measure objective and unaffected by intervention status</P>
<P>7. Selection of the reported result: Low, reported outcomes predefined and measured from routine data</P>
<P>FINANCIAL SUPPORT: <B>Funding:</B> SICPA Foundation and the Société Académique Vaudoise. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: email from authors with additional data about intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-04 02:30:50 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Elligsen-2012">
<CHAR_METHODS MODIFIED="2014-10-26 17:40:30 -0400" MODIFIED_BY="Claire Peden">
<P>STUDY DESIGN: CITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 02:29:14 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the critical care team<BR/>PARTICIPANTS: all critical care patients in the hospital</P>
<P>CLINICAL PROBLEM: decrease use of broad-spectrum antibiotics in critical care patients</P>
<P>SETTING: 1 tertiary-care centre in Ontario, Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-04 02:30:10 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>education, enablement, persuasion<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 02:30:22 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of targeted broad-spectrum antibiotics (days of therapy/1000 OBD)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-04 02:30:50 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Canadian Institutes of Health Research, Ontario Ministry of Health, and Long Term Care Academic Health Services Centre Innovation Award. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Esposito-2011">
<CHAR_METHODS MODIFIED="2015-06-23 00:55:01 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 02:34:52 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all paediatric physicians<BR/>PARTICIPANTS: 319 children with pneumonia were enrolled and randomly assigned 1:1 to the treatment groups, but, as consent was withdrawn during the study in 9 cases (5 intervention and 4 control), the final analysis was based on 310 children (155 intervention and control)<BR/>CLINICAL PROBLEM: children hospitalised with community-acquired pneumonia<BR/>SETTING: 1 university hospital in Italy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>structural - rapid testing for procalcitonin and decision support algorithm<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 76 participants in each group. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 02:36:21 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> % started on antibiotics and % children treated for &gt; 10 days</P>
<P>CLINICAL: length of stay, duration of fever, antibiotic adverse effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-04 02:36:40 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Italian Ministry of Health (Bando Giovani Ricercatori 2007). <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-04 02:46:46 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Everitt-1990">
<CHAR_METHODS MODIFIED="2017-01-04 02:41:41 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 02:43:07 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians in Obstetrics &amp; Gynaecology<BR/>PARTICIPANTS: patients (women) with clinical problem<BR/>CLINICAL PROBLEM: Caesarean section<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-04 02:44:33 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of guidelines; reminders (circumstantial, on the structured order form for intravenous antibiotics, which was triggered for every order for IV antibiotics); restriction by expert approval and by removal<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, restriction<BR/>
</P>
<P>DELIVERER: department physician</P>
<P>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 02:45:42 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: relative use of cefazolin or cefoxitin in Caesarean sections that received &lt; 5 g of either drug perioperatively<BR/>FINANCIAL: estimated financial savings<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-04 02:46:46 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Beth Israel Hospital, Boston, Massachusetts and Fund for Cooperative Innovation of Blue Cross of Massachusetts and the Massachusetts Hospital Association. <B>Competing Interests:</B> no information provided</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-04 02:51:17 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Farinas-2012">
<CHAR_METHODS MODIFIED="2016-12-06 12:44:38 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 02:48:44 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: 1185 patients receiving at least 3 days of IV antibiotics (571 intervention, 614 control)<BR/>CLINICAL PROBLEM: adherence to recommendations for change of therapy<BR/>SETTING: 1 university hospital in Spain</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-04 02:49:28 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing outcome data. Educational outreach (review and recommend change)<BR/>DELIVERER: specialist (ID) physicians<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase appropriate antibiotic treatment</P>
<P>SAMPLE SIZE: 571 intervention, 614 control</P>
<P>POWER CALCULATION: no power calculation. No adjustment for intracluster correlation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 02:50:28 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice </B>but no valid outcome data (% adherence with recommendations, but no data about antibiotic use in terms of choice, route, or duration of treatment)</P>
<P>CLINICAL: <B>Balancing: </B>length of stay and % treatment failure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-04 02:51:17 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Fondo de Investigaciones Sanitarias (FIS PI06/90094), and Instituto de Formación e Investigación Marqués de Valdecilla (IFIMAV) (API 06/03). <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Fine-2003">
<CHAR_METHODS MODIFIED="2017-01-04 02:53:12 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: cluster RCT, service level</P>
<P>
<B>Risk of bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 02:54:04 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospitals</P>
<P>PARTICIPANTS: 608 patients with community-acquired pneumonia (263 intervention, 325 control), 7 clusters (sites)</P>
<P>CLINICAL PROBLEM: duration of IV antibiotic therapy and LOS</P>
<P>SETTING: 7 nonprofit hospitals in Pittsburgh, Pennsylvania, USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>dissemination of educational materials, educational outreach by review and recommend change; reminders (circumstantial, physical, detail sheets in physician notes for patients with community-acquired pneumonia and verbal, telephone calls); restrictive; structural<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion, restriction<BR/>
</P>
<P>DELIVERER: AMT </P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 600 participants in total. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 02:56:45 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>duration of IV antibiotic therapy</P>
<P>CLINICAL: intended clinical outcomes, mortality, re-admission</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-04 02:57:07 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Agency for Healthcare Research and Quality and the National Institute of Allergy and Infectious Diseases (HS08282), Robert Wood Johnson Foundation. <B>Competing Interests:</B> no statement</P>
<P>ADDITIONAL DATA: authors provided additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 10:16:21 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Fitzpatrick-2008">
<CHAR_METHODS MODIFIED="2014-10-27 16:24:29 -0400" MODIFIED_BY="Claire Peden">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 03:00:13 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital</P>
<P>CLINICAL PROBLEM: prescribing of cefuroxime and quinolones</P>
<P>SETTING: 1 hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-04 03:00:53 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>dissemination of guideline<BR/>
<B>Intervention Functions: </B>education</P>
<P>DELIVERER: pharmacist</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-18 10:16:21 -0500" MODIFIED_BY="Julia Worswick">
<P>PRESCRIBING: <B>Choice: </B>use of cefuroxime and ciprofloxacin (DDD/Finished Consultant Episode ratio)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-12 07:51:49 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information provided</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-04 03:07:52 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fowler-2007">
<CHAR_METHODS MODIFIED="2014-10-27 16:55:23 -0400" MODIFIED_BY="Claire Peden">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 03:05:15 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians in the hospital<BR/>PARTICIPANTS: patients 80 years and older</P>
<P>CLINICAL PROBLEM: <I>Clostridium difficile </I>infection in the elderly</P>
<P>SETTING: 3 acute medical wards for the elderly in 1 university hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-04 03:06:38 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback, dissemination of guideline; reminders (physical, laminated pocket version of guideline)</P>
<P>
<B>Intervention Functions: </B>education, enablement, environmental restructuring </P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: reduce inappropriate</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 03:07:24 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>monthly use of target antibiotics</P>
<P>MICROBIAL: monthly count of cases of CDI</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-04 03:07:52 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no funding. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: email response from authors but no additional data </P>
<P>
<B>Microbial Risk of Bias LOW: </B>Planned intervention: <B>Low</B> Case definition: <B>Low</B>, National definition. Other infection control measures: <B>Low</B>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Franz-2004">
<CHAR_METHODS MODIFIED="2017-01-04 18:17:51 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 18:18:41 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians in neonatal units<BR/>PARTICIPANTS: 1291 neonates &lt; 72 hours of age were randomised (656 intervention, 635 control)</P>
<P>CLINICAL PROBLEM: suspected bacterial infection</P>
<P>SETTING: 8 centres in 5 countries (Australia, Austria, Belgium, Germany, Sweden)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT, <B>Interventions: </B>dissemination of guideline; structural, introduction of testing for C-reactive protein and interleukin-8 with decision support algorithm<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring<BR/>
</P>
<P>DELIVERER: department physician</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, total of 1150 participants. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 18:21:18 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> number of newborn infants who received antibiotic therapy</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-04 18:25:28 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>grant P.575 from the Center for Applied Clinical Studies of the University of Ulm and Swedish Research Council. DPC (Los Angeles, CA) provided the Immulite automated analysers and the kits for determination of IL-8 and sponsored the initial meeting of the investigators. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-04 18:30:44 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fraser-1997">
<CHAR_METHODS MODIFIED="2014-10-27 17:35:11 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 18:26:37 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: medical, surgery, intensive care, haematology, and oncology<BR/>PARTICIPANTS: patients with the clinical problem<BR/>CLINICAL PROBLEM: adult inpatients receiving 1 or more of 10 designated parenteral antibiotics for 3 or more consecutive days<BR/>SETTING: single teaching hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-04 18:27:38 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change; reminders (circumstantial, physical, written suggestions placed in the notes of participants receiving IV antibiotics)<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring, persuasion<BR/>DELIVERER: AMT</P>
<P>COMPARISON: usual care<BR/>
</P>
<P>DESIRED CHANGE: decrease excessive</P>
<P>SAMPLE SIZE CALCULATION: no information<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 18:29:23 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>days receiving IV antibiotic therapy per participant, DDDs of IV antibiotics per participant. Antibiotic charges (USD) per participant</P>
<P>CLINICAL: <B>Balancing:</B> clinical response at 3 days after completion of antibiotics; retreatment with antibiotics within 7 days; inpatient mortality; re-admission within 30 days of discharge</P>
<P>FINANCIAL: savings on drug costs in USD<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-04 18:30:44 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>commercial (Bayer Pharmaceuticals) and the Maine Medical Center Research Committee. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-04 18:43:34 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fridkin-2002">
<CHAR_METHODS MODIFIED="2017-01-04 18:34:29 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: CBA</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 18:35:22 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: a total of 50 ICUs located in 20 hospitals</P>
<P>PARTICIPANTS: patients in the ICU</P>
<P>CLINICAL PROBLEM: vancomycin use, prevalence of VRE</P>
<P>SETTING: hospitals in the USA participating in the ICU surveillance component of National Nosocomial Infection Surveillance</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-04 18:41:04 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: 5 interventions were used by 3 to 19 hospitals (some hospitals used more than 1). 3 interventions were hospital-wide and 2 were unit-specific.</P>
<P>
<B>
<I>Hospital-wide interventions (22 ICUs)</I>
</B>
</P>
<P>Intervention 1: educational meetings with dissemination of educational materials, 9 ICUs. <B>Intervention function: </B>education.<BR/>
</P>
<P>Intervention 2: audit and feedback, 19 ICUs. <B>Intervention function: </B>enablement.<BR/>
</P>
<P>Intervention 3: restriction, 3 ICUs. <B>Intervention function: </B>restriction.<BR/>
</P>
<P>
<B>
<I>Unit-specific interventions (11 ICUs)</I>
</B>
</P>
<P>Intervention 4: educational meetings with dissemination of educational materials. <B>Intervention function: </B>education.</P>
<P>Intervention 5: restriction, 3 ICUs. <B>Intervention function: </B>restriction.</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: national benchmark data</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 18:43:18 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>DDDs of vancomycin</P>
<P>MICROBIAL: percentages of VRE and MRSA</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-04 18:43:34 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> CDC Emerging Infections Program. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: email response from authors but no additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Friedberg-2009">
<CHAR_METHODS MODIFIED="2015-10-17 03:11:38 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: unintended consequences, cohort study</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-04 18:49:26 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in EDs<BR/>PARTICIPANTS: 13,042 adult patients<BR/>CLINICAL PROBLEM: presenting with respiratory symptoms<BR/>SETTING: 385 hospitals in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-04 18:50:56 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>audit and feedback, public reporting of antibiotic timing measure as 1 of 10 national quality indicators; financial, institution incentive<BR/>
<B>Intervention Functions: </B>enablement, incentive<BR/>DELIVERER: Hospital Quality Alliance<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-04 18:51:27 -0500" MODIFIED_BY="[Empty name]">
<P>UNINTENDED CONSEQUENCES: rates of pneumonia diagnosis, antibiotic use, and waiting times to see a physician</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey">
<P>ROBINS-I RISK OF BIAS CRITERIA:</P>
<P>1. Confounding: Unclear, analysis says it was adjusted for confounding of the effect of intervention but insufficient detail</P>
<P>2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome</P>
<P>3. Measurement classification of interventions: Low, intervention status well defined, recorded at the time of intervention and unaffected by knowledge of the outcome or risk of the outcome</P>
<P>4. Deviations from intended interventions: Low, no switches to other interventions or evidence of intervention failure</P>
<P>5. Missing data: Unclear, outcome data reported as % with no numerator/denominator (Table 2)</P>
<P>6. Measurement of outcome: High, the effect estimate is based on regression analysis of annual data for 3 years pre- and 2 years postintervention (i.e. only 2 postintervention time points). The authors say that "based on the NHAMCS sample, there were an estimated 40 million (95% confidence interval, 39 to 42 million) ED visits to hospitals by adults with respiratory symptoms between 2001 and 2005." In Table 1, around 10% of these patients had a diagnosis of CAP, so they were not short of data! They should surely have split their data into more time points.</P>
<P>7. Selection of the reported result: Low, single analysis of the intervention-outcome relationship</P>
<P>FINANCIAL SUPPORT:<B> Funding: </B>Primary Care Teaching and Education Fund (internal), Health Resources and Services Administration, and Agency for Healthcare Research and Quality. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 01:55:26 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fukuda-2014">
<CHAR_METHODS MODIFIED="2015-07-16 00:50:38 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 01:54:27 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all adult inpatients receiving target antibiotics for 14 days or more<BR/>CLINICAL PROBLEM: de-escalation of treatment in patients who received carbapenems, cephalosporins, or quinolones for at least 14 days<BR/>SETTING: 1 community hospital in Japan</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 01:55:02 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>enablement, persuasion<BR/>
</P>
<P>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive and decrease cost</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 01:55:13 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>cost of target antibiotics (USD/1000 OBD)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 01:55:26 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 01:57:39 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gerding-1985">
<CHAR_METHODS MODIFIED="2015-09-12 09:42:21 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 01:56:47 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all prescribers in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: requiring aminoglycoside treatment<BR/>SETTING: 1 Veterans Administration hospital in the USA. UBA data about resistance from 14 other similar hospitals</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 01:57:05 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing data. Restrictive.</P>
<P>DELIVERER: specialist physician</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 01:57:10 -0500" MODIFIED_BY="[Empty name]">
<P>MICROBIAL: resistance to gentamicin and aminoglycoside use<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 01:57:39 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> commercial, Bristol Laboratories and the Veterans Administration. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias: MEDIUM</B>, case definition Low, planned intervention Low, other infection control Unclear, no information</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 02:08:57 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Goldstein-2009">
<CHAR_METHODS MODIFIED="2015-07-18 00:40:14 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 02:03:08 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians<BR/>PARTICIPANTS: all adult patients in the hospital<BR/>CLINICAL PROBLEM: patients requiring IV antibiotics<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 02:06:08 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>dissemination of formulary</P>
<P>
<B>Intervention Function: </B>education<BR/>
</P>
<P>After 9 months there was an additional restrictive intervention (autosubstitution of ampicillin sulbactam by ertapenem), but this was not targeted at imipenem use, and no data are provided about prescribing or microbial outcomes for ampicillin sulbactam.<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 02:06:48 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>imipenem use in DDD</P>
<P>MICROBIAL: % susceptibility to imipenem in clinical isolates of <I>Pseudomonas aeruginosa</I>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 02:08:57 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> commercial Merck (manufacturers of ertapenem). <B>Competing Interests:</B> Ellie JC Goldstein is on the advisory boards of Merck, is in the speakers' bureau of Merck, and received research support from Merck; Shuang Lu is employed by Merck Research Laboratories and may own stock or stock options. Anne R Meibohm was formerly employed by Merck Research Laboratories and may own stock or stock options.</P>
<P>ADDITIONAL DATA: email response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias LOW: </B>case definition low risk, planned intervention low risk, other infection control measures low risk, no change</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 02:13:06 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Grohs-2014">
<CHAR_METHODS MODIFIED="2015-07-18 01:40:09 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 02:11:14 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians<BR/>PARTICIPANTS: all adult patients<BR/>CLINICAL PROBLEM: requiring treatment with IV 3rd-generation cephalosporin<BR/>SETTING: 1 university hospital in France</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 02:11:41 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>distribution of antibiotic policy</P>
<P>
<B>Intervention Function: </B>education<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 02:12:29 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>ceftriaxone use in DDD/1000 OBD</P>
<P>MICROBIAL: number of participants carrying high level AmpC beta-lactamase</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 02:13:06 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias: HIGH </B>case definition low, planned intervention low, <B>other infection control measures unclear (no data)</B>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 10:18:00 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Gulmezoglu-2007">
<CHAR_METHODS MODIFIED="2017-01-05 02:14:58 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: cluster RCT, hospital level</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-18 10:18:00 -0500" MODIFIED_BY="Julia Worswick">
<P>PROVIDERS: obstetric teams<BR/>PARTICIPANTS: 1000 consecutively delivered women in obstetric units, 40 clusters (hospitals)<BR/>CLINICAL PROBLEM: women undergoing Caesarean section<BR/>SETTING: 22 hospitals in Mexico City and 18 in Thailand</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>educational meetings and dissemination of brochures; reminders (physical, posters and brochures)<BR/>
<B>Intervention Functions: </B>education, environmental restructuring, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective</P>
<P>POWER CALCULATION: yes, 40 hospitals. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 02:16:30 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> % women receiving antibiotic prophylaxis for Caesarean section</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 02:19:21 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP). <B>Competing Interests:</B> 4 authors were editors of The WHO Reproductive Health Library since its inception in 1997 to date of publication.</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 02:25:20 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gums-1999">
<CHAR_METHODS MODIFIED="2014-10-28 10:25:18 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 02:22:51 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: a total of 272 patients<BR/>CLINICAL PROBLEM: patients receiving inappropriate antibiotic therapy judged on culture results, risk of toxicity or drug interaction, drug cost, and duration of treatment<BR/>SETTING: single 275-bed community hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 02:24:39 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change; reminders (circumstantial and physical, placed in notes of patients who were receiving antibiotics)<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring, persuasion<BR/>
</P>
<P>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: no justification provided for the sample size<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 02:25:20 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>cost of antibiotic therapy</P>
<P>CLINICAL: <B>Balancing:</B> length of stay</P>
<P>FINANCIAL: charges for antibiotics, laboratory and radiology services, total patient charges. Implementation cost based on days per week required for Pharmacy and Infectious Diseases staff.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-22 01:41:36 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL INFORMATION: no response from authors</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 02:29:58 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gupta-1989">
<CHAR_METHODS MODIFIED="2014-10-28 12:18:53 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 02:29:01 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: patients with clinical problem<BR/>CLINICAL PROBLEM: patients receiving cefazolin<BR/>SETTING: 1 university hospital in Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 02:29:49 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>dissemination of memo; reminders (physical, newsletter); restrictive by review and make change<BR/>
<B>Intervention Functions: </B>education, environmental restructuring, persuasion, restriction<BR/>
</P>
<P>DELIVERER: pharmacist</P>
<P>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 02:29:58 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>% of cefazolin doses prescribed at &lt; 8-hour intervals<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-12 10:15:15 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information provided</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 02:33:23 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hadi-2008">
<CHAR_METHODS MODIFIED="2014-10-28 12:44:02 -0400" MODIFIED_BY="Claire Peden">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 02:32:01 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: residents in internal medicine department<BR/>PARTICIPANTS: patients with clinical problem</P>
<P>CLINICAL PROBLEM: antibiotics use in patients with a fever</P>
<P>SETTING: 5 wards in internal medicine department of teaching hospital in Indonesia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 02:32:53 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of guidelines; educational outreach by academic detailing; reminders (physical, pocket book version of guideline)<BR/>
<B>Intervention Functions: </B>education, environmental restructuring, persuasion<BR/>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: reduce inappropriate</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 02:33:01 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> % patients treated and total antibiotic consumption (DDD/100 patient days)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 02:33:23 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Royal Netherlands Academy of Arts and Sciences, Scientific Programme Indonesia-Netherlands (SPIN). <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 02:38:40 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Halm-2004">
<CHAR_METHODS MODIFIED="2017-01-05 02:34:17 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 02:36:21 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospitals<BR/>PARTICIPANTS: all patients with clinical problem</P>
<P>CLINICAL PROBLEM: adults with community-acquired pneumonia</P>
<P>SETTING: 4 university hospitals, New York, USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 02:37:35 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of guidelines; reminders (circumstantial and physical, on computer order system for antibiotics and pocket version of guideline)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 02:38:03 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>percentage of patients treated with guideline-recommended antibiotics</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 02:38:40 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Mount Sinai-New York University Health System, the North Shore-Long Island Jewish Health System, and the Robert Wood Johnson Foundation <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 02:43:58 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hess-1990">
<CHAR_METHODS MODIFIED="2014-10-29 10:40:39 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 02:42:52 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: receiving cefazolin therapy<BR/>SETTING: a 719-bed tertiary-care medical centre in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 02:43:53 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>dissemination of guideline; educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>education, enablement, persuasion<BR/>DELIVERER: pharmacist</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 02:43:58 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>cefazolin expenditure per patient day</P>
<P>FINANCIAL: savings in drug costs<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-12 10:42:54 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 02:47:28 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Himmelberg-1991">
<CHAR_METHODS MODIFIED="2014-10-29 11:24:48 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 02:46:08 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians in the hospital<BR/>PARTICIPANTS: patients in the hospital<BR/>CLINICAL PROBLEM: patients receiving restricted antibiotics<BR/>SETTING: a tertiary-care teaching hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 02:46:43 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>restrictive, removal of restriction</P>
<P>
<B>Intervention Functions: </B>restriction<BR/>
</P>
<P>DELIVERER: specialist physician<BR/>COMPARISON: 6 months in the restriction period were compared with 6 months after restriction was lifted.<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 02:46:54 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>number of courses and cost of restricted drugs</P>
<P>FINANCIAL: cost of drugs<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 02:47:28 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT:<B> Funding: </B>commercial, Pfizer Roerig and the Upjohn companies. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 10:18:26 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Hitti-2012">
<CHAR_METHODS MODIFIED="2017-01-05 02:48:41 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-18 10:18:26 -0500" MODIFIED_BY="Julia Worswick">
<P>PROVIDERS: all physicians in the ED<BR/>PARTICIPANTS: all patients with sepsis in the ED<BR/>CLINICAL PROBLEM: sepsis<BR/>SETTING: 1 hospital in Beirut, Lebanon</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 02:50:46 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>structural<BR/>
<B>Intervention Functions: </B>environmental restructuring, antibiotics required for sepsis treatment were stored in an Automated Dispensing Cabinet in the ED instead of having to be ordered from pharmacy<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 02:50:55 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> time to first antibiotic dose in minutes measured both from arrival in the ED and from ordering the antibiotic</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-05 02:08:04 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 02:58:05 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hochreiter-2009">
<CHAR_METHODS MODIFIED="2014-10-29 12:01:20 -0400" MODIFIED_BY="Claire Peden">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 02:54:43 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in ICU<BR/>PARTICIPANTS: all patients with the clinical problem<BR/>CLINICAL PROBLEM: duration of antibiotic therapy in 110 patients with suspected bacterial infections (57 intervention, 53 control)<BR/>SETTING: surgical intensive care ward in 1 hospital in Germany</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 02:57:15 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>reminders (circumstantial and physical, procalcitonin-based decision support algorithm); structural (introduction of procalcitonin testing)<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring, persuasion<BR/>
</P>
<P>DELIVERER: department (ICU) physician<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: no information provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 02:57:25 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>duration of all antibiotic therapy in days<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 02:58:05 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interests:</B> SS has served as consultant and received payments from B.R.A.H.M.S AG for speaking engagements. All other authors declare no conflicts of interest.</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 03:02:25 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huber-1982">
<CHAR_METHODS MODIFIED="2014-10-29 11:40:12 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 03:00:58 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in hospital<BR/>CLINICAL PROBLEM: appropriateness of inpatient prescribing of cephalexin<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 03:02:07 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>restrictive by expert approval and removal<BR/>
<B>Intervention Functions: </B>restriction<BR/>
</P>
<P>DELIVERER: pharmacists<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 03:02:11 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>cephalexin dosing units<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 03:02:25 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 15:23:12 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hulgan-2004">
<CHAR_METHODS MODIFIED="2017-01-05 03:03:37 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 15:23:12 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians in the hospital<BR/>PATIENTS: all patients with clinical problem</P>
<P>CLINICAL PROBLEM: use of IV and oral quinolones</P>
<P>SETTING: university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 03:05:14 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>reminders (circumstantial and physical, computerised decision support system integrated into an existing provider order entry system)<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring, persuasion<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive use of IV quinolones</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 03:05:32 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>number of orders for oral quinolone</P>
<P>FINANCIAL: savings on drug costs in USD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 03:08:45 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> NIH Training Grant T32 AI 07474-08 and Vanderbilt Clinical Research Scholar Award K12 RR17697 (TH). <B>Competing Interests:</B> DAT and RAM receive authorship royalties through Vanderbilt University from the commercial distribution of WizOrder. STR has received consulting fees from McKesson Information Solutions, which has licensed WizOrder for commercial distribution. None of the other authors has related disclosures or potential conflicts of interest.</P>
<P>ADDITIONAL DATA: email response from authors with additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 15:26:00 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Inaraja-1986">
<CHAR_METHODS MODIFIED="2017-01-05 15:24:05 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 15:24:42 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients receiving antibiotics<BR/>CLINICAL PROBLEM: patients receiving antibiotics<BR/>SETTING: 1 447-bed university hospital in Spain</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 15:25:36 -0500" MODIFIED_BY="[Empty name]">
<P>
<B>Interventions: </B>educational outreach by review and recommend change; restrictive antibiotic policy but mode of restriction not clear<BR/>
<B>Intervention Functions: </B>enablement, persuasion, restriction<BR/>
</P>
<P>DELIVERER: pharmacist</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 15:25:46 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>cephalosporin use measured with costs as a percentage of cephalosporins plus penicillins plus aminoglycosides<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 15:26:00 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Jensen-2011">
<CHAR_METHODS MODIFIED="2015-07-18 02:25:57 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 15:27:55 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in ICUs<BR/>PARTICIPANTS: All adult patients in ICUs for &gt; 24 hrs<BR/>CLINICAL PROBLEM: suspected sepsis<BR/>SETTING: 9 multidisciplinary ICUs across Denmark</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT:<B> Interventions: </B>reminders (circumstantial and physical, drug-escalation algorithm and intensified diagnostics based on daily procalcitonin measurements); structural (rapid procalcitonin testing)<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring, persuasion<BR/>DELIVERER: deparmental physicians (ICU)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective</P>
<P>SAMPLE SIZE: yes, total 1200 participants. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
<P>1200 participants were randomised and included in the analysis.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 15:29:48 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>time to first antibiotic dose; number (%) ICU days spent with at least 3 antibiotics</P>
<P>CLINICAL: <B>intended </B>28-day mortality; <B>unintended (balancing) </B>days in ICU; relative risk of renal impairment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 15:31:56 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Danish State, the Lundbeck Foundation, the Toyota Foundation, the A.P. Møller Foundation, the Horboe Foundation, and the Capitol Region of Denmark. <B>Competing Interests:</B> Dr. Jensen received speaker fee and travel reimbursement from B.R.A.H.M.S Diagnostica and an unrestricted grant from the organisation for sample transport and analysis. The remaining authors have not disclosed any potential conflicts of interest.</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 15:40:48 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jobson-2015">
<CHAR_METHODS MODIFIED="2015-07-24 00:53:22 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 15:37:11 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians and nurses in the paediatric ED<BR/>PARTICIPANTS: all children with central lines<BR/>CLINICAL PROBLEM: time to first antibiotic dose in children with fever<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 15:40:08 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback at individual and group level; educational meetings, dissemination of educational materials; educational outreach by academic detailing at individual and group level; reminders (circumstantial (on electronic health record), physical (cards attached to computers, weekly email newsletter), and verbal); structural (placing antibiotics in front-line Pyxis stock)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>DELIVERER: departmental physicians<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 15:40:16 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>% of participants receiving first antibiotic dose within 60 minutes</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 15:40:48 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> no external. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: authors provided additional data about intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 15:48:57 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jump-2012">
<CHAR_METHODS MODIFIED="2016-12-06 12:47:27 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: CITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 15:43:47 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians and nurses in the hospitals<BR/>PARTICIPANTS: all patients in the hospitals<BR/>CLINICAL PROBLEM: patients requiring antibiotics or with suspected <I>Clostridium difficile</I> infection<BR/>SETTING: 1 long-term care facility (intervention) and 1 hospital (control) in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 15:44:20 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>education, enablement, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 15:44:52 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>days of therapy with all antibiotics/1000 OBD</P>
<P>MICROBIAL: +ve <I>C difficile</I> tests per 1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 15:48:57 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> National Institutes of Health (grants R03-AG040722 to RLPJ, K23-DK087919 to PED, and R01-AI063517 to RAB), Veterans Affairs Merit Review Program, Veterans Integrated Service Network 10 Geriatric Research Education and Clinical Center (VISN 10 GRECC). <B>Competing Interests:</B> RLPJ reports that she has consulted for GOJO and Pfizer and has received grant support ViroPharma. RAB reports that he has consulted for AstraZeneca and has received grant support from AstraZeneca, Ribx, Pfizer, and Steris. CJD reports that he has consulted for BioK, Optimer, and GOJO and has received grant support from ViroPharma, Merck, and Pfizer. All other authors report no conflicts of interest.</P>
<P>ADDITIONAL DATA: email with additional data; further information about the intervention is given in <LINK REF="REF-Jump-2013" TYPE="REFERENCE">Jump 2013</LINK>.</P>
<P>
<B>Microbial Risk of Bias: HIGH</B>. Case definition low; Planned intervention low; <B>Other infection control high, </B>no data about infection control other than that the intervention also increased isolation of participants with <I>C difficile</I> infection. Moreover, the intervention discouraged repeat testing of participants with known <I>C difficile</I> infection, which may have biased the microbial outcome.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 15:51:33 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kallen-2009">
<CHAR_METHODS MODIFIED="2015-05-07 00:23:13 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 15:50:03 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients requiring therapeutic antibiotics<BR/>SETTING: 1 community hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 15:51:07 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>restrictive by removal from all wards</P>
<P>
<B>Intervention Function: </B>restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease use of fluoroquinolones in order to contain an outbreak of <I>Clostridium difficile </I>infection</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 15:51:21 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of fluoroquinolones, DDD/100 OBD</P>
<P>MICROBIAL: <I>C difficile </I>infections</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 15:51:33 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>
<B>Microbial Risk of Bias: HIGH, </B>case definition yes, planned intervention no (part of response to outbreak), other infection control measures no (several important changes made at the same time as prescribing intervention)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 12:38:37 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Kanwar-2007">
<CHAR_METHODS MODIFIED="2015-10-10 00:16:34 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: unintended consequences, cohort study</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 15:54:38 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the ED<BR/>PARTICIPANTS: 518 adult patients<BR/>CLINICAL PROBLEM: hospital admission diagnosis of CAP<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 15:55:40 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>audit and feedback; financial, institution incentive<BR/>
<B>Intervention Functions: </B>enablement, incentive<BR/>DELIVERER: Blue Cross-Blue Shield of Michigan incentive program<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 15:55:50 -0500" MODIFIED_BY="[Empty name]">
<P>UNINTENDED CONSEQUENCES: confirmation of admission diagnosis by chest X-ray, mean antibiotic administration per patient admitted with CAP</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-18 12:38:37 -0500" MODIFIED_BY="Julia Worswick">
<P>NRSI RISK OF BIAS CRITERIA:</P>
<P>1. Confounding: Low, confounding of the effect of intervention unlikely in this study</P>
<P>2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome</P>
<P>3. Measurement class of interventions: Low, intervention status well defined, recorded at the time of intervention and unaffected by knowledge of the outcome or risk of the outcome</P>
<P>4. Departures from intended interventions: Low, no switches to other interventions or evidence of intervention failure</P>
<P>5. Missing data: Low, outcome data and intervention status reported on all 518 patients</P>
<P>6. Measurement of outcome: Low, outcome measure objective and measured from patient administration system</P>
<P>7. Selection of the reported result: Low, single, prespecified analysis of the intervention-outcome relationship</P>
<P>FINANCIAL SUPPORT: <B>Funding,</B> none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Kerremans-2008">
<CHAR_METHODS MODIFIED="2014-10-30 10:36:19 -0400" MODIFIED_BY="Claire Peden">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 15:58:04 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital<BR/>PARTICIPANTS: 1498 patients with bacterial infections (746 intervention, 752 control)</P>
<P>CLINICAL PROBLEM: antibiotic use in adult patients with bacterial infections</P>
<P>SETTING: 1 university hospital in the Netherlands</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Intervention: </B>structural (rapid microbiology laboratory testing)<BR/>
<B>Intervention Functions: </B>environmental restructuring</P>
<P>DELIVERER: specialist physician</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 1500 participants in total. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 15:59:09 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>total antibiotic use (average DDDs per patient)</P>
<P>CLINICAL: <B>Intended:</B> mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 15:59:48 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Dutch Association of University Hospitals (&#8216;VAZ-Doelmatigheidproject&#8217; no. 99207). bioMerieux provided additional funding through an unrestricted grant. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 16:04:34 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kerremans-2009">
<CHAR_METHODS MODIFIED="2015-09-29 02:08:11 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 16:01:49 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital<BR/>PARTICIPANTS: 211 patients with positive blood cultures (93 intervention, 108 control)</P>
<P>CLINICAL PROBLEM: antibiotic use in adult patients with bacterial infections</P>
<P>SETTING: 1 tertiary-care university medical centre in the Netherlands</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 16:03:14 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>structural - other (out-of-hours blood culture incubator intended to reduce laboratory turnaround time)</P>
<P>
<B>Intervention Function: </B>environmental restructuring</P>
<P>DELIVERER: specialist physician</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: increase effective</P>
<P>POWER CALCULATION: no information. In the Discussion, the authors say "our sample size was too small to study the impacts of time to positivity (Gram stain), identification, and susceptibility testing separately on outcome".</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 16:03:36 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>time to first antibiotic regimen change</P>
<P>CLINICAL: <B>Intended:</B> mortality and length of stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 16:04:34 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Becton Dickinson provided the outside BACTEC incubator used in this study. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 16:08:55 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khan-2003">
<CHAR_METHODS MODIFIED="2014-10-30 11:15:20 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 16:07:05 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital<BR/>PARTICIPANTS: all patients in hospital<BR/>CLINICAL PROBLEM: <I>Clostridium difficile-</I>associated diarrhoea<BR/>SETTING: an 800-bed non-teaching hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 16:07:27 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing data. Restriction with educational meetings and dissemination of guideline.</P>
<P>DELIVERER: specialist physician<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 16:08:55 -0500" MODIFIED_BY="[Empty name]">
<P>MICROBIAL: incidence of <I>C difficile-</I>associated diarrhoea</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-05 02:19:36 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 16:13:25 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kim-2008">
<CHAR_METHODS MODIFIED="2016-12-06 12:48:07 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW </B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 16:11:30 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients receiving therapeutic antibiotics<BR/>CLINICAL PROBLEM: outbreak of ESBL infections<BR/>SETTING: 1 hospital in Korea</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 16:12:20 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; restrictive by expert approval<BR/>
<B>Intervention Functions: </B>enablement, restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive, use of cephalosporins to contain outbreak of ESBL</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 16:12:33 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: use of cephalosporins (DDD/1000 OBD)</P>
<P>MICROBIAL: isolates of ESBL and new patients with ESBL infection</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 16:13:25 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>City of Seoul grant #10920 and KICOS project grant (Battelle Institute, Korea University). <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias HIGH. </B>Case definition Low, planned intervention High (response to outbreak of ESBL), other infection control Unclear (no detail, and authors state that they did not take this into account in their analysis)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 16:20:28 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Knudsen-2014">
<CHAR_METHODS MODIFIED="2015-07-23 02:15:31 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: CITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 16:16:46 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians, nurses, and pharmacists in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: the intervention was intended to reduce infections caused by ESBL- and AmpC-producing gram-negative bacteria<BR/>SETTING: 1 university hospital (intervention) and 4 additional hospitals (control) in Denmark</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 16:18:50 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational meetings; dissemination of guidelines; educational outreach by review and recommend change; reminders (physical, intranet and pocket guidelines; circumstantial, verbal by pharmacy technicians and infection control nurses)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion.<BR/>
</P>
<P>The intervention also included the same components targeted at infection control measures (hand hygiene and isolation).<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 16:19:17 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>cefuroxime use in DDD/1000 OBD</P>
<P>MICROBIAL: cases per 1000 OBD per month</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 16:20:28 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: the authors provided multiple additional files of information about the intervention, including examples of the feedback newsletters (in Danish).</P>
<P>
<B>Microbial Risk of Bias: LOW</B>, case definition low, planned intervention low, other infection control measures low</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Kristoffersen-2009">
<CHAR_METHODS MODIFIED="2015-09-13 02:18:47 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 16:25:21 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: 210 patients with suspected lower respiratory tract infection (103 intervention, 107 control)<BR/>CLINICAL PROBLEM: antibiotic consumption and length of stay in patients with suspected lower respiratory tract infections<BR/>SETTING: 3 hospitals in Denmark</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>dissemination of guideline; reminders (circumstantial and physical, decision support algorithm triggered by PCT test result); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring<BR/>
</P>
<P>DELIVERER: specialist physician</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 107 participants in each group. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 16:28:16 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice and exposure: </B>antibiotics prescribed and duration of antibiotic treatment</P>
<P>CLINICAL: <B>Balancing:</B> length of stay and mortality<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 16:28:31 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Danish Medical Research Council and the Danish Lung Association Study ID: NCT00415753, 271-05-0765. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Kritchevsky-2008">
<CHAR_METHODS MODIFIED="2017-01-05 16:31:32 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: cluster RCT, hospital level</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 16:31:55 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians responsible for antimicrobial prophylaxis<BR/>PARTICIPANTS: patients undergoing cardiac surgery, hip and knee replacements, and hysterectomy, 44 clusters (hospitals)</P>
<P>CLINICAL PROBLEM: Preoperative antimicrobial prophylaxis</P>
<P>SETTING: 44 acute care hospitals in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of guideline; educational outreach by academic detailing<BR/>
<B>Intervention Functions: </B>education, persuasion</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: increase effective</P>
<P>POWER CALCULATION: yes, 40 hospitals sampling 100 cases per measurement period. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 16:34:03 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice and exposure: </B>5 performance measures of antimicrobial prophylaxis (timing, receipt, duration, selection, and single preoperative dose)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 16:34:23 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> grant R01 HS11331-01A1 from the Agency for Healthcare Research and Quality and Centers for Disease Control and Prevention. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: authors provided additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 16:38:57 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kumana-2001">
<CHAR_METHODS MODIFIED="2017-01-05 16:35:59 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW </B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 16:37:11 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PATIENTS: all patients in the hospital</P>
<P>CLINICAL PROBLEM: patients receiving glycopeptides (teicoplanin or vancomycin)</P>
<P>SETTING: 1 hospital in Hong Kong</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 16:37:49 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational meetings with dissemination of guidelines<BR/>
<B>Intervention Functions: </B>education, enablement<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 16:38:44 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>DDD per month of glycopeptides</P>
<P>CLINICAL: <B>Balancing: </B>cohort study of patients who died following <I>Staphylococcus aureus </I>bacteraemia</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 16:38:57 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Lacroix-2014">
<CHAR_METHODS MODIFIED="2015-07-24 02:13:11 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 20:02:08 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: 30 physicians<BR/>PARTICIPANTS: 271 children with fever (131 intervention, 140 control)<BR/>CLINICAL PROBLEM: fever without source<BR/>SETTING: 1 university hospital in Switzerland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial and physical, decision support lab score derived from PCT, C-reactive protein, and urine dipstick); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental lab score derived from PCT, C-reactive protein, and urine dipstick<BR/>DELIVERER: departmental physicians<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 140 participants taking into account dropouts. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 20:08:59 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>% patients receiving antibiotics</P>
<P>CLINICAL: re-admission and time to clinical resolution</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 20:09:37 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>commercial, bioMérieux for data management, statistical analysis, and loan of the procalcitonin assay. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 20:15:49 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lafaurie-2012">
<CHAR_METHODS MODIFIED="2016-12-06 12:48:44 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: CITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 20:13:20 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients receiving antibiotics<BR/>CLINICAL PROBLEM: use of fluoroquinolones<BR/>SETTING: 1 university hospital in France (intervention) with control data from 700 hospitals in the Coordinating Centres for Nosocomial Infection Control</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 20:14:31 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational meeting with dissemination of guideline; educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>education, enablement, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 20:14:59 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>fluoroquinolone use in DDD/1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 20:15:49 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias:</B> <B>HIGH, </B>case definition Low, planned intervention Low, other infection control <B>High, </B>increase in use of alcohol-based handrub throughout study period</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 20:20:08 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Landgren-1988">
<CHAR_METHODS MODIFIED="2014-11-10 08:45:11 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: CBA</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 20:18:10 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all surgeons at the hospitals<BR/>PARTICIPANTS: all patients with clinical problem<BR/>CLINICAL PROBLEM: patients receiving surgical antibiotic prophylaxis<BR/>SETTING: 12 hospitals in Australia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 20:19:05 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational meetings with dissemination of guidelines; educational outreach by academic detailing; reminders (physical, posters)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>
</P>
<P>DELIVERER: pharmacist<BR/>COMPARISON: 6 hospitals were used as control in year 1, then intervention and control hospitals were crossed over in year 2<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 20:19:57 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice and exposure: </B>appropriate duration and timing of prophylaxis</P>
<P>FINANCIAL: drug cost savings in AUD<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 20:20:08 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Commonwealth Department of Health. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 20:27:20 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Landman-1999">
<CHAR_METHODS MODIFIED="2017-01-05 20:22:56 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 20:23:20 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients requiring antibiotic treatment<BR/>SETTING: university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 20:23:41 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing outcome data. Restriction.</P>
<P>DELIVERER: specialist physician<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 20:25:16 -0500" MODIFIED_BY="[Empty name]">
<P>MICROBIAL: Incidence (new cases per 1000 discharges per month) of ceftazidime-resistant <I>Klebsiella pneumoniae</I>, MRSA, and cefotaxime-resistant <I>Acinetobacter</I> species (ITS data)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 20:27:20 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias MEDIUM: </B>case definition: Low; planned intervention: Low; infection control practices: High. At the start of the intervention, contact precautions were changed to include patients with <I>Clostridium difficile </I>infection.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-LaRosa-2007">
<CHAR_METHODS MODIFIED="2017-01-05 20:28:44 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: unintended consequences, cross-sectional and cohort study</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 20:30:20 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: 15,440 patients (cross-sectional) and 360 patients (cohort)<BR/>CLINICAL PROBLEM: receiving restricted antibiotics<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 20:30:58 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>restrictive by prior approval<BR/>
<B>Intervention Functions: </B>restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-10 00:49:39 -0400" MODIFIED_BY="[Empty name]">
<P>UNINTENDED CONSEQUENCES: delay in ordering of restricted antibiotics</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey">
<P>ROBINS-I RISK OF BIAS CRITERIA:</P>
<P>1. Confounding: Low, confounding of the effect of intervention unlikely in this study</P>
<P>2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome</P>
<P>3. Measurement of interventions: Low, intervention status well defined, recorded at the time of intervention and unaffected by knowledge of the outcome or risk of the outcome</P>
<P>4. Departures from intended interventions: Low, no switches to other interventions or evidence of intervention failure</P>
<P>5. Missing data: Low, outcome data and intervention status complete for both cross-sectional and cohort study</P>
<P>6. Measurement of outcome: Low, outcome measures objective and ascertained from patient administration system</P>
<P>7. Selection of the reported result: Low, single analysis of prespecified outcomes</P>
<P>FINANCIAL SUPPORT: <B>Funding: </B>Centers for Education and Research on Therapeutics grant (U18-HS10399) from the Agency for Healthcare Research and Quality (AHRQ), the Mentored Patient-Oriented Research Career Development Award (K23-AI-060887-01) of the NIH from the National Institute of Allergy and Infectious Diseases, Public Health Service grant (DK-02987-01) of the NIH, and an Improving Patient Safety Through Reduction in Medication Errors grant (P01-HS11530-01) from the AHRQ.</P>
<P>
<B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 20:40:45 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lautenbach-2003">
<CHAR_METHODS MODIFIED="2017-01-05 20:34:40 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 20:34:53 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians at the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: requiring antibiotic treatment<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 20:35:15 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>restrictive by expert approval, not clear if there was also removal<BR/>
<B>Intervention Functions: </B>restriction<BR/>
</P>
<P>DELIVERER: AMT<BR/>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 20:35:27 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>vancomycin use in DDD per 1000 patient days</P>
<P>MICROBIAL: proportion of enterococci resistant to vancomycin<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 20:40:45 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Public Health Service (grant DK-02987-01) of the National Institutes of Health (to EL). This study was also supported in part by an Agency for Healthcare Research and Quality Centers for Education and Research on Therapeutics co-operative agreement (U18-HS10399). <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: authors provided additional prescribing data to enable segmented regression analysis</P>
<P>
<B>Microbial Risk of Bias HIGH: </B>Case definition: Low. Planned intervention: High: unplanned intervention in response to emergence of VRE over the previous 3 years. Other infection control measures: Low</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 20:52:00 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lawes-2012">
<CHAR_METHODS MODIFIED="2015-09-13 03:46:10 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 20:43:28 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: <I>Staphylococcus aureus </I>bacteraemia and use of antibiotics considered to be high risk for <I>Clostridium difficile </I>infection<BR/>SETTING: 1 university hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 20:44:50 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>dissemination of new antibiotic policy 3 months before the structural intervention; restrictive: the new antibiotic policy included requirement for expert approval; structural: introduction of universal screening for MRSA<BR/>
<B>Intervention Functions: </B>education, environmental restructuring, restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 20:52:00 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>no valid data for re-analysis in the paper, but the authors' ARIMA time series analysis includes the effect of the change in antibiotic policy on the microbial outcomes</P>
<P>MICROBIAL: <I>S aureus </I>bacteraemias, MRSA, and MSSA</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 20:50:28 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Scottish government Health Directorate. <B>Competing Interests:</B> IG has received personal and grant financial support from companies manufacturing diagnostics and therapeutics for MRSA. BE has received grant financial support from Novartis. Other authors: none</P>
<P>ADDITIONAL DATA: authors provided additional data</P>
<P>
<B>Microbial Risk of Bias MEDIUM: </B>case definition High, MRSA screening introduced at the same time as change in antibiotic policy, planned intervention Low, other infection control Low for isolation and personal infection control</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Layios-2012">
<CHAR_METHODS MODIFIED="2015-06-21 02:48:59 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 20:54:15 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the ICUs<BR/>PARTICIPANTS: 389 patients in the ICUs for &gt; 48 h and with PCT measured (211 intervention, 178 control)<BR/>CLINICAL PROBLEM: duration of antibiotic treatment<BR/>SETTING: 5 ICUs in 1 university hospital in Belgium</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial and physical, decision support algorithm triggered by PCT test result); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring</P>
<P>DELIVERER: specialist physician (ICU and respiratory)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 250 participants in each group. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 20:55:42 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> antibiotic consumption as % ICU days and DDD/100 OBD</P>
<P>CLINICAL: mortality, length of ICU stay, days on ventilator</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 20:55:52 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 21:01:20 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-1995">
<CHAR_METHODS MODIFIED="2017-01-05 20:58:41 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 20:59:08 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians<BR/>PATIENTS: a total of 480 patients reviewed during study period</P>
<P>CLINICAL PROBLEM: patients receiving ceftriaxone</P>
<P>SETTING: a hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 20:59:56 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of guidelines; reminders (circumstantial and physical, letters sent to physicians when intervention needed plus posters)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 21:01:20 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>grams of ceftriaxone and cefotaxime</P>
<P>FINANCIAL: cost of intervention (0.5 FTE ID physician and savings on drug costs)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-05 02:36:18 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 21:05:01 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-2007">
<CHAR_METHODS MODIFIED="2017-01-05 21:02:29 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 21:02:52 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all staff in the hospital<BR/>PARTICIPANTS: all patients receiving cephalosporins<BR/>CLINICAL PROBLEM: high endemic rate of ESBL infections<BR/>SETTING: 1 university children's hospital in Korea</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 21:03:29 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>enablement, persuasion<BR/>
</P>
<P>DELIVERER: specialist physicians (paediatric ID)</P>
<P>COMPARISON: pre-intervention</P>
<P>DESIRED CHANGE: decrease in use of extended-spectrum cephalosporins to reduce ESBL infections</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 21:04:12 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> days on target antibiotics/1000 OBD</P>
<P>MICROBIAL: ESBL strains as % total isolates<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 21:05:01 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Wyeth Research. <B>Competing Interests:</B> none declared.</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias LOW: </B>case definition yes, planned intervention yes, stable ESBL for 3 years pre-intervention, other infection control yes</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 21:09:43 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-2014">
<CHAR_METHODS MODIFIED="2015-06-16 01:26:32 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 21:07:21 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the units<BR/>PARTICIPANTS: all patients in the units<BR/>CLINICAL PROBLEM: requiring therapeutic antibiotics<BR/>SETTING: internal medicine (2 units) at 1 university hospital in Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 21:09:12 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational meetings (monthly with residents) with dissemination of educational materials<BR/>
<B>Intervention Functions: </B>education, enablement, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 21:09:26 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>DDD/1000 OBD of target antibiotics</P>
<P>FINANCIAL: intervention cost and savings (cost of all antibiotics)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 21:09:43 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: authors provided additional data about the intervention and for the meta-regression</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Lesprit-2013">
<CHAR_METHODS MODIFIED="2015-07-25 01:55:57 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 21:11:03 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in medical and surgical wards<BR/>PARTICIPANTS: 753 patients receiving antibiotics (376 intervention, 377 control)<BR/>CLINICAL PROBLEM: duration of treatment in patients receiving 1 of the targeted antibiotics for at least 3 days<BR/>SETTING: 1 university hospital in France</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Intervention: </B>educational outreach by review and recommend change</P>
<P>
<B>Intervention Functions: </B>enablement, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 253 participants in each group. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 21:12:40 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>duration of all antibiotic treatment</P>
<P>CLINICAL: <B>Balancing: </B>mortality, ICU admission, new course of antibiotic treatment, length of stay</P>
<P>FINANCIAL: intervention cost and savings (supplementary file)</P>
<P>MICROBIAL: secondary infection and/or colonisation with multidrug-resistant bacteria in the 6 months following randomisation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 21:13:34 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT:<B> Funding:</B> none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: supplementary file online with data about financial and microbial outcomes, no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias:</B> case defintion low, planned intervention low, other infection control <B>unclear</B>, no information</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 21:19:18 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<CHAR_METHODS MODIFIED="2017-01-05 21:16:31 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 21:18:44 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: Departments of Neurology and Neurosurgery</P>
<P>PARTICIPANTS: all patients in the departments<BR/>CLINICAL PROBLEM: colonisation with gentamicin-resistant <I>Enterobacteriaceae</I>
<BR/>SETTING: 1 858-bed university hospital in the Netherlands</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 21:18:59 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing data, restriction by expert approval and removal</P>
<P>DELIVERER: specialist physician</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 21:19:18 -0500" MODIFIED_BY="[Empty name]">
<P>MICROBIAL: prevalence of gentamicin-resistant <I>Enterobacteriaceae</I> in weekly screening stool swabs<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-05 02:48:01 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 21:27:35 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liebowitz-2008">
<CHAR_METHODS MODIFIED="2016-12-06 12:50:12 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 21:25:54 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital</P>
<P>CLINICAL PROBLEM: incidences of MRSA</P>
<P>SETTING: 1 general hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 21:26:45 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>educational meetings with dissemination of guideline; reminders, verbal on rounds</P>
<P>
<B>Intervention Function: </B>education, persuasion</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: reduce inappropriate</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 21:27:17 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>DDDs per 1000 OBD each month</P>
<P>MICROBIAL: Episodes of MRSA blood isolates per 1000 OBD each month</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 21:27:35 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> unrestricted educational grant from Wyeth. <B>Competing Interests:</B> LDL received honoraria for lectures from Bayer and Bard.</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial ROB HIGH; </B>case definition Low, planned intervention Low, other infection control High, no information about infection control other than screening for MRSA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Linkin-2007">
<CHAR_METHODS MODIFIED="2015-10-13 05:56:55 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: unintended consequences, cohort study</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 21:31:20 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: 200 patients<BR/>CLINICAL PROBLEM: requests for restricted antibiotic to the Antimicrobial Stewardship Program<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 21:32:07 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>restrictive<BR/>
<B>Intervention Functions: </B>restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: patients with appropriate vs inappropriate requests<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 21:32:53 -0500" MODIFIED_BY="[Empty name]">
<P>UNINTENDED CONSEQUENCES: accuracy of laboratory and clinical information provided in calls to the Antimicrobial Stewardship Program</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey">
<P>ROBINS-I RISK OF BIAS CRITERIA:</P>
<P>1. Confounding: Low, the effects of inaccurate communication and each of the potential confounders on the risk of inappropriate antimicrobial recommendations were evaluated in bivariable analyses</P>
<P>2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome</P>
<P>3. Measurement of interventions: Low, antimicrobial recommendations were evaluated for appropriateness by a 3-person panel of infectious diseases experts blinded to the accuracy of information communicated during the Antimicrobial Stewardship Program call</P>
<P>4. Departures from intended interventions: Low, no switches to other interventions or evidence of intervention failure</P>
<P>5. Missing data: High, panelists could not agree on appropriateness of treatment for 37 patients. Outcome data complete for the 163 included patients</P>
<P>6. Measurement of outcome: Low, outcome measures objective and ascertained from patient administration system</P>
<P>7. Selection of the reported result: High, multiple secondary analyses were performed using the main study outcome</P>
<P>FINANCIAL SUPPORT: <B>Funding:</B> National Institutes of Health, Agency for Healthcare Research and Quality, and University of Pennsylvania. <B>Competing Interests:</B> none declared.</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-05 21:45:08 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2013">
<CHAR_METHODS MODIFIED="2015-04-04 00:53:45 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 21:43:25 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: Department of Emergency Medicine, ICU staff</P>
<P>PARTICIPANTS: adults (age &gt; 18) with sepsis<BR/>CLINICAL PROBLEM: sepsis without 7 exclusion criteria (cultures positive with <I>Pseudomonas aeruginosa</I>,<I> Acinetobacter baumannii</I>,<I> Mycobacterium tuberculosis </I>or any fungi, viral or parasitic infection, chronic localised inflammation, antibacterial therapy for &gt; 48 h, immunosuppression, cancer, or refusal to consent)<BR/>SETTING: ICU in 1 university hospital in China</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-05 21:44:35 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial, decision support algorithm triggered by measurement of PCT); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring<BR/>
</P>
<P>DELIVERER: specialist physician</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: no information</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 21:45:08 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>duration of all antibiotic treatment</P>
<P>CLINICAL: <B>Balancing: </B>28-day mortality, length of hospital stay, length of ICU stay, recurrence within 28 days<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-15 00:24:53 -0400" MODIFIED_BY="[Empty name]">
<P>Translated from Chinese</P>
<P>FUNDING: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Long-2014">
<CHAR_METHODS MODIFIED="2015-07-26 00:20:02 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-05 21:51:13 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians<BR/>PARTICIPANTS: 216 consecutive patients hospitalised with exacerbations of acute asthma<BR/>CLINICAL PROBLEM: antibiotic treatment of acute asthma<BR/>SETTING: 1 university hospital in China</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial, decision support algorithm triggered by measurement of PCT); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring</P>
<P>DELIVERER: departmental physicians (Internal and Geriatric Medicine)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 90 participants per group. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-05 21:53:44 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> % treated with antibiotics</P>
<P>CLINICAL: <B>Balancing:</B> length of hospital stay; clinical, laboratory, and spirometry outcomes at discharge; and results of spirometry at the 12-month follow-up examination, as well as the results of the Asthma Control Test</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-05 21:53:58 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Shanghai Fifth People&#8217;s Hospital Science Foundation and Minhang District Natural Science Foundation of Shanghai. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 16:41:41 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<CHAR_METHODS MODIFIED="2014-11-20 06:38:47 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 16:37:28 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all prescribers and staff</P>
<P>PATIENTS: all inpatients</P>
<P>CLINICAL PROBLEM: patients receiving antibiotic treatment and patients with MRSA infections</P>
<P>SETTING: university-affiliated veterans hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 16:38:21 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings, in-service training sessions with dissemination of guideline; reminders (circumstantial, electronic, triggered by prescribing target drugs)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 16:38:52 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> change in use of levofloxacin, ciprofloxacin, and other antibiotics</P>
<P>MICROBIAL: MRSA infection rate (number/1000 OBD)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 16:41:41 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: This article is the result of work supported with resources and the use of facilities at the Boise Veterans Affairs Medical Center, and is partially funded by an unrestricted educational grant from Wyeth Pharmaceuticals. <B>Conflict of interest:</B> no information</P>
<P>ADDITIONAL DATA: email response from authors but no additional data</P>
<P>
<B>Microbial ROB: MEDIUM. </B>Case definition Low, Planned intervention Low, Other infection control High, prescribing intervention coincident with infection control interventions</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 16:51:03 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Magedanz-2012">
<CHAR_METHODS MODIFIED="2015-06-03 01:40:14 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 16:49:05 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians in the hospital<BR/>PARTICIPANTS: all patients in hospital</P>
<P>CLINICAL PROBLEM: antibiotic use in cardiology hospital, primary target fluorquinolone use</P>
<P>SETTING: 1 cardiology hospital in Brazil</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 16:50:22 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>enablement, persuasion</P>
<P>DELIVERER: Intervention 1 ID physician (2 h per day), Intervention 2 AMT (physician plus pharmacist, 4 h per day)</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: reduce inappropriate</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 16:50:47 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>monthly consumption (DDDs/100 OBD) of antibiotics, primary target fluoroquinolones</P>
<P>FINANCIAL: hours of time to implement the intervention</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 16:51:03 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 16:53:43 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<CHAR_METHODS MODIFIED="2015-07-26 00:44:40 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 16:52:04 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in cardiac surgery<BR/>PARTICIPANTS: 205 patients undergoing cardiac surgery<BR/>CLINICAL PROBLEM: antibiotic treatment after surgery<BR/>SETTING: 1 university hospital in Serbia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 16:53:20 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial, decision support algorithm triggered by measurement of PCT); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring<BR/>DELIVERER: departmental physicians (ICU and cardiology)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: unclear, target effect size decrease from 45% of antibiotic use in the standard group to 22% in the procalcitonin group, but no data about sample size</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 16:53:43 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>% treated with antibiotics</P>
<P>CLINICAL: ICU stays, hospital stay, rehospitalisation, incidence of infections, severe non-infection complications, and mortality rate with 1-year follow-up</P>
<P>FINANCIAL: cost of antibiotics and PCT tests</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-07-26 00:37:53 -0400" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information provided</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 16:57:06 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marwick-2013">
<CHAR_METHODS MODIFIED="2015-07-29 01:09:54 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 16:55:27 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in medical and surgical wards<BR/>PARTICIPANTS: all patients in medical and surgical wards<BR/>CLINICAL PROBLEM: suspected sepsis (systemic inflammatory response and clinical suspicion of infection)<BR/>SETTING: 1 university hospital in Scotland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 16:56:11 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational meetings with dissemination of guidelines; reminders (physical, posters in the wards and monthly email to doctors)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 16:56:31 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>time to first antibiotic dose</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 16:57:06 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Scottish Government Chief Scientist Office (CSO) Clinical Academic Training Fellowship (CAF/07/06). <B>Competing Interests:</B> salary costs for 2 investigators from CSO, no others declared</P>
<P>ADDITIONAL DATA: email response from authors to request for additional data with additional detail from a PhD thesis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 17:04:40 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Masia-2008">
<CHAR_METHODS MODIFIED="2015-07-29 01:44:59 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 17:01:23 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: 278 patients receiving antibiotics, 146 intervention, 132 control<BR/>CLINICAL PROBLEM: prescription of target antibiotics<BR/>SETTING: 1 university hospital in Spain</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 17:04:15 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>education, enablement<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 140 participants in each group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 17:04:36 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of target drugs in DDD</P>
<P>CLINICAL: length of stay, mortality, re-admissions</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 17:04:40 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 17:10:04 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-May-2000">
<CHAR_METHODS MODIFIED="2016-12-06 12:51:04 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: Controlled ITS</P>
<P>
<B>Risk of bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 17:07:15 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: staff of Trauma &amp; Burns ICU (TBICU), Medical ICU (MICU), and Surgical ICU (SICU)<BR/>PATIENTS: all patients in these ICUs</P>
<P>CLINICAL PROBLEM: adults needing intensive care</P>
<P>SETTING: single &gt; 500-bed university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 17:08:09 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>dissemination of guideline</P>
<P>
<B>Intervention Function: </B>education</P>
<P>DELIVERER: department physician</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 17:09:03 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of vancomycin, 3rd-generation cephalosporins, and piperacillin tazobactam per 1000 patient days</P>
<P>MICROBIAL: MRSA infections and VRE infections per 1000 patient days</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 17:10:04 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial ROB HIGH: </B>Case definition: Low. Planned intervention: High for intervention ward (response to increasing VRE in previous 2 years). However, steady increase not an outbreak and VRE data presented for other wards with no intervention. Other infection control: High, no information about isolation or infection control practices before or after the intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 17:13:41 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McElnay-1995">
<CHAR_METHODS MODIFIED="2014-12-10 10:34:18 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 17:12:09 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital<BR/>PARTICIPANTS: all patients in hospital<BR/>CLINICAL PROBLEM: all patients receiving antibiotics<BR/>SETTING: 370-bed District General Hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 17:13:20 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings and dissemination of new antibiotic policy; educational outreach by academic detailing, "education of junior medical staff on the rationale behind the antibiotic selection was also carried out by clinical pharmacists" (p208); restrictive by compulsory order form and removal<BR/>
<B>Intervention Functions: </B>education, persuasion, restriction<BR/>
</P>
<P>DELIVERER: department physician<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 17:13:41 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>dosage units of target antibiotic</P>
<P>FINANCIAL: expenditure on antibiotics<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 00:06:58 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 17:17:04 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McGowan-1976">
<CHAR_METHODS MODIFIED="2014-12-10 11:43:30 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 17:15:19 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients requiring antibiotic treatment<BR/>SETTING: single university hospital in USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 17:15:43 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>restrictive by expert approval and probably by review and make change</P>
<P>
<B>Intervention Function: </B>restriction</P>
<P>DELIVERER: specialist physician</P>
<P>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 17:16:29 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> grams of chloramphenicol (thousands), data are also presented for other drugs (ampicillin, nafcillin, and cloxacillin)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 17:17:04 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>grants 5R01-A1-23, 2T01-AJ-08, and IT01-Ai-447 from the National Institute of Allergy and Infectious Diseases. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 17:20:32 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McLaughlin-2005">
<CHAR_METHODS MODIFIED="2017-01-06 17:18:07 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH </B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 17:18:55 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: staff from 12 medical wards<BR/>PATIENTS: all patients in the wards</P>
<P>CLINICAL PROBLEM: adults requiring IV antibiotic therapy</P>
<P>SETTING: single university hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 17:20:19 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of protocol for IV to oral switch; educational outreach by academic detailing; reminders (circumstantial, sticker in charts of patients receiving IV antibiotics and physical, posters in wards and at nursing stations)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: modification of existing management (faster switch from IV to oral administration of antibiotics)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 17:20:22 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> appropriateness of timing of IV to oral switch</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 17:20:32 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Greater Glasgow Health Board. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: authors provided additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 17:27:42 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McNulty-1997">
<CHAR_METHODS MODIFIED="2014-12-12 06:05:14 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 17:22:57 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the elderly care unit<BR/>PARTICIPANTS: all patients in the elderly care unit<BR/>CLINICAL PROBLEM: <I>Clostridium difficile</I> in the elderly care unit<BR/>SETTING: elderly care unit in 1 District General Hospital (non-teaching) in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 17:24:23 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>dissemination of new antibiotic policy; restrictive by removal and by review and make change<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion, restriction<BR/>
</P>
<P>DELIVERER: pharmacist<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 17:25:04 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>monthly cost of cefuroxime (ITS data)</P>
<P>MICROBIAL: cases of CDI per month (ITS data)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 17:27:42 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial ROB HIGH: </B>Case definition: Low, CDI, definition unchanged during the study periods. Unplanned intervention: High, antibiotic restriction was implemented in response to increasing cases of CDI in the preceding 7 months despite increased infection control. Other infection control measures: High, changes to environmental cleaning and reminders about hand hygiene implemented 3 months before the start of intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 17:32:12 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mercer-1999">
<CHAR_METHODS MODIFIED="2014-12-15 11:51:43 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 17:29:53 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians<BR/>PARTICIPANTS: all patients with clinical problem<BR/>CLINICAL PROBLEM: patients receiving ceftriaxone<BR/>SETTING: a 360-bed community hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 17:31:55 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>dissemination of guidelines; educational outreach by academic detailing; educational outreach by review and recommend change; reminders (physical, posters in clinical areas); restrictive by compulsory order form, expert approval required, removal and review and make change<BR/>
<B>Intervention Functions: </B>education, environmental restructuring, restriction<BR/>
</P>
<P>DELIVERER: specialist physician (ID)</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: reduction in established management (reduction in antibiotic costs)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 17:32:12 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>cost of antibiotics (USD) as an indicator of use</P>
<P>COSTS: cost of antibiotics<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 00:08:35 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 03:11:03 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Meyer-1993">
<CHAR_METHODS MODIFIED="2015-09-15 23:47:06 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 17:33:17 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients receiving antibiotics<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 17:33:54 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>restrictive by expert approval required<BR/>
<B>Intervention Functions: </B>restriction<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-15 03:11:03 -0500" MODIFIED_BY="Petrer Davey">
<P>PRESCRIBING: <B>Choice: </B>use of ceftazidime, imipenem, and ceftriaxone reported as number of approvals for these drugs</P>
<P>MICROBIAL: incidence of ceftazidime-resistant <I>Klebsiella pneumoniae</I> as the rate per 1000 average daily census<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 17:35:03 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>BMA Medical Foundation. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial ROB: HIGH</B> Case definition Low, Unplanned intervention High, Other infection control High</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 17:44:59 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meyer-2007">
<CHAR_METHODS MODIFIED="2015-09-15 23:58:05 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 17:40:36 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians in the neurosurgical ICU<BR/>PARTICIPANTS: patients with pneumonia</P>
<P>CLINICAL PROBLEM: antibiotic treatment for pneumonia in neurosurgical ICU</P>
<P>SETTING: neurosurgical ICU in 1 hospital in Germany</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 17:43:44 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meeting with neurosurgeons and dissemination of guideline<BR/>
<B>Intervention Functions: </B>education<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive, in the new guideline the duration of antibiotic therapy for nosocomial pneumonia was reduced from 14 to 7 days, while for community-acquired pneumonia the period fell from 10 to 5 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 17:44:41 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>total antibiotic use and cost/1000 OBD</P>
<P>FINANCIAL: changes in total antibiotic cost</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 17:44:59 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 17:49:35 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meyer-2009">
<CHAR_METHODS MODIFIED="2017-01-06 17:46:29 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 17:47:13 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all patients in an adult surgical ICU<BR/>PARTICIPANTS: all staff in the ICU<BR/>CLINICAL PROBLEM: use of 3rd-generation cephalosporins for treatment and prophylaxis of specific infections plus duration of prophylaxis for fractures<BR/>SETTING: 1 surgical ICU in a teaching hospital in Germany</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 17:47:40 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>dissemination of guidelines and educational meetings in departments of surgery and anaesthesiology<BR/>
<B>Intervention Functions: </B>education</P>
<P>DELIVERER: multidisciplinary AMT</P>
<P>COMPARISON: pre-intervention outcomes</P>
<P>DESIRED CHANGE: reduction in use of cephalosporins and resistance in gram-negative bacteria</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 17:48:14 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of cephalosporins in DDD/1000 OBD</P>
<P>MICROBIAL: resistance to cephalosporins and piperacillin in gram-negative bacteria isolated from clinical and surveillance cultures<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 17:49:35 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Federal Ministry of Education and Research (01Kl 9907). <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial ROB: HIGH</B> Case definition Low; Planned intervention Low; Other infection control Unclear, no clear information about isolation or personal-protection policies</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 17:55:35 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meyer-2010">
<CHAR_METHODS MODIFIED="2015-09-16 00:27:50 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 17:51:54 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the ICU<BR/>PARTICIPANTS: all patients with clinical problem</P>
<P>CLINICAL PROBLEM: reducing length of antibiotic prophylaxis for cerebrospinal shunts</P>
<P>SETTING: ICU department in 1 teaching hospital in Germany</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 17:55:15 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>educational meeting and dissemination of new policy. In autumn 2003, a comprehensive teaching session on antibiotic prophylaxis in cerebrospinal shunts was organised by the infection control and neurosurgery teams. This resulted in a revised recommendation of single-shot prophylaxis with cefuroxime for shunt catheters, beginning in January 2004. Prior to implementation of this recommendation, cefuroxime was administered for the whole duration of external cerebrospinal fluid drainage, which could be up to 2 to 3 weeks.</P>
<P>
<B>Intervention Functions: </B>education, persuasion</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive, shorten duration of prophylaxis</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 17:55:20 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> total antibiotic use in DDD/1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 17:55:35 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Federal Ministry of Education and Research (01Kl 9907). <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 18:00:42 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Micek-2004">
<CHAR_METHODS MODIFIED="2015-01-06 07:10:28 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 17:58:31 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: ICU physicians</P>
<P>PATIENTS: 302 adults in the ICU (154 intervention, 148 control)</P>
<P>CLINICAL PROBLEM: VAP requiring antibiotics</P>
<P>SETTING: single ICU in a teaching hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 18:00:06 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>enablement, persuasion</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: no information</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-12-07 01:33:47 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>duration of all antibiotic therapy</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 18:00:42 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>part commercial, Barnes-Jewish Hospital Foundation and an unrestricted grant from Elan Pharmaceuticals. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 18:08:57 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mittal-2014">
<CHAR_METHODS MODIFIED="2015-07-30 00:25:03 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 18:04:46 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the Department of Paediatrics<BR/>PARTICIPANTS: all children &lt; 2 years old with bronchiolitis<BR/>CLINICAL PROBLEM: antibiotic use as part of a new Clinical Practice Guideline to improve management of bronchiolitis<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 18:08:14 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback, educational meeting with dissemination of guideline; reminders (verbal (on rounds, so may have been circumstantial) and physical (pocket-size guideline, screensavers))<BR/>
<B>Intervention Functions: </B>education, enablement, persuasion<BR/>DELIVERER: departmental physicians (paediatrics and respiratory)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 18:08:29 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> % treated with antibiotics</P>
<P>CLINICAL: length of stay, re-admission</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 18:08:57 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>no external. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 18:14:53 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mol-2005">
<CHAR_METHODS MODIFIED="2017-01-06 18:10:53 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 18:11:29 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians in the Department of Internal Medicine<BR/>PATIENTS: all patients in the wards</P>
<P>CLINICAL PROBLEM: receiving antibiotic therapy</P>
<P>SETTING: 1 university hospital in the Netherlands</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 18:14:29 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>1st Intervention: </B>audit and feedback; educational meetings with dissemination of guideline<BR/>
<B>1st Intervention Functions: </B>education, enablement<BR/>
<B>2nd Intervention: </B>audit and feedback; educational meetings with dissemination of guideline; educational outreach by academic detailing</P>
<P>
<B>2nd Intervention Functions: </B>education, enablement, persuasion<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 18:14:45 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> % compliance with guideline; antibiotic cost</P>
<P>FINANCIAL: antibiotic cost</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 18:14:53 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 20:22:44 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Newland-2012">
<CHAR_METHODS MODIFIED="2015-03-30 01:01:10 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: CITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 20:16:07 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital<BR/>PARTICIPANTS: all patients in children's hospital<BR/>CLINICAL PROBLEM: inappropriate use of antimicrobials; a group of broad-spectrum, or &#8220;select&#8221;, antibiotics 2 calendar days after they were initiated by the clinician<BR/>SETTING: 1 children's hospital in the USA (intervention) with data from 25 similar hospitals of the Child Health Corporation of America as control</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 20:20:55 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change.</P>
<P>NB the authors describe their intervention as "audit and feedback", but there was no feedback of data over time about progress to goal, just review with feedback about individual patients<BR/>
<B>Intervention Functions: </B>enablement, persuasion<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 20:22:03 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>total antibiotic use (days of therapy/1000 patient days)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 20:22:44 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Agency for Healtcare Quality and Reseach (grant U18-HS10399). <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: authors provided additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 10:20:49 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Nobre-2008">
<CHAR_METHODS MODIFIED="2015-07-30 02:08:22 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 20:24:45 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the ICU<BR/>PARTICIPANTS: 282 patients with suspected sepsis, 79 randomised (39 intervention, 40 control)<BR/>CLINICAL PROBLEM: duration of antibiotic treatment in patients with sepsis<BR/>SETTING: 1 ICU in 1 university hospital in Switzerland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial, decision support algorithm with each PCT test); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring<BR/>DELIVERER: departmental physician (ICU)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, a total of at least 66 participants. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 20:26:59 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>duration of treatment in days</P>
<P>CLINICAL: <B>Balancing: </B>mortality, relapse of infection, length of ICU stay, length of hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-18 10:20:49 -0500" MODIFIED_BY="Julia Worswick">
<P>FINANCIAL SUPPORT: <B>Funding:</B> commercial B.R.A.H.M.S AG (USD 50,000). <B>Competing Interests:</B> 2 authors received speaker honoraria from B.R.A.H.M.S AG.</P>
<P>ADDITIONAL DATA: online supplementary file with addtional infromation about stopping rules in PCT group. No response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 20:37:58 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nuila-2008">
<CHAR_METHODS MODIFIED="2015-09-17 01:00:31 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 20:35:21 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in hospital<BR/>PARTICIPANTS: all patients receiving antibiotics</P>
<P>CLINICAL PROBLEM: reduce cases of <I>Clostridium difficile</I>-associated disease in hospital by restricting use of parenteral antibiotics</P>
<P>SETTING: 1 teaching hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 20:35:47 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing data. Restriction and educational outreach - review and recommend change</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: reduce inappropriate</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 20:37:06 -0500" MODIFIED_BY="[Empty name]">
<P>MICROBIAL: incidence of <I>Clostridium difficile</I>-associated disease</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 20:37:58 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Merit Review Funding and Department of Veterans Affairs. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: email from authors but no additional data</P>
<P>
<B>Microbial ROB: MEDIUM: </B>Case definition Low, Planned intervention Low, Other infection control High</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Oliveira-2013">
<CHAR_METHODS MODIFIED="2015-07-30 01:35:59 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 20:40:51 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians<BR/>PARTICIPANTS: 355 ICU patients assessed for inclusion, 94 patients randomised<BR/>CLINICAL PROBLEM: 94 patients with suspected sepsis randomised (49 intervention, 45 control)<BR/>SETTING: 1 university hospital ICU in Brazil</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial, decision support algorithm with each PCT test); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring<BR/>DELIVERER: specialist physician (Infectious Diseases)<BR/>COMPARISON: usual care, patients monitored with C-reactive protein<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 58 participants per group. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 20:42:54 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>duration of treatment in days</P>
<P>CLINICAL: mortality, recurrence of infection, ICU length of stay, hospital length of stay, nosocomial infection</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 20:44:09 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Minas Gerais Research Foundation (Fundação de Amparo à Pesquisa do Estado de Minas Gerais). <B>Competing Interests:</B> 1 author received payment for lectures from bioMérieux. No others declared.</P>
<P>ADDITIONAL DATA: online Microsoft Word document with additional information about the criteria for stopping antibiotics, no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Oosterheert-2005">
<CHAR_METHODS MODIFIED="2015-01-07 08:58:50 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 20:48:53 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: hospital physicians</P>
<P>PATIENTS: inpatients with LRTI, 107 randomised (55 intervention, 52 control)</P>
<P>CLINICAL PROBLEM: admitted to hospital for treatment of LRTI</P>
<P>SETTING: 2 Dutch hospitals</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>educational meetings; dissemination of written information about study procedures, test characteristics discussed and results from previous studies; structural, rapid laboratory testing (PCR) for viral and atypical bacterial pathogens<BR/>
<B>Intervention Functions: </B>education, environmental restructuring</P>
<P>DELIVERER: specialist physician (Medical Microbiology)</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, a total of 100 patients. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 20:55:22 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>% patients treated</P>
<P>CLINICAL: mortality, median duration of antibiotic treatment</P>
<P>FINANCIAL: cost of hospitalisation, all diagnostic and treatment costs</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 20:55:46 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Association of Academic Hospitals and the Dutch Health Insurance Council (grant 01233). <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 21:02:06 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ostrowsky-2014">
<CHAR_METHODS MODIFIED="2015-08-01 01:13:47 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: CITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 20:57:59 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospitals<BR/>PARTICIPANTS: all patients in the hospitals<BR/>CLINICAL PROBLEM: reduce use of antibiotics considered high risk for <I>Clostridium</I> <I>difficile </I>infection<BR/>SETTING: 10 hospitals in the USA, 6 intervention and 4 control</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 21:00:45 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings (6 hospitals), dissemination of algorithms (3 hospitals), educational outreach by review and recommend change (2 hospitals), restrictive automatic stop order (1 hospital), unspecified "hospital wide restriction" (3 hospitals).</P>
<P>NB the authors describe the intervention in 2 hospitals as "audit and feedback", but there was no feedback of data over time about progress to goal, just review with feedback about individual patients.</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion, restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive. Each intervention hospital did a case control study to identify high-risk antibiotics; these were piperacillin tazobactam (6 hospitals), fluoroquinolones (5 hospitals), or cefepime (2 hospitals).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 21:01:10 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of target antibiotics in DDD/1000 OBD and in days of therapy</P>
<P>MICROBIAL: <I>C difficile </I>infection (cases per 10,000 OBD)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 21:02:06 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Agency for Healthcare Research and Quality; US Department of Health and Human Services. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: email response from authors with additional data about the intervention used by each of the 6 intervention hospitals</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 13:43:09 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Ozkaya-2009">
<CHAR_METHODS MODIFIED="2017-01-18 13:43:09 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: NRT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 21:05:26 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all staff in the ED<BR/>PARTICIPANTS: all children with influenza-like illness<BR/>CLINICAL PROBLEM: reduction in antibiotic prescribing for influenza<BR/>SETTING: 1 university hospital in Turkey</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 21:06:18 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>structural, rapid laboratory test for influenza</P>
<P>
<B>Intervention Function: </B>environmental restructuring<BR/>DELIVERER: specialist physicians, Department of Paediatrics<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 21:06:23 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>% children prescribed antibiotics</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 00:28:21 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: email response from authors but no additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 13:35:52 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Palmay-2014">
<CHAR_METHODS MODIFIED="2017-01-06 21:10:12 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: cluster RCT, stepped wedge, service level</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 21:12:39 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in 6 hospital services<BR/>PARTICIPANTS: all patients in 6 hospital services, 6 clusters (services)<BR/>CLINICAL PROBLEM: use of targeted antibiotics (carbapenems (ertapenem, meropenem), piperacillin-tazobactam, 3rd-generation cephalosporins (ceftazidime, ceftriaxone), fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin), and intravenous vancomycin)<BR/>SETTING: 1 university hospital in Canada, 6 services: Neurosurgery, Orthopaedics, Nephrology, General Internal Medicine, Cardiology, General Surgery/Trauma</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 21:14:53 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change; reminders (circumstantial, physical, written recommendation on each patient reviewed)</P>
<P>NB the authors describe their intervention as "audit and feedback", but there was no feedback of data over time about progress to goal, just review with feedback about individual patients.<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: no information</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-18 13:35:52 -0500" MODIFIED_BY="Julia Worswick">
<P>PRESCRIBING: <B>Choice:</B> use of target antibiotics in days of therapy/1000 OBD</P>
<P>MICROBIAL: <I>Clostridium difficile </I>infection and infection with antibiotic-resistant organisms</P>
<P>FINANCIAL: time required to implement the intervention in critical-care wards is described in <LINK REF="REF-Elligson-2012a" TYPE="REFERENCE">Elligson 2012a</LINK>.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-18 13:35:52 -0500" MODIFIED_BY="Julia Worswick">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Ontario Ministry of Health and Canadian Institutes of Health Research. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: email response with additional details about the intervention from authors including <LINK REF="REF-Elligson-2012a" TYPE="REFERENCE">Elligson 2012a</LINK> describing the design and cost of implementing the intervention in critical-care wards</P>
<P>
<B>Microbial Risk of Bias:</B> <B>MEDIUM: </B>case definition low, unplanned intervention low, other infection control <B>UNCLEAR</B>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 21:22:22 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Parienti-2011">
<CHAR_METHODS MODIFIED="2015-08-02 01:02:15 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 21:21:28 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients receiving antibiotics in the hospital<BR/>CLINICAL PROBLEM: use of fluoroquinolones; the aim of the study was to assess the effect of removing restriction<BR/>SETTING: 1 university hospital in France</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 21:22:04 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no reliable prescribing data. The intervention was removal of restriction, but only 1 prescribing outcome data point during restriction and 3 after restriction lifted.<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-09-17 01:41:01 -0400" MODIFIED_BY="[Empty name]">
<P>MICROBIAL: monthly MRSA rate (%)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 21:22:22 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT:<B> Funding: </B>Centre Hospitalier Universitaire de Caen and the French Health Ministry (Programme Hospitalier de Recherche Clinique National). <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 21:49:22 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Parikh-2014">
<CHAR_METHODS MODIFIED="2015-08-02 01:17:08 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 21:47:30 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all paediatric physicians in the hospitals<BR/>PARTICIPANTS: children aged 28 days to 2 years<BR/>CLINICAL PROBLEM: antibiotic use in children with a primary diagnosis of acute bronchiolitis<BR/>SETTING: 41 hospitals in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 21:49:22 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>publication of American Academy of Pediatricians (AAP) bronchiolitis guidelines</P>
<P>
<B>Intervention Functions: </B>education but no information about how the guidelines were disseminated<BR/>DELIVERER: departmental physicians (Pediatrics)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 21:48:43 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> % children treated with antibiotics</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 21:49:13 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Academic Pediatric Association. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data. AAP 2006 Bronchiolitis Guidelines downloaded.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 21:54:00 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Patel-1989">
<CHAR_METHODS MODIFIED="2015-01-07 10:11:56 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 21:52:04 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients requiring antibiotic treatment<BR/>SETTING: single hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 21:53:26 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of guidelines; educational outreach by review and recommend change; reminders (physical and verbal, posters and intervention promoted at weekly ward meetings)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion</P>
<P>DELIVERER: pharmacist<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 21:54:00 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>expenditure on oral co-amoxiclav<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 00:33:52 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Paul-2006">
<CHAR_METHODS MODIFIED="2017-01-06 21:55:38 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: cluster RCT, service level</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 21:58:10 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PATIENTS: all patients in the 3 hospitals (intervention 8 wards with 1245 patients, 297 with microbiologically documented infections; control 7 wards with 1081 patients, 273 with microbiologically documented infections), 15 clusters (wards)</P>
<P>CLINICAL PROBLEM: antibiotic prescribing</P>
<P>SETTING: 3 hospitals in 3 countries: Israel, Germany, and Italy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Intervention: </B>reminders (circumstantial, triggered by prescription of antibiotics); structural, computer decision support system</P>
<P>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 1500 patients with microbiologically documented infections. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 21:59:42 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>appropriate antibiotic treatments</P>
<P>COST: Costs, which included the estimated ecological cost of inappropriate antibiotic treatment</P>
<P>CLINICAL: <B>Balancing: </B>length of stay, 30-day mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 22:01:17 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> EU Fifth Framework, Information Society Technologies, IST-9999-11459. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 22:06:45 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pear-1994">
<CHAR_METHODS MODIFIED="2015-01-07 11:49:21 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 22:06:06 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients requiring antibiotic treatment<BR/>SETTING: single university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 22:06:18 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: restrictive, no valid prescribing data</P>
<P>DELIVERER: specialist physician<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 22:06:45 -0500" MODIFIED_BY="[Empty name]">
<P>MICROBIAL: cases of CDAD per month (ITS data). Prevalence of clindamycin-resistant <I>Clostridium difficile</I>
<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 00:37:47 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: none</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 22:17:24 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perez-2003">
<CHAR_METHODS MODIFIED="2015-01-08 07:10:37 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW </B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 22:11:57 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians, surgeons, paediatricians, obstetricians-gynaecologists, and intensivists<BR/>PARTICIPANTS: adults and children with normal renal function<BR/>CLINICAL PROBLEM: inappropriate prescribing of antibiotics (specifically in relation to intervals between doses of aminoglycosides and 1st- and 3rd-generation cephalosporins for Intervention 1 and timing of surgical prophylaxis for Intervention 2)<BR/>SETTING: university hospital in Colombia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 22:15:51 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>
<I>Intervention 1</I>: reminders (posters, not circumstantial); educational meetings and dissemination of guidelines; restrictive by expert approval. <I>Intervention 2</I>: reminder (circumstantial, on blood pressure cuffs in operating theatre); educational meetings and dissemination of guidelines</P>
<P>
<B>Intervention Functions: </B>
<I>Intervention 1: </I>education, environmental restructuring, persuasion. <I>Intervention 2: </I>education, enablement, environmental restructuring, persuasion</P>
<P>DELIVERER: pharmacists<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: Intervention 1: increase effective; Intervention 2: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-12-07 01:38:03 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>reduction in incidence of incorrect antibiotic prescriptions (dosing intervals and timing of surgical prophylaxis).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 22:17:24 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> International Clinical Epidemiology Network (INCLEN, grant #1004-97-6501) and by Pontificia Universidad Javeriana (grant #12-24-01- 31). <B>Competing Interests:</B> no information</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 22:25:01 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Peto-2008">
<CHAR_METHODS MODIFIED="2015-09-29 01:41:07 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 22:20:47 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the surgical ICU<BR/>PARTICIPANTS: adult patients in surgical ICU (excluding general surgical and medical)</P>
<P>CLINICAL PROBLEM: excessive antibiotic use</P>
<P>SETTING: surgical ICU in a university hospital in Hungary</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 22:25:01 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change; restrictive by expert approval<BR/>
<B>Intervention Functions: </B>enablement, persuasion, restriction<BR/>
</P>
<P>DELIVERER: specialist physician</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-12-07 01:39:40 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>total antibiotic consumption (DDD per 100 patient days)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 00:56:15 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 22:33:07 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Petrikkos-2007">
<CHAR_METHODS MODIFIED="2015-08-02 01:52:59 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 22:26:28 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients requiring antibiotics<BR/>CLINICAL PROBLEM: decrease use of cephalosporins<BR/>SETTING: 1 university hospital in Greece</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 22:26:56 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>restrictive by expert approval</P>
<P>
<B>Intervention Function: </B>restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 22:31:59 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of cephalosporins in DDD/100 OBD</P>
<P>MICROBIAL: % ESBL-producing <I>Klebsiella pneumoniae</I> and <I>Escherichia coli</I>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 22:33:07 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias:</B> <B>HIGH</B> case definition Low, planned intervention Low, other infection control Unclear, no data about other infection control measures</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 22:36:15 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pires-2011">
<CHAR_METHODS MODIFIED="2015-09-29 01:43:14 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 22:35:09 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all prescribers in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients receiving carbapenems<BR/>SETTING: 1 teaching hospital in Brazil</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 22:35:30 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention:</B> restriction by removal from availability in the hospital</P>
<P>
<B>Intervention Function: </B>restriction</P>
<P>DELIVERER: Infection Control Committee</P>
<P>COMPARISON: pre-intervention</P>
<P>DESIRED CHANGE: reduction in use of targeted carbapenems and in resistance</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 22:36:05 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of target antibiotics</P>
<P>MICROBIAL: carbapenem resistance in <I>Pseudomonas aeruginosa</I>
<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 22:36:15 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Fundo de Incentivo a Pesquisa e Eventos, Hospital de Clinicas de Port Alegre. <B>Competing Interests:</B> none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 22:43:02 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Po-2012">
<CHAR_METHODS MODIFIED="2015-09-29 01:46:20 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 22:38:50 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital</P>
<P>CLINICAL PROBLEM: reduce linezolid use</P>
<P>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 22:42:16 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>
<I>Intervention 1</I>: educational mettings or dissemination of educational materials. <I>Intervention 2</I>: reminders, structural, circumstantial - computerised physician order entry system (CPOE) and educational meetings or dissemination of educational materials</P>
<P>
<B>Intervention Functions: </B>
<I>Intervention 1: </I>education. <I>Intervention 2: </I>education, enablement, environmental restructuring</P>
<P>DELIVERER: specialist physician</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: reduce inappropriate</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 22:42:54 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>linezolid use (DDD per 1000 patient days)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 22:43:02 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 22:45:39 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Poehling-2006">
<CHAR_METHODS MODIFIED="2017-01-06 22:44:29 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 22:44:49 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: doctors in the ED<BR/>PARTICIPANTS: children with influenza-like illness<BR/>CLINICAL PROBLEM: decrease antibiotic prescribing for influenza<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 22:45:08 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>structural, rapid influenza testing<BR/>
<B>Intervention Functions: </B>environmental restructuring</P>
<P>DELIVERER: specialist physicians, Department of Pediatrics</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 22:45:20 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> % children treated<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 22:45:39 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> New Vaccine Surveillance Network and Robert Wood Johnson Generalist Physicians Faculty Scholars Program. <B>Competing Interests:</B> none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 22:52:53 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Popovski-2015">
<CHAR_METHODS MODIFIED="2015-08-07 01:51:00 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 22:49:22 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients with intra-abdominal infections<BR/>CLINICAL PROBLEM: decrease use of ciprofloxacin for empirical treatment<BR/>SETTING: 1 university hospital in Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 22:50:39 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of guidelines; reminders (physical, posters, and on intranet)<BR/>
<B>Intervention Functions: </B>education, environmental restructuring<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 22:51:06 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of ciprofloxacin in DDD/1000 OBD</P>
<P>CLINICAL: mortality, re-admission (cohort data)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 22:52:53 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> commercial Merck, Pfizer, Astellas, and the Medbuy Corporation. Hamilton Health Sciences Foundation (Jack Hirsh Fellowship). <B>Competing Interests:</B> 1 author received honoraria from Merck and Astellas for lectures. All other authors: none to declare</P>
<P>ADDITIONAL DATA: email response from authors with guideline and additional data about the intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-06 22:58:17 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Price-2010">
<CHAR_METHODS MODIFIED="2015-05-06 05:28:27 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 22:54:38 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: requiring antibiotic treatment or prophylaxis<BR/>SETTING: 1 university hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 22:56:06 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>dissemination of guidelines; restrictive by removal and expert approval<BR/>
<B>Intervention Functions: </B>education, restriction<BR/>
</P>
<P>Note that the published paper says: "The policy was widely disseminated in the hospital but no specific measures were put in place to enforce compliance". However, the antibiotic policy provided by the authors says: &#8220;Cephalosporins and fluoroquinolones. These agents will NOT be ward stock on any general medical or surgical wards &#8211; continuation of therapy beyond 24 hours (in Medicine) and single dose prophylaxis (in Surgery) requires consultant review, prescription by consultant and discussion with Micro ID&#8221;.</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-06 22:56:43 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of cephalosporins and quinolones (combined) in DDD/1000 OBD</P>
<P>MICROBIAL: <I>Clostridium difficile </I>infection<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-06 22:58:17 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> part commercial, Optimer Pharmaceuticals and US Department of Veterans Affairs. <B>Competing Interests:</B> 1 author declared multiple commercial sources of research funding and held patents relevant to <I>C difficile </I>infection licensed to ViroPharma</P>
<P>ADDITIONAL INFORMATION: authors provided the 2008 version of the hospital antibiotic policy, which included details about the restrictions on use of target drugs</P>
<P>
<B>Microbial Risk of Bias MEDIUM: </B>case definition yes, planned intervention yes, infection control no (a cohorting ward was introduced at the same time as the antibiotic policy)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 10:21:21 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Pulcini-2011">
<CHAR_METHODS MODIFIED="2015-05-06 06:59:30 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-06 23:00:02 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the Medical ICU<BR/>PARTICIPANTS: all patients in the ICU<BR/>CLINICAL PROBLEM: receiving antibiotics for 24 h to 96 h<BR/>SETTING: 1 university hospital in France</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-06 23:03:33 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational outreach by academic detailing; reminders (physical, circumstantial, stickers placed in notes of patients receiving target antibiotics)<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring, persuasion<BR/>
</P>
<P>DELIVERER: departmental physician (ICU consultant)</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: increase appropriate</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-12-07 01:42:11 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> % appropriate treatment<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-18 10:21:21 -0500" MODIFIED_BY="Julia Worswick">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL INFORMATION: email from authors with additional information about intervention. The intervention design is described in more detail in <LINK REF="REF-Pulcini-2008" TYPE="REFERENCE">Pulcini 2008</LINK>.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 10:21:47 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Qu-2012">
<CHAR_METHODS MODIFIED="2017-01-18 10:21:47 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 03:09:56 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the ICU<BR/>PARTICIPANTS: 71 patients with with confirmed severe acute pancreatitis</P>
<P>CLINICAL PROBLEM: PCT for guiding duration of antibiotic therapy</P>
<P>SETTING: 1 hospital in China</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 03:10:41 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial, decision support algorithm with each PCT test); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring</P>
<P>DELIVERER: department physician (ICU)</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 03:11:58 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>duration of all antibiotic treatment</P>
<P>CLINICAL: <B>Balancing: </B>mortality and length of stay</P>
<P>FINANCIAL: cost of hospitalisation, but no information about cost of intervention</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 03:12:13 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 13:29:00 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Rattanaumpawan-2010">
<CHAR_METHODS MODIFIED="2017-01-18 13:29:00 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: NRT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 03:15:32 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: 953 hospitalised adults (1028 prescriptions)</P>
<P>CLINICAL PROBLEM: receiving treatment with piperacillin/tazobactam, imipenem, and meropenem</P>
<P>SETTING: 1 hospital in Thailand</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 03:16:06 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions:</B> educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>education, enablement, persuasion, restriction<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: reduce excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 03:16:29 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of target antibiotics</P>
<P>CLINICAL: <B>Balancing: </B>mortality, length of stay</P>
<P>FINANCIAL: cost of target antibiotics and all antibiotics. No information about cost of intervention</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 03:17:27 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: email from authors but no additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 03:26:05 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rattanaumpawan-2011">
<CHAR_METHODS MODIFIED="2015-10-12 01:08:13 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 03:21:52 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: adult patients receiving antibiotics</P>
<P>CLINICAL PROBLEM: unnecessary double coverage for infection with anaerobic bacteria</P>
<P>SETTING: 1 hospital in Thailand</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 03:24:52 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>restrictive by prior approval, the intervention was removal of this restriction<BR/>
<B>Intervention Functions: </B>restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: unnecessary treatment before and after removal of the restriction<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 03:24:55 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: c</B>umulative incidence of unnecessary treatment in DDD/admission</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 03:26:05 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>National Institutes of Health grant K24-AI080942. <B>Competing Interests: </B>1 author received research support from Merck, Ortho-McNeil, Cubist, and AstraZeneca.</P>
<P>ADDITIONAL DATA: email response from authors but no additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 03:34:26 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Richards-2003">
<CHAR_METHODS MODIFIED="2015-01-09 17:31:05 -0500" MODIFIED_BY="Kate Cahill">
<P>STUDY DESIGN:  ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 03:30:43 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients except ICU, ER, ID<BR/>CLINICAL PROBLEM: receiving treatment with target antibiotics<BR/>SETTING: 1 university hospital in Australia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 03:32:23 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational meetings with dissemination of guidelines; reminders (circumstantial and physical, on computer order form when prescribing antibiotics); restrictive by compulsory order form, expert approval, and removal<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion, restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: reduction in established management (reduction in use of target drugs)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 03:34:15 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>Primary: use of cefotaxime or ceftriaxone</P>
<P>Secondary: use of other antibiotics: gentamicin, benzyl penicillin, carbapenems, piperacillin, ticarcillin, and ciprofloxacin</P>
<P>FINANCIAL: cost of intervention<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 03:34:26 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Royal Melbourne Hospital. <B>Competing Interests:</B> none declared.</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 03:41:26 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Richardson-2000">
<CHAR_METHODS MODIFIED="2017-01-07 03:36:21 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 03:38:55 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital. Number, age, and time since qualification NOT CLEAR. 3 intensive care units, 3 general medical, and 1 general surgical<BR/>PARTICIPANTS: a total of 618 episodes of vancomycin use (220 pre- and 398 postintervention). Number of patients, age, gender, and ethnicity NOT CLEAR.<BR/>CLINICAL PROBLEM: patients requiring antibiotic treatment<BR/>SETTING: single tertiary-care teaching hospital in the USA with 150 acute care and 90 long-term care beds</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 03:41:04 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>enablement, persuasion<BR/>COMPARISON: data for 3 months in the previous year (April, August, and January)<BR/>DESIRED CHANGE: decrease excessive (reduction in inappropriate use of vancomycin with the aim of reducing prevalence of VRE infections)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 03:41:26 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>% episodes of vancomycin use deemed inappropriate<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 01:19:00 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 03:20:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Ross-2014">
<CHAR_METHODS MODIFIED="2015-08-07 03:59:00 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 03:46:28 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all paediatricians in the hospitals<BR/>PARTICIPANTS: children with community-acquired pneumonia<BR/>CLINICAL PROBLEM: increase use of guideline-recommended antibiotics<BR/>SETTING: 38 hospitals in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 03:51:32 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention:</B> dissemination of national guidelines</P>
<P>
<B>Intervention Function: </B>education<BR/>DELIVERER: specialist physicians<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 03:51:52 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> % patients treated with guideline-recommended antibiotics</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-15 03:20:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> 1 author has received research funding from Merck and Cubist and has served as a consultant for Merck, Pfizer, Astellas Pharma, and Cubist, and 3 authors have received research funding from Pfizer.</P>
<P>ADDITIONAL DATA: email from authors with no additional data. Paediatric infectious diseases guidelines available online (<A HREF="http://cid.oxfordjournals.org/content/early/2011/08/30/cid.cir531.full">cid.oxfordjournals.org/content/early/2011/08/30/cid.cir531.full</A>)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 18:11:07 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<CHAR_METHODS MODIFIED="2017-01-07 18:08:45 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 18:09:39 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients requiring antibiotic treatment<BR/>SETTING: single 600-bed university hospital in France</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 18:10:45 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings and dissemination of protocol; reminders (physical, pocket-size guideline); restrictive by compulsory order form and expert approval<BR/>
<B>Intervention Functions: </B>education, environmental restructuring, restriction<BR/>
</P>
<P>COMPARISON: data for 3 years after implementation of the programme<BR/>DESIRED CHANGE: reduce excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 18:11:07 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>anti-infective expenditure per hospital patient</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 01:20:46 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 18:19:17 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Salama-1996">
<CHAR_METHODS MODIFIED="2017-01-07 18:15:23 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 18:15:44 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: requiring antibiotic therapy<BR/>SETTING: 1 university hospital in Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 18:19:06 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational meetings with dissemination of guidelines; educational outreach by academic detailing; reminders (circumstantial, physical, and verbal: newsletters, posters, pocket charts, educational rounds, and triggered by prescribing of target drugs); reminders (physical); restrictive by compulsory order form plus automatic 3-day stop order for all antibiotics and review and make change (therapeutic substitution of selected drugs)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion, restriction<BR/>DESIRED CHANGE: reduction in vancomycin and ceftazidime use</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 18:19:17 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>vancomycin and ceftazidime use in units, antibiotic cost as a percentage of total drug cost<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 01:21:21 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 18:22:10 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schnoor-2010">
<CHAR_METHODS MODIFIED="2017-01-07 18:20:11 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: cluster RCT, hospital level</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 18:20:45 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: doctors managing patients with community-acquired pneumonia<BR/>PARTICIPANTS: 623 patients with community-acquired pneumonia (275 intervention, 348 control), 8 clusters (hospitals)<BR/>CLINICAL PROBLEM: community-acquired pneumonia<BR/>SETTING: 8 hospitals in Germany</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 18:21:29 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational meetings with dissemination of guideline; reminders (physical, posters, electronic and pocket versions of guideline)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring<BR/>
</P>
<P>DESIRED CHANGE: increase in compliance of initial treatment with guideline recommendation and decrease in duration of treatment</P>
<P>POWER CALCULATION: no information</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 18:21:54 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>% guideline compliant for initial treatment</P>
<P>CLINICAL: <B>Balancing: </B>mortality, length of stay<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 18:22:10 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>German Medical Assembly grant 06-69 and German Federal Ministry of Education and Research grant 01K10103-105. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 18:33:12 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schouten-2007">
<CHAR_METHODS MODIFIED="2017-01-07 18:27:54 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: cluster RCT, hospital level</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 18:29:11 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians<BR/>PARTICIPANTS: 827 patients with lower respiratory tract infection (before intervention, 212 intervention, 166 control; after intervention, 276 intervention, 166 control). 6 clusters (hospitals)<BR/>CLINICAL PROBLEM: patients with lower respiratory tract infection<BR/>SETTING: 6 hospitals in the Netherlands</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 18:30:57 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational meetings with dissemination of guideline; educational outreach by academic detailing; reminders (physical, desktop on computers, and pocket card)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive (choice and streamlining) and increase effective (timeliness)</P>
<P>POWER CALCULATION: no information</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 18:32:21 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> % patients compliant with guideline for selected drug, timing (within 4 h of presentation), switching from IV to oral and streamlining</P>
<P>CLINICAL: <B>Balancing: </B>mortality, length of stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 18:33:12 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>The Netherlands Organisation for Health Research and Development (Zon/Mw; 2300.0024). <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 18:37:56 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schroeder-2009">
<CHAR_METHODS MODIFIED="2015-08-08 01:39:21 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 18:35:19 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the ICU<BR/>PARTICIPANTS: all patients with sepsis in the ICU<BR/>CLINICAL PROBLEM: receiving antibiotics for suspected intra-abdominal sepsis<BR/>SETTING: 1 university hospital in Germany</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 18:37:15 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial, decision support algorithm with each PCT test); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring<BR/>DELIVERER: departmental physicians<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: no information</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 18:37:26 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> duration of antibiotic treatment (days)</P>
<P>CLINICAL: <B>Balancing: </B>length of hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 18:37:56 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none declared. <B>Competing Interests:</B> 1 author had speaking engagements for B.R.A.H.M.S AG.</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Schuetz-2009">
<CHAR_METHODS MODIFIED="2016-12-06 12:58:51 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 18:39:59 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians<BR/>PARTICIPANTS: 1381 patients with lower respiratory tract infection randomised (687 intervention, 694 control), 6 clusters (hospitals)<BR/>CLINICAL PROBLEM: lower respiratory tract infection<BR/>SETTING: 6 hospitals in Switzerland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial, decision support algorithm with each PCT test); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring<BR/>DELIVERER: departmental physician (respiratory)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 1002 participants total. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 18:41:12 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>% patients treated</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 18:47:18 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> grant SNF 3200BO-116177/1 from the Swiss National Science Foundation and contributions from santésuisse and the Gottfried und Julia Bangerter-Rhyner Foundation and participating hospitals. B.R.A.H.M.S Inc, the major manufacturer of the procalcitonin assay, provided all assay-related material, Kryptor machines if not already available on site, and kits and maintenance required for 10,000 measurements related to the study.</P>
<P>
<B>Competing Interests:</B> 3 authors received support from B.R.A.H.M.S Inc to attend meetings and fulfil speaking engagements, and 1 author served as a consultant and received research support from B.R.A.H.M.S Inc.</P>
<P>ADDITIONAL DATA: authors provided additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 18:56:13 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schwann-2011">
<CHAR_METHODS MODIFIED="2015-10-10 01:48:33 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 18:53:37 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians<BR/>PARTICIPANTS: all patients undergoing elective surgery requiring antibiotic prophylaxis<BR/>CLINICAL PROBLEM: timing of first dose of antibiotic<BR/>SETTING: 1 hospital network in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 18:55:12 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial and physical, point-of care electronic prompt (triggered by operating room admission)); reminders (physical); restrictive; structural<BR/>
<B>Intervention Functions:</B> enablement, environmental restructuring<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 18:55:51 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> % patients with first dose administered within 1 hour of incision</P>
<P>CLINICAL: <B>Intended: </B>surgical-site infection</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 18:56:13 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Lehigh Valley Hospital Network and Allentown Anesthesia Associates. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 19:06:28 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schwartz-2007">
<CHAR_METHODS MODIFIED="2015-09-19 03:27:27 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 18:58:48 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the long-term care facility<BR/>PARTICIPANTS: all patients receiving antibiotics<BR/>CLINICAL PROBLEM: patients receiving antimicrobials<BR/>SETTING: 1 hospital</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 19:00:49 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of guidelines and treatment algorithms; reminders (physical, pocket guidelines)</P>
<P>The guideline has 16 algorithms for management of clinical problems (fever, leukocytosis, confusion, diarrhoea) and common infections in older people.<BR/>
<B>Intervention Functions: </B>education, environmental restructuring<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 19:05:26 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>antibiotic days/100 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 19:06:28 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Chicago Antimicrobial Resistance Project, Centers for Disease Control and Prevention (U50/ CCU515853). <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: email response with the guideline. The guidelines are supposed to be available online, but the link does not work.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Senn-2004">
<CHAR_METHODS MODIFIED="2017-01-07 19:08:50 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>PROVIDERS: residents on medical and surgical wards<BR/>PATIENTS: 251 patients were recruited, 126 intervention and 125 control</P>
<P>CLINICAL PROBLEM: adult patients receiving IV antibiotics for 3 to 4 days with no modification since starting treatment</P>
<P>SETTING: single 800-bed university hospital in Switzerland. Data collected over 5 months.</P>
<P>POWER CALCULATION: yes, 135 patients in each group, but the trial was underpowered because the observed effect was lower than predicted. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 19:15:07 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>dissemination of questionnaire about guidelines; reminders (circumstantial and physical, questionnaire mailed to the resident in charge of patients who were receiving IV antibiotic treatment. The questionnaire asked 3 questions regarding possible adaptation of antibiotic therapy on day 3 or 4, and was collected 24 hours later. If the resident had not yet completed it at that time, he/she was reminded once to do so.)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: control patients with no intervention</P>
<P>DESIRED CHANGE: reduction in established management (reduction in duration of IV therapy)</P>
<P>TIMING: intervention at the point of decision making (potential modification 3 to 4 days after start of antibiotics)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 19:16:13 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> % of patients discontinuing IV antibiotics and hazard ratio adjusted for patients' Karnofsky functional index</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 19:16:45 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Quality Improvement Committee of the Lausanne University Hospital and grant 32&#8211;63128.00 of the Swiss National Science Foundation. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Shehabi-2014">
<CHAR_METHODS MODIFIED="2015-09-19 05:44:42 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 19:21:11 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the ICU<BR/>PARTICIPANTS: 400 patients; 6 withdrew consent, leaving 196 in the intervention and 198 in the control group<BR/>CLINICAL PROBLEM: patients with suspected sepsis and likely to receive antibiotics/remain in the ICU for at least 24 h<BR/>SETTING: 11 university hospitals in Australia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>
<B>Interventions: </B>reminders (circumstantial, decision support algorithm with each PCT test); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring</P>
<P>DELIVERER: departmental physicians (ICU)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, 165 participants per group. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 19:23:32 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>duration of antibiotic treatment (days)</P>
<P>CLINICAL: mortality, re-admission, and length of hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 19:24:32 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Intensive Care Foundation of Australia and New Zealand. Material support was provided by Roche Diagnostics, Thermo Fisher Scientific, and bioMérieux. Roche Diagnostics and Thermo Fisher Scientific provided additional unrestricted grant funding. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: email from authors with additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 19:35:00 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shen-2011">
<CHAR_METHODS MODIFIED="2015-10-10 01:49:24 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 19:30:54 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians on 2 respiratory wards<BR/>PARTICIPANTS: all patients on the wards<BR/>CLINICAL PROBLEM: receiving antibiotics for respiratory infection<BR/>SETTING: 1 hospital</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 19:31:38 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>enablement, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: no information</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 19:34:26 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>score on 6 indicators of inappropriate antibiotic use: indication, choice, dosage, dosing schedule, duration, conversion</P>
<P>CLINICAL: <B>Balancing:</B> length of stay</P>
<P>FINANCIAL: cost (mean, SD) of antibiotics and total patient costs</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 19:35:00 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 10:25:01 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Shojania-1998">
<CHAR_METHODS MODIFIED="2017-01-07 19:36:49 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT with nested ITS analysis (Figures 3 and 4)</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-18 10:25:01 -0500" MODIFIED_BY="Julia Worswick">
<P>PROVIDERS: unit of randomisation - 396 physicians in 7 specialties. Non-physicians (nurses or pharmacists) who were authorised to enter orders that required eventual signing off by physicians were also randomised.<BR/>PARTICIPANTS: There were 5536 episodes of care in 1798 patients.<BR/>CLINICAL PROBLEM: receiving vancomycin treatment<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 20:39:28 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>dissemination of guideline; reminders (circumstantial, delivered through computer screen at the time of physician order entry and after 72 hours of therapy). The reminder required prescribers to produce a response: when someone would enter an order for intravenous vancomycin, a pop-up screen would appear and display the appropriate indications for vancomycin use, which was a checkbox list of indications based on CDC guidelines. Users had to pick a reason or enter free text under 'other' in order to proceed.</P>
<P>
<B>Intervention Functions: </B>education, enablement, environmental restructuring</P>
<P>DELIVERER: AMT<BR/>COMPARISON: no reminder. ITS analysis used 9 months' pre-intervention data.<BR/>DESIRED CHANGE: reduction of established management (reduction in use of vancomycin)</P>
<P>POWER CALCULATION: no information</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 20:39:54 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>initiation and renewal of vancomycin therapy. Duration of vancomycin therapy on a per-prescriber basis. Total use of vancomycin in the hospital.</P>
<P>FINANCIAL: estimated savings<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 20:40:39 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>grant R01-HS08927 from the Agency for Healthcare Policy and Research. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: email from authors with additional details about the intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Singh-2000">
<CHAR_METHODS MODIFIED="2017-01-07 20:58:38 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT, allocation by patient</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 21:04:56 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians on 1 ICU<BR/>PARTICIPANTS: 81 episodes of care (39 intervention, 42 control)<BR/>CLINICAL PROBLEM: suspected ventilator-associated pneumonia with low CPIS<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Intervention: </B>restrictive by expert approval and review and make change</P>
<P>
<B>Intervention Function: </B>restriction<BR/>DELIVERER: ID physician</P>
<P>COMPARISON: choice, number, and duration of antibiotics at the discretion of the care providers<BR/>DESIRED CHANGE: reduction of established management (reduction in duration of antibiotic treatment)</P>
<P>POWER CALCULATION: yes, 88 patients per group. The study was terminated early. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 21:08:00 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> total duration of all antibiotic treatment</P>
<P>CLINICAL: <B>Balancing: </B>mortality, length of ICU stay</P>
<P>MICROBIAL: number of patients with "antimicrobial resistance and/or superinfections" from randomisation until hospital discharge</P>
<P>FINANCIAL: total costs of care for patients with CPIS &lt; 6 at 3 days and no extrapulmonary infections<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 21:08:10 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Bayer Corporation. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 21:17:30 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sirinavin-1998">
<CHAR_METHODS MODIFIED="2017-01-07 21:12:18 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 21:13:48 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients requiring treatment with imipenem vancomycin or injectable ciprofloxacin<BR/>SETTING: 1 hospital in Thailand</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 21:16:02 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of antimicrobial order form; educational outreach by review and recommend change of cases of inappropriate prescribing by ID consultant; restrictive by compulsory order form<BR/>
<B>Intervention Functions: </B>education, enablement, persuasion, restriction<BR/>
</P>
<P>Figure 2 suggests that expenditure increased sharply in the final year of the study when ID consultant review ceased.</P>
<P>DELIVERER: specialist physician (ID)</P>
<P>COMPARISON: data for 4 years' pre-restriction<BR/>DESIRED CHANGE: decrease excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 21:16:34 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>restricted drugs cost in million THB/200,000 OBD<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 21:17:30 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Ramathibodi Research Fund. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 21:23:57 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Skaer-1993">
<CHAR_METHODS MODIFIED="2017-01-07 21:22:17 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 21:22:37 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: physicians (numbers not clear)<BR/>PATIENTS: all patients in the hospital</P>
<P>CLINICAL PROBLEM: adult patients receiving imipenem treatment</P>
<P>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 21:23:33 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>educational outreach by review and recommend change</P>
<P>
<B>Intervention Functions: </B>enablement, persuasion</P>
<P>DELIVERER: pharmacist</P>
<P>COMPARISON: usual care in the pre-intervention phase</P>
<P>DESIRED CHANGE: reduce excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 21:23:44 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>Monthly use (doses) of imipenem</P>
<P>CLINICAL: cohort data about length of stay and hospital charges for patients with a primary diagnosis of infection</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 21:23:57 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Washington State University College of Pharmacy and Pullman Memorial Hospital. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 21:27:04 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Skrlin-2011">
<CHAR_METHODS MODIFIED="2015-10-10 01:50:01 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 21:25:13 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: use of ceftriaxone following removal of restriction<BR/>SETTING: 1 hospital in Croatia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 21:26:15 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>restrictive, removal of restriction by expert approval</P>
<P>
<B>Intervention Function: </B>restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: removal of restriction versus restriction<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 21:26:54 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of ceftriaxone in DDD/1000 OBD</P>
<P>MICROBIAL: number of ESBL-producing strains/1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 21:27:04 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding</B> none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias: LOW </B>case definition Low, planned intervention Low, other infection control Low</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 21:33:39 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Solomon-2001">
<CHAR_METHODS MODIFIED="2017-01-07 21:27:52 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: cluster RCT, service level</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 21:29:08 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: 17 Internal Medicine services randomly assigned to intervention (9 services) or control (8 services)<BR/>PARTICIPANTS: a total of 4500 patients admitted during the baseline and study periods, of whom 260 patients received 278 unnecessary prescriptions for the target drugs; 17 clusters (services)<BR/>CLINICAL PROBLEM: patients receiving ceftazidime or levofloxacin.<BR/>SETTING: 1 hospital in the USA</P>
<P>POWER CALCULATION: no information. The methods say that the statistical model adjusted for clustering, but no results are given (see risk of bias).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 21:32:31 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions:</B> educational meetings with dissemination of policy for necessary use; educational outreach by review and recommend change, either verbal (face to face or telephone) or by email<BR/>
<B>Intervention Functions: </B>education, enablement, persuasion<BR/>COMPARISON: randomly assigned control services<BR/>DESIRED CHANGE: reduce excessive</P>
<P>POWER CALCULATION: no information. <B>Note from Statistician: </B>The study adjusted for some clustering, but possibly only in the repeated measures, not in the hospitals. Just using the results from Table 2, I do not get the P value that they state in the table using a unit of analysis error approach. This suggests to me that they are adjusting for "things". I therefore think on balance that it is probably OK to use the results.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 21:33:24 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>% patients with target antibiotics discontinued. <B>Exposure: </B>% patients with all antibiotics discontinued</P>
<P>CLINICAL: inpatient mortality, transfer to ICU, length of stay, and re-admission within 30 days of discharge</P>
<P>FINANCIAL: estimated annual cost of the intervention<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 21:33:39 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Brigham and Women&#8217;s Hospital and Arthritis Foundation Investigator Award. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: email from authors with information about the intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 21:41:26 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Standiford-2012">
<CHAR_METHODS MODIFIED="2015-09-21 01:00:42 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 21:38:29 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: cost of animicrobials<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 21:39:15 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>enablement, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care pre-intervention and impact of removal of the intervention (2 years)<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 21:39:32 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>quarterly cost of all antimicrobials</P>
<P>CLINICAL: <B>Balancing: </B>cohort data for mortality, length of stay, and unplanned re-admission. The DRG case mix index was monitored to ensure that changes in outcomes were not related to this index.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 21:41:26 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 21:46:36 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stevenson-1988">
<CHAR_METHODS MODIFIED="2015-09-21 01:07:03 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 21:44:37 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: receiving antibiotics<BR/>SETTING: 1 hospital in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 21:45:19 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>dissemination of antibiotic policy</P>
<P>
<B>Intervention Function: </B>education<BR/>DELIVERER: pharmacist</P>
<P>COMPARISON: 10 quarters (30 months) pre-intervention<BR/>DESIRED CHANGE: reduce excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 21:46:36 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING and FINANCIAL: <B>Choice: </B>average cost of antibiotics per patient. Prices were indexed to 1980.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 01:45:41 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 21:51:40 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stocker-2010">
<CHAR_METHODS MODIFIED="2015-09-21 01:24:36 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 21:49:15 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the neonatal ICU<BR/>PARTICIPANTS: 121 neonates (60 intervention, 61 control)<BR/>CLINICAL PROBLEM: suspected sepsis<BR/>SETTING: 1 hospital in Switzerland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 21:50:43 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial, decision support algorithm with each PCT test); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring<BR/>DELIVERER: departmental physician (Paediatrics)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: unclear. The trial was designed to obtain a power of 90% to detect a 30% difference between the 2 groups in the duration of antibiotic therapy, with an estimated standard deviation of 50%. Sample size: no information</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 21:51:10 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>duration, % treated &gt; 72 h</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 21:51:40 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> commercial B.R.A.H.M.S Diagnostica (Berlin, Germany) provided the testing kits for PCT. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Stolz-2007">
<CHAR_METHODS MODIFIED="2015-08-09 01:18:17 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 21:53:43 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in Internal Medicine<BR/>PARTICIPANTS: all patients hospitalised with exacerbations of chronic obstructive pulmonary disease; 288 screened, 226 randomised (113 intervention, 113 control)<BR/>CLINICAL PROBLEM: use of therapeutic antibiotics<BR/>SETTING: 1 hospital</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial, decision support algorithm with each PCT test); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring<BR/>DELIVERER: departmental physician (Respiratory)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION: yes, total 186 participants. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 21:55:38 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>% antibiotic use for the exacerbation and in the subsequent 6 months</P>
<P>CLINICAL: <B>Balancing: </B>length of stay, death, symptom scores</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 21:56:38 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>part commercial University Hospital Basel. B.R.A.H.M.S provided procalcitonin assays for this investigator-driven study. <B>Competing Interests:</B> 1 author served as consultant and received payments from B.R.A.H.M.S to attend meetings and for travel expenses, speaking engagements, or research. </P>
<P>ADDITIONAL DATA: email response from authors with additional information about intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 10:28:48 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Stolz-2009">
<CHAR_METHODS MODIFIED="2015-04-08 23:57:04 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 22:08:11 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all staff in adult ICUs<BR/>PARTICIPANTS: 101 patients with VAP (51 intervention, 50 control)<BR/>CLINICAL PROBLEM: receiving antibiotics for VAP<BR/>SETTING: 3 university hospitals in Switzerland and the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey">
<P>FORMAT: <B>Interventions: </B>reminders (circumstantial, decision support algorithm with each PCT test); structural, introduction of PCT testing<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring<BR/>DELIVERER: respiratory physicians<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
<P>POWER CALCULATION; yes, 84 participants total. Details in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 22:10:02 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>duration of antibiotic treatment</P>
<P>CLINICAL: <B>Balancing:</B> mortality, hospital length of stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-18 10:28:48 -0500" MODIFIED_BY="Julia Worswick">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Swiss National Foundation, Margarete und Walter Liechtenstein Foundation, Freiwillige Akademische Gesellschaft Basel, Will Rogers Foundation, and participating hospitals. B.R.A.H.M.S AG funded assay material and logistics. <B>Competing Interests:</B> not clear. The published paper says that a statement of interest for the study itself is available but the web address provided online and in print does not work.</P>
<P>ADDITIONAL DATA: email response from authors with additional information about intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 22:24:50 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Strom-2010">
<CHAR_METHODS MODIFIED="2017-01-07 22:14:39 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: cluster RCT, professional level</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 22:23:18 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: A total of 1971 clinicians were assigned to either an intervention group receiving a nearly hard-stop alert or a control group receiving the standard practice.<BR/>PARTICIPANTS: 342 patients receiving warfarin and trimethoprim-sulfamethoxazole (194 intervention, 148 control), 1971 clusters (physicians)<BR/>CLINICAL PROBLEM: reduce risk of interaction between warfarin and trimethoprim-sulfamethoxazole<BR/>SETTING: 2 hospitals in the USA</P>
<P>POWER CALCULATION: "It is generally accepted that randomization of at least 100 subjects will produce balance between the study groups and, of course, the present sample size is much larger than this."</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 22:22:21 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>reminder (circumstantial) and restrictive by compulsory electronic order form that would not allow concomitant orders of warfarin and trimethoprim-sulfamethoxazole. The only exception allowed by the order form was the indication of <I>Pneumocystis carinii</I> pneumonia prophylaxis. Expert approval was allowed for other patients when discussed with pharmacy.</P>
<P>
<B>Intervention Functions: </B>enablement, environmental restructuring, restriction<BR/>DELIVERER: pharmacist<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 22:24:06 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> the proportion of desired responses (i.e. not reordering the alert-triggering drug within 10 minutes of firing)</P>
<P>CLINICAL: <B>Balancing: </B>2 potential adverse outcomes of the computerised hard-stop alert were monitored and reported to the Institutional Review Board. The first was a delay in obtaining trimethoprim-sulfamethoxazole when the practitioner believed that an infection was best treated with trimethoprim-sulfamethoxazole and when the potential warfarin interaction was judged less important than the need for the antibiotic. The second was unintentional warfarin cessation in a patient previously undergoing long-term warfarin therapy. The study therefore also assessed the incidence of warfarin cessation on the day when an order of trimethoprim-sulfamethoxazole was attempted in a patient already receiving warfarin.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-07 22:24:50 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> University of Pennsylvania Health System and Agency for Healthcare Research and Quality. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: email response from authors with additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 22:31:15 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sun-2011">
<CHAR_METHODS MODIFIED="2015-09-22 01:09:57 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 22:27:59 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all cardiac surgeons and other professionals<BR/>PARTICIPANTS: all patients undergoing coronary artery bypass surgery<BR/>CLINICAL PROBLEM: improve reliability of administration of prophylaxis (first dose within 1 h of incision and duration not &gt; 24 h)<BR/>SETTING: 1 hospital in Taiwan</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 22:29:00 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational meetings with dissemination of guidelines and evidence base<BR/>
<B>Intervention Functions: </B>education, enablement<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-07 22:31:15 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice and exposure: </B>time to first antibiotic dose, % of prophylaxis &#8804; 24 h</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 01:56:49 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-07 22:33:34 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Suwangool-1991">
<CHAR_METHODS MODIFIED="2015-09-22 01:24:24 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-07 22:32:46 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the Department of Medicine<BR/>PARTICIPANTS: all patients in the Department of Medicine<BR/>CLINICAL PROBLEM: inappropriate antibiotic prescribing<BR/>SETTING: single university hospital in Thailand</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-07 22:33:34 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>dissemination of guidelines; restrictive by expert approval<BR/>
<B>Intervention Functions: </B>education, restriction<BR/>
</P>
<P>DELIVERER: AMT<BR/>COMPARISON: 6 months' data pre-intervention<BR/>DESIRED CHANGE: reduce excessive (cost)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-12-07 01:49:07 -0500" MODIFIED_BY="[Empty name]">
<P>PRESRIBING: <B>Choice: </B>monthly cost of target antibiotics</P>
<P>CLINICAL: cohort data about mortality<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 01:57:02 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 03:42:00 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Talpaert-2011">
<CHAR_METHODS MODIFIED="2015-10-10 01:51:06 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 03:39:36 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients receiving antibiotics for prophylaxis or treatment. The intervention targeted fluoroquinolones, cephalosporins, clindamycin, amoxicillin, and co-amoxiclav, as they were considered to be "high risk" for <I>Clostridium difficile </I>infection<BR/>SETTING: 1 hospital</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 03:41:14 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of guidelines; educational outreach by review and recommend change; reminders (verbal (on rounds) and physical (laminated pocket cards and posters)); restrictive by removal of target drugs from clinical areas<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 03:41:21 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of target antibiotics in DDD/1000 OBD</P>
<P>MICROBIAL: monthly cases of <I>C difficile </I>infection</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 03:42:00 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interests:</B> 1 author was paid lecture fees and provided sponsorship to attend conferences by pharmaceutical companies unrelated to this study.</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias LOW</B>: case definition Low (new cases), planned intervention Low, other infection control Low, fully reported in ORION format</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 03:45:50 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tangd_x00e9_n-2011">
<CHAR_METHODS MODIFIED="2016-12-06 13:01:15 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 03:44:12 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients receiving therapeutic antibiotics<BR/>CLINICAL PROBLEM: aim (i) to reduce the consumption of 2nd- and 3rd-generation cephalosporins; and (ii) to avoid increased prescription of fluoroquinolones and carbapenems.<BR/>SETTING: 1 hospital in Sweden</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 03:44:47 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of guidelines; educational outreach by academic detailing<BR/>
<B>Intervention Functions: </B>education, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-12-07 01:49:35 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of target drugs in DDD/1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 03:45:50 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> no external. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias: HIGH</B>, Case definition Low, Unplanned intervention High (outbreak), Other infection control High. "In August 2006, the hospital director organized a steering group (SG) with the assignment to implement the necessary measures to contain the outbreak, including reinforcement of hygienic measures, such as hand disinfection, use of disposable gloves and aprons, and isolation of patients colonized or infected with ESBL-KP.14 In addition to hygienic measures, the SG decided to perform an antibiotic intervention."</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 03:49:05 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Toltzis-1998">
<CHAR_METHODS MODIFIED="2015-09-22 01:58:17 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM </B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 03:47:17 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the mixed medical and surgical paediatric ICU<BR/>PARTICIPANTS: all patients in the paediatric ICU<BR/>CLINICAL PROBLEM: patients requiring antibiotic treatment<BR/>SETTING: a paediatric ICU in 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 03:48:40 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>restrictive, probably by expert approval ("Prohibition of ceftazidime use unless the patient's microbiological results indicated that the drug was necessary for cure.")</P>
<P>
<B>Intervention Function: </B>restriction</P>
<P>DELIVERER: specialist (ID) physician<BR/>COMPARISON: 7 months' data before the start of the intervention<BR/>DESIRED CHANGE: reduce excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 03:48:44 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>ceftazidime use in doses<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 03:49:05 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> grant HD31323-02 from the National Institutes of Health. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 13:29:10 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Toltzis-2002">
<CHAR_METHODS MODIFIED="2017-01-18 13:29:10 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: NRT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 03:52:01 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians (paediatricians) on the ICU<BR/>PARTICIPANTS: all neonates in the ICU<BR/>CLINICAL PROBLEM: neonates with proven or suspected infections caused by gram-negative bacteria<BR/>SETTING: 1 neonatal ICU in 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 03:52:56 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing data. Restrictive by removal, monthly rotation of the antibiotic regimen used for empirical prescribing of patients with proven or suspected gram-negative infections</P>
<P>DELIVERER: specialist physician (ICU)<BR/>COMPARISON: standard practice<BR/>DESIRED CHANGE: reduce excessive (colonisation with multiresistant bacteria)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 03:54:01 -0500" MODIFIED_BY="[Empty name]">
<P>MICROBIAL: incidence of colonisation with multiantibiotic-resistant aerobic gram-negative bacilli<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 03:54:42 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> grant HD 31323-05 from the National Institutes of Health <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias: MEDIUM</B> Case definition Low, Planned intervention Low, Other infection control Unclear</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 03:59:16 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Toltzis-2014">
<CHAR_METHODS MODIFIED="2015-08-18 04:12:39 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 03:58:40 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all paediatric surgeons and anaesthetists<BR/>PARTICIPANTS: all children undergoing surgery<BR/>CLINICAL PROBLEM: increase % of patients receiving antibiotic prophylaxis within 1 hour of incision as 1 of 3 components of a bundle of care<BR/>SETTING: 8 paediatric hospitals in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 03:59:00 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: no valid prescribing data. Audit and feedback<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 03:59:03 -0500" MODIFIED_BY="[Empty name]">
<P>CLINICAL: surgical-site infection rate per 100 procedures</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 03:59:16 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Ohio Business Roundtable, the Cardinal Health Foundation, and the Ohio Children&#8217;s Hospital Association. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 04:05:16 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Trenholme-1989">
<CHAR_METHODS MODIFIED="2015-09-23 00:14:39 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 04:03:42 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: 226 patients (110 intervention, 116 control)<BR/>CLINICAL PROBLEM: patients with bacteraemia<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 04:05:10 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change (intervention and control); structural, rapid processing and reporting of antimicrobial susceptibility tests (intervention only)<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring, persuasion<BR/>
</P>
<P>DESIRED CHANGE: reduce excessive</P>
<P>POWER CALCULATION: no information</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 04:05:16 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>% changes in therapy in response to recommendation</P>
<P>FINANCIAL: savings in drug costs<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 02:01:50 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 04:10:44 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-U_x00e7_kay-2009">
<CHAR_METHODS MODIFIED="2015-09-23 00:41:04 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 04:07:59 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in one orthopaedic unit<BR/>PARTICIPANTS: all patients in one orthopaedic unit<BR/>CLINICAL PROBLEM: suspected bone and joint infection<BR/>SETTING: 1 hospital in Switzerland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 04:09:46 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change. The intervention is reported in 2 phases, the 1st delivered by "Dedicated ID specialist and one internist" and the 2nd delivered by "ID specialist with experience in Infection Control".<BR/>
<B>Intervention Functions: </B>enablement, persuasion<BR/>DELIVERER: specialist (ID) physician<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 04:09:52 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of IV and oral antibiotics in DDD/1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 04:10:44 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none.<B> Competing Interests:</B> none declared.</P>
<P>ADDITIONAL DATA: email response from authors with additional data about the intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 04:21:05 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Valiquette-2007">
<CHAR_METHODS MODIFIED="2015-09-23 00:59:12 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 04:15:44 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: receiving therapeutic or prophylactic antibiotics<BR/>SETTING: 1 hospital in Canada</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 04:16:44 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of guideline and letter; educational outreach by review and recommend change; reminders (physical, pocket-size guideline)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 04:17:16 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice and exposure: </B>use of individual targeted drugs in DDD/1000 OBD; use of all antibiotics in DDD/1000 OBD</P>
<P>MICROBIAL: <I>Clostridium difficile </I>infections/1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 04:21:05 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>National Foundation for Infectious Diseases. <B>Competing Interests:</B> 1 author has been on the speakers&#8217; bureau for Wyeth; served on advisory boards for Wyeth and Cubist; and received grants from Wyeth, Genzyme, and Arpida. 1 author has been on the speakers&#8217; bureau for Wyeth Canada; served on advisory boards for Bayer, Wyeth, ViroPharma, and Acambis; and received grants from Genzyme.</P>
<P>ADDITIONAL DATA: email from authors but no additional data</P>
<P>
<B>Microbial Risk of Bias: HIGH</B> Case definition Low. Planned intervention High, response to epidemic of infection caused by high-virulence strain. Other infection control High, the rate of CDI was already declining in response to infection control intervention when antimicrobial intervention began.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 04:28:31 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-van-Hees-2008">
<CHAR_METHODS MODIFIED="2015-08-09 01:45:04 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 04:26:43 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the Departments of Internal Medicine, Gastroenterology, Surgery, Urology, and Pulmonary Diseases<BR/>PARTICIPANTS: all patients in the same departments<BR/>CLINICAL PROBLEM: patients receiving ciprofloxacin<BR/>SETTING: 1 university hospital in the Netherlands</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 04:27:41 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings; educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>education, enablement, persuasion<BR/>DELIVERER: specialist physicians (microbiologists)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive (reduce unnecessary ciprofloxacin)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 04:27:45 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of ciprofloxacin in prescriptions/1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 04:28:31 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT:<B> Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 04:32:50 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Van-Kasteren-2005">
<CHAR_METHODS MODIFIED="2015-09-23 01:14:33 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 04:30:54 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospitals</P>
<P>PATIENTS: all patients undergoing elective surgery</P>
<P>CLINICAL PROBLEM: surgical prophylaxis across 4 surgical disciplines</P>
<P>SETTING: 14 hospitals in the Netherlands</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 04:31:32 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT, <B>Interventions: </B>audit and feedback; educational meetings with dissemination of guidelines<BR/>
<B>Intervention Functions: </B>education, enablement<BR/>
</P>
<P>DELIVERER: AMT</P>
<P>COMPARISON: pre-intervention periods</P>
<P>DESIRED CHANGE: reduce excessive duration of surgical prophylaxis</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 04:32:01 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure:</B> total antibiotic use in DDD/100 procedures</P>
<P>CLINICAL: <B>Balancing: </B>cohort data on surgical-site infections</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 04:32:50 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Netherlands Organisation for Health Research and Development (ZonMw). <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 10:30:41 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Volpe-2012">
<CHAR_METHODS MODIFIED="2015-09-23 01:28:49 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-18 10:30:41 -0500" MODIFIED_BY="Julia Worswick">
<P>PROVIDERS: all physicians in the ED<BR/>PARTICIPANTS: all patients with fever and suspected neutropenia<BR/>CLINICAL PROBLEM: fever and suspected neutropenia<BR/>SETTING: 1 university paediatric hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 04:38:11 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback with action planning; educational meetings with dissemination of care algorithm and forms to facilitate care; educational outreach by academic detailing; reminders (circumstantial, root-cause analysis of individual cases not meeting goal); reminders (physical, posters, email, and verbal, during rounds)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective, reduce time to first antibiotic dose</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 04:38:25 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>time (minutes) to first antbiotic dose</P>
<P>BALANCING MEASURE OF UNINTENDED CONSEQUENCES: "For balancing measures during the improvement period, we chose to follow the timeliness of first b-agonist treatment of patients with asthma and the left without being seen (LWBS) rate."</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 04:38:55 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT:<B> Funding: </B>no external funding. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 04:43:10 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Walker-1998">
<CHAR_METHODS MODIFIED="2015-09-23 01:40:00 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: RCT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 04:40:14 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: 50 patients (25 intervention, 25 control)<BR/>CLINICAL PROBLEM: duration of IV antibiotics for patients with community-acquired pneumonia<BR/>SETTING: 1 hospital in the USA<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 04:41:24 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>enablement, persuasion<BR/>A written recommendation to change from IV ceftriaxone to an oral regimen was placed in each patient's prescription chart by the pharmacist. Direct contact with prescribers was not possible "because the medical staff in community hospitals have a large variation in the hours in which they make rounds" and "the physician is frequently busy, phone calls usually involve multiple pharmacists".<BR/>DELIVERER: pharmacist<BR/>COMPARISON: standard practice (no intervention)<BR/>DESIRED CHANGE: reduce excessive</P>
<P>POWER CALCULATION: no information</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 04:41:41 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>number of patients changed to oral antibiotic therapy<BR/>CLINICAL: <B>Balancing: </B>re-admissions (total and for pneumonia)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 04:43:10 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>commercial, Pharmacia and Upjohn. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 04:47:18 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2014">
<CHAR_METHODS MODIFIED="2015-08-10 00:17:43 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 04:44:21 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in 16 adult ICUs<BR/>PARTICIPANTS: all patients in the ICUs<BR/>CLINICAL PROBLEM: use of target antibiotics in patients with positive blood cultures<BR/>SETTING: 1 University hospital in Taiwan</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 04:45:39 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention:</B> educational outreach by review and recommned change; restrictive by expert approval</P>
<P>
<B>Intervention Functions: </B>education, enablement, persuasion, restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive, reduce cost of antimicrobials by reducing unnecessary use</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 04:46:51 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>primary outcome is cost of all antimicrobials (Figure 4G). Also reports impact on use of 7 target antibacterials and use of antifungals in DDD/1000 OBD.</P>
<P>CLINICAL: <B>Balancing: </B>mortality, ICU re-admission (segmented regression analysis)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 04:47:18 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 04:51:43 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wax-2007">
<CHAR_METHODS MODIFIED="2015-10-10 01:52:29 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 04:49:37 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all anaesthetists in the hospital<BR/>PARTICIPANTS: all patients undergoing elective surgery<BR/>CLINICAL PROBLEM: time to first dose for antibiotic prophylaxis<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 04:51:38 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>reminders (physical, electronic on screen during all surgical procedures, not just those requiring prophylaxis)<BR/>
<B>Intervention Functions: </B>education, environmental restructuring, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 04:51:43 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> % patients with first dose within 1 hour of incision</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 02:08:07 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 04:56:32 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weinberg-2001">
<CHAR_METHODS MODIFIED="2017-01-08 04:52:45 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: controlled ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 04:53:39 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: operating theatre teams at participating hospitals</P>
<P>PARTICIPANGS: low-income women needing C-section</P>
<P>CLINICAL PROBLEM: infection after C-section</P>
<P>SETTING: 2 hospitals in Colombia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 04:55:08 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback in the form of run charts for the 2 key process measures (secondary outcomes) with data collected and displayed by the clinical teams; dissemination of flow charts with revised system for administration of prophylactic antibiotics<BR/>
<B>Intervention Functions: </B>education, enablement<BR/>DELIVERER: obstetric teams, doctors and nurses</P>
<P>COMPARISON: physician choice about antibiotic and timing</P>
<P>DESIRED CHANGE: reduce infection after C-section</P>
<P>TIMING: before clinical decision making; the intervention was continued for 2 years</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 04:55:58 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>percentage of women who received prophylaxis; percentage who received prophylaxis within 1 hour</P>
<P>CLINICAL: <B>Intended: </B>SSI rate per 100 C-sections</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 04:56:32 -0500" MODIFIED_BY="[Empty name]">
<P>INSTRUCTIONS: action plan provided, specific target but no specified time for target to be achieved</P>
<P>FINANCIAL SUPPORT: <B>Funding: </B>International Society for Infectious Diseases, Paul Schliesman Memorial Traveling Fellowship, and the Von L. Meyer Award. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 05:01:53 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weiner-2009">
<CHAR_METHODS MODIFIED="2015-08-10 00:58:55 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 04:59:16 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all attending emergency physicans, physician assistants, and emergency nurses<BR/>PARTICIPANTS: all patients with community-acquired pneumonia<BR/>CLINICAL PROBLEM: time to first antibiotic dose<BR/>SETTING: 1 university hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 05:01:09 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; reminders (physical, electronic - weekly emails)</P>
<P>
<B>Intervention Functions: </B>enablement, environmental restructuring, persuasion<BR/>DELIVERER: departmental nurse administrator<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 05:01:34 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> mean time to first antibiotic dose (minutes)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 05:01:53 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 13:48:23 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Weiss-2013">
<CHAR_METHODS MODIFIED="2017-01-18 13:48:23 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: cluster NRT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 05:07:13 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the ICU<BR/>PARTICIPANTS: all patients in the ICU<BR/>CLINICAL PROBLEM: receiving antibiotic treatment<BR/>SETTING: 1 University hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 05:08:00 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention:</B> reminder, verbal (on rounds) based on a scripted electronic checklist of issues to discuss about antibiotics</P>
<P>
<B>Intervention Functions: </B>environmental restructuring, persuasion<BR/>DELIVERER: departmental physicians<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 05:08:54 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> duration of empiric antibiotic treatment before narrowing choice, % patient days on which empiric antibiotics were used. <B>Exposure:</B> duration of all antibiotic treatment</P>
<P>CLINICAL: <B>Balancing: </B>mortality (total, standardised mortality ratio, and adjusted odds of death), length of hospital stay, length of ICU stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 05:13:15 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: National Heart, Lung, and Blood Institute (T32HL076139-07) and Parker B. Francis Fellowship to CHW. Dr Weiss has received funding from the National Institutes of Health. Drs Sung and Rho received a travel award to present a research abstract at American Thoracic Society conference in May 2012 from Northwestern University. Dr Wunderink is a board member for Pfizer and has consulted for Crucell (now Johnson &amp; Johnson), Trius, AstraZeneca, and GlaxoSmithKline. He has received grant support from bioMérieux and payment for lectures from the American Thoracic Society. The remaining authors have not disclosed any potential conflicts of interest.</P>
<P>ADDITIONAL DATA: online supplementary data for this article and further details of intervention in <LINK REF="REF-Weiss-2011" TYPE="REFERENCE">Weiss 2011</LINK>. No response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Welker-2008">
<CHAR_METHODS MODIFIED="2015-10-12 00:08:24 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: unintended consequences, cohort study</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 05:16:43 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the ED<BR/>PARTICIPANTS: 548 patients with an admission diagnosis of community-acquired pneumonia<BR/>CLINICAL PROBLEM: hospital admission diagnosis of community-acquired pneumonia<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 05:19:20 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; financial, institution incentive<BR/>
<B>Intervention Functions: </B>enablement, incentive<BR/>DELIVERER: departmental physicians (ED)<BR/>COMPARISON: usual care (before introduction of core quality measure of 4 hours' time to first antibiotic dose)<BR/>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 05:19:48 -0500" MODIFIED_BY="[Empty name]">
<P>UNINTENDED CONSEQUENCES: accuracy of admission diagnosis, antibiotic-associated adverse drug events</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey">
<P>ROBINS-I RISK OF BIAS CRITERIA:</P>
<P>1. Confounding: Low, confounding of the effect of intervention unlikely in this study</P>
<P>2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome</P>
<P>3. Measurement of interventions: Low, intervention status well defined, recorded at the time of intervention and unaffected by knowledge of the outcome or risk of the outcome</P>
<P>4. Departures from intended interventions: Low, no switches to other interventions or evidence of intervention failure</P>
<P>5. Missing data: Low, outcome data and intervention status complete in all 548 patients</P>
<P>6. Measurement of outcome: High, outcome measures not objective, and investigators were not blinded to intervention status</P>
<P>7. Selection of the reported result: Low, single analysis of prespecified outcomes</P>
<P>FINANCIAL SUPPORT: <B>Funding:</B> commercial: Pfizer, US Pharmaceutical Corporation. <B>Competing Interests:</B> none declared.</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 05:25:37 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wenisch-2014">
<CHAR_METHODS MODIFIED="2015-08-15 02:29:25 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 05:23:36 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients receiving moxifloxacin<BR/>SETTING: 1 university hospital in Austria</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 05:24:54 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>educational meetings; restrictive by compulsory order form</P>
<P>
<B>Intervention Functions: </B>education, restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 05:24:57 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of moxifloxacin in DDD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 05:25:37 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias:</B> Low for case definition, planned intervention, and other infection control</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 05:31:30 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Willemsen-2010">
<CHAR_METHODS MODIFIED="2015-09-25 01:04:28 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 05:28:04 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients receiving therapeutic antibiotics<BR/>CLINICAL PROBLEM: decrease use of ciprofloxacin<BR/>SETTING: 1 hospital in the Netherlands</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 05:29:51 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings with dissemination of guidelines; educational outreach by review and recommend change; reminders (physical, newsletter and on all microbiology reports saying that ciprofloxacin should be prescribed on strict indications only)<BR/>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 05:30:11 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>prescribed daily doses of ciprofloxacin (IV and oral)</P>
<P>MICROBIAL: % quionolone-resistant gram-negative clinical isolates</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 05:31:30 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> Amphia Hospital, Breda/Oosterhout, Netherlands. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias:</B> <B>LOW </B>Case definition infection with quionolone-resistant gram-negative bacteria, Planned intervention Low, Other infection control Low, no changes (information in Discussion)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 05:33:51 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilson-1991">
<CHAR_METHODS MODIFIED="2015-09-25 01:17:56 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 05:33:24 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients receiving amoxicillin or pivampicillin<BR/>SETTING: 3 hospitals in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 05:33:51 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>dissemination of newsletter to all prescribers</P>
<P>
<B>Intervention Function: </B>education</P>
<P>DELIVERER: pharmacists<BR/>COMPARISON: 5 months before introduction of the newsletter<BR/>DESIRED CHANGE: reduce excessive<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-12-07 01:54:31 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of amoxicillin and pivampicillin<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-06 02:12:54 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Winters-2010">
<CHAR_METHODS MODIFIED="2015-10-12 00:19:12 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: unintended consequences, cohort study</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 05:37:10 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: 3251 patients receiving antibiotics<BR/>CLINICAL PROBLEM: time to first antibiotic dose<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 05:39:25 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>restrictive by prior approval<BR/>
<B>Intervention Functions: </B>restriction<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care, 10 restricted vs 15 unrestricted antibiotics; daytime (8 am to 10 pm) when prior approval is required vs nighttime (10 pm to 8 am) when the first dose of all antimicrobials was exempted<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 05:39:50 -0500" MODIFIED_BY="[Empty name]">
<P>UNINTENDED CONSEQUENCES: delays of &gt; 1 hour or &gt; 2 hours in TFAD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey">
<P>ROBINS-I RISK OF BIAS CRITERIA:</P>
<P>1. Confounding: Low, confounding of the effect of intervention unlikely in this study</P>
<P>2. Selection of participants into the study: Low, selection into the study unrelated to intervention or outcome</P>
<P>3. Measurement of interventions: Low, intervention status well defined, recorded at the time of intervention and unaffected by knowledge of the outcome or risk of the outcome</P>
<P>4. Departures from intended interventions: Low, no switches to other interventions or evidence of intervention failure</P>
<P>5. Missing data: Low, outcome data and intervention status complete in all 3251 patients</P>
<P>6. Measurement of outcome: Low, outcome measures objective and ascertained from patient administration system</P>
<P>7. Selection of the reported result: Low, single analysis of prespecified outcomes</P>
<P>FINANCIAL SUPPORT: no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 13:49:01 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Wishaupt-2011">
<CHAR_METHODS MODIFIED="2017-01-18 13:49:01 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: NRT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 05:43:01 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: 614 children &lt; 12 years old (309 intervention, 305 control)<BR/>CLINICAL PROBLEM: acute respiratory infections (NB only 2/3 of randomised patients admitted to hospital)<BR/>SETTING: 1 hospital in the Netherlands</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 05:44:34 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>structural, rapid reporting of microbiology results</P>
<P>
<B>Intervention Function: </B>environmental restructuring<BR/>DELIVERER: specialist physician (Microbiology)<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 05:45:15 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>% treated with antibiotics and duration if treated</P>
<P>CLINICAL: <B>Intended: </B>length of stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 05:46:15 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT:<B> Funding:</B> Research Activity Committee of the Reinier de Graaf Hospital (project 620604). <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: email response and additional files (protocol) from authors</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 05:51:08 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Woodward-1987">
<CHAR_METHODS MODIFIED="2015-09-25 01:49:36 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 05:47:50 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: inpatient prescribing of all antibiotics<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 05:50:17 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>educational meetings; restrictive by expert approval, automatic stop order after 72 hours' treatment, and by removal from formulary<BR/>
<B>Intervention Functions: </B>education, restriction<BR/>DELIVERER: specialist physician (ID)<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 05:50:23 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING and FINANCIAL: total antibiotic costs and average antibiotic cost per day</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 05:51:08 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding:</B> administration of Barnes Hospital. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 05:57:39 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wyatt-1998">
<CHAR_METHODS MODIFIED="2017-01-08 05:54:17 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: cluster RCT, hospital level</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 05:56:32 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: a total of 25 hospitals, 13 control and 12 intervention, targeting 2 providers (lead obstetrician and senior midwife manager) in each hospital<BR/>PARTICIPANTS: 1318 episodes of care in 1318 patients, 25 clusters (hospitals)<BR/>CLINICAL PROBLEM: administration of prophylactic antibiotics to women undergoing Caesarean section. The intervention also targeted 3 other care processes.<BR/>SETTING: 25 district general (non-teaching) hospitals</P>
<P>POWER CALCULATION: As only 25 obstetric units were available for randomisation, and accurate baseline figures for the rates and variability of the 4 marker clinical practices were not available, sample size calculation was not carried out.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 05:57:10 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: educational meeting with dissemination of guideline and slides</P>
<P>COMPARISON: 13 control hospitals with no intervention</P>
<P>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 05:57:15 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>% women that received antibiotic prophylaxis<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 05:57:39 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>regional research implementation initiatives of the North Thames and South Thames regional health authorities; the Imperial Cancer Research Fund; and North Staffordshire Hospital Trust. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 06:12:24 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yealy-2005">
<CHAR_METHODS MODIFIED="2017-01-08 06:02:14 -0500" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: cluster RCT, hospital level</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 06:02:36 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the ED<BR/>PARTICIPANTS: 2075 patients admitted from ED (849 intervention, 1227 control), 32 clusters (EDs)<BR/>CLINICAL PROBLEM: community-acquired pneumonia<BR/>SETTING: 32 EDs in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 06:07:51 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: low-intensity (control, 8 hospitals); moderate-intensity (12 hospitals); and high-intensity (12 hospitals) interventions</P>
<P>
<B>Low-intensity intervention: </B>audit and feedback of baseline data; dissemination of guidelines</P>
<P>
<B>Low-intensity invervention functions: </B>education, enablement</P>
<P>
<B>Moderate-intensity intervention: </B>same as low intensity, but with additional on-site educational meeting before patient enrolment</P>
<P>
<B>Moderate-intensity intervention additional function: </B>education</P>
<P>
<B>High-intensity intervention: </B>same as moderate with additional audit and feedback of data about management of individual patients within a week of enrolment plus 2 monthly feedback of group performance data; educational outreach through academic detailing with Plan Do Study Act cycles to discuss actions to be taken in response to group performance data</P>
<P>
<B>High-intensity intervention additional functions: </B>education, enablement, persuasion</P>
<P>DELIVERER: departmental physicians</P>
<P>COMPARISON: usual care</P>
<P>DESIRED CHANGE: increase effective: 4 process measures including time to first antibiotic dose</P>
<P>POWER CALCULATION: Primary outcome was site of treatment rather than the antibiotic process measures. "We estimated that we would need 96 eligible patients per hospital (3072 in total) to achieve 80% power to detect a 12% difference across the intervention groups for the site-of-treatment decision among low-risk patients."</P>
<P>"For the site-of-treatment decision, this study achieved greater than 80% power to detect differences of 10% between high-intensity and moderate-intensity groups and differences of 12% between high-intensity and low-intensity groups according to separate 1-tailed tests in which the level was 0.025."</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 06:08:45 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>time to first antibiotic dose and choice compliant with guideline</P>
<P>CLINICAL: <B>Intended:</B> mortality and medical complications<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 06:12:24 -0500" MODIFIED_BY="[Empty name]">
<P>INSTRUCTIONS: action plan provided, no explicit target</P>
<P>FINANCIAL SUPPORT: <B>Funding:</B> Agency for Healthcare Research and Quality (grant number R01 HS10049). National Institute of Allergy and Infectious Diseases (grant number K24 AI001769). <B>Competing Interests:</B> 1 author received consultancies, honoraria or grants from Genesoft Pharmaceuticals, Zynx Health Corporation, Healthcare Communications Inc., Stephen Lynn Klein, Kellogg Grants, and Pfizer Inc.</P>
<P>ADDITIONAL DATA: email response from authors to request for additional data with care pathway, slide sets, order sheets, and protocol (<LINK REF="REF-Yealy-2004" TYPE="REFERENCE">Yealy 2004</LINK>)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 06:19:44 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yeo-2012">
<CHAR_METHODS MODIFIED="2015-09-26 00:50:26 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: CITS</P>
<P>
<B>Risk of Bias: LOW</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 06:16:09 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians<BR/>PARTICIPANTS: all patients receiving therapeutic antibiotics<BR/>CLINICAL PROBLEM: use of all carbapenems (ertapenem, imipenem, and meropenem), 3rd- and 4th-generation cephalosporins (ceftriaxone, ceftazidime, and cefepime), piperacillin/tazobactam, and vancomycin<BR/>SETTING: 1 cancer hospital in Singapore</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 06:17:54 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>audit and feedback; educational outreach by review and recommend change<BR/>
<B>Intervention Functions: </B>enablement, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 06:18:09 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of target antibiotics in DDD/1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 06:19:44 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding</B>: none. <B>Competing Interests:</B> 1 author received research funding and speaker&#8217;s honoraria from Pfizer, AstraZeneca, Janssen-Cilag, and Merck Sharp &amp; Dohme.</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 06:24:49 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yong-2010">
<CHAR_METHODS MODIFIED="2015-09-29 01:01:07 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 06:22:26 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients receiving therapeutic antibiotics<BR/>CLINICAL PROBLEM: use of broad-spectrum antibiotics (3rd- and 4th-generation cephalosporins, aminoglycosides, antipseudomonal penicillins, carbapenems, fluoroquinolones)<BR/>SETTING: 1 hospital in Australia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 06:23:14 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>structural, computerised decision support system<BR/>
<B>Intervention Functions: </B>enablement, environmental restructuring, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 06:23:25 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of broad-spectrum antibiotics in DDD/1000 OBD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 06:24:49 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Victorian Department of Human Services Quality Branch and Australian Commonwealth Biotechnology Information Fund, which funded the development of Guidance DS. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: email from authors with additional data about intervention (<LINK REF="STD-Richards-2003" TYPE="STUDY">Richards 2003</LINK>; <LINK REF="REF-Thursky-2006" TYPE="REFERENCE">Thursky 2006</LINK>)</P>
<P>
<B>Microbial Risk of Bias: MEDIUM</B> (Other infection control High)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 13:22:13 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Yoon-2014">
<CHAR_METHODS MODIFIED="2015-08-18 00:48:22 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 06:27:58 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: requiring therapeutic antibiotics and receiving carbapenems<BR/>SETTING: 1 university hospital in Korea, same hospital as <LINK REF="STD-Kim-2008" TYPE="STUDY">Kim 2008</LINK>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 06:29:53 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention 1: </B>restrictive by expert approval (same intervention format as <LINK REF="STD-Kim-2008" TYPE="STUDY">Kim 2008</LINK>)</P>
<P>
<B>Intervention 1 functions: </B>restriction</P>
<P>
<B>Intervention 2: </B>addition of reminders (circumstantial, electronic triggered by computerised antibiotic order, the system is described in more detail in <LINK REF="STD-Kim-2008" TYPE="STUDY">Kim 2008</LINK>)<BR/>
<B>Intervention 2 functions: </B>enablement, environmental restructuring, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 06:30:56 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice:</B> use of carbapenems in DDD/1000 OBD</P>
<P>MICROBIAL: infections with CRAB (carbapenem-resistant <I>Acinetobacter baumanii</I>)/1000 OBD</P>
<P>CLINICAL: <B>Balancing measures of adverse effects</B>, all-cause mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-18 13:22:13 -0500" MODIFIED_BY="Julia Worswick">
<P>FINANCIAL SUPPORT: <B>Funding:</B> commercial, Merck Sharp &amp; Dohme. <B>Competing Interests: </B>supported by Merck Sharp &amp; Dohme Corp.</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias:</B> <B>HIGH </B>case definition Low, planned intervention Low, other infection control High, ICU cleaning intervention during Phase 3</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-08 06:38:11 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Young-1985">
<CHAR_METHODS MODIFIED="2015-09-26 01:46:20 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: ITS</P>
<P>
<B>Risk of Bias: MEDIUM</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 06:34:53 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians in the hospital<BR/>PARTICIPANTS: all patients in the hospital<BR/>CLINICAL PROBLEM: patients requiring aminoglycoside antibiotic treatment<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 06:35:57 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Interventions: </B>restrictive by review and make change (substitution of amikacin for gentamicin) and expert approval from the Infectious Diseases Division<BR/>
<B>Intervention Function: </B>restriction<BR/>DELIVERER: pharmacist</P>
<P>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 06:36:12 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>gentamicin usage as a percentage of total aminoglycoside usage<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 06:38:11 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Veterans Adminstration and Bristol-Myers Squibb. <B>Competing Interests:</B> none declared, but Bristol-Myers Squibb was the manufacturer of amikacin</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 13:22:31 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Yu-2014">
<CHAR_METHODS MODIFIED="2015-09-26 01:53:53 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: CBA</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 06:40:49 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all physicians<BR/>PARTICIPANTS: all patients<BR/>CLINICAL PROBLEM: patients receiving therapeutic antibiotics<BR/>SETTING: 5 hospitals in an integrated healthcare system in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 06:41:51 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention:</B> educational outreach through review and recommend change in 2 hospitals</P>
<P>
<B>Intervention Functions: </B>enablement, persuasion<BR/>DELIVERER: AMT<BR/>COMPARISON: usual care in 3 hospitals<BR/>DESIRED CHANGE: decrease excessive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 06:42:41 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Choice: </B>use of target antibiotics in DDD/1000 OBD</P>
<P>CLINICAL: hospital standardised mortality ratio</P>
<P>MICROBIAL: <I>Clostridium difficile </I>infection rates</P>
<P>FINANCIAL: total and direct acquisitional cost of targeted antimicrobials</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-18 13:22:31 -0500" MODIFIED_BY="Julia Worswick">
<P>FINANCIAL SUPPORT: <B>Funding: </B>none. <B>Competing Interests:</B> none declared</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
<P>
<B>Microbial Risk of Bias:</B> <B>HIGH </B>case definition Not Clear, planned intervention Low, other infection control measures Not Clear</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-18 13:29:22 -0500" MODIFIED_BY="Julia Worswick" STUDY_ID="STD-Zanetti-2003">
<CHAR_METHODS MODIFIED="2017-01-18 13:29:22 -0500" MODIFIED_BY="Julia Worswick">
<P>STUDY DESIGN: NRT</P>
<P>
<B>Risk of Bias: HIGH</B>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-08 06:45:01 -0500" MODIFIED_BY="[Empty name]">
<P>PROVIDERS: all surgeons in the hospital<BR/>PARTICIPANTS: 331 patients undergoing cardiac surgery<BR/>CLINICAL PROBLEM: additional dose of antibiotic prophylaxis for operations that lasted more than 4 hours<BR/>SETTING: 1 hospital in the USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-08 06:46:56 -0500" MODIFIED_BY="[Empty name]">
<P>FORMAT: <B>Intervention: </B>dissemination of guideline; reminder (circumstantial, electronic, automated intra-operative alert)</P>
<P>
<B>Intervention Functions: </B>education, enablement, environmental restructuring, persuasion<BR/>COMPARISON: control group plus 480 patients from the 6 months before the study period<BR/>DESIRED CHANGE: increase effective</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-08 06:47:06 -0500" MODIFIED_BY="[Empty name]">
<P>PRESCRIBING: <B>Exposure: </B>% patients who received additional intra-operative antibiotics</P>
<P>CLINICAL: <B>Intended: </B>wound infection rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-08 06:47:29 -0500" MODIFIED_BY="[Empty name]">
<P>FINANCIAL SUPPORT: <B>Funding: </B>Centers for Disease Control and Prevention cooperative agreement, UR8/CCU115079, University Hospital of Lausanne, and the Leenaards Foundation. <B>Competing Interests:</B> no information</P>
<P>ADDITIONAL DATA: no response from authors to request for additional data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>AB: antibiotic<BR/>AKI: acute kidney injury<BR/>AMT: multidisciplinary antibiotic management team<BR/>APACHE: Acute Physiology and Chronic Health Evaluation<BR/>ARGNB: antibiotic-resistant gram-negative bacilli<BR/>ARGPB: antibiotic-resistant gram-positive bacilli<BR/>ARIMA: autoregressive integrated moving average<BR/>ASP: Antimicrobial Stewardship Program<BR/>BCT: behaviour change technique<BR/>CAP: community-acquired pneumonia<BR/>CBA: controlled before-after study<BR/>CBC: complete blood count<BR/>CDAD: Clostridium difficile-associated diarrhoea<BR/>CDC: Centers for Disease Control and Prevention<BR/>CDI: Clostridium difficile infection<BR/>CDSS: clinical decision support system<BR/>CI: confidence interval<BR/>CITS: comparative interrupted time series<BR/>CPIS: clinical pulmonary infection score<BR/>CRP: C-reactive protein<BR/>C-section: Caesarean section<BR/>DACT: double anaerobic coverage therapy<BR/>DDD: defined daily dose<BR/>DRG: diagnosis-related group<BR/>ED: emergency department<BR/>EPOC: Effective Practice and Organisation of Care<BR/>ER: emergency room<BR/>ESBL-EB: extended-spectrum beta-lactamase-producing Enterobacteriaceae<BR/>FTE: full-time equivalent<BR/>GRE: glycopeptide-resistant enterococci<BR/>IC: infectious control<BR/>ICD: International Classification of Diseases<BR/>ICU: intensive care unit<BR/>ID: infectious diseases<BR/>IDP: infectious diseases physician<BR/>IHC: Intermountain Healthcare<BR/>IL-8: interleukin-8<BR/>ITS: interrupted time series<BR/>IQR: interquartile range<BR/>IV: intravenous<BR/>LOS: length of stay<BR/>MRSA: methicillin-resistant Staphylococcus aureus<BR/>MSSA: methicillin-sensitive Staphylococcus aureus<BR/>LRTI: lower respiratory tract infection<BR/>MICU: medical intensive care unit<BR/>NHAP: nursing home-acquired pneumonia<BR/>NIH: National Institutes of Health<BR/>NRT: non-randomised (controlled) trial<BR/>NRSI: non-randomised studies of interventions<BR/>OBD: occupied bed day<BR/>OR: odds ratio<BR/>PA: parenteral antibiotics<BR/>PCR: polymerase chain reaction<BR/>PCT: procalcitonin<BR/>RCT: randomised controlled trial<BR/>RCOG: Royal College of Obstetricians and Gynaecologists<BR/>RDD: recommended daily doses<BR/>ROB: risk of bias<BR/>ROBINS-I: risk of bias in non-randomised studies of interventions<BR/>RR: risk ratio<BR/>SCIP: Surgical Care Improvement Project<BR/>SD: standard deviation<BR/>SE: standard error<BR/>SHEA: Society for Healthcare Epidemiology of America<BR/>SICU: surgical intensive care unit<BR/>SNF: skilled nursing facilities<BR/>SSI: surgical-site infection<BR/>TFAD: time to first antibiotic dose<BR/>TREAT: computerised decision support system for antibiotic treatment<BR/>UBA: uncontrolled before-after study<BR/>VAP: ventilator-associated pneumonia<BR/>VRE: vancomycin-resistant enterococci<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2017-01-31 09:08:20 -0500" MODIFIED_BY="Petrer Davey" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2017-01-04 18:59:23 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ahronheim-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 18:59:23 -0500" MODIFIED_BY="[Empty name]">
<P>RCT with no relevant data. Antibiotics were only part of a complex care plan for 6% of participants in the intervention group, and the outcome data do not include information about the effect of the intervention on antibiotic prescribing.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 18:59:49 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bruno_x002d_Murtha-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 18:59:49 -0500" MODIFIED_BY="[Empty name]">
<P>ITS of antibiotic cycling with no interpretable data because there are no pre-cycling data. Only provides data for 4 phases of cycling.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:00:15 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burke-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:00:15 -0500" MODIFIED_BY="[Empty name]">
<P>ITS with no interpretable data. 2 different interventions (education, then restriction via order form) with 3 points before the education intervention and 3 after, but the restriction intervention started after the 4th point.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:02:43 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cook-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:02:43 -0500" MODIFIED_BY="[Empty name]">
<P>ITS with no interpretable data because no clearly defined point in time at which the intervention started.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Crist-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey">
<P>NRT with no interpretable data. Unacceptable allocation bias ("the allocation of a patient to a particular group was determined by the attending physician").</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-02 01:42:13 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cunningham-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-02 01:42:13 -0400" MODIFIED_BY="[Empty name]">
<P>ITS with no relevant data. The only valid outcome data are about compliance with a guideline about generic documentation of prescription rather than any specific antibiotic prescribing outcome. The data about time to first antibiotic dose are UBA. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:03:01 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dellinger-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:03:01 -0500" MODIFIED_BY="[Empty name]">
<P>ITS with no interpretable data because no clearly defined point in time at which the intervention started. Only 4 data points for antibiotic use, and the intervention included multiple components in addition to antibiotic use, so even if an intervention effect could be calculated reliably it could not be attributed to change in antibiotic prescribing.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:03:36 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Destache-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:03:36 -0500" MODIFIED_BY="[Empty name]">
<P>RCT with no interpretable data because of incomplete and selective reporting of outcome data. The primary outcome measure was length of stay, but 32% of participants in the intervention group were excluded because they had prolonged length of stay.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:05:07 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ehrenkranz-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:05:07 -0500" MODIFIED_BY="[Empty name]">
<P>RCT with no interpretable data. Only report data for participants whose physicians followed recommendations.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:05:33 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ehrenkranz-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:05:33 -0500" MODIFIED_BY="[Empty name]">
<P>RCT with no interpretable data. Only report data for participants whose physicians followed recommendations.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Evans-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 02:27:29 -0500" MODIFIED_BY="Petrer Davey">
<P>NRT with no interpretable data. The first part compared the drugs that the Antibiotic Consultant programme recommended, with the drugs actually prescribed by physicians. Data from the second part are presented in an uninterpretable format, with the denominator as cultures, not participants or physicians.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:07:29 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Foy-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:07:29 -0500" MODIFIED_BY="[Empty name]">
<P>Cluster RCT with no relevant data. Intervention targeted 5 care processes for women having an abortion. Only 1 included antibiotic prescribing within a composite (antibiotic prophylaxis or screening for lower genital tract organisms). Effect of intervention on prescribing cannot be estimated.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:11:50 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garcia_x002d_San-Miguel-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:11:50 -0500" MODIFIED_BY="[Empty name]">
<P>Cluster RCT with no interpretable data. The study included 9 hospitals with 32 hospitalisation units (wards). Patients were included if they had drugs dispensed from an electronic system.</P>
<P>Baseline: Jan-June 2003 baseline, no intervention</P>
<P>1. Jan-June 2004, intervention in half of the wards that were randomised in each hospital</P>
<P>2. Jan-June 2005, cross-over, intervention in wards that were randomised to control in Period 2</P>
<P>There is no description of the randomisation process. The primary outcome measure was adherence to recommendations; text on page 658 says they do not present data about mortality or re-admission, but that appears to be what is in Figure 4. Figure 4: legend (and text) says it is about DDD and cost of drugs, but labelling says it is mortality and re-admission. We asked authors to clarify and provide valid outcome data but received no reply.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:12:34 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gerding-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:12:34 -0500" MODIFIED_BY="[Empty name]">
<P>ITS with no interpretable data. Describes 10 years of experience with aminoglycoside cycling, but the intervention periods cannot be mapped onto the outcome data about prescribing or resistance.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-31 09:08:20 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Kolar-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-31 09:08:20 -0500" MODIFIED_BY="Petrer Davey">
<P>ITS with no interpretable data due to inadequate control for the effect of other interventions (infection control measures; see detailed critique by <LINK REF="REF-Monnet-2000" TYPE="REFERENCE">Monnet 2000</LINK>).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:14:37 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lan-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:14:37 -0500" MODIFIED_BY="[Empty name]">
<P>ITS with unacceptable missing data and inappropriate statistical analysis. There are 3 monthly data points pre-intervention, then a gap in colonisation data for 3 months at the start of the intervention period followed by 3 monthly data points from months 4 to 6 of the intervention phase.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:19:20 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:19:20 -0500" MODIFIED_BY="[Empty name]">
<P>ITS with no interpretable data. There were no isolates of ESBL-<I>Klebsiella pneumoniae</I> in the last 3 months of the intervention phase, but no data are provided about the number of specimens screened. Appropriate statistical analysis in original paper not done (averages pre- and postintervention with &#967;<SUP>2</SUP> and Fisher's exact test). Re-analysis not possible because there are only 2 reliable data points in the postintervention phase.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-15 03:39:35 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-MacCosbe-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-15 03:39:35 -0500" MODIFIED_BY="Petrer Davey">
<P>RCT with no interpretable data. Only 29% of randomised doctors were followed up, and recommendations were only made in 6% of the intervention group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:20:30 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marrie-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:20:30 -0500" MODIFIED_BY="[Empty name]">
<P>Cluster RCT with no relevant data. Antibiotic prescribing was only 1 component of a care pathway, results for impact on antibiotic prescribing and its contribution to outcome not reported separately.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:21:01 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Martin-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:21:01 -0500" MODIFIED_BY="[Empty name]">
<P>ITS with no interpretable data. No antibiotic data pre-intervention, only data about MRSA; this information is uninterpretable without information about pre-intervention antibiotic prescribing.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 19:21:27 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McGregor-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 19:21:27 -0500" MODIFIED_BY="[Empty name]">
<P>RCT with no interpretable data. Statistical analysis of primary outcome measure (antibiotic costs) not done, and re-analysis not possible from the data presented.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 21:51:48 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nagao-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 21:51:48 -0500" MODIFIED_BY="[Empty name]">
<P>ITS with no interpretable data. Figure 1 reports the number of participants with inappropriate antibiotic use, consultations, significant laboratory test results, and total number of blood cultures obtained. However, the number of participants in each category is not clear in the figure. We asked the authors for raw data but they were unable to provide this information.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 02:27:30 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Naughton-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 02:27:30 -0500" MODIFIED_BY="Petrer Davey">
<P>Cluster RCT in 10 skilled nursing facilities. The intention was to increase use of IV antibiotics for severe pneumonia. The comparison was between the same intervention delivered by a multidisciplinary team (intervention) versus a physician (control). There was no difference in the intervention effect, but the study provides no reliable evidence of intervention effect (UBA data in all 10 skilled nursing facilities).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 02:27:30 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Pastel-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 02:27:30 -0500" MODIFIED_BY="Petrer Davey">
<P>NRT in 1 hospital, no interpretable data because no protection against contamination and unreliable primary outcome measure.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-10-18 01:13:46 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ronning-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-10-18 01:13:46 -0400" MODIFIED_BY="[Empty name]">
<P>RCT with no relevant data. Not primarily an intervention on antibiotic therapy, compared stroke unit versus general medical ward.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 02:27:30 -0500" MODIFIED_BY="Petrer Davey" STUDY_ID="STD-Sanazaro-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 02:27:30 -0500" MODIFIED_BY="Petrer Davey">
<P>NRT with no relevant data. Antibiotic prescribing was only 1 of 3 components of a care pathway, results for impact on antibiotic prescribing and its contribution to outcome not reported separately.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 22:01:36 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Takahashi-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 22:01:36 -0500" MODIFIED_BY="[Empty name]">
<P>ITS with no interpretable data. The only time series data (Figures 2 and 3) are MRSA and <I>Pseudomonas aeruginosa</I> infections. The paper claims that a prophylaxis intervention in early 2007 was responsible for reduction in <I>P aeruginosa</I> and MRSA infections, whereas the figures clearly show the reduction happened between July and December 2006. The paper does not include valid data about prescribing outcomes, and the authors were unable to provide these data.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-03-18 13:44:31 -0400" MODIFIED_BY="Kate Cahill" STUDY_ID="STD-Thomas-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-03-18 13:44:31 -0400" MODIFIED_BY="Kate Cahill">
<P>CBA in 64 hospitals, no interpretable data because no clear point in time for the intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-10-20 00:47:02 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tiley-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-10-20 00:47:02 -0400" MODIFIED_BY="[Empty name]">
<P>ITS with no interpretable data. Multiple interventions are described without clear definition of intervention points.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 22:02:42 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tsiata-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 22:02:42 -0500" MODIFIED_BY="[Empty name]">
<P>RCT with no interpretable data. These are provider interventions, but allocation was by patient randomisation. The unequal numbers of patients in each group (134 Group A, 141 Group B, and 105 Group C) and the differences in baseline characteristics indicate unacceptable allocation bias.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-03-18 14:04:37 -0400" MODIFIED_BY="Kate Cahill" STUDY_ID="STD-Van-Loon-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-03-18 14:04:37 -0400" MODIFIED_BY="Kate Cahill">
<P>ITS with no interpretable data about the impact of antibiotic cycling on resistance because there are no pre-cycling data.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-04 22:04:39 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wahlstrom-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-04 22:04:39 -0500" MODIFIED_BY="[Empty name]">
<P>RCT with no relevant data. Antibiotics included in the indicators for treatment of hospitalised cases of pneumonia (compliance with policy, dose and duration) and diarrhoea (no use of antibiotics without bacterial identification), but no separate data are presented for these outcomes. The only data provided are mean scores on a single composite indicator for each condition.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>CBA: controlled before-after study<BR/>DDD: defined daily dose<BR/>ESBL: extended-spectrum beta-lactamase<BR/>ITS: interrupted time series<BR/>MRSA: methicillin-resistant <I>Staphylococcus aureus</I>
<BR/>NRT: non-randomised trial<BR/>RCT: randomised controlled trial<BR/>UBA: uncontrolled before-after study</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2017-01-19 09:04:16 -0500" MODIFIED_BY="Julia Worswick" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2017-01-18 13:29:17 -0500" MODIFIED_BY="Julia Worswick">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2017-01-18 13:29:17 -0500" MODIFIED_BY="Julia Worswick" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 01:59:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-24 00:51:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Annane-2013">
<DESCRIPTION>
<P>Computer generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 09:16:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:03:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION>
<P>"Physicians of patients considered candidates for intervention were randomised to be either contacted by the clinical pharmacist ... or to be observed"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:27:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bell-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:29:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Benson-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Berild-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:21:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION>
<P>Computer-generated randomisation sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:30:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION>
<P>"We randomly classified the patients ... into 3 different group by means of a computer assisted random list"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-28 02:41:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION>
<P>Computer generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:18:09 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 03:04:50 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION>
<P>Quasi-randomised. "Patients were randomised on the basis of the sum of the day and month of their date of birth ... even numbers assigned to the control group ... odd number to the intervention group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 04:28:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:52:00 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Burton-1991">
<DESCRIPTION>
<P>"Random numbers table used to assign 9 of 17 house staff teams to the intervention group. Patients allocated to intervention or control groups based on house staff team to which they were admitted. The other 8 teams were assigned as control groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:52:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Calil-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:17:30 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Camins-2009">
<DESCRIPTION>
<P>Each month, 6 internal medicine teams were randomly assigned to the intervention arm, and 6 teams were randomly assigned to the control group by means of a random number list.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:25:00 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carling-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:42:26 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:52:50 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:58:57 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 19:08:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION>
<P>"We randomly assigned eligible patients ... according to a computer generated week wise randomisation scheme"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:02:39 -0400" MODIFIED_BY="Kate Cahill" RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION>
<P>"Patients were randomly assigned to one of the two groups by sealed opaque envelopes", no information about generation of randomisation sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 09:49:13 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chu-2003">
<DESCRIPTION>
<P>Control cohort study (CBA)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 01:44:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION>
<P>Odd versus even hospital number</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Climo-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-31 01:53:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION>
<P>Computer generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 09:56:16 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dean-2001">
<DESCRIPTION>
<P>CBA</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:54:25 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dean-2006">
<DESCRIPTION>
<P>CBA</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:05:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 00:07:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ding-2013">
<DESCRIPTION>
<P>Computer-generated numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:06:53 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION>
<P>"Randomised on a one to one basis via a computer generated list"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dua-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dull-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-23 01:10:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION>
<P>Computer generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:15 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-23 02:08:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION>
<P>Computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:57:23 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fine-2003">
<DESCRIPTION>
<P>Physician groups were randomly assigned after stratification for practice type, group size, and patient volume, but details not clear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:08:41 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Franz-2004">
<DESCRIPTION>
<P>"Randomly assigned to 1 or 2 diagnostic algorithms using sealed opaque envelopes"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 18:31:06 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION>
<P>"Patients randomised ... using an unblocked computer generated random number table"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 18:44:06 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION>
<P>CBA - not randomised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:19:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION>
<P>Random number generator used (detailed in other article).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:25:35 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gums-1999">
<DESCRIPTION>
<P>Method of sequence generation not clear; "eligible patients were blindly randomised to the intervention or control group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:12 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halm-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hess-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:59:22 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION>
<P>No explanation of randomisation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huber-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:57 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:32:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION>
<P>Randomisation was performed 1:1 using a computerised algorithm created by the database manager.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:47:39 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Jump-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:59:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION>
<P>Done, computer-generated randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:04:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION>
<P>Computer-generated list by independent epidemiologist</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khan-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kim-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:28:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION>
<P>Computer generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:34:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION>
<P>Computerised random number generator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:10:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION>
<P>Excel-generated random numbers table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 00:56:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:20:59 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION>
<P>CBA; "hospitals were paired being matched as far as possible for type size and surgical load"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landman-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:56:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Layios-2012">
<DESCRIPTION>
<P>"patients were prospectively randomized", but no information about how</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:19:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:15:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION>
<P>Eligible patients were allocated to either the intervention or the control group using a computer-generated randomisation list, which was maintained independently of the IDP.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:04 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-04 01:03:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2013">
<DESCRIPTION>
<P>Random number table method</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:54:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Long-2014">
<DESCRIPTION>
<P>"Allocation to either intervention was conducted according to computer-generated random numbers produced by an independent statistician."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:53:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION>
<P>Computer-generated randomisation scheme</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:08:28 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:04:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Masia-2008">
<DESCRIPTION>
<P>Eligible prescriptions were allocated daily to either the intervention or the control group using a computer-generated randomisation list.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:19:17 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:03:38 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:36:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:22:41 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 18:00:53 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Micek-2004">
<DESCRIPTION>
<P>"Patients were randomly assigned", but no details of how the sequence was generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mol-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Newland-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:31:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION>
<P>The randomisation was performed using a computer-based random number generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:45:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION>
<P>Randomisation was performed using a table of computer-generated random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:56:04 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION>
<P>"Patients were randomly allocated ... by means of a computer generated table"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:07:13 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION>
<P>Does not say how groups were allocated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-01 02:15:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION>
<P>The order of implementation of the intervention on the 6 clinical services was determined by random number generation performed by a statistician uninvolved in daily stewardship activities.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:52:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Patel-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:01:44 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paul-2006">
<DESCRIPTION>
<P>"Wards were randomly allocated ... by drawing a random code from a closed opaque box"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:11:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pear-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:50:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Peto-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pires-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Po-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 00:43:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION>
<P>Random number generator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Price-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:12:29 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qu-2012">
<DESCRIPTION>
<P>Says it was randomised, but no further information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:55:17 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION>
<P>By hospital number, even number in last digit received intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richards-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ross-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salama-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-30 01:17:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION>
<P>Computer, by hospital</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-30 01:23:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION>
<P>Blinded researcher coin flip, hospital level</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-08 01:33:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 10:24:40 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION>
<P>Prespecified, computer-generated randomisation list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:59:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:17:04 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Senn-2004">
<DESCRIPTION>
<P>"Patients allocated ... by using a computer generated randomizations list"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:27:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION>
<P>Patients were variable block randomised 1:1 via a secured central study website into either a PCT-guided (PCT) group or clinician-guided (standard care) group. Randomisation was stratified according to the presence of septic shock (defined by the receipt of inotropes and/or any vasopressors within the previous 24 hours).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:35:24 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>Says it was randomised, no further information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 20:40:51 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION>
<P>"The study was a randomised controlled trial"; no details on how randomisation sequence was generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:08:33 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2000">
<DESCRIPTION>
<P>"Patients were randomized to either the control group or experimental group"; no information about how randomisation sequence was generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:24:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:34:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 10:25:32 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION>
<P>"We assigned services to intervention or control status using a blocked randomization design"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-03 01:21:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:51:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION>
<P>Randomised using assignment cards in envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:19:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION>
<P>No details: "Patients satisfying the entry criteria were randomly assigned to one of two groups at the time of admission to the emergency department "</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:13:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION>
<P>Block size 20 envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-21 02:07:05 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strom-2010">
<DESCRIPTION>
<P>Number randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sun-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:37:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:37:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 13:29:17 -0500" MODIFIED_BY="Julia Worswick" RESULT="NO" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION>
<P>NRT with monthly rotation of regimens</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:02 -0400" MODIFIED_BY="Kate Cahill" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION>
<P>Not stated; "the organism from the patient was randomly assigned"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-23 00:37:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:54 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Walker-1998">
<DESCRIPTION>
<P>"A list of random numbers was generated from Sigmastat version 1.0 statistical software"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:01:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wax-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:14:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION>
<P>Coin toss to allocate 1 medical team to intervention and 1 to control</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:40:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 01:28:52 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION>
<P>By lab number</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:58:04 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION>
<P>Obstetric units were allocated to intervention or control group by the toss of a coin.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 10:31:06 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION>
<P>"After stratifying emergency departments by state, teaching status, and annual volume, our statistician randomly assigned these departments to low-intensity, moderate-intensity, and high-intensity guideline implementation strategies in the ratio of 2:3:3, respectively"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 00:36:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yong-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Young-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:43:44 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yu-2014">
<DESCRIPTION>
<P>Study sites selected from baseline antimicrobial use.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 01:23:42 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION>
<P>Based on a case number assigned to every surgical procedure performed in the hospital, independent of the study itself</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:37:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2017-01-18 12:03:38 -0500" MODIFIED_BY="Julia Worswick" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 01:59:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-24 00:51:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Annane-2013">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 09:16:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 08:38:04 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:27:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bell-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:29:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Benson-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Berild-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:22:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION>
<P>Assignment concealed before allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-21 04:20:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-28 02:41:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION>
<P>Computer generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:18:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 03:04:59 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION>
<P>Allocation not concealed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 04:28:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:44:34 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1991">
<DESCRIPTION>
<P>Not stated but unlikely: 9 house staff teams were in the intervention group, 8 control, groups swapped over after 4 months.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:52:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Calil-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-02 01:20:30 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Camins-2009">
<DESCRIPTION>
<P>Not concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:25:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carling-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:42:26 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:52:51 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:58:57 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 19:08:47 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION>
<P>"We randomly assigned eligible patients either standard antimicrobial therapy (standard group) or procalcitonin-guided antimicrobial treatment (procalcitonin group) according to a computer-generated week wise randomisation scheme". No information about concealment of allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:02:39 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION>
<P>"Sealed opaque envelopes"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:37:42 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chu-2003">
<DESCRIPTION>
<P>Control cohort study (CBA)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 22:37:44 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION>
<P>"Mode of allocation was concealed from the clinicians", but unclear how this was achieved.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Climo-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:25:05 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION>
<P>21 of 73 patients considered for enrolment were excluded, but it is not clear if this was pre- or postrandomisation. The number of participants in the study group was 14, versus 38 in the control group, with no justification for the unequal numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:46:34 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dean-2001">
<DESCRIPTION>
<P>CBA</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:54:31 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dean-2006">
<DESCRIPTION>
<P>CBA</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:05:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 00:07:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ding-2013">
<DESCRIPTION>
<P>Computer-generated numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 00:11:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION>
<P>Randomisations carried out in central pharmacy and "telephone on a consecutive basis".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dua-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dull-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:37:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:15 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:52:19 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION>
<P>Randomisation stratified by clinical units, not blinded. Participants were randomised by groups (stratified randomisation by clinical units) to intervention or non-intervention using the EPIDAT 3.1 programme (Dirección Xeral de Saúde Pública, Xunta de Galicia &amp; Organización Panamericana de la Salud. Santiago de Compostela, Coruña, Spain, 2003).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:51 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:08:42 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 18:31:18 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION>
<P>Not possible; "The patient population was assigned to 1 of 4 medical service groups based on where they were treated at randomizations"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 18:44:11 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION>
<P>CBA - not randomised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-05 01:49:06 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION>
<P>Allocation by hospital</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:25:54 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gums-1999">
<DESCRIPTION>
<P>Not possible to conceal allocation because all intervention participants had a consultation, whereas no control participants did.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:12 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halm-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hess-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:58:37 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION>
<P>Details of allocation process not provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huber-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:57 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:33:22 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION>
<P>Investigators were masked to assignment before randomisation. Concealed block size, pre-stratified for site of recruitment, initial Acute Physiology and Chronic Health Evaluation, and age (entered in an encrypted screening form in a password-protected website)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:47:39 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Jump-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-30 09:42:47 -0400" MODIFIED_BY="Claire Peden" RESULT="NO" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION>
<P>No, states concealment was impossible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-29 02:05:02 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION>
<P>Allocation not concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khan-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kim-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:28:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION>
<P>Concealed until PCT test results available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-13 02:31:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION>
<P>By institution</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-24 02:07:17 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 00:56:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 13:24:53 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION>
<P>Not done, CBA</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landman-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:56:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Layios-2012">
<DESCRIPTION>
<P>"patients were prospectively randomized", but no information about how</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:19:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:15:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION>
<P>Concealment of the allocation was maintained, as the physician in charge of the patient and the IDP were involved only after randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:04 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-04 01:04:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2013">
<DESCRIPTION>
<P>No information about concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-26 00:19:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Long-2014">
<DESCRIPTION>
<P>"After randomization, an opaque, sealed, sequentially numbered envelope containing the PCT or control protocol was prepared for each subject according to group assignment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-26 00:42:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION>
<P>No information about concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:08:28 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:33:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Masia-2008">
<DESCRIPTION>
<P>Concealment of allocation was pharmacy controlled. Instruction in allocation concealment was provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:19:17 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:03:38 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:36:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:22:41 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-21 06:07:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Micek-2004">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mol-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Newland-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-30 02:03:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION>
<P>Allocation was issued using opaque, sealed, numbered envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:45:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION>
<P>Sealed, opaque envelopes were used for the randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:34:39 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION>
<P>Allocation by investigators</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:07:53 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION>
<P>Says there was blinding but unclear who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:19:30 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION>
<P>Following a 6-month control period during which none of the services received antimicrobial stewardship (1 May 2010 to 31 October 2011), the intervention was introduced to each additional service at 1-month intervals, beginning on 1 November 2010. By 1 April 2011, clinical rollout was complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:52:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Patel-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:01:56 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Paul-2006">
<DESCRIPTION>
<P>Allocation could not be concealed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:11:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pear-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:50:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Peto-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pires-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Po-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:46:13 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION>
<P>Does not say, but possibly not due to nature of study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Price-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:43:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qu-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:55:24 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION>
<P>Not concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richards-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ross-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salama-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 07:31:14 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:03:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION>
<P>Allocation at hospital level<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-08 01:33:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:48:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION>
<P>Centralised, password-protected website</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:59:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:54 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Senn-2004">
<DESCRIPTION>
<P>"Concealment of allocation was achieved as the physician in charge of the patient was involved after randomizations"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-08 02:13:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION>
<P>See above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:35:45 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>Patients from 2 wards were randomised, and there is no information about allocation concealment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:23:15 -0400" MODIFIED_BY="Kate Cahill" RESULT="NO" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION>
<P>States "possible that physicians in the control group could learn of the intervention from physicians in the study group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 10:32:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2000">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:24:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:34:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 06:23:28 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION>
<P>Not concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-03 01:21:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:52:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION>
<P>Randomised using assignment cards in envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:19:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:13:07 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION>
<P>Sealed, opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 10:29:27 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Strom-2010">
<DESCRIPTION>
<P>"Each medical practitioner has a unique access code to use the electronic ordering system, and the order system menu can be varied by individual user. In addition, we wanted to keep each practitioner in the same study group for the duration of the study to minimize contamination between the 2 groups. However, there is the possibility"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sun-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:37:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:37:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 10:55:50 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION>
<P>Not possible with this study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:43:32 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Walker-1998">
<DESCRIPTION>
<P>Not stated, but open label, so unlikely to be concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:01:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wax-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-15 01:55:35 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION>
<P>No concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:40:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 01:29:01 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION>
<P>Not concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 14:04:32 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION>
<P>To eliminate bias during data collection at follow-up by a second research midwife, and to allow blinded assessment of guideline quality, the allocation was concealed from everyone except JCW, DGA, RJ, and the first research midwife.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-17 01:12:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 00:36:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yong-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Young-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 01:32:14 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yu-2014">
<DESCRIPTION>
<P>No concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 01:24:36 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION>
<P>No concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:37:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2017-01-18 12:03:38 -0500" MODIFIED_BY="Julia Worswick" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 11:23:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 11:23:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-11 01:59:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-02 22:38:50 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Annane-2013">
<DESCRIPTION>
<P>PCT levels not reported on control participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-05 09:16:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-05 10:11:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 11:27:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Bell-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 11:29:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Benson-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Berild-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-03 02:22:31 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION>
<P>Assignment not concealed postallocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-11 00:35:12 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION>
<P>Not possible with this study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-03-28 02:42:11 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-05 10:18:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-12-07 00:34:40 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-09-02 04:28:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-03 17:44:43 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Burton-1991">
<DESCRIPTION>
<P>"Blinding as to patient status was not performed"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 11:52:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Calil-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-04-02 01:20:36 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Camins-2009">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-05 10:25:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carling-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-12-06 12:42:26 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-05-04 01:52:51 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 11:58:57 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:00:02 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION>
<P>"Single blinded intervention trial"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:02:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-05 10:37:43 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chu-2003">
<DESCRIPTION>
<P>Control cohort study (CBA)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-05-06 01:44:55 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION>
<P>Open study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:03:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Climo-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-03-31 01:58:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION>
<P>Primary outcome data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-05 10:46:37 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dean-2001">
<DESCRIPTION>
<P>CBA</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-05 10:55:07 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dean-2006">
<DESCRIPTION>
<P>CBA</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:05:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-09-12 04:49:15 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ding-2013">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-04 00:11:28 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION>
<P>Not done, acknowledged as a limitation by authors on page 179.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Dua-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Dull-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-04 02:37:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION>
<P>PCT levels only reported on intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:07:15 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-12-06 12:44:52 -0500" MODIFIED_BY="Julia Worswick" RESULT="NO" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION>
<P>Randomisation not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:07:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-04 18:25:44 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Franz-2004">
<DESCRIPTION>
<P>Done, IL-8 results were only provided to physicians in the intervention group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-05 11:37:41 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION>
<P>Not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-05 11:39:52 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION>
<P>CBA, allocation not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:10:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-04-05 01:51:17 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION>
<P>No mention of this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-05 02:26:22 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gums-1999">
<DESCRIPTION>
<P>Unclear, despite objective primary outcome measure (LOS), it is not clearly stated that record linkage was without knowledge of allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:11:12 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:11:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halm-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:11:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hess-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:12:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-10-29 12:14:51 -0400" MODIFIED_BY="Claire Peden" RESULT="NO" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION>
<P>Open trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:12:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huber-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:12:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-18 10:18:53 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION>
<P>Investigators, treating physicians, and the co-ordinator were unaware of outcomes during the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-12-06 12:47:40 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Jump-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-05 16:00:36 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION>
<P>No formal blinding attempted.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-09-29 02:05:08 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:13:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khan-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-05 16:29:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION>
<P>Objective outcome measure: length of stay from routine data system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-05 16:34:45 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION>
<P>Does not say if it was blinded or not</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:13:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-05 20:10:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION>
<P>Outcome measured from routine data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-07-25 00:56:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:14:07 -0400" MODIFIED_BY="Kate Cahill" RESULT="NO" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION>
<P>Not stated; all hospitals in same Australian state, CBA so not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landman-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:14:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-05 21:56:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Layios-2012">
<DESCRIPTION>
<P>Procalcitonin only reported for intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-11 01:19:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-05 21:15:36 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION>
<P>Blinding was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:17:04 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-04-04 01:05:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2013">
<DESCRIPTION>
<P>No information about blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-05 21:55:05 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Long-2014">
<DESCRIPTION>
<P>Blinding was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:17:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-07-26 00:42:31 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION>
<P>Blinding not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-07-29 01:08:28 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-06 17:05:02 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Masia-2008">
<DESCRIPTION>
<P>Blinding was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:17:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:18:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:18:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:19:17 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-18 12:03:38 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:36:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-03-18 01:22:41 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-06 01:30:46 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Micek-2004">
<DESCRIPTION>
<P>Not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Mol-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Newland-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-07-30 02:03:48 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-07-30 01:10:43 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-06 20:56:17 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION>
<P>Investigators were not blinded to patient randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-06 21:07:58 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION>
<P>Says there was blinding but unclear who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-06 21:19:34 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION>
<P>Blinding was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:52:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Patel-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-06 22:03:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paul-2006">
<DESCRIPTION>
<P>Primary outcome was measured by the CDSS.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 13:11:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pear-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-03-10 08:50:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Peto-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Pires-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Po-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-04-06 00:43:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Price-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-10-12 00:47:00 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qu-2012">
<DESCRIPTION>
<P>No mention of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-10-12 00:56:15 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 13:13:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richards-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 13:13:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Ross-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 13:14:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 13:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salama-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-07 18:22:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION>
<P>Not clear who collected outcome data or whether they were blinded to allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-09-19 02:05:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-08 01:33:57 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-07 18:48:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION>
<P>Password-protected website with instructions for PCT and control groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-09-19 02:59:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-05-14 03:06:57 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Senn-2004">
<DESCRIPTION>
<P>"This was a randomised, controlled, open trial"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-07 19:28:11 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION>
<P>Single-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-07 19:35:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>"At the end of the study, a blinded coordinating investigator recorded the patients&#8217; data"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-03-07 10:04:26 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 13:23:56 -0400" MODIFIED_BY="Kate Cahill" RESULT="NO" STUDY_ID="STD-Singh-2000">
<DESCRIPTION>
<P>Page 509: "Because the study was not blinded, physicians and care providers could see the results"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 13:24:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 13:34:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-09-26 06:23:36 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-03 01:21:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-09-21 01:24:27 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-07 22:03:55 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION>
<P>SIngle-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-07 22:13:18 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION>
<P>Primary outcome measure required collection of data from case noes by investigators.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-09-21 02:13:05 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Strom-2010">
<DESCRIPTION>
<P>Not blinded </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 13:37:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 13:37:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-10-06 10:51:43 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION>
<P>Not possible with this study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-08 04:05:53 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION>
<P>Not stated as blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 13:39:54 -0400" MODIFIED_BY="Kate Cahill" RESULT="NO" STUDY_ID="STD-Walker-1998">
<DESCRIPTION>
<P>"Open label"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-10 00:01:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Wax-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-15 01:55:42 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 13:40:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-09-25 01:29:14 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 14:04:34 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION>
<P>To eliminate bias during data collection at follow-up by a second research midwife, and to allow blinded assessment of guideline quality, the allocation was concealed from everyone except JCW, DGA, RJ, and the first research midwife.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-17 01:12:20 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-09-26 00:36:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Yong-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 13:42:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Young-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 01:32:29 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yu-2014">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-10-12 01:24:41 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-03-18 12:03:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-09 01:37:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2017-01-18 12:03:38 -0500" MODIFIED_BY="Julia Worswick" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 11:23:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 11:23:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-11 01:59:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-02 22:39:07 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Annane-2013">
<DESCRIPTION>
<P>No participants lost to follow-up.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-05 09:16:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-02 23:03:07 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION>
<P>No problems found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Bell-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 11:29:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Benson-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Berild-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-03 02:22:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION>
<P>Outcome data reported on 98% of participants in control and intervention groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-03-10 08:24:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-03 02:41:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION>
<P>Outcomes reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-05 10:18:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 11:50:01 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-02 04:28:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-03 17:44:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burton-1991">
<DESCRIPTION>
<P>No problems found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 11:52:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Calil-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-03 18:17:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Camins-2009">
<DESCRIPTION>
<P>Outcomes reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-05 10:25:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carling-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-12-06 12:42:26 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-04 01:52:51 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 11:58:57 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-03 19:08:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION>
<P>Antibiotic data from all treated participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:02:40 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-03 22:32:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chu-2003">
<DESCRIPTION>
<P>Objective primary outcome collected on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-03 22:37:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION>
<P>Primary outcome reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:03:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Climo-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-03 23:25:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION>
<P>Outcomes reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-03 23:53:49 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dean-2001">
<DESCRIPTION>
<P>Objective outcome measure collected on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-02-25 14:02:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dean-2006">
<DESCRIPTION>
<P>Electronic record linkage used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:05:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-04 00:07:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ding-2013">
<DESCRIPTION>
<P>Outcomes reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-04 00:11:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION>
<P>See Table 3; all participants included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Dua-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Dull-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-26 17:29:39 -0400" MODIFIED_BY="Claire Peden" RESULT="UNKNOWN" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-18 10:15:51 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION>
<P>319 randomised, consent was withdrawn during the study in 9 cases (3% participants, 5 in the PCT group and 4 in the control group). Outcomes reported on all participants (Tables 2-3). All 310 children came to the planned follow-up visits. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:07:15 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-04 02:52:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION>
<P>Outcomes reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-12-07 00:55:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:08:42 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-04 18:31:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION>
<P>For primary outcomes, not secondary</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-04 18:45:02 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION>
<P>Not clear: &#8220;Susceptibility reports from isolates obtained as part of infection-control surveillance were excluded.&#8221; Criteria for exclusion of isolates are not described and may not have been consistent across all hospitals.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:10:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-05 02:19:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION>
<P>Field workers collected from hospital data and were able to consult mothers for any missing data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-05 02:27:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gums-1999">
<DESCRIPTION>
<P>No problems found, data were analysed from 93% of randomised participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:11:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:11:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halm-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:11:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hess-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:12:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-05 02:58:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION>
<P>Done, Table 1 and text regarding excluded patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:12:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huber-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:12:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-05 15:36:06 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION>
<P>Outcomes reported on all randomised participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-12-06 12:47:40 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Jump-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-05 16:00:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION>
<P>Done, Figure 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-05 16:04:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION>
<P>1 episode of missing data in each arm of study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:13:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khan-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-05 16:29:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION>
<P>States that 3 patients died, 2 in PCT and 1 in control</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-05 16:35:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION>
<P>Trained data collectors, completeness assured by project staff.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:13:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-05 20:11:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION>
<P>Incomplete outcome data on 3 of 134 control and 4 of 140 intervention children.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-07-25 00:56:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-03-08 06:19:00 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION>
<P>No statement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landman-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:14:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-05 20:56:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Layios-2012">
<DESCRIPTION>
<P>Outcomes reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-11 01:19:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-05 21:15:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION>
<P>No participants were lost to follow-up.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:17:04 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-05 21:47:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2013">
<DESCRIPTION>
<P>Outcome reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-05 21:55:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Long-2014">
<DESCRIPTION>
<P>Outcomes reported on all 180 randomised participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:17:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-06 16:54:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION>
<P>Outcomes reported on all 205 participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-07-29 01:08:28 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-06 17:05:07 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Masia-2008">
<DESCRIPTION>
<P>Outcome data reported on all randomised participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:17:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:18:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:18:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:19:17 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-18 12:03:38 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:36:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-03-18 01:22:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-06 18:01:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Micek-2004">
<DESCRIPTION>
<P>Outcome data were missing from 4 (2.6%) patients in the intervention group and 8 (5.4%) patients in the control group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Mol-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Newland-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-07-30 02:03:56 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-06 20:45:58 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION>
<P>1 patient excluded from intervention and 2 from control. Outcomes measured on all other randomised participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-06 20:56:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION>
<P>Reported on all 107 patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-06 21:07:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION>
<P>All included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-06 21:19:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION>
<P>Prescribing outcome data were from pharmacy computer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:52:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Patel-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-06 22:04:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paul-2006">
<DESCRIPTION>
<P>Outcomes reported on all patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 13:11:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pear-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-03-10 08:50:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Peto-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Pires-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Po-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-06 22:46:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION>
<P>From records, outcomes on all included children</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Price-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-07 03:12:45 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Qu-2012">
<DESCRIPTION>
<P>Outcomes on all 71 participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-07 03:17:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION>
<P>Complete data reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 13:13:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richards-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 13:13:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Ross-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 13:14:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 13:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salama-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-07 18:22:54 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION>
<P>All outcome data given as %, so unclear if some patients were missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-19 02:04:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION>
<P>Outcome data for all patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-07 18:38:07 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION>
<P>Outcomes reported on all patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-07 18:51:16 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION>
<P>Only 1 of 1381 patients lost to follow-up; 16 (2%) patients in PCT group and 6 (1%) patients in control group withdrew.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-19 02:59:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-07 19:17:52 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Senn-2004">
<DESCRIPTION>
<P>Primary outcome measure (duration of IV antibiotics) collected on all patients. Only 70% of questionnaires returned for the intervention group, which could account for the intervention effect being lower than expected. However, this did not affect outcome assessment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-07 19:28:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION>
<P>Outcomes reported on 196/200 intervention and 198/200 control participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-07 19:36:04 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>All outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-03-07 10:05:07 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION>
<P>Not clear for primary outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-07 21:09:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Singh-2000">
<DESCRIPTION>
<P>Most outcomes are reported for 78 (96%) episodes of care; antimicrobial resistance and superinfection in 74 (91%) of episodes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 13:24:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 13:34:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-07 21:35:24 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION>
<P>Figure 2 and text give %, no denominator.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-12-03 01:21:43 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-21 01:23:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION>
<P>Outcomes on all patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-07 22:03:58 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION>
<P>Outcome data reported on all patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-07 22:13:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION>
<P>Text shows that primary outcome was reported for all 101 randomised patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-07 22:25:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strom-2010">
<DESCRIPTION>
<P>Outcome reported on all patients, determined electronically.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Sun-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 13:37:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 13:37:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-06 10:52:08 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION>
<P>Not stated whether screening samples obtained from all patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-08 04:06:58 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION>
<P>Table 2 reports primary outcome for all 226 randomised patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-08 04:43:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walker-1998">
<DESCRIPTION>
<P>No problems found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-10 00:01:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Wax-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-08 05:14:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION>
<P>Outcomes reported on all patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 13:40:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-25 01:30:02 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION>
<P>States missing information was retrieved from records</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 13:42:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION>
<P>"No unit was excluded after randomisation, all intervention units participated in the visits, and data on clinical practices were available for all units, although smaller numbers of case notes were obtainable than planned for steroid usage"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-17 01:15:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION>
<P>Incomplete chart review on only 19 (0.6%) of 3219 patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-26 00:36:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Yong-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 13:42:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Young-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 01:32:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2014">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-10-12 01:25:59 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION>
<P>Outcome on all 273 patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-03-18 12:03:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-09 01:37:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2017-01-18 12:07:12 -0500" MODIFIED_BY="Julia Worswick" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 01:59:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:39:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Annane-2013">
<DESCRIPTION>
<P>No participants lost to follow-up.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 09:16:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:03:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION>
<P>No problems found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bell-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:29:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Benson-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Berild-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:22:58 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION>
<P>Outcome data reported fully on all included participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:24:27 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:43:05 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION>
<P>No primary outcome measure identified. Defined daily dose of antibiotic therapy free from selective reporting, but other outcomes (e.g. % adequate days of antibiotic therapy) were not.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:18:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:50:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 04:28:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:44:49 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burton-1991">
<DESCRIPTION>
<P>No problems found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:52:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Calil-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:17:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Camins-2009">
<DESCRIPTION>
<P>Outcomes reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:25:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carling-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:42:26 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:52:51 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:58:57 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 19:09:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION>
<P>Objective outcome measure in all participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:02:40 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 22:32:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chu-2003">
<DESCRIPTION>
<P>Objective primary outcome collected on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 22:38:59 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION>
<P>Primary outcome reported on all participants. Authors did a secondary analysis excluding participants with penicillin allergy, but this was not prespecified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Climo-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:25:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION>
<P>Outcomes reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:53:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dean-2001">
<DESCRIPTION>
<P>Objective outcome measure collected on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:59:22 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dean-2006">
<DESCRIPTION>
<P>30-day mortality was primary outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:05:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 00:07:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ding-2013">
<DESCRIPTION>
<P>Outcomes reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 00:11:44 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION>
<P>See Table 3; all participants included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dua-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dull-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 10:15:57 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION>
<P>Outcomes reported on all 310 participants (Tables 2-3). All 310 children came to the planned follow-up visits.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:15 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:52:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION>
<P>The primary outcome (clinical failure) was complex and not entirely objective.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:08:42 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:07:12 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION>
<P>Based on microbial response and other clinical parameters</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 18:45:16 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION>
<P>Not clear: &#8220;Susceptibility reports from isolates obtained as part of infection-control surveillance were excluded.&#8221; Criteria for exclusion of isolates are not described and could have led to reporting bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:20:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION>
<P>Field workers collected from hospital data and were able to consult mothers for any missing data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:27:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gums-1999">
<DESCRIPTION>
<P>No problems found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halm-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hess-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:59:07 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION>
<P>No explicit statement, so selective outcome reporting is possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huber-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:36:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION>
<P>Outcomes reported on all randomised participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:47:40 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Jump-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-30 10:33:51 -0400" MODIFIED_BY="Claire Peden" RESULT="YES" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION>
<P>Done, all outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:05:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION>
<P>Complete outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khan-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kim-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:29:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION>
<P>Objective outcome measure: length of stay from routine data system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:35:03 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION>
<P>All outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:11:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION>
<P>Outcomes reported on all remaining children.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 00:56:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:22:06 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION>
<P>Objective primary outcome measure on all patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landman-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:56:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Layios-2012">
<DESCRIPTION>
<P>Outcomes reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:19:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:15:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION>
<P>Outcomes reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:04 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:47:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2013">
<DESCRIPTION>
<P>Outcome reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:55:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Long-2014">
<DESCRIPTION>
<P>Antibiotic use reported for all 180 participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:54:25 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION>
<P>Antibiotic treatment reported on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:08:28 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:05:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Masia-2008">
<DESCRIPTION>
<P>Outcome data reported on all randomised participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:19:17 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:03:38 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:36:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:22:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 15:28:30 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Micek-2004">
<DESCRIPTION>
<P>Done, outcomes were obtained from routine data systems.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mol-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Newland-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:33:12 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION>
<P>8/39 (20%) patients excluded from intervention versus 3/40 (7%) from control; 4 patients excluded from intervention for "complicated infections", which is likely to have biased the results on duration of antibiotic treatment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:46:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION>
<P>Duration of antibiotics measured from patient administration system.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:46:27 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:07:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION>
<P>Yes, all outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:19:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION>
<P>Prescribing outcome data were from pharmacy computer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:52:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Patel-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:04:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paul-2006">
<DESCRIPTION>
<P>The primary outcome was objective, based on whether or not the prescriber selected one of the CDSS top 3 recommendations.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:11:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pear-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:50:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Peto-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pires-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Po-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:47:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION>
<P>From records, outcomes on all included children</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Price-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:49:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Qu-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:18:12 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION>
<P>Some outcomes (favourable clinical outcome, death from infection) subject to selective outcome reporting. No discussion of why there was a significant difference for death because of infection but no difference in the % of patients alive on discharge from hospital.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richards-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ross-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salama-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 07:34:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION>
<P>No details of data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:33:38 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION>
<P>All relevant outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:38:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION>
<P>Outcomes reported on all patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:52:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION>
<P>&gt; 95% surviving patients completed 30-day interview.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:59:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 10:26:14 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Senn-2004">
<DESCRIPTION>
<P>Complete primary outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-08 02:14:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:36:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>All outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-07 10:05:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION>
<P>Based on numbers of vancomycin orders</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:09:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Singh-2000">
<DESCRIPTION>
<P>No problems found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:24:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:34:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:35:30 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION>
<P>Figure 2 and text give %, no denominator.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-03 01:21:43 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-21 01:24:06 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION>
<P>Outcomes on all patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:04:14 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION>
<P>11 (10%) patients excluded from intervention and 7 (6%) from control group for "absence of COPD according to GOLD", but this should have occurred pre-randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:13:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION>
<P>Text shows that primary outcome was reported for all 101 randomised patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:26:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strom-2010">
<DESCRIPTION>
<P>Outcome reported on all patients, determined electronically.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sun-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:37:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:37:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 10:52:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION>
<P>Not stated whether screening samples obtained from all patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:07:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION>
<P>Table 2 reports primary outcome for all 226 randomised patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:43:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walker-1998">
<DESCRIPTION>
<P>No problems found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:01:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wax-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:15:07 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION>
<P>No information about inter-rater reliability of primary outcome measure, which was not objective: "empirical antibiotics were defined as any antimicrobial agent administered without culture-documented infection".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:40:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 01:30:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION>
<P>Outcomes on all patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 11:13:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION>
<P>See above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-17 01:16:03 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 00:36:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yong-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Young-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 01:32:52 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2014">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 01:26:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION>
<P>Outcome on all 273 patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:37:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2017-01-18 12:03:38 -0500" MODIFIED_BY="Julia Worswick" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 01:59:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:39:13 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Annane-2013">
<DESCRIPTION>
<P>Study stopped prematurely because of low recruitment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 09:16:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:03:18 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION>
<P>No power calculation. Prices of antibiotics unlikely to change over the 6-month study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bell-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:29:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Benson-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Berild-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:23:12 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION>
<P>Patients assigned to the trial were &lt; 50% of all patients receiving antibiotics (630/1315).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:31:18 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION>
<P>Not done, adequate prescription was defined by 7 criteria, some of which required clinical judgement. The reliability of the primary outcome measure was not assessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-28 02:43:37 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION>
<P>High microbial risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:18:14 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:50:02 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 04:28:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:45:23 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Burton-1991">
<DESCRIPTION>
<P>Unit of analysis error for length of stay. This was a cluster RCT, but length of stay was analysed at participant level.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:52:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Calil-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-02 01:22:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Camins-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:25:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carling-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:42:26 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:52:51 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:58:57 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 19:09:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:02:40 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 22:32:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chu-2003">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 01:45:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Climo-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:26:44 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION>
<P>Aim was to enrol 180 patients, but only 72 patients were identified, and 21 of them were excluded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:53:58 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dean-2001">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-25 14:02:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dean-2006">
<DESCRIPTION>
<P>Objective primary outcome measure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:05:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-12 04:48:36 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ding-2013">
<DESCRIPTION>
<P>No power calculation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:52:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dua-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dull-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-23 01:11:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:15 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:52:47 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION>
<P>Unit of analysis error, no adjustment for intracluster correlation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:52 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:08:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 18:33:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION>
<P>No problems noted.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 18:48:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION>
<P>NOT CLEAR <B>Microbial Risk of Bias Criteria: </B>Case definition: percentage VRE or percentage MRSA in clinical isolates; Planned intervention: DONE; Other infection control isolation: NOT CLEAR; IC practices: NOT CLEAR Data were collected about infection control changes in response to feedback of data, but the paper does not report any results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:20:26 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION>
<P>End of study in Thai control hospital was conducted at a later stage due to other healthcare-related activities going on.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:27:16 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gums-1999">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halm-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hess-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:59:16 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION>
<P>Done, all biases addressed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huber-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-18 02:24:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:47:40 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Jump-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:00:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION>
<P>No other apparent issues</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-29 02:07:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khan-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kim-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-13 02:18:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION>
<P>Adequately powered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:35:17 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION>
<P>High risk of selection bias, as hospitals nominated themselves to be included into the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:11:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION>
<P>The trial ended after completion of a sufficient number of children at the expected timing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 00:56:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:22:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landman-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:56:48 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Layios-2012">
<DESCRIPTION>
<P>Study did not achieve recruitment required by power calculation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:19:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 01:53:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:04 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:49:13 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2013">
<DESCRIPTION>
<P>The study had 7 exclusion criteria that are not all clearly defined, so there is a high risk of selection bias, especially as allocation was probably not concealed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-26 00:18:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Long-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-26 00:43:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:08:29 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:43:27 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Masia-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:06 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:19:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:03:38 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:36:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:22:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 18:01:40 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Micek-2004">
<DESCRIPTION>
<P>The policy was only implemented at weekends or on holidays when 1 of the 2 investigators was available in the hospital.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mol-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Newland-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-30 02:06:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:47:38 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION>
<P>"Patients showing reduction in SOFA and no sign of active infection were to receive no more than 7 days of antibiotic therapy. We used the</P>
<P>biomarker-guided protocols to further reduce this duration (i.e., to less than seven days)". This suggests that the ID physicians imposed a ceiling of 7 days' treatment for these patients for both intervention and control groups.</P>
<P>Study did not achieve required recruitment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:46:27 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 00:29:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:20:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION>
<P>Unit of analysis was service, and clustering was included in the model. "Negative binomial regression, accounting for clustering at the level of service using random effects as well as for secular and seasonal trends, was used to compare overall targeted antimicrobial utilization in the control and intervention periods for the analysis involving patients qualifying for the stewardship intervention as well as the analysis of all admitted patients. The unit of analysis was each service&#8217;s mean monthly targeted days of therapy count. The covariates included in these multivariable models were study period, study month (as a continuous variable), and season"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:52:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Patel-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:05:13 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Paul-2006">
<DESCRIPTION>
<P>Trial was underpowered for the primary outcome measure.</P>
<P>Adjustment of drug costs for changes in prices not necessary because the intervention lasted only 6 months.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:11:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pear-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:50:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Peto-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pires-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Po-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:46:10 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Price-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:49:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Qu-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:56:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richards-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ross-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salama-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:23:26 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION>
<P>Intervention period (1 April 2007 to 29 February 2008) was different than control period (1 September 2006 to 28 February 2007).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:07:16 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:38:38 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION>
<P>Only 27 of 125 screened patients were randomised.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:39:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:59:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:18:17 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Senn-2004">
<DESCRIPTION>
<P>The study was underpowered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:28:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION>
<P>1567 patients screened, but 1167 excluded; full details of how many patients met each of the exclusion criteria (Figure 1)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 05:53:59 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 20:41:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION>
<P>No issues noted.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:11:52 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Singh-2000">
<DESCRIPTION>
<P>
<B>Microbial Risk of Bias HIGH. </B>Case definition for microbial outcome NOT CLEAR: "Follow-up respiratory cultures or cultures from clinical specimens performed 7 to 28 d after initiation of antibiotics were evaluated to assess the emergence of antimicrobial resistance or superinfections. Emergence of resistance was defined as the detection of new antimicrobial resistance pattern in the old or previously isolated organism. Superinfection was defined as the detection of the following organisms not present at study entry: Acinetobacter species, <I>Serratia marcescens, Pseudomonas aeruginosa, Stenotrophomonas maltophilia</I>, Enterobacter species, Citrobacter species, methicillin-resistant <I>Staphylococcus aureus </I>(MRSA), Enterococcus species, and Candida species." It is therefore impossible to assess the impact of the intervention on colonisation or infection with bacteria resistant to specific antibiotics. Infection control NOT CLEAR. Planned intervention YES<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:24:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:34:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:37:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION>
<P>The methods say: "To estimate the relative reduction in unnecessary use of target antibiotics in the intervention group, we used a fixedeffects model (PROC GENMOD in SAS statistical software).20 This model used a log-linear link function, assumed a Poisson distribution, and accounted for overdispersion. Experimental group assignment (intervention or control) was the independent variable of interest, the individual service was considered a class effect, and covariates included level of baseline prescribing and time, modeled as both a linear and categorical effect. The interaction between assignment and time was also assessed. We further considered a linear randomeffects model to account for variation between services (PROC MIXED in SAS statistical software)20; the results of this analysis were similar to those found in the fixed-effects models with respect to the level of statistical significance, and only the fixedeffects model results are presented." However, no model outputs are given in the results (only point estimates), and the discussion says only: "This significant effect of the intervention remained after adjusting for baseline prescribing, clustering of repeated measures within a given service, and duration of the intervention."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-03 01:21:43 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-21 01:24:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:20:02 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:13:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION>
<P>Multivariate analysis to adjust primary outcome for age, microbiology and centre effect</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-21 02:14:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strom-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sun-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:37:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:56:43 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION>
<P>NOT CLEAR <B>Microbial Outcome Risk of Bias Criteria </B>Case definition: DONE Colonisation by screening. "For the purpose of this study, an 'antibiotic-resistant Gram-negative organism' was defined as any Gram-negative bacillus resistant to gentamicin, piperacillin-tazobactam, or ceftazidime. Pharyngeal and rectal swab specimens were obtained on all infants every Monday, Wednesday, and Friday". Planned intervention: DONE; Other infection control, Isolation: IC practices: NOT CLEAR Not described, but it is reasonable to assume that they were the same for the intervention and control groups due to the controlled clinical trial design.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:07:06 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:43:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walker-1998">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:01:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wax-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-15 02:00:31 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION>
<P>Unit of analysis error, no adjustment for clustering</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:40:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 01:30:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 11:12:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION>
<P>"To reduce the impact of ceiling effects, the proportion of cases in which clinicians failed to carry out each clinical practice was recorded for each obstetric unit at baseline and follow up, and then baseline to follow up ratios were computed to yield the risk ratio for failure to implement each practice in each unit."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-17 01:22:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION>
<P>"The target sample size included an adjustment of 30% to account for the clustering of patients within providers."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 00:36:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yong-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Young-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 01:33:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 01:26:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION>
<P>Outcome on all 273 patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:59 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:37:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2017-01-18 13:07:39 -0500" MODIFIED_BY="Julia Worswick" NO="7">
<NAME>Baseline Outcomes similar?</NAME>
<DESCRIPTION>
<P>Were baseline characteristics similar</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 01:59:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-24 00:52:12 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Annane-2013">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 09:16:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 08:42:18 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bell-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:29:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Benson-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Berild-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-28 01:43:07 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:24:30 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-28 02:42:50 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:18:14 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:34:51 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 04:28:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:45:36 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1991">
<DESCRIPTION>
<P>Not measured before interventions.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:52:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Calil-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-02 01:21:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Camins-2009">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:25:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carling-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:42:27 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:52:51 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:58:57 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:29:46 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 01:00:20 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:40:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chu-2003">
<DESCRIPTION>
<P>Tables 1 and 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 01:45:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Climo-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-31 01:54:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:48:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dean-2001">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:54:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dean-2006">
<DESCRIPTION>
<P>Table 3</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:05:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-20 09:28:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ding-2013">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:50:18 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dua-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dull-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-23 01:11:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:15 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-23 02:09:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:53 -0400" MODIFIED_BY="Kate Cahill" RESULT="UNKNOWN" STUDY_ID="STD-Fine-2003">
<DESCRIPTION>
<P>No data about LOS prior to intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:56:01 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Franz-2004">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 18:33:50 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION>
<P>No information about baseline outcomes pretrial in the allocated groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:08:31 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:20:44 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION>
<P>Appear to be different but unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 06:31:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gums-1999">
<DESCRIPTION>
<P>Done for primary outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halm-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hess-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-29 12:13:34 -0400" MODIFIED_BY="Claire Peden" RESULT="UNKNOWN" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION>
<P>No baseline outcome measurement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huber-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-18 02:24:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:47:40 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Jump-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:00:45 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION>
<P>No baseline measurement of outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:05:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION>
<P>States no significant differences at baseline.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khan-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kim-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-13 02:11:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION>
<P>No beseline outcome measures</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:35:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION>
<P>See Table 3</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-13 02:53:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 00:56:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:22:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION>
<P>Done, pre-intervention data for primary outcome similar in intervention and control hospitals.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landman-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 02:48:07 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Layios-2012">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:19:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 01:55:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:04 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-04 01:04:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2013">
<DESCRIPTION>
<P>No data about baseline outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-26 00:19:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Long-2014">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-26 00:43:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:08:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:39:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masia-2008">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:06 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:19:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:30:09 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:30:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:36:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:22:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 01:32:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Micek-2004">
<DESCRIPTION>
<P>No data about duration of therapy before the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mol-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Newland-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-30 02:07:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-30 01:12:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:34:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 00:27:29 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION>
<P>No baseline outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-01 02:18:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION>
<P>Table 4</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:52:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Patel-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-17 02:28:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paul-2006">
<DESCRIPTION>
<P>Table 1, cohort study before trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:11:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pear-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:50:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Peto-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pires-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Po-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:47:16 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION>
<P>No baseline outcomes taken.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Price-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:44:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Qu-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 10:22:45 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION>
<P>Baseline frequency of inappropriate treatment was 50% in January 2007, but no information about risk of inappropriate treatment in the control group in August 2007.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richards-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ross-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salama-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 13:07:39 -0500" MODIFIED_BY="Julia Worswick" RESULT="NO" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION>
<P>Duration of inpatient antibiotic at baseline was appropriate in only 47% intervention (versus 57% control).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:33:45 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION>
<P>Table 3, also pair-matched clusters for important variables</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-08 01:38:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:34:17 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION>
<P>No baseline outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:59:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:18:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Senn-2004">
<DESCRIPTION>
<P>Pre-study group, data collected for 2 months before intervention to estimate the magnitude of possible observation bias (Figure 2).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-08 02:15:12 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 05:54:06 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 10:31:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION>
<P>No information about pre-intervention vancomycin use</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 10:33:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2000">
<DESCRIPTION>
<P>Not stated, no information about pre-intervention duration of antibiotic treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:24:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:34:53 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 06:43:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION>
<P>Figures 1 and 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-03 01:21:43 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-21 01:22:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:20:09 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-08 23:54:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION>
<P>No data about baseline outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-21 02:14:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Strom-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sun-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:37:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 10:07:26 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 10:57:59 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION>
<P>No information about recommendations for changes in therapy before the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 06:38:26 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Walker-1998">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:01:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wax-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-15 02:01:09 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:40:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 01:30:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-25 14:02:43 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION>
<P>"Accurate baseline figures for the rates and variability of the four marker clinical practices were not available"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-17 01:16:12 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 00:36:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yong-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Young-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 01:33:44 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yu-2014">
<DESCRIPTION>
<P>Table 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 01:29:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION>
<P>Cohort data before start of trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:59 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:37:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2017-01-18 10:30:10 -0500" MODIFIED_BY="Julia Worswick" NO="8">
<NAME>Free of contamination?</NAME>
<DESCRIPTION>
<P>Was the study adequately protected against contamination?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 01:59:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:40:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Annane-2013">
<DESCRIPTION>
<P>PCT levels not reported on control participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 09:16:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 08:42:23 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bell-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:29:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Benson-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Berild-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:23:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION>
<P>Procalcitonin only reported on intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:32:20 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION>
<P>All doctors in the hospital were distributed across all 3 study groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:44:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION>
<P>ETEST results only available for intervention group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:18:14 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 03:05:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION>
<P>Rapid reports only received by intervention group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 04:28:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:46:15 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Burton-1991">
<DESCRIPTION>
<P>Not done, 9 house staff teams were in the intervention group, 8 control, groups swapped over after 4 months.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:52:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Calil-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:17:53 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Camins-2009">
<DESCRIPTION>
<P>Doctors randomised to intervention were in the same hospital as control doctors.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:25:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carling-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:42:27 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:52:51 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:58:57 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 19:09:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION>
<P>Although same doctors treated participants in non-intervention weeks, they did not have data about procalcitonin results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 22:27:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION>
<P>Same doctors in the intervention and control weeks, but they did not have access to procalcitonin results in the control weeks.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 22:32:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chu-2003">
<DESCRIPTION>
<P>Intervention and control were at different sites.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 22:39:41 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION>
<P>Clinicians received results verbally and electronically, so it is likely that they were aware of the intervention, which may have influenced their management of other participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Climo-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:26:57 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION>
<P>Education intervention with study and control in same hospital</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:54:56 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dean-2001">
<DESCRIPTION>
<P>NOT CLEAR, some hospitals had both intervention and control physicians. Intermountain Healthcare provides 50% of regional health care delivery in Utah. In rural IHC hospitals, 90% of pneumonia admissions were cared for by IHC-affiliated physicians, whereas in urban IHC hospitals only 44% of pneumonia admissions were cared for by IHC-affiliated physicians. Non-affiliated physicians caring for patients at IHC hospitals may have been influenced by guideline implementation at these hospitals.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 00:00:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dean-2006">
<DESCRIPTION>
<P>NOT CLEAR, some hospitals had both intervention and control physicians. The 100,000 annual inpatient admissions of Intermountain Healthcare represent almost one-half of Utah hospital admissions. Intermountain Healthcare has an employed physician group and several non-Medicare health maintenance organisation insurance plans, but many non-employed physicians and non-health maintenance organisation patients also utilise its facilities. Non-affiliated physicians caring for patients at Intermountain Healthcare hospitals may have been influenced by guideline implementation at these hospitals.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:05:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 00:07:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ding-2013">
<DESCRIPTION>
<P>Procalcitonin results only available for intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 00:12:07 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION>
<P>Control participants were managed by the same physicians as intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dua-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dull-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:40:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION>
<P>PCT levels only reported on intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:15 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:52:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION>
<P>19 participants in the control group were excluded because they had ID consultation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:52 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:08:42 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 18:33:58 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION>
<P>Doctors likely to have cared for participants in all groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 18:48:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION>
<P>Interventions were at different hospitals from control sites.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:10 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-05 01:52:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION>
<P>Allocation by hospital</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:27:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gums-1999">
<DESCRIPTION>
<P>Participants were randomised to receive a consultation from an ID specialist (intervention) or no consultation (control), so no contamination likely.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halm-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hess-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:59:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION>
<P>Done, procalcitonin results not available for controls.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huber-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:36:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION>
<P>PCT measures only reported for intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:47:40 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Jump-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:00:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION>
<P>Done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:05:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION>
<P>Rapid reporting only occurred for intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khan-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kim-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:30:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION>
<P>PCT results only available for intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-13 02:32:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION>
<P>By institution</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:11:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION>
<P>No lab score released for control children.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 00:56:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:22:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION>
<P>Intervention and control sites were different hospitals.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landman-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:56:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Layios-2012">
<DESCRIPTION>
<P>Procalcitonin only reported for intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:19:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:16:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION>
<P>IDP only visited intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:04 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:49:45 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2013">
<DESCRIPTION>
<P>PCT results only for intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:32:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Long-2014">
<DESCRIPTION>
<P>Procalcitonin only reported on intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:54:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION>
<P>PCT only measured on intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:08:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:05:57 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Masia-2008">
<DESCRIPTION>
<P>The authors say: "To minimize contamination bias, that is, any change in antibiotic prescription practice in the control group, only the infectious diseases physicians and hospital pharmacists were informed about the implementation of the program." However, they were placing written recommendations in case notes for intervention patients, and physicians caring for those patients would also be caring for control patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:06 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:19:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:30:09 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:30:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:36:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:22:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 18:02:16 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Micek-2004">
<DESCRIPTION>
<P>Physicians managing patients in the control group would have seen reminders for the intervention group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mol-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Newland-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:33:30 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION>
<P>PCT only measured for intervention group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:47:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION>
<P>PCT only measured for intervention group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:56:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION>
<P>Test data only reported for intervention patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:08:12 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION>
<P>Within same ward</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:20:37 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION>
<P>Contamination could have occurred during the rollout of intervention over 6 months.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:52:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Patel-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:05:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paul-2006">
<DESCRIPTION>
<P>Only intervention wards had CDSS.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:11:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pear-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:50:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Peto-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pires-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Po-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 00:44:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION>
<P>Influenza testing only on children in intervention group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Price-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:13:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Qu-2012">
<DESCRIPTION>
<P>PCT results only reported for intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 10:22:30 -0500" MODIFIED_BY="Julia Worswick" RESULT="NO" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION>
<P>Invervention and control participants were in the same hospital, and physicians were likely to have patients in both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richards-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ross-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salama-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 07:32:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION>
<P>Randomised by site</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:05:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION>
<P>Allocation at hospital level</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:38:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION>
<P>PCT only measured for intervention patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:53:00 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION>
<P>The study was conducted in 6 hospitals, but patients in each hospital were in both intervention and control groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:59:17 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:18:44 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Senn-2004">
<DESCRIPTION>
<P>The pre-intervention group data were comparable to the control group, suggesting minimal observation bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:29:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION>
<P>PCT only reported for intervention participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:36:13 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>Intervention and control patients were on both wards.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:23:21 -0400" MODIFIED_BY="Kate Cahill" RESULT="NO" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION>
<P>States "possible that physicians in the control group could learn of the intervention from physicians in the study group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 06:39:55 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2000">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:24:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:34:53 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:37:26 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION>
<P>The services were in the same hospital.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-03 01:21:43 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:52:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION>
<P>PCT results only reported for intervention patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:04:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION>
<P>PCT only reported for intervention patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:14:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION>
<P>Procalcitonin only measured for intervention patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 10:30:10 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Strom-2010">
<DESCRIPTION>
<P>"We attempted to reduce contamination by trying to complete this study as rapidly as possible. It was initially planned to last 7 months but had to be terminated early."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sun-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:37:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:57:04 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION>
<P>Not stated, but doctors likely to have been managing patients in more than 1 study phase.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:07:23 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION>
<P>Likely to be contamination as doctors managing control patients would receive advice on intervention patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 06:38:32 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Walker-1998">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:01:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wax-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:15:18 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION>
<P>Intervention and control teams worked on the same ICU.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:40:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 01:30:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION>
<P>Rapid reporting for intervention only</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:59:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION>
<P>Randomisation by units that were located in different hospitals</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-17 01:18:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION>
<P>Cluster RCT</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 00:36:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yong-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Young-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 01:34:06 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yu-2014">
<DESCRIPTION>
<P>Intervention and control sites different hospitals</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:48:36 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION>
<P>Control patients were operated on by the same surgeons, and the reminder for intervention patients is likely to have increased awareness of the need for additional doses.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:59 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:37:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2017-01-08 06:14:45 -0500" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Baseline characteristics similar?</NAME>
<DESCRIPTION>
<P>Were the Baseline characteristics similar?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 01:59:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-24 00:53:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Annane-2013">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 09:16:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:03:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION>
<P>See Table 1 in study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bell-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:29:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Benson-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Berild-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-28 01:43:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION>
<P>ITS</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:24:34 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-28 02:43:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:18:14 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:36:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 04:28:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:46:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burton-1991">
<DESCRIPTION>
<P>See Table 2 in paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:52:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Calil-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-02 01:19:56 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Camins-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:25:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carling-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:42:27 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:52:51 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:58:57 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 15:23:34 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION>
<P>Done, Tables 1 and 2 in the original paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 15:23:47 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION>
<P>Done, Table 1 in the original paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:40:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chu-2003">
<DESCRIPTION>
<P>Tables 3 and 4</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 01:46:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:44 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Climo-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-12 02:49:02 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:51:59 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dean-2001">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:31:58 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dean-2006">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:05:39 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-20 09:29:16 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ding-2013">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:50:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dua-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dull-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-23 01:11:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:15 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-23 02:09:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:52 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:08:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:06:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:08:41 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-05 01:50:29 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 15:27:43 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Gums-1999">
<DESCRIPTION>
<P>Done, Table 1 of the original paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halm-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hess-1990">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:12:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:59:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION>
<P>Done, mainly similar (IC days slightly different)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Huber-1982">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-07 09:31:30 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-18 02:25:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:47:40 -0500" MODIFIED_BY="Julia Worswick" RESULT="UNKNOWN" STUDY_ID="STD-Jump-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:00:25 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION>
<P>Done, Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:05:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION>
<P>States no significant differences at baseline.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khan-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kim-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:30:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION>
<P>Mostly similar apart from those with cancer (7 in PCT and 0 in control), although this was adjusted for using sensitivity analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:35:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION>
<P>See Table 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:13:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-24 02:12:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION>
<P>Table 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 00:56:30 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:22:41 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION>
<P>Only information is about characteristics of hospital (teaching, rural, etc.), no data about case mix and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landman-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 02:48:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Layios-2012">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:19:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lee-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 01:55:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:04 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:49:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2013">
<DESCRIPTION>
<P>Table 1, age, gender, APACHE score, comorbidities</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-26 00:19:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Long-2014">
<DESCRIPTION>
<P>Tables 1 and 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-26 00:44:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION>
<P>Tables 1 and 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:08:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:40:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Masia-2008">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:49 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:06 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:18:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:19:18 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:30:09 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:30:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:36:34 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:22:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 01:31:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Micek-2004">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mol-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Newland-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-30 02:08:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-30 01:13:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:38:33 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION>
<P>"slightly more patients in the intervention group had received previous antibiotic treatment ": 42% vs 23%, which is not "slighly more"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:08:16 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION>
<P>Yes, Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-01 02:20:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:52:43 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Patel-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:10:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paul-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:11:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pear-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:50:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Peto-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pires-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Po-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 00:43:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Price-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:13:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Qu-2012">
<DESCRIPTION>
<P>Yes, Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 01:01:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richards-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:13:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ross-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salama-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:25:28 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION>
<P>75% inpatients in control group versus 50% for intervention, also fewer CURB 0 and more CURB 3</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:04:16 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION>
<P>No clinically relevant differences</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-08 01:39:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:34:27 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:59:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:18:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Senn-2004">
<DESCRIPTION>
<P>Presented in Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-08 02:15:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:47:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shen-2011">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 10:31:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:12:06 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Singh-2000">
<DESCRIPTION>
<P>See Table 1 in study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:24:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:34:53 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 06:44:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-03 01:21:43 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-21 01:22:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:20:16 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-08 23:56:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:48:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strom-2010">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sun-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:37:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 10:55:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION>
<P>Results, paragraph 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-06 10:59:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 06:38:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walker-1998">
<DESCRIPTION>
<P>See Table 1 in paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:01:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wax-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-15 02:01:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:40:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 01:30:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:01:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION>
<P>"Despite randomisation there were baseline differences in two of the four clinical practices" (use of ventouse and use of polyglycolic acid sutures). "There were no other baseline differences." (includes antibiotic prophylaxis)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:14:45 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION>
<P>Demographic characteristics differed between eligible patients who were and were not enrolled. Moreover, authors observed some imbalances in levels of illness severity across the intervention groups; however, their analyses of the site of treatment were performed separately for low-risk and higher-risk patients, and their multivariable analyses were not sensitive to the few imbalances that were observed at baseline.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 00:36:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yong-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Young-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 01:34:32 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yu-2014">
<DESCRIPTION>
<P>Several potentially important differences between intervention and control sites</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 01:28:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION>
<P>Table 1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:03:59 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:37:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2017-01-18 12:03:38 -0500" MODIFIED_BY="Julia Worswick" NO="10">
<NAME>Intervention independent (ITS) ?</NAME>
<DESCRIPTION>
<P>Was the intervention independent of other changes ?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:53:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:23:52 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-23 23:57:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:09:53 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION>
<P>Changes in CDI screening policy and cleaning policy occurred between Phases 1 and 2 (Figure 1).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:13:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION>
<P>Data and segmented regression model of alcohol-based hand rub included as a proxy measure for infection control practices.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:27:50 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION>
<P>Other changes are clearly documented in Figure 1. This includes an outbreak of <I>Acinetobacter</I> infection co-incident with the stewardship intervention, which resulted in appointment of 2 infection control practitioners and associated interventions. The additional staff could have influenced prescribing outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-24 00:52:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Annane-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:47:18 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION>
<P>"In 2000, the Antibiotic Subcommittee of Tayside University Hospitals Trust devised an Alert Antibiotic Policy to reduce inappropriate use of key antibiotics, targeted because they should be reserved for infections caused by organisms that are resistant to first line antimicrobials." There were no other changes in local or national policy likely to influence use of Alert Antibiotics.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:53:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION>
<P>No price changes in the target antibiotics during the study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:28:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:09:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION>
<P>Intervention 1 was independent of other changes. The "crisis" (following the intervention) was a national economic crisis and will be reported separately in the review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:27:26 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 02:46:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-08 23:17:53 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-09 00:01:28 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bell-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:39:25 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION>
<P>&gt; 12 months' pre- and postrestriction data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-20 02:54:06 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Benson-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:44:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Berild-2002">
<DESCRIPTION>
<P>Done, 3 years' pre-intervention and 2 years' postintervention data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 01:04:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-20 08:44:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 01:50:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 02:04:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:32:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:51:41 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION>
<P>Only 4 months' pre-intervention data, so secular changes possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-17 01:17:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:31:23 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION>
<P>Junior staff who were targets of the intervention rotated every 3 months.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 10:08:57 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION>
<P>Although the pre- and postintervention phases were only a 6-month period, data from 1 year prior to the intervention were used to control for any seasonal variation in prescribing patterns.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Burton-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-04 01:15:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:04:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Calil-2001">
<DESCRIPTION>
<P>More than 1 year of data before and after intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Camins-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:34:02 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carling-2003">
<DESCRIPTION>
<P>3 years' pre-intervention data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:45:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2011">
<DESCRIPTION>
<P>States in discussion that biggest limitation was lack of external controls, but that is common to all ITS studies.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:52:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 01:53:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:53:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION>
<P>1 year post- and 2 years' pre-intervention data, so secular changes unlikely. Infection control protocols were unchanged pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 19:01:24 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>Does not mention other changes apart from preceding Antimicrobial Stewardship Programme.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:59:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chu-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-04 03:10:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Climo-1998">
<DESCRIPTION>
<P>Done, infection control measures fully described and same in both phases.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-05 01:47:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-05 02:06:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:15:51 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION>
<P>This and all other ROB criteria are for interventions 1 and 2 only. Intervention 3 and 4 could not be evaluated because they are too close together and also coincided with an influenza epidemic. Neither intervention 3 nor intervention 4 meets the EPOC minimum criteria for ITS. There are insufficient data to adjust for seasonal effects, and the target condition (pneumonia) has large seasonal variation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-12 02:49:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:35:42 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION>
<P>9 months' data pre-restriction includes an additional persuasive intervention 7 months' pre-restriction; effect cannot be assessed because of insufficient pre-intervention data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 00:04:20 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION>
<P>&lt; 1 year data pre- and postintervention, so seasonal trends cannot be excluded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ding-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 00:59:06 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dua-2014">
<DESCRIPTION>
<P>No data about antibiotic prescribing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 01:42:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dull-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 08:39:08 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION>
<P>Done. October to August both pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:47:14 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION>
<P>Only 9 months pre-intervention data, so secular/seasonal changes possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 03:03:32 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION>
<P>No mention of any other changes, although little information given.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 03:08:41 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION>
<P>Ongoing audit and feedback</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 10:00:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-16 00:48:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 01:58:49 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION>
<P>Only 4 months' pre-intervention data, so secular/seasonal changes possible. No information about infection control measures.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-18 00:43:02 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:29:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gums-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:30:20 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION>
<P>Only 3 months' pre-intervention data, so secular/seasonal changes possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:33:35 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION>
<P>No, seasonal variation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:38:52 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Halm-2004">
<DESCRIPTION>
<P>NOT DONE, subjective outcome measure, not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:44:22 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hess-1990">
<DESCRIPTION>
<P>12 months' data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:47:44 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION>
<P>Data collected in same months in 2 consecutive years.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-17 02:02:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-29 12:12:34 -0400" MODIFIED_BY="Claire Peden" RESULT="UNKNOWN" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 03:02:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huber-1982">
<DESCRIPTION>
<P>&gt; 2 years' data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-25 14:02:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION>
<P>Objective outcome measure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:26:36 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION>
<P>Only 12 months' data (9 months' pre- and 3 months' postintervention), so cannot control for seasonal effects.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-24 00:41:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-12-06 12:47:40 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Jump-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:51:51 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION>
<P>No, as this was during an outbreak</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:07:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khan-2003">
<DESCRIPTION>
<P>&gt; 1 year data in each of the 3 phases</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-07 00:48:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:20:40 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION>
<P>The antimicrobial stewardship intervention was simultaneous with an intervention to improve infection control practice (personal protection and isolation).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:39:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION>
<P>Done, 32 months' pre- and 11 months' postintervention, so secular or seasonal effects unlikely.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-24 02:11:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 10:19:27 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION>
<P>Low risk for prescribing outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:07 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-25 14:02:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Landman-1999">
<DESCRIPTION>
<P>Reliable primary outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:51:32 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION>
<P>The change in antibiotic policy was 9 months after the introduction of MRSA screening. The authors' analysis suggests an independent effect from the policy change.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Layios-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 23:50:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:05:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2007">
<DESCRIPTION>
<P>Infection control policies unchanged throughout (page 631).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-16 01:22:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:20:15 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION>
<P>NOT DONE, major changes in infection control 4 weeks before the antibiotic restriction. Separate effect cannot be estimated because no screening before change in infection control.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:28:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION>
<P>18 months' pre- and 15 months' postintervention data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liu-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Long-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:41:49 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION>
<P>Data collected for 11 months postintervention. Season included as a variable in the model, and summer found to be associated with lower MRSA infection rate. Coincident with infection control intervention for norovirus outbreak, infection control variables included in the model and significantly associated with lower MRSA rate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:51:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION>
<P>States in discussion that most changes not related to any other external factor.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:58:07 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION>
<P>There was a national intervention (Scottish Patient Safety Program) that included reducing time to rescue of deteriorating patients throughout the pre- and postintervention phases.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:43:27 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masia-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:10:22 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-May-2000">
<DESCRIPTION>
<P>Only 9 months' data pre-intervention, so secular/seasonal effects possible. No information about infection control practices before or after the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:13:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION>
<P>12 months' data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:17:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION>
<P>Data over 8 years, 4 years pre- and 4 years postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:20:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION>
<P>Not done, data were only collected for 4 weeks before and after the intervention, so secular changes could have accounted for any differences.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:03:38 -0500" MODIFIED_BY="Julia Worswick" RESULT="NO" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-25 14:02:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION>
<P>Full year before and after</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:35:33 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION>
<P>Infection control intervention simultaneous with antibiotic intervention. 14 months' pre- and 11 months' postintervention, so secular change unlikely.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-15 23:58:20 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:23:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:56:14 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION>
<P>Says they could not control for changes over time and that an antimicrobial stewardship programme was implemented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Micek-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 18:09:53 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION>
<P>Antibiotic use was 1 of 10 recommendations in the guideline; the other 9 would have impacted on clinical outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-07 09:48:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mol-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-07 07:05:27 -0500" MODIFIED_BY="Claire Peden" RESULT="UNKNOWN" STUDY_ID="STD-Newland-2012">
<DESCRIPTION>
<P>Unclear, there were some infection control initiatives running.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:38:10 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION>
<P>MRSA control programme introduced simultaneously.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-01 01:09:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 00:55:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 01:14:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:54:22 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Patel-1989">
<DESCRIPTION>
<P>Only 5 months' pre-intervention data, so secular changes possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Paul-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:07:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pear-1994">
<DESCRIPTION>
<P>Enough data to account for seasonal variation, and infection control measures did not change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 14:03:46 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Perez-2003">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-29 01:38:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peto-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 01:50:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:36:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pires-2011">
<DESCRIPTION>
<P>No outbreak or other changes coincident with intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:43:17 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Po-2012">
<DESCRIPTION>
<P>Yes, reports on all likely influencing interventions.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 00:43:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-07 01:47:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:40:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Price-2010">
<DESCRIPTION>
<P>For prescrbiing outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 07:04:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Qu-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:27:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION>
<P>1 year of data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:35:17 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richards-2003">
<DESCRIPTION>
<P>8 months data pre-intervention, 15 months postintervention, not enough to adjust for seasonal variation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:41:47 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION>
<P>Data only collected for 3 months pre- and 6 months postintervention, so secular/seasonal changes possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-07 02:20:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ross-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:12:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION>
<P>4 years' data pre- and 3 years' data postintervention, so enough data to account for seasonal change</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:19:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Salama-1996">
<DESCRIPTION>
<P>&gt; 12 months' data pre- and postintervention, enough to account for seasonal change</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:59:20 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 03:19:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Senn-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:23:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:23:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:20:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION>
<P>4 years' data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:34:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-08 02:49:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 10:26:00 -0500" MODIFIED_BY="Julia Worswick" RESULT="NO" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION>
<P>No information is given about changes in drug pricing over the 12 years of data collection, which is likely to have changed the outcome measure. In addition, there were changes in pharmacy data systems after the intervention, but the timing is clearly documented in Figure 1.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:47:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION>
<P>2 years' data pre- and postintervention, enough to account for seasonal effects</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:19:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Strom-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:07:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:24:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:29:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION>
<P>Change in site - moved to another building</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:45:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:49:23 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION>
<P>NOT CLEAR, data for 7 months pre- and 12 months postintervention, not enough to adjust for seasonal variation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:00:35 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION>
<P>Administration of antibiotics within 1 hour was 1 component of the bundle; the other 2 were avoiding shaving and encouraging use of clorhexidine for disinfection. In addition, 9 months after the intervention began an additional antibiotic element was added to encourage administration of an additional dose for operations lasting more than 3 hours.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-23 00:37:40 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION>
<P>Insufficient information to assess</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:21:40 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION>
<P>Antimicrobial intervention followed an infection control intervention, so it is not possible to assess the independent impact on <I>C difficile </I>infection. Moreover, the infection control intervention could have been responsible for some or all of the reduction in total antibiotic use.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:33:25 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION>
<P>Only 6 months' pre- and postintervention data, and the model was not adjusted for seasonal trends.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 02:06:56 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Walker-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:01:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 00:08:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wax-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:57:04 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION>
<P>Data collection method was the same pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:50:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-15 02:25:59 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 01:04:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:34:32 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION>
<P>Only 5 months' pre-intervention data. Even with 26 months' postintervention data, could still be secular changes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:51:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION>
<P>25 months' pre- and 17 months' postintervention data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:49:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 00:36:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:25:24 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yong-2010">
<DESCRIPTION>
<P>Acinetobacter outbreak during intervention period resulting in hand hygiene and staff education interventions. Also see Table 4.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:33:51 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION>
<P>Intensive environmental cleaning implemented in 2012 in ICU, which was intended to reduce infections with CRAB (microbial outcome).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:38:38 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Young-1985">
<DESCRIPTION>
<P>3 months' data before, 15 months' during, and 22 months' after the restriction. Not enough data to adjust for seasonal variation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yu-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:40:57 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION>
<P>Only 7 months' pre-intervention data, so secular/seasonal changes possible. Very complex case definition with no information about how this was applied reliably across the pre- and postintervention periods.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:37:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="STUDY" MODIFIED="2017-01-18 12:03:39 -0500" MODIFIED_BY="Julia Worswick" NO="11">
<NAME>Analysed appropriately (ITS) ?</NAME>
<DESCRIPTION>
<P>Was the analysis appropriate?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:52:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper (comparison of means, uncontrolled before-after).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:56:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper (comparison of means, uncontrolled before and after).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-23 23:58:06 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-19 02:02:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 01:59:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 01:08:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-24 00:52:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Annane-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:47:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION>
<P>Done in original paper: segmented regression analysis with adjustment for autocorrelation and seasonality.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:53:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION>
<P>Done in original paper: segmented regression analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:28:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-31 00:11:03 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:27:26 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 02:46:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-08 23:17:55 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-09 00:01:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bell-2014">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:39:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper (comparison of means with t-test, uncontrolled before-after).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-20 02:54:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Benson-2014">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:45:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Berild-2002">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper (run charts, Figure 1, with no statistical analysis).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 01:04:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-20 08:45:20 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 01:50:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 02:04:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:32:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:52:06 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION>
<P>Done in original paper: Kaplan-Meier plot and log rank test.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 04:53:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 04:28:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:41:30 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: run charts with no statistical analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:51:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-04 01:16:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:05:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Calil-2001">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after) with logistic regression analysis of relationship between antibiotic prescribing and resistance.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Camins-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:34:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carling-2003">
<DESCRIPTION>
<P>Done in original paper: regression analysis with adjustment for autocorrelation. Analysis repeated by review team because of incomplete reporting of results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-05 00:42:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2011">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:52:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2015">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 01:54:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:54:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION>
<P>Done in original paper: the study is analysed as a CBA adjusting for confounders and slope and level. The ITS analyses are correct, but the results are not well reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-04 02:31:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:59:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chu-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 22:43:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Climo-1998">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after) with t-test.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-05 01:48:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-05 02:06:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-05 01:33:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-12 02:49:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:36:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION>
<P>Analysed by correlation and time-lag modelling, but re-analysed as segmented regression analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:27:27 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ding-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 01:01:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dua-2014">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 01:43:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dull-2008">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:40:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:04:33 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION>
<P>Done in original paper, segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 03:03:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 03:08:44 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 10:00:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-16 00:48:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 01:58:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-18 00:43:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:30:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gums-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:30:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper, &#1061;<SUP>2</SUP> test on mean before-after.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:33:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:39:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Halm-2004">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after) with &#967;<SUP>2</SUP> test.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:44:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hess-1990">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper, no statistical analysis, and only comparison was between mean (uncontrolled) before and after.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:47:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after) with t-test.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-17 02:03:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 03:03:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huber-1982">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: no statistical analysis of time series, presented as chart.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:14:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION>
<P>Done in original paper: segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:26:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-24 00:42:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION>
<P>Statistical process control chart</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-19 00:55:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jump-2012">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-07 00:21:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:08:07 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khan-2003">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: no statistical analysis, mean cases per quarter compared between periods.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-07 00:49:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2008">
<DESCRIPTION>
<P>Not in original paper but re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-19 02:05:06 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:41:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before and after) with &#967;<SUP>2</SUP> test.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-24 02:11:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 00:56:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:07 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:27:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Landman-1999">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after) with t-test.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:48 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-13 03:44:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION>
<P>ARIMA time series analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Layios-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 23:50:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-1995">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-31 01:40:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2007">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-16 01:22:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2014">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:20:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: no statistical analysis, time series data presented as run chart.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:45:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION>
<P>Segmented regresssion analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liu-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Long-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:21:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION>
<P>Done in original paper: segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-03 01:42:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:06:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:43:27 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masia-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:11:03 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-May-2000">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: &#967;<SUP>2</SUP> test, uncontrolled before-after with Poisson regression analysis of VRE rates.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:14:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:17:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:21:03 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after) with &#967;<SUP>2</SUP> test.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:03:39 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:32:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:35:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: run chart with no statistical analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-15 23:58:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:22:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-16 00:25:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Micek-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-30 00:21:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION>
<P>Statistical process control charts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:29:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mol-2005">
<DESCRIPTION>
<P>Done in original paper: segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:23:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Newland-2012">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:38:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-01 01:10:03 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 00:56:14 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 01:15:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:54:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Patel-1989">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Paul-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:07:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pear-1994">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: run chart with no statistical analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:19:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez-2003">
<DESCRIPTION>
<P>Done in original paper: ARIMA analysis, selected in preference to segmented regression analysis because of nonlinear outcome data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-29 01:40:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peto-2008">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 01:50:28 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:37:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pires-2011">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-29 01:45:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Po-2012">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 00:43:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-07 01:49:03 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:42:10 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Price-2010">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 07:04:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Qu-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 01:13:20 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:35:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Richards-2003">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after) with Kruskal-Wallis test.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:41:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-07 02:21:05 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ross-2014">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:12:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after) with Fisher's exact test.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:19:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Salama-1996">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 03:03:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION>
<P>Statistical process control charts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 03:21:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:55 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Senn-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:47:49 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:23:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:20:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: run charts with no statistical analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:24:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:27:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-21 01:03:52 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:47:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION>
<P>Done in original paper: regression analysis testing for structural break associated with intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:19:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Strom-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:07:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2011">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:24:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:42:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:46:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:49:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after) with &#967;<SUP>2</SUP> test.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 02:44:59 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-23 00:38:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION>
<P>Time series analysis with ARIMA modelling</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-23 00:55:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:44:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION>
<P>Done in original paper: segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 02:07:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION>
<P>Statistical process control chart</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Walker-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:00:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2014">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 00:08:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wax-2007">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 01:45:03 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION>
<P>Done in original paper: segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:02:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION>
<P>Re-analysed; our analysis questions the authors' conclusion that the intervention was effective.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-15 02:26:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION>
<P>Re-analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 01:04:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:34:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: run chart with no statistical analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:51:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION>
<P>Done in original paper: ordinary least squares regression analysis adjusting for pre-existing time trends, re-analysis with segmented regression performed for the purposes of comparison of effect size with other studies in the review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 00:48:17 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 01:05:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yong-2010">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 00:46:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:39:49 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Young-1985">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yu-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:41:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION>
<P>Re-analysed. Not done in original paper: comparison of means (uncontrolled before-after) with t-test.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:32:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION>
<P>Segmented regression analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-12" LEVEL="STUDY" MODIFIED="2017-01-18 12:03:39 -0500" MODIFIED_BY="Julia Worswick" NO="12">
<NAME>Shape of effect pre-specified (ITS) ?</NAME>
<DESCRIPTION>
<P>Was the shape of the intervention effect pre-specified ?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:53:06 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:58:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:03:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:09:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:13:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:27:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION>
<P>Point of intervention is point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-24 00:52:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Annane-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:47:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:53:52 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:28:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:10:02 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:27:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 02:47:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-08 23:17:59 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:34:22 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bell-2014">
<DESCRIPTION>
<P>Point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:40:04 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention. Outcome data were collected from all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:42:17 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Benson-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:45:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Berild-2002">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:55:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 00:00:22 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 00:06:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 00:10:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:32:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:52:18 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 03:20:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION>
<P>Point of analysis is point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:31:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:41:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:51:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:52:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:05:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Calil-2001">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Camins-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:34:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carling-2003">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:45:16 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2011">
<DESCRIPTION>
<P>Point of analysis was point of intervention.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:52:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2015">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 01:54:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:54:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 19:01:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:59:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chu-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 22:43:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Climo-1998">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:01:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:08:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:16:08 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-12 02:49:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 04:42:06 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 00:04:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ding-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:09:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dua-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:18:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dull-2008">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:32:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION>
<P>Done, point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:47:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 16:30:26 -0400" MODIFIED_BY="Claire Peden" RESULT="YES" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION>
<P>Done. Intervention point was clear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 16:57:50 -0400" MODIFIED_BY="Claire Peden" RESULT="YES" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION>
<P>Done. Point of analysis is point of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 10:00:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 01:55:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 01:59:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION>
<P>Point of analyses was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:09:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:14:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gums-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:30:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-28 13:11:36 -0400" MODIFIED_BY="Claire Peden" RESULT="YES" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION>
<P>Done, point of analysis is point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:39:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Halm-2004">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:44:45 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hess-1990">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:48:03 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:51:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION>
<P>Point of intervention is point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 03:03:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huber-1982">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 03:14:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION>
<P>Done, intended effect was increase in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:27:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:41:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION>
<P>Point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:49:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jump-2012">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:51:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION>
<P>Point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:08:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khan-2003">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:14:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2008">
<DESCRIPTION>
<P>Point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:20:44 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:42:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-24 02:11:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:17:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION>
<P>Point of intervention was point of anaysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:07 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:27:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Landman-1999">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:52:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION>
<P>Point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Layios-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:01:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-1995">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-31 01:41:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2007">
<DESCRIPTION>
<P>Decrease</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:10:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:20:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:28:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION>
<P>Point of analysis is point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liu-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Long-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:42:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:51:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION>
<P>Point of intervention is point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:58:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:43:27 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masia-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:11:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-May-2000">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:14:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:17:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:21:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:03:39 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:32:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:36:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:45:25 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:50:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:56:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Micek-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 18:10:08 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 18:15:16 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mol-2005">
<DESCRIPTION>
<P>Done, intended effect was increase in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-07 07:06:54 -0500" MODIFIED_BY="Claire Peden" RESULT="YES" STUDY_ID="STD-Newland-2012">
<DESCRIPTION>
<P>Yes, point of analysis is point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:38:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:02:25 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:22:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:49:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:54:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Patel-1989">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Paul-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:07:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pear-1994">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:19:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez-2003">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:25:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peto-2008">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:33:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:37:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pires-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:43:30 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Po-2012">
<DESCRIPTION>
<P>Yes, the point of analysis is the point of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 00:43:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:53:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:58:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Price-2010">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 07:04:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Qu-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:27:08 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:35:45 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Richards-2003">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:42:03 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 04:03:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ross-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:13:49 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:19:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Salama-1996">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:56:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:07:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:55 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Senn-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:23:15 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:24:00 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:20:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:24:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:27:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:43:45 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:47:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:19:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Strom-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:31:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2011">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:33:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:42:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:46:18 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:50:03 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:00:45 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:11:18 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:21:44 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:33:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:39:03 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Walker-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:47:58 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:52:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wax-2007">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:57:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:02:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION>
<P>Point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:26:07 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:32:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:35:08 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:52:18 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:20:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:25:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yong-2010">
<DESCRIPTION>
<P>Point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:33:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:39:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Young-1985">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yu-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:41:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION>
<P>Done, intended effect was decrease in primary outcome, and point of analysis was point of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:29:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION>
<P>Point of intervention was point of analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-13" LEVEL="STUDY" MODIFIED="2017-01-18 12:03:39 -0500" MODIFIED_BY="Julia Worswick" NO="13">
<NAME>Unlikely to affect data collection (ITS) ?</NAME>
<DESCRIPTION>
<P>Was the intervention unlikely to affect data collection?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:53:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:58:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-23 23:58:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION>
<P>Electronic outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-19 02:03:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION>
<P>Electronic data from pharmacy and microbiology</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 01:59:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION>
<P>Electronic data from microbiology</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 01:02:16 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION>
<P>Pharmacy and microbiology routine data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-24 00:52:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Annane-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 14:11:32 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION>
<P>"The aim of this study was to use routine data from the pharmacy stock control computer to evaluate this intervention". Sources and methods of data collection were the same before and after the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:53:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:28:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:10:04 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION>
<P>Data were obtained from pharmacy systems.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:27:27 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 02:47:06 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION>
<P>Routine pharmacy data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-08 23:18:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-09 00:04:17 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bell-2014">
<DESCRIPTION>
<P>Data from laboratory computer system (serum creatinine)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:40:10 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-20 02:55:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Benson-2014">
<DESCRIPTION>
<P>Electronic data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:45:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Berild-2002">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 01:04:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION>
<P>Prescribing data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 00:00:25 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION>
<P>Prescribing outcomes were collected by the investigators.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 01:51:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 02:05:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:32:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:52:22 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION>
<P>Done, screening protocol was the same throughout the study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-17 01:18:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION>
<P>Data from pharmacy and microbiology systems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:31:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION>
<P>Data collection was identical in all 3 phases.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:41:44 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:51:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:53:07 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>Data for ITS from pharmacy computer (Figure 1). Other data in Tables 2 and 3 not valid, UBA.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:05:30 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Calil-2001">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Camins-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:34:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carling-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:45:43 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chan-2011">
<DESCRIPTION>
<P>DDD data from pharmacy computer, the same pre- and postintervention<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:52:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2015">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 01:54:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:54:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 19:01:30 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>Routine pharmacy data used for outcome, so assume complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:59:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chu-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 22:43:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Climo-1998">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:01:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-05 02:05:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:16:15 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION>
<P>Data collection was different in the postintervention phase (see below).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-12 02:49:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 04:42:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION>
<P>Routine data from microbiology and pharmacy computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:27:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION>
<P>Patient administration system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ding-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:13:41 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dua-2014">
<DESCRIPTION>
<P>Outcome relied on ICD discharge coding to identify surgical-site infection, may have been influenced by financial incentives to meet SCIP targets.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 01:43:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dull-2008">
<DESCRIPTION>
<P>Electronic outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:32:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:47:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 03:03:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 03:09:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 10:00:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-16 00:49:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:42:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION>
<P>Routine data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-18 00:43:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:29:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION>
<P>Outcome data from microbiology and pharmacy computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gums-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:31:03 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-28 13:12:02 -0400" MODIFIED_BY="Claire Peden" RESULT="YES" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION>
<P>Done, data was collected by trained data collectors.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:39:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Halm-2004">
<DESCRIPTION>
<P>Done, data collection same pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:44:49 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hess-1990">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:48:07 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-17 02:03:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION>
<P>Retrospective data collection using the same methods throughout</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 03:03:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huber-1982">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 03:14:08 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:27:04 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:41:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION>
<P>Primary outcome was time to first antibiotic dose from patient administration system.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-19 00:56:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jump-2012">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-07 00:22:06 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:08:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khan-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-07 00:49:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2008">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-19 02:05:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computuers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:42:16 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-24 02:11:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 01:02:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:07 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:27:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Landman-1999">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-13 03:45:05 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION>
<P>Routine patient administration systems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Layios-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 23:50:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-1995">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:05:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2007">
<DESCRIPTION>
<P>Data about prescribing and microbial outcomes were from routine, electronic data systems.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:10:04 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2014">
<DESCRIPTION>
<P>Outcomes were measured from electronic pharmacy data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:20:45 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION>
<P>Screening protocol was the same pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:28:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION>
<P>Pharmacy data used pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liu-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Long-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 09:01:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION>
<P>Not clear, no information about protocols for sampling or testing for MRSA over the study period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-03 01:43:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION>
<P>Data from electronic pharmacy records</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:58:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION>
<P>Objective primary outcome measure (time to first antibiotic dose) collected by single person (CM).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:43:27 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masia-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 14:01:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-May-2000">
<DESCRIPTION>
<P>Done, objective outcome measure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:14:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:17:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 08:45:33 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:03:39 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:32:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:36:30 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:45:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>Outcome from pharmacy database pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:24:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-16 00:25:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION>
<P>Data from pharamacy computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Micek-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-30 00:23:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION>
<P>All outcome data from hospital patient administration system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 18:15:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mol-2005">
<DESCRIPTION>
<P>Data collection method was same throughout study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:23:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Newland-2012">
<DESCRIPTION>
<P>Yes, data collection was the same pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-17 00:59:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION>
<P>Routine data from microbiology computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-01 01:10:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 00:56:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION>
<P>MRSA data from microbiology computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 01:15:28 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION>
<P>Data from patient administration systems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:54:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Patel-1989">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Paul-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:07:43 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Pear-1994">
<DESCRIPTION>
<P>Not done, the method of detection of <I>C difficile </I>toxin changed from cell culture assay in the first 4 years of the study to a latex test in the final year (5 months after the start of clindamycin restriction).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:19:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-29 01:39:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peto-2008">
<DESCRIPTION>
<P>Routine data from pharmacy</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 01:50:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:35:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pires-2011">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:43:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Po-2012">
<DESCRIPTION>
<P>Yes, pharmacy data used both pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 00:43:28 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-07 01:49:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION>
<P>Outcome data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:41:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Price-2010">
<DESCRIPTION>
<P>Pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 23:03:25 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION>
<P>Primary outcome was appropriateness of treatment at 24 to 96 hours, which was the same in pre- and postintervention period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Qu-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:28:35 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION>
<P>Primary outcome (unnecessary DACT) not objective.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:35:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Richards-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:42:13 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION>
<P>The reliability of the assessment of appropriate vancomycin use was not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 04:04:02 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ross-2014">
<DESCRIPTION>
<P>Outcome data from Pediatric Health Information System</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:13:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:19:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Salama-1996">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:58:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION>
<P>Electronic data for prescribing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:07:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION>
<P>Days of antimicrobial use calculated automatically by pharmacy computer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:55 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Senn-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:23:15 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:24:00 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:20:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:34:56 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-08 02:50:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:43:49 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION>
<P>Data were from the Pharmacy Administration and were independent from the AMT.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:47:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:19:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Strom-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:08:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2011">
<DESCRIPTION>
<P>From Taiwan Quality Improvement Project database</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:23:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:42:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION>
<P>From electronic records, so unlikely</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:47:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION>
<P>DDD from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:50:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:00:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION>
<P>Patient administration systems and routine collection of surgical-site infection data by each hospital's infection prevention teams</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:11:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION>
<P>Outcome data were from routine pharmacy systems.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:21:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:33:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 02:07:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION>
<P>Outcome data from patient administration system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Walker-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:01:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 00:15:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wax-2007">
<DESCRIPTION>
<P>Outcome data from electronic patient record, Anaesthesia Information Management System (AIMS)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:57:17 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION>
<P>Data collection method was the same pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:52:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION>
<P>TFAD from patient administration system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-15 02:26:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 01:05:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION>
<P>Outcomes from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:35:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:52:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 00:43:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION>
<P>Prescribing outcome in DDD from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 01:06:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yong-2010">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 00:47:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:40:03 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Young-1985">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yu-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:41:32 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION>
<P>Case definition included clinical interpretation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:29:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION>
<P>Data for primary outcome measure were from pharmacy computer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-14" LEVEL="STUDY" MODIFIED="2017-01-18 12:03:39 -0500" MODIFIED_BY="Julia Worswick" NO="14">
<NAME>Knowledge of the allocation adequately prevented(ITS)?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:53:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:58:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-23 23:58:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION>
<P>Electronic outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 01:55:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION>
<P>Electronic data from pharmacy and microbiology</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 02:00:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION>
<P>Electronic data from microbiology</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 01:02:20 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION>
<P>Pharmacy and microbiology routine data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-24 00:52:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Annane-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-25 00:38:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION>
<P>"After evaluation of the intervention according to patient records and its shortcomings, we decided to use the pharmacy stock data. During the 4 year period of analysis no restriction policy for dispensing the Alert Antibiotics was implemented by the hospital pharmacy, therefore the pharmacy data about dispensed Alert Antibiotics would provide us with the best available independent indicator for evaluation of the intervention."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:53:58 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:28:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 08:33:35 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION>
<P>Prescribing data were processed by the investigators to convert grams to DDD and identify only IV antibiotics.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:27:27 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 02:47:14 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION>
<P>Routine pharmacy data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-08 23:18:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-09 00:02:20 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bell-2014">
<DESCRIPTION>
<P>Data from laboratory computer system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:40:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-20 02:55:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Benson-2014">
<DESCRIPTION>
<P>Electronic data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:45:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Berild-2002">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 01:04:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION>
<P>Prescribing data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 00:00:27 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION>
<P>Prescribing outcomes were collected by the investigators.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 01:51:16 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 02:05:03 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:32:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:52:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION>
<P>Done, screening protocol was the same throughout the study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-17 01:19:02 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION>
<P>Data from pharmacy and microbiology systems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:31:38 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION>
<P>The nurse and physicians who collected data were not blinded to allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:41:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:51:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:53:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>Data for ITS from pharmacy computer (Figure 1). Other data in Tables 2 and 3 not valid, UBA.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:05:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Calil-2001">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Camins-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:34:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carling-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:45:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2011">
<DESCRIPTION>
<P>DDD data from pharmacy computer, the same pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:53:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2015">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 01:54:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:54:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 19:01:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>Routine pharmacy data used for outcome, so assume complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:59:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chu-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 22:43:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Climo-1998">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:01:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-05 02:05:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:16:56 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION>
<P>Compliance to therapy was assessed with a "computerised algorithm". However, the criteria for guideline adherence presented in the supplementary materials (Table S2) would require chart review, unless the hospitals had very sophisticated electronic patient records, which is not stated. The fact that patients were excluded because of "incomplete files" suggests that chart review was required, so knowledge of the allocated interventions could not be adequately prevented.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-12 02:49:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 04:42:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION>
<P>Routine data from microbiology and pharmacy computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:27:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION>
<P>Patient administration system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ding-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 01:02:27 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dua-2014">
<DESCRIPTION>
<P>Electronic outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 01:43:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dull-2008">
<DESCRIPTION>
<P>Electronic outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:32:35 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION>
<P>No, the intervention was open to all participants and prescribers, difficult to conceal.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:47:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 16:26:54 -0400" MODIFIED_BY="Claire Peden" RESULT="YES" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION>
<P>Done. Outcomes are objective.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 03:09:15 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION>
<P>No, not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 10:00:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-16 00:49:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:42:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION>
<P>Routine data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-18 00:43:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:29:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION>
<P>Outcome data from microbiology and pharmacy computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gums-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:31:06 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-28 13:12:29 -0400" MODIFIED_BY="Claire Peden" RESULT="NO" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION>
<P>No, blinding was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 09:28:03 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Halm-2004">
<DESCRIPTION>
<P>NOT DONE, subjective outcome measure, not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:44:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hess-1990">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:48:10 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:51:34 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION>
<P>Data were collected from case records, and allocation was not concealed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 03:03:16 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huber-1982">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 03:14:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:27:07 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:41:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION>
<P>Primary outcome was time to first antibiotic dose from patient administration system.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-19 00:56:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jump-2012">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-07 00:22:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:08:17 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khan-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 00:52:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2008">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-19 02:05:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computuers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:42:18 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-24 02:11:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 01:02:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:07 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:28:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Landman-1999">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-13 03:45:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION>
<P>Routine patient administration systems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Layios-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 23:51:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-1995">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:05:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2007">
<DESCRIPTION>
<P>Data about prescribing and microbial outcomes were from routine, electronic data systems.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:10:07 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2014">
<DESCRIPTION>
<P>Outcomes were measured from electronic pharmacy data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:20:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION>
<P>Screening protocol was the same pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:28:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION>
<P>Pharmacy data used pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liu-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Long-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-25 14:02:25 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION>
<P>Objective data about MRSA</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-03 01:43:28 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION>
<P>Data from electronic pharmacy records</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:58:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION>
<P>Objective primary outcome measure (time to first antibiotic dose) collected by single person (CM).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:43:27 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masia-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:17:49 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-May-2000">
<DESCRIPTION>
<P>Objective outcome measure, VRE infections</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:14:30 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:17:44 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:19:21 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:03:39 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:32:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:36:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-16 00:00:09 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>No mention of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:24:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-16 00:25:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION>
<P>Data from pharamacy computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Micek-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-30 00:23:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION>
<P>All outcome data from hospital patient administration system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-25 14:02:29 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mol-2005">
<DESCRIPTION>
<P>Subjective outcome without blinded assessment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:23:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Newland-2012">
<DESCRIPTION>
<P>Yes, objective outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-17 00:59:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION>
<P>Routine data from microbiology computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-01 01:10:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 00:56:56 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION>
<P>MRSA data from microbiology computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:49:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION>
<P>Data from patient administration systems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:54:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Patel-1989">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Paul-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:07:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pear-1994">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:19:52 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-29 01:39:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peto-2008">
<DESCRIPTION>
<P>Routine data from pharmacy</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 01:51:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:36:02 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pires-2011">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:43:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Po-2012">
<DESCRIPTION>
<P>Outcome is objective.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 00:43:29 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-07 01:49:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION>
<P>Outcome data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:41:17 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Price-2010">
<DESCRIPTION>
<P>Pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 23:03:49 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION>
<P>Dual data entry, the ICU consultant was blinded to study period, although the ID physician was not.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Qu-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:28:36 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION>
<P>Primary outcome (unnecessary DACT) not objective.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:35:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Richards-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:42:18 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION>
<P>Retrospective assessment of appropriateness without concealment of study phase.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 04:04:16 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ross-2014">
<DESCRIPTION>
<P>Outcome data from Pediatric Health Information System</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:13:52 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:19:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Salama-1996">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:56:55 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION>
<P>Infection control personnel were blinded for assessment of wound infection, unsure about compliance data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:07:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION>
<P>Days of antimicrobial use calculated automatically by pharmacy computer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:58 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Senn-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:23:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:24:00 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:20:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:34:56 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-08 02:50:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:43:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION>
<P>Data were from the Pharmacy Administration and were independent from the AMT.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:47:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:19:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Strom-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:31:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2011">
<DESCRIPTION>
<P>Outcome data from Taiwan Quality Improvement Project database.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:23:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:42:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION>
<P>From electronic records, so unlikely</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:47:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION>
<P>DDD from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:50:07 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:01:23 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION>
<P>Infection prevention teams were not prevented from knowing about allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:11:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION>
<P>Outcome data were from routine pharmacy systems.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:22:10 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:33:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:39:07 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION>
<P>Outcome data from patient administration system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:55 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Walker-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:01:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 00:09:52 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wax-2007">
<DESCRIPTION>
<P>Outcome data from electronic patient record (AIMS)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:57:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION>
<P>Prescribing outcome data were from electronic systems.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:56:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION>
<P>TFAD from patient administration system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-15 02:27:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 01:06:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION>
<P>Outcomes from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:35:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:52:22 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 00:47:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION>
<P>Prescribing outcome in DDD from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 01:06:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yong-2010">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 00:47:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:40:06 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Young-1985">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yu-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 06:51:46 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION>
<P>NOT CLEAR because of case definition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:29:16 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION>
<P>Data for primary outcome measure were from pharmacy computer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-15" LEVEL="STUDY" MODIFIED="2017-01-18 12:03:39 -0500" MODIFIED_BY="Julia Worswick" NO="15">
<NAME>Incomplete outcome data addressed (ITS) ?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:53:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:58:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-23 23:58:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION>
<P>Electronic outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 01:55:56 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION>
<P>Electronic data from pharmacy and microbiology</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 02:00:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION>
<P>Electronic data from microbiology</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 01:02:28 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION>
<P>Pharmacy and microbiology routine data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-24 00:52:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Annane-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:48:08 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:54:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:28:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-31 00:12:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION>
<P>Routine pharmacy data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:27:27 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 02:47:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION>
<P>Routine pharmacy data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-08 23:18:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:34:29 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bell-2014">
<DESCRIPTION>
<P>Completeness of pre- and postoperative creatinine data presented in full for all services (Table 2). There was a significant increase in testing after policy change in gynaecology.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:40:17 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-20 02:55:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Benson-2014">
<DESCRIPTION>
<P>Electronic data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:45:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Berild-2002">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 01:04:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION>
<P>Prescribing data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 00:00:39 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION>
<P>Data are presented as % compliance per quarter, but it is not clear whether complete data were collected from all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 01:51:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 02:05:06 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:32:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:52:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION>
<P>Done, screening protocol was the same throughout the study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-17 01:19:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION>
<P>Data from pharmacy and microbiology systems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:31:44 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION>
<P>Data were collected from all eligible participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:41:49 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:51:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:53:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>Data for ITS from pharmacy computer (Figure 1). Other data in Tables 2 and 3 not valid, UBA.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:05:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Calil-2001">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Camins-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:34:30 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carling-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:45:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2011">
<DESCRIPTION>
<P>DDD data from pharmacy computer, the same pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:53:27 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2015">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 01:54:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:54:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 19:01:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>Routine pharmacy data used for outcome, so assume complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:59:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chu-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 22:43:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Climo-1998">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:01:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-05 02:05:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:17:21 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION>
<P>The 477 included participants had complete data for assessment of outcomes. 5 patients were excluded because of incomplete patient records.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-12 02:49:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 04:42:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION>
<P>Routine data from microbiology and pharmacy computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:05:45 -0400" MODIFIED_BY="Kate Cahill" RESULT="UNKNOWN" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION>
<P>No explicit statement about complete follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ding-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:14:27 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dua-2014">
<DESCRIPTION>
<P>Outcome data were restricted to inpatient coding, but most surgical-site infections likely to present postdischarge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 01:43:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dull-2008">
<DESCRIPTION>
<P>Electronic outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:32:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:47:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 16:29:44 -0400" MODIFIED_BY="Claire Peden" RESULT="YES" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 03:09:29 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION>
<P>Done, data were from routine systems so unlikely to be incomplete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 10:00:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-16 00:49:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:42:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION>
<P>Routine data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-18 00:43:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:29:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION>
<P>Outcome data from microbiology and pharmacy computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:46 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gums-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:31:08 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-28 13:13:44 -0400" MODIFIED_BY="Claire Peden" RESULT="YES" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION>
<P>Done, states they assured completeness of data by collecting while patients were still in the department.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:40:17 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halm-2004">
<DESCRIPTION>
<P>Not stated whether outcome data collected on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:44:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hess-1990">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:48:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:51:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION>
<P>Outcome data reported on all 110 included participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 03:03:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huber-1982">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 03:14:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:27:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:41:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION>
<P>Primary outcome was time to first antibiotic dose from patient administration system.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-19 00:56:16 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jump-2012">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-07 00:22:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:08:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khan-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 00:53:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2008">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-19 02:05:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computuers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:42:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-24 02:11:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 01:02:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:07 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:28:03 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landman-1999">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-13 03:45:17 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION>
<P>Routine patient administration systems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Layios-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 23:51:02 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-1995">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:05:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2007">
<DESCRIPTION>
<P>Data about prescribing and microbial outcomes were from routine, electronic data systems.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:10:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2014">
<DESCRIPTION>
<P>Outcomes were measured from electronic pharmacy data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:21:06 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION>
<P>NOT CLEAR, no explicit statement about complete screening samples for all participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:28:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION>
<P>Pharmacy data used pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liu-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Long-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:43:06 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION>
<P>Identification of cases was the same in the pre- and postintervention phases.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-03 01:43:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION>
<P>Data from electronic pharmacy records</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:58:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION>
<P>Outcome data collected on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:43:27 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masia-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 09:43:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-May-2000">
<DESCRIPTION>
<P>Done, objective outcome measure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:14:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:17:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-15 01:40:17 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION>
<P>No information about reliability or completeness of primary outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:03:39 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:32:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:36:38 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION>
<P>Pre-intervention data were incomplete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:45:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>Outcome from pharmacy database pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:24:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-16 00:25:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION>
<P>Data from pharamacy computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Micek-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-30 00:23:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION>
<P>All outcome data from hospital patient administration system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 18:15:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mol-2005">
<DESCRIPTION>
<P>Not stated whether compliance was assessed in all patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:23:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Newland-2012">
<DESCRIPTION>
<P>Routine data, so could assume complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-17 00:59:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION>
<P>Routine data from microbiology computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-01 01:10:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 00:57:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION>
<P>MRSA data from microbiology computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:49:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION>
<P>Data from patient administration systems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:54:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Patel-1989">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Paul-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:07:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pear-1994">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:19:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-29 01:39:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peto-2008">
<DESCRIPTION>
<P>Routine data from pharmacy</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 01:51:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:36:05 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pires-2011">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:43:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Po-2012">
<DESCRIPTION>
<P>Yes, pharmacy data, so should be complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 00:43:29 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-07 01:49:59 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION>
<P>Outcome data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:41:14 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Price-2010">
<DESCRIPTION>
<P>Pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 23:03:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION>
<P>Outcome data on all participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Qu-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:29:18 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION>
<P>Figure 1 includes 4 months with no unnecessary DACT, but it is not clear whether this was because there was no DACT or because all DACT was necessary. With the exception of July 2008, these months had relatively high use of ampicillin/sulbactam and metronidazole, so suggests they missed some DACT patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:35:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Richards-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:44:40 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION>
<P>Assessment of appropriateness from retrospective assessment of all patients treated in 1 month but only done every 4 to 6 months.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 04:04:18 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ross-2014">
<DESCRIPTION>
<P>Outcome data from Pediatric Health Information System</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:13:59 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION>
<P>There is no information about change in price of antibiotics over the study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:19:52 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Salama-1996">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:59:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION>
<P>Electronic data for prescribing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:08:07 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION>
<P>1 and 2 January 2000 start data were censored, but this was reported and would have little impact on the other 48 data points.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:59 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Senn-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:23:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:24:00 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:21:00 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION>
<P>NOT DONE, there is no information about change in price of antibiotics over the study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:34:56 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-08 02:50:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:43:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION>
<P>Data were from the Pharmacy Administration and were independent from the AMT.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:47:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:19:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Strom-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:31:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2011">
<DESCRIPTION>
<P>Outcome reported on all patients pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:23:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:42:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION>
<P>From electronic records, so unlikely</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:47:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION>
<P>DDD from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:50:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 02:49:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:11:25 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION>
<P>Outcome data were from routine pharmacy systems.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:22:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:33:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:39:10 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION>
<P>Outcome data from patient administration system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:55 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Walker-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:02:02 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 00:09:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wax-2007">
<DESCRIPTION>
<P>Outcome data from electronic patient record (AIMS)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 00:38:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION>
<P>For prescribing outcome. Not stated whether SSI was evaluated in all patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:05:02 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION>
<P>TFAD from patient administration system, outcome reported on all included patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-15 02:27:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 01:06:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION>
<P>Outcomes from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:35:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:52:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 00:48:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION>
<P>Prescribing outcome in DDD from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 01:06:38 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yong-2010">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 00:47:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:40:08 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Young-1985">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yu-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:42:03 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION>
<P>Availability of all data required for the case definition not documented.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:29:18 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION>
<P>Data for primary outcome measure were from pharmacy computer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-16" LEVEL="STUDY" MODIFIED="2017-01-18 12:03:41 -0500" MODIFIED_BY="Julia Worswick" NO="16">
<NAME>Free of selected reporting (ITS) ?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:53:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION>
<P>Done, data were from routine pharmacy systems database.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:58:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-23 23:58:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION>
<P>Electronic outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 01:56:03 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION>
<P>Electronic data from pharmacy and microbiology</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-11 02:00:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION>
<P>Electronic data from microbiology</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-02 01:02:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION>
<P>Pharmacy and microbiology routine data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-24 00:52:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Annane-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:48:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:54:03 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:28:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:11:56 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION>
<P>Processing of data has potential for selective outcome reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:27:27 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 02:47:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION>
<P>Routine pharmacy data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-08 23:18:07 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-09 00:06:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bell-2014">
<DESCRIPTION>
<P>Data from laboratory computer system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:40:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-20 02:55:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Benson-2014">
<DESCRIPTION>
<P>Electronic data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:45:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Berild-2002">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 01:04:59 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION>
<P>Prescribing data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 00:00:51 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION>
<P>Data are presented as % compliance per quarter, but it is not clear whether complete data were collected from all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 01:51:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-07 02:05:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:32:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 02:52:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION>
<P>Done, screening protocol was the same throughout the study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-17 01:19:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION>
<P>Data from pharmacy and microbiology systems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:32:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION>
<P>Data were collected from all eligible participants. The accuracy of data collection was checked in a 5% sample of participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:41:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION>
<P>Done, the analysis included all prescriptions for metronidazole.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:51:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:53:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>Data for ITS from pharmacy computer (Figure 1). Other data in Tables 2 and 3 not valid, UBA.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:05:41 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Calil-2001">
<DESCRIPTION>
<P>Not clear, no information about changes in sampling or testing protocol over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Camins-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:34:39 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carling-2003">
<DESCRIPTION>
<P>Not clear, no information about changes in sampling or testing protocol over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:46:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2011">
<DESCRIPTION>
<P>DDD data from pharmacy computer, the same pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-04 01:53:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2015">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 01:54:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 14:12:31 -0400" MODIFIED_BY="Kate Cahill" RESULT="UNKNOWN" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION>
<P>Not clear, no information about changes in sampling or testing protocol over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-04 02:28:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:59:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chu-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 10:42:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Climo-1998">
<DESCRIPTION>
<P>Not clear, no information about changes in sampling or testing protocol over study period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:01:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-05 02:05:27 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION>
<P>Routine data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-05 01:34:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-12 02:49:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 04:42:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION>
<P>Routine data from microbiology and pharmacy computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:05:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ding-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 01:02:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dua-2014">
<DESCRIPTION>
<P>Electronic outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 01:43:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dull-2008">
<DESCRIPTION>
<P>Electronic outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:32:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION>
<P>Done, Figures 1 and 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:47:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 03:03:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION>
<P>Done. Figures 1 and 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 03:09:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION>
<P>Done, Figures 3 and 4</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 10:00:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-16 00:49:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-07 00:42:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION>
<P>Routine data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-18 00:43:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:29:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION>
<P>Outcome data from microbiology and pharmacy computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gums-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:31:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:33:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION>
<P>Done, Figure 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:40:23 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halm-2004">
<DESCRIPTION>
<P>Not stated whether outcome data collected on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:45:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hess-1990">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:48:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-17 02:05:14 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION>
<P>Exclusion rates similar pre- (13/69) and post- (11/65) intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 03:03:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huber-1982">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 03:14:17 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION>
<P>1 year of data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:27:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:41:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION>
<P>Primary outcome was time to first antibiotic dose from patient administration system.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-19 00:56:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jump-2012">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-07 00:22:27 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:08:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khan-2003">
<DESCRIPTION>
<P>Done: "The standard operating procedure for selection and processing stool specimens did not change over the study period. All stool specimens from inpatients with liquid or bloody diarrhoea and those receiving antibiotic therapy were tested for C. difficile toxin. C. difficile toxin was detected by cytotoxic activity on a fibroblast cell line, with specific neutralization by Clostridium sordelli antiserum"<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 00:53:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2008">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-19 02:05:44 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computuers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:42:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION>
<P>11 months' postintervention data, 32 months' pre-intervention data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-24 02:11:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-25 01:02:46 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:07 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-08 00:14:11 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landman-1999">
<DESCRIPTION>
<P>Not clear, no information about protocols for clinical sampling or testing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:49 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-13 03:45:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION>
<P>Routine patient administration systems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Layios-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-14 23:51:05 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-1995">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:06:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2007">
<DESCRIPTION>
<P>Data about prescribing and microbial outcomes were from routine, electronic data systems.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:10:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2014">
<DESCRIPTION>
<P>Outcomes were measured from electronic pharmacy data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:21:10 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION>
<P>NOT CLEAR, no explicit statement about complete screening samples for all participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:28:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION>
<P>Pharmacy data used pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liu-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Long-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:43:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION>
<P>In addition to the primary outcome of MRSA infections, the figure shows percentage of MRSA for all <I>Staphylococcus aureus </I>isolates with a reduction coincident with the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-03 01:43:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION>
<P>Data from electronic pharmacy records</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:58:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION>
<P>Outcome data collected on all participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:43:27 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masia-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-05 14:01:25 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-2000">
<DESCRIPTION>
<P>Not clear, no information about protocol for sampling or testing over study period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:14:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:17:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-15 01:40:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION>
<P>No information about reliability or completeness of primary outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:03:41 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:32:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 10:20:11 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period. Criteria for sampling and testing were unchanged over the study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:45:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>Outcome from pharmacy database pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:24:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-16 00:25:52 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION>
<P>Data from pharamacy computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Micek-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-30 00:23:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION>
<P>All outcome data from hospital patient administration system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 18:15:30 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mol-2005">
<DESCRIPTION>
<P>Not stated whether compliance was assessed in all patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-07 07:08:45 -0500" MODIFIED_BY="Claire Peden" RESULT="YES" STUDY_ID="STD-Newland-2012">
<DESCRIPTION>
<P>Yes, all relevant outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-17 00:59:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION>
<P>Routine data from microbiology computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-01 01:11:03 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 00:57:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION>
<P>MRSA data from microbiology computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:49:52 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION>
<P>Data from patient administration systems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:54:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Patel-1989">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Paul-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:08:03 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Pear-1994">
<DESCRIPTION>
<P>Not done, change in method of testing for <I>C difficile </I>during the study period (see case definition).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:19:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-29 01:39:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peto-2008">
<DESCRIPTION>
<P>Routine data from pharmacy</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 01:51:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-18 01:36:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pires-2011">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:43:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Po-2012">
<DESCRIPTION>
<P>Yes, all outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 00:43:29 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-07 01:50:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION>
<P>Outcome data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 00:41:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Price-2010">
<DESCRIPTION>
<P>Pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-06 07:06:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION>
<P>No evidence of selective reporting</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Qu-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:29:33 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION>
<P>Not clear if outcome was reported on all patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:35:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Richards-2003">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:44:56 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION>
<P>Not clear, data were only collected intermittently.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 04:04:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ross-2014">
<DESCRIPTION>
<P>Outcome data from Pediatric Health Information System</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:14:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION>
<P>The intervention was targeted at specific antibiotics, but no information is provided about their use or cost.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:19:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Salama-1996">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-19 02:59:36 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION>
<P>Electronic data for prescribing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:08:12 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION>
<P>Days of antimicrobial use calculated automatically by pharmacy computer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:59 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Senn-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:23:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:24:00 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:21:03 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:34:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-08 02:50:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:43:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION>
<P>Data were from the Pharmacy Administration and were independent from the AMT.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:47:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION>
<P>Done, drug costs were adjusted to 1980 prices.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:19:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Strom-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:09:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sun-2011">
<DESCRIPTION>
<P>Objective outcomes from Taiwan Quality Improvement Project database</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:23:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION>
<P>Data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:42:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION>
<P>From electronic records, so unlikely</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 01:47:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION>
<P>DDD from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:50:11 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-02 02:49:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION>
<P>Data reported for all months when operations took place</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:12:01 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION>
<P>The information in Table 1 does not include total antibiotic use or cost, so cannot be used to support the claims made in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:22:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:33:52 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:39:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION>
<P>Outcome data from patient administration system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:55 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Walker-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-10 00:02:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2014">
<DESCRIPTION>
<P>Outcome data from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 00:10:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wax-2007">
<DESCRIPTION>
<P>Outcome data from electronic patient record (AIMS)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 00:39:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION>
<P>For prescribing outcome. Not stated whether SSI was evaluated in all patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:05:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION>
<P>"Patients were excluded if the time of antibiotic administration was not documented in the electronic medical record, if the patient was documented as having received antibiotics within 48 hours prior to arrival, or if the patient was referred from another facility or clinic with a known diagnosis of pneumonia." Exclusion rate in pre-intervention period (37/281, 13%) similar to intervention period (40/342, 12%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-15 02:27:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-25 01:06:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION>
<P>Outcomes from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:35:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:52:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 00:48:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION>
<P>Prescribing outcome in DDD from pharmacy computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-26 01:06:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yong-2010">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 00:47:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION>
<P>Data from pharmacy and microbiology computers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:40:10 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Young-1985">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yu-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:42:09 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION>
<P>Not clear, no information about changes in sampling or testing protocol over study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:29:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION>
<P>Data for primary outcome measure were from pharmacy computer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-17" LEVEL="STUDY" MODIFIED="2017-01-18 13:21:37 -0500" MODIFIED_BY="Julia Worswick" NO="17">
<NAME>Free of other bias (ITS) ?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:53:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abramowitz-1982">
<DESCRIPTION>
<P>Price of target antibiotics constant over the study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 21:58:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Adachi-1997">
<DESCRIPTION>
<P>Not clear, no information about changes in price of vancomycin over the study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:03:44 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Akenroye-2014">
<DESCRIPTION>
<P>&gt; 1 year of data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:10:10 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2012">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:13:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aldeyab-2014">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:28:06 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ananda_x002d_Rajah-2010">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-24 00:52:26 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Annane-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:48:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ansari-2003">
<DESCRIPTION>
<P>"Correcting for autocorrelation avoids underestimating standard errors<BR/>and overestimated significance of the effects of an intervention. For<BR/>estimating seasonal autocorrelation, the autoregression model needs to<BR/>evaluate correlations between error terms separated by multiples of<BR/>12 months. Accounting for seasonally correlated errors usually requires<BR/>at least 24 monthly data points."</P>
<P>Data about cost of antibiotics adjusted for price changes during study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 22:54:05 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avorn-1988">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:28:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bailey-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:12:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bantar-2006">
<DESCRIPTION>
<P>3 years' data pre- and 2 years' data postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:27:27 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Barlow-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:26:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bassetti-2009">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention. <B>Microbial Risk of Bias: </B>case defintion done, planned intervention done, other infection control measures done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-08 23:18:09 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Baysari-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:34:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bell-2014">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:40:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Belliveau-1996">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:42:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Benson-2014">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:45:50 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Berild-2002">
<DESCRIPTION>
<P>Changes in antibiotic price were documented with their contribution to reduction in cost over the study period (Table 1 in study).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 23:55:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2014a">
<DESCRIPTION>
<P>&gt; 24 months' data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 00:00:57 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Borde-2014b">
<DESCRIPTION>
<P>Only 9 months' data postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 00:06:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015a">
<DESCRIPTION>
<P>&gt; 24 months' data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 00:10:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borde-2015b">
<DESCRIPTION>
<P>&gt; 12 months' data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouadma-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:32:38 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bouza-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 08:34:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bradley-1999">
<DESCRIPTION>
<P>
<B>Microbiology Risk of Bias Criteria: </B>Case definition: DONE, colonisation by screening; Planned intervention: DONE; Other infection control, isolation, and IC practices: DONE, same throughout study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bruins-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 03:21:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buising-2008a">
<DESCRIPTION>
<P>5 years' pre- and 2 years' postintervention data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:33:17 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Buising-2008b">
<DESCRIPTION>
<P>1 year of data in pre- and Intervention 1 time series, but only 6 months' data for Intervention 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:42:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bunz-1990">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:51:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:53:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buyle-2010">
<DESCRIPTION>
<P>21 months' pre- and 24 months' postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Calfee-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:07:47 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Calil-2001">
<DESCRIPTION>
<P>Not done. </P>
<P>
<B>Microbial Risk of Bias Criteria: </B>Case definition: infection, monthly infections with <I>E cloacae</I>; Unplanned intervention: other infection control measures: barrier precautions, isolation of participants, and personal IC procedures fully described and same in both phases.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Camins-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:37:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carling-2003">
<DESCRIPTION>
<P>VRE isolation unlikely to have influenced <I>C difficile </I>or resistant gram-negative bacteria. <B>Microbial Risk of Bias Criteria: </B>Planned intervention: DONE Implementation of antimicrobial management team in response to increase in use of target drugs. Case definition<B>: </B>DONE for <I>C difficile </I>infection (diarrhoea and toxin positive) or infection with clinical isolates of gram-negative bacteria resistant to ceftazidime, or MRSA (CDC definition of nosocomial infection). Other infection control measures: DONE For <I>C difficile </I>contact precautions and procedures for cleansing equipment and patient care areas remained unchanged. Other infection control processes are not described in detail but may have changed during the study period (e.g. VRE isolation introduced after intervention). <B>Data about VRE infections NOT RELIABLE:</B> There were no cases in the pre-intervention phase and none in the first 3 years postintervention, but there was an outbreak in the 4th and 5th postintervention years caused by admission of patients from other hospitals who were colonised with VRE.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:46:22 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2011">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:49:18 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chan-2015">
<DESCRIPTION>
<P>21 months' pre- and 51 months' postintervention data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:51:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chandy-2014">
<DESCRIPTION>
<P>&gt; 18 months' data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 18:56:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charbonneau-2006">
<DESCRIPTION>
<P>
<B>Microbial Risk of Bias Criteria: </B>Planned intervention: DONE Case definition: DONE clear case definition of clinical infection: "A new case was defined as a case in a patient with no previous history of MRSA or ESBL-EB colonization or infection who was infected with MRSA or ESBL-EB no less than 48 h after hospital admission." Other infection control measures: DONE "The measures recommended by French national guidelines for the prevention of nosocomial infections were implemented in the 4 study hospitals several years before the study began"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 19:01:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2009">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 11:59:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Christ_x002d_Crain-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chu-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Clerc-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 22:48:42 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Climo-1998">
<DESCRIPTION>
<P>NOT DONE <B>Microbial Risk of Bias Criteria: </B>Planned intervention: NOT DONE; Case definition: DONE infection, diarrhoea, and toxin positive Other infection control measures: DONE barrier precautions, isolation of participants with <I>C</I> <I>difficile</I>-associated diarrhoea, and personal IC procedures fully described and same in both phases.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Connor-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:02:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011a">
<DESCRIPTION>
<P>2 years' pre- and postintervention data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:08:22 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cook-2011b">
<DESCRIPTION>
<P>5 years' pre- and 4 years' postintervention data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:18:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cortoos-2011">
<DESCRIPTION>
<P>Insufficient data to account for seasonal effects. Although information about guideline compliance is reported for 2 hospitals, the ITS in Figure 1 only has data from 1 hospital (UZL). The data for the second hospital (ZOL) are actually a UBA and have been excluded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-12 02:49:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Danaher-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 23:37:35 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dancer-2013">
<DESCRIPTION>
<P>Only 9 months' pre-intervention data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dean-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:05:41 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dempsey--1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ding-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dranitsaris-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:14:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dua-2014">
<DESCRIPTION>
<P>&gt; 1 year of pre- and postintervention data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 02:18:36 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dull-2008">
<DESCRIPTION>
<P>10 months' pre- and 12 months' postintervention data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Duvoisin-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-26 17:47:19 -0400" MODIFIED_BY="Claire Peden" RESULT="YES" STUDY_ID="STD-Elligsen-2012">
<DESCRIPTION>
<P>Done, no other apparent biases</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Esposito-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:07:16 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Everitt-1990">
<DESCRIPTION>
<P>Antibiotic costs adjusted to 1986 prices over the whole study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Farinas-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fine-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 03:04:04 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fitzpatrick-2008">
<DESCRIPTION>
<P>Done. No other bias apparent.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-04 03:09:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fowler-2007">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-10 10:00:02 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Franz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fraser-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:09:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fridkin-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Friedberg-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 01:55:52 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fukuda-2014">
<DESCRIPTION>
<P>Only 6 month pre-intervention data, so cannot adjust for seasonal effects.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:01:34 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gerding-1985">
<DESCRIPTION>
<P>NOT CLEAR<B> Microbial Outcome Risk of Bias: </B>Planned intervention: DONE Implementation in response to emergence of gentamicin resistance over the previous 5 years; Case definition: DONE Infection from clinical isolates; Other infection control measures: NOT CLEAR, no information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:10:24 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Goldstein-2009">
<DESCRIPTION>
<P>Only 6 months' pre-intervention data for intervention 1 and 9 months' for intervention 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:14:37 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Grohs-2014">
<DESCRIPTION>
<P>Short time series, annual data with only 5 pre- and 7 postintervention data points</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gulmezoglu-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:10:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gums-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:31:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gupta-1989">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-28 13:14:24 -0400" MODIFIED_BY="Claire Peden" RESULT="YES" STUDY_ID="STD-Hadi-2008">
<DESCRIPTION>
<P>Done, all biases addressed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:11:27 -0400" MODIFIED_BY="Kate Cahill" RESULT="NO" STUDY_ID="STD-Halm-2004">
<DESCRIPTION>
<P>NOT DONE, the only reliable data for analysis are about compliance with the antibiotic policy, which was 80% at baseline. Serious risk of ceiling effect.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:45:16 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hess-1990">
<DESCRIPTION>
<P>On page 588 the authors state that "a proportion of these savings can be attributed to a decrease in acquisition cost", but they do not say how much.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:48:17 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Himmelberg-1991">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 02:52:32 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hitti-2012">
<DESCRIPTION>
<P>Data only collected for 7 months pre- and 8 months postintervention, so secular trends possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hochreiter-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 03:03:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huber-1982">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-25 14:02:22 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hulgan-2004">
<DESCRIPTION>
<P>Objective primary outcome, cost analysis adjusted to 2003 prices.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:27:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Inaraja-1986">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jensen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:41:44 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jobson-2015">
<DESCRIPTION>
<P>Only 8 months' pre-intervention data, so seasonal effects cannot be excluded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:49:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jump-2012">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 15:52:02 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kallen-2009">
<DESCRIPTION>
<P>&lt; 1 year data postintervention, fluoroquinolones reintroduced</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kanwar-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kerremans-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:09:55 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Khan-2003">
<DESCRIPTION>
<P>NOT DONE for the intervention that was intended to reduce <I>C difficile </I>infection in Phase 3 <B>Microbial Outcome Risk of Bias: </B>Planned intervention: NOT DONE for unplanned intervention Phase 3 Case definition: DONE <I>C difficile </I>infection; all stool specimens from inpatients with liquid or bloody diarrhoea and those receiving antibiotic therapy were tested for <I>C difficile</I> toxin. Other infection control measures: DONE, well described and same in all 3 phases</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:14:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kim-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 16:20:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Knudsen-2014">
<DESCRIPTION>
<P>&gt; 1 year of data pre- and postintervention. Microbial risk of bias low</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kristoffersen-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kritchevsky-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-25 14:02:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kumana-2001">
<DESCRIPTION>
<P>Reliable primary outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LaRosa-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-24 02:11:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lacroix-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:17:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lafaurie-2012">
<DESCRIPTION>
<P>&gt; 1 year of data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 12:14:08 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landgren-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:28:24 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Landman-1999">
<DESCRIPTION>
<P>Change in infection control practices at start of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-04-21 00:53:11 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lautenbach-2003">
<DESCRIPTION>
<P>
<B>Microbial outcome risk of bias: HIGH </B>.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 20:52:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lawes-2012">
<DESCRIPTION>
<P>Other microbial ROB criteria low</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Layios-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:02:11 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lee-1995">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention, but only 4 postintervention time points (quarterly data)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:06:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2007">
<DESCRIPTION>
<P>4 years' data pre- and 3 years' data postintervention, so can account for temporal trends.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:10:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2014">
<DESCRIPTION>
<P>&gt; 12 months' data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lesprit-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:24:45 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Leverstein_x002d_van-Hall-2001">
<DESCRIPTION>
<P>
<B>Microbial Outcome Risk of Bias Criteria: </B>Case definition: DONE colonisation by screening; Planned intervention: NOT DONE, in response to increase in GRE; Other infection control practices: NOT DONE changes 4 weeks before antibiotic restriction; Isolation: isolation of gentamicin-resistant<I> Enterobacteriaceae</I>-positive patients in either side-rooms or cohorted with other positive patients; IC practices: increase in education plus several new hygiene practices: disposable washing gloves, elbow-directed soap dispensers; new room-cleaning protocol. Hygiene was emphasised and more stringent barrier precautions.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-05 21:29:10 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liebowitz-2008">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Linkin-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Liu-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Long-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:47:40 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Madaras_x002d_Kelly-2006">
<DESCRIPTION>
<P>NOT DONE data are MRSA infection rates in 6-month time periods based on very small numbers of cases (80 cases in 3½ years).</P>
<P>
<B>Microbial Outcome Risk of Bias: </B>Case definition: MRSA infection. Screening for nosocomial infections was performed through daily review of hospital admissions and discharges, intravenous antibiotic use by patients admitted to the emergency department, and laboratory reports with case confirmation by review of medical records. &#8220;An infection was assumed to be caused by MRSA if cultures of blood, intravenous line, sputum, urine, tissue, or stool obtained at the time of symptom development yielded MRSA.&#8221; Planned intervention: YES. Intervention introduced in July 2003 in response to May 2003 SHEA recommendations that institutions where MRSA is endemic should consider limiting the use of broad-spectrum antibiotics, especially fluoroquinolones. Other infection control: NOT DONE. Antibiotic intervention coincident with environmental decontamination and hand hygiene campaign because of norovirus outbreak. Data about some infection control variables showed no change after start of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:51:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Magedanz-2012">
<DESCRIPTION>
<P>&gt; 12 months' data in each of the 3 study phases</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 16:59:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marwick-2013">
<DESCRIPTION>
<P>Data collected over winter months in pre- and postintervention period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-29 01:43:27 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Masia-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:03:21 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-May-2000">
<DESCRIPTION>
<P>&gt;1 year of data pre- and post-intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:14:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McElnay-1995">
<DESCRIPTION>
<P>Antibiotic costs were adjusted to 1989 prices.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:17:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McGowan-1976">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:21:48 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-McLaughlin-2005">
<DESCRIPTION>
<P>Only 4 weekly time points pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 12:03:41 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-McNulty-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-25 14:02:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mercer-1999">
<DESCRIPTION>
<P>Antibiotic costs were adjusted to 1995 prices and excluded ancillary or administrative charges.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:39:13 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Meyer-1993">
<DESCRIPTION>
<P>NOT DONE. <B>Microbial Outcome Risk of Bias Criteria: </B>Planned intervention: NOT DONE, unplanned intervention. Case definition: DONE, microbial outcome was colonisation by surveillance screening. Clinical infection was diagnosed by CDC definition but not used as an outcome. Infection or colonisation by case note review. Other infection control measures: NOT DONE, barrier precautions were instituted on colonised and infected patients at the same time that ceftazidime restriction was implemented.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:46:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2007">
<DESCRIPTION>
<P>&gt; 1 year of data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:50:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2009">
<DESCRIPTION>
<P>Data for &gt; 2 years' pre- and postintervention, so secular trends accounted for.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:56:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-2010">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Micek-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 18:10:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mittal-2014">
<DESCRIPTION>
<P>Data collected over 3 winters, 1 pre- and 2 postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 18:15:45 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mol-2005">
<DESCRIPTION>
<P>The kappa value for the primary outcome measure was 0.71, which is below the level set by EPOC, but for the reasons given in the text we feel is adequate for assessment of compliance with an antibiotic guideline. Drug costs were adjusted to April 2001 prices.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:23:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Newland-2012">
<DESCRIPTION>
<P>Yes, all biases addressed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nobre-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 20:39:42 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nuila-2008">
<DESCRIPTION>
<P>Only 6 months' data postintervention</P>
<P>
<B>Microbial Outcome Risk of Bias Criteria: </B>Case definition: DONE, CDC definition of <I>C difficile</I>. Planned intervention: DONE. Other infection control measures: NOT DONE, MRSA control programme introduced simultaneously.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oosterheert-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:03:06 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ostrowsky-2014">
<DESCRIPTION>
<P>Intervention targets and intervention design were different in each of the 6 hospitals. <B>Microbial ROB MEDIUM: </B>case definition low, planned intervention low, other infection control <B>UNCLEAR</B>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ozkaya-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Palmay-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:24:25 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parienti-2011">
<DESCRIPTION>
<P>
<B>MICROBIAL RISK OF BIAS: </B>case defiinition Low, planned intervention Low, other infection control Low, use of alchohol-based hand rub (ABHR) unchanged during period of fluoroquinolone restriction (2001-2) and for 3 years after restriction lifted (2003-5). Data are also presented for a further 6 years of increased use of ABHR (2006-11).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:50:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Parikh-2014">
<DESCRIPTION>
<P>Monthly data points for 20 months' pre- and 60 months' postintervention. "Guideline published in October 2006. Study phases: preguideline (November 2004 to March 2005), postguideline early (November 2007 to March 2008), and postguideline late (November 2011 to March 2012). These time periods were selected for the unadjusted analysis because they represent 3 bronchiolitis seasons, before and after guideline publication; the 2006 to 2007 season was not included because this is the year the guideline was published and was a period of distribution and assimilation. For the adjusted segmented regression analysis, publication of the guidelines, October 2006, was considered the event point."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 21:54:45 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Patel-1989">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Paul-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:10:09 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Pear-1994">
<DESCRIPTION>
<P>
<B>Microbial Outcome Risk of Bias Criteria: </B>Case definition: NOT DONE Infection: diarrhoea with positive assay for <I>C difficile</I> cytotoxin and antibiotic therapy within the previous 60 days. However, the method of detection of toxin changed from cell culture assay in the first 4 years of the study to a latex test in the final year (5 months after the start of clindamycin restriction). Planned intervention: NOT DONE Response to an outbreak of CDAD starting 12 months before restriction. Other infection control, isolation, and IC practices: DONE Infection control measures were identical in the year before and after the start of clindamycin restriction. Hospital staff education and increased availability of gloves and improvement of environmental hygiene were implemented a year before restriction of clindamycin with no apparent impact on the frequency of new cases.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:19:58 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez-2003">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:25:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peto-2008">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:34:09 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Petrikkos-2007">
<DESCRIPTION>
<P>1 year (6 x 2-monthly time points) pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:36:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pires-2011">
<DESCRIPTION>
<P>Data for 18 months' pre- and 3 years' postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:43:54 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Po-2012">
<DESCRIPTION>
<P>&lt; 1 year data for phases 1 and 2</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-06 00:43:29 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Poehling-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:54:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Popovski-2015">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 22:59:11 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Price-2010">
<DESCRIPTION>
<P>1 year data pre- and postintervention<BR/>
<B>Microbial Risk of Bias:</B> cohorting introduced at the same time as prescribing intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 23:04:13 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Pulcini-2011">
<DESCRIPTION>
<P>&lt; 1 year of data (25 weeks) in the pre- and postintervention phases</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Qu-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rattanaumpawan-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-12 01:11:59 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rattanaumpawan-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:35:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Richards-2003">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 03:45:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Richardson-2000">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 04:04:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ross-2014">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:14:25 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saizy_x002d_Callaert-2003">
<DESCRIPTION>
<P>No adjustment of antibiotic costs for change in price, so change in price of antibiotics (rather than change in use) over the study period may have been responsible for reduction in cost per patient over the study period. No data about number of admissions pre-intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:19:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Salama-1996">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schnoor-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schouten-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schroeder-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schuetz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 18:57:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwann-2011">
<DESCRIPTION>
<P>1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 19:08:20 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwartz-2007">
<DESCRIPTION>
<P>Only 10 months' pre-intervention data, so secular trends could not be addressed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:14:59 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Senn-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shehabi-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shen-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:23:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shojania-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:24:00 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:21:19 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sirinavin-1998">
<DESCRIPTION>
<P>NOT CLEAR, no adjustment of antibiotic costs for change in price, so change in price of antibiotics (rather than change in use) over the study period may have been responsible for some of the change in cost. Data were not adjusted for number of admissions or occupied bed days.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 14:04:04 -0400" MODIFIED_BY="Kate Cahill" RESULT="YES" STUDY_ID="STD-Skaer-1993">
<DESCRIPTION>
<P>Yes for primary outcome but fatally flawed (UBA) for secondary outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:27:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Skrlin-2011">
<DESCRIPTION>
<P>24 months' data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:44:03 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Standiford-2012">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 21:48:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stevenson-1988">
<DESCRIPTION>
<P>Drug costs were adjusted to 1980 prices and adjusted for number of discharges or deaths.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stocker-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-09 01:19:37 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stolz-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Strom-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:32:06 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sun-2011">
<DESCRIPTION>
<P>&lt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-07 22:35:44 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Suwangool-1991">
<DESCRIPTION>
<P>&lt; 1 year data pre- and postintervention. During the 18-month study period, no adjustment was made to antibiotic costs for changes in prices, so changes in cost may have been due to changes in price as well as use.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:42:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Talpaert-2011">
<DESCRIPTION>
<P>1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:46:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tangd_x00e9_n-2011">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 03:50:15 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Toltzis-1998">
<DESCRIPTION>
<P>&lt; 1 year data pre-intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Toltzis-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:01:35 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Toltzis-2014">
<DESCRIPTION>
<P>Only 8 months' pre-intervention data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:03 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trenholme-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:13:44 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-U_x00e7_kay-2009">
<DESCRIPTION>
<P>&lt; 1 year pre-intervention data</P>
<P>Insufficient information to assess. In particular, it is not clear what difference the "ID specialist with experience in Infection Control" would make compared with "Dedicated ID specialist and one internist".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:22:47 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Valiquette-2007">
<DESCRIPTION>
<P>
<B>Microbial Risk of Bias HIGH</B>
</P>
<P>&gt; 1 year of data pre-intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:34:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-Kasteren-2005">
<DESCRIPTION>
<P>Done, data were from routine systems and unlikely to change over study period. Change in price unlikely to be a problem because only 6 months' data pre- and postintervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:39:25 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Volpe-2012">
<DESCRIPTION>
<P>&gt; 12 months' data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:39:55 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Walker-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:48:26 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2014">
<DESCRIPTION>
<P>&gt; 12 months' data pre- and postintervention. However, no adjustment of primary outcome for changes in drug pricing over the 5 years of the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:52:28 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wax-2007">
<DESCRIPTION>
<P>Only 6 months' data pre-intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:57:50 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weinberg-2001">
<DESCRIPTION>
<P>&lt; 1 year of data in each of the 3 study phases</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:05:54 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weiner-2009">
<DESCRIPTION>
<P>Only 11 months' data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weiss-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:27:16 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wenisch-2014">
<DESCRIPTION>
<P>&lt; 12 months' data in the pre-intervention (5 months) and postintervention (7 months) phases</P>
<P>
<B>Microbial Risk of Bias LOW</B>: case definition Low, planned intervention Low, other infection control Low</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:32:30 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Willemsen-2010">
<DESCRIPTION>
<P>1 year data pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:35:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilson-1991">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Winters-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wishaupt-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 05:53:50 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Woodward-1987">
<DESCRIPTION>
<P>The abstract states: "Even after some cost increases (not significant) in new and other antibiotics, the program saved $1.33 per antibiotic day", but it is not clear whether the analysis was adjusted for changes in the price of antibiotics during the 3½-year study period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-18 13:42:05 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wyatt-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yealy-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:20:31 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yeo-2012">
<DESCRIPTION>
<P>Same 11 months of data (Aug-Jun) in consecutive years pre- and postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 13:21:37 -0500" MODIFIED_BY="Julia Worswick" RESULT="YES" STUDY_ID="STD-Yong-2010">
<DESCRIPTION>
<P>&gt; 1 year data pre- and postintervention, so low risk for prescribing outcome</P>
<P>
<B>Microbial Risk of Bias: MEDIUM </B>Case definition Low, % susceptibility of Pseudomonas isolates, Planned intervention Low for outcome (outbreak was of Acinetobacter), Other infection control High, enhanced during prescribing intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:34:01 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yoon-2014">
<DESCRIPTION>
<P>&gt; 1 year data in each study phase</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 06:40:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Young-1985">
<DESCRIPTION>
<P>No other apparent biases found.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yu-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zanetti-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-18 10:14:12 -0500" MODIFIED_BY="Julia Worswick" RESULT="NO" STUDY_ID="STD-de-Champs-1994">
<DESCRIPTION>
<P>
<B>Microbial outcome risk of bias: </B>Unplanned intervention: implementation of change in response to emergence of gentamicin-resistant <I>E cloacae</I>; Case definition:<B> i</B>nfection from clinical or screening isolates combined with 7 clinical criteria and 5 additional laboratory criteria assessed by a resident paediatrician and a consultant microbiologist and verified by a consultant paediatrician. Reliability of this outcome measure not clear. Other infection control measures: well documented, no changes during the study period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-08 04:29:38 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-van-Hees-2008">
<DESCRIPTION>
<P>Only 3 months' pre- and 6 months' postintervention data, so cannot be adjusted for seasonal trends.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-18" LEVEL="GROUP" NO="18">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-19" LEVEL="GROUP" NO="19">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2017-02-20 12:00:37 -0500" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2017-02-20 12:00:37 -0500" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2017-01-04 22:20:51 -0500" MODIFIED_BY="[Empty name]">Effects of interventions to improve use of antibiotics on prescribing, clinical outcomes, adverse events, and effect modifiers (heterogeneity)</TITLE>
<TABLE COLS="6" ROWS="25">
<TR>
<TD COLSPAN="6">
<P>
<B>Patient or population: </B>adults or children undergoing inpatient antibiotic prophylaxis or treatment</P>
<P>
<B>Settings: </B>mainly high-income countries (North America or Western Europe)</P>
<P>
<B>Intervention: </B>any intervention targeting healthcare professionals that aimed to improve antibiotic prescribing to hospital inpatients</P>
<P>
<B>Comparison: </B>usual care (varied across studies)</P>
</TD>
</TR>
<TR>
<TH ALIGN="CENTER" COLSPAN="6" VALIGN="BOTTOM">
<P>
<B>Effectiveness: prescribing outcomes from RCTs</B>
</P>
</TH>
</TR>
<TR>
<TH ROWSPAN="2" VALIGN="BOTTOM">
<P>Outcomes</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="2" VALIGN="BOTTOM">
<P>
<B>Absolute effect*</B>
</P>
</TH>
<TH ROWSPAN="2" VALIGN="BOTTOM">
<P>No of participants</P>
<P>(No of studies)</P>
</TH>
<TH ROWSPAN="2" VALIGN="BOTTOM">
<P>
<B>Certainty of the evidence (GRADE)</B>
</P>
</TH>
<TH ROWSPAN="2" VALIGN="BOTTOM">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH VALIGN="BOTTOM">
<P>
<B>Without intervention</B>
</P>
</TH>
<TH VALIGN="BOTTOM">
<P>
<B>With intervention</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Proportion of participants who were treated according to antibiotic prescribing guidelines</P>
<P/>
<P>Follow-up to end of study</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>43 per 100</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>58 per 100</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>23,394 participants</P>
<P/>
<P>(29 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>High</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>We have graded the certainty of evidence as high because heterogeneity was explained by prespecified effect modifiers (see below). The intervention effect varied between the studies, but the direction of effect was consistent. Restricting the analysis to studies at low risk of bias gave a similar result (RD 11%, 95% CI 10% to 12%).</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Difference: 15 more participants per 100 (95% CI 15 to 23) received appropriate treatment following intervention.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Duration of all antibiotic treatment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11.0 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9.1 days</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>3318 participants</P>
<P/>
<P>(14 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>High</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Difference: 1.95 fewer days per participant (95% CI 2.22 to 1.67)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Mortality</P>
<P/>
<P>Follow-up to end of study</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 per 100</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 per 100<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>15,827 participants</P>
<P/>
<P>28 (RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<SUP>1</SUP>
<BR/>Moderate</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Mortality and length of stay were measured to determine the impact of reduced antibiotic use on clinical outcomes. The results were similar for studies that targeted antibiotic choice or exposure.</P>
<P/>
<P>Only 1 of the interventions in the RCTs with mortality or length-of-stay outcomes had a restrictive component (<LINK REF="STD-Singh-2000" TYPE="STUDY">Singh 2000</LINK>). This evidence is therefore at high risk of indirectness because 7 studies in the next section of the table (see below) raise concerns about the safety of restrictive interventions. Moreover, the ITS studies showed that restrictive components were included in 42 (34%) of 123 hospital interventions.</P>
<P/>
<P/>
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Difference: 0 more deaths per 100 participants (95% CI 1 to 0 fewer)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Mean length of hospital stay per participant</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12.9 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11.8 days</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>3834 participants</P>
<P/>
<P>15 (RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<SUP>1</SUP>
<BR/>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Difference: 1.1 fewer days per participant (95% CI 1.5 to 0.7 fewer)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Delay in treatment</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Restrictive interventions increased the risk of delay in all 3 studies. The risk to patients resulted in termination of the RCT by the Trial Monitoring Committee.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 RCT, 2 cohort</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<SUP>2</SUP>
<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>The evidence from these 7 studies of unintended consequences raises concerns about the directness of the evidence of safety from the 29 RCTs in the previous section of the table (see above).</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Negative professional culture</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Loss of trust in infection specialists because of failure to record approvals for restricted drugs or provide warning about stopping treatment</P>
<P/>
<P>Misleading or inaccurate information from prescribers in order to meet criteria for restricted drugs. In 1 hospital, misdiagnosis of hospital-acquired infection was large enough to trigger an outbreak investigation.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 case control, 2 cohort, 1 qualitative</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8854;&#8854;<SUP>3</SUP>
<BR/>Low<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="CENTER" COLSPAN="6" VALIGN="BOTTOM">
<P>
<B>Effect modifiers (heterogeneity) for immediate effect of intervention on prescribing outcomes: </B>
<BR/>
<B>impact of behaviour change functions (</B>enablement<B> or restriction) and additional impact of feedback, RCTs and ITS studies. A positive value for Beta means the modifier is associated with increased effect</B>
</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Effect modifier</B>
</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<P>
<B>Adjusted effect in meta-regression</B>
<BR/>
<B>Beta</B>
<BR/>
<B>(95% CI)</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Number of studies</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Certainty of the evidence (GRADE)</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Comments</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Enablement</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>15.12</P>
<P>(8.45 to 21.8)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>29 RCTs</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>High</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>The effect of enablement and restriction is similar in the RCTs and ITS studies. Of the 29 RCTs, only 8 (31%) of interventions were hospital-wide, the majority being in single units. In contrast, 64 (70%) of the interventions in ITS studies were hospital-wide.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>12.86</P>
<P>(4.11 to 21.6)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>91 ITS</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Restriction</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>34.91</P>
<P>(13.52 to 56.29)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>29 RCTs</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>High</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>24.69</P>
<P>(13.74 to 35.64)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>91 ITS</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Addition of feedback to enablement</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>10.88</P>
<P>(7.16 to 19.32)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>23 RCTs</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<SUP>2</SUP>
<BR/>Moderate</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Feedback was included in 4 (17%) of 23 RCTs and 20 (47%) of 43 ITS studies with interventions that included enablement. There were not enough interventions with goal setting and action planning to analyse as effect modifiers.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>15.63</P>
<P>(0.56 to 30.70)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>43 ITS</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Addition of enablement to restriction</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>38.36</P>
<P>(18.94 to 57.78)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>29 ITS</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8854;&#8854;<SUP>3</SUP>
<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Enablement was included in 13 (45%) of 29 ITS studies with restrictive interventions.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>*The risk WITHOUT the intervention is based on the median control group risk across studies. The corresponding risk WITH the intervention (and the 95% confidence interval for the difference) is based on the overall relative effect (and its 95% confidence interval).<BR/>
<B>CI:</B> confidence interval; <B>ITS:</B> interrupted time series; <B>RCT:</B> randomised controlled trial; <B>RD:</B> risk difference</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>GRADE Working Group grades of evidence<BR/>
<B>High certainty:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate certainty:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low certainty:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low certainty:</B> We are very uncertain about the estimate.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>Details of five GRADE criteria for all outcomes from RCTs are in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
<P>
<SUP>1</SUP>We downgraded the evidence to moderate because of indirectness.<BR/>
<SUP>2</SUP>We downgraded the evidence because most studies are non-randomised studies.<BR/>
<SUP>3</SUP>We graded the evidence as low because it is all from non-randomised studies.<BR/>
<SUP>4</SUP>We graded the evidence as very low because it is all from non-randomised studies and there was too much heterogeneity for reliable evidence synthesis.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2017-02-21 14:31:32 -0500" MODIFIED_BY="Julia Worswick">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2017-01-04 23:33:21 -0500" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2017-01-04 23:30:12 -0500" MODIFIED_BY="[Empty name]">Definition of behaviour change techniques and intervention functions</TITLE>
<TABLE COLS="3" ROWS="6">
<TR>
<TH VALIGN="BOTTOM">
<P>I<B>ntervention Function</B>
</P>
</TH>
<TH VALIGN="BOTTOM">
<P>
<B>Definition</B>
</P>
</TH>
<TH VALIGN="BOTTOM">
<P>
<B>Intervention components</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Education</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Increasing knowledge or understanding</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Educational meetings;</P>
<P>Dissemination of educational materials;</P>
<P>Educational outreach</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Persuasion</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Using communication to induce positive or negative feelings or to stimulate action</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Educational outreach by academic detailing or review and recommend change</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Restriction</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Using rules to reduce the opportunity to engage in the target behaviour (or increase the target behaviour by reducing the opportunity to engage in competing behaviours)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Restrictive</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Environmental restructuring</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Changing the physical context</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Reminders (physical) such as posters, pocket-size or credit card-size summaries or on laboratory test reports;</P>
<P>Structural (e.g. new laboratory tests or rapid reporting of results)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Enablement</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Increasing means/reducing barriers to increase capability or opportunity</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Audit and feedback;</P>
<P>Decision support through computerised systems or through circumstantial reminders that were triggered by actions or events related to the targeted behaviour;</P>
<P>Educational outreach by review and recommend change</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2017-01-04 23:42:16 -0500" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2017-01-04 23:38:36 -0500" MODIFIED_BY="[Empty name]">Unintended consequences of ITS studies: mortality*</TITLE>
<TABLE COLS="6" ROWS="5">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Study</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Prescribing target</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Restriction</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Design of analysis</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Effect estimate</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>95% CI</B>
</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Lee-2014" TYPE="STUDY">Lee 2014</LINK>
</P>
</TD>
<TD>
<P>Choice of drug</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Cohort</P>
</TD>
<TD>
<P>Incidence rate ratio 1.1</P>
</TD>
<TD>
<P>0.9 to 1.5</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Popovski-2015" TYPE="STUDY">Popovski 2015</LINK>
</P>
</TD>
<TD>
<P>Choice of drug</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Cohort</P>
</TD>
<TD>
<P>Increase by 1.4%</P>
</TD>
<TD>
<P>-1.2% to 4.1%</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Wang-2014" TYPE="STUDY">Wang 2014</LINK>
</P>
</TD>
<TD>
<P>Choice of drug</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>ITS, segmented regression</P>
</TD>
<TD>
<P>Change in slope -0.0172</P>
</TD>
<TD>
<P>No data</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Yoon-2014" TYPE="STUDY">Yoon 2014</LINK>
</P>
</TD>
<TD>
<P>Choice of drug</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Cohort</P>
</TD>
<TD>
<P>+0.43 per 1000 OBD</P>
</TD>
<TD>
<P>No data</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>*Mortality was measured in all patients in the hospital rather than just those patients who were the targets of the interventions.</P>
<P>CI: confidence interval<BR/>ITS: interrupted time series<BR/>OBD: occupied bed day<BR/>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2017-01-04 23:42:25 -0500" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2017-01-04 23:40:19 -0500" MODIFIED_BY="[Empty name]">Unintended consequences of ITS studies: length of stay*</TITLE>
<TABLE COLS="6" ROWS="3">
<TR>
<TH VALIGN="BOTTOM">
<P>
<B>Study</B>
</P>
</TH>
<TH VALIGN="BOTTOM">
<P>
<B>Prescribing</B> t<B>arget</B>
</P>
</TH>
<TH VALIGN="BOTTOM">
<P>
<B>Restrictive</B>
</P>
</TH>
<TH VALIGN="BOTTOM">
<P>
<B>Design of analysis</B>
</P>
</TH>
<TH VALIGN="BOTTOM">
<P>
<B>Effect estimate</B>
</P>
</TH>
<TH VALIGN="BOTTOM">
<P>
<B>95% CI</B>
</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Mittal-2014" TYPE="STUDY">Mittal 2014</LINK>
</P>
</TD>
<TD>
<P>Exposure, % treated</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Cohort</P>
</TD>
<TD>
<P>-0.5 days</P>
</TD>
<TD>
<P>No data</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Skaer-1993" TYPE="STUDY">Skaer 1993</LINK>
</P>
</TD>
<TD>
<P>Choice of drug</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Cohort</P>
</TD>
<TD>
<P>-0.1 days</P>
</TD>
<TD>
<P>-0.49 to +0.29</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>*Length of stay was measured in all patients in the hospital rather than just those patients who were the targets of the interventions.</P>
<P>CI: confidence interval<BR/>ITS: interrupted time series<BR/>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" MODIFIED="2017-01-04 23:45:03 -0500" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2017-01-04 23:43:36 -0500" MODIFIED_BY="[Empty name]">Unintended consequences of ITS studies: other</TITLE>
<TABLE COLS="6" ROWS="4">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Study</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Prescribing target</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Design of analysis</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Effect measure</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Effect estimate</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>95% CI</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bell-2014" TYPE="STUDY">Bell 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Antibiotic choice</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>ITS, segmented regression</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Risk of postoperative acute kidney injury</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Increase 98%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>93.8% to 94.2%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Van-Kasteren-2005" TYPE="STUDY">Van Kasteren 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Exposure, duration</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cohort</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Surgical-site infection</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Decrease 0.8%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-2.2% to 0.6%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Volpe-2012" TYPE="STUDY">Volpe 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Time to first antibiotic dose</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cohort</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Left without being seen rate</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Decrease 0.4%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No data</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CI: confidence interval<BR/>ITS: interrupted time series</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" MODIFIED="2017-01-08 09:12:56 -0500" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2017-01-04 23:45:51 -0500" MODIFIED_BY="[Empty name]">Unintended consequences studies (case control, cohort, or qualitative)</TITLE>
<TABLE COLS="7" ROWS="15">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Study</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Design</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Patients</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Intended target</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Unintended consequence</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Effect estimate</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>95% CI</B>
</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="7" VALIGN="BOTTOM">
<P>
<B>Interventions with a restrictive component</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Baysari-2013" TYPE="STUDY">Baysari 2013</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Qualitative</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>36 physicians</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Reduce unnecessary use of restricted antibiotics</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Inaccurate feedback</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Not quantified; qualitative study</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Calfee-2003" TYPE="STUDY">Calfee 2003</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Case control</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not clear</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Increase in physician-based diagnosis of nosocomial infection</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>No denominator data</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Connor-2007" TYPE="STUDY">Connor 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cohort</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>120</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Failure to warn prescribers about discontinuation</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Duvoisin-2014" TYPE="STUDY">Duvoisin 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cohort</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>222</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Reduce unnecessary laboratory tests</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Delay in TFAD (HR &gt; 1 shows delay less likely in intervention period)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Multivariate HR 1.56</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.17 to 2.07</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<LINK REF="STD-LaRosa-2007" TYPE="STUDY">LaRosa 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cross-sectional</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15,440</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="5" VALIGN="TOP">
<P>Reduce unnecessary use of restricted antibiotics</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Orders for restricted antibiotics (% all orders) from 10 to 11 pm vs all other hours</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cohort</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>360</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>% appropriate orders 10 to 11 pm vs 9 to 10 pm</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-23.7%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-31.8% to -15.5%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Linkin-2007" TYPE="STUDY">Linkin 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cohort</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>200</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Risk of inaccurate information in orders judged inappropriate vs appropriate</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>OR 2.2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.0 to 4.4</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>
<LINK REF="STD-Winters-2010" TYPE="STUDY">Winters 2010</LINK>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Cohort</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>3251</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Risk of 1-hour delay in TFAD</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>OR 1.5</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.2 to 1.8</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Risk of 2-hour delay in TFAD</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>OR 1.8</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.4 to 2.2</P>
</TD>
</TR>
<TR>
<TH COLSPAN="7" VALIGN="BOTTOM">
<P>
<B>Interventions with no restrictive component</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Friedberg-2009" TYPE="STUDY">Friedberg 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cohort</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13,042</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Reduce time to first antibiotic dose for patients with community-acquired pneumonia</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>% CAP diagnoses</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1% increase</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No denominator data</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kanwar-2007" TYPE="STUDY">Kanwar 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cohort</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>518</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>% correct CAP diagnoses</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-7.9% decrease</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-15.4% to -0.4%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Welker-2008" TYPE="STUDY">Welker 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cohort</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>548</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>% correct CAP diagnoses</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-16.0% decrease</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-7.6% to -24.4%</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CAP: community-acquired pneumonia<BR/>CI: confidence interval<BR/>HR: hazard ratio<BR/>OR: odds ratio<BR/>TFAD: time to the first antibiotic dose<BR/>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-06" MODIFIED="2017-02-21 14:31:32 -0500" MODIFIED_BY="Julia Worswick" NO="6">
<TITLE MODIFIED="2017-02-21 10:09:07 -0500" MODIFIED_BY="Petrer Davey">Summary of intervention components for 29 RCTs (Analysis 1.1; Figures 3 and 7) and 91 ITS studies (Figure 10)</TITLE>
<TABLE COLS="3" ROWS="22">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Intervention function and components</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>RCT</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>ITS</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Enablement</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>24</P>
<P>studies</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>59</P>
<P>studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Number of enabling or restrictive intervention components</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>27</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>76</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Studies with &gt; 1 Enabling intervention component</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2</P>
<P>8%*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>19</P>
<P>32%*</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Audit and feedback</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4</P>
<P>17%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>24</P>
<P>41%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Computerised decision support</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
<P>4%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3</P>
<P>5%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Circumstantial reminders</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>16</P>
<P>67%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18</P>
<P>31%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Review and recommend change</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6</P>
<P>25%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>31</P>
<P>53%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Restriction</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2</P>
<P>studies</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>29</P>
<P>studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Number of Restrictive intervention components</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>41</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Studies with &gt; 1 Restrictive intervention component</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
<P>50%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10</P>
<P>34%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Expert approval</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
<P>50%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18</P>
<P>62%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Compulsory order form</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
<P>50%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7</P>
<P>24%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Removal</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10</P>
<P>34%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Review and make change</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
<P>50%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6</P>
<P>21%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No Enablement or Restriction</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4</P>
<P>studies</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18</P>
<P>studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Number of intervention components</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>25</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Studies with &gt; 1 intervention component</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2</P>
<P>50%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6</P>
<P>33%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Educational materials or meetings</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3</P>
<P>75%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>16</P>
<P>89%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Educational outreach (academic detailing)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
<P>25%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6</P>
<P>33%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Physical reminders</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
<P>25%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2</P>
<P>11%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Structural intervention</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
<P>25%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
<P>6%</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>*The denominator for all percentages is the number of studies for each intervention function. One RCT, <LINK REF="STD-Strom-2010" TYPE="STUDY">Strom 2010</LINK>, and 16 ITS studies (<LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>) included both enabling and restrictive intervention components.</P>
<P>ITS: interrupted time series<BR/>RCT: randomised controlled trial</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-07" MODIFIED="2017-01-05 00:15:53 -0500" MODIFIED_BY="[Empty name]" NO="7">
<TITLE MODIFIED="2017-01-05 00:15:07 -0500" MODIFIED_BY="[Empty name]">Data from 5 studies about the effect of removal of interventions. The intended effect of all interventions was reduction in unnecessary antibiotic use</TITLE>
<TABLE COLS="5" ROWS="6">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Study</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Intervention function</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Intervention effect (95% CI)</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Time intervention was in place</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Effect of removal (95% CI)</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kallen-2009" TYPE="STUDY">Kallen 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Restriction</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-87.5%</P>
<P>-115.4 to -59.7</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>398.9%</P>
<P>238.2 to 559.5</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kim-2008" TYPE="STUDY">Kim 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Restriction</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-23.1%</P>
<P>-53.7 to +7.4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6.0%</P>
<P>-23.4 to 35.4</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Standiford-2012" TYPE="STUDY">Standiford 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Enablement</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-28.6%</P>
<P>-46.5 to -10.6</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>31.0%</P>
<P>6.8 to 55.3</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Himmelberg-1991" TYPE="STUDY">Himmelberg 1991</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Restriction</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>No data</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8220;long-standing&#8221;</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>301.2%</P>
<P>230.9 to 371.5</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Skrlin-2011" TYPE="STUDY">Skrlin 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Restriction</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>255.8%</P>
<P>194.7 to 316.9</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CI: confidence interval</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-08" MODIFIED="2017-01-05 00:29:57 -0500" MODIFIED_BY="[Empty name]" NO="8">
<TITLE MODIFIED="2017-01-05 00:17:21 -0500" MODIFIED_BY="[Empty name]">Randomised controlled trials with microbial outcomes</TITLE>
<TABLE COLS="4" ROWS="6">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Study</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Design</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Microbial outcome</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Reason not in meta-analysis</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Annane-2013" TYPE="STUDY">Annane 2013</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RCT</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Colonisation with MRSA (nasal swab) and GNRB (rectal swabs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not comparable with any other RCT</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bouza-2007" TYPE="STUDY">Bouza 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RCT</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Number of cases of <I>Clostridium difficile</I>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not in prescribing meta-analysis</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lesprit-2013" TYPE="STUDY">Lesprit 2013</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RCT</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Secondary infection and/or colonisation with multidrug-resistant bacteria in the 6 months following randomisation</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not in prescribing meta-analysis. It is impossible to assess the impact of the intervention on colonisation or infection with bacteria resistant to specific antibiotics.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Palmay-2014" TYPE="STUDY">Palmay 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RCT</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>CDI and infection with antibiotic resistant organisms cases/1000 OBD</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not in prescribing meta-analysis</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Singh-2000" TYPE="STUDY">Singh 2000</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RCT</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Number of participants with "antimicrobial resistance and/or superinfections" from randomisation until discharge from hospital</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>It is impossible to assess the impact of the intervention on colonisation or infection with bacteria resistant to specific antibiotics.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CDI: <I>Clostridium difficile</I> infection<BR/>GNRB: gram-negative resistant bacteria<BR/>MRSA: methicillin-resistant <I>Staphylococcus aureus</I>
<BR/>OBD: occupied bed day<BR/>RCT: randomised controlled trial</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-09" MODIFIED="2017-01-05 00:35:27 -0500" MODIFIED_BY="[Empty name]" NO="9">
<TITLE MODIFIED="2017-01-05 00:30:49 -0500" MODIFIED_BY="[Empty name]">Microbial outcomes from 26 ITS studies from the prescribing meta-analysis that include reliable data about prescribing outcomes at 6 months and microbial outcomes at 12 months postintervention</TITLE>
<TABLE COLS="4" ROWS="13">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Prescribing target</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Microbial outcome</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>N</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Study ID</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Cephalosporins</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>GNRB</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Grohs-2014" TYPE="STUDY">Grohs 2014</LINK>; <LINK REF="STD-Kim-2008" TYPE="STUDY">Kim 2008</LINK>; <LINK REF="STD-Knudsen-2014" TYPE="STUDY">Knudsen 2014</LINK>; <LINK REF="STD-Lee-2007" TYPE="STUDY">Lee 2007</LINK>; <LINK REF="STD-McNulty-1997" TYPE="STUDY">McNulty 1997</LINK>; <LINK REF="STD-Meyer-2009" TYPE="STUDY">Meyer 2009</LINK>; <LINK REF="STD-Petrikkos-2007" TYPE="STUDY">Petrikkos 2007</LINK>; <LINK REF="STD-Tangd_x00e9_n-2011" TYPE="STUDY">Tangdén 2011</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MRSA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-May-2000" TYPE="STUDY">May 2000</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Carbapenems</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>GNRB</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Goldstein-2009" TYPE="STUDY">Goldstein 2009</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Fluoroquinolones</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>GNRB</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Cook-2011b" TYPE="STUDY">Cook 2011b</LINK>; <LINK REF="STD-Lafaurie-2012" TYPE="STUDY">Lafaurie 2012</LINK>; <LINK REF="STD-Willemsen-2010" TYPE="STUDY">Willemsen 2010</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MRSA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lafaurie-2012" TYPE="STUDY">Lafaurie 2012</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>High-risk antibiotics</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>CDI</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Aldeyab-2012" TYPE="STUDY">Aldeyab 2012</LINK>; <LINK REF="STD-Chan-2011" TYPE="STUDY">Chan 2011</LINK>; <LINK REF="STD-Dancer-2013" TYPE="STUDY">Dancer 2013</LINK>; <LINK REF="STD-Fowler-2007" TYPE="STUDY">Fowler 2007</LINK>; <LINK REF="STD-Talpaert-2011" TYPE="STUDY">Talpaert 2011</LINK>; <LINK REF="STD-Valiquette-2007" TYPE="STUDY">Valiquette 2007</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>GNRB</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Buising-2008a" TYPE="STUDY">Buising 2008a</LINK>; <LINK REF="STD-Chan-2011" TYPE="STUDY">Chan 2011</LINK>; <LINK REF="STD-Dancer-2013" TYPE="STUDY">Dancer 2013</LINK>; <LINK REF="STD-Liebowitz-2008" TYPE="STUDY">Liebowitz 2008</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MRSA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Aldeyab-2014" TYPE="STUDY">Aldeyab 2014</LINK>; <LINK REF="STD-Ananda_x002d_Rajah-2010" TYPE="STUDY">Ananda-Rajah 2010</LINK>; <LINK REF="STD-Chan-2011" TYPE="STUDY">Chan 2011</LINK>; <LINK REF="STD-Dancer-2013" TYPE="STUDY">Dancer 2013</LINK>; <LINK REF="STD-Fowler-2007" TYPE="STUDY">Fowler 2007</LINK>; <LINK REF="STD-Liebowitz-2008" TYPE="STUDY">Liebowitz 2008</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Total antibiotic use</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>CDI</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Cook-2011a" TYPE="STUDY">Cook 2011a</LINK>; <LINK REF="STD-Jump-2012" TYPE="STUDY">Jump 2012</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MRSA</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Cook-2011a" TYPE="STUDY">Cook 2011a</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Vancomycin</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>VRE</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lautenbach-2003" TYPE="STUDY">Lautenbach 2003</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Total microbial</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>34*</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>*Some studies had more than one microbial outcome, so the total is 34 microbial outcomes from 26 studies.</P>
<P>CDI: <I>Clostridium difficile</I> infection<BR/>GNRB: gram-negative resistant bacteria<BR/>ITS: interrupted time series<BR/>MRSA: methicillin-resistant <I>Staphylococcus aureus</I>
<BR/>VRE: vancomycin-resistant enterococci<BR/>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2017-02-17 00:00:05 -0500" MODIFIED_BY="Petrer Davey">
<COMPARISON ID="CMP-001" MODIFIED="2017-02-17 00:00:05 -0500" MODIFIED_BY="Petrer Davey" NO="1">
<NAME>Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use</NAME>
<DICH_OUTCOME CHI2="367.97577884063173" CI_END="0.15587832534442883" CI_START="0.13568414630070122" CI_STUDY="95" CI_TOTAL="95" DF="28" EFFECT_MEASURE="RD" EFFECT_SIZE="0.14578123582256503" ESTIMABLE="YES" EVENTS_1="4594" EVENTS_2="3075" I2="92.39080352293334" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.8072142686323651" LOG_CI_START="-0.8674708935071652" LOG_EFFECT_SIZE="-0.8362983724731485" METHOD="MH" MODIFIED="2017-02-17 00:00:05 -0500" MODIFIED_BY="Petrer Davey" NO="1" P_CHI2="5.551115123125783E-16" P_Q="1.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.78" SORT_BY="STUDY" STUDIES="29" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="11671" TOTAL_2="11723" WEIGHT="100.0" Z="28.297854665472563">
<NAME>Dichotomous outcomes, increase in desired practice</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.33825678026787065" CI_START="-0.0953996374107278" EFFECT_SIZE="0.12142857142857141" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 08:43:34 -0400" MODIFIED_BY="[Empty name]" ORDER="161" O_E="0.0" SE="0.11062866999067965" STUDY_ID="STD-Annane-2013" TOTAL_1="30" TOTAL_2="28" VAR="0.012238702623906705" WEIGHT="0.2489687876292405"/>
<DICH_DATA CI_END="0.36864324907305945" CI_START="0.08302015601500337" EFFECT_SIZE="0.2258317025440314" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="44" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 08:43:37 -0400" MODIFIED_BY="[Empty name]" ORDER="162" O_E="0.0" SE="0.07286437284333144" STUDY_ID="STD-Burton-1991" TOTAL_1="70" TOTAL_2="73" VAR="0.005309216829852017" WEIGHT="0.6142971135327531"/>
<DICH_DATA CI_END="0.49560389840942476" CI_START="0.2776880270564137" EFFECT_SIZE="0.38664596273291924" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="60" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 08:43:38 -0400" MODIFIED_BY="[Empty name]" ORDER="163" O_E="0.0" SE="0.05559180502088395" STUDY_ID="STD-Camins-2009" TOTAL_1="112" TOTAL_2="138" VAR="0.003090448785479978" WEIGHT="1.062797960631702"/>
<DICH_DATA CI_END="0.49865552828990317" CI_START="0.2781132437350357" EFFECT_SIZE="0.38838438601246944" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 08:43:38 -0400" MODIFIED_BY="[Empty name]" ORDER="164" O_E="0.0" SE="0.05626182070039981" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="124" TOTAL_2="119" VAR="0.003165392468523937" WEIGHT="1.043892998995249"/>
<DICH_DATA CI_END="0.1992164138003377" CI_START="0.0789292815639007" EFFECT_SIZE="0.1390728476821192" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="2" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 08:43:38 -0400" MODIFIED_BY="[Empty name]" ORDER="165" O_E="0.0" SE="0.03068605678095275" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" VAR="9.416340807638563E-4" WEIGHT="1.2978980012243384"/>
<DICH_DATA CI_END="0.3566435570269232" CI_START="0.06759886721550104" EFFECT_SIZE="0.21212121212121213" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 08:43:38 -0400" MODIFIED_BY="[Empty name]" ORDER="166" O_E="0.0" SE="0.0737372451972" STUDY_ID="STD-Ding-2013" TOTAL_1="33" TOTAL_2="35" VAR="0.005437181329271994" WEIGHT="0.2919891296092931"/>
<DICH_DATA CI_END="0.15900931827288955" CI_START="-0.04059158080753299" EFFECT_SIZE="0.05920886873267828" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="102" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 08:43:42 -0400" MODIFIED_BY="[Empty name]" ORDER="167" O_E="0.0" SE="0.05091953236254568" STUDY_ID="STD-Dranitsaris-2001" TOTAL_1="162" TOTAL_2="147" VAR="0.0025927987760203364" WEIGHT="1.3248523543649195"/>
<DICH_DATA CI_END="0.2126197370912472" CI_START="0.09705768226359152" EFFECT_SIZE="0.15483870967741936" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 08:43:46 -0400" MODIFIED_BY="[Empty name]" ORDER="168" O_E="0.0" SE="0.0294806577414673" STUDY_ID="STD-Esposito-2011" TOTAL_1="155" TOTAL_2="155" VAR="8.691091808695359E-4" WEIGHT="1.332279405230281"/>
<DICH_DATA CI_END="0.1882949032020166" CI_START="0.08127010544019572" EFFECT_SIZE="0.13478250432110617" ESTIMABLE="YES" EVENTS_1="419" EVENTS_2="320" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 08:43:46 -0400" MODIFIED_BY="[Empty name]" ORDER="169" O_E="0.0" SE="0.027302746021360298" STUDY_ID="STD-Franz-2004" TOTAL_1="656" TOTAL_2="635" VAR="7.454399403069056E-4" WEIGHT="5.5468310041500795"/>
<DICH_DATA CI_END="0.20725079739241611" CI_START="0.17805504191839663" EFFECT_SIZE="0.19265291965540637" ESTIMABLE="YES" EVENTS_1="895" EVENTS_2="135" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:04:20 -0400" MODIFIED_BY="[Empty name]" ORDER="170" O_E="0.0" SE="0.00744803366396318" STUDY_ID="STD-Gulmezoglu-2007" TOTAL_1="3891" TOTAL_2="3613" VAR="5.5473205459528794E-5" WEIGHT="32.20549502348588"/>
<DICH_DATA CI_END="0.04158495406995895" CI_START="-0.0012050000580502568" EFFECT_SIZE="0.020189977005954346" ESTIMABLE="YES" EVENTS_1="374" EVENTS_2="331" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:26:13 -0400" MODIFIED_BY="[Empty name]" ORDER="171" O_E="0.0" SE="0.01091600520864947" STUDY_ID="STD-Kritchevsky-2008" TOTAL_1="2225" TOTAL_2="2238" VAR="1.1915916971526237E-4" WEIGHT="19.180363020142522"/>
<DICH_DATA CI_END="0.1266686442566147" CI_START="-0.10823898231550252" EFFECT_SIZE="0.009214830970556087" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="81" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:25:45 -0400" MODIFIED_BY="[Empty name]" ORDER="172" O_E="0.0" SE="0.059926516105662804" STUDY_ID="STD-Lacroix-2014" TOTAL_1="131" TOTAL_2="140" VAR="0.0035911873325622633" WEIGHT="1.1633855156254425"/>
<DICH_DATA CI_END="0.5123580631531928" CI_START="0.26541971462458486" EFFECT_SIZE="0.38888888888888884" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:25:33 -0400" MODIFIED_BY="[Empty name]" ORDER="173" O_E="0.0" SE="0.06299563422502304" STUDY_ID="STD-Long-2014" TOTAL_1="90" TOTAL_2="90" VAR="0.0039684499314128945" WEIGHT="0.7735815901337115"/>
<DICH_DATA CI_END="0.4021762555483166" CI_START="0.1573135597952966" EFFECT_SIZE="0.2797449076718066" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="55" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:25:22 -0400" MODIFIED_BY="[Empty name]" ORDER="174" O_E="0.0" SE="0.06246612123601905" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011" TOTAL_1="102" TOTAL_2="103" VAR="0.0039020163022730303" WEIGHT="0.8810025133815473"/>
<DICH_DATA CI_END="0.15866760313043904" CI_START="0.0065005620377260875" EFFECT_SIZE="0.08258408258408256" ESTIMABLE="YES" EVENTS_1="216" EVENTS_2="176" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:25:10 -0400" MODIFIED_BY="[Empty name]" ORDER="175" O_E="0.0" SE="0.03881883603295447" STUDY_ID="STD-Paul-2006" TOTAL_1="297" TOTAL_2="273" VAR="0.0015069020309534042" WEIGHT="2.445332121233196"/>
<DICH_DATA CI_END="0.07369989857584966" CI_START="-0.13426634737759266" EFFECT_SIZE="-0.0302832244008715" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="121" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:24:59 -0400" MODIFIED_BY="[Empty name]" ORDER="176" O_E="0.0" SE="0.053053588635774314" STUDY_ID="STD-Poehling-2006" TOTAL_1="135" TOTAL_2="170" VAR="0.0028146832671339613" WEIGHT="1.293529872026862"/>
<DICH_DATA CI_END="0.2039709232919804" CI_START="0.0506999231030041" EFFECT_SIZE="0.12733542319749225" ESTIMABLE="YES" EVENTS_1="182" EVENTS_2="186" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:24:47 -0400" MODIFIED_BY="[Empty name]" ORDER="177" O_E="0.0" SE="0.03910046342635844" STUDY_ID="STD-Schnoor-2010" TOTAL_1="275" TOTAL_2="348" VAR="0.001528846240155994" WEIGHT="2.640690500295923"/>
<DICH_DATA CI_END="0.25666660809670216" CI_START="0.11904731009213229" EFFECT_SIZE="0.18785695909441724" ESTIMABLE="YES" EVENTS_1="296" EVENTS_2="154" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 08:46:01 -0400" MODIFIED_BY="[Empty name]" ORDER="178" O_E="0.0" SE="0.035107608887227866" STUDY_ID="STD-Schouten-2007" TOTAL_1="460" TOTAL_2="338" VAR="0.001232544201778561" WEIGHT="3.3493864002781812"/>
<DICH_DATA CI_END="0.15923790871711993" CI_START="0.0799244458442605" EFFECT_SIZE="0.11958117728069022" ESTIMABLE="YES" EVENTS_1="136" EVENTS_2="61" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:24:36 -0400" MODIFIED_BY="[Empty name]" ORDER="179" O_E="0.0" SE="0.0202333980365134" STUDY_ID="STD-Schuetz-2009" TOTAL_1="628" TOTAL_2="629" VAR="4.093903961039843E-4" WEIGHT="5.402174685439719"/>
<DICH_DATA CI_END="0.17147365485914218" CI_START="-0.06963238501787233" EFFECT_SIZE="0.05092063492063492" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="73" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:24:24 -0400" MODIFIED_BY="[Empty name]" ORDER="180" O_E="0.0" SE="0.06150777304553252" STUDY_ID="STD-Senn-2004" TOTAL_1="126" TOTAL_2="125" VAR="0.003783206145020736" WEIGHT="1.0786994284733031"/>
<DICH_DATA CI_END="0.7119964003908533" CI_START="0.34294865455420165" EFFECT_SIZE="0.5274725274725275" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:24:13 -0400" MODIFIED_BY="[Empty name]" ORDER="181" O_E="0.0" SE="0.09414656308678457" STUDY_ID="STD-Singh-2000" TOTAL_1="39" TOTAL_2="42" VAR="0.008863575341053906" WEIGHT="0.34763419606008766"/>
<DICH_DATA CI_END="0.3653608308926722" CI_START="0.14067838479360223" EFFECT_SIZE="0.2530196078431372" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="69" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:24:02 -0400" MODIFIED_BY="[Empty name]" ORDER="182" O_E="0.0" SE="0.05731800376724685" STUDY_ID="STD-Solomon-2001" TOTAL_1="125" TOTAL_2="153" VAR="0.003285353555862124" WEIGHT="1.1826337259238395"/>
<DICH_DATA CI_END="0.42827319068897163" CI_START="0.11107107160611032" EFFECT_SIZE="0.26967213114754096" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:23:51 -0400" MODIFIED_BY="[Empty name]" ORDER="183" O_E="0.0" SE="0.0809203948605462" STUDY_ID="STD-Stocker-2010" TOTAL_1="60" TOTAL_2="61" VAR="0.006548110304386711" WEIGHT="0.5199832176105389"/>
<DICH_DATA CI_END="0.4253461163905209" CI_START="0.16695873007636772" EFFECT_SIZE="0.2961524232334443" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="32" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:23:40 -0400" MODIFIED_BY="[Empty name]" ORDER="184" O_E="0.0" SE="0.06591636079853505" STUDY_ID="STD-Stolz-2009" TOTAL_1="102" TOTAL_2="106" VAR="0.004344966620922649" WEIGHT="0.8935859137313772"/>
<DICH_DATA CI_END="0.5258034662344774" CI_START="0.34825616040246876" EFFECT_SIZE="0.43702981331847307" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:23:29 -0400" MODIFIED_BY="[Empty name]" ORDER="185" O_E="0.0" SE="0.045293512338103956" STUDY_ID="STD-Strom-2010" TOTAL_1="194" TOTAL_2="148" VAR="0.002051502259921975" WEIGHT="1.4432147248810347"/>
<DICH_DATA CI_END="0.24148826251293623" CI_START="0.06133305410148379" EFFECT_SIZE="0.15141065830721" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="90" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:22:31 -0400" MODIFIED_BY="[Empty name]" ORDER="186" O_E="0.0" SE="0.04595880583329432" STUDY_ID="STD-Trenholme-1989" TOTAL_1="110" TOTAL_2="116" VAR="0.002112211833622448" WEIGHT="0.9705900776898878"/>
<DICH_DATA CI_END="0.7472206120714603" CI_START="0.29277938792853975" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:22:43 -0400" MODIFIED_BY="[Empty name]" ORDER="187" O_E="0.0" SE="0.11593101396951551" STUDY_ID="STD-Walker-1998" TOTAL_1="25" TOTAL_2="25" VAR="0.01344" WEIGHT="0.2148837750371421"/>
<DICH_DATA CI_END="0.03620678240953791" CI_START="-0.10440468500234514" EFFECT_SIZE="-0.03409895129640361" ESTIMABLE="YES" EVENTS_1="224" EVENTS_2="222" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:22:52 -0400" MODIFIED_BY="[Empty name]" ORDER="188" O_E="0.0" SE="0.035870931435732584" STUDY_ID="STD-Wyatt-1998" TOTAL_1="314" TOTAL_2="297" VAR="0.0012867237220670282" WEIGHT="2.623846951543541"/>
<DICH_DATA CI_END="0.23194484500416424" CI_START="0.15100532505063902" EFFECT_SIZE="0.19147508502740163" ESTIMABLE="YES" EVENTS_1="631" EVENTS_2="677" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-02 11:23:03 -0400" MODIFIED_BY="[Empty name]" ORDER="189" O_E="0.0" SE="0.020648216138655057" STUDY_ID="STD-Yealy-2005" TOTAL_1="849" TOTAL_2="1227" VAR="4.263488297086151E-4" WEIGHT="8.626179991638411"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="143.97509761634555" CI_END="0.19338395597522567" CI_START="0.14876079124111796" CI_STUDY="95" CI_TOTAL="95" DF="28" EFFECT_MEASURE="RD" EFFECT_SIZE="0.17107237360817182" ESTIMABLE="YES" EVENTS_1="1649" EVENTS_2="1169" I2="80.55219238356597" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.7135795598314076" LOG_CI_START="-0.8275115203457518" LOG_EFFECT_SIZE="-0.7668201187946588" METHOD="MH" MODIFIED="2016-11-13 03:17:01 -0500" MODIFIED_BY="Petrer Davey" NO="2" P_CHI2="-2.220446049250313E-16" P_Q="1.0" P_Z="4.822220193497392E-51" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="29" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2904" TOTAL_2="2898" WEIGHT="100.00000000000001" Z="15.027875903454872">
<NAME>Dichotomous outcomes, all RCTs with results of cluster RCTs adjusted by inflation factor</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.33825678026787065" CI_START="-0.0953996374107278" EFFECT_SIZE="0.12142857142857141" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="179" O_E="0.0" SE="0.11062866999067965" STUDY_ID="STD-Annane-2013" TOTAL_1="30" TOTAL_2="28" VAR="0.012238702623906705" WEIGHT="1.0021167013441967"/>
<DICH_DATA CI_END="0.36864324907305945" CI_START="0.08302015601500337" EFFECT_SIZE="0.2258317025440314" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="44" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="180" O_E="0.0" SE="0.07286437284333144" STUDY_ID="STD-Burton-1991" TOTAL_1="70" TOTAL_2="73" VAR="0.005309216829852017" WEIGHT="2.4725886442257163"/>
<DICH_DATA CI_END="0.6375031729206653" CI_START="0.15752788297995585" EFFECT_SIZE="0.3975155279503106" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:11:35 -0400" MODIFIED_BY="Petrer Davey" ORDER="181" O_E="0.0" SE="0.12244492595953123" STUDY_ID="STD-Camins-2009" TOTAL_1="23" TOTAL_2="28" VAR="0.014992759893235084" WEIGHT="0.873740967054352"/>
<DICH_DATA CI_END="0.6163969760124414" CI_START="0.18602237882626835" EFFECT_SIZE="0.40120967741935487" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:22:21 -0400" MODIFIED_BY="Petrer Davey" ORDER="182" O_E="0.0" SE="0.10979145550145639" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="32" TOTAL_2="31" VAR="0.012054163701128277" WEIGHT="1.0895273342505614"/>
<DICH_DATA CI_END="0.1992164138003377" CI_START="0.0789292815639007" EFFECT_SIZE="0.1390728476821192" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="2" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="183" O_E="0.0" SE="0.03068605678095275" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" VAR="9.416340807638563E-4" WEIGHT="5.22412980379314"/>
<DICH_DATA CI_END="0.3566435570269232" CI_START="0.06759886721550104" EFFECT_SIZE="0.21212121212121213" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="184" O_E="0.0" SE="0.0737372451972" STUDY_ID="STD-Ding-2013" TOTAL_1="33" TOTAL_2="35" VAR="0.005437181329271994" WEIGHT="1.1752765725323484"/>
<DICH_DATA CI_END="0.15900931827288955" CI_START="-0.04059158080753299" EFFECT_SIZE="0.05920886873267828" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="102" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="185" O_E="0.0" SE="0.05091953236254568" STUDY_ID="STD-Dranitsaris-2001" TOTAL_1="162" TOTAL_2="147" VAR="0.0025927987760203364" WEIGHT="5.332622951521886"/>
<DICH_DATA CI_END="0.2126197370912472" CI_START="0.09705768226359152" EFFECT_SIZE="0.15483870967741936" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="186" O_E="0.0" SE="0.0294806577414673" STUDY_ID="STD-Esposito-2011" TOTAL_1="155" TOTAL_2="155" VAR="8.691091808695359E-4" WEIGHT="5.362517348264482"/>
<DICH_DATA CI_END="0.1882949032020166" CI_START="0.08127010544019572" EFFECT_SIZE="0.13478250432110617" ESTIMABLE="YES" EVENTS_1="419" EVENTS_2="320" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="187" O_E="0.0" SE="0.027302746021360298" STUDY_ID="STD-Franz-2004" TOTAL_1="656" TOTAL_2="635" VAR="7.454399403069056E-4" WEIGHT="22.326380915949652"/>
<DICH_DATA CI_END="0.2737243823485359" CI_START="0.0921496268296034" EFFECT_SIZE="0.18293700458906967" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="4" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:11:54 -0400" MODIFIED_BY="Petrer Davey" ORDER="188" O_E="0.0" SE="0.046320941851781726" STUDY_ID="STD-Gulmezoglu-2007" TOTAL_1="102" TOTAL_2="94" VAR="0.002145629654036144" WEIGHT="3.3848463683449537"/>
<DICH_DATA CI_END="0.11762772106569783" CI_START="-0.07989187200909406" EFFECT_SIZE="0.018867924528301883" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:11:54 -0400" MODIFIED_BY="Petrer Davey" ORDER="189" O_E="0.0" SE="0.05038857719652025" STUDY_ID="STD-Kritchevsky-2008" TOTAL_1="106" TOTAL_2="106" VAR="0.0025390087118896806" WEIGHT="3.667269928490549"/>
<DICH_DATA CI_END="0.1266686442566147" CI_START="-0.10823898231550252" EFFECT_SIZE="0.009214830970556087" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="81" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="190" O_E="0.0" SE="0.059926516105662804" STUDY_ID="STD-Lacroix-2014" TOTAL_1="131" TOTAL_2="140" VAR="0.0035911873325622633" WEIGHT="4.682707685616979"/>
<DICH_DATA CI_END="0.5123580631531928" CI_START="0.26541971462458486" EFFECT_SIZE="0.38888888888888884" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="191" O_E="0.0" SE="0.06299563422502304" STUDY_ID="STD-Long-2014" TOTAL_1="90" TOTAL_2="90" VAR="0.0039684499314128945" WEIGHT="3.113719750605183"/>
<DICH_DATA CI_END="0.4021762555483166" CI_START="0.1573135597952966" EFFECT_SIZE="0.2797449076718066" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="55" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="192" O_E="0.0" SE="0.06246612123601905" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011" TOTAL_1="102" TOTAL_2="103" VAR="0.0039020163022730303" WEIGHT="3.5460964444290575"/>
<DICH_DATA CI_END="0.3253610042931851" CI_START="-0.11237399130617204" EFFECT_SIZE="0.10649350649350653" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="21" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:12:17 -0400" MODIFIED_BY="Petrer Davey" ORDER="193" O_E="0.0" SE="0.11166914266082309" STUDY_ID="STD-Paul-2006" TOTAL_1="35" TOTAL_2="33" VAR="0.012469997422603258" WEIGHT="1.1752765725323484"/>
<DICH_DATA CI_END="0.07369989857584966" CI_START="-0.13426634737759266" EFFECT_SIZE="-0.0302832244008715" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="121" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="194" O_E="0.0" SE="0.053053588635774314" STUDY_ID="STD-Poehling-2006" TOTAL_1="135" TOTAL_2="170" VAR="0.0028146832671339613" WEIGHT="5.20654777970047"/>
<DICH_DATA CI_END="0.4350715879164683" CI_START="-0.1885729884766924" EFFECT_SIZE="0.12324929971988796" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:12:42 -0400" MODIFIED_BY="Petrer Davey" ORDER="195" O_E="0.0" SE="0.15909592760693297" STUDY_ID="STD-Schnoor-2010" TOTAL_1="17" TOTAL_2="21" VAR="0.02531151418111046" WEIGHT="0.6500572812666962"/>
<DICH_DATA CI_END="0.5098750011996108" CI_START="-0.21575735414078723" EFFECT_SIZE="0.1470588235294118" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:12:42 -0400" MODIFIED_BY="Petrer Davey" ORDER="196" O_E="0.0" SE="0.18511369623730167" STUDY_ID="STD-Schouten-2007" TOTAL_1="17" TOTAL_2="12" VAR="0.034267080534636" WEIGHT="0.48674239779575273"/>
<DICH_DATA CI_END="0.37189255249562103" CI_START="-0.10522588582895429" EFFECT_SIZE="0.13333333333333336" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:13:16 -0400" MODIFIED_BY="Petrer Davey" ORDER="197" O_E="0.0" SE="0.12171612389003691" STUDY_ID="STD-Schuetz-2009" TOTAL_1="15" TOTAL_2="15" VAR="0.014814814814814815" WEIGHT="0.5189532917675305"/>
<DICH_DATA CI_END="0.17147365485914218" CI_START="-0.06963238501787233" EFFECT_SIZE="0.05092063492063492" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="73" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="198" O_E="0.0" SE="0.06150777304553252" STUDY_ID="STD-Senn-2004" TOTAL_1="126" TOTAL_2="125" VAR="0.003783206145020736" WEIGHT="4.341840289688502"/>
<DICH_DATA CI_END="0.7119964003908533" CI_START="0.34294865455420165" EFFECT_SIZE="0.5274725274725275" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="199" O_E="0.0" SE="0.09414656308678457" STUDY_ID="STD-Singh-2000" TOTAL_1="39" TOTAL_2="42" VAR="0.008863575341053906" WEIGHT="1.3992518385435637"/>
<DICH_DATA CI_END="0.48708493678044884" CI_START="0.03753305982396546" EFFECT_SIZE="0.26230899830220716" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="17" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:13:45 -0400" MODIFIED_BY="Petrer Davey" ORDER="200" O_E="0.0" SE="0.11468370860446703" STUDY_ID="STD-Solomon-2001" TOTAL_1="31" TOTAL_2="38" VAR="0.013152353019274303" WEIGHT="1.1813081694727554"/>
<DICH_DATA CI_END="0.42827319068897163" CI_START="0.11107107160611032" EFFECT_SIZE="0.26967213114754096" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="201" O_E="0.0" SE="0.0809203948605462" STUDY_ID="STD-Stocker-2010" TOTAL_1="60" TOTAL_2="61" VAR="0.006548110304386711" WEIGHT="2.09296864778971"/>
<DICH_DATA CI_END="0.4253461163905209" CI_START="0.16695873007636772" EFFECT_SIZE="0.2961524232334443" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="32" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="202" O_E="0.0" SE="0.06591636079853505" STUDY_ID="STD-Stolz-2009" TOTAL_1="102" TOTAL_2="106" VAR="0.004344966620922649" WEIGHT="3.5967455067888077"/>
<DICH_DATA CI_END="0.5188883949565952" CI_START="0.3564768885033697" EFFECT_SIZE="0.4376826417299825" ESTIMABLE="YES" EVENTS_1="133" EVENTS_2="24" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:14:08 -0400" MODIFIED_BY="Petrer Davey" ORDER="203" O_E="0.0" SE="0.041432268075920466" STUDY_ID="STD-Strom-2010" TOTAL_1="232" TOTAL_2="177" VAR="0.0017166328379149384" WEIGHT="6.947122403632233"/>
<DICH_DATA CI_END="0.24148826251293623" CI_START="0.06133305410148379" EFFECT_SIZE="0.15141065830721" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="90" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="204" O_E="0.0" SE="0.04595880583329432" STUDY_ID="STD-Trenholme-1989" TOTAL_1="110" TOTAL_2="116" VAR="0.002112211833622448" WEIGHT="3.906692627111321"/>
<DICH_DATA CI_END="0.7472206120714603" CI_START="0.29277938792853975" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:10:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="205" O_E="0.0" SE="0.11593101396951551" STUDY_ID="STD-Walker-1998" TOTAL_1="25" TOTAL_2="25" VAR="0.01344" WEIGHT="0.8649221529458841"/>
<DICH_DATA CI_END="0.12719518983111122" CI_START="-0.209013371649293" EFFECT_SIZE="-0.040909090909090895" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="39" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:14:24 -0400" MODIFIED_BY="Petrer Davey" ORDER="206" O_E="0.0" SE="0.08576906620029104" STUDY_ID="STD-Wyatt-1998" TOTAL_1="55" TOTAL_2="52" VAR="0.007356332716869907" WEIGHT="1.8494783980749372"/>
<DICH_DATA CI_END="0.3415182503171368" CI_START="0.04122912191918074" EFFECT_SIZE="0.19137368611815875" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="49" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-27 03:14:24 -0400" MODIFIED_BY="Petrer Davey" ORDER="207" O_E="0.0" SE="0.0766057771384062" STUDY_ID="STD-Yealy-2005" TOTAL_1="62" TOTAL_2="89" VAR="0.005868445090979158" WEIGHT="2.528551226466431"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="212.68544407349475" CI_END="0.12365808583377971" CI_START="0.09501389029001453" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="RD" EFFECT_SIZE="0.10933598806189712" ESTIMABLE="YES" EVENTS_1="2753" EVENTS_2="2159" I2="93.41750910082864" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.9077774804496377" LOG_CI_START="-1.02221289960238" LOG_EFFECT_SIZE="-0.961236866008265" METHOD="MH" MODIFIED="2017-01-05 16:47:21 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="-2.220446049250313E-16" P_Q="1.0" P_Z="1.2905569319733642E-50" Q="0.0" RANDOM="NO" SCALE="0.57" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="6460" TOTAL_2="6626" WEIGHT="100.00000000000003" Z="14.962514725749655">
<NAME>Dichotomous outcomes, low or medium 'Risk of bias' studies only</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.49865552828990317" CI_START="0.2781132437350357" EFFECT_SIZE="0.38838438601246944" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-04 04:41:21 -0400" MODIFIED_BY="[Empty name]" ORDER="146" O_E="0.0" SE="0.05626182070039981" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="124" TOTAL_2="119" VAR="0.003165392468523937" WEIGHT="1.8698695643699728"/>
<DICH_DATA CI_END="0.1992164138003377" CI_START="0.0789292815639007" EFFECT_SIZE="0.1390728476821192" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="2" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 02:09:12 -0500" MODIFIED_BY="[Empty name]" ORDER="147" O_E="0.0" SE="0.03068605678095275" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" VAR="9.416340807638563E-4" WEIGHT="2.3248551072589936"/>
<DICH_DATA CI_END="0.2126197370912472" CI_START="0.09705768226359152" EFFECT_SIZE="0.15483870967741936" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 02:09:12 -0500" MODIFIED_BY="[Empty name]" ORDER="148" O_E="0.0" SE="0.0294806577414673" STUDY_ID="STD-Esposito-2011" TOTAL_1="155" TOTAL_2="155" VAR="8.691091808695359E-4" WEIGHT="2.3864406730141985"/>
<DICH_DATA CI_END="0.1882949032020166" CI_START="0.08127010544019572" EFFECT_SIZE="0.13478250432110617" ESTIMABLE="YES" EVENTS_1="419" EVENTS_2="320" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 02:09:12 -0500" MODIFIED_BY="[Empty name]" ORDER="149" O_E="0.0" SE="0.027302746021360298" STUDY_ID="STD-Franz-2004" TOTAL_1="656" TOTAL_2="635" VAR="7.454399403069056E-4" WEIGHT="9.935741003481118"/>
<DICH_DATA CI_END="0.04158495406995895" CI_START="-0.0012050000580502568" EFFECT_SIZE="0.020189977005954346" ESTIMABLE="YES" EVENTS_1="374" EVENTS_2="331" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-03 12:15:39 -0400" MODIFIED_BY="Petrer Davey" ORDER="150" O_E="0.0" SE="0.01091600520864947" STUDY_ID="STD-Kritchevsky-2008" TOTAL_1="2225" TOTAL_2="2238" VAR="1.1915916971526237E-4" WEIGHT="34.35675598883393"/>
<DICH_DATA CI_END="0.1266686442566147" CI_START="-0.10823898231550252" EFFECT_SIZE="0.009214830970556087" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="81" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 02:09:12 -0500" MODIFIED_BY="[Empty name]" ORDER="151" O_E="0.0" SE="0.059926516105662804" STUDY_ID="STD-Lacroix-2014" TOTAL_1="131" TOTAL_2="140" VAR="0.0035911873325622633" WEIGHT="2.0839101032296345"/>
<DICH_DATA CI_END="0.5123580631531928" CI_START="0.26541971462458486" EFFECT_SIZE="0.38888888888888884" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 02:09:12 -0500" MODIFIED_BY="[Empty name]" ORDER="152" O_E="0.0" SE="0.06299563422502304" STUDY_ID="STD-Long-2014" TOTAL_1="90" TOTAL_2="90" VAR="0.0039684499314128945" WEIGHT="1.3856752294921153"/>
<DICH_DATA CI_END="0.15866760313043904" CI_START="0.0065005620377260875" EFFECT_SIZE="0.08258408258408256" ESTIMABLE="YES" EVENTS_1="216" EVENTS_2="176" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-03 12:15:40 -0400" MODIFIED_BY="Petrer Davey" ORDER="153" O_E="0.0" SE="0.03881883603295447" STUDY_ID="STD-Paul-2006" TOTAL_1="297" TOTAL_2="273" VAR="0.0015069020309534042" WEIGHT="4.380192330699813"/>
<DICH_DATA CI_END="0.25666660809670216" CI_START="0.11904731009213229" EFFECT_SIZE="0.18785695909441724" ESTIMABLE="YES" EVENTS_1="296" EVENTS_2="154" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-03 12:15:41 -0400" MODIFIED_BY="Petrer Davey" ORDER="154" O_E="0.0" SE="0.035107608887227866" STUDY_ID="STD-Schouten-2007" TOTAL_1="460" TOTAL_2="338" VAR="0.001232544201778561" WEIGHT="5.999576292994544"/>
<DICH_DATA CI_END="0.15923790871711993" CI_START="0.0799244458442605" EFFECT_SIZE="0.11958117728069022" ESTIMABLE="YES" EVENTS_1="136" EVENTS_2="61" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 02:09:12 -0500" MODIFIED_BY="[Empty name]" ORDER="155" O_E="0.0" SE="0.0202333980365134" STUDY_ID="STD-Schuetz-2009" TOTAL_1="628" TOTAL_2="629" VAR="4.093903961039843E-4" WEIGHT="9.67662589502589"/>
<DICH_DATA CI_END="0.17147365485914218" CI_START="-0.06963238501787233" EFFECT_SIZE="0.05092063492063492" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="73" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 02:09:12 -0500" MODIFIED_BY="[Empty name]" ORDER="156" O_E="0.0" SE="0.06150777304553252" STUDY_ID="STD-Senn-2004" TOTAL_1="126" TOTAL_2="125" VAR="0.003783206145020736" WEIGHT="1.932216455467093"/>
<DICH_DATA CI_END="0.42827319068897163" CI_START="0.11107107160611032" EFFECT_SIZE="0.26967213114754096" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 02:09:12 -0500" MODIFIED_BY="[Empty name]" ORDER="157" O_E="0.0" SE="0.0809203948605462" STUDY_ID="STD-Stocker-2010" TOTAL_1="60" TOTAL_2="61" VAR="0.006548110304386711" WEIGHT="0.931418060595251"/>
<DICH_DATA CI_END="0.5258034662344774" CI_START="0.34825616040246876" EFFECT_SIZE="0.43702981331847307" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-03 12:15:42 -0400" MODIFIED_BY="Petrer Davey" ORDER="158" O_E="0.0" SE="0.045293512338103956" STUDY_ID="STD-Strom-2010" TOTAL_1="194" TOTAL_2="148" VAR="0.002051502259921975" WEIGHT="2.5851531636892537"/>
<DICH_DATA CI_END="0.03620678240953791" CI_START="-0.10440468500234514" EFFECT_SIZE="-0.03409895129640361" ESTIMABLE="YES" EVENTS_1="224" EVENTS_2="222" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-03 12:15:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="159" O_E="0.0" SE="0.035870931435732584" STUDY_ID="STD-Wyatt-1998" TOTAL_1="314" TOTAL_2="297" VAR="0.0012867237220670282" WEIGHT="4.699956375776529"/>
<DICH_DATA CI_END="0.23194484500416424" CI_START="0.15100532505063902" EFFECT_SIZE="0.19147508502740163" ESTIMABLE="YES" EVENTS_1="631" EVENTS_2="677" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-03 12:15:44 -0400" MODIFIED_BY="Petrer Davey" ORDER="160" O_E="0.0" SE="0.020648216138655057" STUDY_ID="STD-Yealy-2005" TOTAL_1="849" TOTAL_2="1227" VAR="4.263488297086151E-4" WEIGHT="15.451613756071664"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="119.94917801321172" CI_END="-1.6735616803800308" CI_START="-2.222587261011966" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.9480744706959985" ESTIMABLE="YES" I2="89.16207662667924" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2017-01-05 16:48:02 -0500" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="-4.440892098500626E-16" P_Q="1.0" P_Z="5.597620985717623E-44" Q="0.0" RANDOM="NO" SCALE="10.27" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1695" TOTAL_2="1623" UNITS="" WEIGHT="99.99999999999999" Z="13.90884482056862">
<NAME>Continuous outcomes, duration of all antibiotic treatment (days)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.4464668397829259" CI_START="-5.953533160217076" EFFECT_SIZE="-3.200000000000001" ESTIMABLE="YES" MEAN_1="15.72" MEAN_2="18.92" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="195" SD_1="9.47" SD_2="10.92" SE="1.4048896724310207" STUDY_ID="STD-Bouza-2004" TOTAL_1="167" TOTAL_2="83" WEIGHT="0.9939042474542246"/>
<CONT_DATA CI_END="-0.7357431581334171" CI_START="-3.064256841866584" EFFECT_SIZE="-1.9000000000000004" ESTIMABLE="YES" MEAN_1="10.9" MEAN_2="12.8" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="196" SD_1="3.6" SD_2="5.5" SE="0.5940195080369296" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="119" TOTAL_2="124" WEIGHT="5.559395496394525"/>
<CONT_DATA CI_END="-4.9947317719469275" CI_START="-7.605268228053072" EFFECT_SIZE="-6.3" ESTIMABLE="YES" MEAN_1="6.8" MEAN_2="13.1" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="197" SD_1="5.1" SD_2="6.4" SE="0.6659654148488753" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" WEIGHT="4.423088558178624"/>
<CONT_DATA CI_END="0.046763903849662114" CI_START="-4.246763903849661" EFFECT_SIZE="-2.0999999999999996" ESTIMABLE="YES" MEAN_1="4.5" MEAN_2="6.6" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="198" SD_1="3.0" SD_2="4.6" SE="1.0953078325842012" STUDY_ID="STD-Danaher-2009" TOTAL_1="14" TOTAL_2="38" WEIGHT="1.6351462390191651"/>
<CONT_DATA CI_END="-2.964770384568788" CI_START="-8.635229615431214" EFFECT_SIZE="-5.800000000000001" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="14.5" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="199" SD_1="6.6" SD_2="5.2" SE="1.446572303264316" STUDY_ID="STD-Ding-2013" TOTAL_1="33" TOTAL_2="35" WEIGHT="0.9374512557773217"/>
<CONT_DATA CI_END="-1.5606051831703358" CI_START="-2.439394816829664" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="5.9" MEAN_2="7.9" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="200" SD_1="1.7" SD_2="0.5" SE="0.22418514844943804" STUDY_ID="STD-Hochreiter-2009" TOTAL_1="63" TOTAL_2="57" WEIGHT="39.03150606850202"/>
<CONT_DATA CI_END="-2.77706192509831" CI_START="-9.822938074901684" EFFECT_SIZE="-6.299999999999997" ESTIMABLE="YES" MEAN_1="26.6" MEAN_2="32.9" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="201" SD_1="24.5" SD_2="31.9" SE="1.797450413727075" STUDY_ID="STD-Kerremans-2008" TOTAL_1="497" TOTAL_2="503" WEIGHT="0.6071767731697876"/>
<CONT_DATA CI_END="-0.5550038382944014" CI_START="-2.844996161705599" EFFECT_SIZE="-1.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="6.8" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="202" SD_1="3.64" SD_2="4.77" SE="0.5841924498292735" STUDY_ID="STD-Kristoffersen-2009" TOTAL_1="103" TOTAL_2="107" WEIGHT="5.748004597794638"/>
<CONT_DATA CI_END="3.6509712777979737" CI_START="-2.4109712777979717" EFFECT_SIZE="0.620000000000001" ESTIMABLE="YES" MEAN_1="14.73" MEAN_2="14.11" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="203" SD_1="20.6" SD_2="13.69" SE="1.546442333484639" STUDY_ID="STD-Layios-2012" TOTAL_1="258" TOTAL_2="251" WEIGHT="0.8202788741626051"/>
<CONT_DATA CI_END="-0.3687822462050401" CI_START="-2.0312177537949623" EFFECT_SIZE="-1.200000000000001" ESTIMABLE="YES" MEAN_1="8.1" MEAN_2="9.3" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="204" SD_1="1.94" SD_2="1.9" SE="0.4240984836208729" STUDY_ID="STD-Liu-2013" TOTAL_1="42" TOTAL_2="40" WEIGHT="10.906754738189495"/>
<CONT_DATA CI_END="-0.7853493158931422" CI_START="-3.214650684106858" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="6.0" MEAN_2="8.0" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="205" SD_1="4.9" SD_2="5.6" SE="0.6197311244940557" STUDY_ID="STD-Micek-2004" TOTAL_1="150" TOTAL_2="140" WEIGHT="5.10766458996189"/>
<CONT_DATA CI_END="2.3556740751195564" CI_START="-0.5556740751195572" EFFECT_SIZE="0.8999999999999995" ESTIMABLE="YES" MEAN_1="8.1" MEAN_2="7.2" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="206" SD_1="3.7" SD_2="3.5" SE="0.7427045020223474" STUDY_ID="STD-Oliveira-2013" TOTAL_1="49" TOTAL_2="45" WEIGHT="3.556287583907963"/>
<CONT_DATA CI_END="-3.925900030385619" CI_START="-6.4140999696143775" EFFECT_SIZE="-5.169999999999998" ESTIMABLE="YES" MEAN_1="10.89" MEAN_2="16.06" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="207" SD_1="2.85" SD_2="2.48" SE="0.6347565462568094" STUDY_ID="STD-Qu-2012" TOTAL_1="35" TOTAL_2="36" WEIGHT="4.868717876103005"/>
<CONT_DATA CI_END="0.1905108586627805" CI_START="-1.1905108586627806" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="6.6" MEAN_2="7.1" MODIFIED="2016-01-11 01:22:44 -0500" MODIFIED_BY="[Empty name]" ORDER="208" SD_1="1.1" SD_2="0.7" SE="0.35230793224234835" STUDY_ID="STD-Schroeder-2009" TOTAL_1="14" TOTAL_2="13" WEIGHT="15.804623101384744"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="119.94236555993288" CI_END="-1.6685164086157944" CI_START="-2.233192189888495" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.9508542992521447" ESTIMABLE="YES" I2="89.16146105730743" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2016-11-12 03:26:13 -0500" MODIFIED_BY="Petrer Davey" NO="5" P_CHI2="-4.440892098500626E-16" P_Q="1.0" P_Z="8.756787517862479E-42" Q="0.0" RANDOM="NO" SCALE="13.713800220296397" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1695" TOTAL_2="1623" UNITS="" WEIGHT="100.0" Z="13.542653297442506">
<NAME>Continuous outcomes, duration of all antibiotic treatment with results of cluster RCTs adjusted by inflation factor</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.4464668397829259" CI_START="-5.953533160217076" EFFECT_SIZE="-3.200000000000001" ESTIMABLE="YES" MEAN_1="15.72" MEAN_2="18.92" MODIFIED="2016-08-28 03:02:03 -0400" MODIFIED_BY="Petrer Davey" ORDER="252" SD_1="9.47" SD_2="10.92" SE="1.4048896724310207" STUDY_ID="STD-Bouza-2007" TOTAL_1="167" TOTAL_2="83" WEIGHT="1.051375153928053"/>
<CONT_DATA CI_END="7.095110781415137" CI_START="-10.895110781415138" EFFECT_SIZE="-1.9000000000000004" ESTIMABLE="YES" MEAN_1="10.9" MEAN_2="12.8" MODIFIED="2016-08-28 03:03:11 -0400" MODIFIED_BY="Petrer Davey" ORDER="253" SD_1="13.82" SD_2="49.12" SE="4.589426567206042" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="119" TOTAL_2="124" WEIGHT="0.09852020316513159"/>
<CONT_DATA CI_END="-4.9947317719469275" CI_START="-7.605268228053072" EFFECT_SIZE="-6.3" ESTIMABLE="YES" MEAN_1="6.8" MEAN_2="13.1" MODIFIED="2016-08-28 03:02:03 -0400" MODIFIED_BY="Petrer Davey" ORDER="254" SD_1="5.1" SD_2="6.4" SE="0.6659654148488753" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" WEIGHT="4.678846504181617"/>
<CONT_DATA CI_END="0.046763903849662114" CI_START="-4.246763903849661" EFFECT_SIZE="-2.0999999999999996" ESTIMABLE="YES" MEAN_1="4.5" MEAN_2="6.6" MODIFIED="2016-08-28 03:02:03 -0400" MODIFIED_BY="Petrer Davey" ORDER="255" SD_1="3.0" SD_2="4.6" SE="1.0953078325842012" STUDY_ID="STD-Danaher-2009" TOTAL_1="14" TOTAL_2="38" WEIGHT="1.729695927094656"/>
<CONT_DATA CI_END="-2.964770384568788" CI_START="-8.635229615431214" EFFECT_SIZE="-5.800000000000001" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="14.5" MODIFIED="2016-08-28 03:02:03 -0400" MODIFIED_BY="Petrer Davey" ORDER="256" SD_1="6.6" SD_2="5.2" SE="1.446572303264316" STUDY_ID="STD-Ding-2013" TOTAL_1="33" TOTAL_2="35" WEIGHT="0.991657859263069"/>
<CONT_DATA CI_END="-1.5606051831703358" CI_START="-2.439394816829664" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="5.9" MEAN_2="7.9" MODIFIED="2016-08-28 03:02:03 -0400" MODIFIED_BY="Petrer Davey" ORDER="257" SD_1="1.7" SD_2="0.5" SE="0.22418514844943804" STUDY_ID="STD-Hochreiter-2009" TOTAL_1="63" TOTAL_2="57" WEIGHT="41.28843981291572"/>
<CONT_DATA CI_END="-2.77706192509831" CI_START="-9.822938074901684" EFFECT_SIZE="-6.299999999999997" ESTIMABLE="YES" MEAN_1="26.6" MEAN_2="32.9" MODIFIED="2016-08-28 03:02:03 -0400" MODIFIED_BY="Petrer Davey" ORDER="258" SD_1="24.5" SD_2="31.9" SE="1.797450413727075" STUDY_ID="STD-Kerremans-2008" TOTAL_1="497" TOTAL_2="503" WEIGHT="0.6422857885837989"/>
<CONT_DATA CI_END="-0.5550038382944014" CI_START="-2.844996161705599" EFFECT_SIZE="-1.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="6.8" MODIFIED="2016-08-28 03:02:03 -0400" MODIFIED_BY="Petrer Davey" ORDER="259" SD_1="3.64" SD_2="4.77" SE="0.5841924498292735" STUDY_ID="STD-Kristoffersen-2009" TOTAL_1="103" TOTAL_2="107" WEIGHT="6.080373672076317"/>
<CONT_DATA CI_END="3.6509712777979737" CI_START="-2.4109712777979717" EFFECT_SIZE="0.620000000000001" ESTIMABLE="YES" MEAN_1="14.73" MEAN_2="14.11" MODIFIED="2016-08-28 03:02:03 -0400" MODIFIED_BY="Petrer Davey" ORDER="260" SD_1="20.6" SD_2="13.69" SE="1.546442333484639" STUDY_ID="STD-Layios-2012" TOTAL_1="258" TOTAL_2="251" WEIGHT="0.8677101740893391"/>
<CONT_DATA CI_END="-0.3687822462050401" CI_START="-2.0312177537949623" EFFECT_SIZE="-1.200000000000001" ESTIMABLE="YES" MEAN_1="8.1" MEAN_2="9.3" MODIFIED="2016-08-28 03:02:03 -0400" MODIFIED_BY="Petrer Davey" ORDER="261" SD_1="1.94" SD_2="1.9" SE="0.4240984836208729" STUDY_ID="STD-Liu-2013" TOTAL_1="42" TOTAL_2="40" WEIGHT="11.537420200277017"/>
<CONT_DATA CI_END="-0.7853493158931422" CI_START="-3.214650684106858" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="6.0" MEAN_2="8.0" MODIFIED="2016-08-28 03:02:03 -0400" MODIFIED_BY="Petrer Davey" ORDER="262" SD_1="4.9" SD_2="5.6" SE="0.6197311244940557" STUDY_ID="STD-Micek-2004" TOTAL_1="150" TOTAL_2="140" WEIGHT="5.4030070383931745"/>
<CONT_DATA CI_END="2.3556740751195564" CI_START="-0.5556740751195572" EFFECT_SIZE="0.8999999999999995" ESTIMABLE="YES" MEAN_1="8.1" MEAN_2="7.2" MODIFIED="2016-08-28 03:02:03 -0400" MODIFIED_BY="Petrer Davey" ORDER="263" SD_1="3.7" SD_2="3.5" SE="0.7427045020223474" STUDY_ID="STD-Oliveira-2013" TOTAL_1="49" TOTAL_2="45" WEIGHT="3.7619241647479336"/>
<CONT_DATA CI_END="-3.925900030385619" CI_START="-6.4140999696143775" EFFECT_SIZE="-5.169999999999998" ESTIMABLE="YES" MEAN_1="10.89" MEAN_2="16.06" MODIFIED="2016-08-28 03:02:03 -0400" MODIFIED_BY="Petrer Davey" ORDER="264" SD_1="2.85" SD_2="2.48" SE="0.6347565462568094" STUDY_ID="STD-Qu-2012" TOTAL_1="35" TOTAL_2="36" WEIGHT="5.150243617060118"/>
<CONT_DATA CI_END="0.1905108586627805" CI_START="-1.1905108586627806" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="6.6" MEAN_2="7.1" MODIFIED="2016-08-28 03:02:03 -0400" MODIFIED_BY="Petrer Davey" ORDER="265" SD_1="1.1" SD_2="0.7" SE="0.35230793224234835" STUDY_ID="STD-Schroeder-2009" TOTAL_1="14" TOTAL_2="13" WEIGHT="16.718499884224048"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="32.902236184408906" CI_END="-2.3719720053470463" CI_START="-3.7562441284436425" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.0641080668953444" ESTIMABLE="YES" I2="93.9213858025014" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2017-01-05 16:48:34 -0500" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="7.167610094338528E-8" P_Q="1.0" P_Z="4.0698107158766154E-18" Q="0.0" RANDOM="NO" SCALE="11.87" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="373" TOTAL_2="382" UNITS="" WEIGHT="100.0" Z="8.676822072265987">
<NAME>Continuous outcomes, low or medium 'Risk of bias' studies only</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.7357431581334171" CI_START="-3.064256841866584" EFFECT_SIZE="-1.9000000000000004" ESTIMABLE="YES" MEAN_1="10.9" MEAN_2="12.8" MODIFIED="2016-08-03 12:16:01 -0400" MODIFIED_BY="Petrer Davey" ORDER="209" SD_1="3.6" SD_2="5.5" SE="0.5940195080369296" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="119" TOTAL_2="124" WEIGHT="35.341530827510006"/>
<CONT_DATA CI_END="-4.9947317719469275" CI_START="-7.605268228053072" EFFECT_SIZE="-6.3" ESTIMABLE="YES" MEAN_1="6.8" MEAN_2="13.1" MODIFIED="2016-01-11 01:26:14 -0500" MODIFIED_BY="[Empty name]" ORDER="210" SD_1="5.1" SD_2="6.4" SE="0.6659654148488753" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" WEIGHT="28.11793489652879"/>
<CONT_DATA CI_END="-0.5550038382944014" CI_START="-2.844996161705599" EFFECT_SIZE="-1.7000000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="6.8" MODIFIED="2016-01-11 01:26:14 -0500" MODIFIED_BY="[Empty name]" ORDER="211" SD_1="3.64" SD_2="4.77" SE="0.5841924498292735" STUDY_ID="STD-Kristoffersen-2009" TOTAL_1="103" TOTAL_2="107" WEIGHT="36.54053427596119"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.9895736192750306" CI_END="-0.12519561600847184" CI_START="-0.36779077225478196" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.2464931941316269" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2016-11-13 03:17:41 -0500" MODIFIED_BY="Petrer Davey" NO="7" P_CHI2="0.8037748264441844" P_Q="1.0" P_Z="6.807548722883752E-5" Q="0.0" RANDOM="NO" SCALE="0.95" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="528" TOTAL_2="525" UNITS="" WEIGHT="100.0" Z="3.9829136773177174">
<NAME>Continuous outcome, consumption of targeted antibiotic only, standardised mean reduction (original outcome cost, days or DDD)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.006781511807191221" CI_START="-0.7769272836533473" EFFECT_SIZE="-0.38507288592307803" ESTIMABLE="YES" MEAN_1="19.8" MEAN_2="35.8" MODIFIED="2016-02-03 01:09:36 -0500" MODIFIED_BY="[Empty name]" ORDER="120" SD_1="36.5" SD_2="45.48541" SE="0.19992938687708892" STUDY_ID="STD-Bailey-1997" TOTAL_1="51" TOTAL_2="51" WEIGHT="9.581970048163058"/>
<CONT_DATA CI_END="0.019935586067128475" CI_START="-0.4755691808422245" EFFECT_SIZE="-0.227816797387548" ESTIMABLE="YES" MEAN_1="2078.0" MEAN_2="2663.0" MODIFIED="2016-02-03 01:09:36 -0500" MODIFIED_BY="[Empty name]" ORDER="121" SD_1="2208.9" SD_2="2873.4" SE="0.1264066000237329" STUDY_ID="STD-Gums-1999" TOTAL_1="127" TOTAL_2="125" WEIGHT="23.97002995996914"/>
<CONT_DATA CI_END="-0.0746523072282321" CI_START="-0.4934621748729192" EFFECT_SIZE="-0.28405724105057567" ESTIMABLE="YES" MEAN_1="832.0" MEAN_2="943.9" MODIFIED="2016-02-03 01:09:36 -0500" MODIFIED_BY="[Empty name]" ORDER="122" SD_1="373.0" SD_2="412.0" SE="0.10684121518257629" STUDY_ID="STD-Shen-2011" TOTAL_1="176" TOTAL_2="178" WEIGHT="33.5529291205001"/>
<CONT_DATA CI_END="0.030068150061137555" CI_START="-0.3929088104947957" EFFECT_SIZE="-0.18142033021682907" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="2.0" MODIFIED="2016-02-03 01:09:36 -0500" MODIFIED_BY="[Empty name]" ORDER="123" SD_1="1.1" SD_2="1.1" SE="0.10790426862236284" STUDY_ID="STD-Shojania-1998" TOTAL_1="174" TOTAL_2="171" WEIGHT="32.89507087136769"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2017-01-05 16:51:06 -0500" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use</NAME>
<DICH_OUTCOME CHI2="16.338961057658256" CI_END="0.0034634239936694334" CI_START="-0.012892132417855388" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="RD" EFFECT_SIZE="-0.004714354212092977" ESTIMABLE="YES" EVENTS_1="697" EVENTS_2="668" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-2.4604943387019373" LOG_CI_START="NaN" LOG_EFFECT_SIZE="NaN" METHOD="MH" MODIFIED="2016-11-12 03:28:52 -0500" MODIFIED_BY="Petrer Davey" NO="1" P_CHI2="0.9461753882160201" P_Q="1.0" P_Z="0.25852390320157026" Q="0.0" RANDOM="NO" SCALE="0.51292" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="8031" TOTAL_2="7796" WEIGHT="100.00000000000003" Z="1.1298869000330758">
<NAME>Mortality, all RCTs</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.11634437467259318" CI_START="-0.33139813811345337" EFFECT_SIZE="-0.1075268817204301" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="156" O_E="0.0" SE="0.11422212763034993" STUDY_ID="STD-Annane-2013" TOTAL_1="31" TOTAL_2="30" VAR="0.01304669444040395" WEIGHT="0.38674306708187134"/>
<DICH_DATA CI_END="0.09132487169953446" CI_START="-0.09132487169953446" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-10-08 08:49:18 -0400" MODIFIED_BY="[Empty name]" ORDER="86" O_E="0.0" SE="0.046595178493019966" STUDY_ID="STD-Bailey-1997" TOTAL_1="51" TOTAL_2="51" VAR="0.0021711106587963907" WEIGHT="0.6468589686514524"/>
<DICH_DATA CI_END="0.16415237084098322" CI_START="-0.09850054196860747" EFFECT_SIZE="0.032825914436187875" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="43" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="157" O_E="0.0" SE="0.06700452530795549" STUDY_ID="STD-Bouza-2007" TOTAL_1="167" TOTAL_2="83" VAR="0.004489606411744448" WEIGHT="1.4064489669769071"/>
<DICH_DATA CI_END="0.008883818933315149" CI_START="-0.04384412089869325" EFFECT_SIZE="-0.01748015098268905" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="18" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-10-06 01:44:03 -0400" MODIFIED_BY="[Empty name]" ORDER="88" O_E="0.0" SE="0.01345125222910208" STUDY_ID="STD-Camins-2009" TOTAL_1="390" TOTAL_2="394" VAR="1.8093618653092366E-4" WEIGHT="4.971806178620557"/>
<DICH_DATA CI_END="0.043541279303559256" CI_START="-0.04625204102760371" EFFECT_SIZE="-0.0013553808620222277" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="158" O_E="0.0" SE="0.02290688018745273" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="124" TOTAL_2="119" VAR="5.247251599223145E-4" WEIGHT="1.5403939226048307"/>
<DICH_DATA CI_END="0.06155035755254892" CI_START="-0.08804042377771451" EFFECT_SIZE="-0.013245033112582794" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="159" O_E="0.0" SE="0.03816161483328684" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" VAR="0.001456308846684138" WEIGHT="1.9152098875758692"/>
<DICH_DATA CI_END="0.2969186080313665" CI_START="-0.16704847816123655" EFFECT_SIZE="0.06493506493506496" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="160" O_E="0.0" SE="0.11836112547279343" STUDY_ID="STD-Ding-2013" TOTAL_1="33" TOTAL_2="35" VAR="0.01400935602318635" WEIGHT="0.43086626804638267"/>
<DICH_DATA CI_END="0.03248251730749968" CI_START="-0.055467023966917994" EFFECT_SIZE="-0.011492253329709157" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="29" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-10-08 11:37:34 -0400" MODIFIED_BY="[Empty name]" ORDER="88" O_E="0.0" SE="0.022436519744279085" STUDY_ID="STD-Fine-2003" TOTAL_1="283" TOTAL_2="325" VAR="5.033974182354252E-4" WEIGHT="3.8373873607918827"/>
<DICH_DATA CI_END="0.10734948123812013" CI_START="-0.05406215135504558" EFFECT_SIZE="0.026643664941537276" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-10-08 12:22:05 -0400" MODIFIED_BY="[Empty name]" ORDER="89" O_E="0.0" SE="0.04117719352660561" STUDY_ID="STD-Fraser-1997" TOTAL_1="141" TOTAL_2="111" VAR="0.0016955612667275306" WEIGHT="1.5754730342925432"/>
<DICH_DATA CI_END="0.013918909748278072" CI_START="-0.12793465777977414" EFFECT_SIZE="-0.05700787401574803" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-10-08 12:27:35 -0400" MODIFIED_BY="[Empty name]" ORDER="90" O_E="0.0" SE="0.03618779953279117" STUDY_ID="STD-Gums-1999" TOTAL_1="127" TOTAL_2="125" VAR="0.0013095568350254812" WEIGHT="1.5980214950734217"/>
<DICH_DATA CI_END="0.16379917380686354" CI_START="-0.16578527112563218" EFFECT_SIZE="-9.930486593843213E-4" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="161" O_E="0.0" SE="0.08407920949880093" STUDY_ID="STD-Hochreiter-2009" TOTAL_1="57" TOTAL_2="53" VAR="0.007069313469943257" WEIGHT="0.6966705683764841"/>
<DICH_DATA CI_END="0.04235974219296726" CI_START="-0.022216379521703314" EFFECT_SIZE="0.010071681335631974" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="162" O_E="0.0" SE="0.01647380314741464" STUDY_ID="STD-Kristoffersen-2009" TOTAL_1="103" TOTAL_2="107" VAR="2.7138619013976855E-4" WEIGHT="1.33128528356819"/>
<DICH_DATA CI_END="0.16517848333896393" CI_START="-0.12946419762467823" EFFECT_SIZE="0.01785714285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="163" O_E="0.0" SE="0.07516533040600389" STUDY_ID="STD-Liu-2013" TOTAL_1="42" TOTAL_2="40" VAR="0.005649826895043732" WEIGHT="0.5197145228763463"/>
<DICH_DATA CI_END="0.062224598763543165" CI_START="-0.08030950262800154" EFFECT_SIZE="-0.00904245193222919" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="164" O_E="0.0" SE="0.03636140830031458" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011" TOTAL_1="102" TOTAL_2="103" VAR="0.0013221520135821858" WEIGHT="1.3000287565092605"/>
<DICH_DATA CI_END="0.14086375952321165" CI_START="-0.06943518809464025" EFFECT_SIZE="0.0357142857142857" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="33" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-10-08 12:32:16 -0400" MODIFIED_BY="[Empty name]" ORDER="91" O_E="0.0" SE="0.053648676525860466" STUDY_ID="STD-Masia-2008" TOTAL_1="140" TOTAL_2="132" VAR="0.0028781804929764116" WEIGHT="1.7234650721855307"/>
<DICH_DATA CI_END="0.058019319489938256" CI_START="-0.16087646234708114" EFFECT_SIZE="-0.051428571428571435" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="52" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="165" O_E="0.0" SE="0.055841786778645264" STUDY_ID="STD-Micek-2004" TOTAL_1="150" TOTAL_2="140" VAR="0.003118305150631681" WEIGHT="1.836922020511224"/>
<DICH_DATA CI_END="0.16301637632605273" CI_START="-0.23920685251652898" EFFECT_SIZE="-0.038095238095238126" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="166" O_E="0.0" SE="0.10260985202158489" STUDY_ID="STD-Oliveira-2013" TOTAL_1="49" TOTAL_2="45" VAR="0.010528781731891548" WEIGHT="0.5950454843039018"/>
<DICH_DATA CI_END="0.014945117335504493" CI_START="-0.043050180943415145" EFFECT_SIZE="-0.014052531803955326" ESTIMABLE="YES" EVENTS_1="149" EVENTS_2="145" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-10-06 01:44:03 -0400" MODIFIED_BY="[Empty name]" ORDER="89" O_E="0.0" SE="0.01479499081013201" STUDY_ID="STD-Paul-2006" TOTAL_1="1153" TOTAL_2="1012" VAR="2.1889175307189063E-4" WEIGHT="13.67166293611169"/>
<DICH_DATA CI_END="0.16752543267999104" CI_START="-0.21196987712443544" EFFECT_SIZE="-0.0222222222222222" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="167" O_E="0.0" SE="0.09681180695100447" STUDY_ID="STD-Qu-2012" TOTAL_1="35" TOTAL_2="36" VAR="0.009372525965118558" WEIGHT="0.4501752557309197"/>
<DICH_DATA CI_END="0.02411480755423438" CI_START="-0.032602285669481396" EFFECT_SIZE="-0.0042437390576235065" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="13" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="90" O_E="0.0" SE="0.014468912100194943" STUDY_ID="STD-Schnoor-2010" TOTAL_1="302" TOTAL_2="348" VAR="2.0934941736316763E-4" WEIGHT="4.101495636162476"/>
<DICH_DATA CI_END="0.04671909278919563" CI_START="-0.05643073181504353" EFFECT_SIZE="-0.004855819512923951" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="91" O_E="0.0" SE="0.02631421429625029" STUDY_ID="STD-Schouten-2007" TOTAL_1="207" TOTAL_2="194" VAR="6.924378740289833E-4" WEIGHT="2.5403708829010836"/>
<DICH_DATA CI_END="0.28136100040829815" CI_START="-0.39824411729141507" EFFECT_SIZE="-0.05844155844155843" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="168" O_E="0.0" SE="0.17337183822262847" STUDY_ID="STD-Schroeder-2009" TOTAL_1="14" TOTAL_2="11" VAR="0.03005779428869326" WEIGHT="0.15626083321148812"/>
<DICH_DATA CI_END="0.025735016398298022" CI_START="-0.020323967287287043" EFFECT_SIZE="0.0027055245555054896" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="33" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="169" O_E="0.0" SE="0.011749956644329297" STUDY_ID="STD-Schuetz-2009" TOTAL_1="671" TOTAL_2="688" VAR="1.380614811436182E-4" WEIGHT="8.61709587961176"/>
<DICH_DATA CI_END="0.07819968546073924" CI_START="-0.031215558476612268" EFFECT_SIZE="0.023492063492063488" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-10-06 01:44:03 -0400" MODIFIED_BY="[Empty name]" ORDER="92" O_E="0.0" SE="0.027912564924765196" STUDY_ID="STD-Senn-2004" TOTAL_1="126" TOTAL_2="125" VAR="7.791112806792323E-4" WEIGHT="1.5917551372955827"/>
<DICH_DATA CI_END="-0.006514458807576701" CI_START="-0.35612290382978595" EFFECT_SIZE="-0.18131868131868134" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="170" O_E="0.0" SE="0.0891874666524171" STUDY_ID="STD-Singh-2000" TOTAL_1="39" TOTAL_2="42" VAR="0.007954404207876012" WEIGHT="0.5129774827649862"/>
<DICH_DATA CI_END="0.008896367791828064" CI_START="-0.007359116079415397" EFFECT_SIZE="7.686258562063335E-4" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="55" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="171" O_E="0.0" SE="0.004146883309965041" STUDY_ID="STD-Solomon-2001" TOTAL_1="2624" TOTAL_2="2489" VAR="1.7196641186466615E-5" WEIGHT="32.40278641588242"/>
<DICH_DATA CI_END="0.03172599999900439" CI_START="-0.10349810506744686" EFFECT_SIZE="-0.03588605253422123" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:25:25 -0500" MODIFIED_BY="[Empty name]" ORDER="172" O_E="0.0" SE="0.03449657905274835" STUDY_ID="STD-Stolz-2007" TOTAL_1="102" TOTAL_2="106" VAR="0.0011900139663425162" WEIGHT="1.318597128404884"/>
<DICH_DATA CI_END="0.0363058832500854" CI_START="-0.025577981225425088" EFFECT_SIZE="0.0053639510123301565" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="61" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-10-06 01:44:03 -0400" MODIFIED_BY="[Empty name]" ORDER="93" O_E="0.0" SE="0.015786990210953495" STUDY_ID="STD-Yealy-2005" TOTAL_1="617" TOTAL_2="701" VAR="2.492290599207415E-4" WEIGHT="8.324481553876053"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.329535070614405" CI_END="0.006127002795964683" CI_START="-0.01929279669573559" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="RD" EFFECT_SIZE="-0.006582896949885454" ESTIMABLE="YES" EVENTS_1="500" EVENTS_2="470" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-2.212751921484309" LOG_CI_START="NaN" LOG_EFFECT_SIZE="NaN" METHOD="MH" MODIFIED="2016-11-12 03:29:06 -0500" MODIFIED_BY="Petrer Davey" NO="2" P_CHI2="0.9778246291086676" P_Q="1.0" P_Z="0.31004236153214504" Q="0.0" RANDOM="NO" SCALE="0.6237999999999999" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4227" TOTAL_2="4105" WEIGHT="99.99999999999997" Z="1.0151331791524734">
<NAME>Mortality, all RCTs with results of cluster RCTs adjusted by inflation factor</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.11634437467259318" CI_START="-0.33139813811345337" EFFECT_SIZE="-0.1075268817204301" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:02:59 -0400" MODIFIED_BY="Petrer Davey" ORDER="208" O_E="0.0" SE="0.11422212763034993" STUDY_ID="STD-Annane-2013" TOTAL_1="31" TOTAL_2="30" VAR="0.01304669444040395" WEIGHT="0.735961368653862"/>
<DICH_DATA CI_END="0.09132487169953446" CI_START="-0.09132487169953446" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:02:59 -0400" MODIFIED_BY="Petrer Davey" ORDER="209" O_E="0.0" SE="0.046595178493019966" STUDY_ID="STD-Bailey-1997" TOTAL_1="51" TOTAL_2="51" VAR="0.0021711106587963907" WEIGHT="1.2309547407968626"/>
<DICH_DATA CI_END="0.16415237084098322" CI_START="-0.09850054196860747" EFFECT_SIZE="0.032825914436187875" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="43" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:02:59 -0400" MODIFIED_BY="Petrer Davey" ORDER="210" O_E="0.0" SE="0.06700452530795549" STUDY_ID="STD-Bouza-2007" TOTAL_1="167" TOTAL_2="83" VAR="0.004489606411744448" WEIGHT="2.676433515636912"/>
<DICH_DATA CI_END="0.01782855851117831" CI_START="-0.05042349522003906" EFFECT_SIZE="-0.016297468354430376" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:08:51 -0400" MODIFIED_BY="Petrer Davey" ORDER="212" O_E="0.0" SE="0.01741155813820582" STUDY_ID="STD-Camins-2009" TOTAL_1="237" TOTAL_2="240" VAR="3.031623568001213E-4" WEIGHT="5.7562959392054545"/>
<DICH_DATA CI_END="0.049342145224278364" CI_START="-0.05287072673451125" EFFECT_SIZE="-0.0017642907551164433" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:09:32 -0400" MODIFIED_BY="Petrer Davey" ORDER="213" O_E="0.0" SE="0.026075191372145534" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="109" TOTAL_2="104" VAR="6.79915605094013E-4" WEIGHT="2.569106681703624"/>
<DICH_DATA CI_END="0.06155035755254892" CI_START="-0.08804042377771451" EFFECT_SIZE="-0.013245033112582794" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:02:59 -0400" MODIFIED_BY="Petrer Davey" ORDER="214" O_E="0.0" SE="0.03816161483328684" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" VAR="0.001456308846684138" WEIGHT="3.6445914874573777"/>
<DICH_DATA CI_END="0.2969186080313665" CI_START="-0.16704847816123655" EFFECT_SIZE="0.06493506493506496" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:02:59 -0400" MODIFIED_BY="Petrer Davey" ORDER="215" O_E="0.0" SE="0.11836112547279343" STUDY_ID="STD-Ding-2013" TOTAL_1="33" TOTAL_2="35" VAR="0.01400935602318635" WEIGHT="0.8199266007037925"/>
<DICH_DATA CI_END="0.04802642083176994" CI_START="-0.07298882684680755" EFFECT_SIZE="-0.012481203007518801" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="16" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:10:04 -0400" MODIFIED_BY="Petrer Davey" ORDER="216" O_E="0.0" SE="0.030871803929340108" STUDY_ID="STD-Fine-2003" TOTAL_1="152" TOTAL_2="175" VAR="9.530682778516193E-4" WEIGHT="3.9267729334048744"/>
<DICH_DATA CI_END="0.10734948123812013" CI_START="-0.05406215135504558" EFFECT_SIZE="0.026643664941537276" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:02:59 -0400" MODIFIED_BY="Petrer Davey" ORDER="217" O_E="0.0" SE="0.04117719352660561" STUDY_ID="STD-Fraser-1997" TOTAL_1="141" TOTAL_2="111" VAR="0.0016955612667275306" WEIGHT="2.9980816446018825"/>
<DICH_DATA CI_END="0.013918909748278072" CI_START="-0.12793465777977414" EFFECT_SIZE="-0.05700787401574803" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:02:59 -0400" MODIFIED_BY="Petrer Davey" ORDER="218" O_E="0.0" SE="0.03618779953279117" STUDY_ID="STD-Gums-1999" TOTAL_1="127" TOTAL_2="125" VAR="0.0013095568350254812" WEIGHT="3.0409907423202918"/>
<DICH_DATA CI_END="0.16379917380686354" CI_START="-0.16578527112563218" EFFECT_SIZE="-9.930486593843213E-4" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:02:59 -0400" MODIFIED_BY="Petrer Davey" ORDER="219" O_E="0.0" SE="0.08407920949880093" STUDY_ID="STD-Hochreiter-2009" TOTAL_1="57" TOTAL_2="53" VAR="0.007069313469943257" WEIGHT="1.3257448384838937"/>
<DICH_DATA CI_END="0.04235974219296726" CI_START="-0.022216379521703314" EFFECT_SIZE="0.010071681335631974" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:02:59 -0400" MODIFIED_BY="Petrer Davey" ORDER="220" O_E="0.0" SE="0.01647380314741464" STUDY_ID="STD-Kristoffersen-2009" TOTAL_1="103" TOTAL_2="107" VAR="2.7138619013976855E-4" WEIGHT="2.533399103328146"/>
<DICH_DATA CI_END="0.16517848333896393" CI_START="-0.12946419762467823" EFFECT_SIZE="0.01785714285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:02:59 -0400" MODIFIED_BY="Petrer Davey" ORDER="221" O_E="0.0" SE="0.07516533040600389" STUDY_ID="STD-Liu-2013" TOTAL_1="42" TOTAL_2="40" VAR="0.005649826895043732" WEIGHT="0.9890023742413817"/>
<DICH_DATA CI_END="0.062224598763543165" CI_START="-0.08030950262800154" EFFECT_SIZE="-0.00904245193222919" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:02:59 -0400" MODIFIED_BY="Petrer Davey" ORDER="222" O_E="0.0" SE="0.03636140830031458" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011" TOTAL_1="102" TOTAL_2="103" VAR="0.0013221520135821858" WEIGHT="2.473918796138085"/>
<DICH_DATA CI_END="0.14086375952321165" CI_START="-0.06943518809464025" EFFECT_SIZE="0.0357142857142857" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="33" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:05:53 -0400" MODIFIED_BY="Petrer Davey" ORDER="236" O_E="0.0" SE="0.053648676525860466" STUDY_ID="STD-Masia-2008" TOTAL_1="140" TOTAL_2="132" VAR="0.0028781804929764116" WEIGHT="3.27970640281517"/>
<DICH_DATA CI_END="0.058019319489938256" CI_START="-0.16087646234708114" EFFECT_SIZE="-0.051428571428571435" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="52" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:05:53 -0400" MODIFIED_BY="Petrer Davey" ORDER="223" O_E="0.0" SE="0.055841786778645264" STUDY_ID="STD-Micek-2004" TOTAL_1="150" TOTAL_2="140" VAR="0.003118305150631681" WEIGHT="3.4956118399910903"/>
<DICH_DATA CI_END="0.16301637632605273" CI_START="-0.23920685251652898" EFFECT_SIZE="-0.038095238095238126" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:05:53 -0400" MODIFIED_BY="Petrer Davey" ORDER="224" O_E="0.0" SE="0.10260985202158489" STUDY_ID="STD-Oliveira-2013" TOTAL_1="49" TOTAL_2="45" VAR="0.010528781731891548" WEIGHT="1.132355111997114"/>
<DICH_DATA CI_END="0.02972172091653045" CI_START="-0.060799293133343126" EFFECT_SIZE="-0.015538786108406338" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="60" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:10:34 -0400" MODIFIED_BY="Petrer Davey" ORDER="225" O_E="0.0" SE="0.02309251975135558" STUDY_ID="STD-Paul-2006" TOTAL_1="474" TOTAL_2="416" VAR="5.332644684667477E-4" WEIGHT="10.695068500078808"/>
<DICH_DATA CI_END="0.16752543267999104" CI_START="-0.21196987712443544" EFFECT_SIZE="-0.0222222222222222" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:05:53 -0400" MODIFIED_BY="Petrer Davey" ORDER="226" O_E="0.0" SE="0.09681180695100447" STUDY_ID="STD-Qu-2012" TOTAL_1="35" TOTAL_2="36" VAR="0.009372525965118558" WEIGHT="0.8566710706457039"/>
<DICH_DATA CI_END="0.037957090890783564" CI_START="-0.039067379565839076" EFFECT_SIZE="-5.551443375277562E-4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:11:38 -0400" MODIFIED_BY="Petrer Davey" ORDER="227" O_E="0.0" SE="0.019649460669732156" STUDY_ID="STD-Schnoor-2010" TOTAL_1="168" TOTAL_2="193" VAR="3.861013046113509E-4" WEIGHT="4.335720657823852"/>
<DICH_DATA CI_END="0.06129401494918457" CI_START="-0.07114016879533844" EFFECT_SIZE="-0.004923076923076933" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:11:38 -0400" MODIFIED_BY="Petrer Davey" ORDER="228" O_E="0.0" SE="0.03378485135164395" STUDY_ID="STD-Schouten-2007" TOTAL_1="125" TOTAL_2="117" VAR="0.001141416180852678" WEIGHT="2.917308877678515"/>
<DICH_DATA CI_END="0.28136100040829815" CI_START="-0.39824411729141507" EFFECT_SIZE="-0.05844155844155843" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:05:53 -0400" MODIFIED_BY="Petrer Davey" ORDER="229" O_E="0.0" SE="0.17337183822262847" STUDY_ID="STD-Schroeder-2009" TOTAL_1="14" TOTAL_2="11" VAR="0.03005779428869326" WEIGHT="0.29736004718857545"/>
<DICH_DATA CI_END="0.04217764893174614" CI_START="-0.03987700014878934" EFFECT_SIZE="0.0011503243914783995" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:12:04 -0400" MODIFIED_BY="Petrer Davey" ORDER="230" O_E="0.0" SE="0.020932693082059688" STUDY_ID="STD-Schuetz-2009" TOTAL_1="206" TOTAL_2="211" VAR="4.381776396677095E-4" WEIGHT="5.031709104572947"/>
<DICH_DATA CI_END="0.07819968546073924" CI_START="-0.031215558476612268" EFFECT_SIZE="0.023492063492063488" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:05:53 -0400" MODIFIED_BY="Petrer Davey" ORDER="231" O_E="0.0" SE="0.027912564924765196" STUDY_ID="STD-Senn-2004" TOTAL_1="126" TOTAL_2="125" VAR="7.791112806792323E-4" WEIGHT="3.0290660366456663"/>
<DICH_DATA CI_END="-0.006514458807576701" CI_START="-0.35612290382978595" EFFECT_SIZE="-0.18131868131868134" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:05:53 -0400" MODIFIED_BY="Petrer Davey" ORDER="232" O_E="0.0" SE="0.0891874666524171" STUDY_ID="STD-Singh-2000" TOTAL_1="39" TOTAL_2="42" VAR="0.007954404207876012" WEIGHT="0.9761819730938082"/>
<DICH_DATA CI_END="0.016712261645363807" CI_START="-0.015924374553009737" EFFECT_SIZE="3.939435461770349E-4" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:12:35 -0400" MODIFIED_BY="Petrer Davey" ORDER="233" O_E="0.0" SE="0.00832582548858223" STUDY_ID="STD-Solomon-2001" TOTAL_1="656" TOTAL_2="623" VAR="6.931937006632554E-5" WEIGHT="15.424931582786435"/>
<DICH_DATA CI_END="0.03172599999900439" CI_START="-0.10349810506744686" EFFECT_SIZE="-0.03588605253422123" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:05:53 -0400" MODIFIED_BY="Petrer Davey" ORDER="234" O_E="0.0" SE="0.03449657905274835" STUDY_ID="STD-Stolz-2007" TOTAL_1="102" TOTAL_2="106" VAR="0.0011900139663425162" WEIGHT="2.509253894701297"/>
<DICH_DATA CI_END="0.0419829856138765" CI_START="-0.03161934925024012" EFFECT_SIZE="0.00518181818181819" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="44" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-28 02:13:05 -0400" MODIFIED_BY="Petrer Davey" ORDER="235" O_E="0.0" SE="0.018776450854373457" STUDY_ID="STD-Yealy-2005" TOTAL_1="440" TOTAL_2="500" VAR="3.5255510668670174E-4" WEIGHT="11.297874133304537"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.660067991393917" CI_END="0.011330563800748185" CI_START="-0.017054706201104063" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RD" EFFECT_SIZE="-0.0028620712001779383" ESTIMABLE="YES" EVENTS_1="287" EVENTS_2="284" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-1.9457484794162312" LOG_CI_START="NaN" LOG_EFFECT_SIZE="NaN" METHOD="MH" MODIFIED="2017-01-05 16:50:32 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9145695340312094" P_Q="1.0" P_Z="0.6926626866835937" Q="0.0" RANDOM="NO" SCALE="0.17" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="3152" TOTAL_2="3097" WEIGHT="99.99999999999999" Z="0.39524418638061515">
<NAME>Mortality, low or medium 'Risk of bias' RCTs</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.043541279303559256" CI_START="-0.04625204102760371" EFFECT_SIZE="-0.0013553808620222277" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:38:43 -0500" MODIFIED_BY="[Empty name]" ORDER="173" O_E="0.0" SE="0.02290688018745273" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="124" TOTAL_2="119" VAR="5.247251599223145E-4" WEIGHT="3.896549548623668"/>
<DICH_DATA CI_END="0.06155035755254892" CI_START="-0.08804042377771451" EFFECT_SIZE="-0.013245033112582794" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:38:43 -0500" MODIFIED_BY="[Empty name]" ORDER="174" O_E="0.0" SE="0.03816161483328684" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" VAR="0.001456308846684138" WEIGHT="4.844676490500415"/>
<DICH_DATA CI_END="0.04235974219296726" CI_START="-0.022216379521703314" EFFECT_SIZE="0.010071681335631974" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:38:43 -0500" MODIFIED_BY="[Empty name]" ORDER="175" O_E="0.0" SE="0.01647380314741464" STUDY_ID="STD-Kristoffersen-2009" TOTAL_1="103" TOTAL_2="107" VAR="2.7138619013976855E-4" WEIGHT="3.3675925324380374"/>
<DICH_DATA CI_END="0.014945117335504493" CI_START="-0.043050180943415145" EFFECT_SIZE="-0.014052531803955326" ESTIMABLE="YES" EVENTS_1="149" EVENTS_2="145" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:38:43 -0500" MODIFIED_BY="[Empty name]" ORDER="176" O_E="0.0" SE="0.01479499081013201" STUDY_ID="STD-Paul-2006" TOTAL_1="1153" TOTAL_2="1012" VAR="2.1889175307189063E-4" WEIGHT="34.583564152575086"/>
<DICH_DATA CI_END="0.04671909278919563" CI_START="-0.05643073181504353" EFFECT_SIZE="-0.004855819512923951" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:38:43 -0500" MODIFIED_BY="[Empty name]" ORDER="177" O_E="0.0" SE="0.02631421429625029" STUDY_ID="STD-Schouten-2007" TOTAL_1="207" TOTAL_2="194" VAR="6.924378740289833E-4" WEIGHT="6.426071196363915"/>
<DICH_DATA CI_END="0.025735016398298022" CI_START="-0.020323967287287043" EFFECT_SIZE="0.0027055245555054896" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="33" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:38:43 -0500" MODIFIED_BY="[Empty name]" ORDER="178" O_E="0.0" SE="0.011749956644329297" STUDY_ID="STD-Schuetz-2009" TOTAL_1="671" TOTAL_2="688" VAR="1.380614811436182E-4" WEIGHT="21.797632779132844"/>
<DICH_DATA CI_END="0.07819968546073924" CI_START="-0.031215558476612268" EFFECT_SIZE="0.023492063492063488" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:38:43 -0500" MODIFIED_BY="[Empty name]" ORDER="179" O_E="0.0" SE="0.027912564924765196" STUDY_ID="STD-Senn-2004" TOTAL_1="126" TOTAL_2="125" VAR="7.791112806792323E-4" WEIGHT="4.026471846409411"/>
<DICH_DATA CI_END="0.0363058832500854" CI_START="-0.025577981225425088" EFFECT_SIZE="0.0053639510123301565" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="61" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-01-07 01:38:43 -0500" MODIFIED_BY="[Empty name]" ORDER="180" O_E="0.0" SE="0.015786990210953495" STUDY_ID="STD-Yealy-2005" TOTAL_1="617" TOTAL_2="701" VAR="2.492290599207415E-4" WEIGHT="21.05744145395661"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="17.31532008167441" CI_END="-0.7041254434825748" CI_START="-1.542717129373761" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.1234212864281679" ESTIMABLE="YES" I2="19.146744420758154" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2016-08-28 02:14:16 -0400" MODIFIED_BY="Petrer Davey" NO="4" P_CHI2="0.239763682079279" P_Q="1.0" P_Z="1.509962154495037E-7" Q="0.0" RANDOM="NO" SCALE="25.9" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1900" TOTAL_2="1934" UNITS="" WEIGHT="100.0" Z="5.251340546084485">
<NAME>Length of stay, all RCTs</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.7031152381522356" CI_START="-1.7031152381522356" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="4.9" MEAN_2="4.4" MODIFIED="2015-10-08 08:51:04 -0400" MODIFIED_BY="[Empty name]" ORDER="93" SD_1="5.25" SD_2="4.74" SE="1.1240590416610343" STUDY_ID="STD-Bailey-1997" TOTAL_1="41" TOTAL_2="38" WEIGHT="3.622152112977241"/>
<CONT_DATA CI_END="-0.10605257157028447" CI_START="-8.493947428429717" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="20.3" MODIFIED="2015-10-05 02:15:41 -0400" MODIFIED_BY="[Empty name]" ORDER="55" SD_1="11.03" SD_2="14.72" SE="2.139808415619388" STUDY_ID="STD-Burton-1991" TOTAL_1="72" TOTAL_2="75" WEIGHT="0.9995284240540063"/>
<CONT_DATA CI_END="1.9659680845428986" CI_START="-2.9659680845428986" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="10.7" MEAN_2="11.2" MODIFIED="2016-01-07 01:58:00 -0500" MODIFIED_BY="[Empty name]" ORDER="181" SD_1="8.9" SD_2="10.6" SE="1.2581701010804995" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="124" TOTAL_2="119" WEIGHT="2.8911206143902133"/>
<CONT_DATA CI_END="1.0414080477300756" CI_START="-3.0414080477300756" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="13.0" MODIFIED="2016-01-07 01:58:00 -0500" MODIFIED_BY="[Empty name]" ORDER="182" SD_1="9.1" SD_2="9.0" SE="1.0415538570261706" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" WEIGHT="4.218727445002891"/>
<CONT_DATA CI_END="-0.2618141949772066" CI_START="-1.5781858050227933" EFFECT_SIZE="-0.9199999999999999" ESTIMABLE="YES" MEAN_1="5.01" MEAN_2="5.93" MODIFIED="2016-01-07 01:58:00 -0500" MODIFIED_BY="[Empty name]" ORDER="183" SD_1="2.43" SD_2="1.7" SE="0.3358152548794156" STUDY_ID="STD-Esposito-2011" TOTAL_1="79" TOTAL_2="76" WEIGHT="40.58299456811791"/>
<CONT_DATA CI_END="-1.913466991548682" CI_START="-4.686533008451318" EFFECT_SIZE="-3.3" ESTIMABLE="YES" MEAN_1="5.7" MEAN_2="9.0" MODIFIED="2015-10-08 12:31:02 -0400" MODIFIED_BY="[Empty name]" ORDER="94" SD_1="5.64" SD_2="5.59" SE="0.7074277993820872" STUDY_ID="STD-Gums-1999" TOTAL_1="127" TOTAL_2="125" WEIGHT="9.144936353258911"/>
<CONT_DATA CI_END="0.5960911860443883" CI_START="-2.196091186044388" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="5.9" MEAN_2="6.7" MODIFIED="2016-01-07 01:58:00 -0500" MODIFIED_BY="[Empty name]" ORDER="184" SD_1="5.17" SD_2="5.15" SE="0.7123045102137474" STUDY_ID="STD-Kristoffersen-2009" TOTAL_1="103" TOTAL_2="107" WEIGHT="9.02014549570094"/>
<CONT_DATA CI_END="9.268241976487523" CI_START="-19.268241976487523" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="27.0" MEAN_2="32.0" MODIFIED="2016-01-07 01:58:00 -0500" MODIFIED_BY="[Empty name]" ORDER="185" SD_1="31.7" SD_2="34.1" SE="7.279849063061156" STUDY_ID="STD-Liu-2013" TOTAL_1="42" TOTAL_2="40" WEIGHT="0.08635752388673543"/>
<CONT_DATA CI_END="2.1642885289479095" CI_START="-3.8642885289479088" EFFECT_SIZE="-0.8499999999999996" ESTIMABLE="YES" MEAN_1="12.08" MEAN_2="12.93" MODIFIED="2016-01-07 01:58:00 -0500" MODIFIED_BY="[Empty name]" ORDER="186" SD_1="11.28" SD_2="10.73" SE="1.5379305705228423" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011" TOTAL_1="102" TOTAL_2="103" WEIGHT="1.9349576836604494"/>
<CONT_DATA CI_END="4.216807472430724" CI_START="-3.6368074724307258" EFFECT_SIZE="0.28999999999999915" ESTIMABLE="YES" MEAN_1="15.7" MEAN_2="15.41" MODIFIED="2016-01-07 01:58:00 -0500" MODIFIED_BY="[Empty name]" ORDER="187" SD_1="18.2" SD_2="15.9" SE="2.0035100151864427" STUDY_ID="STD-Micek-2004" TOTAL_1="150" TOTAL_2="140" WEIGHT="1.14014974860231"/>
<CONT_DATA CI_END="1.255113774734233" CI_START="-2.4951137747342313" EFFECT_SIZE="-0.6199999999999992" ESTIMABLE="YES" MEAN_1="8.83" MEAN_2="9.45" MODIFIED="2015-10-05 02:18:42 -0400" MODIFIED_BY="[Empty name]" ORDER="56" SD_1="11.29" SD_2="11.52" SE="0.9567082811341894" STUDY_ID="STD-Paul-2006" TOTAL_1="297" TOTAL_2="273" WEIGHT="5.000182605438096"/>
<CONT_DATA CI_END="9.601763642696827" CI_START="-23.901763642696825" EFFECT_SIZE="-7.149999999999999" ESTIMABLE="YES" MEAN_1="16.66" MEAN_2="23.81" MODIFIED="2016-01-07 01:58:00 -0500" MODIFIED_BY="[Empty name]" ORDER="188" SD_1="23.7" SD_2="45.3" SE="8.54697523772508" STUDY_ID="STD-Qu-2012" TOTAL_1="35" TOTAL_2="36" WEIGHT="0.06264985062473276"/>
<CONT_DATA CI_END="0.6427905420951987" CI_START="-2.0427905420951973" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.7" MODIFIED="2015-10-05 02:20:20 -0400" MODIFIED_BY="[Empty name]" ORDER="57" SD_1="7.6" SD_2="9.5" SE="0.685109804408121" STUDY_ID="STD-Schnoor-2010" TOTAL_1="275" TOTAL_2="348" WEIGHT="9.750447899617887"/>
<CONT_DATA CI_END="5.238129142669455" CI_START="-5.038129142669459" EFFECT_SIZE="0.09999999999999787" ESTIMABLE="YES" MEAN_1="19.4" MEAN_2="19.3" MODIFIED="2015-10-05 02:21:28 -0400" MODIFIED_BY="[Empty name]" ORDER="58" SD_1="24.51" SD_2="16.22" SE="2.6215426320066917" STUDY_ID="STD-Senn-2004" TOTAL_1="126" TOTAL_2="125" WEIGHT="0.6659338360576956"/>
<CONT_DATA CI_END="-0.32880615771502764" CI_START="-2.871193842284975" EFFECT_SIZE="-1.6000000000000014" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="15.8" MODIFIED="2015-10-08 12:49:08 -0400" MODIFIED_BY="[Empty name]" ORDER="97" SD_1="6.2" SD_2="6.0" SE="0.6485802046935497" STUDY_ID="STD-Shen-2011" TOTAL_1="176" TOTAL_2="178" WEIGHT="10.879715838609968"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="16.250522334337095" CI_END="-0.7624224099059442" CI_START="-1.684848512905357" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.2236354614056506" ESTIMABLE="YES" I2="13.848923056348639" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2016-11-12 03:30:03 -0500" MODIFIED_BY="Petrer Davey" NO="5" P_CHI2="0.29831594481327106" P_Q="1.0" P_Z="1.99349986273318E-7" Q="0.0" RANDOM="NO" SCALE="35.35413552087348" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1900" TOTAL_2="1934" UNITS="" WEIGHT="99.99999999999999" Z="5.199942687577335">
<NAME>Length of stay, all RCTs with results of cluster RCTs adjusted by inflation factor</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.7031152381522356" CI_START="-1.7031152381522356" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="4.9" MEAN_2="4.4" MODIFIED="2016-08-28 02:20:55 -0400" MODIFIED_BY="Petrer Davey" ORDER="237" SD_1="5.25" SD_2="4.74" SE="1.1240590416610343" STUDY_ID="STD-Bailey-1997" TOTAL_1="41" TOTAL_2="38" WEIGHT="4.3825688584044915"/>
<CONT_DATA CI_END="-0.10605257157028447" CI_START="-8.493947428429717" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="20.3" MODIFIED="2016-08-28 02:20:55 -0400" MODIFIED_BY="Petrer Davey" ORDER="238" SD_1="11.03" SD_2="14.72" SE="2.139808415619388" STUDY_ID="STD-Burton-1991" TOTAL_1="72" TOTAL_2="75" WEIGHT="1.209364490424075"/>
<CONT_DATA CI_END="9.285773548047105" CI_START="-10.285773548047105" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="10.7" MEAN_2="11.2" MODIFIED="2016-08-28 02:22:17 -0400" MODIFIED_BY="Petrer Davey" ORDER="239" SD_1="34.15" SD_2="42.98" SE="4.992833350630949" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="124" TOTAL_2="119" WEIGHT="0.22213288338398895"/>
<CONT_DATA CI_END="1.0414080477300756" CI_START="-3.0414080477300756" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="13.0" MODIFIED="2016-08-28 02:20:55 -0400" MODIFIED_BY="Petrer Davey" ORDER="240" SD_1="9.1" SD_2="9.0" SE="1.0415538570261706" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" WEIGHT="5.104386272549175"/>
<CONT_DATA CI_END="-0.2618141949772066" CI_START="-1.5781858050227933" EFFECT_SIZE="-0.9199999999999999" ESTIMABLE="YES" MEAN_1="5.01" MEAN_2="5.93" MODIFIED="2016-08-28 02:20:55 -0400" MODIFIED_BY="Petrer Davey" ORDER="241" SD_1="2.43" SD_2="1.7" SE="0.3358152548794156" STUDY_ID="STD-Esposito-2011" TOTAL_1="79" TOTAL_2="76" WEIGHT="49.10278823956992"/>
<CONT_DATA CI_END="-1.913466991548682" CI_START="-4.686533008451318" EFFECT_SIZE="-3.3" ESTIMABLE="YES" MEAN_1="5.7" MEAN_2="9.0" MODIFIED="2016-08-28 02:20:55 -0400" MODIFIED_BY="Petrer Davey" ORDER="242" SD_1="5.64" SD_2="5.59" SE="0.7074277993820872" STUDY_ID="STD-Gums-1999" TOTAL_1="127" TOTAL_2="125" WEIGHT="11.064779176526944"/>
<CONT_DATA CI_END="0.5960911860443883" CI_START="-2.196091186044388" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="5.9" MEAN_2="6.7" MODIFIED="2016-08-28 02:20:55 -0400" MODIFIED_BY="Petrer Davey" ORDER="243" SD_1="5.17" SD_2="5.15" SE="0.7123045102137474" STUDY_ID="STD-Kristoffersen-2009" TOTAL_1="103" TOTAL_2="107" WEIGHT="10.913790341964269"/>
<CONT_DATA CI_END="9.268241976487523" CI_START="-19.268241976487523" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="27.0" MEAN_2="32.0" MODIFIED="2016-08-28 02:20:55 -0400" MODIFIED_BY="Petrer Davey" ORDER="244" SD_1="31.7" SD_2="34.1" SE="7.279849063061156" STUDY_ID="STD-Liu-2013" TOTAL_1="42" TOTAL_2="40" WEIGHT="0.10448699642374923"/>
<CONT_DATA CI_END="2.1642885289479095" CI_START="-3.8642885289479088" EFFECT_SIZE="-0.8499999999999996" ESTIMABLE="YES" MEAN_1="12.08" MEAN_2="12.93" MODIFIED="2016-08-28 02:20:55 -0400" MODIFIED_BY="Petrer Davey" ORDER="245" SD_1="11.28" SD_2="10.73" SE="1.5379305705228423" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011" TOTAL_1="102" TOTAL_2="103" WEIGHT="2.3411731540370178"/>
<CONT_DATA CI_END="4.216807472430724" CI_START="-3.6368074724307258" EFFECT_SIZE="0.28999999999999915" ESTIMABLE="YES" MEAN_1="15.7" MEAN_2="15.41" MODIFIED="2016-08-28 02:20:55 -0400" MODIFIED_BY="Petrer Davey" ORDER="246" SD_1="18.2" SD_2="15.9" SE="2.0035100151864427" STUDY_ID="STD-Micek-2004" TOTAL_1="150" TOTAL_2="140" WEIGHT="1.3795071621205517"/>
<CONT_DATA CI_END="15.131440111775827" CI_START="-16.371440111775826" EFFECT_SIZE="-0.6199999999999992" ESTIMABLE="YES" MEAN_1="8.83" MEAN_2="9.45" MODIFIED="2016-08-28 02:22:53 -0400" MODIFIED_BY="Petrer Davey" ORDER="247" SD_1="94.84" SD_2="96.77" SE="8.036596710970802" STUDY_ID="STD-Paul-2006" TOTAL_1="297" TOTAL_2="273" WEIGHT="0.08573588683440642"/>
<CONT_DATA CI_END="9.601763642696827" CI_START="-23.901763642696825" EFFECT_SIZE="-7.149999999999999" ESTIMABLE="YES" MEAN_1="16.66" MEAN_2="23.81" MODIFIED="2016-08-28 02:20:55 -0400" MODIFIED_BY="Petrer Davey" ORDER="248" SD_1="23.7" SD_2="45.3" SE="8.54697523772508" STUDY_ID="STD-Qu-2012" TOTAL_1="35" TOTAL_2="36" WEIGHT="0.07580225119423971"/>
<CONT_DATA CI_END="21.287999885946693" CI_START="-22.68799988594669" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.7" MODIFIED="2016-08-28 02:24:04 -0400" MODIFIED_BY="Petrer Davey" ORDER="249" SD_1="124.45" SD_2="155.56" SE="11.218573432667757" STUDY_ID="STD-Schnoor-2010" TOTAL_1="275" TOTAL_2="348" WEIGHT="0.04399787737934948"/>
<CONT_DATA CI_END="5.238129142669455" CI_START="-5.038129142669459" EFFECT_SIZE="0.09999999999999787" ESTIMABLE="YES" MEAN_1="19.4" MEAN_2="19.3" MODIFIED="2016-08-28 02:20:55 -0400" MODIFIED_BY="Petrer Davey" ORDER="250" SD_1="24.51" SD_2="16.22" SE="2.6215426320066917" STUDY_ID="STD-Senn-2004" TOTAL_1="126" TOTAL_2="125" WEIGHT="0.8057367003467524"/>
<CONT_DATA CI_END="-0.32880615771502764" CI_START="-2.871193842284975" EFFECT_SIZE="-1.6000000000000014" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="15.8" MODIFIED="2016-08-28 02:20:55 -0400" MODIFIED_BY="Petrer Davey" ORDER="251" SD_1="6.2" SD_2="6.0" SE="0.6485802046935497" STUDY_ID="STD-Shen-2011" TOTAL_1="176" TOTAL_2="178" WEIGHT="13.163749708841051"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.33543787880181614" CI_END="-0.3227700603824196" CI_START="-1.3845413656081522" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8536557129952859" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.06" MODIFIED="2017-01-05 16:51:06 -0500" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.9969229799791953" P_Q="1.0" P_Z="0.0016238354597204205" Q="0.0" RANDOM="NO" SCALE="11.87" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="880" TOTAL_2="851" UNITS="" WEIGHT="100.0" Z="3.151591014812579">
<NAME>Length of stay, low or medium 'Risk of bias' RCTs only</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.9659680845428986" CI_START="-2.9659680845428986" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="10.7" MEAN_2="11.2" MODIFIED="2016-01-07 02:20:23 -0500" MODIFIED_BY="[Empty name]" ORDER="189" SD_1="8.9" SD_2="10.6" SE="1.2581701010804995" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="124" TOTAL_2="119" WEIGHT="4.634758120631831"/>
<CONT_DATA CI_END="1.0414080477300756" CI_START="-3.0414080477300756" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="13.0" MODIFIED="2016-01-07 02:20:23 -0500" MODIFIED_BY="[Empty name]" ORDER="190" SD_1="9.1" SD_2="9.0" SE="1.0415538570261706" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" WEIGHT="6.763045853963287"/>
<CONT_DATA CI_END="-0.2618141949772066" CI_START="-1.5781858050227933" EFFECT_SIZE="-0.9199999999999999" ESTIMABLE="YES" MEAN_1="5.01" MEAN_2="5.93" MODIFIED="2016-01-07 02:20:23 -0500" MODIFIED_BY="[Empty name]" ORDER="191" SD_1="2.43" SD_2="1.7" SE="0.3358152548794156" STUDY_ID="STD-Esposito-2011" TOTAL_1="79" TOTAL_2="76" WEIGHT="65.05863598285534"/>
<CONT_DATA CI_END="0.5960911860443883" CI_START="-2.196091186044388" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="5.9" MEAN_2="6.7" MODIFIED="2016-01-07 02:20:23 -0500" MODIFIED_BY="[Empty name]" ORDER="192" SD_1="5.17" SD_2="5.15" SE="0.7123045102137474" STUDY_ID="STD-Kristoffersen-2009" TOTAL_1="103" TOTAL_2="107" WEIGHT="14.460203554772201"/>
<CONT_DATA CI_END="1.255113774734233" CI_START="-2.4951137747342313" EFFECT_SIZE="-0.6199999999999992" ESTIMABLE="YES" MEAN_1="8.83" MEAN_2="9.45" MODIFIED="2016-01-07 02:20:23 -0500" MODIFIED_BY="[Empty name]" ORDER="193" SD_1="11.29" SD_2="11.52" SE="0.9567082811341894" STUDY_ID="STD-Paul-2006" TOTAL_1="297" TOTAL_2="273" WEIGHT="8.015797341642271"/>
<CONT_DATA CI_END="5.238129142669455" CI_START="-5.038129142669459" EFFECT_SIZE="0.09999999999999787" ESTIMABLE="YES" MEAN_1="19.4" MEAN_2="19.3" MODIFIED="2016-01-07 02:20:23 -0500" MODIFIED_BY="[Empty name]" ORDER="194" SD_1="24.51" SD_2="16.22" SE="2.6215426320066917" STUDY_ID="STD-Senn-2004" TOTAL_1="126" TOTAL_2="125" WEIGHT="1.0675591461350686"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2017-01-05 16:52:20 -0500" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Adverse effects: Clinical outcomes of interventions targeting antibiotic choice</NAME>
<DICH_OUTCOME CHI2="9.01276602943545" CI_END="0.00928440575794712" CI_START="-0.015868151521318725" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RD" EFFECT_SIZE="-0.0032918728816858024" ESTIMABLE="YES" EVENTS_1="343" EVENTS_2="341" I2="0.0" I2_Q="100.0" ID="CMP-003.01" LOG_CI_END="-2.0322458877565426" LOG_CI_START="NaN" LOG_EFFECT_SIZE="NaN" METHOD="MH" MODIFIED="2016-07-28 00:45:47 -0400" MODIFIED_BY="Petrer Davey" NO="1" P_CHI2="0.5308925313713759" P_Q="0.0" P_Z="0.6079334490302482" Q="4.568066409962074E-33" RANDOM="NO" SCALE="0.15" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="3890" TOTAL_2="3768" WEIGHT="100.0" Z="0.513025551887468">
<NAME>Mortality for trial patients</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.09132487169953446" CI_START="-0.09132487169953446" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:30:31 -0500" MODIFIED_BY="[Empty name]" ORDER="124" O_E="0.0" SE="0.046595178493019966" STUDY_ID="STD-Bailey-1997" TOTAL_1="51" TOTAL_2="51" VAR="0.0021711106587963907" WEIGHT="1.3406363302843187"/>
<DICH_DATA CI_END="0.008883818933315149" CI_START="-0.04384412089869325" EFFECT_SIZE="-0.01748015098268905" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="18" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:30:31 -0500" MODIFIED_BY="[Empty name]" ORDER="126" O_E="0.0" SE="0.01345125222910208" STUDY_ID="STD-Camins-2009" TOTAL_1="390" TOTAL_2="394" VAR="1.8093618653092366E-4" WEIGHT="10.304230617821549"/>
<DICH_DATA CI_END="0.03248251730749968" CI_START="-0.055467023966917994" EFFECT_SIZE="-0.011492253329709157" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="29" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:30:31 -0500" MODIFIED_BY="[Empty name]" ORDER="127" O_E="0.0" SE="0.022436519744279085" STUDY_ID="STD-Fine-2003" TOTAL_1="283" TOTAL_2="325" VAR="5.033974182354252E-4" WEIGHT="7.9531105829399005"/>
<DICH_DATA CI_END="0.10734948123812013" CI_START="-0.05406215135504558" EFFECT_SIZE="0.026643664941537276" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:30:31 -0500" MODIFIED_BY="[Empty name]" ORDER="128" O_E="0.0" SE="0.04117719352660561" STUDY_ID="STD-Fraser-1997" TOTAL_1="141" TOTAL_2="111" VAR="0.0016955612667275306" WEIGHT="3.265219297429174"/>
<DICH_DATA CI_END="0.013918909748278072" CI_START="-0.12793465777977414" EFFECT_SIZE="-0.05700787401574803" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:30:31 -0500" MODIFIED_BY="[Empty name]" ORDER="129" O_E="0.0" SE="0.03618779953279117" STUDY_ID="STD-Gums-1999" TOTAL_1="127" TOTAL_2="125" VAR="0.0013095568350254812" WEIGHT="3.3119517185284093"/>
<DICH_DATA CI_END="0.14086375952321165" CI_START="-0.06943518809464025" EFFECT_SIZE="0.0357142857142857" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="33" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:30:31 -0500" MODIFIED_BY="[Empty name]" ORDER="130" O_E="0.0" SE="0.053648676525860466" STUDY_ID="STD-Masia-2008" TOTAL_1="140" TOTAL_2="132" VAR="0.0028781804929764116" WEIGHT="3.5719376274011254"/>
<DICH_DATA CI_END="0.014945117335504493" CI_START="-0.043050180943415145" EFFECT_SIZE="-0.014052531803955326" ESTIMABLE="YES" EVENTS_1="149" EVENTS_2="145" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:30:31 -0500" MODIFIED_BY="[Empty name]" ORDER="132" O_E="0.0" SE="0.01479499081013201" STUDY_ID="STD-Paul-2006" TOTAL_1="1153" TOTAL_2="1012" VAR="2.1889175307189063E-4" WEIGHT="28.33496776857552"/>
<DICH_DATA CI_END="0.028780625462640097" CI_START="-0.0307659964135283" EFFECT_SIZE="-9.926854754441009E-4" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="13" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:30:31 -0500" MODIFIED_BY="[Empty name]" ORDER="133" O_E="0.0" SE="0.015190743897812548" STUDY_ID="STD-Schnoor-2010" TOTAL_1="275" TOTAL_2="348" VAR="2.3075870016892914E-4" WEIGHT="8.075969962434097"/>
<DICH_DATA CI_END="0.029034827235804733" CI_START="-0.006051878358477657" EFFECT_SIZE="0.011491474438663538" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="7" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:30:31 -0500" MODIFIED_BY="[Empty name]" ORDER="134" O_E="0.0" SE="0.008950854676678206" STUDY_ID="STD-Schouten-2007" TOTAL_1="587" TOTAL_2="444" VAR="8.011779944301212E-5" WEIGHT="13.290251820594564"/>
<DICH_DATA CI_END="0.07819968546073924" CI_START="-0.031215558476612268" EFFECT_SIZE="0.023492063492063488" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:30:31 -0500" MODIFIED_BY="[Empty name]" ORDER="135" O_E="0.0" SE="0.027912564924765196" STUDY_ID="STD-Senn-2004" TOTAL_1="126" TOTAL_2="125" VAR="7.791112806792323E-4" WEIGHT="3.2989644874584827"/>
<DICH_DATA CI_END="0.0363058832500854" CI_START="-0.025577981225425088" EFFECT_SIZE="0.0053639510123301565" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="61" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:30:31 -0500" MODIFIED_BY="[Empty name]" ORDER="136" O_E="0.0" SE="0.015786990210953495" STUDY_ID="STD-Yealy-2005" TOTAL_1="617" TOTAL_2="701" VAR="2.492290599207415E-4" WEIGHT="17.252759786532852"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="13.957865887416805" CI_END="-0.8334925491814352" CI_START="-2.1583811903155414" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.4959368697484883" ESTIMABLE="YES" I2="57.013485812261045" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2016-07-28 00:46:21 -0400" MODIFIED_BY="Petrer Davey" NO="2" P_CHI2="0.03011040980622981" P_Q="1.0" P_Z="9.599395540348437E-6" Q="0.0" RANDOM="NO" SCALE="9.55" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1114" TOTAL_2="1162" UNITS="" WEIGHT="100.0" Z="4.426005774104673">
<NAME>Length of stay for trial patients</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.7031152381522356" CI_START="-1.7031152381522356" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="4.9" MEAN_2="4.4" MODIFIED="2016-02-09 06:39:16 -0500" MODIFIED_BY="[Empty name]" ORDER="137" SD_1="5.25" SD_2="4.74" SE="1.1240590416610343" STUDY_ID="STD-Bailey-1997" TOTAL_1="41" TOTAL_2="38" WEIGHT="9.041163714763758"/>
<CONT_DATA CI_END="-0.10605257157028447" CI_START="-8.493947428429717" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="20.3" MODIFIED="2016-02-09 06:39:16 -0500" MODIFIED_BY="[Empty name]" ORDER="138" SD_1="11.03" SD_2="14.72" SE="2.139808415619388" STUDY_ID="STD-Burton-1991" TOTAL_1="72" TOTAL_2="75" WEIGHT="2.4948980157556586"/>
<CONT_DATA CI_END="-1.913466991548682" CI_START="-4.686533008451318" EFFECT_SIZE="-3.3" ESTIMABLE="YES" MEAN_1="5.7" MEAN_2="9.0" MODIFIED="2016-02-09 06:39:16 -0500" MODIFIED_BY="[Empty name]" ORDER="139" SD_1="5.64" SD_2="5.59" SE="0.7074277993820872" STUDY_ID="STD-Gums-1999" TOTAL_1="127" TOTAL_2="125" WEIGHT="22.82644796575057"/>
<CONT_DATA CI_END="1.255113774734233" CI_START="-2.4951137747342313" EFFECT_SIZE="-0.6199999999999992" ESTIMABLE="YES" MEAN_1="8.83" MEAN_2="9.45" MODIFIED="2016-02-09 06:39:16 -0500" MODIFIED_BY="[Empty name]" ORDER="140" SD_1="11.29" SD_2="11.52" SE="0.9567082811341894" STUDY_ID="STD-Paul-2006" TOTAL_1="297" TOTAL_2="273" WEIGHT="12.480831320560243"/>
<CONT_DATA CI_END="0.6427905420951987" CI_START="-2.0427905420951973" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="10.7" MODIFIED="2016-02-09 06:39:16 -0500" MODIFIED_BY="[Empty name]" ORDER="141" SD_1="7.6" SD_2="9.5" SE="0.685109804408121" STUDY_ID="STD-Schnoor-2010" TOTAL_1="275" TOTAL_2="348" WEIGHT="24.337850262246466"/>
<CONT_DATA CI_END="5.238129142669455" CI_START="-5.038129142669459" EFFECT_SIZE="0.09999999999999787" ESTIMABLE="YES" MEAN_1="19.4" MEAN_2="19.3" MODIFIED="2016-02-09 06:39:16 -0500" MODIFIED_BY="[Empty name]" ORDER="142" SD_1="24.51" SD_2="16.22" SE="2.6215426320066917" STUDY_ID="STD-Senn-2004" TOTAL_1="126" TOTAL_2="125" WEIGHT="1.6622208695839233"/>
<CONT_DATA CI_END="-0.32880615771502764" CI_START="-2.871193842284975" EFFECT_SIZE="-1.6000000000000014" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="15.8" MODIFIED="2016-02-09 06:39:16 -0500" MODIFIED_BY="[Empty name]" ORDER="143" SD_1="6.2" SD_2="6.0" SE="0.6485802046935497" STUDY_ID="STD-Shen-2011" TOTAL_1="176" TOTAL_2="178" WEIGHT="27.156587851339374"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2017-01-05 16:52:56 -0500" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Adverse effects: Clinical outcomes of interventions targeting antibiotic exposure</NAME>
<DICH_OUTCOME CHI2="9.723511757427282" CI_END="0.005766419039790773" CI_START="-0.013543647900085675" CI_STUDY="95" CI_TOTAL="95" DF="17" EFFECT_MEASURE="RD" EFFECT_SIZE="-0.0038886144301474514" ESTIMABLE="YES" EVENTS_1="370" EVENTS_2="334" I2="0.0" I2_Q="100.0" ID="CMP-004.01" LOG_CI_END="-2.2390938010639614" LOG_CI_START="NaN" LOG_EFFECT_SIZE="NaN" METHOD="MH" MODIFIED="2016-07-28 00:46:56 -0400" MODIFIED_BY="Petrer Davey" NO="1" P_CHI2="0.9148025924918175" P_Q="0.0" P_Z="0.42988668602059654" Q="7.750489705697644E-33" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4701" TOTAL_2="4472" WEIGHT="100.00000000000001" Z="0.7893855838596607">
<NAME>Mortality for trial patients</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.11634437467259318" CI_START="-0.33139813811345337" EFFECT_SIZE="-0.1075268817204301" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="144" O_E="0.0" SE="0.11422212763034993" STUDY_ID="STD-Annane-2013" TOTAL_1="31" TOTAL_2="30" VAR="0.01304669444040395" WEIGHT="0.6672862856317334"/>
<DICH_DATA CI_END="0.16415237084098322" CI_START="-0.09850054196860747" EFFECT_SIZE="0.032825914436187875" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="43" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="145" O_E="0.0" SE="0.06700452530795549" STUDY_ID="STD-Bouza-2007" TOTAL_1="167" TOTAL_2="83" VAR="0.004489606411744448" WEIGHT="2.426686311886576"/>
<DICH_DATA CI_END="0.043541279303559256" CI_START="-0.04625204102760371" EFFECT_SIZE="-0.0013553808620222277" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="146" O_E="0.0" SE="0.02290688018745273" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="124" TOTAL_2="119" VAR="5.247251599223145E-4" WEIGHT="2.6577948682583004"/>
<DICH_DATA CI_END="0.06155035755254892" CI_START="-0.08804042377771451" EFFECT_SIZE="-0.013245033112582794" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="147" O_E="0.0" SE="0.03816161483328684" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" VAR="0.001456308846684138" WEIGHT="3.304502138147256"/>
<DICH_DATA CI_END="0.2969186080313665" CI_START="-0.16704847816123655" EFFECT_SIZE="0.06493506493506496" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="148" O_E="0.0" SE="0.11836112547279343" STUDY_ID="STD-Ding-2013" TOTAL_1="33" TOTAL_2="35" VAR="0.01400935602318635" WEIGHT="0.7434164334943671"/>
<DICH_DATA CI_END="0.16379917380686354" CI_START="-0.16578527112563218" EFFECT_SIZE="-9.930486593843213E-4" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="149" O_E="0.0" SE="0.08407920949880093" STUDY_ID="STD-Hochreiter-2009" TOTAL_1="57" TOTAL_2="53" VAR="0.007069313469943257" WEIGHT="1.202035034237551"/>
<DICH_DATA CI_END="0.04235974219296726" CI_START="-0.022216379521703314" EFFECT_SIZE="0.010071681335631974" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="150" O_E="0.0" SE="0.01647380314741464" STUDY_ID="STD-Kristoffersen-2009" TOTAL_1="103" TOTAL_2="107" VAR="2.7138619013976855E-4" WEIGHT="2.2969989318524697"/>
<DICH_DATA CI_END="0.16517848333896393" CI_START="-0.12946419762467823" EFFECT_SIZE="0.01785714285714285" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="151" O_E="0.0" SE="0.07516533040600389" STUDY_ID="STD-Liu-2013" TOTAL_1="42" TOTAL_2="40" VAR="0.005649826895043732" WEIGHT="0.8967151659000793"/>
<DICH_DATA CI_END="0.062224598763543165" CI_START="-0.08030950262800154" EFFECT_SIZE="-0.00904245193222919" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="152" O_E="0.0" SE="0.03636140830031458" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011" TOTAL_1="102" TOTAL_2="103" VAR="0.0013221520135821858" WEIGHT="2.2430689364157694"/>
<DICH_DATA CI_END="0.058019319489938256" CI_START="-0.16087646234708114" EFFECT_SIZE="-0.051428571428571435" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="52" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="153" O_E="0.0" SE="0.055841786778645264" STUDY_ID="STD-Micek-2004" TOTAL_1="150" TOTAL_2="140" VAR="0.003118305150631681" WEIGHT="3.169424293267521"/>
<DICH_DATA CI_END="0.16301637632605273" CI_START="-0.23920685251652898" EFFECT_SIZE="-0.038095238095238126" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="154" O_E="0.0" SE="0.10260985202158489" STUDY_ID="STD-Oliveira-2013" TOTAL_1="49" TOTAL_2="45" VAR="0.010528781731891548" WEIGHT="1.0266911673403833"/>
<DICH_DATA CI_END="0.16752543267999104" CI_START="-0.21196987712443544" EFFECT_SIZE="-0.0222222222222222" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="155" O_E="0.0" SE="0.09681180695100447" STUDY_ID="STD-Qu-2012" TOTAL_1="35" TOTAL_2="36" VAR="0.009372525965118558" WEIGHT="0.7767321507444348"/>
<DICH_DATA CI_END="0.04671909278919563" CI_START="-0.05643073181504353" EFFECT_SIZE="-0.004855819512923951" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="157" O_E="0.0" SE="0.02631421429625029" STUDY_ID="STD-Schouten-2007" TOTAL_1="207" TOTAL_2="194" VAR="6.924378740289833E-4" WEIGHT="4.383154592449919"/>
<DICH_DATA CI_END="0.28136100040829815" CI_START="-0.39824411729141507" EFFECT_SIZE="-0.05844155844155843" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="158" O_E="0.0" SE="0.17337183822262847" STUDY_ID="STD-Schroeder-2009" TOTAL_1="14" TOTAL_2="11" VAR="0.03005779428869326" WEIGHT="0.2696123598806238"/>
<DICH_DATA CI_END="0.025735016398298022" CI_START="-0.020323967287287043" EFFECT_SIZE="0.0027055245555054896" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="33" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="159" O_E="0.0" SE="0.011749956644329297" STUDY_ID="STD-Schuetz-2009" TOTAL_1="671" TOTAL_2="688" VAR="1.380614811436182E-4" WEIGHT="14.867932722944945"/>
<DICH_DATA CI_END="-0.006514458807576701" CI_START="-0.35612290382978595" EFFECT_SIZE="-0.18131868131868134" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="160" O_E="0.0" SE="0.0891874666524171" STUDY_ID="STD-Singh-2000" TOTAL_1="39" TOTAL_2="42" VAR="0.007954404207876012" WEIGHT="0.8850910804161892"/>
<DICH_DATA CI_END="0.008896367791828064" CI_START="-0.007359116079415397" EFFECT_SIZE="7.686258562063335E-4" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="55" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="161" O_E="0.0" SE="0.004146883309965041" STUDY_ID="STD-Solomon-2001" TOTAL_1="2624" TOTAL_2="2489" VAR="1.7196641186466615E-5" WEIGHT="55.90775073156082"/>
<DICH_DATA CI_END="0.03172599999900439" CI_START="-0.10349810506744686" EFFECT_SIZE="-0.03588605253422123" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-09 06:48:19 -0500" MODIFIED_BY="[Empty name]" ORDER="162" O_E="0.0" SE="0.03449657905274835" STUDY_ID="STD-Stolz-2007" TOTAL_1="102" TOTAL_2="106" VAR="0.0011900139663425162" WEIGHT="2.2751067955710735"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.330749082597956" CI_END="-0.33283349245636484" CI_START="-1.4160185956422664" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8744260440493156" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2016-07-28 00:47:31 -0400" MODIFIED_BY="Petrer Davey" NO="2" P_CHI2="0.987598601934529" P_Q="1.0" P_Z="0.0015537536707330177" Q="0.0" RANDOM="NO" SCALE="25.9" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="786" TOTAL_2="772" UNITS="" WEIGHT="100.0" Z="3.1644518530391115">
<NAME>Length of stay for trial patients</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.9659680845428986" CI_START="-2.9659680845428986" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="10.7" MEAN_2="11.2" MODIFIED="2016-02-09 06:51:56 -0500" MODIFIED_BY="[Empty name]" ORDER="163" SD_1="8.9" SD_2="10.6" SE="1.2581701010804995" STUDY_ID="STD-Christ_x002d_Crain-2004" TOTAL_1="124" TOTAL_2="119" WEIGHT="4.823590852843511"/>
<CONT_DATA CI_END="1.0414080477300756" CI_START="-3.0414080477300756" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="13.0" MODIFIED="2016-02-09 06:51:56 -0500" MODIFIED_BY="[Empty name]" ORDER="164" SD_1="9.1" SD_2="9.0" SE="1.0415538570261706" STUDY_ID="STD-Christ_x002d_Crain-2006" TOTAL_1="151" TOTAL_2="151" WEIGHT="7.038590854033898"/>
<CONT_DATA CI_END="-0.2618141949772066" CI_START="-1.5781858050227933" EFFECT_SIZE="-0.9199999999999999" ESTIMABLE="YES" MEAN_1="5.01" MEAN_2="5.93" MODIFIED="2016-02-09 06:51:56 -0500" MODIFIED_BY="[Empty name]" ORDER="165" SD_1="2.43" SD_2="1.7" SE="0.3358152548794156" STUDY_ID="STD-Esposito-2011" TOTAL_1="79" TOTAL_2="76" WEIGHT="67.70930289294058"/>
<CONT_DATA CI_END="0.5960911860443883" CI_START="-2.196091186044388" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="5.9" MEAN_2="6.7" MODIFIED="2016-02-09 06:51:56 -0500" MODIFIED_BY="[Empty name]" ORDER="166" SD_1="5.17" SD_2="5.15" SE="0.7123045102137474" STUDY_ID="STD-Kristoffersen-2009" TOTAL_1="103" TOTAL_2="107" WEIGHT="15.049351828428485"/>
<CONT_DATA CI_END="9.268241976487523" CI_START="-19.268241976487523" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="27.0" MEAN_2="32.0" MODIFIED="2016-02-09 06:51:56 -0500" MODIFIED_BY="[Empty name]" ORDER="167" SD_1="31.7" SD_2="34.1" SE="7.279849063061156" STUDY_ID="STD-Liu-2013" TOTAL_1="42" TOTAL_2="40" WEIGHT="0.14408024356400995"/>
<CONT_DATA CI_END="2.1642885289479095" CI_START="-3.8642885289479088" EFFECT_SIZE="-0.8499999999999996" ESTIMABLE="YES" MEAN_1="12.08" MEAN_2="12.93" MODIFIED="2016-02-09 06:51:56 -0500" MODIFIED_BY="[Empty name]" ORDER="168" SD_1="11.28" SD_2="10.73" SE="1.5379305705228423" STUDY_ID="STD-Maravic_x002d_Stojkovic-2011" TOTAL_1="102" TOTAL_2="103" WEIGHT="3.2283136639432093"/>
<CONT_DATA CI_END="4.216807472430724" CI_START="-3.6368074724307258" EFFECT_SIZE="0.28999999999999915" ESTIMABLE="YES" MEAN_1="15.7" MEAN_2="15.41" MODIFIED="2016-02-09 06:51:56 -0500" MODIFIED_BY="[Empty name]" ORDER="169" SD_1="18.2" SD_2="15.9" SE="2.0035100151864427" STUDY_ID="STD-Micek-2004" TOTAL_1="150" TOTAL_2="140" WEIGHT="1.9022436735625068"/>
<CONT_DATA CI_END="9.601763642696827" CI_START="-23.901763642696825" EFFECT_SIZE="-7.149999999999999" ESTIMABLE="YES" MEAN_1="16.66" MEAN_2="23.81" MODIFIED="2016-02-09 06:51:56 -0500" MODIFIED_BY="[Empty name]" ORDER="170" SD_1="23.7" SD_2="45.3" SE="8.54697523772508" STUDY_ID="STD-Qu-2012" TOTAL_1="35" TOTAL_2="36" WEIGHT="0.10452599068379297"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2017-01-05 16:53:35 -0500" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Modifiers of intended effect: Comparison of enabling interventions with and without feedback</NAME>
<DICH_OUTCOME CHI2="14.977971109570431" CI_END="0.22367353065552856" CI_START="0.16258496551493376" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RD" EFFECT_SIZE="0.19312924808523116" ESTIMABLE="YES" EVENTS_1="1201" EVENTS_2="1077" I2="79.97058494736247" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="-0.6503854069199113" LOG_CI_START="-0.7889196167726077" LOG_EFFECT_SIZE="-0.714151950352468" METHOD="MH" MODIFIED="2016-11-12 03:31:04 -0500" MODIFIED_BY="Petrer Davey" NO="1" P_CHI2="0.0018355750717844455" P_Q="1.0" P_Z="2.862129986521767E-35" Q="0.0" RANDOM="NO" SCALE="0.6594399999999999" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1696" TOTAL_2="2051" WEIGHT="100.0" Z="12.39270785742566">
<NAME>Enablement with feedback</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.49560389840942476" CI_START="0.2776880270564137" EFFECT_SIZE="0.38664596273291924" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="60" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-14 23:53:03 -0500" MODIFIED_BY="[Empty name]" ORDER="363" O_E="0.0" SE="0.05559180502088395" STUDY_ID="STD-Camins-2009" TOTAL_1="112" TOTAL_2="138" VAR="0.003090448785479978" WEIGHT="6.778456804996175"/>
<DICH_DATA CI_END="0.2039709232919804" CI_START="0.0506999231030041" EFFECT_SIZE="0.12733542319749225" ESTIMABLE="YES" EVENTS_1="182" EVENTS_2="186" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-14 23:53:03 -0500" MODIFIED_BY="[Empty name]" ORDER="364" O_E="0.0" SE="0.03910046342635844" STUDY_ID="STD-Schnoor-2010" TOTAL_1="275" TOTAL_2="348" VAR="0.001528846240155994" WEIGHT="16.842153593313665"/>
<DICH_DATA CI_END="0.25666660809670216" CI_START="0.11904731009213229" EFFECT_SIZE="0.18785695909441724" ESTIMABLE="YES" EVENTS_1="296" EVENTS_2="154" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-14 23:53:03 -0500" MODIFIED_BY="[Empty name]" ORDER="365" O_E="0.0" SE="0.035107608887227866" STUDY_ID="STD-Schouten-2007" TOTAL_1="460" TOTAL_2="338" VAR="0.001232544201778561" WEIGHT="21.36217030754628"/>
<DICH_DATA CI_END="0.23194484500416424" CI_START="0.15100532505063902" EFFECT_SIZE="0.19147508502740163" ESTIMABLE="YES" EVENTS_1="631" EVENTS_2="677" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-14 23:53:03 -0500" MODIFIED_BY="[Empty name]" ORDER="366" O_E="0.0" SE="0.020648216138655057" STUDY_ID="STD-Yealy-2005" TOTAL_1="849" TOTAL_2="1227" VAR="4.263488297086151E-4" WEIGHT="55.017219294143885"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="22.902218611791493" CI_END="0.17303081477817306" CI_START="0.09051996522147455" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RD" EFFECT_SIZE="0.1317753899998238" ESTIMABLE="YES" EVENTS_1="688" EVENTS_2="563" I2="73.80166480067209" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="-0.7618765471810298" LOG_CI_START="-1.0432556215768383" LOG_EFFECT_SIZE="-0.8801656897817906" METHOD="MH" MODIFIED="2016-11-12 03:31:19 -0500" MODIFIED_BY="Petrer Davey" NO="2" P_CHI2="8.298999506813898E-4" P_Q="1.0" P_Z="3.84017677794033E-10" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="915" TOTAL_2="912" WEIGHT="100.0" Z="6.260389266041843">
<NAME>Enablement without feedback</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.36864324907305945" CI_START="0.08302015601500337" EFFECT_SIZE="0.2258317025440314" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="44" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-14 23:49:06 -0500" MODIFIED_BY="[Empty name]" ORDER="356" O_E="0.0" SE="0.07286437284333144" STUDY_ID="STD-Burton-1991" TOTAL_1="70" TOTAL_2="73" VAR="0.005309216829852017" WEIGHT="7.84413836857593"/>
<DICH_DATA CI_END="0.15900931827288955" CI_START="-0.04059158080753299" EFFECT_SIZE="0.05920886873267828" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="102" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-14 23:49:06 -0500" MODIFIED_BY="[Empty name]" ORDER="357" O_E="0.0" SE="0.05091953236254568" STUDY_ID="STD-Dranitsaris-2001" TOTAL_1="162" TOTAL_2="147" VAR="0.0025927987760203364" WEIGHT="16.91742473899468"/>
<DICH_DATA CI_END="0.15866760313043904" CI_START="0.0065005620377260875" EFFECT_SIZE="0.08258408258408256" ESTIMABLE="YES" EVENTS_1="216" EVENTS_2="176" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-14 23:49:06 -0500" MODIFIED_BY="[Empty name]" ORDER="358" O_E="0.0" SE="0.03881883603295447" STUDY_ID="STD-Paul-2006" TOTAL_1="297" TOTAL_2="273" VAR="0.0015069020309534042" WEIGHT="31.22515651386625"/>
<DICH_DATA CI_END="0.17147365485914218" CI_START="-0.06963238501787233" EFFECT_SIZE="0.05092063492063492" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="73" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-14 23:49:06 -0500" MODIFIED_BY="[Empty name]" ORDER="359" O_E="0.0" SE="0.06150777304553252" STUDY_ID="STD-Senn-2004" TOTAL_1="126" TOTAL_2="125" VAR="0.003783206145020736" WEIGHT="13.77422649178249"/>
<DICH_DATA CI_END="0.3653608308926722" CI_START="0.14067838479360223" EFFECT_SIZE="0.2530196078431372" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="69" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-14 23:49:06 -0500" MODIFIED_BY="[Empty name]" ORDER="360" O_E="0.0" SE="0.05731800376724685" STUDY_ID="STD-Solomon-2001" TOTAL_1="125" TOTAL_2="153" VAR="0.003285353555862124" WEIGHT="15.101393741119189"/>
<DICH_DATA CI_END="0.24148826251293623" CI_START="0.06133305410148379" EFFECT_SIZE="0.15141065830721" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="90" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-14 23:49:06 -0500" MODIFIED_BY="[Empty name]" ORDER="361" O_E="0.0" SE="0.04595880583329432" STUDY_ID="STD-Trenholme-1989" TOTAL_1="110" TOTAL_2="116" VAR="0.002112211833622448" WEIGHT="12.393746773092088"/>
<DICH_DATA CI_END="0.7472206120714603" CI_START="0.29277938792853975" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-14 23:49:06 -0500" MODIFIED_BY="[Empty name]" ORDER="362" O_E="0.0" SE="0.11593101396951551" STUDY_ID="STD-Walker-1998" TOTAL_1="25" TOTAL_2="25" VAR="0.01344" WEIGHT="2.743913372569369"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2017-02-21 10:08:14 -0500" MODIFIED_BY="Petrer Davey">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2017-01-24 14:10:35 -0500" MODIFIED_BY="Julia Worswick" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Figure 1 Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAgQAAAY+CAYAAAA3rDZOAACAAElEQVR42uydD2RXX/z/v+QjSRKZ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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2017-01-18 13:29:18 -0500" MODIFIED_BY="Julia Worswick" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
<P>Blank sections in this graph are due to use of different ROB criteria for CBA, NRT and RCT <I>versus </I>ITS studies</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlIAAAH6CAMAAAD7plJfAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD/gADAwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID///8AAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///9BjlLGAAA9Q0lEQVR42u19C3AcV5nuL0v9mhlpZloWseLdrGVpoWrNVrFm440T
yyHjOMT7SAK1XFIQFsitdR6wcFOkdpPcu5C9twrHAQPBBIJJ4Q1Zb5ENlYsTwCGWlMQjZ0GB3GXB
XG5WL+REo6w1PZIsqaenZ6R7Xv2Y0YyeI2lG/r/Emu7z+M+Znm9On+45X38ACERZUQNRPAiIMiK1
CY8BorxASiGQUgikFAIphUAgpRBIKQRSCoFYFOrwEKwcKTwEvjvmSKl1HevnVMx5m5Eq/VbhiQ+B
cykEUgqBlEIgkFIIpNQqwVjziogC1IK27LqxlpaWN9XIdLGsgXV6P1/NFm87WpeZv4clKoq0wqzZ
RtO3l65ZbnfnVJz1NtVq4lHapVF6RaNUV1fXSN1URb213aRXxcYg87fLq+i804L9rImj2mqd+PSB
LECTJis6+SpHVJm82AGF3kq1g1LQpomKfNxU5TgrbsqKFqd5cojk9QRUPUaKAPtnBJSgwSooZAjo
UWkUkQa0rBIhheyQzKKGD8imG4c0LPoQY//RdN620+7TciOYkqKytiVaB9xYtrrPrUhaCXh9YO1q
LBLAZk1SSY/isqxuBmm6FbmzWnOp7RLAZDAzRgermeEQeYmqCXoPuPGkTT5HkpjovLt5uHMfK90Q
sl64nuSNZWhe7MfDSS/SFePW81FWYSwMcJ02mPbSAK6UEzM0aorVBDjR2eDGgS8Pw8VgJjhFRhM2
njSe5OmzTrv3yKzt07TtXt4vFkshWxHtF9NOxZhiqVe4fWDtvjnKf2GYMuwAOcfvC2VOT5JvUQa5
sxqUisVicjZAxp5R0K4h+4O6QV6yvTolyq07oY+QApJ6++5+vX0Pq6Fk4jssAEsCg7zYO/Ss72Qi
QbvGomikcLav2fTSALR+FpXUTJGaMKC3t7tx4GYd0qNAG+ewRNsDTru510nbNm+7mddxa2f7RtNu
H/qg13b7QJHSNT6pMTXWgGTFd5Dir2eROyXnh8tXyMS6wNQnyCiV3J7L7e6i+/SfnGEvdE+xnET2
j5Ao8uEn6kfZqa47A5LtlqQvPNHZ46MGTyM4eKxYIW8vuT07w/sgKssZX7u0T7Tthgu+OnRLft5p
qXhF710YLbns1V2QvMKuGWzm/XGQwt/4UtGVHwwOTfkM+XsbXAj5WGoA/aJ3G2DMFpaXph4KkNPG
WTKxJx/yXl5SXMKLRC9KXlqfiJpXyFflNhid8NKNgpsC7QZv+6I/At163mnJq9ieV9N2Im0F+Qw9
W06NaLeRDvfhcLRKc6mxx8mMt3PUtHzXk62wmV4Dt0HrnOtg1dSfJV9EJQHRIMCrGtBZzVnToBwn
Y5bpVfhpW0Jjacf5ie/V7bC5mwSwIRpwC4k4FJ2nzUbOCZpe2PZN50jVOGtbbXLqkFgdJNZPWptU
9g0geFiDtp/m9ThMvjZsY+Y3vVfSL1Fcf4685XM/Qe6s1vR8fL8B4/XNvjivZlR6uyVpyZlkYel6
XWZnqd+X6Y2Mwc0KLTkW3qLTC/WIHL3ojaTTLeRD7grLd/HBZ9BiZZMR6aqgW0jEYf3Yy/ogbYFi
bT9IZkb1+3nbplOHxDpCYr1oThBiyazi7kY5nX/DYFxtGmQbwdubKfGD+5V94wB7ZOTOKsylyoJY
1+JvWJjmclsxLr8olbPXya3DOs6lis+l1p1SirW4cvd+FWpf3rXsZqJGTTl7HZL8KzmRUhVFqY0A
XCjsWyicwoXC5TycCMDFLQikFAIphUBKIRArAU7P8YqvzJcoSKm1GutLlMmVrIDSUAQCKYVASiGQ
UgikFAKxIShlrH9oFFFVF6X0GF3pJPRVRbC1ZM6iMF/dz/IX85EF6ny2eJhY8dIhE6mzvpTK9Gye
N39+XeaK8Gs+BkV3L1xuCdLQoSiOautKKcNOZd2PwNCUQA+Tk5JvekKT1Q5Hl2kEZM1wFaYEtubX
f4aZzpPXE6rOJk1ReNFYRDlomgekuKcLZeVjfIB5TdkFuiJrJleb9vCeBGWqA01oilmoKQ1rQlMK
TQHWJ7ctXZa0OIm1HblTAit5JsKi8WAop/53CVoG6P+PqpP1387AJnksnIVfv7ap/oncQEsXzXmo
fqrhixloefP8Y1PspnKYlYlKUwHNgpbE+QOxGVHv705D6FOvwEzo4uSmHAv85ht310XO/Om+HERT
UE/yeHkamuCZHx2HmcBUw/5eePTFxyaO17D2pqFrlwXflAM1ThdIW0HW1hBti6Dl/NCxz7LSoq1c
YPri01no+I7tvb9FPROhRJnZkhUuyWciLBbHZJBd2Zvdy9SXH+qX0gCnNEi5gk7V1WUKkWeGlbH6
oN9Tg/J6RyVIHQWqB3UknEl9VChQqeLzqFue40M7AOoMs/cUaX8XCLGnJkF7hka84C5Wzm8L2NYF
Xlq09YWsaZIO7PgwDkclvzurvyTRaCYMOZvQ56gvSda2jx27ums+XSYUJOdJRu3N2b1Wl09eWkpi
SqWhxu/kZsOF0tC4vbA0lCeItnqus6FrT/6a+RT+xlc+aeiioNV2dXXVnhN7rxhApQVccLd10z95
OquzPAf8CcA1pnPSuL4zDKPPzmkuXz3q3SPQpxOh95H23WwqLLUdBZ+oW6gphSanT6KtXVMjwX14
z2Gdp+dUeQnqjWKv7hy0SgDSdpskz0i9dC1EnM2XJQ3a8qRRvMyn2mC7WpBGFaJBgCzXgxbMQbji
0yEJm/PI5FR/wNThCdJ+D+j8xJ/mulO5tUlxyql5bVFMw9u5NFS0per6MJn/aLiEYz0p1d5L/vTm
xBd76L03WkMA/2GFTgMEJ++jV2wKmxANNcrpIX9FXuaQJdnJgrRk5GCa0Gb8O83PzGkuGZH+wlOP
Skxa//3LAF7Vpckx0sp1N05zuX2K605T6feNOeUGrIN2vp61VzMH2YZoa8CU30eKXnYSubOOc6kK
gNEc31XOeD3tiaVKQy+ZudSlouPTrbI+re+Rg/57L0gplIaW+3jiIUBp6CodTgTg4hYEUgqBlEIg
pRCIlQCn53jFV+ZLFKTU6oz1+Sm55QRFaSgCgZRCIKUQSCkEUgqBQEotD8YC+4h1oBT1uaLmenMU
n6UkoNF7iyTG5YZlNZ73srjCeVuFcoQPL00air8Ur8oo1dU18twNfGtOVrFxIX2oSOq+zomVdGHZ
Na25+0uQhqbSOKqtzolPvz7njkvhAzLXZeoiIcoUnoamRvh3vFWSIKYrWo/f+zO253Ouv2hYZQrP
46ZKFZ7xgKxGvLiafNytR2Grws1TlDMlReOSZsfD1GlfESNKT0Cmdw95DCoEFf6hPbSE6xoq0/6J
uqXbkSR0DV2luZTPdQpOdD4J0HhqxDE/5B6iTynDM3w/Q518sgn1SubXeYpqA2pPULdOx1+0dpja
dX7k7ubhiX0AN/w4o5lu3Ohz4bu8egSPDz/Pt0S5T4esF97PEj7I/EPd9rWEuHd9pTpCe1LHYrB2
h+wLJMZ1yqDpuIZeqWZo/yA3HJqctx35QeTOKlCKTKb+yBPLDuhUtmC9Ux90E6jC83vc7ZPgqteB
Kjj7VKbe3EvPPL1sKEgLj0+6xz1GqQbTbOeqUR43s/NC2qtH8G69nXt9inL/bMd3cPnp14R/qGi/
12lf5VuqG8NqBI1sXdXf7LqGqr1A+0fVqXvmbef1Z5E7JbCChcJUNZloSftEleQfVUzmJQgPUQDH
I5S+zlVvFviLkn89+5lLZwkTUa+OKGdHrU31o+xU1WTP7C7dfr40tDszRxoq2UVdQwvakX1SwRT+
xlc+aWjzzNyL8578Y+uKLTfRVxuM2jnen0axS/i9NbKnGs1XhLIZk1NHlJMm3wrwc1V4djRUrP3a
Qt9R4Tl6tsA1NP+QlGinvMZZeOLz0FHocqe8BtfnJZjbYRt/CEod1Rs3QiuZUlk2nPFmYelfQasy
J/QsV40KSK9Rgamv3hScU/zlhB8pna7leZiarbCNb8nCzZTHaDNASbK54MNtCZXtA1OntqbzulGi
nXMPI3dWZS4l3xQoSEveotTmJbyaUTbxRr5EZyeblAyZa2Uj8iFPvZk9UMRfFIJ/vMXnSK0dmUjl
1XtJvTHpL1cflYVb5Hj9B/I8TBWhHh209tH0ZESiMf55CyR/T06TrbunW1Jsn94saFSs/NVPJdrZ
g9PzVZhLLf5WQ3qanRK3Tkixro1x2OyGN3WcSxWfS606pRrSNZsm+Okxak8u1iO00jHb6J/9IaVQ
Glru44mHAKWhq3Q4EYCLWxBIKQRSCoGUQiBWApye4xVfmS9RkFKVN9aLaPVV+q3CEx8C51IIpBQC
KYVAIKUQSKl5YSwra6lVDH8WiqjKhTVYibDoNVJewcB0yUJqesnRtDyLT/PYp710kUXKqumiHRVp
hVnLeO75Br+JsLa2REvHVaWzrl56tDzDUCOy25cutrtY3CVIQ3eja+g6n/hikQMHTeHPCcngQaa2
7FAOmnGVpsfMg0LxaXzmoNBtJoNykK/QdcrTOFzSqVLppxFQqOdnLKooZ+JOSpB/0mSrA/yepJsD
B4VClPqHuuksXkQVcZlrKG+L9xdYjAB3Dd2sKQej1DWUeo/uUl5D7pTAGriGMk/P+NTpHNjnAjU5
OBw8G7JqoOXLb0x1PXWeprec73hP8yvMyPPMv000WdTCc6YD6qdeofWd8gM0FM1q+MrZqSw8VD9Z
/7kaahf698nDzGf0oVcemzjClCsPNQwdTwzAr489Xt/Hqlz72r+Hp9naSuof6qYzr9C3fnuYxyUt
bDr1adYW7y/t/OD3H/tChrmGnv7WJ/93DmaCUxff3wtjz/lEV+nyymVENKWaeLTWrqFUavnxPQDf
ZP6cd/RDHz1cSf3juwdYOqT0nUdZuTsk0G5lW0eF96dX3kX2A1QmqvVBL1dxahZXgaq7QOPvTOvV
HyAvp9ohxbWrpzQQTqT2Dn86Ra9vFfkdO3lbvL8Uh/RRPoCm2+Hj11DvUd08RWZkNg5H6ztK3cle
rr2T7ofvhMN1ZGgaAiedvByuZRbF4ZaWlufY1rVkayjnLz8Awh2Zh9lLkjfN8BAiPKnyW1al5hCQ
kQeMb6S132VVev5F2kS26Bv+PPjSvb7x/522eBrtPOkl75rdWFdLKr31NeuL+jTrL45S6zlKcXB/
Tiq//Gjh5bzxMbZB1Zpc8dDmKTjd8mJKfNYNk9/7s26VTVwFenlNo1CXXlvzo4ve3QIvvRBz+5Zw
WmmYPdUPzHs0+D6851Ap96W4P2e6DVq/mZ+xDbbzp0wpNlNrEu41kK0DnPa8fLdpfJ5+6DbUnaQy
Ueoxmn9DQXL9QJWn4X7yMis7nqQ5SRWP56D+oV56t3v+Omv72vKhDc7xiXpudMcRYN6jNU+QU6uM
3KkESqXS7yMXYllLtrMFp185y589lYzI6T7yuW+BQxEp/TM+deLlOxuaHyd7dSEYu+siod2QrqRf
zYsydJ08zR9W1XGPSssGJ7cIT9LQZLtQrNZd5k+XXKl7XUi0lcnvW0B7L1+40VnP2n9Al6bGAC7D
VUHreKuzjDdDy4Dy+If27B1eqmvoJXOrsyIodfDYGjamZyZXHiR0Ae+eVzSlqh24UBiloat1OBGA
i1sQSCkEUgqBlEIgVgKcnuMVX5kvUZBSFTTWe2Hob9LoGopAIKUQSCkEUgqBlEIgNjaljDWosbJ6
iEqjlB2UlFnv4yx05/ydxRqDuthaooYeXFa9Eq6hszpSp1IpFT75ViLyVMnsq5ZsDLq7hGXpX55f
Vj2BwqysiaNapVIqu1PXx/+b3w/UDsrMy5OqPblgU+0BW3XS6ZARUV3fUV0J9LA6XNGpCokn9Ro1
SXrgYJQPMNsb9GXVgx5N6FI3a7IapV7MsroZpOmTyJ0KpZTccjxBfYUbUxmFCw4axzLUQ/Q6zfXy
VG6AlxUnnaJm2C2fTBA2QONJnpcY7nIGlBOdDSRdekiMJvbNy6sHV77Zy1udMjL0UQ37QpnTkwBN
n0TuVCilUmN3b1ObmB+oIbw8+Va2r9l5OsZIFvb9wFcC+nR3L6v32p7vqOlOcQb09nYSa0AXvxRQ
Rehy6kFKb+atmlxdKlnxHaTK61nkTglUwEJhY3s6Pa+Xp3HfMTVd4BjqKyVnCnxHi1mWOltLrUf/
3vg8fTFamGto8gq7ZrA5f718Cn/jq6Ant8gG6GOz83t56mrE9As/KZzyNvPv7DbAmC32hfE8THuW
WY8UvEJcEspn6Hl5akS7jXwPnsDhqEJPfOo2w4jUMi/PDm4XqSQgSi7469oSGpkMM2J9Z6fupjv1
RPnNTB+qtkGrKjjjvxRTWuD6bk7dP1xePQiD9l22MfObXuqHqsb1RBzgHC7hqFRKDcKWZnuceXke
4YRJ/r5MBfZj0y3kQ1aYl2d/vM9NF3DKb5KtV8me5fqOypf5oieziniD0mXLqwfjatMg2wjc3kzT
QvuVcCfAHlQbV/BcaiVYWFR65kZuWXrfQ/py6pVA8rYTqyAN3RhzqSqnlJyZN3v2+rg0xi1Lj//N
5LLqFUdI8q/kREqhNLTcxxMPAUpDV+lwIgAXtyCQUgikFAIphUCsBDg9xyu+Ml+iIKXWd6ynNXPF
s1AaikAgpRBIKQRSCoGUQiCQUmUD6qjKgjWwJap4xIO/kCPTAF/NQmygSL5ILJrHsAJbIlpztniW
Wk3HcL1siSoTTdd/13rhol3gLjoXXXio8MS3OPyP4Ci0B6JcG6orjv9oD5WMcgOzpoDGnUObNJat
y5IWxwOHlCqFv+0lf/psrkPNJoJTAFe8ZI1eSVK/l2AlrDdC/PeGi0FrbBJgMmAb+/HAIaVK4Rq6
ilwXLnyDzH/U3gUancrs5AvMB/QLfGKTHgVtD8AXsqaZxgOHlCoFphh0dHmcQ9fEYrFZdw8anSm0
HQ5Sj8DdM+Et3XjgkFKl8HAr+dOa9/t5vgwVmpiOFKiob/RZ8rJreiS4Dw8cUqoU7p7eDE3TAb86
1PMfZZiGt/N5eva0SZ+5oen68CweOKRUKUj1tyqT9RcA5PucpKHrlA+FvBK9mjnINsa/0/wMeek3
5UgID1wJoOiqDEjheqkKeswGYsMBV3WWAzOrUTOFlLp0gXMHnJ4jkFIIpBQCKYVA4PS8YoDSUJSG
rvpYv8LBn938RGkoAoGUQiClEEgpBFIKgUBKLQRUfCKlfIjFYnJJfVOslEHoAVkzvd2ty2h2/nZ6
ArLag9yp0lGqq2vkuRvmyS6Slph+IGNEN7v7u5fR6vyNxOSMei1yp2pPfPr1OarJlJkmU2HjjxFQ
AoY7gERVWag5edoRrR00Lc2HFu4G2nRAMZmPMvcIVeTjpirFXa9SU1I0TkHuCcrCRhTFJONd3Bmi
4gFZiTBfUbAvQH8OuVO9c6loAOCDwQyVbE4GyPgD8OS4lfR+AMgNhyYBnhq3Rnna0T7ypy/jjTFd
YP5rQ4R6hNrMI3Qm0Xl38/DEPoC6VOYUSWkIWS9cZIWFJyiwUh167kTnk06cG36cCdDTae0J6hP5
DryuqVZKkcnUH80CfG2UW3baTJP5dxIZhtwig7qxB+AeknY92+dSz7wnX2T6L1ieR2hSb9/dr1ON
pyrBXpKh2PEd3BpUso7vEKJPWmpAb+91YpjtkCJdgF4a3p5AOUP1zqW6TpDP2I4EKYdenIk0kxPV
1YRo3gpbrt+kaXwez7RT+Zd5e3TxlzFNggIJaApizfzENwZ3NHPRuq+UuHAMhzS3uYbgKHKnek98
zeRDD8+O0mFh13Qi8Ik5yk0GL81iUk/JfwOBK/TOGoU3FISHqDT5VoCf7qSpEa2leDcur5En3J2Z
XqROFVOqg7AjO2rSM5Nm6jX/CPAVO0+5yeCljZhxiJv/QSikG9s4n+RW+yA58f0KWpW8SqoNZ8hM
TTX1Z/+KJXwyridKKAxmpV5v2YalI3Wqdy4l3zQGMF7/AdrT4PulqXGAd0fk6ZcLCnppzanPyzek
mknpqS21ZP/OLZAyP7Gb8PKA6xEqkIzIh4IA9VF530dYwnf3K+Hx4j0Z++Mtx0rcuEL4gdLQMiCF
66VQGopYPeCqznJgZsGE5XzxkVKXLnDuUGVXfAikFAIphUAgpRA4Pd/IQGkoSkMrZ6x3ahZZfoXS
UAQCKYVASiGQUgikFAKBlFoujDKWQnio7vVSbCXc/NaLZqSUp6dfPupFLIympuem2ZFM3YTku4LG
mwi+9VJVfl9qYSfPcNAqkbO7azEBr+6am1ZXNxUIT+N4tIFPfLGICsmgHEz6FaJG4MaAAbE972Lj
inaQaUNZmViHKseZZHSzqhyMUnWpopyJKzfqjihUJoU3azcejAppKYl+kKlKwyqNc8cADNyG3NnQ
c6maYTg0llEOAURfchSiUeV5NQpijIkqf0VSG+WMRPUvzw+P72M5k6et3XS0ySXGDv15omeKR5tJ
jIcBJl94fveUU1+Xjsl0QJ8d/gjJOqbDufPInY1JqViMTaf6dDgqgXGUTH12OapRrQ96XRPzTP+e
NIDVB/30NPgA04USpNvh41TuOahr1gDzCwW+t4fn7XHq39EPfQrLamdpif3PIHc25vS8y32h1OrO
OC8iUbJFEe+vnOHFu+j/dlM2t7vLSRCJYsvLE2mK5RaEoOz/qRin5xtSztDGVZ6eQpQKQd1312aI
v8bH/JUaZk/1lwrYMHvhDXeHBvuo/5qvD0ejjT2XogywIXqAnK5cv8+0Bm2up7X6Wg85CTZosL3B
rdFtQ250x5FSAXOj5iFKJpsFa4PWb/oyMygN3fiUOhSR0j8jw+51yjTXmad0Jf2qk3v/X7SfJmU2
S/Yht4YUgs765sdLBRR5EnueRtaS7az/jIvM2aBzqUqZSOBcCqWhiNUDruosB9A1FClVXuDcYUNO
zxFIKQRSCoFASiFwel6dQGkoSkMreKwXoXIoDUUgkFIIpBQCKYVASiEQSKmFYCwxHbFRKBWLxRxP
vCKZ8615W2A13NYShbcuPuac5g1N0WzkTqWPUl1dCfX982QvN+7uEmF2zxdzAdfQJxVLaUDuVP6J
T089ARA/wLw5TVmhlsZ2UA7Z7kgRPiBz70+R1sT2QZepJajwFaUqURHDVvfpTNgpvEGp32eMhpYO
xB3JJyvjeIWC227M9Rb1XEM3a5IaZepQeLYf+meQO1Uwl4pqADc8w7w5qY/n9QCNYxnm8ylwopOM
DY29tkgz/3WK3mHOjoyFAS5yX1GqEhUxItovppm0szGVUWiN2hO0VvhH9jP7HcknK+PzChXtUnBv
0c59TuNThh2gMtLaYejU4R01yJ1KpxS1B6U00Zg3p5JhPp6WBIb3SIMBvb2dpDU7aXa/RDeEkpP7
ilKVqIiR7RvlChknCvP7hLp9zHmUg5eRrM3CK1S0S8G9RdtddSiJariuoT0Tp5E7lT+X6vrlfyEz
34bQJ8leavZJ6uMpXD2dMyP766Vdo/uSk+GgY+pphFmMaxxhFK1xnVvwjWBkS5MTkpcZggnhFSra
pSjiGqq6zb0n2I7cqYIT3wUyl7p804Uv089z6iHq41nMHrTbTev23wi4DUYdU8+tNSxGjeGr8bxH
zOnEN137T16mcWpE44/NEO0Wv3SUz7g7WXQNrY65VC315jTp4gjq45kj56EERIMFpdQmJ03ebnsm
oJ2nTWfWNcNj/KS1SWW8U23oCLgFNV2/ddbhIy+jxvXnuC+yaLcYZn7Te6W7g9LQqphLKdY4QPDi
Fvpp1esyffZA8vfldKHjbNJ00lLpUIebPL632XkvwUkW40VzghBJ3gLJiHTEI+YLfyKHQyzdLRPa
r+zjXqGi3WII3t4cXezNsEsaKA0tA1K4XgqloYjVA67qLAdmViMUSkMvYeDcoVKv+BBIKQQCKYVA
SiFwen4JAqWhKA2t7rF+bmu5hStF1uxbhSc+BM6lEEgpBFIKgUBKIZBSC8BYcYFVaxlRTZTKU27O
j88WXwcXm2dvgSbzW46GqCyLA+ygIjcY8IhYy2kH5EACuVNlo9TuhQr8uri0s6tMLRtX0TstXV1d
7F/DlxLdsA12T/Mh7H45U3c7cqdaKBWLKIrJFZ1BoejU1B6wVW/f8fyMga+MHHcGnVhElXWmMqd3
dO2gxEroikb44KpEWXmyR8cdIygHDKdejI9brWd93sWQ+4C+ayINu+TX2O7RfhjsRO5UzSg1kxgL
c0XnWEa5nySMvCnfAG9T3H0Y7ow50k7qA8pUDG92emewmeHQFMAVRoLeVG4M2EwXmkxohGH3pzLy
/W75RmmEeg1FxzI/3ubUE4Ezsr9PUkvUhgzAW7ewXUuHt9cid6qGUoOOpafFfUDB1N/Kgv0Dd58r
RDkcH1B/GolANZy2qSfJzq0XwLiVDkU69RA9KkHKi3Frnz5IdjQJ2jNuPY7s6/4+nR/LBDQyezI/
JBLsSZzFl0JlyRk8z076P3Af0C4wmi017dv3rDzzfUDzIpBkJ8pZyy2YF0Ox3CJx2xcYmN8o33IE
Mz037D7FQjAE5DFft1P4G191yBk8DaieDpv+fV8Zo+RF/yaeRdWlFrs3QD1EC2J4Rey5tX1QDNg1
1um7wWD342hUbVd8+YrOzneT6VC+wrObkUBtg+1q8QhmK9AJktIEUVprG7TJLIZPa6psZ0XSNhz3
1ILxHvq37pw/Vnq7bTSQ+XqbM8OyURpadZSS76OKzr8QH//O7l7w74Pj5jlgHbSTJYbijEpd0gem
5TQ1In5GsQZpjINpj5YDtkIX96TC8l0THs/YTE7+VV6sVOi+GXKqy35/8Te8cC61wRFb4g0r48PP
SnMSe/YOFx2dcC7ln0tdKpRSrCVWiBpznyAVuqABUmohSl0qqzqtJR+jIs8km9RKFF7bR+Itq7W1
W8yMC4XLAJSGVsP0HIGUQiCQUgikFKIagNPzclxB4yFAaeilN9aH1+xbhSc+BM6lEEgpBFIKgUBK
IZBSlQNcRX6pUCoam/tr7LK9Q+ersLVokOP50lBZmTXgXrFaqicgqz3InaqjlHHzqnq95vmHFmn9
riHwpKGRkyOJSBQOmXxEi8kZ9VrkTrVRylB2ZwxHKep4ggJoNvRooCuyRlKNgBI0mD5UDB9xMnxE
mA6UaT1NR0tKxxWNjCuxuN8/NM58QH2+ogAHbGhiC4lbZf/6zcxOXR9XQZpuZbt2P/TnkDvVRqlf
ybskuv57JjFGSPJB4QkK8sswIcFUIGOQ0+JT49YoeWk8xRSeBDf8OEOpBsmE+hR5aRph/qK1w3Cl
mlGpT9WekZP09wLuH3oD8wEVvqKnmML07NsgyxYI3/6WvzNKi56gq/i6ubrG0uE/cBJadZR6VgKJ
qj0Hde0agK8JT1D4wS3w7FtQZzPnz3sk0K4nn/A7mcKTwGxnfqGQ1Xu/R89beh81A+3VQe2FPqqk
eVVvUMDxD3V8QJkKdS9b9ylnIPMDunH0l/7OpMbMbWoTwI6rRIK9N4TcqTJKGUf/KLZTMRzjTjvC
PUGh3TYeM+HFXKSZnKiuJlNn+igE3bH37AmHWDEJdJq+C/Qalk3dQfUZlrJLpNA2wrNCsOU6kY7m
jNwOlrTL3xupxkyoF0k9x+SxITiK3KkySrXVkWmx1OrshmdHxbCgRD+lwy4zEQh5pqIGiOuvvTUy
U0/ZTAcKnm70LFeGknK+WwZbaxoFRTzFqLmtlvGtJu/WgmyAPkY4ZziHawZdQ6uOUkkqwjzlfq7Z
UVMIEurUx8kk3WTDz8M26GRUUl4D4Zo+K/WypRWN0EanVFFoFbaikgat9Bx4PbzmGY3O/N9eWq/b
AMuGM1ze130rV3/Wtfl7o7YYRqSWtOss3LBQGlp1lFKpnPOdmsOp8foPiJ72XnMBIPh+aWqMXP5H
5OmXCf1uUcRzVIJ/vOUYe1ey9So9v8kZoRvtalQsuv7iC/ItnpI0ePsWGvTOLZCNyIe46nRH739y
DuY9P2pwdkuzPU569aXl3ga7hFB1Or74e6cXLCN0oHPloAsLRDdPmXyedXkRFahdXxHS0GVhtddL
VbE0lN2JWgDi+SpypkTGfFXHhVZPt6bmZM7qxddvIqUuRbXx6h5PPARw6amN1+ZwIgBXIiCQUgik
FAIphUCsBDg9xyu+Ml+iIKUukbEepaEI/H4hEEgpBFIKgZRCIKWqFSjvREpRnzyqtlzkYjZdmfV2
TPnevH1YhMloccRo5EeKOo1GZ33S0J6AIjfYEDTdvmtNyJ1Ko1RYeouqLReJqTHfY8jDnV/M24dF
mIwWRxfAZPDTxdblGSbVcTnS0GuVxAjcD+ejfDSsq7PlKeROpVHqtn6mtqTDBBV9Nn2SaT9jcTmQ
pD6eTNtJP9oAdfSMXfNndCcZlINJiO35HN0XZRKaMBmlA4x5kCk/O1QwHpGdtXqmImlxmsnK8xhg
q6w5EuxdtK7xGVbTCCgdvFKr7Pf7mOnT9YkJ0IVr6B0DMHAbcqcEakFbn4b/3yPB0HQOoOWNNx6b
ysHM6xfDkzloefjNR79swUPTs8duZPqFR7/2TOhIZqCFjSQzHVA/9QrZofuijH0usCkr8lvOd7yn
+RVo2fatww/9z8cmjvCRLBiYvvh0lmRe+PrnakQMaFC1KZI2QGu2DMBDZ/5toom02zB0PDHAvmrq
NE0H/kc9GjjzrZ8DdPw50yT//DD8+Q99Gpl0TeV/0Orqhk+7NEqv2yiVAnNCpR8Q9+pMj4JBLaZS
TM2pSfBxvqbXvhn63GcjHBW+oQyizDf7L6S9oPpOmn+zDuou0MS7rMsyHSnVi6pujGyfrxoZdyTQ
biUxe/UHeEIu3zU0l9lDXUN3OF1J7H8Gh6MSWM+Fwsb2dNrx6rSb7L0Wt+xULMfHE8BvCwo+z898
r0+fZajrIcqKxuh0qec9WZiSWKpk+31D/e6jwLxFXa9Qx3PUU0AYLVef8tyNgrL/p2Jce14RrqGO
2tJ5x7Ojz/K7Afk+nlTT6Z5W2vyen6JMt5F3L8H4mJebYVNr2DU9EgyB4xsqYpzNv+0gvEU3GSDG
oZpC11B9nLqGftS5Xu3D0ajipuefEmpLgexpkz3nYhtTc3o+ntJJaHUnyuQ6PnrAPWfzMnJrk+J4
iJLa2xtEbg9TjVIc0PXhWZZ5UnFj1LU1+WcXis28RZWn4X5xtsxzDVVabCNMuqGdEAkZlIZWHqUe
oGrLN9zd8b3NbHZSK1MX0FfDivDxHPqEnB5yCh2KSOmfuQMsL6Ol3zfmeIiS2tlDIvc98rRwAv22
KYdp9jPKJwfdGGPTFwO+3iQjzFu04x6qZWaD6B5/ZwfHQluypJm/P5l/8wpRYXOpYvceu1at9tJC
G5dfnOsaaocSKA1dcC61bjcRiuPNFT0JbP/P58kcXlLow13PzJWRfu2VB4tfQeNNBN9NBJSGluWG
CAKloatzOBGAi1sQSCkEUgqBlEIgVgKcnuMVX5kvUZBSG3isd7pF78hF1uxbhSc+BM6lEEgpBFIK
gUBKIZBSC8FYfjFjFdpBVCKlYr6/YitWsJjNt1NM7BmX7zXlfIupYpafW+frQuHiua0l1tPpQZ80
tCkkK6EeCImbL4amaDZypyJHqXlWxRUTez45/sVIaHLBYkvSie4u3gvjL8+DJw2d+v5IovZ6+G2a
j2lPKpbSgNypIErFIqrw5OTjQ/hex/8TQO0BW2U5zFGYe3nCZk3eF4VY75/FrnmX6xV6QD7uaEJJ
yePAvUV52uY7FIUPKT1MA2oHHK0pLc09Qm11n84Kx9x84VFKsL3Bv34zS11Dr4RG6Wm2+2w/9M8g
dypplJoZDvn03x25L8IV49bzjALKe+FlhY1fXeQTzJzkd/enjMz/MWkaTRZl6z4TvosVI2g8OfJp
8nIxmBm7k6VN3maN8Sau0wYJSaKKpV7hNNiYylA30Yj2i2kngJPPPUqB6Qd9kLfpTdBJXu9hu506
vAOvayqKUlwNKhA5MgTU/bWdmzNm4JYRkWP1w06+vpX6e17tDhm8rLLTE3daO5lvaHoUNB443Q4a
FyRk+5pN+hd63dmPJUHKommjbgAnn3uUUkrt8Hc4BelxqmN93Vls3DPxAnJn/SnVzf5Sn7s8TUCW
DhPU/5OdSkY/bNji+SjM6lPMbMIhb+20KLvHF2WWl0yGhbco2JFHNDcIrUMKuKJB4RF6jS+Ak+8l
5fVRmpgeUckI5cZ4T7AdubP+lKqjw4B9vjB58qtXeP6fAN/dJjmfZrcBxqy4LJPPuBVEWb8mtIb7
ht4Gjrdow0yDkFxxDShVmLokEB6hfvVnXj4fh/JOfFTHegy8Mll0Da0ESiWjNtjRB+ak35Frospx
k49Db2W+7/DJaoPXuGB85je9V3pDhtCEvkbFnZwxwje08zTzFiVpueTNjYLIbQmNuYa2/dQJoHId
6E9aaQDOzLx8RqI/9O85rqHnfiISUBpaEZTS5PrYTVKRE8YLZJYckaMX+bTpan55Ll8GWUu6Jct2
grc3e+txusLyXS+TcEcmThMubGFs5b6h43svp++HpHXWN4vnYIxNtxjUNVQ23XsFyYh0VRDgRXMi
wNqBgnzGscvyvg1/vWVLhrS5R557Aw1RgIoTXcVvMCuhG8Z9D1W/a+harpeqYItHZawytKrH/2Zy
Ttq93y7+8w1SCl1Dy3088RCgNHSVDicCcHELAimFQEohkFIIxEqA03O84ivzJQpSagOO9bQ7hQ9o
Q2koAr9fCARSCoGUQiClEEipMsJYs0rlCYAa0VWgFFtX1lHymeuxefbyED9IV9FtLV0mVjJr64Kr
2xbI3rrYgvPUdGqbj/jUocmgrHzDgFl6/yUZkAMJ5M4iR6nI8+MrjrnvI3Td97KMPHfPKxddXIBy
1TSiNMlRh94mjSTu2wbZq8hodkjO1N2O3FkcpTqyXyTf0LAqxUEoM6lWM9bE9ZpMldnDcnS2p3bE
XKUlMM9fshXb8zng2k4wD1KlpRGUhS6zSWMWoSBKC4UmTdqsKgc9oSaL4/TDq+e0y+PZQcUU4x35
Fw9IapQrSp3+aDYk2Hq+WFwW8YTXqJYA+4AThytVuRZV8nmHvqbs8h2ZTupyaoF0thXgaD8MdiJ3
FkWpjpuZBdDscNc+gEY5IzWCfAM0vWLB29iq6yteskavZErMJNmLysPPA1dacn+oOsmW64Takv29
7KExch6NjmV+zO/XXwxaY+5iSR4fIlr9NMDkaWv3lCPU5HGcfnj1nHZ5vPtHE8e8ru9P2gGu9HT7
I78N/oAbwRwYoVpQqB0mda1Ht8H0H8Dbzrr9YkpVVrPXVki5qJqg7+uWH/gPjbTteBNYJCj5Z+nw
9lrkzmIo1XELFzwN6u17yIHrg34L3spCVs6BzY6vvQs0MlzdulOnN+C1fp36SlGlJffyvKMf+u7w
BxzUqUBTc3SfTLvpWkjx+EKhmW6Hj7tyUScO74dXz2mXxztq6nd7TaU1EHpTtz/yg/DgD1lSSu+7
lbz06sJrtDsDD8puv1yl6q3NYHjeoR/KU4cOjX9iXG1y1KH2JM7mS8FvS9Qy9ZLccZy83sksfa+9
Ew7X5i4+nKt54+ELhx8+TJNaWlqGcvCrzwPdqzkEtV4iQZjU+FWO2wHTvyLQXlJgkAk/bb3u+twA
y3Li0xea01i3z81x4twprIWdeqJdEa/286x5WoL86/kXadPv8ri8Py0D0/bPbzx8mHZlyI3H6x75
Qq7m3504ohnaLkl4LkffF23ml58Hn73xwzX2ha9PZVmXAeoV/29olWZLRLszW5C2Tt7GD8DgAe8h
N93MwVOXOiRd2safi+EoOLm3p/DY7HZlnWeNopfingdoGLg3qC++UOKFZ09926tQGMepl+cp+jG3
FH25tka+KOK6/enY9rAOXj2vL/rDkbi/X75MMm7WCu/QOcahKfI5cQ9Tux9Ho0Wd+HRy1CLugVTb
YDvhdt0RCequ4SsWJO7FqWyHbZSP2+H+bq60DHKCtkGr+5iBuKvX9TxAHW/QvPjMvzM7uuOIy6+8
OL56Trs8XkMbW1ERjxs0MVfXW8d56vWn2xKP7IkyL1JfXxp2XvD3S/RXaWKaUbMVNtPzZp5UR9nW
w9WhtXzYROos9iaCdMpd+DJgHaQOnhes/wTJusAnFNcpHwqRHFuhH18qozxeQ5WWB9PcgdOw5IzL
SMWdNKVcD9Dx7zR7zuUi/tiHqH/neH0z9et8uHlOHF89p10e74HMQdrXiX0sr2OKqUfl+3z92XHN
TeK7wrxIeV9kWvems6a/X6K/A9PMOzRlKfSwfD9PHToIjzf/wxsAv1KWc9PrUsIKRVe6ub5Czvmt
QDdPmYsoVQrG5Wd2zUm0bzoxd4BK4XqpMun4GizYNCGt68GT5n2+odzJ5fJyZnnfF2tqTtpsY5HZ
IlIKpaHlPp54CFAaukqHEwG4uAWBlEIgpRBIKQRiJcDpOV7xlfkSBSm1Ecd6X3+c+1MoDUXg9wuB
QEohkFIIpBQCKbXGMJaVVcYqiIqmVGzpBUv7e8KHlx7t8vlLxJYU73jIpwu1g7LSYFD3I4aegKz2
IHcqcpSaR8hpLT3a1eUcP+9iyjGhC42cHEnURCFr8oEwJmfUa5E7a0KpWJT5gXK1J/kuaz00TVGi
mxWaHtMd786eoBzoYXJM1y/ULQ8gJKK2Rr1AhYKUGXrqB2SmWZVCjhaVySw2q1Q5SqtQ31A+lNC0
qFuCxI7w/jnKUVNStDhdQiwdiDv9cUoTtMr+FZ0Z6hqqgjTdypu9AP055M7ajFI55gf6dab2vFLN
qNSfKpcYs+wE8wlNJtSnWLkrxzLJ65kc86lxa5TfzHfKM9Cs6HPhuwDqZO4dOpPo0HMnOp8EaByy
Za6KqJOZVnTytDX2l6zKB4OZIF+KSdM+QMqeGsmy2CPcOXaYKkdPkdqfDlkvkFhTP7Kf+bzTHyce
JdFb/reltOgJOm528+WhloSuoWtGKa6y/Fum9lR7oU9ladpVA1x9mdV7v8fKqRJo/NR2D9m6nqeJ
8r6xgfqCqn3QQCUESb1994De3gtwayMYvLLap78K3COUG+R9bdQRiIo0653MT1Tt1RlX+nTKh72k
9j/b5o5jhET7TPOU2x8Rjw5Ev/T3JDVmbqO60B1XiQR7IoTcKYEyLhSOdTHdgHjhIgLJdtKcdDnD
tkh+3Ha2+Jc/v3xeGF7JzSKpZxmn6KJykmA3/cN9u7v4lj2zm1UTaYrFStA16k7/eIN2JLOpnhDw
d7IQvuD0R8Sj45IlthwphLE9nfbWumua//Iyhb/x+daer8rB8Jw6C8LbTsorrirzbJ6wdJP/bgAP
0z1HbyoUnMCMP2leeGanEE+FZx3fUCeN+4k6ak9wlaPS1FuBSTKXmh4JTbj9qfHaymuTuYZSXajz
fmbQNXRtr/jqWhMHmBNnvsCTzJmhjcugTJtpTAlpvsK3wC3fbRqU8W0GSMwX1NIc71B3ZpMEnQv1
lNeYVvS25A46tzprQ3bUFGVFmvATlbnak02EbDhDaqum/uxfkeFG19/0+iPi0bfQ5m/RdQ11Fm5Y
KA1dW0q9aG77KXXiVKyClUQ1ssXnKqmwMk0Gh7ot8O6IPP0yn5Hz8uPhLf9IP8Ut1BeU7Gc3yzdn
86Ikf0+e5nLi5M3KI/ReRH0zfR91IRiv/4B4RyJN+IkOWvucd5qNyIdI7fqovO8jAC/8iRwOuv0R
8Si/854fNTi7pdl+CWDPl5Z6Dw7nUquLWFfVHBfj8uEqdg1d17nUmlJqmRLNdUFRXahefP0mUspP
qTVd1VlFjCr6g2FNqRXBMxXW+SL9WbvFzLhQuAxAaeiqT88RSCkEAimFQEohLhHg9LwcV9B4CFAa
uqHH+iK9yaE0FIHfLwQCKYVASiGQUgikVPXDWPUKiAXgtyVaV8RaCAbmLRI/EZyj7osVVPlqdr7c
IngkW7xU1KyJDbBOkW71nNhUd8/LtUHxlHe7ARTT555WYbZERXozu162ROuKLqrBnBf7xicWjLJk
19Cri/uUGmYWPGnotUoicex+OB/lY1pdnS2HcTiqkhNfrEMFIyAHDdc7FLg6NAmxPX9Gd0xZVuNA
vYaDSZHLytmfVKJFvD/dmEyBGjPlAM8TfqHCp5QJT10fVKDSUL/tRK5P1ycmQJdfY7t3DMDAbcid
aplLnR+GK17KULVo3Rjz8ATuL9riWIqGg5lv7Ac4NJZRDvExg5eL/lP9VayMs8+9P0XM6Etcgdo0
Qp2Nooql0r2aYREUZhLU33Qb90ElsGR/p6SWaA8cA/jhzWz3mA7nziN3Kp5S9HEWBDfrzJuUnJrv
kJiHJ7j+ouLjfTB+cxrgKMkVXqW8nN0/esq/L7w/RUyVx6T+oQrJ64NeOrnoc5eSc3/TDPdBpePS
6/6+vZjL7NESADsc5VZi/zPInZJTuQpZkiikDj7xpqcA9alDCXWimZr6UbeQqxR1haRiX6hBC2J2
MdVnURWqpyAF8ESirjS05epTXDFKEZT9PxWn8De+1ZaGrhBCLeopQNsMMD7mjlKTIz+cJGmepJSX
O+s3BrVcT9P8mOA6lRrF3rlXp2aOZeh4J6n9UZFg9+FoVE33pdLCm9RmHp4EDRpsb3ByVVNXZkga
yT3AP29erq51M9nv7nH2lafh/jkxYRvzD5U0OClUq2f99msK90GlE7STeZRqsY0wma9rJ0RCBqWh
VUWp1HtkptOMMA9PgkObJfuQk1sfVfaRAeNQREr/jCWIcmPmRTK/kfc4+x33qI/7Yl7HtJ9Qy/xD
h3TlE+J5GpL/eRmDFvNBpSe+j/l7NDgW2pIbA7jMIRpKQ6tgLrWmM7Z5IHxQjcsvzjWvtEOJapCG
rvNc6hKj1ALi1Nk7nnB8UKP25JzsR/6h+M83SCl0DS338cRDgK6hq3Q4EYCLWxBIKQRSCoGUQiBW
Apye4xVfmS9RkFLVNdZ7LS3xWf4oDUXg9wuBQEohkFIIpBQCKbUxgfJPpNQC4Fae80KXZ72drSXW
zM1nJ6oHfa6hiZAsz/ZASNx8MTRFs5E7JVAxauOloKVrYGABHfFMyGdfs3cAigqZRWKxLGP4R4db
SCsDtC34xskj937zO1bi4f88TDMvj0+F6nyy5jVUG3stzS6t4qWoNl7GYBVxPUDzvEepH+k176I7
3HGUiT+PM99SRyEaUVhhWwtwn1LhMWpyD1GC7Q3+9ZtZ6hp6JTRKT7PdZ/uhfwaHow01SvFxpWVk
6HDUgJBqwaNjs13vYN/gYw2ToeMZMrjQnej3j5NcutPy7Tcem8o55VqOHqHDTcvY+ce+UkPDzZz+
1uSmHAR/9I+/fJoNP3X/6zhvhv3RHgmGpslG/Q/Y+W7gMHw7g6PUhhqlxFSKe4CmLDKMSNDO3xT1
HnXnOdZO6BMnQO5n6pTbycegpD7KDzX1GN3DPUR5+cwOf3spSI+rJOrrzq8gPROncTjaaHMp+nIn
wLUtLS1DOdhLXn7LPu9r74TD//XnYiCjO7U5ukPLkhdRju7RAEMAvKzdePjl3x2Atx6VR4emadb+
vwbfKFVr2RcevaOHBWM4Efg64Ci18eZSFN2ejJQrFajx5xNO7tlCx1GvHEMTGN9hGw0zDVSSpU8l
dvOnw3T1+Ksx19BjZCrW7kyu0DV0w96XUrkOVLLhOP+e/PQctLlyKaUNWlXmZSvglWOYhrfzx2nk
kjfTJ3poun6rINEf5rXSYhjROoBzN4kElIZuXEolI9JVQTKohOW7+PAydIOSHnJzLTmTJPy4zEnw
yjEEDpiDbKOTe4wKD1HKvcvyWvnrLVuslwAOPAjz3MpCiHMzyjuKwWguogJNbl1319CKXS+FOr4F
cfxv5kpD7/32uktDkVKXBnChMEpDV+twIgAXtyCQUgikFAIphUAgpRBIKQRSCoFASiGQUlWL1DrX
r6wASCkEjlIIpBTikgKuRKiAudRGAK5EWKXjuUxKrvRrXQEB8MSHwLkUAimFwOk5AlGOaxWcnpfr
mi/KXqKLn+q6ddjrkqp6U+Lo8tr2ptTRRfeAZ3m9LtUoUqosjOIHlv2/aEY5H0ZU7C2+at6F5nLa
9qqnYLE9SBW805KN4lxqnW88LP/yPRUt23ehrK3hKLUKA9ZyzpnLqJoqvCG29Laji+5BdNFvGClV
zoEnRf9PLfqKxznvkdelVgW35jLbnhNnWT0oVgcpVe6TmZhpLPH8t4yq0RW3vdIeFK+Dc6n1O++l
VnjaWvk5N7ry2dncOkipdWbf8n9yLteP1eX+0RtvdZbrY/Gu6Bd3SH13hZZaNb/RFQSILqXzxe5L
FamDj9lAlPvbhSc+RJmBlEIgpRBIKQRSCoFASiEqBr4fZFDngVgBokUohXeoEMtHCk98CJxLIZBS
CKQUAoGUQlQe6uafvVfXtSD2u2IpVTh2zVTpu8lWS78LXEdnq5lReOJDIKUQG4ZSqUXmzimXSnmp
6/CjT6pow6mKfy9uv0t1p1IPeblEVwtJ6atp3llh7yVaZYd86Se+VEp8c9xvQor9J3L83zBeMlXw
zRHFvNJrNlw5DfvfifOSqtj3wtuBvL5X8iFf8ihVTEWfiubn+PedpzC4AsL8BzWsKaei3v9zO+L1
s/LeC20jr+FKPuTLPPFFU+K/grE1OmfcnTP+RtdtTI4WbTea/1o57yVVcMTndq4yD3kZBexR3wOT
Fj5U0dS6z6zmmb9WwntZhHK0Ig95XXmPAf22LCCrT/kekrW+nIrm9acq30sldnPTsoekKBQ8rGqx
dxl8E/s1OeqpOSeG1AJ3GCrxvaRWcmNnTQ953RLfVLT06OnlcK7ll4ym3Eyes2YnvoKW/B2hW6I/
Ff1eivaxUg+5T8DufZMLNcgz1fLza+FvfNXS78Lf+KIL3WyqwPcQLfEhICrz84IqWp2AlKoGVNVi
l+KUmqnSQ5+t0n7PbiT+11X9lwL7XWHAxS0IpBQCKYVASiEQSCkEUgqxUeG/iYBPA0KUl1L4LCAE
nvgQSCkEUgqBQEohkFIIpBQCgZRCIBDViv8Pa3OzaUjYZbkAAAAASUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2017-02-17 00:00:06 -0500" MODIFIED_BY="Petrer Davey" NO="3" REF_ID="CMP-001.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Prescribing: RCTs of all interventions to reduce unnecessary prescribing, outcome: 1.1 Dichotomous outcomes, increase in desired practice.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAxgAAAJQCAMAAAA63zLjAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2017-01-18 13:29:18 -0500" MODIFIED_BY="Julia Worswick" NO="4" REF_ID="CMP-001.04" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use, outcome: 1.4 Continuous outcomes, duration of all antibiotic treatment (days).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAzUAAAFQCAMAAACxlKAeAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey" NO="5" REF_ID="CMP-002.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use, outcome: 2.1 Mortality, all RCTs.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAw8AAAJACAMAAAD8e6rpAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD/gADAwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID///8AAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///9BjlLGAABEk0lEQVR42u19a5Adx3Xe2ce9d+/ucoG+ACySJiWCgOWUrSgx+AAW
CyrWgpJM0y7KMeVK2ZEi+4elxA/mB+M4fkSSXRWbVimxE8u25KRkhSUnpgmFpE2ZssktUfsgsSYh
l+OoIgXAUpQI0AJwG1hisY+LxWbe0z3TM9M90zPTF3s+cnHvnek5/Zg+3adnztdngAACgfAwiE2A
QKA+IBCoDwhEKobaBhdueu+S92331tXM1Haa8AoFzL7+6vefm/vDiDToJZRFcxX3vjb07ktXQvHs
t72vNf7wSfsI2RpujVt/PbN7k1XiM0OtHUm1OdOYWLWPdLYGmxPW31XzatAn88PbJ+XSzMyoyz57
7+zrX7n7+6PSDlVUtZmNifWVhILPvD786G773OWps9+y/4y/UTPrE4cSa3N26B/POrU5/Pprlw+v
vIb2kvqIM03GWqtN6wt0J1rNh7vWkdH29Lh1anx691arOdH10jTsNNPTAA+3WhP2hZ9pj0g9PLtx
qt3pzlwBsOTvsC/sjLY+03Sljbd9eSXivDUVWQXf0242x5wJoNe6z5sIOiNwxTrXvAcefJP11wna
YKwdtoddXuhabTG2xzrYbFlNUiPOw6ZbG6c8FhZbI35tnoEfsGtzBB688Qi8p9P179/oKHTZe2nX
rWG1RffhZmuri/rA4lp76qENa3CBvXf+1fiJvdaRC9964e4e9O5+YePo6KU77SPXRqce6tlpLOw4
Mfr0nVa/hn89fnhVJoMR+JrzuePOp8fu2Gl92Tw19S83XGnnXgvllYbd0LA/3pg8u+OgnVFvHJ5q
eOe+bvUuALs0Tv1uu/Nptw2e+VbYHnZ54bajoysHL1sHx8buvK3O+zULw/bHj0xe3mGVx6rNOwaW
/Np8L1z1auO0723+/btwKfxu32+7njuttth7Yvyvjt6G+sBi6Tx81vmyDiMnYc36srprBHZZ/7Xu
glOr1mErzTkvjZPs1IR/8JpMBlPQ8S6cOAW2Bi3dFFy42gnllTYDvn3xkluOf3718Sv2xDc16ncg
q2hbbOINmHDb4Ht3he3hlNdqi8bMqvX71ElLUo3z+UeOO7U5BRO937Rb84bDIzcl1Ca4f9bkHt5L
+35vwIFz1pS9BiffZqsPrqcd7IWlvfBh2Ptm62MJBt7y7GPw6qZ95MyJl9eGpv/s59/82GPwjU0m
jfU39OYP/+HeV655ByVyee3NLz9ifw685Zce2ftNXtqHrRby5S2VU8WZS6fg/COW+Iunb77pxNLq
XvjmN7d6XvWh+5hdIr9ubhu4ZWTbwynvh537aTfJ85u13bCZr357wK3N0uGbPna5sRdenf6bpNq8
Ft4/9rtVm3cwtXnlWoU16KPnrUPw+MyMO1h0HpvaOfVYZzA8wqLbhXsV5Dbhu53Pe+0LBwQJFOWp
otuedNY59OzTD5xcsb5cHDm4xz/5Vqva0TZYj7WHhQVw7OwBcZNUh/bopGPg0DPvX5yyrb+Ljx3c
HdZmmO98YWEHE2tT6TO1PtGH/Vb7NOHEnukx9/ep+YPzp6wjt/emR9k0znJg3wmrPRXuYPNXuh1L
zDyc2Gdd7WEOuv7yQlGeMi4utOz+337w4r9y9LF9em7F15Vz8EVed8M2YL/bv/b1ptvQgn1np2ud
8y8urJ11avNvXnV0uX0urM0atPnahPePv5dO3Ubttj8bHkR9CPD43K3wynP3Xzp+0f29aw0au+CV
l+4Yc21vP41tf760cv9LlxRkn/tfz9y4svglS9r9Ky9f9I9+au4Wb/2iKi/HmHrEXjYsH79t7MVx
p3aNQ7OuNX5j+/33sCnZNmC/W79eWhlbXIZXDqy85cXna71XI0e+y/r3+ePLbzru1KbRmPRqc9PV
vznP1Ya5f/y9dOp2yW77245fqrLwA+jPh0D04/oBgUB9QCBQHxAI1AcEAvUBgUB9QCDM1ofueKt5
dGwRdvOvc2yX0QQsbh1ttsZ6EinzYNqB8NTsqNxFTDpOUoro3aPZUscSpC5Ctznd7MLi9EjsvPeN
udaVa7W3L9r5CK5wsxSWMjjYG3f8PxfdtDtaOwG2PB/G3e1m8+Ge7nuS0uw9mM1fke5YqznRg56b
ljStioyv+vew0RpfrKoijP/SzZcvvvHVd/7a1UO3cp46KY47f3zP537r8jt/4OXslHmwF2aWlsQS
v3FLUk5LS/ZlgnRc4VJEHxKJlpT68bWP3gtv/heNx2/62Wf8CyMp+ZLvBfj42lOz4J5zkgQSnTKC
sJRBGnLXZx4//KGBYzc+8PtWwoGJK1d7Y67HyZ7lxmu/esOFXkluV/ESwdcaT9yUuyKfPPi/dx+4
uL7x1sWvWQm3Vn7y5V7T0+v/OnTmV9/561crqggzP/wCXIX2zFrAI7D+emM2haA9vcfSXGfI87kF
444a9eB7rCs+7acG2HFfuweLoyM7nQFhdDTkFDh/09OfaY2quaPMOq/rR6dXXb/+6enV9kjHISfM
jjWb7cWk65x8nXR7rHQju0UzgePsMDa9m+URuJfYvvtnBZfYPvrQspP0xpqt9mzkdBdugjnrrwsf
6/rltVK2djqNs9squXMti4UuvHchdeDd3WpDd7TZ87gA3fZ94SvUNbjnFPwgbMJH7V/Xzm3CLm9m
Wj0y0mnPrFRnaCxYfSS9Ir2mVZF2c7fH23D7lj/RQfskbMCbXM/3rcZnYVfLq+LURasiq1VVY5D9
esC+wz6PwMbwwdGu7UzSg0ftbhByAc453KYh+D6+T2y9OPl7cNehP3eJgBe+GXIKPDw0dmhYqXz3
fM+hHpw99MKNvl//m8YPX3Gc59918PVvTP6ThMvcfJ10l1sb3zj8hiDN+RcOWjP0wRd6LI/AuWTZ
ZiLcLpB69OmxO3es20l2/MXG5clHI+fb1i39uPX3czAU8hCGD459zDl7bvnw6jrTuG6//RD00m/2
+ZHJZ28/1G7sPTE+evQ2eHTyxdB7dcB2snoOfg3e17Ju1ODZwe7Gab+Dfb1aw/uRTbj6SGqKRnuS
3D45ct7jbbh9y+84dkW24Bpc+emxC/DBHnT/mVeRH4c3alo/LC/A5EfGuBG3BSf/GuB16xb/rD3Y
2t71Lhdg1aEMPB+94pVT8BSMwAR17/WukFPgJzgJLbUVxB2wCz4Bvx349T/rsxquwc3PPJ7UlZh8
Vwcnfop3u/dFt1wWBc8jcPGdru9+BHfCgVNOSoArgxMTIefCxfzh3tW5ybmrva/OnQt5CFYbumRX
2oC4HzY5uWeqw5aKL6Njcy380JWFJZsLcMq6EU/BqVfCLgb7n7Q+fnn+k6OHboWR29q3N/+06Qw/
PqmjMkxM7jk8kVGR1pU7Fp71eRtu3/LQhCfbVuNvzU9MHvwY3DHW3vsnt7sVOVltRRh9aJw5sQAH
uRH3CHTutoa9+atnry6cc9TY+m3fVLeMd595mb+i04FZq1p3u3QWK9Em3M1Vx0owIF+4GQsPLKx1
//PC+7bgwQetkdDK0y6VjU/NHX705iTvKyZf8vZrf+1dEhF9en69tz5/ehN+8UFHYTq+6NH5yQP3
CPRh1i6/J/XfXzsd5d00YPhI8+7mkWHr9gblteXe7TdHrBhwDr5t/ceUii+jc93I4SPNjitx074F
YYu++sDKz8wDXF5vnLKM3Yvrp1df+fmVH3N0Eyomjf4C/Ir1l16Rhamtlt1/nPY+4reLM1YsfmjP
3CCsrJ97AP4APrRxeuP82jfWaqgI+7y1c/HMV7whbN6xm2ynZ7s0jSPfdcRZ3nwwwgXoXDpzwur/
c+AV2iEQDEE3WCMMuYdm/QSLypXrNI/cYnWHuF//T77+N88dvpL0mCDkMqzAqwmmQ2dkaufUSGco
Jpqe/Zjrux9rrK5ffktqbKIbtsa8YSvrEesvLO9AeJHIiJhvLTRiAyr/FG91YW6953MB5llxnYfW
r2w1fJMD4ESrM9X4rKubb61WH87N/8L8ufSK9NbmF1Z7Pm+Dq0jj8sblgSHfCATYf6Vx+KZrbkVu
qEkfRqY7naesG2rzCAbg7G7H7Nhv28BfsEZlh2P8JzwXYGR6tfNn1hUfhN23uc8L9lnlX4UTw+E8
6HAKhmCPm+De/Sr2kmtizR2afSXi128PGqMP/kU3cbLx8rXTDcINJ5JM87mD8+cjPAKb99B+8Ede
5Xk4AqnfHZPasMa8c3DemjYaTHlbsJ9ZZ8SGu+EjQ9EBNdKj7p36y7GpYZ8L0IB9e4M01jL7y0da
0G7tbjvMgh+2MnPHovb+te7q9FiFPakx1cioyK6psT8/8nt+e6+5fctN026d7UxdgHZzz985HWT1
Kszvcfrm/5vf2f1ydRwIRh/eOL7S/OjilxweAZ3/Kbt2V1+8/Dt2v5+DBYcDG+ECfHnxhxr3Ll6E
yfnL7tOxoSsLM0Bf+ASxpwynM790/8pLF4EuvPEFN7vLxy+orR+gsw4bnYhf/9jcd8Klt91z84tJ
Y4eXr51udH7smQTRjXUYbkR4BDbv4fnjyze6vvtRqb+x8vIlS+ItMLpw6Z/Gh0hoNaCxAPNfZ8p7
4cWVEb85wLmWw3+ERiyfefbHnjsX3kFfODrncAG+BDMvXBkI0nxxaPQ3vtKF54eWdxxYAtg9eM62
vZ2yfH7zxh0vXaxQH4Yh/qRkjq9Iq3vvwpO7vfb2+pabZmzgtitfacN449K7XrKWR7ODDWhfckbO
m5699qaPPVfZRjsy/Icu3Hz4b89Li2yOnj75i8dFj/qmYQa2HVojSze85wWVB4Z73ljTkqZ27F5Z
1ZKmQsjoQ2trcFTB7p999yY0Rs8JrZiN7acPnbWrMPT83QpXjLXPa0lTO8bOt7WkMUwfEAgEAlEi
ftTMYg3j/ICoBWZ2PPT3RiBQHxAI1AcEAvUBgZBeT3O/qMIih7pLIu/Du5RWuE6iMqsyvngyUmXq
Eal7as6BUGr/Ti4Hk95L5Kel3okwhSj/2PXOAQr4wCS3PlAirxDUvbneh9s5g1+VPaCgcqXMTMcr
WVY9InVPzTkQ6lyQog5hesoWJVT6MIUo/9j17gFCsY/nnx98rXBHMsoMQvyv2MBMidRorX2KIBI6
ExZPRiCV1MQyK0UzikJSi6HxXhThLD8B7y0ie8YYfWCGHnYCIGlDYj2TsvRUJF08UmIHly0wKVgU
jXWYKe/qaTNd2Yb57uVM6NwNIcmtLLq7xtmr5RQoh1R7gqW6iuOJyZBG67wXE9CPGI4bz0KLOjUJ
NzhRsxSinAKpSKXM+EJFF2Y/hIil8MQY19rX1/pBtPCMrEaJIaOPEQWQX6P762Caz8Ah13X7mITB
SPOJ7hgV/hRbS+Z1xdqlEkI022xUqhioDprW0wKzl/kVPAx3vhJuKifUMD+tnAXKuMw7nZqK+M/l
IuuzpCsE6RNT8Pm7l8Sup0ABXz6oAvkPfWBvkQKnTZ0lDH2+hP4a/bEAMctg3Mb2EqJ+o6/AaZz+
cX5AIFAfEAjUBwQC9QGBKH89HXGLpGJvAI4gQMOX2tWv3GSer1MIHCU0ipaRKmArSPIfouwGVf4D
exb5D/n1IXKLSWJXiHrgyzARSlAHKbIFRynQJjpbqoitIMd/iLMb1PgP3FnkPxTQB36oocyoFLR2
kld+Da99iGTHBgX+g5xodanbdpBOaqGhJzaNbKrhrNExMlQSMEUdVAwfUq9UGvKStps+JFV42dAh
YlhgFov4PvGpXs6prOTOLmMu5eqE6aLVpLrGi1b+Q9bwW/+9ycBEH/CBgvUDzWxUz8uPd/arYfCh
Rd7d5hZNVGWxrZtHPWnCIJXW+jXfm+to/cCrBMm6x4CuxdITBc2rnTn0Eu9JDgzKzLTOTEAMM5ak
MqeliDZk2O1bY6lf5gd//cDOtGInfxkGQOnWkkTmpfIfZERQhiIiyX9IaltZ/oMJ96ZvMaC2Txei
FjOrwGnkP+iwl1AdjFKIWi5FewkXZ0YC+Q/mzQ8IBOoDAoH6gECgPiAQiBT+QwJ43/taCBAy4Rc4
noZK+Wi2aJUCsDK18R9EUSow/oNufZAizvC+97UQIGTCL/A8DYXyUeYyDQXgZOriP4iiVGD8B/36
wA81lDCxBBLiPghHw4qQ8RqK8umUyke0FkB79dJlx6peH1KKecz7HIJNXfejLH3gxh2ZoRDMe1/H
bNuoFC+L6hpQiUimplYiSlU34S7E4b+fNowIIfJfyqqYAX2fypYkp4N1el8KPZIUbqY6/6Fgf6Z9
sRu+YWEiJNYPtB56dFbP0mn5xFWdSKwfJOMv0Lz8B8IGoFPv2biQ1rV+EKgDQ4mgkqGCyp+G1WOS
yEw8tAR2aWr8B+za5mBQej1Ea+n6aaUqoSRerAaqVA45mRrXoohK1w+hA71j8Nq/QhOFj/tQi5O9
7+ovYUbUF/9BoLPa+A+iA0lnEUrA+A/mA/kPpthLCDMUopZL0V5CGAnkP+D8gECgPiAQqA8IBOoD
AmH6ejrxkbXwqZ2ICVFN0GOa7bOat1QCZkGi1HSncACet6A//gPPsYiddZ0KcEWdWx+SvVhJQs+J
MSEoqeCRt8TugHlLRVMbIiou9WkmiV2kOf4Dz7GInXU99c174Lpsmg9fkj64LmpeU3rkBxIMa9R7
t5rJhKhgdqDMR3pnzCdag9TCgwLR00omwS3QkPN5zMxnwcOi+0DDPxp6WfpjXO3vPAmUpo9EX5cT
mVyaG66MEaH8G+cyHvphv/toUxKuWQXfkpYVZgxGJHdxkn1/5KVGx40c8R+uz00RJ0wu3HCaga7W
VZi7bsZgFAQhybVeT1pIhVIlIsxFjwj5D9mLfXEK3EO0Cn3wbSKJcU90Q0zljZYhVZUskWDfZFPS
SaKaoE7oxWBk6Of3aEifOoRPYIxauukuDi81ldhQPOfMrp6TWIGQnR98WyjNyiDMY3EBE8IUr/ti
pUpKryCucPyHGL1DIJHRm6SzCCUg/8F8IP+hHnsJYapC1HIp2ksII4H8B5wfEAjUBwQC9QGBQH1A
IExfT9PYnpU07qsUf7wdi9UuYh6U8eCPSsZ/yJE9TSWCpLMk4g0GpAz+A7ffrpgdgfyHAvogcNsh
wtucliiBeVDGgz+aeS539jT1cDpLIibBfxunnf9AUq731AUfuObWh5D/4I9lNGRDUKa1nUTOOQoR
doQpT/iCwBVlSJWhFmjf5F5tdjQRTKMNwRObaYOuIfaSXzhuePIDzZC0RFk7V5fBTkmTSYpln+55
J3P/iNASIro7WMVNXghMWZdNfTMyCFL3nYgTEXEHNGrgKrUwUj2OOFGrCHVGD519lPRtOKyJiff2
w3pa3Oph9I+YXtAaO6WCTE2L6XjDyPRHEp9TVYb55BSkvnFgmzxfErdjwuoNIIEokeAHXl5chexu
ocxUkEpPlDWY5hNDSmseRLK9xPIfEueAaCI5dSjDVV9KpucMrZi9XHqViKXVG2vIjig8P4g95wn/
VoJNJLIYDAgQEStMSetDufgPOfkPKfEf+BTIf9AI5D+YD+Q/1GMvIUxViFouRXsJYSSQ/4DzAwKB
+oBAoD4gEKgPCITp6+ny+A96n4nL0w98ioDsY8es4ipIjTaYKv8h3AYxhf+QEv/Bc0vGFXVufSiP
/6B3V3AV+oHapsZZxVWQSuMylfgPjPQE/gNXyoSzyH/Irw8l8x/0qYM8/SDws5LsFkSb1MLe1jrc
teufG0R1GIJNJ/6DaWWN20sAZfEfdE7cKvQDGvVL15KzhFSSakJV0pdNsJVEJXACQPRT/IcS+A9Z
6pKnqWXWJOp2mkxyou4umyf+Q77ht8Qm1wOTA0BUxH+AkvgPlFSerbJU3+lRP/8hnX+BC2kt+lAO
/6FvUELhScaSIDf/AXu8dlTEfzBpOVdcHWi5ZahdMM4PaRa5Dv5DGT75ClEYFLoYW3gNUvPzH7JT
pPMfkAaRB8h/6HsTDvkPJdlLCFMVAm2q+tbTCNOA/AecHxAI1AcEAvUBgUB9QCDMXk8HO2InuTqz
PvcyFISyECUIZCeVLqdcelH8haRCBgXVGP+B2cOfpF+P/If8+hDoglAdeJ97GQpCaepAkjxFskqt
Kb0o/kJiGr/jaoz/4NWci2uB/Af9+uA0ckBd8Uld3vvPyN0rI7yCJAhXBpmkRFG0bAEqqmlcd9Ji
S9Q1IahpXpT/MASwWUpjFdQHZrzx/i8tbzCg/lrstsxJJ19oFJrpx2fUy2e1skTfTxsSEWI4s3aE
prV+TfapfEegvq860SnaFadkLSrzH/LzF/px0WAIKWK48KBguHc38S19reV0xBE1BSOKfZwoT0R9
c1P6aP2gY0w2aHowQTQNV7o0r/qZfkeuFwxmtjFNtZYMVweqWk4V/oPsHgUVB2LAJ0q65of48/SQ
4CBkBtTjY68Q1EGVC6DEf0hNxZETAl3TE/9BpMLIf9ACCf4DzspmW4fIf6hu/ZD6BhZh/nIJjSet
+oC6YACQ/1DjehqBQH1AIBCoDwgE6gMCIbGe9lxWJdgPpQR1kIdM9jlLmpE+JhVU+AwY/6Gv9CFl
w/oKgjooqINE9jlLmpE+elqK/4DxHyJYNnhL42HhnQnZD2lBHeoaeWRIDSRfSYlKzqkaRoprPS1U
YMPmBaYyQ/avY2aWczhxtKpxAugXKNuLuuM/9JE1RLj5gfTF+2maNvYaxH7g9hdPTcPs1a/If6Dp
PZBm8x+CgEmBP5Hu+A8Z3uOmakvfxH/I2NpbpPSGTx+Mpa80NidGVmDlELnG8cugPf6DbAEQhe2l
eIMb1bSy00Nu0USuAHqWBLnjPyC0I/P9A02zlvpFHVT5DzRjUZieqt7GMaYAfYkBYdAf5pEfY00T
Q94/+O9J0kZOcYFlRWe8f8hKxSYl/PsEmlZiQXruM5qCI0SknzUOhq6nMf6D+UD+g0H2EsIAhUCr
yYz1NMIEIP8B5wcEAvUBgUB9QCBQHxAIs9fT0lt2c7Ef+Efy1UAm+AT/9J4SPaL5V4FybwRz8h9S
4j+I+BfR6BBZ7zsQWfogvSFp2NrBqzsuFkHp6sAWIDVNkFaTaCr6SC9AXv5DSvwHEf8iFh3CG6Lw
gWt+ffBb1t3lPvYi2rudSY75lb35kWEG8GmkN07NiGvhneY/ZAqQo2lybxQnU7oaECmNy38YSgj6
QAzSh2QiXKqvW3UvQolCGrdXlMMHkn7wT0uKoCK26kjNXUquad3308umFVPEf+AjZpHk3qK8W3DJ
Y47+JYouUd7WrWr8Byqhnn3u0W0cFSJp/eBFKKOQuDLwOALJVIHSBxyJnKlBgYxU4z8w/IXUiQBR
sr0EIZ+dJAdYVCET12c30ZwlK6U6uuM/ILRjMNUWoSmmSV8YS3ljL1AjgtPVZy3i/JBkDCWGEqg9
zECJOVNt1A7KBJPQFv+BTxGN/4AoAOQ/mA/kP5hgLyHMUYhaLkV7CWEkkP+A8wMCgfqAQKA+IBCo
DwiE6etpKu9WacBOTDL8B2V2RrjVGJGpfNoGTOXxH0QsDXH8COQ/FNAHqf28ReyHWjYCl+E/KLMz
/FREQmq6ipXIfxCxNBLiRyD/Ib8+uLeY7eU0iDATDlb90cIxIoOcugbcARmpGey4gvyHNK0kEhNe
nTcqnnOM6HAMjHwYPJx2D6irDdxg1SfTL0kyXuQuk9tQO81g08B/SPbtKKBLtbS+gOjQD/EforeY
NwnS2Q/VD0aS/ku57Dgi5QYhaSXm5D9I+Ib3z+pgok/KORzrCFSq7/Hsh1pIECUuWojGVNn8h+zJ
iCa63KP/Xtn2kuSAqUCdrHkhkXuS0D3pYPwH8zEYmQQSwkVlsB+o4epQfD0oVLK664bdt9z5wbeK
4uZPkjN+nSQImUxzEhkyRHtSpQpQBv9BdCB2PSIPkP9gPpD/UI+9hDBVIdCmMm09jagPyH/A+QGB
QH1AIFAfEAjUBwTC7PW0+FWuwL8gxemgGlpEBkmBL1ZWqGpxdSnJlCoTfxrYaNWa+Q98rcTsCOQ/
5NcHWZCEbpS4L7h2dUgpiLCw6vwHKiE1tXq8RzCFEvgPXK0S2BHIf9ChDyyjKxjYgqgQthsO+4NA
tc/1MkgK4slNif8gJ1Vhp25SRgMkCGbqUOncoKJ5Q/DEZsERuEJ9YBldwvGexIJCVIkMkoLQClHl
PxAqI1VVHTS1VbqSMxYUqeO2yGDZ1Dcjw+kazgz9JNfNoeXegMwOVo7CksCCl5etHv+h+CLLWG/w
ib7gA2V6bVK1rl4uLYJoSqNu34QedSo9TpX/kH8+qsFY2p7raZLS3tTkiB2qAyXVOa3QDCssN/8B
yUDaMai6RkqaIoQru9rXb3njj6SHjTCe9YHQOj+EHvhEdNzt/iSy+w9LCaiEFiEjvZwSyFRPEI9B
N/+BG4mS2BEIJSD/wXwg/8EYewlhhELUcinaSwgjgfwHnB8QCNQHBAL1AYFAfUAgzF5Ps/wHoWMo
TXl+zqEaMoR8/Af1vCnJlprBqiga/yGkYsT4D6Jaxa/396NG5NMH9i4mcBxkvaarIEMoxH9QzpvK
SE1nVRSN/8CIJuIUGfEfXNYSPnAtpA/UozRQEhCsfKoD9VktEOFDMLQIVWJAEWS8hioSfiHJ3Tt2
PK1/05yZZ5Qhf63MgFerY0MQhIQgxupD1GSy3TII/43hPUTGKZMcjEkpVytElSAqVlgpvd3QyDVe
vaaf6IN4KDFjiWTWi4jvYDVkCPn+VasdTX1vMO38hz72cDUzIkQkfhzbvkkOYTSWQqqf1xIjgtHV
GruOmzmB3FNonkcR6AxeWB8I8AqRSWrwUhCpm6H//tR9y5VZFXkHBJKnABR1Qh2D8VFcwrqJEwBo
5n2iNXbHWg1pWo8+ZnA4EDLraWBmiMAa4qkOzI8kT/1qyBAysR3KyVtBXP74D9kpvAbA+A8agfwH
84H8h/rsJYSJCmGisbZN7CWEcUD+A84PCATqAwKB+oBAoD4gEGavpylhP/yDvKs9xyqoGXKloHn4
D5mhJbKlcnyEUuI/JPEf2OgQyH/Irw+iRxJRF1b2YN3qIFUKmq/ApKhU9qQ/kmiO/5DAf+CiQyD/
obA+cPeCRE4pRNqpAkRrsuhMqU9v9VYt/TakR4eoaOLOxDGwo0BsQjk3UKc+mFAs2XbPnh7yDZAZ
9pWaVHaXzwpGAQI1q4NUN7HfTy+bZ8xJ6IPYOc+E9YOK87SyuaSvNwVuRar8B0qKDwgmw0AKxHDe
W2yAXwzRrQXSq4dcS5ES+A8EPbor14f+bnGfBEBJGVKVJzSqlryQnYqqkgODWWui6uM6aJ1CPBKA
Yt+gclL1rS5zWkuIUueH4KlFyO3kqQx+fzDi/YMKC0HxBYScaMn4Dzn5D7EyJ0V4SIj/gMgD5D/0
gc2H/If67SWEUYugGi5Fewlh5iKowGmc/nF+QCBQHxAI1AcEAvUBgSh/PR2N/BBFjBjBP/AW+iJw
R4RcitxPBKXCL+SM/5CYXkFq3fEfvE3ZcUWdVx8iUQfSn1XEvSBI1jVCLkX+J4Iy4Rdyxn9ITK8g
te74D/6m7NjHc+tDZKwJQzz4USHiHpWUjQgRTBPia4RcikK7ssuEX0ifRVTzk5ZaQfwHuSGjdsSr
YfMejhlZ1sh+xk4kFBCEeEiwidwNkKPjVPo1kfoTKEMdSmrdouEbKo3/YIqtFC+EzXsw9P30cFoN
gq27CTPTM3u3pm7sLbimTu8BpZxlXaMke1xJ8R9I5vrFUGcNM0M/pNtLybOdZx4J3UavE2tVdr0h
2eMy4j9QGbo2US4lLqR16QO72hUssVMeQ2V0EFpbcBwjRsqEJYGEJy121IowGJmBiXiGYB6MSE8B
8Wv6xFrKv1Askgxh7voh3KckEuUq9N8P1g+x8BAkYteS8Pm5gEtR8lougUtQzDJXiCpRZvyHBP5D
WfE2tgU08h+QilLP5Ib8h9LsJVQHMxWilkvRXipmmmBjlmX0FTiNd6Wu+QGBQH1AIFAfEAjUBwRi
O62nE/gPafEgctILCoPK0w/U4j9kVSgH/8HnaSjzH8L968X8B54AEosO4bka44o6rz4k8B9S4kHk
pBcUVwemKGlJQDX+Q1aF8vAfPM1R5j/wEgQpuDSx+A++YwH28dz6IB4lPS0RcRjMRU72QIYTOh94
gUgXoLTBQribqHk6ICiQz38YgtQgEKROfYjwHwRDVt90dlJK58hJX6Akj15IFF0oj5inF4Ji+u+n
l80aY4czik/EJlMk/XXkKuMZ3Bl2NwVl7rd+/sN1AcO4EGn8B8KHBMy0uitdTGtPGgwAzjUZjusk
l2Qljg6bLs94g/4z2vTBX1fz9pI57awQfoGWWmA50TSfBUMjARlVs6eoE+pI4z9Q4fMaAza6lw+/
oBapQXbPj0raQrXouq/H+SFi6jL2UlI8iFpd7RVylU4qVyEFVgVn9WjmP3BZYPwHLcD4D32wxEf+
Q032EsJMhajlUrSXEEYC+Q84PyAQqA8IBOoDAoH6gECYvZ4O3kVHn9HRqJN91P+/8od60vwH/zW7
Av8hNb0Cq6Jo/Idgg9w4/4GnYSRfj/yHIvrA+mkk32IB7aHyh3oK/AdV/9z09FS9ALnjPzB7vEVS
8DSMhOsx/kNhfeD1gh8B+TtkPILoEjnmnUz+g0IBCk6BmbJJtnJXPEwlYYjnORyrt6hS+uDzHyAc
0LKjaNXgaK/Cf9AVKIuXKl8A2T6uUhTGfE3dPbrqTpaa3TJ/up/iP8RrRw2I4BArn0xfV3XpkRoA
cpVTmf9AZDw1UmcRo5w1DA76IKcPzAxIc07sJS6m5RYFqkUjKgVQKG6O+A8ke6owyli6jtcPsTYl
/HOV+P2sVicqyLAUagHGfzAeSfyHhLlBGAiuakd7hQypuqZJqEMlNcYHQybND4TyPADiPVgVsB9M
Xj+ollQpXkS58R9i0mMMB4z/oB/IfzAfyH+oy15CmKkQaHUZsp5GGADkP+D8gECgPiAQqA8IBOoD
AmH6epomeRUkOhkwz9ahsjgQfKZZifPEf8gUTTmGQpqk3PyHzPgPfDHF7AjkPxTQB8YjiGQ8pohQ
IAQO+SWqA0kKVSHuZurxHzJF04RmEbVlbv5DVvwHrpgJ7AjkP+TXB5fi4De5fxv9157OkYQ4EHxc
hLJBuEzrE62yuXcZpUwsFi0n2/h4oAiWAnFMX4XLs5fShq20iDi1zMmSewnTEkT7bCPZQgBR1iCZ
ootTSLIjym/7GFgKRN/xH0h0dieZcSCqo6CoW2W0BNGSVpg7kOiN/yCRr2H8B+gLCsSwWj+imT3E
rFtAo/sxa5WqNpgq8h+y4z9Q5D9Urw/xaIq5h+g6pgcacnE0iq6E/5AW/yF4goT7eevFIGchAe9O
LAoORFOtJdPUwWMqUL2ilaXmMtFTSBaeizdGeCh3fhC4zPOHkuJAJF9fzsMN1XyI/MpXQXSqVEG0
Bm3xH/hSJsR/QP5DHiD/wXwg/6EeewlhqkLUcinaSwgjgfwHnB8QCNQHBAL1AYFAfUAgzF5Pi31U
Ked8nxAAoirIhF+gLDVAPv5DVDSIGCBSdI/ISb9ZlfkP4ftQNf4Dez3yH/Lrg+9hk9RbYpEfaNUB
wGXCL0S2FZSN/0D5TyI8LUX3iJ709EuZ/0C5+yLPf+CuN5D/sAwGe/YJ7SVKqdfY2Z70laoDkU7D
fxBF0bGMhKdTIwgR1YLnqWyZ15dx/xy43475Xw2eH2JDjcSAXWWry4RfiHjASW9UyYuO7RUpPwak
OaKq9FEp3aeFrq8aJJgfSF/wHzyrmUgPOHW72FOZW0CJuuKq8Eslxwq9/AdEResHuW5W6xikQGpg
QrCp9G8t9Ypmqch/yE7Rp77eE32jD6y9ZHLrK5MalEVrtdFphp2XO/4D8h+qWU+LYj8Y1PAK9AOZ
+EY5RWdaS1W1A6Lk+cEzRDh7RBj5oV4X+zLiP2SIJpGIzyliY3wEjfyHSDGI3PUICSD/wXwg/6F2
ewlhlELUcinaSwgjgfwHnB8QCNQHBAL1AYFAfUAgTF9Px59c1xnmIQNSW4qH5VcqckYNZegfHB8h
D/+BIVAk8R8S9rQMfcEJ+ksV0Ie4Y2udYR6yECEAiDuZX1S14mbUUIb+wZ70+64S/yEWjCONISGI
/+B5MeID19z6EMR/4LksbIIqwzxI9ttMnQHt2kuEX3MXMjOTxFpRcX7VbbGbQ9u8IBDHdDVGmfaS
KaXSpQ6y9k/+7kCUMtfbQUnG4Qrm8Bw5eEEg+i7+Q2qr9o9bpdtlFS28TBcgmuy9Lew0+eI/ZJhs
/Qmzg0Bc9++n3VgkOSae1B5HFBzOCbve0cl/QJSuD/Hhy+Dpoe/GSEX+A7NXd56qIzUiByLxHwjh
nlFcB9ZS3mWfvlUk1a/u2NUrmR9c1gPJCvNA+2f+1sx/UJBaOP5DrJUV4z8g8gD5D/1gZhU4jfyH
3PYSwmyrr+JL0V5CmGn0FTiN0z/ODwgE6gMCgfqAQKA+IBAVrKc5loDUK9Ca2BESGeUNVJEumg+8
kMWSIBGZuvkPkbdCorPIf8ivD5SA2vPqutgREhnlDVSRLpoPvJDFkojJ1Mx/4PJPOGsm/2G5P+aH
8AayAxqND7TejRWyI8qHTEYKG9QLRBMpqRqLmwukwNm64DbFUMB/IKbrQ0IcoOhUQGq8AaR20TJd
PEhDBBbUtkUQAuJHzec/kHD9wIz+JLXfmHuHaaEQPUl2N3tczSuqjPgPGdKMvTnmciBk48f140hU
pCpJVxOGwpC5gImPIZr5DwRnnLLX03ke9PQB9BZUJvCCII3u+A/Xy80xCIMZz0b6tcVpoYLS9OMy
gRcqCM5AUR0qWT+InPSFLv9CdkRl4Qdk6AdJXIKcotVrmj/+Q0x6UoqE+A8UWaY5gPyHvrf1kP9Q
vr2EMNj4q+jSbW8vIcwE8h9wfkAgUB8QCNQHBAL1AYEwfD2dzX8QHxRQDcrdCDwgKUAWnUC5NBmi
I/QIWmv8h0z+A8Z/KKIPNJ//kpBqIBOcIb86eJ9EtlDypckQHaFH0MwChMKq5j94Tpn4wDX//BDe
9ZD/AOFLUNv9xtkdjuVFyGw/qn12oJnySb7SZIhWoDKQ8tshfUgw7EUc13BDkfgPxFx9SCA+eCd5
CgSVYkuW1geoEtFHh2iSSz3Kiv+Q4e9tlrsGV5R+5j/IVLCesSiDBFrM3TvLDUJBB3PHf5DIIKWU
Bu/mel3xH0yxSOujyXn7PdO64z/gm+ny19N5OksS9b5eg7XECSx8kKO0KX3F/AeEOhT4DzTpdE1d
n+pYMOSaAqVoEJTUO5/igyVd6wciIAn7ISHcHUx4ZjLHgqiM/pCek5CaoUe0JPHB2/8od/yHovwH
gvSHHED+g/lA/kPt9hLCKIVAq6kOewlhJpD/gPMDAoH6gECgPiAQqA8IhOHrafn4D4lOB3nDLuSB
lHSay5UuSzTNpD+I+Aja+A+i+BMY/0G3PtAC+7fShH3BS3z+LSWdRj71iKbZQkVsBV38B1H8ib6K
/9An80N4u7n4DyQ26jMkMWEoiEpApDo2LUF0wJKgusqp89Lc+ZWpOkOwyR84VnVXyKkPKeM8M9Ax
A5LR24SSYnqRLrXs7Z9pCtWK1jTA5MVyVPr09RT/gb0dGYTrMgtfonGsOU4DyRH/gebfzZ4a579k
LuMhZX7IWj9Qxa7uOwGWN/pTlU0CShGtNvyq8B9IYgpKJOuMW3wXXk/LT6gku88ZcztorX0jfMal
if9Ay2MGbnOoxn+gSU9thJygsvu49NCsGIyBlqIO+maa9OqgOuhdP8Sc9HmPes8KSgsFUYkLfonS
NYgO+QhBIAZt/AfRgVh+yH/IA+Q/mA/kP9RuLyGMUohaLt329hLCTCD/AecHBAL1AYFAfUAgUB8Q
CMPX02rxH2pgPPA5S4RfCAI/yD52zKiGQmXL5D/Ixn9A/kMRfVDjP9TAeOBzlgm/4KeiuSolV+eM
QpbAf5CK/2A2/2H5CTNd/CT4D96fO9rQ4AbVN+4QpXR+5AoV0URD7sUvKibU2HnBuRVDwHQlk/Uh
NgKyww8pQqErYZ5IJagFm0TqbPRc9gctK/5DX8Jpg2VDFTZ//Aeog/Eg3yvzsge42EgJUmXcswgX
BaWc+A9ZJHeD1w4TfcAHSl14Uql7UDbjIShoZncnRUQn8h+IzCojYs+zRlhOLc25KzPOR8XX05n9
i6Y+garyBsiQGozqEblpnqQfanddQIb/kLBHRfWMBz4TVVKDgug+8YLLsJYQ6uD8vf31Q+TBEgme
LwVdEcJH+0a/f1Defkn3+4ew6YLWlE0fq2U0BeWMooTr0d87vz4g+m8aQP5DFfYSwiiFqOXSbb+e
RpgJ5D/g/IBAoD4gEKgPCATqAwJh+HqaZizAEp6+1/VIL/1dByUAuV+LJLZEVKpkQHbkP/ShPmQ5
ryZ4/9f1SI9mdS+A/LQMIiE1c/CINhvyH/prfuCHGkoo8wH99ezOcxUimT08fWhPlZoRQYlCvsyl
L+nHkT9oFCf+QywqBDFOHwgX2SHGg8i68aYgvgOwjnhZRN5gI6LM0f8uaADn/fSycTqdwH9gy668
03pVTSu3KKB5/KyJlBuEpBWWm/8gEQ2MFG2eWmEeZVTIf1AZ8OvTEJVFgWIhiVah5fEf0qRh/Act
6+nUG53g4m1ys5dTtnxSFU1LZidv7KgVYTBr3ZPVC8pgIdTfcaWk0pqLjo+Oqlk/JFmewhgPZq8f
csZCyEivIJUyydTiP9ColZQUISIa/8GU+9OXQP6D+UD+Q/32EsIkhajl0m1vLyHMBPIfcH5AIFAf
EAjUBwQC9QGBMHw97b1/iD2iozEv+xo2XYoji64BeUrIERwyksnHfwCSyn9gBEXyl+M+CFNk7PeE
yNIH3/Mtg2RTT9AHEeR2XFYqYYTgkJpMdv/WoHcm8R+YtLH8ZbgPwhTedmX4wDX//BA2rU968Dbn
AxMpEDIdnCjLpPKXEX3ljOQvlykpKCpzWJBGjMeg/cbUpg/cHu32/+Ev01CCmUZ0ddsES4bo6ya0
zHgoihcvXzdWWRL/gYgOKg93pZtL2YVhDHA1XZMzr4h0OVX4D6m+R7SI53g5mAC4DvUBCPSTy7ys
URP0RTXhlBTTglg5hb1Y3PHZ1UEshSuClDpP4vpB9jb3J8VEc6GpavDJRDNLB0salUEfBiVuvaHq
QOXTUL2ifc6HyiOrKmuN0L5+CI6QSGgUAQWiJk97mWxzllAuPU2zVGJ8hBT+A4mGaojln859SMgP
oY4BmcCEiPomQVLw5iD/If96Wjg5ozqYrBBoXlWpD6gLhj8IIAWvR6iupxEI1AcEAvUBgdjmwP01
EJVj2fs00M0jJf6D5JMNMRWi1Md8qaSGYkEqAq5CRDYvR6EA7EW64z9w0pD/oFsf8rggJFAhSn3M
l0pqKBqkQrCJM0BEjkIBAiUrIf4DVynkP5S3fqCUct8o2B/uQfaIoOMoTS0FILPPPMnDfxCXnyiX
rIJhuT83Iuuf+cG/j4Khxg28xE4AqQ6gZd8KKuVNwRoTsuNkBr80F8kmvEhvHy2R/4D6ACL/JbZt
SWJrVz4SZUZoYdMoO2d73tSUJI63hDHtUzSRCnzB0J7vo/mhX/gPRDUNzRGqIcOcSmFVkDizmWld
nfEfEKWvp3WbsdWDClSheJAKkRxJXzsamp+0vAGgj2A/Z71u9zPuB3WQDlKRyJcQyaFpIpjoMmZH
yEBkrR9C8zjuSh87UkNQiNS8+PJQRVMjSTQvJ7UAfM7cGwKl+A/ZHAheVZH/oAP4ftp8YPyHfrKX
EOUrRC2Xbnt7CWEmMP4Dzg8IBOoDAoH6gECgPiAQhq+nY/EfBP713IfCZtglIH33Dy6Qguoj+cT0
ClLZ99N5+A/MHvhR/oMoSoWYP4H+Uvn1IZX/IOQVKDEL9CMzQkPeCBWJ6RWk0njLKfEfGAlR/oMo
SkUCfwL5DwXmB/9Gutvck6DlCWS6uNUxPaSqA9cRiLYsqaxKhklJCTWnxQaL6uZvHkyciGPmlDNV
H4gTASUYbTID5ZBa25tU2xtigcQUC6DUWsm9vk9MoHgxmTgRfbA/H8nYjs+0V/9KRpAyD1ZOptye
6J4/UsX8B/PWDubHicjmPxhLiCixXJLxIuRZFX7EBqEGJceAkJkJs7JFFFpPJ98WSsyfMnRND6Sk
QlCFzGgkICOiAgyW1aPqWK5pKzytq5yslhSkTeCDJW3rB/cxnfd8KXiaXTnPIduokY3/kJMGkXFa
pgBS8R/YkibzF1JCPoAMfwIhAeQ/9L2th/yHWuwlRF9Yhmg1abOXEGYC+Q84PyAQqA8IBOoDAoH6
gEAYvZ4Wb3eaRYGoIwapm2U6+YILkSDP00iPX+HLkYlyIeAjKPIfwu3ySZLENP5DsA01Ipc+kCyW
QEJohTpCsfv/0IyyegmkeRoZ8Ss8OTJRLkR8BDX+A+WrmxohIpE/YSz/4QkzvfuGk0cqLsxMYsev
4X1PuksV13vzbDVPUgkGlN0Yj0orb55a0nIE1wyvVkPBN2KqPhBKIuEdZDpRDW4BUkG5KBcPRVod
aHoYFUqK9EeqHlelyLBh5Nzg1WvZTH3m/b2Fd5sw07zghpLq5wiZLPPuLK/LSZp1HyqN/9DHq4P3
ms8HisxoVEXdaxhhSimXtuqw02sG/yH/HJwmDbkPuvSBWb4Z3cYKpdFV8GJyqo3/QFEn1DGYtuih
ETOKksTJpIYVWZ8tIKsWjGEnNM0Pof98ZDgTUiBqcLNXID6UIVqNeVEG/4Fveoz/oBFS/Aecdk22
C5H/UL69hOpwnVhcyH8ovp7WsppD6LMPC5zGe6d/fkAgUB8QCNQHBAL1AYFAoD4gEKgPCATqAwKB
+oBAoD4gEKgPCATqAwKB+oBAoD4gEKgPCATqAwKB+oDYDuidRX1AIHzs+gTqAwLhY+O/9IE+TDvw
f+0eZU44H50R6I03W1tdWHRT7mjtBNha9dK3m82He3bakTo5ilYJm2OL0B1vNbd6sGes2RrdYx8f
nS4i1Wsa76O31Ty6tQiw875me5ZPOGZl4+VtpWqNd50yPdxsji/CzsanrASzwlJH03oy3KydJIvj
R+32BWDOjQeVCo956Tw5zA01CIsbvZ6h+jDUDr4uLe2FmSX/16Fbgq97wf7aPfN/18ldn3n88IcG
jt34wO8vLcHAxJWrvbEBJ82e5cZrv3rDhZ6VdnT924/UVp8bDl789jt//epv3nO+dfji+mBvR+uO
qZehd8MhWCogdWlp6atvfbFnffz3Lx3vDR69+Duv/eY6OfDyzH/7H+yN3TN40Mrm5stO3uTIhcad
D29Yh8lA94nT/27gAwvPbZ797U+L5P/bdiStV36n8d2NKD59zy89Ac4RTz6c/YODQaXC9F46T87S
3kL1LgmPr1+45aYlI/VBYC893GpNQNMamaDXbjXbHe/w7SeHYA3uOQU/CJvwUfvItXObsGvEPbt6
ZKTTnlmxvz59eF999bkK59tW+X4QTp+EDbi8ce5V+BzAewrL7ZLZL9kf75obhRacP2AJ7811795Y
YRP9w6v2v8+4eW/AqVNwj2MdwMkD0IbPNrbgH7SE0n83mtYrP4M2HDjlHvHkw09cC8+G6b10nhxD
zaULu9b7Zv2w48To03fusNp2Bia66yuTV/w5HU7CAFiT+nPwa/C+1mgXBs8OdjdO+2e/7gv4Hqix
suswOwsft8rY6cCW9fu++1941Zqgv1VU7u2HR+92PkbOua3wAfjxgdHWWJdNdPyM/e+tbt5b9sdz
9gHn2wesNvpgd/20ULqT4lYmbVD+AB8Ijnjy4YHXwrNh+g8wuX/A0E53N1zo9Y0+rMOpCa9Hr946
8bNwLdCHDjRg/5PW11+e/+TooVth5Lb27c0/be60z06BP49Y3WWzvvrQ1kc+MjcJR9y+BfC590++
BeByp+j0sLrg2Ixr+5+19+jZb432cHLqk2MHb2VTrTjZnHTzngoOO98+C+2xO25v7W3tFIh3UvwR
kzYof4CTwRH/20NMpY5Ez3pyzMQpgGt9ow/WyHK316N3vv3XP+82tdPNAV59YOVn5q3utd44ZVkm
F9dPr77y8ys/Zp+dh2CkjAxs1eLN63/79JF3wpxf4s4DvNmRE/unVu3e938O/09rlvjm8cudefvo
Ayfhajytl/d8cGDebdaLG+9bO78+sSYQH0sblD8qlfuWcnY+plAG4cIuGOkbfbBGwS7c63y5Au//
GqMnXeg8tH5lq+H/BjjR6kw1nFGoAW8NLo/erEpNU3v90IOjdiUGkquofAfB6cYnnP3bOisbq1vD
iV3Oyrtn5T1gF+GoWwDrm12K/cONw+c248+u+LSL1j9s+d0kQ/YRVn40Ty+9l86TYyZaF+z1aZ/o
wwjsOwEL1jjThQ/CW8OlsV2D0Wbvy0da0G7tbjuLtR9uwX7XEmzvX+uuTo85j3ikNv0rCcP2+mHI
6qsn9lklbjf3/B20NIj9ObdOv+iYI6M/3SNHmpbcE23ROGfl/R1gn95/Ar5gP4Buwr598J9s+7MN
C2ejLT4zM8OkbcC+98AjfvmZJNaJ/ZZSWkk8+YGueHna6V0BdjpPjpn4+122ydQn+rD00sr9L12C
T83dApPz/yhcL1prB/ji0OhvfKULzw8t7zhg2dO7B8/BHWPOU4xzn9+8ccdLF91HPL9bX30uve3o
0ePPwyuL9688dwHGG5feZdWlOD4Nzqy46aySvvjNsdUTFJZfun+HlUcMXt7nn7t8/6Kzfer5Aysr
i3cAzA6ds9dcAvFh2gt22klfBoNnF1cuH7jKyOdMpfCYl86TYyYazRs7hhZtQPrlWfemEbmeNbFx
xtTa9iGmIX0j7N0rq0Uurwc7Lg4Yur+3vD7A7LtXpdKNjnSxG2tDc2sw9fH12Pm0twytLS2PE3Rj
99lG/+sDAqFx3uvf+A8IxHYB6gMCgfqAQKA+IBCoDwgE6gMCoQ7GtcKPvu7/DJ7EZsUXrS7+qBdZ
2Qu1zJZWr2jAEM6oD8T4yLrULaL3QUBjOFleNCUYZRjtpaBvUGr3NOp9ixyG8ISVRpiyTJDyZiYi
yAGxbecHfqgk0WGS/eF/d9KQCgdUyvVWrTl6oinqA+qDzFjsHaKE6YUkI3UJBhMloNNOiop2Pwiu
H1AfxItM8Q8aU5NKOhDxMyO0HNHeB64fUB+SFpnC8Z8IulN1HYiUsXpAILLfP9Dor8BcopAyX5S8
iEAgKpsffNvHXikzhglrEkXMIydlBfaSl0sZmfGicf2wXYH8B0QtQP4DAtH36wcEAvUBgUB9QCBQ
HxDbCdQQGXDMzMqgPiAQIdj3D55rkDTvIa5rJHZN8C7DS2CrI4lfBizlgLJuE3yyqLddnAnhZhF/
exAT75SEyUFYtiAtOnBsP30oDCLSEOD8/0h8lqORlME3KhQnEM8kto+Q5JTsNxJRCEHZQg8/zo0R
sc30wRkWqdMPPNek4Ks9Vnp+Te4JlrFGqD+UMnMNoewQG/Onpswr8AStCi6PdnMCReay2Nfr3deb
mrSAoAbJIOn6EGdAcN7QFCIMCGbM9Xt31PnPN6Uo6yVIuJQxW4hxYvXUkZk2iLB3RyysZP3yVZh4
0wsIy5YyNfUjNBl9WprClIJEZAzLqRtPdKBpJhIRmhaE/ySpiw8qZl4IsxTkRWOqJhpW4p2DJFcJ
/JkPsY3sJRKfVKncVKVh4uIMecHKvMgyJt651fo2ET8sQGyT9QPJ7ltEvgsmDOFZfZImTIjctdFn
YhK5ZHVq4VWUoJf5tn6+lPLYlQpP0NAZnAD7VdRZSbb6RK+komvTR2ySIp4SpauuFxBDZBhTECKh
DxwDIjCrA2qA840zOZhffHeTt0yI/4gqco0rKIEiSqMbJSU+FY2JDw+kqYYv3r3u+tAU7k2MUp3E
73AKFqJY+fOVIrkJcvEfMuxovdtekDKTb0OmNFPjHG3Lv8PJ3XIFLtZQipQmGM6hnVChOihPf2q5
b+sVcuEnFjW3noZSxK4dzlmIss3L3NKIeuptqxOFWbFm0GqLlCJ67TAgti2KWjz1e3UVLkX0WtSH
7TsfkNxXlmIJVGVBpF6L+rC95gNdV5qx8NJfCuQ/bOvpolhHpEaoA9XZBMzzViocCvznUmoPqknM
sy76+J5xKhUNQNHXgZQNTCHPcEAfiyTbJ/RRznFl4ACWe84p/P6hUCmSm2Aga//4VIcIWX0QEYVS
XzNT4H2w+SfGVIrhwHwgEPntJS+WQxgGgg3xQH3+jigaRDwOhC+EPenLpcnqEHUWUfa+M2rFh+gb
JMZ/YEgQ7lsu/m1gYjQIvndzTAqWL8HyDuKGE5FdyKX7BVKf4YBA5NaHjAcSEXchPhqEZNcTUhiy
vF0JrwbpDAf00EbotZeIfAgsJqXQXko6mbhoEakQx0KyoKp1iDLQLZyg9BIUnh9Cnpjk8Mp7o9LE
PpnJd4Acjopg7NPxPsK0/Y/8DsPhZsQ3ZyX9idStixXzFeE7E0qm1V6SNTVInLhMUztn/HEVJRLa
kujGrZQakYiZnKkPZ124ni67+C7fk1o3Ch8U9XHq7NrifgT92/8d/8V8J5QSgayoYFeu+7DJtqIS
LDMqkJPIU/OSeI+zaHgAlUMas6PNkZ0w0oPFNvTGm2M9dwS3/qZ3tqDTbNw36w/r0zvua85aX6Zh
caw5umgdICMje6DXZn43O04CK/XiaLMdHMuf7577WqsAvbGGk2LHSMMtgVUW6LZbo13d+kB86zz8
IMG61fsdmvDh46DwDCHespqwyQgrAXy5/rWi1QCJPGvikpCEFYafFfGLjqqghnd/caO9Cs3n4T1N
GG5sPMlYD0+dhZUv9D7/H8Ijn3vuUWt4n4G7Lm5cuNc+cGb1KnxHI/h97cz4ipPAwl0jGyN3WZ+b
Z8YvF8h39YXLDwHserLX3GX92jqzfNTNYOhz8OjI+siby1lPmw1FIjNOD3Irgml7QF69B+gU/P1T
0PtzGDkFEyNhgrd1YPjo6upfBAeWOvecdL6MNKBtWUVwqvNHPdhoBb+XOt0pP/HISThlC3ul0z1S
IN+N041PA6wdgFNrjrC2J+xkB546BScPFm8HjA+ECJehi+/a3Jyc6d603lp3DjU3nA/rz/7o3nIV
dpzzkofH7Q4927O/dW9es4b58LefwE3dCI4Vydf710sYSmcu217zA6I8vGOguQzQaexoAcx1/UeZ
vlneufL6+HL8ovmZmZmem2CIDLG/mTSWsMHi+c51fWHxUlgHB7ajvYQoD1uNk7bp/sQd1r/rbThh
mT37V7u3eWfbnc5rsW7Yg7UedNrur+b3WcM489vCfqfrNtqwb614vs19PUtj1v4O9rVYRbDxW23Y
/1uoDwidGLvzRss+h4k5a2VwdXfjgasA79/xPr+P/OXB5o6xyBXD40B3tK5408a351aB/W3hj2+0
/53Z1VqnxfOlq+PPWinua25cCEvgZACTu5prk7h+QCB0AucHBAL1AYFAfUAgUB8QCNQHBAL1AYFA
fUAgUB8QCNQHBAL1AYGoAv8f93nUkddofbwAAAAASUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey" NO="6" REF_ID="CMP-002.04" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use, outcome: 2.4 Length of stay, all RCTs.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA08AAAFgCAMAAABUhbLiAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="RCT MR small.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey" NO="7" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Meta-regression by effect modifier for 29 RCTs. A positive value for Beta indicates enhanced intervention effect. One RCT had both enabling and restrictive components in the intervention (<LINK REF="STD-Strom-2010" TYPE="STUDY">Strom 2010</LINK>).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAu4AAAHpCAYAAADd8LnvAAB2f0lEQVR42uy995dV1buv+f0Tukf/
1mN033tu97nnnHH6fvWYE1DEgsqZJBkDSBJQEFByDgISBBUQAckKKDlLzqkIEgRBJUjOKLxdn4lz
u2qzK6C7il3F84wxR1WtvfZau/Z615zPmuudc/3j8OHDdvz4cfvhhx8oFAqFQqFQKBRKjBW5upz9
H/oFAAAAAABiFzn7P2TxAAAAAAAQu8jZEXcAAAAAAMQdAAAAAAAQdwAAAAAAxB0AAAAAABB3AAAA
AABA3AEAAAAAEHcAAAAAAEDcI3HlyhU7deqU/fTTTw8ULb948eID7zly5Ih98803tmTxErcOAAAA
AADiXsK88sorFh8fbzVr1nygVK9e3Wrn1M63ft26da1GjRpWq1YtS0hIsKpVq1rLli056gAAAACA
uJckFSpUcIIuGfclKSnJCXpOTo7Vq1cvtG79+vUtIyPDSXvHjh3d35mZmZaYlGgfffQRRx4AAAAA
EPeS4u7du3b79m27c+eOK+LgwYNO3tPT02348OFu2bZt21zPfEpKis2fPz/0/qZNm1p2drbFxcVx
5AEAAAAAcS9NOnfu7HrSlQZz6dIlt2zosKFO5LUsyNy5c53Mqxf+0KFDHH0AAAAAQNxLg6tXr1q1
atUsKyvL2rZtG1rerl07lyaj9Jkg6olPTEx0PfRLly7l6AMAAAAA4l4aDBkyxPWsa3Dqvn37Qstr
167tUmIk70EOHDjgBqlK3FesWMHRBwAAAADEvTRQKox61SXqQZKTk91ySX2Q3NzcEhH3e/fuuQIA
pQvnHgAAIO5lgAkTJlhqaqqTcM3THqRhw4YufUa97kE0kFXiLrGPZqrMP/7xD1cAoHR57rnn7Omn
n+aLAAAAxD2WkbCrV10DTcNp3aq1G7CqdYKsX7/eLVOe+9atWxF3gDKOzn9NCwsAAIC4xygLFixw
Ap6WlmajRo164PUhgwe7NBk16Ldu3QotHzNmjFtepUqV0HSSiDsA4g4AAIC4lxCSb/W262FM165d
e+D1LVu2uHncNTi1R48edv36dTt69KiTfS2L9tNTEXcAxB0AAABxD2PNmjVuFhnJe6dOnQpcr3nz
5i6XXaKu9ZXbrt81feSZM2cQdwDEHQAAAHEvSfr16xcaYHrixIki11WvvFJjNAON5no/e/Zs1D8T
4g6AuAMAACDuZQDEHQBxBwAAQNwRdwBA3AEAABB3xB0AcQcAAEDcEXcAQNwBAAAQd8QdAHFH3AEA
AHEHxB0AcQcAAEDcEXcAQNwBAAAQd8QdAHEHAABA3AFxB0DcAQAAEHfEHQAQdwAAAMQdcQdA3AEA
ABB3xB0AEHcAAADEHXEHAMQdAAAQd0DcARB3AAAAxB1xBwDEHQAAAHFH3AEQdwAAAMQdEHcAxB0A
AABxR9wBAHEHAABA3BF3AMQdAAAAcQfEHQBxBwAAQNwRdwBA3AEAABB3xB0AcQcAAEDcEXcAQNwB
AAAQd8QdAHFH3AEAAHEHxB0AcQcAAEDcEXcAQNwBAAAQd8QdAHEHAABA3AFxB0DcAQAAEHfEHQAQ
dwAAAMQdcQdA3AEAABB3xB0AEHcAAADEHXEHAMQdAAAQd0DcARB3AAAAxB1xBwDEHQAAAHFH3AEQ
dwAAAMQ9Bpk8ebJ16tTJMjMzrUWLFjZs2LAH1jlw4IB1797d6tevb40aNbJ+ffvZ6dOnEXcAxB0A
AABxL2kuXbpkiYmJlpSU5Brt+Ph4i68Zby+88IIdOXIktN7q1autYsWKlpqa6tbTe9LT092ykydP
Iu4AiDsAAADiXpLUqV3b9bJLxOfNm2cnTpywzZs324ABA+zy5ctunbt371pcXJxlZ2dbs2bNbO/e
vbZo0SL3nqysLNf7jrgDIO4AAACIewkhQa9Zs6ZrrPfv31/gel999ZUlJye79Y4H/reBAwdaRkaG
Va1aNST5iDsA4g4AAIC4Rxn1qqelpbme9MJ4//33naCrUQ+yZMkSJ/TqeddFAOIOgLgDAAAg7iWA
0l6Up96jRw+X+tKmTRurW7eudenSxbZu3Rpar2WLli6dJicnJ9/7Dx06ZAkJCU7ely5dirgDIO4A
AACIe0nQuHFjJ+OS8urVq7siEVfveqVKlWzRwoVuPQ1c1XqS/CC5ublufb2+YsUKxB0AcQcAAEDc
S4K4PDmvXbu2K1OnTnWzw6xcuTIk6jnZOfnEXUKPuAMg7gAAAIh7KdOkcRNLz0i3jh075lseHHQq
2rRu43rl69Spk2+9ffv2hcR9+fLliDsA4g4AAIC4lwRKlZGQv/rqq/mWjxs3zqXFeHHv3LmzW8//
7VFevPLbNTNNNP9nxB0AcQcAAEDcAwwaNMgJuh66FKRp06ZufnZJufjss8/cg5c0e4zSYzwazCqh
j3ZDj7gDIO4AAACIewA9SEm96P7BSpresVvXrm6KSMn89OnT3Xq3bt1yT0hVLryEfuzYsdatWzcn
80qV0d+IOwDiDgAAgLiXIP3793fyrt51NdgScf3dq1evfOstXLjQyXtKSopr3NX7rllo2rdvH/XP
hLgDIO4AAACIewR27dplY8aMsZEjR7r89u+//z7iej///LONHz/erTd69GjbsX17iXwexB0AcQcA
AEDcywCIOwDiDgAAgLgj7gCAuAMAACDuiDsA4g4AAIC4I+4AgLgDAAAg7og7AOKOuAMAAOIOiDsA
4g4AAIC4I+4AgLgDAAAg7og7AOIOAACAuAPiDoC4AwAAIO6IOwAg7gAAAIg74g6AuAMAACDuiDsA
IO4AAACIO+IOAIg7AAAg7oC4AyDuAAAAiDviDgCIOwAAAOKOuAMg7gAAAIg7IO4AiHs0+O677+zV
V1+1119/3ZW6desadTAAACDuiDsA4h5jfPvtt/bCCy9Ydna2ZWZm2jPPPGMHDx7kYAIAAOKOuAMg
7rHEvXv37O7du+5z16lTJ7QMAAAAcUfcARD3GKRq1apWu3ZtDiIAACDuiDsA4o64AwAA4g6IOwDi
jrgDAADijrgDAOIOAACAuCPuAIg74g4AAIg74g4AiDviDgAAiDviDgCIOwAAIO6AuAMg7og7AAAg
7og7ACDuiDsAACDuiDsA4o64AwAA4g6IOwDijrgDAADijrgDAOIOAACAuCPuAIg74g4AAIg7IO4A
iDviDgAAiDviDgCIOwAAQNkT99OnTz9Yfjlt58+fL/AfXLx4sS1fttx++eUXxB0AcUfcAQAAcS9p
Dh06ZC+88ILVrFkzX4mPj7eXXnrpgfXr169v1atXd417QkKCayjbtG6DuAMg7og7AAAg7iX9YdVQ
16lTx8m6L2q4n3322XzrNmjQwNIz0t367dq1s7p161pmZqYlJibaqFGjEHcAxB1xBwAAxL0kP6x6
2FNSUtzf169fd+XatWt2586d0Ho7duxwQq/1vvrqq9DyJk2aWHZ2tsXFxSHuAIg74g4AAIh7SYt7
UlJSoesNGzbM0tPTXcMYZM6cOU7m1dh///33iDsA4o64AwAA4l6S4u573C9fvmw3btx4YL23271t
GRkZlpOTk2/51q1bXaqMxH/p0qWIOwDijrgDAADiXhIcO3bMpcBIyKtVq+YabP3MysqyXbt2hdar
U7uOS4mRvAc5cOCAG6QqcV+xYgXiDoC4I+4AAIC4l5S4S9Q1OPXNN990vedpaWlO5CtUqGAnTpxw
6yUnJ7tlSpcJkpubi7gDIO6IOwAAIO6PgpEjRzpBV+nbp69bphll1AuvXvcgBw8edOIusSdVBgBx
R9wBAABxL0Xu3bvn0mc01WOXLl3cslatWrm/JehB1q9f73rb1VO/ZcsWxB0AcUfcAQAAcS8tLly4
4BrvjMyMkLgPHjzY9cCrQb9z+89pIseOHetSa6pUqWK3b99G3AEQd8QdAAAQ95Kgf//+NmvmTDeb
jMqpU6dCc7Or13358uVuvU2bNrm/NTi1V69eduvWLTtx/ITrgdcy5cdHE8QdAHFH3AEAAHEPoEbO
Py1V00IqX10irt/btW2Xb92mTZu6aSP9635dDW49ffo04g6AuCPuAACAuJcU3333nethr169uhPw
ypUrW/369W3BggUR11dvu9ZTA6ny1ltvRV3aEXcAxB1xBwAAxL2MgLgDIO6IOwAAIO6IOwAg7gAA
AIg74g6AuCPuAACAuCPuAIC4I+4AAIC4I+4AiDviDgAAiDsg7gCIO+IOAACIO+IOAIg74g4AAIg7
4g6AuCPuAACAuAPiDoC4I+4AAIC4I+4AgLgDAAAg7og7AOKOuAMAAOKOuAMA4o64AwAA4o64AwDi
DgAAiDsg7gCIO+IOAACIO+IOAIg74g4AAIg74g6AuCPuAACAuAPiDoC4I+4AAIC4I+4AgLgDAAAg
7og7AOKOuAMAAOIOiDsA4o64AwAA4o64AwDiDgAAgLgj7gCIO+IOAACIO+IOAIg74v44sHLlSlu/
fr0ra9eutX379vGlAADijrgDAOIOscZTTz1lNWvWtKSkJKtUqZK9++67fCkAgLgj7gCAuEOsMWbM
GGvTpo2lpaVZ7969bfHixXwpAIC4I+4AgLhDLDJq1Ch3XA8cOMCXAQCIO+IOAIg7xCrDhw93x3Xn
zp18GQCAuCPuAIC4A+IOAIg7IO4AiDviDog7ACDuiDsAIO6IO+IOAIC4I+4AiDviDog7ACDugLgD
IO6IOyDuAIC4I+4AgLgD4g4AgLgj7gCIO+IOiDsAIO6AuAMg7og7IO4AgLgXTqdOnVxp3769TZ48
+YHXV61aZS1atLDq1au7Br5t27a2b98+xB0AcUfcAXEHAMS9tBg9erQlJCRYZmampaSkOHkPMnPm
TKtSpYqlpaW5xj0xMdGtW6FChajLO+IOgLgj7oC4AwDiHoHbt2+HpLxBgwZOyNXz7rlx44ZVqlTJ
srKyrE2bNnbu3DlXkSYlJVl2drbl5BXEHQBxR9wBcQcAxL2E6dy5s+ttHzdunBN2CXxQ3L/88kvX
C1+zZk07c/pMaPmIESMsPT3dpc6cPXsWcQdA3BF3QNwBAHEvKY4cOeIqRt9YK4c9XNy7dOliGRkZ
Lj0myMqVK12vu5Zv2LABcQdA3BF3QNwBAHEvKerVq+ca6xkzZri/33jjjQfE/fXXX3fpM9lhKTGH
Dh1yPfWS92XLliHuAIg74g6IOwAg7iXB6lWrLD4+3vWmeyKJe3JysuXk5Li0mCC5ubkhcV+xYgXi
DoC4I+6AuAMA4l4SKMVFDfX+PAH3+FQZpceEi3tQ8MX+/ftD4r58+XLEHQBxR9wBcQcAxD3abNq0
yTXSaugWLFhg06ZNs7lz51qjRo3c7DHqeZ8yZYpbt127di5VJrxR3L17t5N/ibvmeEfcARB3xB0Q
dwBA3KPMunXr3Gww6kVXY+2Letbr1q3r8tlfeukll8fe/YPuTtw1ZWSQb775xs02o3SbEydOIO4A
iDviDog7ACDu0eb06dPWtWtX69Gjh/Xs2dOVfv36Wf369Z28q+e9e/fubl0/HaR61rds2RLaRvPm
zV3vvBr7aIK4AyDuiDsg7gCAuBeBz3GX1AeJi4tzjaLy3SX0SqVRb71625Vmg7gDIO6IOyDuAIC4
lyLqcVdF2apVq3zLt23bZhUqVHC97mrcNSi1cuXKNmjQoKh/BsQdAHFH3AFxB4ByIe4//vij6+WW
NA8dOjRfGTBggBts+ldRTrvmZI/0P/z222/29ddf2/Tp023WrFn2888/l8j/h7gDIO6IOyDuAFDm
xX1enjir51s550pp0dzqKv53pbLooUplGcQdAHFH3AFxB4AyL+7VqlVzjVPNmjWdrOt3DRBNTU11
Mq+88zVr1iDuAOWU89fuWO5P1+zgL9ejWn65ZZaUWMsSasa736O9fX1mfXbEHRB3AHgsxP3SpUuu
N0x55levXnXLKlWqZKNHj3a/z5kzx+Wdr1y5EnEHKKfs/PGqfbj0Rxu98lRUy4St1y09OcHSk2q5
36O9fX3mHSeuIO6AuAPA4yHuR44ccXOvt27d2v19+/Ztq1ixoo0cOTK0jqS+br26iDtAOWXvqWs2
Jk+EP/vu56iWqbtuWnrKfXHX79He/phVp2z3yauIOyDuAPB4iPvNmzfdQ5AaNmwYWqa/GzRoEPpb
KTRKm0HcARB3xB0QdwCARyTuQk8wVUV2/vx593e7t992ue7KbdfAVOW7N27cGHEHQNwRd0DcAQAe
pbjPnDHDnn32WevVq5f7Ozc3115++eXQrDKacWbt2rWIOwDijrgD4g4A8CjFXZw7dy7f38p979ev
nw0aONCOHTtW5r9ExB0AcUfcAXEHgDIv7ls2b7HVq1dHfO369evu4UsXL15E3AEQd8QdEHcAgEcp
7k899ZS9/MrL9ssvvzzw2saNG13aTPPmzRF3AMQdcQfEHQDgUYj7nTt3Qo1TQkKC/fTTT+7v33//
3RUxa9Ys9xAmDVJF3AEQd8QdEHcAgFIWd/WkP//8824O97p167qiR5Pr72DRNJDZ2dn5podE3AEQ
d8QdEHcAgFIS9zVr1li1atXcrDFe3DUtpP4OFvW2v/LKK7Z06VLEHQBxR9wBcQcAKG1x15zt/fv3
t9GjRzs515ztAwYMcE9MVcWmMmzYMJsxY0YohQZxB0DcEXdA3AEASlncg1SqVMnN1e7z2ssjiDsA
4o64A+IOAGVe3INcuXLFTp06hbgDIO6IO+KOuAMAxKK4z549280sowGp6n2fPn26Wz5t2jTr0KFD
mU+XQdwBEHfEHRB3ACjz4i5J10DVtLQ0N4uMct4l8mLhwoUulWbQoEGIOwDiHnPifuDnOyUs7nUI
EMQdACB2xL1KlSpunvYhg4fYvHnzXK/7nDlz3Gs3b950Ul+/fn3EHQBxjylx/3TtOZuw8Wv7fPv7
Nmlbr6iVz7f3til7+1lKrXTLqV3bZnw/IKrbVxm3qYsd/XU3wYe4AwDiXnx+/fVXV4m1f/tt9/fP
P/9sFStWDIm7F3vNOoO4AyDusSbukzcvtBm7B9j0XUOjVmbsHmazDwzPE/cM1+M+79hHUd2+yuTt
fe34hf0EH+IOAIh78dFAVIl5jx493N8nTpzIJ+63b9+2GjVquBQaxB0AcY81cf9iy31xl2xHswTF
ff6xUVHfPuKOuAMA4v6XqJon7omJibZ161a7cOGCy2lfsmSJe61jx45O2lu3bo24AyDuiDvijrgD
ADxKcdeDliTuSUlJrtSpU8dycnJcrruepqoe92+//RZxB0DcEXfEHXEHAHiU4i46dujoBqGqdz09
Pd0VzTKjNJp+/fqV+S8RcQdA3BF3QNwBoFyIuzhy5IiNHTvWBg8e7MqYMWPs+A/Hy8WXiLgDIO6I
OyDuAFBuxL08g7gDIO6IOyDuAFCmxf3atWt248aN0N937961bt26WU52jtWrV88mTpyIuAMg7og7
4o64AwA8SnFv2KChq8AqV65sLVu2dMuys7JcnrsGp2ZnZ1utWrWsc+fOiDsA4o64I+6IOwDAoxD3
N954ww0+lZzrpwaj6umoWX+Iu2aXSUhIcH+rkivrqTqIOwDijrgD4g4AZU7cL1+65CouTfX45ptv
2pQpU9yTUb3Ej/v449C66omXxI8fPx5xB0DcEXfEHXEHAChNcd+9e7fVrFnTzdfuUa675mtXCbJy
xUq3rE+fPog7AOKOuCPuiDsAQGmK+8aNG52Md+3SNd9y9bYr3z3IimUr3Lr9+/dH3AEQd8QdcUfc
AQBKU9w3bdpk8fHx9m7Hd93fV69edT+VOqOHMAn1wP/222+2YP4C1zuPuAMg7og74o64AwA8AnFP
TEx0A08l8L7Url3b6tatm29ZSmqKy39H3AEQd8QdcUfcAQBKWdy/W/udValSxaXGFKdoSsju3bs/
1D72799vs2bNsnHjxtmyZcvszp07BV9IbNxkn3/+uU2dOrXEKlPEHQBxR9wBcQeAMifut27dsjFj
xtinn35arKJ19+zZU+wPq9786tWrux775ORkNytNXFycrVu3Lv/nuHnTva4LAxW9T+/Rg58QdwDE
HXEHxB0AHntxL0l69+5tFStWtAYNGtjIESNd6o1ScpSGo17+IErBUV69hH3gwIHWqlUrN598SkqK
9e3bF3EHQNwRd0DcAQBxLynmz59ve/fuzbesUaNG7kmsGuR6+PBht0y97+plV4/76tWrQ+tqXnmJ
vnroEXcAxB1xB8QdABD3UqRr165OxjVjzZkzZ9yyIUOGuN718F74BQsWuB53PbX1wIEDiDsA4o64
A+IOAIh7abB161bX065Brkqf8bRp08alygQfAiV27NjhUmfUE79o0SLEHQBxR9wBcQcAxL2k6Nev
XyhXXRKuPPYePXrkW0c98NnZ2U7eg2g2GvW2a0DrihUrEHcAxB1xB8QdABD3kuLtt9+2ChUquCeu
StyV356amuqmfPSoR13LJfhBcnNzEXcAxB1xB8QdABD30uT69eu2fft2J+gqynGfN2+ee61Jkyau
113Lgxw6eNCJu8R+yZIliDsA4o64A+IOAIh7aaEZZCTiSo1p2rSpW9a2TVuXQiNJD/Ldd9+53nYt
3717N+IOgLgj7oC4AwDiXlps3LjRybh62N944w23bOgfs8rogUuXLl0KrTts2DC3XBXr3bt3EXcA
xB1xB8QdABD3kkCzxwwdOtT27dtnR44csQ3rN7gnoSolRvI+YcIEt54GoerpqpL5d959x06cOGGb
N212Pe0Sd+XJRxPEHQBxR9wBcQcAxD1AVmaW60XXFJB6wJIGp2rmGAm5nqIapF27diFR9+tK/LVM
+fGIOwDijrgD4g4AiHsJcfr0aRs0aFBeY1fb9bBLyFu2bOmeqBqJTz75xPW6a13NPNO7d2+7efNm
1D8X4g6AuCPuMGrkCCfuuXt38WUAAOIeqyDuAIg74l42+P3uPZu47mebvvl0VMtXe69Zhw8GWnKt
GjZixiqbteNCVLc/bdNpm7fzHAcQAHFH3BF3AMQdcX88uJsn7h8u/dHGr/kpqmXS5kvWpusAS0us
Yf2/WG6frT8X1e1/vPqUTc2TdwBA3BF3xB0AcUfcHxtxH7n8ZNTjZfLWy9a2231xHzBluU3ceC6q
25e8f7n5DAcQAHFH3BF3AMQdcUfcEXcAQNwRdwDEHXFH3BF3xB0AEHfEHQBxR9wRd8QdABB3QNwB
EHfEHXFH3AEAcUfcARB3xB1xR9wfrbhv3rzZPTRKZfv27Xb8+HECBQBxR9wBEHfEHXFH3GNN3J94
4gn3RHI9YbxChQo2YMAAAgUAcUfcARB3xB1xR9xjTdwl6q+99pqlp6dbjx49bOnSpQQKAOKOuAMg
7og74o64x2KOe58+faxq1ap25gx59ACIO+IOgLgj7og74h6z4q6edok7PgCAuCPuAIg74o64I+6I
OwAg7og7AOKOuCPuiDviDoC4A+IOgLgj7og74g4AiDviDoC4I+6IO+KOuAMA4o64AyDuiDsg7og7
AOIOiDsA4o64I+6IOwAg7og7AOKOuCPuiDviDgCIO+IOgLgj7og74o64AyDuiDsAIO6IO+KOuAMA
4o64AyDuiDvijrgj7gCIOyDuAIg74o64I+4AgLgj7gCIO+KOuCPuiDsAIO6IOwDijrgj7og74g6A
uAPiDoC4I+6IO+IOAIg74g6AuCPuiDvijrgDAOKOuAMg7og74o64I+4AiDvijrgDIO6IO+KOuAMA
4o64AyDuiDvijrgj7gCIO+KOuAMg7og74o64I+4AiDviDoC4I+6IO+KOuAMUTdu2ba1ixYpWrVo1
F5MvvvgiXwrijrgDIO6IO+KOuCPuEGt06dLFUlJS8urH2paVlWU1a9bkS0HcEXcAxB1xR9wRd8Qd
YpHc3FwXjxMmTODLKE/ifvPmTcQdimTZsmU2atQoGzdunH388ceuAOKOuCPuiDviDrHJpk2bXDyO
GTOGL6Osi/ucOXOsadOmLvdJJb5GvPXp0yfiul9O+9LS09ND6+q2y4rlyxH3x4xevXpZ5cqVLS0t
zd1yU2UAiDvijrgj7og7IO6IewkycuRIdyCTkpJcycjIsDp16rhcqHr16uVb96OPPrIaNWo4cY+P
j7datWpZdna2xcXF2dq1axH3x4hjx4653vbExETr16+fbdu2jS8FcUfcEXfEHXEHxB1xL0l69+7t
ekwnTpxoW7dudX9LzOvWreskfd++fW698+fPux7WzMxMN8hBnP7lF0tNTbXsnBxLTUlF3B8z1q1b
5yqByZMn82Ug7og74o64I+6AuCPupfFhw8nJE3GlwKg39bvvvnPLJPaSdPW0X7l8JbSucpuVLiHJ
P3XqFOL+GLF69WpXCSg2AHFH3BF3xB1xB8QdcX8ESNpV1BO/f//9hqpz584ujUYpNEEk9kqxkeSr
BxZxR9wBcUfcEXfEHXEHxB1xLwV+/PFH16sucZeQe5o1bebm/lQJcujQIUtISHDraqYRxB1xB8Qd
cUfcEXfEHRB3xL0UePPNN52cV69e3dasWRNanpyc7FJolP8eRPOCenFfsWIF4v5Qjd1d+/33391P
ld9++w1xB8QdcUfcEXcAxB1xL5oPP/zQCbgkXdP9BZGwS9w1ODWIUmm8uC+P4rSQj4O4v/fee1ah
QgU3PkAXSk8++STiDog74o64I+4AiDviXjiTJk1yKTIaaPraa6898HrrVq2dtGv6xyA7duxw+e0S
92hOCfk4iPvw4cPdlJv6TuvXr//ARRHiDog74o64I+4AiDvino8ZM2a4Hl9Je8uWLSKu061bNyeW
4Q/amTt3rhuwKulnVpmH58iRI+47HT16dJn77Ig74o64A+KOuAPijriXIhs2bHDzs6vXt0OHDgWu
p6erKoVGZenSpaHlDRo0cDnx4bPNIO7FY9euXe5EUpoS4g6IO+KOuCPuAIg74l4gdfIaOeWu64FL
flBqtWrVXNETUbXco9e0rlJjXn/9dfdevUeBsHDhQsQdcQfEHXFH3BF3xL1cMmjQIDemT2P+VCpW
rIi4I+6lj+Zml6Qr1SW8aHl21p857XrMvZYpcGvVquWK5H7KlClR/1yIO+IOiDvijrgj7hAr9OzZ
02UoaLpsifsTTzyBuCPupc+dO3fs2rVrdv369QeKlt+8eTPiwV+1cpUbjFpSUxgi7og7IO6IO+KO
uEMscfLkSdeBOXjw4DL32RH3ciLusQrijrgD4o64I+6IO8QSeuikjmm/fv0Qd8QdEHfEHRB3xB1x
R9wBcUfcEXfEHXFH3BF3xB1xR9wRd0DcAXFH3BF3QNwRd8QdcUfcEXfEHXFH3BF3xB0Qd8QdcUfc
AXFH3BF3xB1xR9wRd8QdcUfcEXdA3BF3QNwRd0DcEXfEHXEHxB1xR9wRd8QdcUfcEXfEHXFH3AFx
L4zNm7e4zz527FgOJOKOuCPugLgj7og74o64I+5/l1u/XbebeeXWbzeiVsx+t+82rLXq1arbqNEf
/bGfG1EtN+5cRdwRd8QdcQfEHXFH3BF3eHzEffrOITZha3ebtK1X1MoXu/vYgKnvuDqyQ583bFpu
v6huX2XMhncQd8QdcUfcAXFH3BF3xB0eH3H/at8Y+3LX4OjWj/uH27AZ3Vwd2alfK/vq+5FRryMn
bu2JuCPuiDviDog74o64I+6AuCPuiDvijrgj7og74o64P9biPn3LuRL7Xnr17O3qyJ9PniZIEHfE
HXFH3BF3xB1xR9wRd8T9r8fjL/bZusM2d98gm71nZFTLN0c/tlbvvGbJNdPss6UD7Kv9o6K6fcXk
isMzCD7EHXFH3BF3xB1xR9wRd8T9cRD3007cp+/unSdKQ6Ja5n4/3N56p7mLyY8X97aZ+4ZGdftT
dgywJYemEHyIO+KOuCPuiDvijrgj7oj74yHuE9Yftpl7+kY9Xr4+PDJP3F9zMTl+SR+bte/DqG5/
2s5Btuz7qQQf4o64I+6IO+JePNasXmvVqlazzyd9TsAi7o9W3PcMszkHR/wp7j8g7og74g6IO+KO
uCPuZVDcP9/Wxz7b2t0mbO0RtTJ5d2/rO6m9qwTeHdjCpuzrE9Xtq4za0IETAXEvVpm5536Pe2pC
htWpU9fmHfvIyTzijrgj7oC4I+6IO+JepsR95u7hLicymifonDxJGjyli6sEugxpa3MPjYh6JSB5
B8S9OLHY99N3rVblFNfbnpNd2+IrJtuYb3tGVZYQd8QdcQfEHXEHxB1xR9wR97/ZIA364j3Lyapt
9V+t50p2Zo59vKQ34o64I+6AuCPuiDvijrgj7oh7LKXKqFFSekywRFuUEHfEHXEHxB1xB8QdcUfc
EfcyUBB3xB1xB8QdcQfEHXFH3BF3xB1xjxSPO29Yuw8GOXEf9OVq+3zLRcQdcUfcEXfEHXFH3BF3
xB1xR9xjSdzVuz74yzXWon1Xy0xNsi5DJ9rwr7flifYZxB1xR9wRd8QdcUfcEXfEHXFH3GNF3BV/
teKet8y0ZMvOyrDUhOrW/K23bfK2K4g74o64I+6IO+KOuCPuiDvijrjHirgrv71lx/etbdd+rrTu
3Nu6DptkkzadR9wRd8QdcUfcEXfEHXFH3BF3xD1WxN3Le7BEU9oRd0DcEXfEHXFH3BF3xB1xR9zL
SEHcAXFH3BF3xB1xR9wRd8QdcUfcEXfEHXFH3BF3xB1xB8QdcUfcEXfEHXFH3BF3xB1xR9wRd8Qd
cUfcEXdA3BF3QNwRd8QdcUfcEXfEHXFH3BF3xB1xR9wRd8QdcUfcEXfEHRD3sCJRHzH7AxePnQe0
tvk/jELcEXfEHXFH3BF3xB1xR9wRd8Q9lsR9Vu6HNnp+D+syqK1lpGZZq7y4HDq9m+uFR9zLgbgv
X77cVqxYYb///nuB62zdutWmTJli06dPtz179iDuiDvijrgj7og74o64I+4xKO6KxeYtGltyzXTL
ysjJq+OzLKFKatR73RH30haBvXstMTHREhISrEKFCu7vcG7fvm2pKalWs2ZNq1Wrllu3RnwNa/Bq
A8QdcUfcEXfEHXFH3BF3xD3GxF3tdZ/x71in/q3tvYFtXHm3b6uot9uIeynSqVMnq1KliqWnp1vd
unWdkB84cOCB9bKysiwzM9O93rdvX2vZooV7T0pKivXv3x9xR9wRd8QdcUfcEXfEHXGPIXH3bbba
6WAhx72MivvBAwftueees/r169vQoUNDYh4u7uvXr3e97MnJybZyxcrQ8jfeeMOys7MtLi4OcUfc
EXfEHXFH3BF3xB1xjzFxL42CuJcSFy9edPnqYtWqVU7MI4n7kCFDXO+6euaDzJ8/3/W41yqglx5x
R9wRd8QdcUfcEXfEHXFH3BH3KLN48eICxb1NmzaWkZFhderUybd8x44dLjde71u0aBHijrgj7og7
4o64I+6IO+KOuCPuj1Lcld+ulBjJe5D9+/e79ZOSktxsNIg74o64I+6IO+KOuCPu5ZEfjn7v2uyB
A/qX2D7mIe6IezTEXctzcnJcukyQ3NxcxP1vsH/fblcJjBwxvMT2MWsP4o64I+6IO+KOuD8+LNl3
3qZvOWOztkavzN15wcbN22TJtWpY2849bH7ujahuX2X21qs2fdcom757COKOuP89cW/cuLHrdZe8
Bzl48KBbX+9bsmRJuRX3BbvP2bTNp11FEK0yO68SGDlrtasE2r8/wL7aey2q21eZsSWvEtj5YdQr
AcQdcUfcAXFH3GMVSfDYVads/JqfolY+XX/WBs9Yb2mJNfKObXebtOVyVLevMm7VBftyl+ZXR9wR
978p7spx14wzymcP8t1337nedr1HaR/lVdwl7R+vjm4l8Nn6czZgygpXCbTu0i+vErgU/Upg9cW8
q/cPo14JIO6IO+IOiDviHqvM2X72fjsbxXiZuOGcDZ15X9xbvdvdJm+7EvWY/GTNRdfjjrgj7sVC
T0314n706NF8r/lZZeLj4+3K5Suh5crN9rPN3L17t9yKu3qvo14JbDxng6audJVAm679bfLWyyVS
CcxA3BF3xB1xR9wRd8QdcUfcy4e4S9g3b95sY8aMcRKemppqM2fOtHXr1tnhw4fdOvv27bPq1au7
Xnc9sOnUqVO2bds2J/l6T9u2baP6mRD32BZ3NUrDpndzjVK3D9vZguOjEHfEHXFH3BF3xB1xR9wR
95Ikd1+uPf/881ajRg2XBiMx9w9h0kOVWrVqFVpX6TJaR6KuhzHp97S0NPf7tWvXEPfHRNxn5w63
D2d2s7Zd3rTM9Gx78+1m1mtMR5tzYATijrgj7og74o64I+6IO+JeUly5csXat29v3bt3f6B06dLF
Jk2alG/9sWPH3pf1mrUsKTHJevToYdevX4/650LcY1fcv/p+pLXq9Jol1Ui3zLRsS0vKdI3T/GOj
EHfEHXFH3BF3xB1xR9wR98cNxD12xX1W7oc2Ys4H1mfcO9b303et7yf3i/LeEXfEHXFH3BF3xB1x
R9wRd8QdcY+hHHfJu0Q9WMhxR9wRd8QdcUfcEXfEHXFH3BH3GBP30iiIO+KOuCPuiDvijrgj7og7
4o64I+6IO+KOuCPuiDvijrgj7og74o64I+6IO+KOuCPuiDvijrgj7og74o64I+6IO+KOuCPuiDvi
jrgj7og74o64I+6IO+KOuCPuiDvijrgD4o64I+6IO+KOuCPuiDvijrgj7og74o64I+6IO+KOuCPu
iDvijrgj7og74o64I+6IOyDuiDvijrgj7oC4I+6IO+KOuCPuiDvijrgj7og74o64I+6Ie5Fl2p47
IXHX74g74o64I+6IO+KOuAPijrgj7jEm7p+syROvdb9YRlqyZaQk2YR1p+2T1ScRd8QdcUfcEXfE
HXEHxB1xR9xjRdwVi/0nLraEKi9Z7ZxsVxKqvGx9J3yb99qviDvijrgj7og74o64A+KOuCPuMSHu
G87akC/X2qsNG1uT11q6ot8HT1vtXkPcEXfEHXFH3BF3xB0Qd8QdcY8Bcffy/sX2a/lKNKUdcUfc
EXfEHXFH3BF3xB1xR9wR9zIjSog74v54iPuCE6OtVaf74v7pin425+AIxB1xR9wRd8QdcUfcEXfE
HXFH3GNJ3Gfu/dCGTe9mr73VxDJSs6zn6I42bnHvqPa6I+6IO+KOuCPuiDvijrgj7og74v43y+z9
w636y4mWmZZtWRk5llQ9zdp1fdO++n4k4o64I+6IO+KOuCPuiDvijrgj7rEi7upZb9+9pXUe0NqV
d/u0skGT33NCj7gj7og74o64I+6IO+KOuCPuiHsM5bjPPTQiX4mmtCPuiDvijrgj7og74o64I+6I
O+JeRgrijrgj7og74o64I+6IO+KOuCPuiDvijrgj7oC4I+6IO+KOuCPuiDvijrgj7og74o64I+6I
O+KOuCPuiDsg7og74o64I+6IO+KOuCPuiDvijrgj7og7IO6IO+KOuCPuiDvijrgj7og74o64I+6I
O+KOuCPuiDvijrgj7og74o64I+6IO+KOuCPuiDvijrgj7og74o64I+6AuCPuiDvijrgj7og74o64
I+6IO+KOuCPuiDvijrgj7og74o64I+6IO+KOuCPuiDvijrgj7og74o64I+6IO+KOuCPuiDsg7og7
4o64I+6IO+KOuCPuiDvijrgj7og7IO6IO+KOuCPuiDvijriXGXFXGz3i6+2uzW7duZd9ufd3xB1x
j31mzpxpWVlZVq1aNVfq1atnq1etRtwRd8QdcUfcEXfEHXEvl+I+aeOv1mvcHHvrne6WnZlujZu/
Ye3eH2iTNp1H3BH32GXMmDFWvUZ1S09Pt/j4eKtVq5ZlZ2dbpUqVbP369Yg74o64I+6IO+KOuCPu
5U7c1T637NDVUuKrWGZasmWkJFp8xWejni6DuCPuUePixYtWuXJly8zMtPfee88tO3XqlKWkpDh5
T0tNQ9wRd8QdcUfcEXfEHXEvd+I+YcNZGzprvfX57BvrN3GhK73Hf20T85Yj7oh7TDJx4kRLTU11
Pe2XLl3K1wuflpZmNWrUsJ9++glxR9wRd8QdcUfcEXfEvVyJu5d3pcwECznuiHvM0rlzZ8vIyHA9
7EHWrl1rSUlJlpiYaOvWrUPcEXfEHXFH3BF3xB1xL3fiXhoFcUfco0azZs3coFSlxQQ5dOiQJSQk
OHlftmxZuRX3xUfu2vQ9t23mvjtRK3MOmo1esMPqZKZY534f2ddHLKrbV5mxJ++z//ipLT45zhad
HF+mypyjQ2h9CuCnW2ZTdt2KeryUeNlrNu/wBlt8anSZi8d5P4ywa3aa4Cvoruz2m2UwHn+32fsv
2JJTI8pcPH57YoxtPf8NgVcAK/IU7Msot9mlUdRmL/xxcl6b/XGZi8m5x4Yi7rFEcnKy5eTkuIGp
QXJzc0PivmLFiqiLu1JwKlSo8EhLXKWK9u9PvmD/+s/n7X8+EcXy5Iv2L//+T/s//vf/zf7P/+u/
27/918vR3X5e+dd/vmT/8dT/KJPlX//r/7a4inFWsULFRx4DsVQqVaxoTz//sv2/0Y7HUij/+sSL
eXH+/+Ud3/9e5uLx3/7rv9lzLz6T9/1XIg4DpWJePFbM+/k//lfZi8f/+cQLeeVZ+4+n/1uZi8d/
f+pf7H8982957VMccRihzf6P/yqBNrs06si8Nvvfn/p/8o7xv5S5mPyfeW12xbz6UXXCo46Bf/7z
n7Zx48bHW9yVxy5x1+DUIPv37w+J+/Lly6O2vw0bNoTknUKhUCgUCoVCKW7R9OWPtbi3bt3aSXt4
qsyOHTtcfrvEXfnu0URTTG7fvp1CoVAoFAqFQilWUW/75cuXH29x79q1qxP3qlWr5lv+1dy5bsCq
Zps5efIkiXUAAAAAQI77o2T27Nkuz10lmMvesGFDN2hVywEAAAAAEPcYoFq1ai7PXakxLVu2tLp1
67peeC3/5htGtwMAAAAA4h4THDlyxKXKaDBqrVq13M+4uDibNGkSRx0AAAAAEPdYQw9a0pztq1at
slu3bnHEAQAAAABxBwAAAAAAxB0AAAAAAHEHAAAAAADEHQAAAAAAEHcAAAAAAMQdAAAAAAAQdwAA
AAAAQNwBAAAAABB3AAAAAABA3AEAAAAAAHEHAAAAAEDc4bHh3r17dvz4cbtz506R6/7+++9u3bt3
7/LFAQAAlAK3b992bW9pcfbsWTt48CBfPOIOBfHbb7+5g/njjz/mKydOnLDTp0+X6L4bNGhgcXFx
1rRp0yLXTUlJceu+/fbbHLTHkFMnT7mY9PH5w7EfXOzGKm3atLE6derYsmXLorI9nYuNGze2+vXq
2cmTJwmIcsKxo8ceqHuDRXXzjRs3+KKgQI4ePfpnzJy433ZHQp1eb775ptWuXds2bdpU7O2//PLL
ru3t27dvif8v9evXt2rVqll8fLw9++yzBa73008/5WsPCruw6Nyps9WtW9e+/PJLxB1xLx9IMKpW
rWq1atV6oDz37HMluu9WrVpZWlqatW3btsh1GzZs6NZ9//33y9X3f/yH43bkyBHuJBT2HeVVyi+8
8IKLSVXoNWrUsJo1a7oKPjMj07Zv315i+/7ll19cw/gw8pSbm2uVKlWy1NRUJ+/R2N+ECRPc/67v
YMiQIQRFOWDDhg1OihTLKsG61y+TMA0cODCm/w/VX4cPH+aAPgImT55sFStWdDGjetHXjVWqVHGS
fvXq1dC669evd8vVCfb6668Xex9JSUmu7R0+fHiJ/i8DBgxwny0zM9PVm889F9k/Tp06Zc8//3y+
9kA/5THqDFQd6vn111/dOZaenu7+d8QdcS8XdOzY0bKystxVuALbFzUYlfNKaYh7u3btHktxVwUj
IZXkTZw4kWAsAImsKmnFqCrm5s2bW2JioiUnJ1tOTo5VqFDBdu3aVSL7fvrpp9350LVr14d632uv
veYaoEWLFv2l/b333nsPxIr+1+zs7AJ71KBssWPHDnvxxReddKjo2EpYFOd+maRs9OjRMfs/bN68
2YnRK6+8YsuXL+egljJTp051HQSqG5o0aeLqxqp59UdGRoarf9S5YffuuXWVmtq4UWP32rp164q9
D9WzpSHu6hXXZ5MXFIbqP98eqIdedyLlMJJ+/axcubJL7/GoYzA7K9td5CDuiHu54J133nEnuE7O
h+XeHxVCYSg3/WHEPXjCPay4FydXvqjPXpz/6WH3VRDXr193vSOqeOfMmUMwFsCxY8dcRa0YXbly
ZWj5ggUL3DLF77vvvvu3jlVBcacLWG1fvUGlgd9fv379/tL7CzvfIPY7UXTsJR9FESvpMwcOHHAX
0eqV3bp1KwfxEYm72pFg6mDPnj2dBOu4fP3113+rXSwtcc/JzinWfry4S9QXLlwYWv7JJ5+49+vz
zpo1K+p1ZkFtBOIOMSvuEmfdirpy5YpNmjjJqlev7q7mdZtq5YqV+dZVzln37t1D6+h9Osn0vkji
3q1bN3fbWJWMX/+zzz4rlrjrFq16GdTrqp5KvX/YsGH51vn222/dNj/66COXK6yrb62rK3MvZGvX
rnXb13pxleLs008/jSiQ6kn1+9K6QwYPzrfOkiVL3PJhQ4fZ+V/Pux5i7UdC1r59+9B6s2bOdJWP
ethU1Fjr/3/Ynt3HTdy/+eabfK/5nspGjRrlW65e+vC4GDp06APbViOhGNYxUu+mjq9Ef9fOnS5+
1auj46N9qIGsV6+ee5/yzPU+Hd9bt25ZUmKSu3viG4zkpGRLqJVgs2fNzrc/5bwr/nxMqLdIDdHe
vXsj7k+9UEK3h30vrP63ILro0zlcpXIVtw2VXr165WuEVVdruR9PorEi+n/1OfQ/3CkHjVJZRx0Y
Oo4qkVBKmI6b6hcdSx071RsrVqzIt55iSPGuNAn1NqpHPDiOSIKj80nHXzEswVMqgd6zbdu20Hqr
Vq2y2jk57o6g9pWUJ+jBPGHVs6qzfB2mz63tfvzxxxzMRyDu58+fDy3/+eefLSEhwbVpY8eODS3X
Mq27dOnS0LLdu3e7OqBipYquTlIdozazMHHv1KmT229x0k/0Pl3cKW69C4wZMyb0ui74wus+fc6R
I0cWKe7BDq+LFy+Glk+bNi20XP+bthfcp+pDuYR3FP0f+n+++OKLBy5kunTp4uLfOUNcZXeBjbhD
mRB3BbXWU26czynTyayTTXIkWfe89NJL7oRQBZGRnuFOJp2MOmmDV8gSdzU8ek3raptqCLRNvV+V
UmHivm/vPteo6ETVCd+yZUu3L1USHTp0CK2nk1jLlPOnn/F5+9JPvUfv1fu0P+3fb0sn6s48efMc
PHAgtC99vtC+8j5vMEdf4qZK4o033ri/r7xt6m+9R/9bjx493Hof51Wm+j4kZipqOPW9aj0oWNyD
gz3PnDnjluu7Uw+Tx+eYR4qL4MVTv779Qtt96623nPxrQNSypcvcrWTFtT8+ilOt6wdMqadRx9a/
rm2oYvcNhhpA7T94AapGQcdc55Heq5jTMVf8SMoK259mWfB50MG41IWeluvc8DnwOldV9L149uzZ
49Z79dVX3cWH9uvPS4mbbrVD7Ir7zZs37ZlnnnExo/rE16s6bhLwYI654iArO8vFs2JQx92Lu8ZH
6HWdC4o7n2ahekfnjE93mT17totnraeLS71f9Zf2P+GPmJbQaNs+ZrUtxbfaFCh9cVeMBNshLVeM
+GOqcVSSVB1H38GgjizVO6oDVC9ozJuOuzoeChJ31WM+v1wXgYWhWFYMahuKJX+hqBj2dbEuIl6p
8IqLQV/3KY4KGvsWFPfgBcaHH37o6jylbV24cCGfu2jd/v37h5YpRz7cUXQeaL/BixrVl3qv/n99
N6ovn3r6KdcmIe7wSMXd57j7AFdRJR7MpdXJpnV08vXu3dv1Miov20vCuHHj8smEep6DaJvaRufO
nfOJu04EnWzqSVLqiPI+tQ+dRHpPYeLue4o6tP9T0oM99xo0JaZPn+4+o/5PFS0/dOhQqMdb29EJ
qpNdOcnav5YFZVCfR/sKVibqKfD7OrD/QKj3U59b/5cqLUmkRsBrv9qGyzm0+2kyqiD896LeK60r
GYXI4q7vULIwfvx4l/frLybV0AR7m7SejynPpo0bQ8fq+++/d8skPOFpShIgxYF6Wvbt2+cqdh1L
peIoZnydp9/V+Ch+1IDp8+iiwufaqwFQvPqxC9qePqe2pbxM3xs+Y8aMUJqPjr/fn87L4P70mbU/
FfWQ+Z4y/T+Kn+B5oZ4l/V/6f/3Fr/4XfwEZn9d4qjdVPbK6wNT+1IhpGjaI3R53HavgQOxLly65
46Y40zkR7FVVXGp5ixYtXB66j3HFoOJiy5YtofV9qovuOnp0buj9wfx6DZDWMrUNfv/qgVesably
iHWBePnyZQ5mKYu76gCJq9phCapiIHjHztdBEudgT7XE27f5QRQz4eKuOyk6tl7+i5plZmJevGg9
FbXBHgmw6mhtx0/7qJ+1c2q72Jc/qGMkKN+RxF11mS4q5RFervVTdy+D6LvRa4MGDQotk4eEz/il
z6l1lQEgVB/6/9W3Ga4teYgZeRB3KFFxV0XvR6WraER3sBfHD3YJv02kk1qSJJkvDM2MoJMnOMuG
TjhtV1IeRI2F74HW7a9I4u5TFbR/ybrwOWi+53zu3Ln5xL1mfM18uaHqldf/LlkKUrfO/R5wP0BQ
vRJqILVN37j5ffmKUAIWFHdtM9iATfniC/cZtL5/r0a8+xx3pqoqWtx9r56Or78Qk+xcu3YttK4u
kvwx0SwK+eKixv24UG+i8JKsW6mS5kjozovivk+fPvmWe3FXnIwYMeKB94WLu9IZ1ABIkgobSOv3
F34+RRJ3nVP+PAnH5/77gV5e3PUZNm38s+GRCGqZXiupAb4QHXGPhHrCFWe6oA2KuzoJgtIWjEvF
fXDch84lxeXSJfd7GiU0PibOnT3ncqfVW6sYTPxjueJJ6O6PF/+HGfAI0RV3HWufBqM21Yt8kEji
rjuEqiu0jUjpob4u0faUaqpOB9U5SpUpCq2rWFb9GkQXfL7dC/bY+xz3omZR8uKu/1n/i2Lau4Di
XtvwnXYFiXskdCGi9dSJJ+QKPh2tdevW+WarQdzhkYu7Ti6dREISpBLea+KDP3wqujo593t2wgfT
qdevWbNmodxhnew6qXyOsBd3vTd8bnb11uskVEXk0wLCxX3H9vs98zp5/ewLKuoN8mkDviLy4l69
WvV8+1Hun9YNF59mTZq55T7fXKKkz6J9qcIJ7kv/l/bl8wi9uIdvc/78+aHlfjCM8hB9BTZlyhSC
sQhx94M258yeE7qDoeMSvDOkePHH6oG4SL8fF5+Mu99YaNCWliu2fcpM8NZrUKSVMx5J3FX0e1Hi
7uNC+9fdqqLEPXi3pyBxV3wq/iINZpTQaTuNGjbKJ+4qh78/HPH/8DIGsSnuqpcHDx7sehmVt664
9nf2fC+hF/fw3GaPlivedZdHnR/qqVf9o235u1bqRFCs6hxSD70/h3xM6+d3333n1tVdRy/uq1ev
5iA+InHXcVEKi9o8n/YRPhVtJHEX6lX2d85VHyqdMzhgU/WitqXjrHjT38W5SFNMqH4K7/Tw+9Rr
wXFHGvuj/yOY0lKYuGtdxaouKm9cv+EuOP1nDLa/BYm7OgjlKEprVHwrZUbfW7AjUR0o6rTTNrRN
+YuvfxF3eOTiXlSOe0HBXzu79gPiroZD25OUqldbgqF8S51QxRF3pZB4cfcyES7uXtD0uXTyq5HS
ieiLlvn4LEjcR40aFVHcmzZpmk/cdetN+9L3pIZTtwzD9+Wv8AsS93nz5iHuf1PcFRM+/1DfYXAK
PY+/yNKx0kVmpLgI5ifqlqzGbahy9uMwZs6c+VDirvSAosRdd3+8uAdzUf+OuEvW1PhFEj01SFr+
av1XHxD3QwcO5fv/EffYF3el1il31/eO61a/6ic/hV4kcY90J0ipFL6zQbGm+kiyFuz51N1DxarW
03J1wgTPIdWBN/+4cxkUd6VfwaMRd7UjihGhu8KKAR1D9ZIXJe6+LfTj1lSC42P8XXXFjjoCVE9q
3aLw74uUUuPFPegTDyvuwbvqHt1l0Pmgz+fb5Ejuou9L79d2lEWgc0mOoU6Q8AwAzWSmtBx/h1Zj
AspqXYm4I+4RxV1BrkpDJ0QwX9unyoSLu7YbfitNwqXlkh9/Szdc3CUcOpH0uYuahuzvirtm8VBF
EEzLKYiHEXfNFOLF3afaQOHiHpxVRnGiyl/foU/zkFD7uAjmaRaFejN1a1cVd916f6YYSGp0foQ3
Jg8r7gvmLwgN0ArvsQlO4+b3F34HK5K4a+Ym3xMUjr9l7tO9EPeyLe4+F1nHKV9d9UeqTHHEXR0F
knW9rge/KTZVLwXHh/i6SrGqc+56IA0tEsr39eJeVN0IJSvuwePoB5z7MVVFibtn/LjxLna0PX+3
O5jjLufz42qKSpfRe1Sf+tQTj+70ePEO5r7/FXEPn+pSHTNe3P2d2HB3UeePd5Tgd6Y7A1ovXNw9
uhDwdxF69uiJuMOjF3cFrCpzSYiK5CA4yKO44q6UEAV38KRQnrp/eEy4uGuZn8td623csNFVLloe
POEjDU71s2Loatj3NgjtNzhY6++Ku/C34FSuXvnzaXQaQBPsrXoYcRe6Fa3KTVf9ysUOH1gDBYu7
cg7VU67vLzhoWJWyjpNiLhgXF87nP1bqRb9+7c/XNcuBKuXg1Hl+oLHiT9vauWPnXxJ3DQTVLVl9
Jt19Ui6+xjho1pngRbPiNLS/a/cHaxck7upZ84IejFV/QeOmav1j3nvEvWyLu2b0UDwFxV3jMvzg
9uKIuyRbQqPYUEqFRFsxpJ5yxaJHU/4qVnVehT8MR/ISlC091djHoKRJKZY8RfXRi7tmjfGDTv2Y
nkjivvDbb23NmjWh9+3ds9e131rPDxwNn1VGnQE63qp7lbJaEIo/fTa9/4vJ96dZVFqLZvBSbKnn
OpiS+7DirjjWHSDVYToX9D/rs/vpJAtyF/XS+wtTv3/Fv94X7HG/fOnSA1NS+rTiovLlEXcoUfyU
YArI4OBUnZRPPfVUPoEJn1LJBXLG/eme/GA6pQGo11AngU4iDepQIyDx9bPXeDTjgU4qnzuuovfk
/DF3sJcWod5Q7Sc4CEtSom37XkedyDph1SPwxBNP5Kvc3HR9latErFjC56Jt1OD+NGrBGXCU0+nz
ocP39eSTT4bWU5qF/geJWxBVFn55sIdVA2G1TT/K/q88CKu8IxHQd64Y0oVhEM27ru9Px9DPiqJc
24LiInisFN86HrpA9D0pet/ixYtD60iI/KAnxed//ud/hoRXEqRlkXIe/XSQwQFfOke0vo61H0jm
0308ujAN7a/Wn/tTI+r3F5wO0k/T50W9RvUaoYY8OC2fnw5S2/AzIIn9+/eHthvpAgRKDwmNjqMk
Ixwdf5/Trtc1w4yf8jQ4kF74wfnhgxOF6mM//a6fm1oCo3gNSopSLNQG+Dta6Wl/ptcE0yj8Raqf
VlTbK+rJlxA9NJOP6gsdq3PnzuV7zXcK6bh4cdexUn3h0wGVBqUULB1jCatPsQlOD+t7t4P56KpL
/ZS1BSFJ9xeRer+fclnxozgKf0iScsy1XqSc+PCOHL9//e/eWXznjl7TBWVB7qK7q/5c0neheA06
iu9c1KQUmqRDn1vfjb9A1XnHdJDwSFFutQJXvY3BorxzzX/tUc6sTsJPw+ZtVQOi5cGBUBIABb9O
Dp0QEhYJgk6u4DzaknA/PZ96AHRieDne8MeMIMELDO0nvDFSOoQ+g7bjGyJ91mCvkG6N6aRWxRBk
2tRpbrlynIN0yPuM2lf4QFzNwKG54P2+VPSY6eDDHnQxcb+hy9/4qlfDDahJzb9c6UQabOYfFFTU
vLiPI5qFQANLU5JTHhgUpWnt3HiIWgn5cmy1PDwuJLnB2Xv0uy4k/eA7pWyF5+kqVUvnh39gUtc/
Lhx1u9dPdRapEvcDXnWnJYifQlXb0h0g3WlRylRB+/NCpnU0t7L2F/4AJjW+vjHUe5TzH8zT9xW2
+7zJSXbyx5Oh5Xr+QvIf/wf1+aNFdZvkQfVXJDRVbdofAwgVz7pbozm6JRa6exjs5FD9Ff4wGfUq
+piV8Km3XXewdPEridF2g+mNX82d6+4OKaYUW9qPLi7CB6Gqbtf7K1ao+MCzOqBkUbvipy/WXb0g
ignVjTrevmfZp8H4ek71iu706Ljp+KuNDu9N9g8wUswE293UtPvzxG/cuLHAz6dOKo3X0Xb9QwsV
35He8/prr7v9BKeWLmibqtvDfUWpO+H1Xj53CXSiqPND9aR3FOXh5+7LdR0f7wY6PHRO+umxK+et
p/Y/OGMN4g4AAAAlggRKEiJRD6LeSckfd10AyjeIOwAAQBmhR/ceTtz9cyOU/qfnC/j5tiMNcgYA
xB0AAABKGQ06Ve6yBD2YQqYUmNSUVDdgGgAQdwAAAIgRNNhbDxrTQG+VSA8QAwDEHQAAAAAAEHcA
AAAAAEDcAQAAAAAQdwAAAAAAQNwBAAAAABB3xB0AAAAAAHEHAACAh+bixYu2ZcsW+/nnn/ky4LHh
1q1bLu6PHTvKl4G4w1/l3r17tnz5cvvss89s4sSJtmnTpgLX3bp1q33xxRc2evRoW7Jkid29e7fQ
bf/yyy+2bds227x5c8TXd+3aZdu3b7f9+/dzIOChWb9+vU2ePNnGjx9vq1atKnJ9xdmOHTtczEVC
cap4VdxC+WXv3r02Y8YMy83NLXAdycXUqVNt7Nixtmzpsr+0n3Xr1rmnoE6ZMsU2bNiQ77UWLVq4
ByzVqVMnqv9bjx493AOc2rZty4EuR1y+fNnmzp1rS5cuLZYAqo5TKY4Hqk7clte2R6r3zv963rX7
wTpz9+7dVrNmTfewsId9MNjAgQNd3L/44oscVMQd/gpDhw61uLg4S0xMDD1uWyeknuAXLuw62XSi
xsfHu3WTkpLc0/327dtX4PZnz55tFSpUsKpVq9qwYcPyN5579torr7zittu3b18OBhSbr776ysVe
MG4TEhJcbJ47d67A90lmJDWKSQl6EF2M+gZFj5uH8km3bt1cfVSrVi1r2rTpA6+vXLnSxYHiKTk5
2dLS0lyc6T3Hjh0r1j6mT5/utqH3+aL9KT4PHDjg1nn33Xfdtl9//fWo/n/PPfecZWRm2LPPPsvB
LieoHVX8KR5feuklu3PnToHrnj9/3l5++WUXv2rLFXuFce3aNXvhhRdcvH700UcPvN67d2+37+ef
ez6fN/h4nvz55w/1v4waNcrFvd4PiDv8BZ5//nl3guvk9o1U3bp1nQh17949tF6rVq2c7Lz11lt5
gjPGiX12drb7qfcXhral9SRMQVq3bm2ZmZmuUiiq5x4gSHp6uqv4dSGZkZHhLiIVt1lZWVa7du0C
3/frr7864VfshguTHi2v9zdq1IgvuByiizEdY8WNerl1rFUHhdOsWTMnPKqvFCeq3xRbqsMUZ0Ux
ZswYF5eKQ/1s3ry5tWvXzu1X+x8yZEiJivvneSKlelp3CqBscyFPwuvVq+fiSG2l4lC///777wW+
p2XLlm5dxbdiVu8pjJs3bzoBVyx+8sknD7yuDjfVt9WrVQ8tO3XqlHOCNm3aOPFH3BF3KEV0Yuu2
sWf48OHuJFWjE2ykZs6c+UAupioHrafG6NKlSwXuY9GiRaGeUd0yFj//9JN7n07gESNGRHyfckBP
nz5d6OdXms/Jkyft9u3bHMzHCKUZrFixIvT3ggULXHxJyHQhWFiPVNeuXV3sKv5OnDjhls2aNctd
uErYdNs4EurJV29WYWi/ikcuRGMPCY3upii1SjKkGIgk7p06dbL58+eH/laKi78wlDSdOXOmyAtD
xaGE/4ewHvpRH42yadOmFSjuqmNVpxXGb7/95sTp+vXrf+l70PuKeq/SH65evUrQPGK+/vpr17nW
sWNH69Wrl5PxwsRdd79Vr6ld1l1sdWqUhLgXhdJ6rly5UmxxV9wXVmcj7gBFVNhqcHTipySnFLpu
kyZNnPhXqlSpyO1KqtR75S8G1OukykCSFd5QffPNN+4zVK5Sxd2+U0Oo23XhjZd6lbRvraOf2j4n
/+OLGjQJkxouxUdhcqWYkbhJ4v1FqEqk3vYJEya43tcqf8SjSngDd/bsWXv11VddrOr1ihUrup5b
iB10cafOAKG6oiBxj4SOvwRIglOYuCt/V/Wa6rtv8+qxwvDi/vbbb9u3337r9qHtV6xQMWLqoC4o
/YWpYl1xrnpy4cKF+dZTOphSH5o3a/7A+/W5tB+9V9sJj+M+ffrki3PtR+Of4NFw8OBBN45HjBs3
zsVLYeKumJYQr1692nWI+TvoxRV3jXML58MPP3xA3Hfu3GlPP/20S8cK5sXrs6qTTvWg4ks/1TYr
vcdfoHpx10WFtuPvnGrdVm+1QtwRd/grjZsqd1UAusovrCdAJ6hEvHPnzkVud9HCRaH1NfjVp+Wo
hz+IevZ1wmtdNWjvv/++O7H1d3A/jRs3dik46oFQI9emdRtXkRTUWwrlG+UNhy44U1KKXP+9995z
DYfiSuM39DNSb3u/fv3ccsVgly5drGOHDi6G1dBoQKxHr6txk7xLfl577TV74oknQqIIsYXqjeKK
u+76+fQaCW9h1PsjpUZ1WFFI3PU5dBHh5UVx6Hv2JfMejcfQxaDWl2QpzvQevVeCHVy3ffv2rm59
8403Q8s0mFCpjn5fqn+1nWAevFJ6tFxFA1zffPNNV8dqDBRjPh49GoNTmLhr4KqOrR+fpnbxYcRd
9Zf2ob8vnL/gyu1bt23AgAFuzERQ3NWG+3EbP/74Y+giQzGq+FFsv/POO64u1v61LCju2pfOJz/A
VdupXae226ZSzRB3gIfA562r4dGJGEQ93OqF94O2dPJFGsxSEGoEJFb+Z6Te9qpVqrrKRhWIR7OF
aH+6Ir+QJ0KqtKrk/a5lwZHuuvIvrKcVyi9qJHxvUzDNoSCU9qL4U+OheFTcN2zYMN86Fy5ccDGn
xifYq6leKcWo7giJQ4cOuYZP50VQ1L///nsOTDkQd128+XEUmnWrMBRTqtu0/eKKu2JJHRTBWNLy
4KwwXtL1mT2qB/Ve1dd6j6dD3sWllrd4s0VomR+TpP/BpzCcOnnKXWCKjRs3um1oP8ePH8/3GX3q
JMS2uOv46cLSz5T0sOKu9XSsJdPB4tNtguKuGZe8uCs10O9P8aXB356RI0e6ZboQ9HhxV4wrfc1d
KOTVtapnFafaH+IOUEw0mEknj0qkW7X169d3t71Ucehk9L2bc+bMKdb2fa67ZEknbnhuu3JJ/UWB
hFx5b0rd0QWE9qeydu1at656mXSSK1e1oKkm4fFgzZo1ruGR1DxMeop60PUe3/MT3tuuafwU34pZ
xaHyinVxqNvQWq73qNHS4KxKcXGhAa+FTTEIZUvclTPsB6mGz7QVUdwr3xf3omQpKMWqw4JoIKuW
666iOHz4sIs1xZzuiAbR7DW68FT8e4EKF3eNP/LjiSKlQgilImqf+j9v3LjhelGV/qXxAFoePrEA
xJa4S5DVdupui+evirt+D5biirvkXJ/h008/Da2n+FG7/cYbb+QTd30uxXQQn5KjzjvEHaAYqAHw
M3QUNauGBoJu3rQp1BOjXknNV1wcsv+Y9UP7Cu9t17zwknZVEmoodNtNxfd6qjdr3rx5bl1Nj6WL
CH0GVRaqQIp7AQHlh107d7qLOJ8C8DCo191PfRop5pX/6xs+pQv4eFRsKh4Vf0pBELqdrOW+x0rv
C5+3G8qWuKv99B0EqoOKczcvvma8uxAM9oAXJu6Kk6DUCI270HI/VaVizM/8FZxIQCxetMjVmXrd
3yENF3ddcComJVAF1dP6LPo+/JglH+uqpxXrylHWg3Mg9sRd47pUP6n+C97xk7irPlKHW3HEXesq
TUXb08WeimJe4zbCU2UiifvsWbNdrCgedddTYyP0eRWbwbEUBc0q43P4i0pHQ9wB8lifV5lLOiTt
D/MwEM2lrd4eVfiaiaE4aPooSZYqmnC8uOvk1cNRJOfKeVfRrB+6eldvUDDI3+nY0X12NThqZL8p
YkAYlB90R0aNmCRMjcDDTksmFDt6v8ZTFCTuaowWL17sYtDHo4oeRBZEd4k0240aHsWjcorpfS+b
4q50EgmH6irFSFGzW3l0AegvIv2MRUWJe/h0kLoTVJC4hz84bNmyZSFx98/TCBd33S2SuGs9zVFf
0GdR/a99qg4NxrmviyE2xV3irOOrDgbFgV4PTh+pjjJdeIUPYg4X94cZnBpJ3P1YEDmBH9yscyf8
WQkFifvHH3+MuCPuUBx0Asb9cZv/tebNH+q9XtxV4fsczaLQ3K/al3qwwlFvkG+gwvPri9MQ63Po
wgDKP8H52IuTT1yUuCs9IRw9NdOnxDzMdKPqyVcMqxHyc3ZDbOHzxSM9XVQ9yxIfraP67WGmXdTF
nGKmoItB9WYqj/1hxN3nveuzqPMiyKBBg1y9p3PB38EMF3flD/u7QeEPwdNromfPnm47xblTAI8G
L7aKzSCa5UiDjCW8weJTXCTummVIF3lFiXtxp4OMJO5K+dJdHXXAaTC19hfpSayIO+IOfwM1SJJ2
n3OuOdanTZ1mkz+f7IpmzfBzt7/y8isuj27Xrl1uBg/lq/t53HXSq0fy74q70Emr11XhnD1z1i27
d/ee7dyx0zVSQr0NHdp3yFcpaJYFnfTBh0ZB+SUpMcn1aisGFZfqFfRxqxxLn8Lyd8Rdt511fuh1
9aT7uz2SLw2Y9rmcP5444eZY9vNeaw53NWDq4dRUkhAbqN5avGixS2HygzU1OHP9uvUud9yLr384
k4rqHHe374/YUo+kZtQoDNVtqhdVHylPXY+o1zgMjSFS+omfgrS44i70tz6vZEn712wfGmvhZzMK
3jmINDhVn8e/Xz2vR44ccemRTz31lItXzawkIdS2NCuS/y5052H+vPnFGvAN0Uffv2YM0tguDfpU
TOrCUHKsNtdLs6+XfBE6jpHGUJSUuCcnJYfqSl1gqmNPF7LB520g7og7/E0k4cob15W5in9Esi+6
1e9zyvW7TjQ/NZ7ExPfQFHcuZKFGSpWAbt1FYumSpS7HUiewtu1vt+lzqtET6v185pln3HL/KHKt
r/epQYLyf8GpWPBxq1gMxq1k21/kFYW24ySnRYuIr0u2FF/q7ZTY+HiUnPm8eN0dUo+Wn8ZUr7sG
qEZ1HmITQyiXXMfNC6pixx/X5557LjQL0IsvvBiKLf9QLl90/Iua/lY55VrP341UfCou/PzWn//x
iHj1yOs1PQ8jiGZI0vIGDRqElulCNDimR59ZP31OcTD/XncR9P7Xmr0WWqbceNXhutDVa6rDVfRw
n+D7tEzblDzpf9BPva9///4E0CNA47bUVup46zj7uFTbqOMiCS4I3UXRsS7qjqTqU8Wl1o30tF3l
uGvfcZX+TG/1sxCprvMpYepl97PN+eev+DjVT18Xagpo7St8ylT9L1oeKY0WcQf4A90mVe+PKuVI
Rb3Xe/bsCTVGWqaBLr7BUwOjXp+HQT1W6knq9G6nQi8o1Dj6Sko9RUrFUa+QR1fzugjQ51DRvNz6
jPB4oN6nguJWDZZ6pIqDZmGQOOlOU0EoL1iSJaHx40DUmxW8SNQ0gZpO0j9YRLN0IO2xJ0G6MxIp
ZhRPPm2koHVU9FpxBsGrx1o9iOpxV0xImFWn6U6NR683adzkgYtM3clpkve+cFlWe/7BBx/cj7H0
DFcXRxItDTDUdocOHZpv+ZHDR9yzOSRXqjNV9+suRBDltGv+du3DP5dAs38pNQ1KH80opGNeUD0X
jKdw9IRexZ/eXxRKMVU9GOlhW7q7ru3obrnn6NGj1rRJUzf3v39qumb0UtyoLVbdqDEXukjVMsWb
j3Pd3dL2wlPJdCdIyx+mIxBxBwAAAAB4CDQI3z9IKXySAHVk6CKwZ4+efFGIOwAAAAA8So4dO+ZS
uXR3XHdsdFdKabZKv5K46zWet4K4AwAAAEAMoIGoPq9dP1WUx65c+IKmogTEHQAAAAAeEbn7ct3M
TevXr7cjR5ksAnEHAAAAAEDcAQAAAAAAcQcAAAAAAMQdAAAAAABxBwAAAAAAxB0AAAAAAHEHAAAA
AADEHR5fVq1aZWPHjrX333/fJk2cZPv37y90/evXr9vXX39t33zzje3Zs+eB1+/cuWPzF8znYQ0Q
YufOnTZhwgT74IMPbOTIkQ88fe+3335zMbVo0aKIRU/vu3TpUoHbv3T5kltHMbk/N/eB12/eumXz
815ftGgxB6MMNHoff/yxexBMOHoku45xpBhRfbNi+fJCt7182XK3Xvh7F8xfYLSzUJocPnzYtbtT
p06N+HqkOPWxWhRa79tvv7WjR4/yRSPuUJ44c+aMZWZmWq1ataxmzZqu6GlpL7zwQqHv6927t1sv
OTnZKlasaMvDGktJmpa//PLLduHCBb7ox5grV65YUlKSiy39TE9Pt7S0NBc/7d9+O7SeGhk9Tjsx
MTFf0XsUZ3p63/z58wvcT5cuXaxG/P2YrFChgntoSBD9re2/9NJLduPGDQ5MjDJq1Cj3lMbU1FR7
5ZVXXCdAED2KXbEUHic67irPPvtsoR0OOv5aT+9RveeL4qtPnz4cACgVhg4dGorzF1988YHXr169
6tpPH6vBovb59u3bBW77119/de/V9j/99FO+bMQdyhNqALOyslzDNXbMWNeTNWbMGMvJySn0fQMG
DLCMjAyrW7eu1a5d29LT0vO9vm/fPktISHCPSC6slxTKP7qbExcX52KtdevWlpqS4mJOsaP4WLFi
RehiT5Jep06dUNE6DRs2dL/rNfUiFUTP7j0tI/N+TCp+JXhBtm7d6ho97fPWrVscmBjj1KlTTlIU
J+pM0HHUxd3vv/+eb73OnTu7+AnGSaNGjUK/S8ALQhdsOv6qsxo3bmxt27a1Vq1audK8efNCLwwB
osHx48dd2xiM82rVqkW8yPSxqrjWTxXVbWqvC+PixYvuvbooiHTXChB3KKN8/vnnrqGsXr26O9Ef
hoEDBzpxV1FlIqmaMX1GscX9bl5jfOTIEZdmo15/KL/s3r3bhgwZkm9ZkyZNnFir9z38tXDe6djR
iVqVKlXs7t27BYt7j56uIdQ21dBJ0oMiVpS4q4frwIEDruh3KF2UJvXMM8/Y4MGDbdCgQe5YRhL3
SCjNSiKk+qhXr14Frnfz5k13/HXHR/VfYduLFCOKP20j+Hew5/P8r7/atm3b7NrVa4V+3h9//NFd
qJ44caLQ9VRHar3z589H/F8K+h8jXbB4VOeqRzacX375xe3r2NFjBGMJMmPGDBfnI0aMsL59+7q6
rTBxj/RaUTysuIeO/bFjxY4pH1f37t17cP0bNwu9I4C4A/xFXn31VdeAKe3lYZG4p6SkWNeuXV3P
lSRMol4ccX/vvfdcD6waZb2uCwf1Ipw9e5aD8pgwOU+aFHsqH330UaGCo/iQkKmRKwyJe0pqihM3
ibtiKjkvRosSd0m6elt1W9nHpH5v1qwZB6oUUU+kFwflt/t0quKIu465YkSx8tNPPxVL3D/55JMC
13v++eddDGh7wYb4ueeec9K1YcMGt0ypPEpbOP7DcevQoYO7uFS9p/ot0gWEpE3b1Gfwsab3zJ07
N996ShvTnQN9Br2utMNOnTqFXtfFqfYh6Quiejh8eYMGDdxnXL1qlYtp7V9pFEHJU+eL35dEUdvQ
+QLRRxdjJ0+edL8PHz7cHctHJe47duxw6ygmfDwqnbB///6hdcaPH+/iXClowbTXzyd9HlqudEjP
lClT3PInn3yyWOcu4g7wEKhh0Emr9AMNFFQPgHo/v/rqq2KL+7vvvGvr1q1zQqS/dZIXJu4SKu1T
PfRN8oS/ZcuWlpD3XjU4ajgK61GF8sPrr78euthbuXJlget169bN9byqYfn/2zsP7yqqrg9/f5LL
xgJ7o1pBRQEbHSkvJYCKCliwo6KAgAiiEqqFF5SmBFGpEQJIVV5QCEEQCCKKgPPdZ4c9nEzmFjSB
BH/PWrOSO3fmzJk5+878zj777PGHXU7hnrHBoUOHRgsXLoxjnnmQ5BLulO3zPAiZIOyCchCCCDxx
7hk9enTBwh3PHuIGe8rX2XLhjlgiJJD7DR03ltArzT3R51e4qO7Ro4fVCdt1sF9EL0KZcptnFtZx
n6Pu//3vmUmETECkntga9lVUVGT2SQcTwTx/ftWkaUKGEOpsh5ODDka3bt1s3obTrl07+x6nSQgi
nfU4ZRzqTf2oJ/de6kn5wPwB6sT1oMyJEydGPXv2tM9sw+RJUXeMHDkyr3DHBpctWxYtXbo0Kikp
iY5UVtaKcN+6davZFL+bFs1bmD1iOyzYsDv02I57I7YahioS9ohdsX7e3Hnx+r59+9o5cR/9NyPh
LmodhAs/bB4w/MgQLyzcJFyEFyLce/fsbZ/btG5jDyD3UBFukBTuzJBnHftNmzYtLosHFscNhb+4
cEEMIGqwF2wvlyBz7yHiIx8u3AcOHGif+Z9jYINQWlpaQ7i/MWqUPdwIs1i3bl1cFqMAiDTs1WPw
Rf0U7u6dp61WrVxVkHAnrhjbo3wWnAa3ZO5BIQgYRA02QxgBNsJ2YXiLi3TKXLRoka3je7bF9tre
3TbeFk8m5XXp0qXacbBT1mOHUFxcbOuoV1KMJYU7IWchzAdhPQI+FO4ellY0YEB09OhR+y0AE4E5
FuKrWgegw312Tek4i/Mj3Gkn7n8+kuQiHjvKN/pYiHBv3759LLzTnCo49rwz66OejLA71Bnbx97I
FBY6QjguGcQk3CXcRS2LJ3rR/PD44RJXiuezT58+9kNk3fhx4/IK9149e9lnPAKUx82eVH94jZLC
He8RP/7mzZrXKI/jcVx68eLCBhtA1PAAIhQmGz6M3CJjRytXrChYuBOyAHjdsUEeImRW2LZtWw3h
7g+ejh071igP4cTxXx35qhqtHgt3BAT2VMjoiAt32h3Rwj4+Apj0EBKrjgBnWx+BCQWKC3dshAwh
Idgg5ftEWTIauQc/GYKCR516cB4nTp6IVq1aZefN/oxIEs6Q5GyFO+vwuCdhHedFZxfPKoIepwuC
nfWcuzg/wp3REMKjEOmMhPD8dNvl76xZs/62cD/22zHrhGJ3SWcZ9ukOPEbTAbvHHjwcduOGDbHt
e+IAd9h5hrp/expKCXdR67jHnQcSmWRC+BFyo+ehUahwNy9N5mFhw26ZHy4PG8R4KNx5OPBDTxNJ
/iAKh6HFhYcLZR4axPHmwuc+tL6jdUFlJ4W7H8+9pggxvg+FO+IIm0zzYCG6eFiF8Z6ifgl3Ru5o
UxbixwsV7pQ9ZcqUvNsTNoL9YEfc1/Yn5uEgXtxZkSbGORYTXXFseErU5GR8Qrl81OfAz1WTRnGg
cO6U4Q6R8H0Z2UJlsgl39h80aFCN82O9ZQU7HRrjC3XxzCfi/Aj3NHwkG5tkXs7fFe7EqvM9z2gf
KXI2nBbl2KuneSYzmNtvRUVFNHnyZLNLOhSeCYoJ1Bzr1swxCb35tyPhLmod4uf8wTAu4VnnYcDN
P1eMWppwL1tXZjcDxFbnTp3tgRAKdwQVQig5oQoYuuaYuW5GomFD/LiHZWV74YjD9y7Ipk6d+reF
+4oVK+KwBWzLbdKFu2dGIsVgEjoXfDdixAg1Xj0V7ggT2rZQ4RMK93xheZWVlVGzps3i1KJp90oX
7sTLhyQnHRKfjPBheyYnhhRPLY5jz8MJ+nQ0XcD7CJVnO8KOuV8mY/r93p0m3MPfhcPvhe15BwK/
FWKofSFEjLlKov4Id8Ae8s3nyCfcEdnuuEtOjOYFZy7cXdSfOnkqnhM3d948i2OnHhV7K6L+/fub
Y4T4d5xzlEm6aAl3CXdRB3ge2WR4Cj9CBAs387MR7kD8JjcVHiyep9uF+7Bhw6xc1p1KPIx9ghQh
O+LCA88lN328M8kRnjSwQWwoV07uQoS7iZlMBzRpky7c8VDSkUzO6diyZYs9vKjv7Nmz1YDnGASy
C/ds4AXETrhvcD86W+GeLwaXyXo+GRVx4hlbwjR32byf2LqLfRfheCjThJKHJ4YZbEIQz4goFn8T
NR1N73SGcC04bqHCHeeMhdwkPPfi3EBCiLMR7njK/d0r3FMLEe5pI1FMymZCNG0fxq0D3nTsJZmh
CTvC3gb0rwoDc3vFyYJtItqxPf5fWrJUwl3CXdQFhAdw0+DhQ7wcP1IycvDj5EZCrOXZCndSurEv
Aikp3Jng5dkf8Mgz7EesPSE53Ah4KOr1zBceTLZDtCCcEQoMr5K9yJdkOtIFCxbEb1h9+Sw6ctmE
++ZNm+0h4zaJGHThPnPmTLN/87oPfiR+twATt3yC1ok/T6gRzwGEkCCmuRchml34EkpCzvVNmzZV
2/7ee6petMXISFpe8lzCnfsN7U2nbFrxNFvwTJauqZq0idcRm8E2iPPlHuYZYcKQE5+cSj3J/ILX
evjw4Wa7iKbwHQVsS335SwgC84DenjAhfjOwx8mTz577697yvfYZz7e/b4MwBmAUiGOw4BDB28n/
Pn+kUOHOb9MTBlBX0vpxjegsECK2fPlyGWYtQ7tPmjTJ7Lxfv37xxGTeg4JoZi6Od856dO9uc89I
5UmnzR0Q2CLr8gl3tsc7TigX3v2Rr4yMnn+uyhtOZ9Tj1gntol542H2+WYf2HaqV6SFd2Be/H15e
5s98OhMeUsbvUUi4izqCFycglrmp47lC0PAQ4aaQz4OF2OLH2qVzlxrfcUPgZsCPn3RTYe7XYZmO
gc8658bicXYMA4eZZsSFAy/TwVawMwQC/4cLubFDLyb2wLbE2oa2k48hjw2J386ahM4hNo5NkmM4
TP3HKJF7Q90m+R/bxVMqzg14ops0aRLfhzzPP+1BW4T5/r/5+hvzGGIrhGAVCpk6KMvueTe3irPK
sGBvPp8BEULZYdYjRJbfq5jI6WIcIYVQpgzsj3ubjy6dPHkmvS0dQo7hGXDYHpvE9sJ5P3hIybPO
fZhz5HsWOgZOeXm51QN79vh4ln4ZkcZxw7cGE1LB8bJN/Od7yvd7P8KLv40bN66WzlLUDoT+0b5p
ds69yd8vwIg37UC70j4+0R6bSE6GTkJH1m3NY9N9ueSSSzIP/6pOLJ+517EN9fG0j/wN75Eu0C3L
TZvWtl84R+T666vmA1FWrpEACXchagEmTtETZ6gXAcOwGRkQ8kEKx4FFA6Mp76ZP8CLNGDPi8Swk
IX4SbwJD0BwXz7887RcuZCkYO3asZXZJWxgudnhYkMEAO8z1Zss05nwyx4ZrpxUX1/iOoeFRmePg
LU2Lr8fLiQepa7euUfeMQOLBeLZvExb/DDx+b44enWoj2E/YiSJMhvsLdpIvv38SYtuzHQOPOeKe
cADuUWE8OmKIbCscl1EhF+6II+5zeKkR1506djLHB/fWJMQEE/+OWO7WtZs5OcLc2A7eTQQQ90g6
JmnhWtQNbyr3UDKOELfMtaBMzsfBizt40OCcjhE6TexHnXgOPPH4E/abELUPAnh0FjtnroSnpWU+
A7bKfcnsKmMzdCwLza1PmtS0Y7A+hI4CozIcg85d2jPbwXb5DTAyH06yZgQJG2RJjoxJuAshhBCi
XuDCPex8CiGEhLsQQggh4S6EkHAXQgghxNlCHDgTmJUyVAgh4S6EEELUY/bv328xvWnx7EIICXdd
CSGEEEIIISTchRBCCCGEEBLuQgghhBBCSLgLIYQQQgghJNyFEEIIIYQQEu5CCCGEEEJIuAshhBBC
CCEk3IUQQgghhBAS7kIIIYQQQki4CyGEEEIIISTchRBCCCGEkHAXQgghhBBCSLgLIYQQQgghJNyF
EEIIIYSQcBdCCCGEEEJIuAshxPlh9erV0a233hrdcccd0f79++P177zzTjR+/PiosrKywZ3T6NGj
o5tuuil6+OGH/xVt+OOPP0a33357dNttt0UbNmyI17///vvRmDFjovLy8gZ3TkuXLo1uvvnm6M47
74x+/fVX/VCFkHCXcBdC1D1Dhw6NmjdvHrVq2Sr1+8eHPB41a9bMhPP5YPbs2VGrVq2sDlu2bLF1
n332WXT99deb+EW8NzR69eoVtW7dOrrxxhsbTJ3nzp1r9UV8X3vttdHRo0cL3nfFihVmYy1btow+
//xzW4eAv+aaa2z9k08+2eDacMqUKdEtt9xiNvjTTz/pRiKEhLuEuxAiOzv2H4vW7joSlf34a86F
bXYe+D1rOQMHDjQR2bxZ89Tv+/frb9+3aNHivJznJ598Yh53RN+2bdts3bfffhs1atQouuKKK0zY
1wVPDR8e3XDDDXVy3v369TNPbV1d06PHK6MNe7+ONu1blXdZX/5VQWV27drV6ty2bVtrj8mTJxdc
H0ZN6HzhoS4pKbF1+/btiy677LLo6quvjl577bU6uQ7z58+38q+66qpqozW1wQcffGCdGDoee/bs
0Q1JCAl3CXchRHbmlu2PRi3+KRqzZHfOhW0WbPwlazmDBw+O2rRpE7Vs0TJd2A8YaN8jvOqLcD8X
PPbYY3beeJcbmnAvP/K/aMLKx6P3SkfkXcateDRveQcPHjRvO6L9rrvuiu6++277Wyhr1qypIdzP
BR9//LF5xRHXFRUVtVr21KlTJdyFEBLuQojCmL/xQDSuZE80cVl5zuWtkt3R55sP1qpw37p1q3mk
58yZY58JV8Ej27dv3+ijjz6qUcb6svXRyy+/bN936tTJRPG8efOyCiJiv3v06GEhMYRWJIX7qVOn
ohdffDF64YUXol07d9o6PLhPP/109Mwzz0Q///xzXB6eVlv/9DPRL7+c6cAQl0ydOFbPnj2j559/
Pjp8+LB9R9kPPvigCVVis19//fVoeOZ8Oa5z4sSJ6M0334x69+ptdeX7HTt21DgftqPsLl262LXe
vXt3NGTIkDoV7hW/7oreLX0mml42MucyreyVaNLq4XnLe++996wNqDPtyzUhdGlP5lxSO5Vz51rn
pHPnzuaZ3rhxo4n2pHB/9dVX7dqsLyuL1z333HO2LF++vFqZbMf6lStXxuv++uuvaOzYsVGfPn2i
bt26WRvsPl0njtu7d2/rYGC/fIdtfP/999XKnT59ejRgwACr6+BBg7J2LJhTQTtT5hdffGG2L+Eu
hJBwF0LUe+E+a9YsCyPp379/1LFjR4vz5Xu2wzOL0HPeffddC1VgG75r2rSpCT8+jxo1qtqxENCI
Wb7nL+IQ4XXPPfdUE+54gImPpoxPP/3U1i1atCg+Rij6lixZYutYli1bZusQ8IRQIEaJlb/uuuvs
M9cCCOHguPfee68t1IWwnK++qgor2VtebvtwzuzPgiilDLzLzp9//ml14nw4FiKP82/fvr11ChqK
cL/vvvtMpNLROX78uJ0Tcx6S7QfPPvusnSPf02a0IXZBGyaF+5VXXmnXZMKECfb5yJEj1q5clzB8
5tixY2ZDrKcODm3KdcUWaQ9GR2gv4C/edm9D/mebl156Kd6fkQPqSDl85//TUQt56KGHrK1Du2Rf
zknCXQgh4S6EqNfC3cNXELeIuDGjR0fTp023bRCkiBln5MiR5qlFQOMJr9hbYV539kVwOYhtBB/r
u3fvbl7Np556yspEeIXCHc844gkxhmAHBCHCkO2JqXYQ677eBf2IESNMiHbo0KGawMfbD2+99ZbV
kXNhu0mTJtl5OJw7cf9du3Qxry88+uijti4MrcHT76Id7zJ1vf/++2Mh2xCEOxlfaGOu/7p162wd
HQ/alGsTwiRNOjGIWsQ+54u4xx7ShDvlUobHyzPhlXblmpFtxvnjjz/izsIbb7wRdwgpj2vLqAbQ
7oyCAGEyRUVFVk/ahVEUBDkZbgDvO/bD8V14M+GUz4h498wvXLjQ2oly/vOf/5hdMmLknQIJdyGE
hLsQokEId4TT11+dmdyI2EJcIbJ+++23rMcsLS014YNIO3DgQCym0zKt4GFlfW0KdzLpUE8E5u/H
0ifuEs7CeSNEQ7777rs4QwrhOQ6iE4HHQmgI0BFB8BGGEYKI5dgNQbi//fbbJmbDuoYTMwmbchDg
vu2unbvi9dOmTbP1tSncx40bZ/tiA9mEM+Es2Cn1Sca4067s/+GHH1Zbz+/AO2vgcx04fsiwYcNs
vYS7EELCXQhRb4R70YCirMIdYVqtTvPnx4IcsRWKWmKJiUkn9R8hNnjWET0ek0w4AgIdT3cI8dLJ
GPd/KtzJSkNYC3Wgo0DcsnuTnUceecTOOxwVAGK8OS7CG0H+wAMPWDw8fxHp1BOvLGEyXB9EoHvy
HWKqG0qMu3vWQyENtB1COgw9obNjGYqaV89QtHbt2tTJqf9EuCPECbWhDZtmvsNuyK0eQkiXC/fw
ecrIAHVkRAW78/ajDD9fOpJA+ZwT3vYQ7Fkx7kIICXchxDkV7qSDzCXcCQFxz2KacD958mQ1kZ0U
7osXLY7jlvnbpHETE2HJMANEMMIMUR+SllUmTbgjltOEO3HpSeEOSzLb33ZrlXeY4+KB5cVISeGe
9Lj7OSLcCbXxGGoWPvMd925iwakjdeccQuo6q0xtCfft27fbOTBCwLWgvVm4lqxD+NIujo9ktL27
bbVy0tJBpgl3JgwXKtyhrKzM6uHvGaBu2Gs+4b53795YuBP2E7YhnzlXhDmwjrKTueaVVUYIIeEu
hDjnwp1MHQgTBEgY+uEgRBGZTEL9O8IdjzUeS5/4CZ5lJBQ9Xbt0jdrc2aZG3DSZZQoR7u7VZQm9
54jGNOEeij88rghxvPB4ysFHIrIJ96RXOQnnjzc/KTaBzklDEO7EhFP/ULSH4t3nHniml2FDh1lb
J0cpeNlSIcLd1yHcfcKq4xNek9fSOxi81OrOu+6y9vLsPjNmzIiF+65dZ0J3sHO3n+XffJPzWrZr
187aCkEfMnPmTAl3IYSEuxDi3Ap3wgsQH4QEIGB9siUwIRMRhcAh1vlshDsC2MUr2/obMyHNW0kW
EY4VCmwms/qE13zC/YcffrDyEJlPPPGErTt06JAJSfYPyw0zv9jn1Wvit2B6zD3ZUdiX44QwudEF
eRgm4lAPh/PhulK2Q6gNQrIhTE71SbiMPgBt7e1NbDvXm+9JtehilnNlvxnTZ8T70CZ0jAoR7kzu
ZVvPDgOke0Q8h8KduQZhes59FfvMRrim3nFbsGCB1Ye2X79+fbVza3Z6/gGhMklCkc8kVg//4Zj+
vU+4lXAXQki4CyHy8tmGA/aCpfFL9+RcxnyxO1q86ZecZRHfi4DymG8EiXs4EZ8IrxAydrhw94we
SeHuHnfEGgIJbyiTGomDJmuHix6PcUekE0rjqR+tDs2axtk7EGQ+ETJNuLsQRKQjtBBrfGY/1lGP
b057VwkP4jyJY2aSI+fHPpyTw4RKDwnhGuCNx6sPxMSzLQtx0XRwHs+cF8cI4/6Li4urHd9DjjiW
n39dsPfIThPkU9e+lHeZuOrJ1DKYQEzdqfeXX36Zuo2/jCns3NC2nK+HE1EG7YnnmrLI3pNLuA8a
NCieOMy+PhGYaxamoOQvKSIJYZk4cWLsGceGwgcpHnhvQ8ryEJwZ06fb8WkTFiZBk8Wofaaciy66
KKqsrKwqY8cO60xQRquWVfbg9U7asBBCwl1XQgiRSsnWg9H7y/dGxSsrci5s8/X2w3nLI3sGIgeR
hBhBNCHCBhYNrLEtohbRdOmll1YT7sQUM2GQ9b//XpWtBbGNSEbcUR750MnkgRC+/PLLLd7YIQsI
66kDAph6HDp4yPa/vNHlFhIBHguNOCRdn8Ox2L9FyyrBh/CmfI7ZpEmTWLjj8Wc7Qjo4Z+ustL0n
rrODEKQeXIvLMnUNBRoTTNmXelAOZSDwiPMOISWhX1e2I6Rj06ZNVh+uYV3w89Hd0az1o6I5m8bn
XWaWvZZaBukTEcG0UTbo9Ni8hcy5MMcAVq9abe3s+c455+82brQXUDVq1CjeLptwx0N/W6ZDxL5c
M8oiXAqvP8d55ZVXqux/SUm1NvSykiKa0RfP0Y5tMirgvDPxHWszq+eNZ9qQTkAIHc5rrr4mtks6
IOSWb9y4cQ0bFkJIuAshxDmDeOQN6zfEYQHZIL83AjoJIoYX6SQhVIFsLh7ewL6EsiTh+29LvzVx
65Ba8uAvB6vdIBFRCKjFixfXKINQCc7Dwfsfvk01rBMx7rk8ptu3bYtK15SaUEtCp4X9uV5hfdOu
1bq166rHWVfsi+Pp6yu0JZNs822TJlztugRtQDnhHAquHYIZsU3+9CSbN282OwhDt9JCUrBT2vH7
05261I5Mpu0ZQaAd0tiyZYu1IXaT7XyP/3Hc7JdtHWz48KHDumkIISTchRAijZkzZphX2ydM5hJs
on4yb948mx/g+flLgvAZIYSQcBdCiAuEiy++2GLLCZMhxlg0PAhhQrATd558F4AQQki4CyHEBQLZ
XogbZ0JoGEYhGg7jx4+3OQIjMm2ZFm4lhBAS7kIIIYQQQggJdyGEEEIIISTchRBCCCGEEBLuQggh
hBBCCAl3IYQQQgghJNyFEEIIIYQQEu5CCCGEEEIICXchhBBCCCEk3IUQQgghhBAS7kIIIYQQQggT
7jt37tSVEEIIIYQQoh6DZv+/7du32z+oeC1atGjRokWLFi1atNSvBa2+bdu26P8B8X6COYaly58A
AAAASUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey" NO="8" REF_ID="CMP-005.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison 5: RCTs of enablement with and without feedback, outcome: 5.1 Enablement plus feedback.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAwQAAADACAMAAACNtFTvAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-09" MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey" NO="9" REF_ID="CMP-005.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison 5: RCTs of enablement with and without feedback, outcome: 5.2 Enablement without feedback.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAwQAAADwCAMAAACJzlNCAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="ITS MR 91 studies small.png" FILE_TYPE="PNG" ID="FIG-10" MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey" NO="10" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Meta-regression by effect modifiers of intervention for 91 ITS studies. Outcome is effect on prescribing six months' postintervention. There are 16 studies with both enabling and restricting intervention components (<LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAu4AAAHpCAYAAADd8LnvAACAAElEQVR42uzdZ3QVV573+347d+7M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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Fig 16 ITS MR restrictive small.png" FILE_TYPE="PNG" ID="FIG-11" MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey" NO="11" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Meta-regression of prescribing outcome by effect modifiers for 29 ITS studies of interventions that included restriction. </P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAu4AAAHpCAYAAADd8LnvAACAAElEQVR42uy9h3sV1b7/f/+V3/e5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</FILE>
</FIGURE>
<FIGURE FILENAME="ITS 43 enablement small.png" FILE_TYPE="PNG" ID="FIG-12" MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey" NO="12" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Meta-regression by effect modifier for 43 ITS studies of interventions that included enablement but not restriction. Outcome is effect on prescribing six months' postintervention. Note that four studies with feedback were not included in this analysis because they also included restriction.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAvcAAAHvCAYAAADQEvDQAACAAElEQVR42uy9B3MVx7q/e77HqXvq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</FILE>
</FIGURE>
<FIGURE FILENAME="ITS microbial small.png" FILE_TYPE="PNG" ID="FIG-13" MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey" NO="13" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Meta-regression by effect modifiers for 34 microbial outcomes 12 months' postintervention from 26 ITS studies. The bars show the results for unadjusted versus adjusted analyses, the comparison for unplanned interventions is with planned interventions in both the unadjusted and adjusted analysis.</P>
<P>CDI: <I>Clostridium difficile </I>infection<BR/>GPC: infection with antibiotic-resistant gram-positive cocci<BR/>GNB: infection with antibiotic-resistant gram-negative bacteria</P>
<P>Other infection control: 'Yes' means there were changes to infection control processes during the study period.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAu4AAAHpCAYAAADd8LnvAACAAElEQVR42uy993cU17q/ef+Ku2bW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</FILE>
</FIGURE>
<FIGURE FILENAME="ITS microbial 20 planned small.png" FILE_TYPE="PNG" ID="FIG-14" MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey" NO="14" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Meta-regression by effect modifiers for 20 microbial outcomes 12 months' postintervention from 14 ITS studies of planned interventions that provided details about other infection control changes or interventions.</P>
<P>CDI: <I>Clostridium difficile </I>infection<BR/>GPC: infection with antibiotic-resistant gram-positive cocci<BR/>GNB: infection with antibiotic-resistant gram-negative bacteria</P>
<P>Other infection control: 'Yes' means there were changes to infection control processes during the study period.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAu4AAAHpCAYAAADd8LnvAAB+bElEQVR42uzd95cUVf7/8e+f8vnl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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey">
<APPENDIX ID="APP-01" MODIFIED="2016-12-13 05:34:04 -0500" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2016-12-07 05:23:57 -0500" MODIFIED_BY="[Empty name]">Search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2016-12-13 05:34:04 -0500" MODIFIED_BY="[Empty name]">
<P>
<B>MEDLINE &lt;1946 to Present&gt; and MEDLINE In-Process &amp; Other Non-Indexed Citations (Searched 19 January 2015) (OvidSP)</B>
</P>
<P>1 (hospital$ and antibiotic?).ti.</P>
<P>2 ((antibiotic? or alamethicin? or amdinocillin? or amdinocillin pivoxil? or amikacin? or amoxicillin? or amoxicillin-potassium clavulanate combination? or amphotericin? or ampicillin? or anisomycin? or antimycin? or aurodox? or azithromycin? or azlocillin? or aztreonam? or bacitracin? or bacteriocin? or bambermycin? or bongkrekic acid? or brefeldin? or butirosin sulfate? or calcimycin? or candicidin? or capreomycin? or carbenicillin? or carfecillin? or cefaclor? or cefadroxil? or cefamandole? or cefatrizine? or cefazolin? or cefixime? or cefmenoxime? or cefmetazole? or cefonicid? or cefoperazone? or cefotaxime? or cefotetan? or cefotiam? or cefoxitin? or cefsulodin? or ceftazidime? or ceftizoxime? or ceftriaxone? or cefuroxime? or cephacetrile? or cephalexin? or cephaloglycin? or cephaloridine? or cephalosporin? or cephalothin? or cephamycin? or cephapirin? or cephradine? or chloramphenicol? or chlortetracycline? or citrinin? or clarithromycin? or clavulanic acid? or clavulanic acid? or clindamycin? or cloxacillin? or colistin? or cyclacillin? or dactinomycin? or daptomycin? or demeclocycline? or dibekacin? or dicloxacillin? or dihydrostreptomycin sulfate? or diketopiperazine? or distamycin? or doxycycline? or echinomycin? or edeine? or enviomycin? or erythromycin? or erythromycin estolate? or erythromycin ethylsuccinate? or filipin? or floxacillin? or fluoroquinolone? or fosfomycin? or framycetin? or fusidic acid? or gentamicin? or gramicidin? or hygromycin? or imipenem? or josamycin? or kanamycin? or kitasamycin? or lactam? or lasalocid? or leucomycin? or lincomycin? or lincosamide? or lucensomycin? or lymecycline? or mepartricin? or methacycline? or methicillin? or mezlocillin? or mikamycin? or minocycline? or miocamycin? or moxalactam? or mupirocin? or mycobacillin? or nafcillin? or natamycin? or nebramycin? or neomycin? or netilmicin? or netropsin? or nigericin? or nisin? or norfloxacin? or novobiocin? or nystatin? or ofloxacin? or oleandomycin? or oligomycin? or oxacillin? or oxytetracycline? or paromomycin? or penicillanic acid? or penicillic acid? or penicillin?? or piperacillin? or pivampicillin? or polymyxin b? or polymyxin? or pristinamycin? or prodigiosin? or ribostamycin? or rifabutin? or rifamycin? or ristocetin? or rolitetracycline? or roxarsone? or roxithromycin? or rutamycin? or sirolimu? or sisomicin? or spectinomycin? or spiramycin? or streptogramin?? or streptomycin? or streptovaricin? or sulbactam? or sulbenicillin? or sulfamerazine? or sulfamethoxypyridazine? or talampicillin? or teicoplanin? or tetracycline? or thiamphenicol? or thienamycin? or thiostrepton? or ticarcillin? or tobramycin? or troleandomycin? or tunicamycin? or tylosin? or tyrocidine? or tyrothricin? or valinomycin? or vancomycin? or vernamycin? or viomycin? or virginiamycin? or beta-lactams) adj2 (resistant or resistance)).ti,ab. and (pc.fs. or (preventi$ or best practice? or evidence$ or policy or policies or pathway?).ti,ab,hw. or (guidance or guiding or guide? or guideline? or algorithm? or collaborat$ or computer$ or decision$ or emergency or formulary or guidance or guideline? or icu or impact or initiat$ or intensive care interdisciplin$ or interprofession$ or multidisciplin$ or multi-disciplin$ or notification? or order entry or pharmacist? or pharmacy or pharmacies or policy or policies or prescrib$ or (quality adj2 (manag$ or improv$ or circle?)) or ((patient? or hospital?) adj2 record?) or reminder? or rotating or rotation or support or team$).ti,ab.)</P>
<P>3 (antibiotic? and (education$ or continuing-education$ or cme or decision-making or evidence-based or ebm or guidance or guideline? or habit? or impact or improper$ or inappropriat$ or influenc$ or intervention? or management or overprescrib$ or overuse or overusing or pattern? or policy or policies or prescribing or prudent$ or stewardship? or rational or unnecessary or "use" or "usage")).ti.</P>
<P>4 (antibiotic? adj4 (education$ or continuing-education$ or cme or decision-making or evidence-based or ebm or guidance or guideline? or habit? or impact or improper$ or inappropriat$ or influenc$ or intervention? or management or overprescrib$ or overuse or overusing or pattern? or policy or policies or prescribing or prudent$ or rational or stewardship or unnecessary or "use" or "usage")).ab.</P>
<P>5 antibiotic?.ti. and evidence-based.hw.</P>
<P>6 ((antimicrobial? or anti-microbial? or penicillin?) and (stewardship or guidance or guideline? or policy or policies)).ti.</P>
<P>7 ((antimicrobial? or anti-microbial? or penicillin?) adj3 (stewardship or guidance or guideline? or policy or policies)).ab.</P>
<P>8 (antibiotic? adj5 (hour? or immediat$ or emergency)).ab. or (antibiotic? and (hour? or immediat$ or emergency)).ti. or (antibiotic? adj3 (rotat$ or timing or time or decision$ or notification or appropriat$)).ab. or (antibiotic? and (rotat$ or timing or time or decision$ or notification or appropriat$)).ti.</P>
<P>9 or/1-8</P>
<P>10 exp anti-bacterial agents/</P>
<P>11 antibiotic?.ti,ab.</P>
<P>12 (alamethicin or amdinocillin or amdinocillin pivoxil or amikacin or amoxicillin or amoxicillin-potassium clavulanate combination or amphotericin or ampicillin or anisomycin or antimycin or aurodox or azithromycin or azlocillin or aztreonam or bacitracin or bacteriocins or bambermycins or bongkrekic acid or brefeldin or butirosin sulfate or calcimycin or candicidin or capreomycin or carbenicillin or carfecillin or cefaclor or cefadroxil or cefamandole or cefatrizine or cefazolin or cefixime or cefmenoxime or cefmetazole or cefonicid or cefoperazone or cefotaxime or cefotetan or cefotiam or cefoxitin or cefsulodin or ceftazidime or ceftizoxime or ceftriaxone or cefuroxime or cephacetrile or cephalexin or cephaloglycin or cephaloridine or cephalosporins or cephalothin or cephamycins or cephapirin or cephradine or chloramphenicol or chlortetracycline or citrinin or clarithromycin or clavulanic acid or clavulanic acids or clindamycin or cloxacillin or colistin or cyclacillin or dactinomycin or daptomycin or demeclocycline or dibekacin or dicloxacillin or dihydrostreptomycin sulfate or diketopiperazines or distamycins or doxycycline or echinomycin or edeine or enviomycin or erythromycin or erythromycin estolate or erythromycin ethylsuccinate or filipin or floxacillin or fluoroquinolones or fosfomycin or framycetin or fusidic acid or gentamicins or gramicidin or hygromycin or imipenem or josamycin or kanamycin or kitasamycin or lactams or lasalocid or leucomycins or lincomycin or lincosamides or lucensomycin or lymecycline or mepartricin or methacycline or methicillin or mezlocillin or mikamycin or minocycline or miocamycin or moxalactam or mupirocin or mycobacillin or nafcillin or natamycin or nebramycin or neomycin or netilmicin or netropsin or nigericin or nisin or norfloxacin or novobiocin or nystatin or ofloxacin or oleandomycin or oligomycins or oxacillin or oxytetracycline or paromomycin or penicillanic acid or penicillic acid or penicillin? or piperacillin or pivampicillin or polymyxin b or polymyxins or pristinamycin or prodigiosin or ribostamycin or rifabutin or rifamycins or ristocetin or rolitetracycline or roxarsone or roxithromycin or rutamycin or sirolimus or sisomicin or spectinomycin or spiramycin or streptogramin? or streptomycin or streptovaricin or sulbactam or sulbenicillin or sulfamerazine or sulfamethoxypyridazine or talampicillin or teicoplanin or tetracycline or thiamphenicol or thienamycins or thiostrepton or ticarcillin or tobramycin or troleandomycin or tunicamycin or tylosin or tyrocidine or tyrothricin or valinomycin or vancomycin or vernamycin or viomycin or virginiamycin or beta-lactams).ti,ab.</P>
<P>13 (infection control$ or nosocomial$ or cross infection? or hospital acquired infection? or mrsa).ti,ab.</P>
<P>14 methicillin resistan$.ti,ab.</P>
<P>15 aminoglycosides/ or metronidazole/ or anti-infective agents/ or anti-infective agents, urinary/</P>
<P>16 or/10-15</P>
<P>17 (programs or programmes).ti.</P>
<P>18 empiric.ti.</P>
<P>19 (quality adj3 improvement?).ti.</P>
<P>20 (adherence or alert? or benchmark$ or (change adj3 treatment) or computer assist$ or computer support or computeri?ed or clinical decision$ or dosing or education$ or formulary or guidance or guideline? or impact or intervention or justification or methicillan-resistant or overuse or over-prescrib$ or overprescrib$ or pathway? or pharmacist? or policy or policies or program or programme or (quality adj3 improv$) or reminder? or resistance or restriction? or rotation? or timing or turnaround or unnecessary).ti.</P>
<P>21 or/17-20</P>
<P>22 16 and 21</P>
<P>23 22 not 9</P>
<P>24 (randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti.</P>
<P>25 exp animals/ not humans.sh.</P>
<P>26 43 not 45</P>
<P>27 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or community or complex or design$ or doctor? or educational or family doctor? or family physician? or family practitioner? or financial or gp or general practice? or hospital? or impact? or improv$ or individuali?e? or individuali?ing or interdisciplin$ or multicomponent or multi-component or multidisciplin$ or multi-disciplin$ or multifacet$ or multi-facet$ or multimodal$ or multi-modal$ or personali?e? or personali?ing or pharmacies or pharmacist? or pharmacy or physician? or practitioner? or prescrib$ or prescription? or primary care or professional$ or provider? or regulatory or regulatory or tailor$ or target$ or team$ or usual care)).ab.</P>
<P>28 (pre-intervention? or preintervention? or "pre intervention?" or post-intervention? or postintervention? or "post intervention?").ti,ab.</P>
<P>29 (hospital$ or patient?).hw. and (study or studies or care or health$ or practitioner? or provider? or physician? or nurse? or nursing or doctor?).ti,hw.</P>
<P>30 demonstration project?.ti,ab.</P>
<P>31 (pre-post or "pre test$" or pretest$ or posttest$ or "post test$" or (pre adj5 post)).ti,ab.</P>
<P>32 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab.</P>
<P>33 trial.ti. or ((study adj3 aim?) or "our study").ab.</P>
<P>34 (before adj10 (after or during)).ti,ab.</P>
<P>35 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or experimental) adj3 (method$ or study or trial or design$))).ti,ab,hw.</P>
<P>36 ("time series" adj2 interrupt$).ti,ab,hw.</P>
<P>37 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or hour? or day? or "more than")).ab.</P>
<P>38 pilot.ti.</P>
<P>39 pilot projects/ [ml]</P>
<P>40 (clinical trial or controlled clinical trial or multicenter study).pt. [ml]</P>
<P>41 (multicentre or multicenter or multi-centre or multi-center).ti.</P>
<P>42 andom$.ti,ab. or controlled.ti.</P>
<P>43 (control adj3 (area or cohort? or compare? or condition or design or group? or intervention? or participant? or study)).ab. not (controlled clinical trial or randomized controlled trial).pt. [ml]</P>
<P>44 "comment on".cm. or review.ti,pt. or randomized controlled trial.pt. [ml]</P>
<P>45 review.ti.</P>
<P>46 (rat or rats or cow or cows or chicken? or horse or horses or mice or mouse or bovine or animal?).ti.</P>
<P>47 exp animals/ not humans.sh.</P>
<P>48 (animal$ not human$).sh,hw.</P>
<P>49 *experimental design/ or *pilot study/ or quasi experimental study/ [em]</P>
<P>50 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or experimental) adj3 (method$ or study or trial or design$))).ti,ab.</P>
<P>51 ("time series" adj2 interrupt$).ti,ab.</P>
<P>52 or/26-43</P>
<P>53 or/44-48</P>
<P>54 52 not 53</P>
<P>55 9 or 23</P>
<P>56 54 and 55</P>
<P>
<B>EMBASE &lt;1996 to 2015 Week 03&gt; (Searched 22 January 2015) (OvidSP)</B>
</P>
<P>1 exp *antibiotic agent/</P>
<P>2 (bundle or bundles or education$ or continuing-education$ or cme or decision-making or guidance or (guideline? adj2 (adherence or implement$ or complian$ or comply$)) or improper$ or inappropriat$ or incorrect$ or nurse led or overprescrib$ or overuse or overusing or pharmacist initiated or physician? practice? or policy or policies or practice pattern? or (prescribing adj2 (ebm or evidence-based or habit? or pattern? or practice or practices)) or prudent$ or rational or stewardship or unnecessary or underprescrib$).ti.</P>
<P>3 ("antibiotic use" or "antibiotic usage").ti.</P>
<P>4 (hospital$ and antibiotic?).ti.</P>
<P>5 ((antibiotic? or alamethicin? or amdinocillin? or amdinocillin pivoxil? or amikacin? or amoxicillin? or amoxicillin-potassium clavulanate combination? or amphotericin? or ampicillin? or anisomycin? or antimycin? or aurodox? or azithromycin? or azlocillin? or aztreonam? or bacitracin? or bacteriocin? or bambermycin? or bongkrekic acid? or brefeldin? or butirosin sulfate? or calcimycin? or candicidin? or capreomycin? or carbenicillin? or carfecillin? or cefaclor? or cefadroxil? or cefamandole? or cefatrizine? or cefazolin? or cefixime? or cefmenoxime? or cefmetazole? or cefonicid? or cefoperazone? or cefotaxime? or cefotetan? or cefotiam? or cefoxitin? or cefsulodin? or ceftazidime? or ceftizoxime? or ceftriaxone? or cefuroxime? or cephacetrile? or cephalexin? or cephaloglycin? or cephaloridine? or cephalosporin? or cephalothin? or cephamycin? or cephapirin? or cephradine? or chloramphenicol? or chlortetracycline? or citrinin? or clarithromycin? or clavulanic acid? or clavulanic acid? or clindamycin? or cloxacillin? or colistin? or cyclacillin? or dactinomycin? or daptomycin? or demeclocycline? or dibekacin? or dicloxacillin? or dihydrostreptomycin sulfate? or diketopiperazine? or distamycin? or doxycycline? or echinomycin? or edeine? or enviomycin? or erythromycin? or erythromycin estolate? or erythromycin ethylsuccinate? or filipin? or floxacillin? or fluoroquinolone? or fosfomycin? or framycetin? or fusidic acid? or gentamicin? or gramicidin? or hygromycin? or imipenem? or josamycin? or kanamycin? or kitasamycin? or lactam? or lasalocid? or leucomycin? or lincomycin? or lincosamide? or lucensomycin? or lymecycline? or mepartricin? or methacycline? or methicillin? or mezlocillin? or mikamycin? or minocycline? or miocamycin? or moxalactam? or mupirocin? or mycobacillin? or nafcillin? or natamycin? or nebramycin? or neomycin? or netilmicin? or netropsin? or nigericin? or nisin? or norfloxacin? or novobiocin? or nystatin? or ofloxacin? or oleandomycin? or oligomycin? or oxacillin? or oxytetracycline? or paromomycin? or penicillanic acid? or penicillic acid? or penicillin?? or piperacillin? or pivampicillin? or polymyxin b? or polymyxin? or pristinamycin? or prodigiosin? or ribostamycin? or rifabutin? or rifamycin? or ristocetin? or rolitetracycline? or roxarsone? or roxithromycin? or rutamycin? or sirolimu? or sisomicin? or spectinomycin? or spiramycin? or streptogramin?? or streptomycin? or streptovaricin? or sulbactam? or sulbenicillin? or sulfamerazine? or sulfamethoxypyridazine? or talampicillin? or teicoplanin? or tetracycline? or thiamphenicol? or thienamycin? or thiostrepton? or ticarcillin? or tobramycin? or troleandomycin? or tunicamycin? or tylosin? or tyrocidine? or tyrothricin? or valinomycin? or vancomycin? or vernamycin? or viomycin? or virginiamycin? or beta-lactams) adj2 (resistant or resistance) adj10 (best practice? or (chang$ adj (practice or clinical practice)) or evidence-base? or policy or policies or pathway? or ((treatment or care) adj (algorithm? or pathway? or protocol)) or collaborat$ or computeri?ed or computer-supported or decision-mak$ or (support adj decision?) or formulary or guidance or (guideline? adj (adher$ or implement$ or concord$ or comply or complian$)) or interdisciplin$ or interprofession$ or multidisciplin$ or multi-disciplin$ or notification? or order entry or (pharmacist? adj2 (led or initiat$ or intervention? or participat$)) or policy or policies or (prescrib$ adj (practice? or method? or algorithm? or protocol? or habit?)) or (quality adj (manag$ or improv$ or circle?)) or ((patient? or medical or electronic) adj2 record?) or reminder? or rotating or rotation or team$)).ti,ab.</P>
<P>6 (antibiotic? and (bundle or bundles or education$ or continuing-education$ or cme or decision-making or guidance or (guideline? adj2 (adherence or implement$ or complian$ or comply$)) or improper$ or inappropriat$ or incorrect$ or nurse led or overprescrib$ or overuse or overusing or pharmacist initiated or physician? practice? or policy or policies or practice pattern? or (prescribing adj2 (ebm or evidence-based or habit? or pattern? or practice or practices)) or prudent$ or rational or stewardship or unnecessary or underprescrib$)).ti.</P>
<P>7 (antibiotic? adj3 (bundle or bundles or education$ or continuing-education$ or cme or decision-making or guidance or (guideline? adj2 (adherence or implement$ or complian$ or comply$)) or improper$ or inappropriat$ or incorrect$ or nurse led or overprescrib$ or overuse or overusing or pharmacist initiated or physician? practice? or policy or policies or practice pattern? or (prescribing adj2 (ebm or evidence-based or habit? or pattern? or practice or practices)) or prudent$ or rational or stewardship or unnecessary or underprescrib$)).ab.</P>
<P>8 ((antimicrobial? or anti-microbial? or penicillin?) and (bundle or bundles or education$ or continuing-education$ or cme or decision-making or guidance or (guideline? adj2 (adherence or implement$ or complian$ or comply$)) or improper$ or inappropriat$ or incorrect$ or nurse led or overprescrib$ or overuse or overusing or pharmacist initiated or physician? practice? or policy or policies or practice pattern? or (prescribing adj2 (ebm or evidence-based or habit? or pattern? or practice or practices)) or prudent$ or rational or stewardship or unnecessary or underprescrib$)).ab. or ((antimicrobial? or anti-microbial? or penicillin?) and (bundle or bundles or education$ or continuing-education$ or cme or decision-making or guidance or (guideline? adj2 (adherence or implement$ or complian$ or comply$)) or improper$ or inappropriat$ or incorrect$ or nurse led or overprescrib$ or overuse or overusing or pharmacist initiated or physician? practice? or policy or policies or practice pattern? or (prescribing adj2 (ebm or evidence-based or habit? or pattern? or practice or practices)) or prudent$ or rational or stewardship or unnecessary or underprescrib$)).ti.</P>
<P>9 1 and 2</P>
<P>10 or/3-8</P>
<P>11 9 or 10</P>
<P>12 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or community or complex or design$ or doctor? or educational or family doctor? or family physician? or family practitioner? or financial or gp or general practice? or hospital? or impact? or improv$ or individuali?e? or individuali?ing or interdisciplin$ or multicomponent or multi-component or multidisciplin$ or multi-disciplin$ or multifacet$ or multi-facet$ or multimodal$ or multi-modal$ or personali?e? or personali?ing or pharmacies or pharmacist? or pharmacy or physician? or practitioner? or prescrib$ or prescription? or primary care or professional$ or provider? or regulatory or regulatory or tailor$ or target$ or team$ or usual care)).ab.</P>
<P>13 (pre-intervention? or preintervention? or "pre intervention?" or post-intervention? or postintervention? or "post intervention?").ti,ab.</P>
<P>14 (hospital$ or patient?).hw. and (study or studies or care or health$ or practitioner? or provider? or physician? or nurse? or nursing or doctor?).ti,hw.</P>
<P>15 demonstration project?.ti,ab.</P>
<P>16 (pre-post or "pre test$" or pretest$ or posttest$ or "post test$" or (pre adj5 post)).ti,ab.</P>
<P>17 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab.</P>
<P>18 trial.ti. or ((study adj3 aim?) or "our study").ab.</P>
<P>19 (before adj10 (after or during)).ti,ab.</P>
<P>20 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or hour? or day? or "more than")).ab.</P>
<P>21 pilot.ti.</P>
<P>22 (multicentre or multicenter or multi-centre or multi-center).ti.</P>
<P>23 random$.ti,ab. or controlled.ti.</P>
<P>24 review.ti.</P>
<P>25 or/12-23</P>
<P>26 25 not 24</P>
<P>27 11 and 26</P>
<P>
<B>Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library Issue 1 2015 (Searched 22 January 2015)</B>
</P>
<P>#1 antibiotic?:ti,ab,kw</P>
<P>#2 ((antibacterial or anti-bacterial or antiinfective or anti-infective) and (agent? or drug?)):ti,ab,kw</P>
<P>#3 ((alamethicin? or amdinocillin? or amdinocillin pivoxil? or amikacin? or amoxicillin? or amoxicillin-potassium clavulanate combination? or amphotericin? or ampicillin? or anisomycin? or antimycin? or aurodox? or azithromycin? or azlocillin? or aztreonam? or bacitracin? or bacteriocin? or bambermycin? or bongkrekic acid? or brefeldin? or butirosin sulfate? or calcimycin? or candicidin? or capreomycin? or carbenicillin? or carfecillin? or cefaclor? or cefadroxil? or cefamandole? or cefatrizine? or cefazolin? or cefixime? or cefmenoxime? or cefmetazole? or cefonicid? or cefoperazone? or cefotaxime? or cefotetan? or cefotiam? or cefoxitin? or cefsulodin? or ceftazidime? or ceftizoxime? or ceftriaxone? or cefuroxime? or cephacetrile? or cephalexin? or cephaloglycin? or cephaloridine? or cephalosporin? or cephalothin? or cephamycin? or cephapirin? or cephradine? or chloramphenicol? or chlortetracycline? or citrinin? or clarithromycin? or clavulanic acid? or clavulanic acid? or clindamycin? or cloxacillin? or colistin? or cyclacillin? or dactinomycin? or daptomycin? or demeclocycline? or dibekacin? or dicloxacillin? or dihydrostreptomycin sulfate? or diketopiperazine? or distamycin? or doxycycline? or echinomycin? or edeine? or enviomycin? or erythromycin? or erythromycin estolate? or erythromycin ethylsuccinate? or filipin? or floxacillin? or fluoroquinolone? or fosfomycin? or framycetin? or fusidic acid? or gentamicin? or gramicidin? or hygromycin? or imipenem? or josamycin? or kanamycin? or kitasamycin? or lactam? or lasalocid? or leucomycin? or lincomycin? or lincosamide? or lucensomycin? or lymecycline? or mepartricin? or methacycline? or methicillin? or mezlocillin? or mikamycin? or minocycline? or miocamycin? or moxalactam? or mupirocin? or mycobacillin? or nafcillin? or natamycin? or nebramycin? or neomycin? or netilmicin? or netropsin? or nigericin? or nisin? or norfloxacin? or novobiocin? or nystatin? or ofloxacin? or oleandomycin? or oligomycin? or oxacillin? or oxytetracycline? or paromomycin? or penicillanic acid? or penicillic acid? or penicillin?? or piperacillin? or pivampicillin? or polymyxin b? or polymyxin? or pristinamycin? or prodigiosin? or ribostamycin? or rifabutin? or rifamycin? or ristocetin? or rolitetracycline? or roxarsone? or roxithromycin? or rutamycin? or sirolimu? or sisomicin? or spectinomycin? or spiramycin? or streptogramin?? or streptomycin? or streptovaricin? or sulbactam? or sulbenicillin? or sulfamerazine? or sulfamethoxypyridazine? or talampicillin? or teicoplanin? or tetracycline? or thiamphenicol? or thienamycin? or thiostrepton? or ticarcillin? or tobramycin? or troleandomycin? or tunicamycin? or tylosin? or tyrocidine? or tyrothricin? or valinomycin? or vancomycin? or vernamycin? or viomycin? or virginiamycin? or beta-lactams) and (prescrib$ or resistance or "use" or "usage" or utlii?ation)):ti,ab,kw</P>
<P>#4 ((antibacterial agent? or anti-bacterial agent?) and (prescrib$ or resistance or "use" or "usage" or utili?ation)):ti,ab,kw</P>
<P>#5 "stewardship":ti,ab,kw</P>
<P>#6 (antibiotic* or antimicrobial*) and (prescrib* or prescrip*):ti,ab,kw</P>
<P>#7 #1 or #2 or #3 or #4 or #5 or #6</P>
<P>
<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey" NO="2">
<TITLE MODIFIED="2017-01-07 01:44:01 -0500" MODIFIED_BY="[Empty name]">Decisions based on 5 GRADE criteria about quality of evidence from RCTs in 'Summary of findings' table</TITLE>
<APPENDIX_BODY MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey">
<SUBSECTION>
<HEADING LEVEL="3">Outcome prescribing, % compliance with guideline</HEADING>
<TABLE COLS="3" ROWS="6">
<TR>
<TH VALIGN="BOTTOM">
<P>
<B>Criterion</B>
</P>
</TH>
<TH VALIGN="BOTTOM">
<P>
<B>Evidence</B>
</P>
</TH>
<TH VALIGN="BOTTOM">
<P>
<B>Decision</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Risk of bias</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Effect estimate lower for 15 studies with low/medium risk of bias.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious, 95% confidence interval for effect estimate 10% to 12% in studies at low or medium risk of bias.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Imprecision<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>23,394 patients and 3660 events</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Inconsistency</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Chi<SUP>2</SUP> = 367.98, df = 28 (P &lt; 0.00001); I<SUP>2</SUP> = 92%</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious, effect size rather than direction (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). Variation partially explained by prespecified subgroup analysis by intervention function (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>). Direction of effect consistent despite high levels of statistical heterogeneity.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Indirectness</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Only 2 RCTs of restrictive interventions (<LINK REF="STD-Singh-2000" TYPE="STUDY">Singh 2000</LINK>; <LINK REF="STD-Strom-2010" TYPE="STUDY">Strom 2010</LINK>)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious because this is a concern for safety rather than effectiveness.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Publication bias</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Large trials, few commercially sponsored</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious</P>
</TD>
</TR>
</TABLE>
<P>
<SUP>1</SUP>Imprecision, optimal information size threshold 862 patients for &#916; 10%, control compliance 43%, &#945; 0.05, &#946; 0.2, dropout 10%.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcome prescribing, reduction in duration of all antibiotic treatment</HEADING>
<TABLE COLS="3" ROWS="6">
<TR>
<TH VALIGN="TOP">
<P>
<B>Criterion </B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Evidence</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Decision</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Risk of bias</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Effect estimate greater for 3 studies with low/medium risk of bias (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>).</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Imprecision<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3318 patients</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious, number of patients is &gt; OIS to detect &#916; 1 day (3018 patients).</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Inconsistency<SUP>2 </SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All trials: Chi<SUP>2</SUP> = 119.95, df = 13 (P &lt; 0.00001); I<SUP>2</SUP> = 89%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious, most variation is effect size rather than direction (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>).</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Indirectness</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious for effectiveness</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Publication bias</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Large trials, few commercially sponsored</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious</P>
</TD>
</TR>
</TABLE>
<P>
<SUP>1</SUP>Imprecision, OIS is 754 patients for &#916; 2 days, standard deviation 9.3 days (highest of the 3 studies contributing &gt; 10% of weight), &#945; 0.05, &#946; 0.8, dropout 10%, and 3018 patients for &#916; 1 day.</P>
<P>OIS: optimal information size</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcome mortality</HEADING>
<TABLE COLS="3" ROWS="6">
<TR>
<TH VALIGN="TOP">
<P>
<B>Criterion</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Evidence</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Decision</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Risk of bias</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Effect estimate and confidence interval similar for 8 studies with low/medium risk of bias</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Imprecision<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>17,697 patients and 1587 events<BR/>This is &gt; OIS for 2% difference in mortality (6726 patients).</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Inconsistency</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Heterogeneity: Chi<SUP>2</SUP> = 16.55, df = 28 (P = 0.96); I<SUP>2</SUP> = 0%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Indirectness</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No trials of restrictive interventions.</P>
<P>Mortality lower in trials at low/medium risk of bias.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Serious</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Publication bias</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Large trials, few commercially sponsored</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious</P>
</TD>
</TR>
</TABLE>
<P>
<SUP>1</SUP>Imprecision, OIS threshold for patients for non-inferiority is 6726 patients for a 2% difference in mortality.</P>
<P>OIS: optimal information size</P>
<SUBSECTION>
<HEADING LEVEL="5">All trials:</HEADING>
<P>Mortality, control 11%, power 80%, dropout 10%</P>
<TABLE COLS="2" ROWS="5">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Non-inferiority criteria</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Total number of patients to be recruited</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1%</P>
</TD>
<TD VALIGN="TOP">
<P>26,900</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>2%</P>
</TD>
<TD VALIGN="TOP">
<P>6726</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>3%</P>
</TD>
<TD VALIGN="TOP">
<P>2988</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>4%</P>
</TD>
<TD VALIGN="TOP">
<P>1682</P>
</TD>
</TR>
</TABLE>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcome length of hospital stay</HEADING>
<TABLE COLS="3" ROWS="6">
<TR>
<TH VALIGN="TOP">
<P>
<B>Criterion</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Evidence</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Decision</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Risk of bias</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Effect size only slightly smaller for 6 RCTs at low or medium risk of bias, and the 95% CI did not include increase in length of stay.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Imprecision<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3834 patients (&gt; OIS for &#916; 1 day but not 0.5 day). The lower bound of CI is reduction by 0.7 days for all RCTs and 0.3 days for RCTs at low or medium risk of bias.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Inconsistency</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Heterogeneity: Chi<SUP>2</SUP> = 17.32, df = 14 (P = 0.24); I<SUP>2</SUP> = 19%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious, effect size rather than direction (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Indirectness</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No trials of restrictive interventions</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Serious</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Publication bias</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Large trials, few commercially sponsored</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not serious</P>
</TD>
</TR>
</TABLE>
<P>
<SUP>1</SUP>Imprecision, OIS is 2014 patients for &#916; 1 day and 7640 patients for &#916; 0.5 day, standard deviation 7.6 (highest of the 3 studies contributing &gt; 20% of weight), &#945; 0.05, &#946; 0.2, dropout 10%.</P>
<P>CI: confidence interval<BR/>OIS: optimal information size<BR/>RCT: randomised controlled trial<BR/>
</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2017-01-17 02:27:30 -0500" MODIFIED_BY="Petrer Davey" NO="3">
<TITLE MODIFIED="2015-12-05 00:41:31 -0500" MODIFIED_BY="[Empty name]">Details of power calculations for RCTs</TITLE>
<APPENDIX_BODY MODIFIED="2017-01-17 02:27:30 -0500" MODIFIED_BY="Petrer Davey">
<P>
<LINK REF="STD-Annane-2013" TYPE="STUDY">Annane 2013</LINK>
</P>
<P>Based on a previous study, the authors estimated that on day 5, &#8764;85% of control patients would be on antibiotics. They thus calculated that 57 patients in each arm would be needed to detect in a two-sided test with an 80% probability and a 0.05 type I error, a 25% absolute reduction in the proportion of antibiotic-treated patients on day 5. They also estimated that 20% of patients would eventually be withdrawn from the study after showing indisputable infection. One hundred and forty patients in total (70 in each arm) would thus be needed.</P>
<P>
<LINK REF="STD-Bouadma-2010" TYPE="STUDY">Bouadma 2010</LINK>
</P>
<P>Power: Assuming a mean of 12 days without antibiotics for the control group, 133 patients per study group would provide 90% power to detect a 3-day increase in number of days without antibiotics.</P>
<P>
<LINK REF="STD-Bruins-2005" TYPE="STUDY">Bruins 2005</LINK>
</P>
<P>The sample calculation was based on the difference in mortality of 6.5% as detected by <LINK REF="REF-Doern-1994" TYPE="REFERENCE">Doern 1994</LINK>. With 296 patients in each study group in each study period, the study would have power of 80.1% to yield a statistically significant result (&#945; = 0.05, two-tailed, specific proportions 0.120 vs 0.055).</P>
<P>
<LINK REF="STD-Christ_x002d_Crain-2004" TYPE="STUDY">Christ-Crain 2004</LINK>
</P>
<P>We designed the trial to enrol 105 patients with completed follow-up in each group. This number gave the study 95% power to detect a 30% reduction in antibiotic exposure. Assumptions included use of a two-tailed test, a 5% level of significance, and a standard deviation (SD) of 6 days in both groups.</P>
<P>
<LINK REF="STD-Christ_x002d_Crain-2006" TYPE="STUDY">Christ-Crain 2006</LINK>
</P>
<P>A study sample of 150 patients in each group gave the study a power of 95% to detect a 30% reduction in antibiotic exposure from 10 to 7 days per patient assuming a two-tailed test, a 1% level of significance, and a SD of 6 days in both groups. This sample size gave the study a power of 74% to detect a 10% increase in the combined treatment failure and complication rate (from 10% to 20%), using the procalcitonin algorithm with a one-sided value of 0.05.</P>
<P>
<LINK REF="STD-Dranitsaris-2001" TYPE="STUDY">Dranitsaris 2001</LINK>
</P>
<P>This study was designed to compare the two cefotaxime groups with the hypothesis that a higher proportion of cefotaxime orders would be within hospital guidelines in the intervention group. Inappropriate antibiotic prescribing has been shown to be as high as 40% (17). By assuming an alpha of 5% (two-tailed), power of 80%, probability of appropriate prescribing with and without the intervention at 75% and 60% (absolute difference = 15%), respectively, the case sample size for the uncorrected Chi<SUP>2</SUP> test in this randomised study was 300, which was then increased by 10% to account for patient dropouts.</P>
<P>
<LINK REF="STD-Esposito-2011" TYPE="STUDY">Esposito 2011</LINK>
</P>
<P>Pre-study power calculations (with 90% power) showed that 76 patients in each group were necessary to detect a 15% lower antibiotic use, considering that 100% of children hospitalised for community-acquired pneumonia were treated with antibiotics and assuming a two-tailed test and a 5% level of significance. Since we planned to analyse the data in subgroups of mild and severe community-acquired pneumonia, we doubled the number of patients per group (n = 152). We thus decided to enrol 160 patients in each group to allow for a 5% dropout participant.</P>
<P>
<LINK REF="STD-Fine-2003" TYPE="STUDY">Fine 2003</LINK>
</P>
<P>This study was designed with 80% power to detect a 1-day decrease in length of stay from an assumed baseline of 7.2 days. The sample size was adjusted for the clustering on physician group assuming an average of 3.5 patients per group and an intraclass correlation coefficient of 0.1.</P>
<P>
<LINK REF="STD-Franz-2004" TYPE="STUDY">Franz 2004</LINK>
</P>
<P>The sample size calculation was based on the following assumptions: a significance level .05, a power .80, a proportion of initially missed infections of 4% in the interleukin-8 group and 9% in the standard group, and an equivalence limit of 3%. On the basis of these assumptions, a sample size of 207 patients with infection in each group was required to demonstrate 1-sided equivalence of the proportions of initially missed infections. Assuming a rate of bacterial infection of 18% in the study population, a total of 1150 patients needed to be enrolled into the study.</P>
<P>
<LINK REF="STD-Gulmezoglu-2007" TYPE="STUDY">Gulmezoglu 2007</LINK>
</P>
<P>We calculated the power using standard formulae for comparison of proportions in a completely randomised design and estimated that with 40 hospitals, we would have 90% power to detect a decrease or an increase in a practice equal to the SD between hospitals, in a one-sided significance test at 5% level of significance. For example, if the SD of use of episiotomy is 20%, we would be able to detect a decrease in the end-of-study rate of use of episiotomy from 70% to 50%. We used a one-sided significance test because we believed the intervention could only improve the use of evidence-based practices.</P>
<P>
<LINK REF="STD-Jensen-2011" TYPE="STUDY">Jensen 2011</LINK>
</P>
<P>The final (adjusted) sample size of 1200 patients was based on an estimated mortality in the standard-of-care-only group of 31.0% and a proposed absolute risk reduction of 7.5%. Detailed sample size considerations are available in the supplemental data (see Supplemental Digital Content 2, <A HREF="http://links.lww.com/CCM/A257">links.lww.com/CCM/A257</A>).</P>
<P>
<LINK REF="STD-Kerremans-2008" TYPE="STUDY">Kerremans 2008</LINK>
</P>
<P>It was calculated that 1500 patients were needed to demonstrate a 6% absolute reduction in mortality (power of 80% and a two-sided alpha of 0.05) from 25% in the control group to 18% in the rapid group (Sample Power, SPSS, Chicago, USA).</P>
<P>
<LINK REF="STD-Kristoffersen-2009" TYPE="STUDY">Kristoffersen 2009</LINK>
</P>
<P>Pre-study power calculations (with 90% power) showed that 107 patients in each group were necessary to detect a 20% reduction in antibiotic use (from 10 to 8 days), assuming a two-tailed test and a 5% level of significance.</P>
<P>
<LINK REF="STD-Kritchevsky-2008" TYPE="STUDY">Kritchevsky 2008</LINK>
</P>
<P>A priori power calculations determined that 40 hospitals sampling 100 cases per measurement period would give 80% power to detect a 15% difference in the pre&#8211;post change between groups in the timing of prophylaxis based on an intraclass correlation coefficient of 0.15, estimated from an earlier study of intensive care unit process improvement (0.05, 2-tailed test).</P>
<P>
<LINK REF="STD-Lacroix-2014" TYPE="STUDY">Lacroix 2014</LINK>
</P>
<P>Power calculation suggested that 97 patients should be enrolled in each group to give 80% power at the 5% level of significance to detect a 20% difference in antibiotic prescription rate. Taking into account the possibility for lost to follow-up patients or missing or incomplete results, we considered including 140 patients in each group.</P>
<P>
<LINK REF="STD-Layios-2012" TYPE="STUDY">Layios 2012</LINK>
</P>
<P>Assuming a mean stay of 7 days with 50% antibiotic exposure, a study sample of at least 250 patients in each group was deemed necessary to detect a 20% reduction in antibiotic consumption with 95% power at the 5% significance level.</P>
<P>
<LINK REF="STD-Lesprit-2013" TYPE="STUDY">Lesprit 2013</LINK>
</P>
<P>We hypothesized that the intervention might result in a 20% reduction of the duration of hospitalisation. The sample size was estimated based on the results of previous observations performed in our hospital showing that the mean length of hospital stay for patients treated with one of the targeted antibiotics was 15 ± 7 days. To detect a 20% reduction in the length of hospital stay in the intervention group with a type I error of 5% and a type II error of 80%, it was necessary to enrol a total of 506 patients (253 patients in each group).</P>
<P>
<LINK REF="STD-Long-2014" TYPE="STUDY">Long 2014</LINK>
</P>
<P>"Assuming 90% of the patients in the control group would use antibiotics, and anticipating a 15% decrease in antibiotic usage in the procalcitonin (PCT) group, a sample size of 158 patients (79 patients per group) was necessary to detect a significant difference in antibiotic prescription rate between the groups with 80% power and an &#945; error of 0.05. To account for possible loss of patients to follow-up, we planned to enrol 180 patients." One hundred and eighty eligible patients were randomised to intervention (n = 90) or control (n = 90).</P>
<P>
<LINK REF="STD-Masia-2008" TYPE="STUDY">Masia 2008</LINK>
</P>
<P>We hypothesised a difference of at least 15% in defined daily doses of the targeted antibiotics between intervention and control groups based on the results of previous reports. One hundred and forty-four patients were required in each group to reach 80% power, alpha 0.05, and, within awaited group, standard deviation of 5 days.</P>
<P>
<LINK REF="STD-Nobre-2008" TYPE="STUDY">Nobre 2008</LINK>
</P>
<P>The trial was designed to enrol at least 66 patients to obtain a power of 90% to detect a 33% (4-day) difference in the duration of antibiotic therapy for the initial infection between the two groups based on an estimated baseline duration of 12 days.</P>
<P>
<LINK REF="STD-Oliveira-2013" TYPE="STUDY">Oliveira 2013</LINK>
</P>
<P>Sample size calculation was based on data from a previous study, in which the mean duration of antibiotic therapy for the index infection was 8.6 ± 5.0 days among patients treated according to a PCT-guided protocol, as compared with 10.7 (± 4.0) days in the control group (V. Nobre, unpublished observation, 2008). We thus hypothesised that the duration of the antibiotic therapy in patients treated with a PCT-guided protocol would be at least 25% shorter than the duration observed in patients treated according to a protocol based on the serum C-reactive protein levels. We found that 58 patients per group (a total of 116 individuals) would be necessary to demonstrate this difference, with a power of 80% and an alpha error of 5%.</P>
<P>
<LINK REF="STD-Oosterheert-2005" TYPE="STUDY">Oosterheert 2005</LINK>
</P>
<P>In the control group, all patients were expected to receive a complete course of antibiotic treatment. On the basis of an expected detection rate of 20% for atypical and viral pathogens in the intervention group and an estimate of the number of possible dropouts, 100 patients would be required to demonstrate a reduction in the use of antibiotic treatment from 100% to 80%.</P>
<P>
<LINK REF="STD-Paul-2006" TYPE="STUDY">Paul 2006</LINK>
</P>
<P>The primary outcome measure was % inappropriate treatment, which could only be assessed in patients with microbiologically documented infections. The planned sample of 1500 patients in 15 wards had a power of greater than 99% to detect a 15% reduction in inappropriate antibiotic treatment (from 35% to 20%), for a two-tailed test, assuming cluster randomisation of wards stratified within three hospitals by a two-way analysis of variance and a between-ward variance of 0.0005. We chose a sample size that would allow us to detect a difference even if two wards defaulted. The authors say that "Owing to the grant time limits the trial was stopped before attaining the planned sample size"; they recruited 570 patients for the primary outcome measure instead of the planned 1500.</P>
<P>
<LINK REF="STD-Schuetz-2009" TYPE="STUDY">Schuetz 2009</LINK>
</P>
<P>To define non-inferiority with regard to the primary combined endpoint, the planning committee agreed on a 7.5% absolute difference as the clinically tolerable upper limit (i.e. at worst the risk of an overall adverse outcome in the PCT group was increased by 7.5%). Based on this non-inferiority boundary, a minimal sample size of 1002 patients was determined, allowing for an overall adverse outcome rate in the control group of at most 20% and aiming for a power of 90%. Instead of a fixed sample size, we predefined a fixed recruitment period of 18 months with the goal to randomise all eligible patients from the 6 participating hospitals during that period and an extension if fewer than 1002 patients had been recruited. This prospective rule allows for the possibility of a higher number of patients and thus better power for subgroup analyses, while maintaining the integrity of the trial.</P>
<P>
<LINK REF="STD-Senn-2004" TYPE="STUDY">Senn 2004</LINK>
</P>
<P>The sample size was estimated according to the Freedman method of sample size estimation under the proportional-hazards model, on the basis of pre-study observation. One hundred and thirty-five patients were required in each group to reach 80% power of demonstrating a 40% increase in the hazard ratio (a difference that would correspond approximately to a 25% reduction in the expected number of antibiotic-days until modification). For practical reasons, study duration was determined before the beginning of prospective data collection: we chose a five-month period, which was the estimated time necessary to achieve the calculated sample size. However, the observed effect (14% reduction) was lower than predicted, so the trial was underpowered.</P>
<P>
<LINK REF="STD-Shehabi-2014" TYPE="STUDY">Shehabi 2014</LINK>
</P>
<P>Sample size calculations were derived from the findings of Schuetz in which patients with lower respiratory tract infections treated with a PCT-based algorithm showed a 35% (29% to 40%) reduction in antibiotic exposure. Assuming a median baseline exposure level of 9 days and a standard deviation of 6 days, with 165 patients per group this study had greater than 90% power to detect a clinically relevant reduction in duration of antibiotic usage of 25% (9.0 versus 6.7 days). As duration of antibiotic usage is unlikely to follow a normal distribution, in accordance with Lehmann this figure was inflated by 15%. To further account for potential dropout or loss to follow-up (anticipated to be less than 5%), a total of 400 participants were recruited.</P>
<P>
<LINK REF="STD-Singh-2000" TYPE="STUDY">Singh 2000</LINK>
</P>
<P>Assuming that the patients in the experimental therapy group would have 10% worse outcome than patients in the standard therapy arm, a sample size of 200 patients (100 in each arm) would detect a difference at 0.05 and power 0.5. Assuming a 20% incidence of development of resistance in the standard therapy group and 5% in the experimental therapy group, a sample size of 176 patients (88 in each group) would be needed for significance at 0.05 and power 0.8.</P>
<P>NB: The study was terminated prematurely because providers caring for patients in the control group were influenced by the favourable results in the intervention group.</P>
<P>
<LINK REF="STD-Stolz-2007" TYPE="STUDY">Stolz 2007</LINK>
</P>
<P>The trial was designed to demonstrate the persistent superiority of procalcitonin guidance in decreasing antibiotic use up to six months after the index exacerbation. The sample size was calculated from the following assumptions: a 75% use of antibiotics to treat the index exacerbation and an expected absolute reduction of this frequency from 75% to 45% with procalcitonin guidance. Considering an exacerbation rate of 70% within 6 months and 75% antibiotic use in the following exacerbations, a sample size of 186 patients (93 patients per group) was necessary to detect a significant difference in antibiotic use between both groups with a power of 85% and an error of 0.05. Considering a 20% dropout rate after assignment to the study, 223 inclusions were planned.</P>
<P>
<LINK REF="STD-Stolz-2009" TYPE="STUDY">Stolz 2009</LINK>
</P>
<P>Considering 13 antibiotic-free days in the control group and 18 antibiotic-free days in the procalcitonin group, a sample size of 84 patients (42 per group) was necessary to detect a significant difference in antibiotic-free days alive between both groups with a power of 90% and an error of 0.05 using a two-tailed test. Assuming 8% lost to follow-up, we planned the inclusion of 100 participants.</P>
<P>
<LINK REF="STD-Yealy-2005" TYPE="STUDY">Yealy 2005</LINK>
</P>
<P>The primary outcome was site of treatment rather than the antibiotic process measures. "We estimated that we would need 96 eligible patients per hospital (3072 in total) to achieve 80% power to detect a 12% difference across the intervention groups for the site-of-treatment decision among low-risk patients."</P>
<P>"For the site-of-treatment decision, this study achieved greater than 80% power to detect differences of 10% between high-intensity and moderate-intensity groups and differences of 12% between high-intensity and low-intensity groups according to separate 1-tailed tests in which the level was 0.025."</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2017-01-15 08:35:23 -0500" MODIFIED_BY="Petrer Davey" NO="4">
<TITLE MODIFIED="2016-11-30 01:35:51 -0500" MODIFIED_BY="Petrer Davey">Contribution of 49 RCTs to meta-analyses and to meta-regression</TITLE>
<APPENDIX_BODY MODIFIED="2017-01-07 02:27:32 -0500" MODIFIED_BY="[Empty name]">
<TABLE COLS="8" ROWS="51">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Study</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>MA</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>MR</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>
</P>
</TH>
</TR>
<TR>
<TD>
<P>Annane 2013</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Bailey 1997</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Bouza 2004</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Bouza 2007</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Burton 1991</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Camins 2009</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Christ-Crain 2004</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Christ-Crain 2006</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Danaher 2009</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Ding 2013</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Dranitsaris 2001</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Esposito 2011</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Fine 2003</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Franz 2004</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Fraser 1997</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Gulmezoglu 2007</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Gums 1999</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Hochreiter 2009</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Kerremans 2008</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Kristofferson 2009</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Kritchevsky 2008</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Lacroix 2014</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Layios 2012</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Liu 2013</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Long 2014</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Maravic-Stojkovic 2011</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Masia 2008</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Micek 2004</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Oliveira 2013</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Paul 2006</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Poehling 2006</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Qu 2012</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Schnoor 2010</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Schouten 2007</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Schroeder 2009</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Schuetz 2009</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Senn 2004</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Shen 2011</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Shojania 1998</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Singh 2000</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Solomon 2001</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Stocker 2010</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Stolz 2007</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Stolz 2009</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Strom 2010</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Trehnholme 1989</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Walker 1998</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Wyatt 1998</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Yealy 2005</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Totals</P>
</TD>
<TD>
<P>49</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD>
<P>14</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>28</P>
</TD>
<TD>
<P>15</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey" NO="5">
<TITLE MODIFIED="2017-01-07 02:40:19 -0500" MODIFIED_BY="[Empty name]">Contribution of 109 ITS studies to meta-regression of prescribing outcomes for intervention effect (n = 107) or removal (n = 5, 2 studies only had data about intervention removal)</TITLE>
<APPENDIX_BODY MODIFIED="2017-01-31 11:40:34 -0500" MODIFIED_BY="Petrer Davey">
<TABLE COLS="6" ROWS="110">
<TR>
<TH>
<P/>
</TH>
<TH VALIGN="BOTTOM">
<P>Intervention effect</P>
</TH>
<TH VALIGN="BOTTOM">
<P>Intervention removal <LINK REF="TBL-07" TYPE="TABLE">Table 7</LINK>
</P>
</TH>
<TH VALIGN="BOTTOM">
<P>
<LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>
</P>
</TH>
<TH VALIGN="BOTTOM">
<P>
<LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>
</P>
</TH>
<TH VALIGN="BOTTOM">
<P>
<LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>
</P>
</TH>
</TR>
<TR>
<TD>
<P>TOTALS</P>
</TD>
<TD>
<P>107</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>91</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD>
<P>43</P>
</TD>
</TR>
<TR>
<TH COLSPAN="6" VALIGN="BOTTOM">
<P>Study</P>
</TH>
</TR>
<TR>
<TD>
<P>Abramowitz 1982</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Adachi 1997</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Akenroye 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Aldeyab 2012</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Ananda Rajah 2010</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Ansari 2003</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Avorn 1988</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Bantar 2006</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Barlow 2007</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Bassetti 2009</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Belliveau 1996</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Benson 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Berild 2002</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Borde 2014a</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Borde 2015a</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Borde 2015b</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Bradley 1999</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Buising 2008a</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Buising 2008b</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Bunz 1990</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Buyle 2010</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Chan 2011</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Chan 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Chandy 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Cheng 2009</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Cook 2011</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Cook 2011a</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Cortoos 2011</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Dancer 2013</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Dull 2008</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Elligsen 2012a</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Everitt 1990</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Fitzpatrick 2008</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Fowler 2007</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Fukuda 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Grohs 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Gupta 1989</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Hadi 2008</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Halm 2004</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Hess 1990</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Hitti 2012</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Huber 1982</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Hulgan 2004</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Inaraja 1986</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Jobson 2015</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Jump 2012</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Kallen 2009</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Kim 2008</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Knudsen 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Kumana 2001</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Lafuarie 2012</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Lautenbach 2003</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Lee 1995</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Lee 2007</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Lee 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Liebowitz 2008</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Magedanz 2012</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Marwick 2013</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>May 2000</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>McElnay 1995</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>McGowan 1976</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>McNulty 1997</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Mercer 1999</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Meyer 2007</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Meyer 2009</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Meyer 2010</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Mittal 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Mol 2005</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Newland 2012</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Parikh 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Patel 1989</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Perez 2003, Intervention 2</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Peto 2008</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Petrikkos 2007</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Po 2012, Intervention 1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Popovski 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Price 2010</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Richards 2003</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Ross 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Saizy-Callaert 2003</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Salama 1996</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Schwann 2011</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Schwartz 2007</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Sirinavin 1998</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Skaer 1993</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Standiford 2012</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Stevenson 1988</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Sun 2011</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Suwangool 1991</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Talpaert 2011</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Tangden 2011</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Toltzis 1998</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Valiquette 2009</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>van Kasteren 2005</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Volpe 2012</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Wang 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Wax 2007</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Weinberg 2001</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Weiner 2009</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Wenisch 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Willemsen 2010</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Wilson 1991</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Woodward 1987</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Yeo 2012</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Yong 2010</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Yoon 2014</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Young 1985</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2017-01-15 08:34:43 -0500" MODIFIED_BY="Petrer Davey" NO="6">
<TITLE MODIFIED="2017-01-07 02:48:52 -0500" MODIFIED_BY="[Empty name]">RCTs and ITS studies not included in any evidence synthesis</TITLE>
<APPENDIX_BODY MODIFIED="2017-01-07 03:02:49 -0500" MODIFIED_BY="[Empty name]">
<P>Reasons for exclusion of 9 RCTs from prescribing meta-analysis. Note that these studies had no valid clinical outcome data and so were not included in any meta-analysis:</P>
<TABLE COLS="3" ROWS="3">
<TR>
<TH VALIGN="BOTTOM">
<P>Reason</P>
</TH>
<TH VALIGN="BOTTOM">
<P>Number</P>
</TH>
<TH VALIGN="BOTTOM">
<P>Studies</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Prescribing outcome continuous variable with no standard deviation</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Lesprit-2013" TYPE="STUDY">Lesprit 2013</LINK>; <LINK REF="STD-Nobre-2008" TYPE="STUDY">Nobre 2008</LINK>; <LINK REF="STD-Oosterheert-2005" TYPE="STUDY">Oosterheert 2005</LINK>; <LINK REF="STD-Palmay-2014" TYPE="STUDY">Palmay 2014</LINK>; <LINK REF="STD-Shehabi-2014" TYPE="STUDY">Shehabi 2014</LINK>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Insufficient detail to quantify impact on prescribing outcomes used in the meta-analyses</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bouadma-2010" TYPE="STUDY">Bouadma 2010</LINK>; <LINK REF="STD-Farinas-2012" TYPE="STUDY">Farinas 2012</LINK>; <LINK REF="STD-Jensen-2011" TYPE="STUDY">Jensen 2011</LINK>; <LINK REF="STD-Kerremans-2009" TYPE="STUDY">Kerremans 2009</LINK>
</P>
</TD>
</TR>
</TABLE>
<P>Reasons for exclusion of 28 ITS studies from meta-regression:</P>
<P>16 ITS studies did not include time series data about prescribing outcomes: <LINK REF="STD-Aldeyab-2014" TYPE="STUDY">Aldeyab 2014</LINK>; <LINK REF="STD-Calil-2001" TYPE="STUDY">Calil 2001</LINK>; <LINK REF="STD-Carling-2003" TYPE="STUDY">Carling 2003</LINK>; <LINK REF="STD-Charbonneau-2006" TYPE="STUDY">Charbonneau 2006</LINK>; <LINK REF="STD-Climo-1998" TYPE="STUDY">Climo 1998</LINK>; <LINK REF="STD-de-Champs-1994" TYPE="STUDY">de Champs 1994</LINK>; <LINK REF="STD-Dempsey--1995" TYPE="STUDY">Dempsey 1995</LINK>; <LINK REF="STD-Dua-2014" TYPE="STUDY">Dua 2014</LINK>; <LINK REF="STD-Gerding-1985" TYPE="STUDY">Gerding 1985</LINK>; <LINK REF="STD-Khan-2003" TYPE="STUDY">Khan 2003</LINK>; <LINK REF="STD-Landman-1999" TYPE="STUDY">Landman 1999</LINK>; <LINK REF="STD-Lawes-2012" TYPE="STUDY">Lawes 2012</LINK>; <LINK REF="STD-Leverstein_x002d_van-Hall-2001" TYPE="STUDY">Leverstein-van Hall 2001</LINK>; <LINK REF="STD-Nuila-2008" TYPE="STUDY">Nuila 2008</LINK>; <LINK REF="STD-Pear-1994" TYPE="STUDY">Pear 1994</LINK>; <LINK REF="STD-Toltzis-2014" TYPE="STUDY">Toltzis 2014</LINK>. Note that <LINK REF="STD-Bell-2014" TYPE="STUDY">Bell 2014</LINK> did not include data about prescribing outcomes but did include valid clinical outcome data (<LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>).</P>
<P>13 ITS studies included time series data about prescribing outcomes but were excluded from meta-regression for the following reasons:</P>
<TABLE COLS="2" ROWS="14">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Reason</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Borde-2014b" TYPE="STUDY">Borde 2014b</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Only 3 postintervention points and compound outcome (choice and dose) not comparable with other studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Goldstein-2009" TYPE="STUDY">Goldstein 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Intervention was substitution of ertapenem for ampicillin-sulbactam, but there are no ampicillin-sulbactam data.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Madaras_x002d_Kelly-2006" TYPE="STUDY">Madaras-Kelly 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Effect size reported for segmented regression analysis but no variance.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-McLaughlin-2005" TYPE="STUDY">McLaughlin 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Large, unjustified gap between pre- and postintervention data</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Meyer-1993" TYPE="STUDY">Meyer 1993</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Restriction of cephalosporins was in place throughout the study period. The paper reports an outbreak of cephalosporin-resistant <I>Klebsiella pneumoniae.</I> Following the outbreak "approvals were reduced by 80%", but unclear whether this was because of change in restriction or reduction in requests.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Parienti-2011" TYPE="STUDY">Parienti 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Removal of restriction of fluoroquinolone and effect on MRSA, BUT only one data point prior to removal so cannot be re-analysed.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Ostrowsky-2014" TYPE="STUDY">Ostrowsky 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Non-standardised intervention and prescribing outcomes across multiple hospitals</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Pires-2011" TYPE="STUDY">Pires 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>"Intervention" was introduction of ertapenem into the formulary with no instruction to use less of anything else.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Pulcini-2011" TYPE="STUDY">Pulcini 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 months' pre- and postintervention data in 2 weekly time points. Data format not compatible with other studies.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Rattanaumpawan-2011" TYPE="STUDY">Rattanaumpawan 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Removal of restriction only, and there is not enough unnecessary use before de-restriction to detect change.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Richardson-2000" TYPE="STUDY">Richardson 2000</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not truly 3 pre-intervention time points, and time intervals irregular.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-U_x00e7_kay-2009" TYPE="STUDY">Uçkay 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Comparison is between the deliverer of the same intervention (infectious disease physicians with and without infection control training). No pre-intervention data</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-van-Hees-2008" TYPE="STUDY">van Hees 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Large, unjustified gap between pre- and postintervention data</P>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-07" MODIFIED="2017-01-31 11:40:15 -0500" MODIFIED_BY="Petrer Davey" NO="7">
<TITLE MODIFIED="2017-01-06 01:42:54 -0500" MODIFIED_BY="[Empty name]">Details of disagreements with other reviews</TITLE>
<APPENDIX_BODY MODIFIED="2017-01-31 11:40:15 -0500" MODIFIED_BY="Petrer Davey">
<P>A systematic review on current evidence about antimicrobial stewardship objectives reported that "guideline-adherent empirical therapy was associated with a relative risk reduction for mortality of 35% (odds ratio 0.65, 95% CI 0.54-0.80)" (<LINK REF="REF-Schuts-2016" TYPE="REFERENCE">Schuts 2016</LINK>). This analysis was based on 39 studies, of which 19 were identified by our literature search. We have reviewed the 20 studies that were not identified by our literature search. Only two of the 39 studies in this review reported an intervention, and both were identified by our literature review: one was invalid because it was an uncontrolled before-after study (<LINK REF="REF-Garcia-2007" TYPE="REFERENCE">Garcia 2007</LINK>), and one controlled before-after study (CBA) is in our 'Characteristics of included studies' table (<LINK REF="STD-Dean-2006" TYPE="STUDY">Dean 2006</LINK>). The remaining 27 studies used case control or cohort designs to compare the outcomes of patients with and without guideline-adherent antibiotic treatment, and did not include an intervention to change professional practice. The results of this review are in marked contrast to our analysis of mortality in 11 randomised controlled trials targeting antibiotic choice (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>). The aim of these interventions was to increase adherence with antibiotic guidelines for the antibiotic or route of administration. We have presented results as risk differences (Figure 8), but the odds ratio for mortality in these 11 randomised controlled trials is 0.96 (95% confidence interval (CI) 0.82 to 1.13). The most likely explanation for the discrepancy between our results and those of <LINK REF="REF-Schuts-2016" TYPE="REFERENCE">Schuts 2016</LINK> is confounding by indication. It is likely that patients with less complex or severe illness were more likely to receive guideline-adherent antibiotic treatment and that there was residual confounding after adjustment for available clinical information. The only valid intervention study in the analysis by <LINK REF="REF-Schuts-2016" TYPE="REFERENCE">Schuts 2016</LINK> was a CBA. This study compared outcomes for community-acquired pneumonia (CAP) for patients in 16 hospitals that had implemented a policy based on national guidelines with 19 control hospitals from the same state (<LINK REF="STD-Dean-2006" TYPE="STUDY">Dean 2006</LINK>). The CAP policy included several important elements in addition to antibiotic choice, such as antibiotic administration in the outpatient or emergency department before admission to hospital; administration of enoxaparin; and early ambulation of hospital inpatients. This study did not include any measures of process compliance, so it is unclear whether there is any relationship between mortality and adherence with the antibiotics recommended in the CAP policy.</P>
<P>A systematic review on the effect of antibiotic stewardship programmes on <I>Clostridium difficile</I> infection (CDI) reported that interventions were associated with a consistent, significant protective effect (pooled risk ratio for CDI 0.48, 95% CI 0.38 to 0.62) (<LINK REF="REF-Feazel-2014" TYPE="REFERENCE">Feazel 2014</LINK>). This analysis was based on 16 studies, of which 10 were identified by our literature search. We have reviewed the six studies that were not identified by our literature search. Of the 16 studies included in this systematic review, four were interrupted time series (ITS) studies that we have included in our review (<LINK REF="STD-Elligsen-2012" TYPE="STUDY">Elligsen 2012</LINK>; <LINK REF="STD-Fowler-2007" TYPE="STUDY">Fowler 2007</LINK>; <LINK REF="STD-Price-2010" TYPE="STUDY">Price 2010</LINK>; <LINK REF="STD-Talpaert-2011" TYPE="STUDY">Talpaert 2011</LINK>); the remaining 12 studies were either uncontrolled before-after or inadequate ITS studies. <LINK REF="STD-Elligsen-2012" TYPE="STUDY">Elligsen 2012</LINK> only has reliable data about prescribing outcomes; CDI data are in the form of an inadequate CBA with aggregated before and after data from one intervention and one control site. The statistical analysis in this review, <LINK REF="REF-Feazel-2014" TYPE="REFERENCE">Feazel 2014</LINK>, was not appropriate for the three ITS studies included in our review (<LINK REF="STD-Fowler-2007" TYPE="STUDY">Fowler 2007</LINK>; <LINK REF="STD-Price-2010" TYPE="STUDY">Price 2010</LINK>; <LINK REF="STD-Talpaert-2011" TYPE="STUDY">Talpaert 2011</LINK>). Calculation of risk ratios for the post- versus pre-intervention periods is an uncontrolled before-after analysis, which does not provide a reliable estimate of intervention effect. This is most clearly demonstrated by the results of one study (<LINK REF="STD-Price-2010" TYPE="STUDY">Price 2010</LINK>), in which CDIs were declining pre-intervention by -0.04 cases per 1000 occupied bed days per month (95% CI -0.08 to -0.01; P = 0.03). Postintervention CDI continued to decline at a slightly greater rate, but our estimate of the intervention effect was only a 10% reduction at 12 months (95% CI 85% reduction to 65% increase). In the systematic review (<LINK REF="REF-Feazel-2014" TYPE="REFERENCE">Feazel 2014</LINK>), the reported risk ratio in the post- versus pre-intervention phase was 0.52 (95% CI 0.44 to 0.61), but this result is mainly attributable to a steady decline in CDI over the entire study period rather than to any intervention effect.</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;Data from 169 studies included in Figures and Additional Tables:&lt;/p&gt;&lt;p&gt;158 studies included in quantitative synthesis (meta-analysis or meta-regression):&lt;/p&gt;&lt;ul&gt;&lt;li&gt;49 RCT&lt;/li&gt;&lt;li&gt;109 ITS&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;11 NRS included in tables about unintended consequences&lt;/p&gt;&lt;ul&gt;&lt;li&gt;1 case control&lt;/li&gt;&lt;li&gt;8 cohort&lt;/li&gt;&lt;li&gt;1 ITS&lt;/li&gt;&lt;li&gt;1 qualitative&lt;/li&gt;&lt;/ul&gt;" WIDTH="157">
<FLOWCHARTBOX TEXT="&lt;p&gt;267 studies included in qualitative synthesis&lt;/p&gt;&lt;p&gt;Included studies (n = 221)&lt;/p&gt;&lt;p&gt;Excluded studies (n = 46)&lt;/p&gt;" WIDTH="157">
<FLOWCHARTBOX TEXT="&lt;p&gt;780 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="144">
<FLOWCHARTBOX TEXT="&lt;p&gt;18,172 of records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;18,172 records after duplicates removed&lt;/p&gt;" WIDTH="127">
<FLOWCHARTBOX TEXT="&lt;p&gt;18,921 records identified through database searching&lt;/p&gt;" WIDTH="129"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;1063 additional records identified through other sources&lt;/p&gt;" WIDTH="164"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;17,392 records excluded&lt;/p&gt;" WIDTH="166"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;513 full-text articles excluded&lt;/p&gt;&lt;p&gt;Reasons for exclusion:&lt;/p&gt;&lt;p&gt;169 NOT ELIGIBLE: Abstracts from conferences (n = 5), Ambulatory (n = 52), Descriptive&lt;span&gt; (n = 79)&lt;/span&gt;, Interventions not directed at antibiotics (n = 23), RCTs comparing treatments (n = 5), Systematic reviews (n = 4)&lt;/p&gt;&lt;p&gt;344 NOT VALID: Case control study of intended effect (n = 33), Cohort study of intended effect (n = 32), Inadequate CBA (n = 7), Inadequate cluster NRS (n = 3), Inadequate ITS (n = 61), Uncontrolled before-after studies (n = 208)&lt;/p&gt;" WIDTH="166"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;98 studies not included in Figures or Additional Tables&lt;/p&gt;&lt;p&gt;46 excluded studies&lt;/p&gt;&lt;p&gt;52 included studies&lt;/p&gt;&lt;ul&gt;&lt;li&gt;6 CBA&lt;/li&gt;&lt;li&gt;8 NRT&lt;/li&gt;&lt;li&gt;9 RCT with insufficient detail about prescribing outcome (&lt;a link_type=&quot;APPENDIX&quot; href=&quot;04&quot; protected=&quot;true&quot;&gt;Appendix 4&lt;/a&gt;)&lt;/li&gt;&lt;li&gt;16 ITS with no prescribing outcome data (&lt;a link_type=&quot;APPENDIX&quot; href=&quot;04&quot; protected=&quot;true&quot;&gt;Appendix 4&lt;/a&gt;)&lt;/li&gt;&lt;li&gt;13 ITS with insufficient detail about prescribing outcome (&lt;a link_type=&quot;APPENDIX&quot; href=&quot;04&quot; protected=&quot;true&quot;&gt;Appendix 4&lt;/a&gt;)&lt;/li&gt;&lt;/ul&gt;"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>